Citrus Sinensis ID: 009644
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 530 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.641 | 0.409 | 0.347 | 5e-47 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.554 | 0.717 | 0.358 | 2e-46 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.532 | 0.294 | 0.349 | 3e-46 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.605 | 0.336 | 0.337 | 2e-45 | |
| Q9LZM4 | 657 | Wall-associated receptor | no | no | 0.515 | 0.415 | 0.373 | 4e-45 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.683 | 0.511 | 0.334 | 5e-45 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.507 | 0.375 | 0.393 | 6e-45 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.692 | 0.481 | 0.345 | 7e-45 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.684 | 0.533 | 0.312 | 9e-45 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.658 | 0.680 | 0.329 | 1e-44 |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 189 bits (479), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 125/360 (34%), Positives = 192/360 (53%), Gaps = 20/360 (5%)
Query: 156 KLAAVVGGVVAALLVIGFVVFVYICLMCVKRRIRRSEGESSVPSPSAELERGDISPYPGA 215
L +VG + +LL VVF+ C + K+R R +G S P + S Y
Sbjct: 403 NLGLIVGSAIGSLLA---VVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNG 459
Query: 216 --VSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR---HL 270
++ I T ++ +K ATNNF E IG G FG YKG L DG+ V +KR
Sbjct: 460 TTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKS 519
Query: 271 QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG 330
Q + F E++ +++ HRHLV L+G+C+EN++ +LIY+Y+ NG V++HLY S GLP
Sbjct: 520 QQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGS-GLP-- 576
Query: 331 KLTMRQRLSIALGAAKGLEHLHS-LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL--- 386
LT +QRL I +GAA+GL +LH+ P+ H +++N+LL+EN+ AKV+D+GL K
Sbjct: 577 SLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPE 636
Query: 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446
+ +H + + +LDPE + + SDVYSFGV L E++ R N
Sbjct: 637 LDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 696
Query: 447 L---ILQVKRSCDLGKYVDKTL-GEQTVGAATEMMELALQCV-DVSSRRPSMRQIAGELE 501
L ++ ++ L + +D++L G + + E +C+ D RPSM + LE
Sbjct: 697 LAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLE 756
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 118/329 (35%), Positives = 182/329 (55%), Gaps = 35/329 (10%)
Query: 198 PSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGL 257
PSP E G+I P NLK + ELK AT NF +++GEG FG +KG
Sbjct: 39 PSPRTE---GEILQSP---------NLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGW 86
Query: 258 LQDGSL----------VVIKRHLQTQIQ---NFLHEVKHIARVHHRHLVKLVGFCEENHQ 304
+ + SL + +K+ Q Q +L EV ++ + HRHLVKL+G+C E+
Sbjct: 87 IDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEH 146
Query: 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFR 364
+LL+Y+++P G+++NHL+ GL L+ + RL +ALGAAKGL LHS + + F+
Sbjct: 147 RLLVYEFMPRGSLENHLF-RRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFK 205
Query: 365 TSNVLLEENYTAKVSDYGLLK---LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYS 421
TSN+LL+ Y AK+SD+GL K + SH + + PE + + + SDVYS
Sbjct: 206 TSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYS 265
Query: 422 FGVFLLELISGREAHGRNHSNSDQNLILQVK----RSCDLGKYVDKTLGEQ-TVGAATEM 476
FGV LLEL+SGR A +N + ++NL+ K + + +D L +Q ++ A ++
Sbjct: 266 FGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKV 325
Query: 477 MELALQCVDVSSR-RPSMRQIAGELEGIQ 504
L+L+C+ + RP+M ++ LE IQ
Sbjct: 326 ATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 108/309 (34%), Positives = 176/309 (56%), Gaps = 27/309 (8%)
Query: 212 YPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ 271
+P P++ +++K EL AT++FS+++ IG G +G YKG L G +V +KR Q
Sbjct: 604 HPLPKPPMNMESVKGYNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQ 663
Query: 272 TQIQ---NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP 328
+Q F E++ ++R+HHR+LV L+G+C++ +Q+L+Y+Y+PNG++Q+ L P
Sbjct: 664 GSLQGQKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQP 723
Query: 329 IGKLTMRQRLSIALGAAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL- 386
L++ RL IALG+A+G+ +LH+ PP+ H + SN+LL+ KV+D+G+ KL
Sbjct: 724 ---LSLALRLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLI 780
Query: 387 ------VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGRE--AHGR 438
V H ++DPE LS + SDVYS G+ LE+++G +HGR
Sbjct: 781 ALDGGGVQRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGR 840
Query: 439 NHSNSDQNLILQVKRSCDLG---KYVDKTLGEQTVGAATEMMELALQCV-DVSSRRPSMR 494
N++ +V +CD G +D+++G+ + MELA++C D RP M
Sbjct: 841 -------NIVREVNEACDAGMMMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWML 893
Query: 495 QIAGELEGI 503
+I ELE I
Sbjct: 894 EIVRELENI 902
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 124/367 (33%), Positives = 201/367 (54%), Gaps = 46/367 (12%)
Query: 157 LAAVVGGVVAALLVIGFVVFVYICLMCVKRRIRRSEGESSVPSPSAELERGDISPYPGAV 216
+A +V G VAA + + + I L+ +++R+R G S+V A +R +
Sbjct: 561 VAGIVLGSVAAAVTLTAI----IALIIMRKRMR---GYSAV----ARRKRS-------SK 602
Query: 217 SPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ- 275
+ + + +K T EL AT+NF+ IG+G +G YKG L G++V IKR + +Q
Sbjct: 603 ASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQG 662
Query: 276 --NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT 333
FL E++ ++R+HHR+LV L+GFC+E +Q+L+Y+Y+ NG +++++ P L
Sbjct: 663 EKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEP---LD 719
Query: 334 MRQRLSIALGAAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL------ 386
RL IALG+AKG+ +LH+ PP+FH + SN+LL+ +TAKV+D+GL +L
Sbjct: 720 FAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDM 779
Query: 387 --VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGRE--AHGRNHSN 442
++ H + +LDPE L+ + SDVYS GV LLEL +G + HG+
Sbjct: 780 EGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGK---- 835
Query: 443 SDQNLILQVKRSCDLGKY---VDKTLGEQTVGAATEMMELALQCV-DVSSRRPSMRQIAG 498
N++ ++ + + G VDK + + LAL+C + + RPSM ++
Sbjct: 836 ---NIVREINIAYESGSILSTVDKRMSSVPDECLEKFATLALRCCREETDARPSMAEVVR 892
Query: 499 ELEGIQE 505
ELE I E
Sbjct: 893 ELEIIWE 899
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (463), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 109/292 (37%), Positives = 169/292 (57%), Gaps = 19/292 (6%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ---NFLHEVKHIARV 287
E+ ATNNFS+ N+IG G FG +K +L+DG++ IKR + L+EV+ + +V
Sbjct: 355 EITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEVRILCQV 414
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
+HR LV+L+G C + LLIY++IPNG + HL+ S LT R+RL IA A+G
Sbjct: 415 NHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWKPLTWRRRLQIAYQTAEG 474
Query: 348 LEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----- 401
L +LHS PP++H ++SN+LL+E AKVSD+GL +LV + A + S +
Sbjct: 475 LAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNESHIFTGAQGT 534
Query: 402 --FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD--- 456
+LDPE + + SDVYSFGV LLE+++ ++A D NL++ + + D
Sbjct: 535 LGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLVMYINKMMDQER 594
Query: 457 LGKYVD----KTLGEQTVGAATEMMELALQCVDVSSR-RPSMRQIAGELEGI 503
L + +D KT + + ++ LA C++ + RPSM+++A E+E I
Sbjct: 595 LTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVADEIEYI 646
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 136/407 (33%), Positives = 207/407 (50%), Gaps = 45/407 (11%)
Query: 139 PTL-TPLQQDDVKRPRKQKLAAVVGGVVAALLVIG--FVVFVYICLMCVKRRIRRSEGES 195
PTL PL + AVVG VA LV+ F +FV+ CL ++R+ G
Sbjct: 259 PTLRPPLDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVW-CLRKREKRLSAVSGGD 317
Query: 196 SVPSPSAELERGDISPYP-GAVSPIDTQ--------------NLKQL-TILELKHATNNF 239
PSP + R D + + + +P+ N K L + EL ATN F
Sbjct: 318 VTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGF 377
Query: 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLV 293
S+ N++GEG FG YKG+L DG +V +K Q +I + F EV+ ++R+HHRHLV
Sbjct: 378 SQENLLGEGGFGCVYKGILPDGRVVAVK---QLKIGGGQGDREFKAEVETLSRIHHRHLV 434
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+VG C ++LLIYDY+ N ++ HL+ + + L R+ IA GAA+GL +LH
Sbjct: 435 SIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV----LDWATRVKIAAGAARGLAYLHE 490
Query: 354 LV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--LDPELNLS 410
P + H ++SN+LLE+N+ A+VSD+GL +L + +T + F + PE S
Sbjct: 491 DCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASS 550
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK-------RSCDLGKYVDK 463
+ SDV+SFGV LLELI+GR+ + D++L+ + + + D
Sbjct: 551 GKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADP 610
Query: 464 TLGEQTVGAAT-EMMELALQCV-DVSSRRPSMRQIAGELEGIQEREI 508
LG V + M+E A CV ++++RP M QI E + ++
Sbjct: 611 KLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDL 657
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 6e-45, Method: Compositional matrix adjust.
Identities = 113/287 (39%), Positives = 168/287 (58%), Gaps = 18/287 (6%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQN---FLHEVKHIARV 287
EL ATN FSE N++G+G FG +KG+L++G V +K+ + Q F EV I+RV
Sbjct: 346 ELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGIISRV 405
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
HHRHLV LVG+C + Q+LL+Y+++PN ++ HL+ +G P + RL IA+G+AKG
Sbjct: 406 HHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLH-GKGRPT--MEWSSRLKIAVGSAKG 462
Query: 348 LEHLH-SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--LD 404
L +LH + P + H + SN+L++ + AKV+D+GL K+ + ++ ST + F L
Sbjct: 463 LSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLA 522
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK----RSCDLGKY 460
PE S + SDV+SFGV LLELI+GR N+ ++D +L+ + + +LG +
Sbjct: 523 PEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELGNF 582
Query: 461 ---VDKTL-GEQTVGAATEMMELALQCV-DVSSRRPSMRQIAGELEG 502
VDK L E M+ A CV + RRP M Q+A LEG
Sbjct: 583 EVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEG 629
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 144/417 (34%), Positives = 211/417 (50%), Gaps = 50/417 (11%)
Query: 133 GGDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRRIRR-- 190
G DN P P D +AAVVG + LV+ ++ V +C C+K+R +R
Sbjct: 304 GPDNPSPN-NPTPVTDNSSSSGISIAAVVGVSIGVALVLLTLIGVVVC--CLKKRKKRLS 360
Query: 191 ---------SEGESSVP-SPSAELERGDISPYPGAVSPIDT-----------QNLKQLTI 229
+ ESS P S SA L+ +P G S T Q+ + +
Sbjct: 361 TIGGGYVMPTPMESSSPRSDSALLKTQSSAPLVGNRSSNRTYLSQSEPGGFGQSRELFSY 420
Query: 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI------QNFLHEVKH 283
EL ATN FS+ N++GEG FG YKG+L D +V +K Q +I + F EV
Sbjct: 421 EELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVK---QLKIGGGQGDREFKAEVDT 477
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALG 343
I+RVHHR+L+ +VG+C +++LLIYDY+PN N+ HL+ + G P L R+ IA G
Sbjct: 478 ISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLH-AAGTP--GLDWATRVKIAAG 534
Query: 344 AAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF 402
AA+GL +LH P + H ++SN+LLE N+ A VSD+GL KL + +T + F
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTRVMGTF 594
Query: 403 --LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK-------R 453
+ PE S + SDV+SFGV LLELI+GR+ + D++L+ +
Sbjct: 595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATE 654
Query: 454 SCDLGKYVDKTLGEQTVGAAT-EMMELALQCVDVS-SRRPSMRQIAGELEGIQEREI 508
+ + D LG VG M+E A C+ S ++RP M QI + + E ++
Sbjct: 655 TEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDL 711
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 9e-45, Method: Compositional matrix adjust.
Identities = 136/435 (31%), Positives = 213/435 (48%), Gaps = 72/435 (16%)
Query: 124 RNRRIASSIG-----GDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVY 178
R + IA G G+N +P+ +P K GG+VA +++G +VF+
Sbjct: 204 REKPIAKPTGPASNNGNNTLPSSSP-----------GKSEVGTGGIVAIGVIVG-LVFLS 251
Query: 179 ICLMCV---KRRIRRSEG-------------------------ESSVPSPSAELERGDIS 210
+ +M V ++R R+ G SS P P G
Sbjct: 252 LFVMGVWFTRKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRSSAP-PKMRSHSGSDY 310
Query: 211 PYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHL 270
Y + S + + + EL T+ FSE N++GEG FG YKG+L DG V +K
Sbjct: 311 MYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVK--- 367
Query: 271 QTQI------QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS 324
Q +I + F EV+ I+RVHHRHLV LVG+C +LL+YDY+PN + HL+ +
Sbjct: 368 QLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH-A 426
Query: 325 EGLPIGKLTMRQRLSIALGAAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGL 383
G P+ +T R+ +A GAA+G+ +LH P + H ++SN+LL+ ++ A V+D+GL
Sbjct: 427 PGRPV--MTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGL 484
Query: 384 LKLVT----GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN 439
K+ +H + ++ PE S S +DVYS+GV LLELI+GR+ +
Sbjct: 485 AKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTS 544
Query: 440 HSNSDQNLIL-------QVKRSCDLGKYVDKTLGEQTV-GAATEMMELALQCVDVS-SRR 490
D++L+ Q + + + VD LG+ + G M+E A CV S ++R
Sbjct: 545 QPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKR 604
Query: 491 PSMRQIAGELEGIQE 505
P M Q+ L+ ++E
Sbjct: 605 PKMSQVVRALDTLEE 619
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 128/389 (32%), Positives = 191/389 (49%), Gaps = 40/389 (10%)
Query: 129 ASSIGGDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRRI 188
AS G + PT+TP P + AVVG + G V I +C K+R
Sbjct: 95 ASPSGQEPTTPTMTPGFSLSPPSPSRLSTGAVVGISIGG----GVFVLTLIFFLCKKKRP 150
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
R D P + + + T EL ATN FSE N++GEG
Sbjct: 151 R------------------DDKALPAPIGLVLGIHQSTFTYGELARATNKFSEANLLGEG 192
Query: 249 SFGLAYKGLLQDGSLVVIKRHLQTQIQ---NFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305
FG YKG+L +G+ V +K+ Q F EV I+++HHR+LV LVG+C Q+
Sbjct: 193 GFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQR 252
Query: 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH-SLVPPLFHMHFR 364
LL+Y+++PN ++ HL+ +G P + ++ RL IA+ ++KGL +LH + P + H +
Sbjct: 253 LLVYEFVPNNTLEFHLH-GKGRPTMEWSL--RLKIAVSSSKGLSYLHENCNPKIIHRDIK 309
Query: 365 TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--LDPELNLSKNYSAGSDVYSF 422
+N+L++ + AKV+D+GL K+ ++ ST + F L PE S + SDVYSF
Sbjct: 310 AANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSF 369
Query: 423 GVFLLELISGREAHGRNHSNSDQNLI-------LQVKRSCDLGKYVDKTL-GEQTVGAAT 474
GV LLELI+GR N+ +D +L+ +Q + D L E
Sbjct: 370 GVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMA 429
Query: 475 EMMELALQCVDVSS-RRPSMRQIAGELEG 502
M+ A CV ++ RRP M Q+ LEG
Sbjct: 430 RMVACAAACVRYTARRRPRMDQVVRVLEG 458
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 530 | ||||||
| 297746255 | 521 | unnamed protein product [Vitis vinifera] | 0.967 | 0.984 | 0.614 | 1e-165 | |
| 255578858 | 518 | serine-threonine protein kinase, plant-t | 0.964 | 0.986 | 0.602 | 1e-160 | |
| 359478699 | 515 | PREDICTED: receptor-like protein kinase | 0.956 | 0.984 | 0.607 | 1e-159 | |
| 356541906 | 430 | PREDICTED: proline-rich receptor-like pr | 0.752 | 0.927 | 0.599 | 1e-124 | |
| 356547182 | 429 | PREDICTED: receptor-like protein kinase | 0.750 | 0.927 | 0.596 | 1e-122 | |
| 357453905 | 945 | Receptor-like protein kinase ANXUR2 [Med | 0.837 | 0.469 | 0.491 | 1e-112 | |
| 449452038 | 379 | PREDICTED: nodulation receptor kinase-li | 0.686 | 0.960 | 0.426 | 2e-72 | |
| 255543513 | 381 | serine/threonine protein kinase, putativ | 0.692 | 0.963 | 0.425 | 3e-72 | |
| 157101244 | 632 | receptor-like kinase [Marchantia polymor | 0.675 | 0.566 | 0.443 | 1e-71 | |
| 326518874 | 378 | predicted protein [Hordeum vulgare subsp | 0.637 | 0.894 | 0.451 | 5e-71 |
| >gi|297746255|emb|CBI16311.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 321/522 (61%), Positives = 392/522 (75%), Gaps = 9/522 (1%)
Query: 17 MYLFWWQQLPLLLLIQLLQSTSTDHKVYAEALLACKSALGTPGQSSGRIGRYPCIRQRAC 76
M L+WWQQLPLL+LIQLL+ HK+YAEALL CKS +G+P Q SGR GRYPC+RQ
Sbjct: 1 MRLYWWQQLPLLILIQLLEPNRLSHKLYAEALLTCKSTVGSPRQFSGRAGRYPCLRQWVF 60
Query: 77 LNCYEPKDPGVASLIFHRI----PEICALS---FNPNFFHSNSEFPFQEKNCKSRNRRIA 129
++ ++ KD GV SL F + P+I +++ F P + S+ Q K K+RN RI
Sbjct: 61 VDYHKLKDQGVVSL-FPKAHPPSPQIRSINLSPFAPKLYLSHKSIQSQAKLHKTRNLRIT 119
Query: 130 SSIGGDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRRIR 189
+++ GD+G+PTLT L +V +P KQ+LAA+VGG+ AALLV+ VV VYICLM VKR IR
Sbjct: 120 AAVDGDSGVPTLTTLPPTNVNKPSKQRLAAIVGGIGAALLVVIIVVLVYICLMRVKRFIR 179
Query: 190 R-SEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
R SE SSVPSP E + + S A+SP T +L+QLTI+EL+HAT NFS+ NIIGEG
Sbjct: 180 RTSETASSVPSPPVEWDGRNTSLQASALSPYGTTHLRQLTIMELEHATCNFSQNNIIGEG 239
Query: 249 SFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308
FGL YKGLL DGS+V IKR L T Q F HEVK IARV H+HLVKL+G+CEENHQQLL+
Sbjct: 240 GFGLVYKGLLLDGSIVAIKRRLHTPTQFFAHEVKRIARVQHKHLVKLIGYCEENHQQLLV 299
Query: 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368
DY+ NGNV NHLYDSEGLP+G+L + QRLSIALGAAKGLEHLHSLVP HMHFRTSNV
Sbjct: 300 NDYLQNGNVGNHLYDSEGLPMGRLEIWQRLSIALGAAKGLEHLHSLVPSFLHMHFRTSNV 359
Query: 369 LLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLE 428
L++EN+TAKVSD+GL +L+ AGS+SA+DCFLDPEL SK++S SDVYS+GVFLLE
Sbjct: 360 LVDENFTAKVSDFGLSRLLAEGARAGSSSAIDCFLDPELRSSKDFSETSDVYSYGVFLLE 419
Query: 429 LISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS 488
LISGREAHGR+ NS QNL+L + DL +VDKTLG+ T+ A EMMELAL CVD+S
Sbjct: 420 LISGREAHGRDEPNSQQNLVLHARCINDLNNFVDKTLGDHTMDAVKEMMELALACVDISV 479
Query: 489 RRPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSELFK 530
RRP+M+++ ELE IQ REIG L ++ GEEI V LGSELFK
Sbjct: 480 RRPTMKKVVEELERIQHREIGHLQAQLGEEIGVVTLGSELFK 521
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578858|ref|XP_002530283.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530181|gb|EEF32090.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1470), Expect = e-160, Method: Compositional matrix adjust.
Identities = 314/521 (60%), Positives = 390/521 (74%), Gaps = 10/521 (1%)
Query: 17 MYLFWWQQLPLLLLIQLLQSTSTDHKVYAEALLACKSALGTPGQSSGRIGRYPCIRQRAC 76
M+LFWWQQLPLL+LIQLL+ S +K+ EAL+A KS + TP S+GRIGRYPC+RQ A
Sbjct: 1 MHLFWWQQLPLLILIQLLEPNSISYKLCVEALVASKSTICTPQHSTGRIGRYPCLRQWAS 60
Query: 77 LNCYEPKDPGVASLIFHRIPEICALSFNPNFFHSN---SEFPFQEKNCKSRNRRIASSIG 133
NC + DPGV SL R + S SN S QE+ K+RNRRIA+ +G
Sbjct: 61 ANCNKLNDPGVVSLSPSRRHLLFLKSGFVKLSSSNFISSPIELQERLHKARNRRIAAEVG 120
Query: 134 GDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRRIR-RSE 192
DNG+PTLTPLQ + K+ KQK AA++ G AALLVI V VY+CLM +K+ +R RSE
Sbjct: 121 RDNGVPTLTPLQPANDKKSSKQKFAAIIAGAGAALLVIVIVALVYMCLMRIKKVLRHRSE 180
Query: 193 GESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGL 252
SS+PS ++L RG+I PY A SP + ++L+QL+I+E++HAT+NFS+ NIIGEGSFG
Sbjct: 181 TASSMPSSPSDLARGNIFPYAAAQSPFNARDLRQLSIVEVEHATHNFSQSNIIGEGSFGF 240
Query: 253 AYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312
AYKGLL DGS+V IKR L +Q+F+HEVKHIA VHH+HLV L+G+CE+ HQ+ L+YDYI
Sbjct: 241 AYKGLLLDGSIVAIKRCLHKPVQDFVHEVKHIASVHHKHLVDLIGYCEDTHQKFLVYDYI 300
Query: 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372
NGNV ++LY GLPIGKL MRQRLSIALGAAKGL++LHS+VPPL HMHFR+SNVLL +
Sbjct: 301 SNGNVGSYLY---GLPIGKLDMRQRLSIALGAAKGLQYLHSMVPPLLHMHFRSSNVLLGD 357
Query: 373 NYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
N AKVSDYGLLKL SH AG++SA+D FLDPEL+LSKN+S SDVYSFGVFLLELISG
Sbjct: 358 NIIAKVSDYGLLKLAMESHRAGTSSAIDYFLDPELSLSKNFSERSDVYSFGVFLLELISG 417
Query: 433 REAHGRNHSNSDQNLILQVKRS---CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSSR 489
EA GR S S NLI +V ++ C+L ++D+TLGE+T+ AA +MELALQC+DVS +
Sbjct: 418 HEARGRYMSISGHNLIQEVNKTSLECNLENFIDRTLGERTIQAAKPLMELALQCIDVSMK 477
Query: 490 RPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSELFK 530
RPSM +I E+E IQ REI +EF EEI +V LGSELFK
Sbjct: 478 RPSMTRIVQEIEQIQGREIRYSQAEFDEEIGSVTLGSELFK 518
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478699|ref|XP_002285143.2| PREDICTED: receptor-like protein kinase THESEUS 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1465), Expect = e-159, Method: Compositional matrix adjust.
Identities = 317/522 (60%), Positives = 387/522 (74%), Gaps = 15/522 (2%)
Query: 17 MYLFWWQQLPLLLLIQLLQSTSTDHKVYAEALLACKSALGTPGQSSGRIGRYPCIRQRAC 76
M L+WWQQLPLL+LIQLL+ HK+YAEALL CKS +G+P Q SGR GRYPC+RQ
Sbjct: 1 MRLYWWQQLPLLILIQLLEPNRLSHKLYAEALLTCKSTVGSPRQFSGRAGRYPCLRQWVF 60
Query: 77 LNCYEPKDPGVASLIFHRI----PEICALS---FNPNFFHSNSEFPFQEKNCKSRNRRIA 129
++ ++ KD GV SL F + P+I +++ F P + S+ Q K K+RN RI
Sbjct: 61 VDYHKLKDQGVVSL-FPKAHPPSPQIRSINLSPFAPKLYLSHKSIQSQAKLHKTRNLRIT 119
Query: 130 SSIGGDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRRIR 189
+++ GD+G+PTLT L +V +P KQ+LAA+VGG+ AALLV+ VV VYICLM VKR IR
Sbjct: 120 AAVDGDSGVPTLTTLPPTNVNKPSKQRLAAIVGGIGAALLVVIIVVLVYICLMRVKRFIR 179
Query: 190 R-SEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
R SE SSVPSP E + + S A+SP T +L+QLTI+EL+HAT NFS+ NIIGEG
Sbjct: 180 RTSETASSVPSPPVEWDGRNTSLQASALSPYGTTHLRQLTIMELEHATCNFSQNNIIGEG 239
Query: 249 SFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308
FGL YKGLL DGS+V IKR L T Q F HEVK IARV H+HLVKL+G+CEENHQQLL+
Sbjct: 240 GFGLVYKGLLLDGSIVAIKRRLHTPTQFFAHEVKRIARVQHKHLVKLIGYCEENHQQLLV 299
Query: 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368
DY+ NGNV NHLY GLP+G+L + QRLSIALGAAKGLEHLHSLVP HMHFRTSNV
Sbjct: 300 NDYLQNGNVGNHLY---GLPMGRLEIWQRLSIALGAAKGLEHLHSLVPSFLHMHFRTSNV 356
Query: 369 LLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLE 428
L++EN+TAKVSD+GL +L+ AGS+SA+DCFLDPEL SK++S SDVYS+GVFLLE
Sbjct: 357 LVDENFTAKVSDFGLSRLLAEGARAGSSSAIDCFLDPELRSSKDFSETSDVYSYGVFLLE 416
Query: 429 LISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS 488
LISGREAHGR+ NS QNL + DL +VDKTLG+ T+ A EMMELAL CVD+S
Sbjct: 417 LISGREAHGRDEPNSQQNLARCIN---DLNNFVDKTLGDHTMDAVKEMMELALACVDISV 473
Query: 489 RRPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSELFK 530
RRP+M+++ ELE IQ REIG L ++ GEEI V LGSELFK
Sbjct: 474 RRPTMKKVVEELERIQHREIGHLQAQLGEEIGVVTLGSELFK 515
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541906|ref|XP_003539413.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1162), Expect = e-124, Method: Compositional matrix adjust.
Identities = 242/404 (59%), Positives = 302/404 (74%), Gaps = 5/404 (1%)
Query: 128 IASSIGGDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRR 187
I + I G+N +PTLTPLQ+ V++P + AA+VG +VAAL+VI +V V ICLM VKR
Sbjct: 31 ITAKIDGNNDVPTLTPLQETQVRKPGGTRAAAIVGILVAALVVIVILVTVCICLMRVKRF 90
Query: 188 IRR-SEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIG 246
+R+ SE SS+PSP+ E+ R + + A P T N +QLTILEL+ AT NFS NII
Sbjct: 91 MRQTSEAASSMPSPTVEMGRVNNTQNVNAFPPHYTLNTRQLTILELEQATRNFSHSNIIS 150
Query: 247 EGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306
EG FG YKGLLQDGS+V IKR L Q+F+ EV IA +HH HLVKL+G+ E+++QQL
Sbjct: 151 EGGFGFVYKGLLQDGSIVAIKRRLFALTQDFVLEVNQIAHIHHTHLVKLIGYYEDSYQQL 210
Query: 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366
L+Y+Y+PNGNV +HLY GLPIG+L + +R+SIALGA+KG+EHLHSLVPPL H +FRTS
Sbjct: 211 LVYEYLPNGNVGSHLY---GLPIGRLDLWRRISIALGASKGVEHLHSLVPPLVHTNFRTS 267
Query: 367 NVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFL 426
NVLL+ENYTAKV+ YG KL T +AGS+S VDCFLDPEL+ +NYS SDV+SFGVFL
Sbjct: 268 NVLLDENYTAKVAVYGFCKLQTQVDNAGSSSHVDCFLDPELSFPQNYSEKSDVHSFGVFL 327
Query: 427 LELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDV 486
LELISG EAH ++ SN D+N++ + K S DL +VD TLGEQ A MM+LAL CVDV
Sbjct: 328 LELISGCEAHRKSLSNPDENIVFKAKNSVDLDNFVDITLGEQEKHGARRMMKLALLCVDV 387
Query: 487 SSRRPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSELFK 530
+SRRPSM QI ELE IQ REI ++S+F EEI AV LGSELF+
Sbjct: 388 TSRRPSMAQIVQELEQIQ-REIAPVYSQFNEEIGAVTLGSELFQ 430
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547182|ref|XP_003541995.1| PREDICTED: receptor-like protein kinase THESEUS 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1147), Expect = e-122, Method: Compositional matrix adjust.
Identities = 241/404 (59%), Positives = 302/404 (74%), Gaps = 6/404 (1%)
Query: 128 IASSIGGDNGIPTLTPLQQDDVKRPRKQKLAAVVGGVVAALLVIGFVVFVYICLMCVKRR 187
I + I G+N +PTLTPLQ+ V++P + AA+ G VVAAL+VI +V VYICLM VKR
Sbjct: 31 ITAKIDGNNDVPTLTPLQETQVRKPGGTRAAAIFGIVVAALVVIVILVTVYICLMRVKRF 90
Query: 188 IRR-SEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIG 246
+R+ SE SS+PSP+ E+ R + + + A SP T N +QLTILE++ AT NFS NIIG
Sbjct: 91 MRQTSEVASSMPSPTVEIGRVN-NAHVNAFSPHYTHNTRQLTILEVEQATRNFSHSNIIG 149
Query: 247 EGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306
EG FG YKGLLQDGS+V IKR L Q+F+ +VK IA +HH HLVKL+G+ E+++QQL
Sbjct: 150 EGGFGFVYKGLLQDGSIVAIKRRLFVLTQDFVLKVKQIAHIHHNHLVKLIGYYEDSYQQL 209
Query: 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366
L+Y+Y+PNGNV +HLY GLPIG+L + +R+SIA GA+KG+EHLHSLVPPL H +FRTS
Sbjct: 210 LVYEYLPNGNVGSHLY---GLPIGRLDLWRRISIASGASKGVEHLHSLVPPLIHTNFRTS 266
Query: 367 NVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFL 426
NVLL+ENYTAKVSDYG T + GS+S VDCFLDPEL+ +NY+ SDVYSFGVFL
Sbjct: 267 NVLLDENYTAKVSDYGFCNSKTQVDNVGSSSNVDCFLDPELSFPQNYTEKSDVYSFGVFL 326
Query: 427 LELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDV 486
LELI G EA ++ SN D+N++ Q K S DL K+VD TLGEQ A +M+LAL CVDV
Sbjct: 327 LELICGCEAQNKSMSNPDENIVFQAKNSVDLDKFVDITLGEQEKHGARRVMKLALLCVDV 386
Query: 487 SSRRPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSELFK 530
+SRRPSM QI ELE IQ REI ++S+F EEI AV LGSELF+
Sbjct: 387 TSRRPSMAQIVHELEQIQ-REIAPMYSQFNEEIGAVTLGSELFQ 429
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357453905|ref|XP_003597233.1| Receptor-like protein kinase ANXUR2 [Medicago truncatula] gi|355486281|gb|AES67484.1| Receptor-like protein kinase ANXUR2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-112, Method: Compositional matrix adjust.
Identities = 244/496 (49%), Positives = 311/496 (62%), Gaps = 52/496 (10%)
Query: 42 KVYAEALLACKSAL--------GTPGQSSGRIGRYPCIRQRACLNCYEPKDPGVASLIFH 93
KV+ + LA L P Q I ++PC Q CL+C + +PG
Sbjct: 286 KVFFQLFLAVSKDLLNFKGLLEAGPQQLGCDIVKHPCQMQWPCLDCSKQNEPG------- 338
Query: 94 RIPEICALSFNPNFFHSNSEFPFQEKNCKSRNRRIASSIGGDNGIPTLTPLQQDDVKRPR 153
R+ +I +N P L ++ VK+P
Sbjct: 339 ---------------------------------RVKENIDKNNDTPILA--KEAQVKKPG 363
Query: 154 KQKLAAVVGGVVAALLVIGFVVFVYICLM-CVKRRIRRSEGESSVPSPSAELERGDISPY 212
++A + GG AAL +I V + ICL C + + + S+ SSVPS + E+ R + S Y
Sbjct: 364 GGRVAVIAGGAGAALTIIVIAVIICICLRRCKRFKKQPSDSASSVPSQAVEMGRINNSQY 423
Query: 213 PGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT 272
A SP QN + LTILE++ AT F++ NIIGEG FG YKGLLQDGS V IKR L
Sbjct: 424 VNAFSPHYMQNTRLLTILEIEQATGKFNQSNIIGEGRFGFVYKGLLQDGSFVAIKRRLFA 483
Query: 273 QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKL 332
++F+ EVK IA++HH HLVKL+G+ ++++QQLL+Y+Y+PNGNV NHLYDSEGLPIGKL
Sbjct: 484 LTRDFIPEVKQIAQIHHIHLVKLIGYYDDSYQQLLVYEYLPNGNVGNHLYDSEGLPIGKL 543
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
+++R+SIALGA+KGLEHLHSLVPPL H +F T NVLL+ENYTAKVSDYG KL T
Sbjct: 544 NLQRRVSIALGASKGLEHLHSLVPPLLHTNFSTRNVLLDENYTAKVSDYGFFKLQTEIDQ 603
Query: 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK 452
AGS+S VD F DPEL+LS+NYS SDVYSFGVFLLELISG EA+ RN SN ++L+ + K
Sbjct: 604 AGSSSNVDYFHDPELSLSQNYSEESDVYSFGVFLLELISGCEAYNRNMSNPYESLVFEAK 663
Query: 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQIAGELEGIQEREIGRLH 512
S DL K++DK LGEQ A +M+LAL CVDV RRPSM I ELE IQ R+I L+
Sbjct: 664 YSSDLEKFIDKALGEQEKHGARRIMKLALLCVDVILRRPSMAHIVQELERIQ-RDIAPLY 722
Query: 513 SEFGEEIDAVKLGSEL 528
SE EEI VKLGS++
Sbjct: 723 SENNEEIGVVKLGSDV 738
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452038|ref|XP_004143767.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus] gi|449529349|ref|XP_004171662.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 279 bits (714), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 163/382 (42%), Positives = 232/382 (60%), Gaps = 18/382 (4%)
Query: 157 LAAVVGGVVAALLVIGFVVFVYICLMCVKRRIRRSEGESSVPSPSAELERGDISPYPGAV 216
LAA++GG A+ ++G ++ + L + R SE SS PS G
Sbjct: 5 LAAILGGSAGAVALVGLIIILLRFLARSRNTARTSETGSSDPSVQVGRHVG--------- 55
Query: 217 SPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQN 276
+ ++ ++ + EL ATN+FS+ N+IGEG FG YKG+LQDG V IK+ Q+
Sbjct: 56 IELTLRDARRFEMAELVLATNDFSDKNLIGEGKFGEVYKGMLQDGMFVAIKKRHGAPSQD 115
Query: 277 FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQ 336
F+ EV +++ + HR+LV L+G+C+EN+ Q LI+DYIPNG+V +H+Y +E KL +
Sbjct: 116 FVDEVHYLSSIQHRNLVTLLGYCQENNLQFLIFDYIPNGSVSSHIYGTEQRSAEKLEFKI 175
Query: 337 RLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL---LKLVTGSHHA 393
RLSIALGAAKGL HLHS+ P L H +F+TSNVL++EN+ AKV+D GL ++ S +
Sbjct: 176 RLSIALGAAKGLSHLHSMSPRLTHRNFKTSNVLVDENFIAKVADAGLHNVMRRFDVSESS 235
Query: 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV-- 451
+A + FL PE+ + +S SDVYSFGVFLLEL+SG++A SN + L+ +
Sbjct: 236 SRATADEIFLAPEVKEFRQFSEKSDVYSFGVFLLELVSGQKATDAPVSNPNYTLVDWIQN 295
Query: 452 -KRSCDLGKYVDKTLGEQ-TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508
+R D+G D LG+ T E+M+L LQCV+ SS RRP M + ELE I E+E+
Sbjct: 296 NQRKSDIGSITDPRLGKSFTEEGMGELMDLILQCVEYSSERRPVMSYVVTELERILEKEM 355
Query: 509 GRLHSEFGEEIDAVKLGSELFK 530
L + GE V LGS+LFK
Sbjct: 356 N-LTTVMGEGSPTVTLGSQLFK 376
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543513|ref|XP_002512819.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547830|gb|EEF49322.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 279 bits (713), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 164/385 (42%), Positives = 231/385 (60%), Gaps = 18/385 (4%)
Query: 155 QKLAAVVGGVVAALLVIGFVVF-VYICLMCVKRRIRRSEGESSVPSPSAELERGDISPYP 213
+ LAA++GG + ++G V+F ++ CL K R SE SS PS A P
Sbjct: 3 KTLAAILGGAAGVVALVGIVIFLIWFCLSHKKSVSRTSETGSSDPSIQA--------PGR 54
Query: 214 GAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ 273
+ + ++ + EL HAT NF + N+IG G FG YKGLL DG LV IK+
Sbjct: 55 HVGVELSLREARRFEMDELSHATKNFVDKNLIGIGKFGEVYKGLLNDGMLVAIKKRSGAS 114
Query: 274 IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT 333
Q F+ EV++++ + HR++V L+G+C+EN+ Q L+Y+YIP+G+V +HLY GKL
Sbjct: 115 SQEFVDEVRYLSPIQHRNIVTLLGYCQENNLQFLVYEYIPSGSVSSHLYGPSQFSDGKLE 174
Query: 334 MRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393
+ RLSIALGAAKGL HLHSL P L H F+T+NVL++EN+ AKV+D GL + A
Sbjct: 175 FKHRLSIALGAAKGLAHLHSLSPRLVHKDFKTANVLVDENFIAKVADAGLPNFLGRVDVA 234
Query: 394 GSTSAV---DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450
G +S V + F PE+ + +S DV+SFGVFLLEL+SGREA +S QNL+
Sbjct: 235 GPSSQVTADEIFQAPEVREFRRFSDKGDVFSFGVFLLELLSGREATESPSPDSSQNLVEW 294
Query: 451 VKRSCDLGKY---VDKTLGEQ-TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505
V+ + D + VD+ LG + T E ++L +QC++ SS RRPSM + EL+ I E
Sbjct: 295 VQNTQDYSAFSSVVDQRLGTRFTAEGMEEFIQLIIQCLEPSSERRPSMSYVVMELDRILE 354
Query: 506 REIGRLHSEFGEEIDAVKLGSELFK 530
+E+ L + GE V LGS+LFK
Sbjct: 355 KEM-TLTTVMGEGTPTVTLGSQLFK 378
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|157101244|dbj|BAF79953.1| receptor-like kinase [Marchantia polymorpha] | Back alignment and taxonomy information |
|---|
Score = 277 bits (708), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 166/374 (44%), Positives = 226/374 (60%), Gaps = 16/374 (4%)
Query: 171 IGFVVFVYICLMCVKRRIR-RSEGESSVPSPSAELERGDISPYPGAVSP-IDTQNLKQLT 228
I +V V CL+ K S+ SS PS + +G P +V+P DT + +
Sbjct: 259 IATIVLVSCCLLRAKSWPSATSDTGSSDPSAQVDWAKGPEGPIARSVAPESDTSKARYFS 318
Query: 229 ILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH 288
+ EL+HAT FS N IG G FG YKGLL+DG++V +K Q+F V+ ++R+
Sbjct: 319 LEELEHATKKFSANNKIGRGGFGEVYKGLLEDGTIVAVKGRQGAATQDFQAAVEFLSRMR 378
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
H+HLV ++GFC+EN QQ+++YDY+PNG+V HLYD G P+GKL RQRL+IALGAAKGL
Sbjct: 379 HKHLVNVLGFCQENDQQIVVYDYLPNGSVCGHLYDDNGAPVGKLDFRQRLAIALGAAKGL 438
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSH-------HAGSTSAVD 400
E+LH+ P L H F+TSNVLL+ AKV+D+GL L L G H + +
Sbjct: 439 EYLHTTTPKLIHRDFKTSNVLLDAYLVAKVTDFGLSLLLAEGPHPQEGPVLSSLNGDGTA 498
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI---LQVKRSCDL 457
FLDPE ++ + SDVYSFGVFLLEL+SGREA ++ S+ +L+ + ++ DL
Sbjct: 499 GFLDPEYYTTQRLTEKSDVYSFGVFLLELVSGREAISQDRPRSEWSLVEWGRSLLQAGDL 558
Query: 458 GKYVDKTLGEQTVGAAT-EMMELALQCV-DVSSRRPSMRQIAGELEGIQEREIGRLHSEF 515
G VD+TLG + A +M+E+ CV + RRPSM ++ ELE E+E G L S
Sbjct: 559 GALVDRTLGSSFMEVAMRKMVEVGFHCVEETGDRRPSMAEVVKELEEALEKERG-LTSGG 617
Query: 516 GEEIDAVKLGSELF 529
GE V LGSELF
Sbjct: 618 GEGATTVTLGSELF 631
|
Source: Marchantia polymorpha Species: Marchantia polymorpha Genus: Marchantia Family: Marchantiaceae Order: Marchantiales Class: Marchantiopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326518874|dbj|BAJ92598.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326525349|dbj|BAK07944.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 275 bits (703), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 157/348 (45%), Positives = 216/348 (62%), Gaps = 10/348 (2%)
Query: 186 RRIRRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINII 245
RR R SE SS PS E +G S S + Q +Q ++ EL ATNNFSE N++
Sbjct: 35 RRNRTSETGSSDPSTLVEWGKGGRSS-----SAPERQGARQFSLEELAQATNNFSEANLV 89
Query: 246 GEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305
G GSFGL YKGLL DGS+V IKR + F EV+ ++ + HR++V L+G+C+E Q
Sbjct: 90 GAGSFGLVYKGLLFDGSVVAIKRRMGAPRLEFADEVRRLSEICHRNIVTLIGYCQEGGLQ 149
Query: 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRT 365
+L+++Y PNGNV +HLYDS + +L +QRL+IA+GAAKGL HLHSL+PPL H +F+T
Sbjct: 150 MLVFEYSPNGNVCSHLYDSGKGSMTRLEFKQRLAIAIGAAKGLNHLHSLMPPLIHKNFKT 209
Query: 366 SNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVYSFG 423
SNVL++EN+ AKV+D GL++L G GS+ + DPE + +S SDVYSFG
Sbjct: 210 SNVLVDENFIAKVADAGLVRLFRGHEDIGSSHGFSSSVYQDPEAHSVAQFSESSDVYSFG 269
Query: 424 VFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ-TVGAATEMMELALQ 482
VFLLELI+G+EA S ++L ++ + +D LG T E + LA Q
Sbjct: 270 VFLLELITGKEAANLQPPESRESLAHWLEAHFSSNELIDPRLGGGFTTEGMKEFVGLAFQ 329
Query: 483 CVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSELF 529
C++ SS RRP MR +A EL+ I E E+ L + G+ + LGS+LF
Sbjct: 330 CLNPSSRRRPKMRLVAAELDRILETEMS-LTTIMGDGTAIITLGSQLF 376
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 530 | ||||||
| TAIR|locus:2090797 | 380 | AT3G26700 [Arabidopsis thalian | 0.649 | 0.905 | 0.421 | 5.8e-66 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.539 | 0.438 | 0.384 | 1.4e-48 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.520 | 0.291 | 0.384 | 1.9e-48 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.524 | 0.324 | 0.374 | 2.2e-48 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.567 | 0.315 | 0.375 | 8.6e-48 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.539 | 0.442 | 0.384 | 3.3e-47 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.552 | 0.301 | 0.381 | 2.3e-46 | |
| TAIR|locus:2031230 | 629 | AT1G25390 [Arabidopsis thalian | 0.516 | 0.435 | 0.373 | 6e-46 | |
| TAIR|locus:2199857 | 375 | AT1G24030 [Arabidopsis thalian | 0.511 | 0.722 | 0.378 | 1.9e-44 | |
| TAIR|locus:2019180 | 399 | AT1G74490 [Arabidopsis thalian | 0.562 | 0.746 | 0.352 | 1e-43 |
| TAIR|locus:2090797 AT3G26700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 5.8e-66, P = 5.8e-66
Identities = 153/363 (42%), Positives = 227/363 (62%)
Query: 178 YICLMCVKRRIRRSE-GESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHAT 236
++ CV RR S E+ PS + E ++ A+ + + ++ + EL AT
Sbjct: 24 FLLWFCVFRRKNLSRTSETGSSDPSTQ-EGRNV-----AIE-LSMREARRFEMEELAQAT 76
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
+F+ ++IG G FG YKGLLQDG LV IK+ Q F++EV++++ +HHR+LV L+
Sbjct: 77 KSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIHHRNLVTLL 136
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEG-LPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
GFC+E++ Q L+Y+Y+PNG+V +HLY + G +P +L R RL+I++GAAKGL HLHSL
Sbjct: 137 GFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKGLAHLHSLS 196
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV---DCFLDPELNLSKN 412
P L H F+T+NVL++EN+ AKV+D G+ + G G++S + FL PE+ K
Sbjct: 197 PRLIHKDFKTANVLVDENFIAKVADAGVRNFL-GREDVGTSSHIVADQIFLSPEVQEFKR 255
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI--LQ-VKRSCDLGKYVDKTLG-EQ 468
+S SDVY+FGVFLLEL+SGREA + S+S Q L+ +Q + D+ +D+ LG
Sbjct: 256 FSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTDYADIPMMIDERLGGTY 315
Query: 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEEIDAVKLGSE 527
T E++ L L+CVDVSS +RP+M + ELE I ++E+ L + GE V LGS+
Sbjct: 316 TAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVS-LTTVMGEGTPTVTLGSQ 374
Query: 528 LFK 530
LFK
Sbjct: 375 LFK 377
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 1.4e-48, Sum P(2) = 1.4e-48
Identities = 118/307 (38%), Positives = 167/307 (54%)
Query: 211 PYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHL 270
P PG V T EL ATN FSE N++G+G FG +KG+L G V +K+
Sbjct: 255 PSPGLVLGFSKSTF---TYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 311
Query: 271 QTQIQN---FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGL 327
Q F EV+ I+RVHHRHLV L+G+C Q+LL+Y+++PN N++ HL+ +G
Sbjct: 312 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLH-GKGR 370
Query: 328 PIGKLTMRQRLSIALGAAKGLEHLHS-LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386
P + RL IALG+AKGL +LH P + H + SN+L++ + AKV+D+GL K+
Sbjct: 371 PT--MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 428
Query: 387 VTGSHHAGSTSAVDCF--LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444
+ ++ ST + F L PE S + SDV+SFGV LLELI+GR N+ D
Sbjct: 429 ASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVD 488
Query: 445 QNLILQVK----RSCDLGKY---VDKTLG-EQTVGAATEMMELALQCVDVSSRR-PSMRQ 495
+L+ + R+ + G + D +G E M+ A CV S+RR P M Q
Sbjct: 489 DSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQ 548
Query: 496 IAGELEG 502
I LEG
Sbjct: 549 IVRALEG 555
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.9e-48, Sum P(2) = 1.9e-48
Identities = 112/291 (38%), Positives = 177/291 (60%)
Query: 225 KQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQN---FLHEV 281
K T EL TNNFS+ N +G G +G YKG L +G ++ IKR Q +Q F E+
Sbjct: 620 KAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEI 679
Query: 282 KHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
+ ++RVHH+++VKL+GFC + +Q+L+Y+YIPNG++++ L G+ KL +RL IA
Sbjct: 680 ELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGV---KLDWTRRLKIA 736
Query: 342 LGAAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
LG+ KGL +LH L PP+ H +++N+LL+E+ TAKV+D+GL KLV A T+ V
Sbjct: 737 LGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQVK 796
Query: 401 C---FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR-NHSNSDQNLILQVKRSC- 455
+LDPE ++ + SDVY FGV +LEL++G+ R ++ + + R+
Sbjct: 797 GTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLY 856
Query: 456 DLGKYVDKTLGEQT--VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503
DL + +D T+ + + + + +++ALQCV+ RP+M ++ ELE I
Sbjct: 857 DLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESI 907
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 2.2e-48, Sum P(2) = 2.2e-48
Identities = 110/294 (37%), Positives = 177/294 (60%)
Query: 225 KQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLH---EV 281
K T E++ NNFS N +G G +G YKG+L G L+ IKR +Q L E+
Sbjct: 520 KAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKTEI 579
Query: 282 KHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
+ ++RVHH+++VKL+GFC + +Q+L+Y+YIPNG++++ L G+ +L +RL IA
Sbjct: 580 ELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGI---RLDWTRRLRIA 636
Query: 342 LGAAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
LG+ KGL +LH L PP+ H ++SNVLL+E+ TAKV+D+GL +LV + A T+ V
Sbjct: 637 LGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLVEDAEKANVTAQVK 696
Query: 401 C---FLDPELNLSKNYSAGSDVYSFGVFLLELISGREA--HGRNHSNSDQNLILQVKRSC 455
+LDPE ++ + SDVY FGV +LEL++G+ +G+ + + + K
Sbjct: 697 GTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMNKSKNLY 756
Query: 456 DLGKYVDKTLG---EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505
DL ++D T+ + + + +++AL+CVD +RPSM ++ E+E I +
Sbjct: 757 DLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENIMQ 810
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 8.6e-48, P = 8.6e-48
Identities = 121/322 (37%), Positives = 187/322 (58%)
Query: 202 AELERGDISPYPG---AVSPIDTQNL---KQLTILELKHATNNFSEINIIGEGSFGLAYK 255
AE G +P+ + S ID L K T ELK T+NFSE N +G G +G Y+
Sbjct: 588 AERATGQNNPFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYR 647
Query: 256 GLLQDGSLVVIKRHLQTQIQN---FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312
G+L +G L+ IKR Q +Q F E++ ++RVHH+++V+L+GFC + ++Q+L+Y+YI
Sbjct: 648 GILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYI 707
Query: 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV-PPLFHMHFRTSNVLLE 371
NG++++ L G+ +L +RL IALG+ KGL +LH L PP+ H +++N+LL+
Sbjct: 708 SNGSLKDSLSGKSGI---RLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLD 764
Query: 372 ENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---FLDPELNLSKNYSAGSDVYSFGVFLLE 428
EN TAKV+D+GL KLV T+ V +LDPE ++ + SDVY FGV LLE
Sbjct: 765 ENLTAKVADFGLSKLVGDPEKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLE 824
Query: 429 LISGREAHGRN-HSNSDQNLILQVKRSC-DLGKYVDKTL--GEQTVGAATEMMELALQCV 484
L++GR R + + + RS DL + +D T+ + + ++LAL+CV
Sbjct: 825 LLTGRSPIERGKYVVREVKTKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCV 884
Query: 485 DVSS-RRPSMRQIAGELEGIQE 505
+ RPSM ++ E+E I +
Sbjct: 885 EEEGVNRPSMGEVVKEIENIMQ 906
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 3.3e-47, Sum P(2) = 3.3e-47
Identities = 118/307 (38%), Positives = 166/307 (54%)
Query: 211 PYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHL 270
P PG V T EL ATN FSE N++G+G FG +KG+L G V +K+
Sbjct: 250 PSPGLVLGFSKSTF---TYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLK 306
Query: 271 QTQIQN---FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGL 327
Q F EV+ I+RVHHRHLV LVG+C ++LL+Y+++PN N++ HL+ EG
Sbjct: 307 VGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLH-GEGR 365
Query: 328 PIGKLTMRQRLSIALGAAKGLEHLHS-LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386
P + RL IALG+AKGL +LH P + H + SN+L++ + AKV+D+GL K+
Sbjct: 366 PT--MEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 423
Query: 387 VTGSHHAGSTSAVDCF--LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444
+ ++ ST + F L PE S + SDV+SFGV LLELI+GR N+ D
Sbjct: 424 ASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVD 483
Query: 445 QNLILQVK----RSCDLGKYVDKTLGEQTVGAATE----MMELALQCVDVSSRR-PSMRQ 495
+L+ + R+ + G + + G E M+ A CV S+RR P M Q
Sbjct: 484 DSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQ 543
Query: 496 IAGELEG 502
I LEG
Sbjct: 544 IVRALEG 550
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.3e-46, P = 2.3e-46
Identities = 119/312 (38%), Positives = 181/312 (58%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQN---FLHEVKHIARV 287
ELK TNNFS + +G G +G YKG+LQDG +V IKR Q Q F E++ ++RV
Sbjct: 630 ELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRV 689
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
HH++LV LVGFC E +Q+L+Y+Y+ NG++++ L G+ L ++RL +ALG+A+G
Sbjct: 690 HHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGIT---LDWKRRLRVALGSARG 746
Query: 348 LEHLHSLV-PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV---TGSHHAGSTSAVDCFL 403
L +LH L PP+ H +++N+LL+EN TAKV+D+GL KLV T H + +L
Sbjct: 747 LAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLGYL 806
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD---LGKY 460
DPE ++ + SDVYSFGV ++ELI+ ++ + + ++ K D L
Sbjct: 807 DPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRDK 866
Query: 461 VDKTLGEQTVGAATEM---MELALQCVD-VSSRRPSMRQIAGELEGIQEREIGRLHSEFG 516
+D++L + VG E+ MELAL+CVD + RP+M ++ E+E I + S
Sbjct: 867 MDRSLRD--VGTLPELGRYMELALKCVDETADERPTMSEVVKEIEIIIQNSGASSSSSAS 924
Query: 517 EEIDAVKLGSEL 528
A G +L
Sbjct: 925 ASSSATDFGEKL 936
|
|
| TAIR|locus:2031230 AT1G25390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 6.0e-46, Sum P(2) = 6.0e-46
Identities = 109/292 (37%), Positives = 173/292 (59%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR---HLQTQIQNFLHEVKHIARV 287
EL+ AT+NFS+ ++G+G FG Y G ++DG V +KR H +++ F++E++ + R+
Sbjct: 283 ELQAATDNFSKDRLLGDGGFGTVYYGKVRDGREVAVKRLYEHNYRRLEQFMNEIEILTRL 342
Query: 288 HHRHLVKLVGFCEENHQQLL-IYDYIPNGNVQNHLYDSEGLPI-GKLTMRQRLSIALGAA 345
HH++LV L G ++LL +Y++IPNG V +HLY E P G LT RLSIA+ A
Sbjct: 343 HHKNLVSLYGCTSRRSRELLLVYEFIPNGTVADHLY-GENTPHQGFLTWSMRLSIAIETA 401
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG--SHHAGSTSAVDCFL 403
L +LH+ + H +T+N+LL+ N+ KV+D+GL +L+ +H + + ++
Sbjct: 402 SALAYLHA--SDIIHRDVKTTNILLDRNFGVKVADFGLSRLLPSDVTHVSTAPQGTPGYV 459
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI-LQVKRSCDLGKY-- 460
DPE + + + SDVYSFGV L+ELIS + A + S+ NL L + + + +
Sbjct: 460 DPEYHRCYHLTDKSDVYSFGVVLVELISSKPAVDISRCKSEINLSSLAINKIQNHATHEL 519
Query: 461 VDKTLGEQT---VGAATEMM-ELALQCVDV-SSRRPSMRQIAGELEGIQERE 507
+D+ LG T V T M+ ELA QC+ ++ RP+M Q+ EL+GIQ E
Sbjct: 520 IDQNLGYATNEGVRKMTTMVAELAFQCLQQDNTMRPTMEQVVHELKGIQNEE 571
|
|
| TAIR|locus:2199857 AT1G24030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 1.9e-44, P = 1.9e-44
Identities = 111/293 (37%), Positives = 173/293 (59%)
Query: 228 TILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR-HLQT-----QIQNFLHEV 281
T+ E++ AT++FS+ N++G+G FG Y+G L+ G +V IK+ L T + F EV
Sbjct: 65 TLKEMEEATSSFSDENLLGKGGFGRVYQGTLKTGEVVAIKKMDLPTFKKADGEREFRVEV 124
Query: 282 KHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
++R+ H +LV L+G+C + + L+Y+Y+ NGN+Q+HL G+ K++ RL IA
Sbjct: 125 DILSRLDHPNLVSLIGYCADGKHRFLVYEYMQNGNLQDHL---NGIKEAKISWPIRLRIA 181
Query: 342 LGAAKGLEHLHSLVP---PLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT-GSHHAGSTS 397
LGAAKGL +LHS P+ H F+++NVLL+ NY AK+SD+GL KL+ G +
Sbjct: 182 LGAAKGLAYLHSSSSVGIPIVHRDFKSTNVLLDSNYNAKISDFGLAKLMPEGKDTCVTAR 241
Query: 398 AVDCF--LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455
+ F DPE + + SD+Y+FGV LLEL++GR A ++QNL+LQV+
Sbjct: 242 VLGTFGYFDPEYTSTGKLTLQSDIYAFGVVLLELLTGRRAVDLTQGPNEQNLVLQVRNIL 301
Query: 456 D----LGKYVDKTL--GEQTVGAATEMMELALQCVDVSSR-RPSMRQIAGELE 501
+ L K +D L ++ A T +LA +C+ + S+ RPS+ EL+
Sbjct: 302 NDRKKLRKVIDVELPRNSYSMEAITMFADLASRCIRIESKERPSVMDCVKELQ 354
|
|
| TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 461 (167.3 bits), Expect = 1.0e-43, P = 1.0e-43
Identities = 117/332 (35%), Positives = 185/332 (55%)
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
R+ E S++P P E GDI + +Q LK T+ ELK+AT NF ++IGEG
Sbjct: 53 RKCEAISALPPPHKE---GDI---------MHSQYLKSFTLDELKNATGNFCPESLIGEG 100
Query: 249 SFGLAYKGLLQDG---SLVVIKRHLQTQ-IQN---FLHEVKHIARVHHRHLVKLVGFCEE 301
FG +KG + G L V + L+T+ +Q +L EV ++ R+HH +LVKL+G+ E
Sbjct: 101 GFGFVHKGCINGGPGIELAVAVKKLKTEGLQGHKEWLREVNYLGRLHHPNLVKLIGYSLE 160
Query: 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHM 361
N +LL+Y+++PNG+++NHL++ L+ R+ +A+GAA+GL LH + +
Sbjct: 161 NEHRLLVYEHLPNGSLENHLFERSS---SVLSWSLRMKVAIGAARGLCFLHEANDQVIYR 217
Query: 362 HFRTSNVLLEENYTAKVSDYGLLK---LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSD 418
F+ +N+LL+ + AK+SD+GL K SH + + PE + + + D
Sbjct: 218 DFKAANILLDSGFNAKLSDFGLAKEGPKDNRSHVTTEVMGTEGYAAPEYLATGHLTTKCD 277
Query: 419 VYSFGVFLLELISGREAHGRNHSNSDQNLI------LQVKRSCDLGKYVD-KTLGEQTVG 471
VYSFGV LLE++SGR ++ S ++NL+ L+ KR + + +D K +G+
Sbjct: 278 VYSFGVVLLEILSGRRVIDKSKSREEENLVDWATPYLRDKRK--VFRIMDTKLVGQYPQK 335
Query: 472 AATEMMELALQCVDVSSRRPSMRQIAGELEGI 503
AA M LALQC+ RPSM ++ LE +
Sbjct: 336 AAFMMSFLALQCIGDVKVRPSMLEVVSLLEKV 367
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024534001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (448 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 530 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.002 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.003 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.003 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.004 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.004 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.004 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-35
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 45/283 (15%)
Query: 243 NIIGEGSFGLAYKGLLQDGS----LVVIKR----HLQTQIQNFLHEVKHIARVHHRHLVK 294
+GEG+FG YKG L+ V +K + + ++FL E + + ++ H ++V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHL----YDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
L+G C E L+ +Y+ G++ ++L L+++ LS A+ AKG+E+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS---------AVDC 401
L S H N L+ E+ K+SD+GL + V + + A
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA--- 175
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN-HSN-SDQNLILQVKRSCDLGK 459
PE +++ SDV+SFGV L E+ + G + S++ ++ +++
Sbjct: 176 ---PESLKDGIFTSKSDVWSFGVLLWEIFT----LGATPYPGLSNEEVLEYLRK------ 222
Query: 460 YVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELE 501
L + E+ EL L C RP+ ++ LE
Sbjct: 223 --GYRL-PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 39/276 (14%)
Query: 242 INIIGEGSFGLAYKGLLQDGS-----LVVIKR----HLQTQIQNFLHEVKHIARVHHRHL 292
+GEG+FG YKG L+ V +K + QI+ FL E + + ++ H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
VKL+G C E ++ +Y+ G++ ++L + KL++ LS AL A+G+E+L
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQIARGMEYLE 119
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-----FLDPE- 406
S H N L+ EN K+SD+GL + + + ++ PE
Sbjct: 120 SK--NFIHRDLAARNCLVGENLVVKISDFGLSRDL---YDDDYYRKRGGKLPIRWMAPES 174
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465
L K +++ SDV+SFGV L E+ + G + + SN + ++ +K L
Sbjct: 175 LKEGK-FTSKSDVWSFGVLLWEIFTLGEQPYP-GMSNEE--VLEYLKN--------GYRL 222
Query: 466 GEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGEL 500
Q E+ +L LQC + RP+ ++ L
Sbjct: 223 -PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 242 INIIGEGSFGLAYKGLLQDGS-----LVVIKR----HLQTQIQNFLHEVKHIARVHHRHL 292
+GEG+FG YKG L+ V +K + QI+ FL E + + ++ H ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
VKL+G C E +++ +Y+P G++ ++L + +L++ LS AL A+G+E+L
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE 120
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-----FLDPE- 406
S H N L+ EN K+SD+GL + + + ++ PE
Sbjct: 121 SK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRWMAPES 175
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465
L K +++ SDV+SFGV L E+ + G E + S+ ++ +K+ G +
Sbjct: 176 LKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYLKK----GYRL---- 223
Query: 466 GEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGEL 500
+ E+ +L LQC + RP+ ++ L
Sbjct: 224 -PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 46/280 (16%)
Query: 242 INIIGEGSFGLAYKGLLQDGS-----LVVIKR----HLQTQIQNFLHEVKHIARVHHRHL 292
+GEG+FG YKG L+ V +K + + + FL E + ++ H ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V+L+G C + ++ +Y+P G++ + L KLT++ L +AL AKG+E+L
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQIAKGMEYLE 119
Query: 353 SLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD--- 404
S +F N L+ EN K+SD+GL + + L
Sbjct: 120 S-------KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED--DYYRKRGGGKLPIKW 170
Query: 405 --PE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461
PE L K +++ SDV+SFGV L E+ + E SN + ++ ++ L
Sbjct: 171 MAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLELLEDGYRL---- 223
Query: 462 DKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGEL 500
+ E+ EL LQC RP+ ++ +L
Sbjct: 224 -----PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 61/193 (31%), Positives = 100/193 (51%), Gaps = 14/193 (7%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+GEG FG Y + G V IK + ++ L E++ + +++H ++VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
E+ + L+ +Y G++++ L ++E GKL+ + L I L +GLE+LHS +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSN--GII 114
Query: 360 HMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTSAV-DCFLDPE-LNLSKNYSAG 416
H + N+LL +N K++D+GL KL+T T ++ PE L YS
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 417 SDVYSFGVFLLEL 429
SD++S GV L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
+ + +GEGSFG Y + G LV IK + ++ + L E+K + ++ H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+L E+ + L+ +Y G++ + L G+L+ + LE+LHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-----GRLSEDEARFYLRQILSALEYLHS 115
Query: 354 LVPPLFHMHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS 410
+H R N+LL+E+ K++D+GL + + + ++ PE+ L
Sbjct: 116 ----KGIVH-RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 411 KNYSAGSDVYSFGVFLLELISGR 433
K Y D++S GV L EL++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 76/269 (28%), Positives = 129/269 (47%), Gaps = 36/269 (13%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
IG+G FG G + G V +K + T Q FL E + + H +LV+L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
+ ++ +Y+ G++ ++L S G + +T+ Q+L AL +G+E+L H
Sbjct: 73 NPLYIVTEYMAKGSLVDYL-RSRGRAV--ITLAQQLGFALDVCEGMEYLEE--KNFVHRD 127
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS-----TSAVDCFLDPELNLSKNYSAGS 417
NVL+ E+ AKVSD+GL K + +G T+ PE K +S S
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA-------PEALREKKFSTKS 180
Query: 418 DVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG-EQTVGAATE 475
DV+SFG+ L E+ S GR + R + +K D+ +V+K E G E
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPR----------IPLK---DVVPHVEKGYRMEAPEGCPPE 227
Query: 476 MMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ ++ C ++ ++RP+ +Q+ +L I
Sbjct: 228 VYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 26/264 (9%)
Query: 244 IIGEGSFGLAYKGLLQ-DGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKLVG 297
+G GSFG YK + G +V +K + Q E++ + R+ H ++V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357
E+ L+ +Y G++ ++L G L+ + IAL +GLE+LHS
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSN--G 118
Query: 358 LFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---FLDPE-LNLSKNY 413
+ H + N+LL+EN K++D+GL K + S + S + ++ PE L Y
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 414 SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473
DV+S GV L EL++G+ + DQ +++ L K +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPF-SGENILDQLQLIRRILGPPLEFDEPKWSSG-----S 230
Query: 474 TEMMELALQCVDVS-SRRPSMRQI 496
E +L +C++ S+RP+ +I
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 6e-21
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
IG G FGL + G + V IK R ++F+ E + + ++ H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
L+++++ +G + ++L G K + L + L +G+ +L S + H
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLES--SNVIHRD 125
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA---VDCFLDPELNLSKNYSAGSDV 419
N L+ EN KVSD+G+ + V + ST V + PE+ YS+ SDV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFSFSKYSSKSDV 184
Query: 420 YSFGVFLLELISGREAHGRNHSNSD 444
+SFGV + E+ S + N SNS+
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCE 300
IG+G+FG YKG+L+ + V +K T + FL E + + + H ++VKL+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFH 360
+ ++ + +P G++ L + +LT+++ L ++L AA G+E+L S H
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLES--KNCIH 116
Query: 361 MHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---FLDPE-LNLSKNYSAG 416
N L+ EN K+SD+G+ + G + S + PE LN + Y++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR-YTSE 175
Query: 417 SDVYSFGVFLLELISGREAHGRNHSNS 443
SDV+S+G+ L E S + SN
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQ 202
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 9/197 (4%)
Query: 239 FSEINIIGEGSFGLAYKGLLQDGSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVKL 295
F+ +G G FG ++GL ++ V ++K + Q+F EV+ + R+ H+HL+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
C +I + + G++ L EG L + + +A A+G+ +L
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE-- 122
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-FLDPELNLSKNYS 414
H N+L+ E+ KV+D+GL +L+ + S + + PE +S
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 415 AGSDVYSFGVFLLELIS 431
SDV+SFG+ L E+ +
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 245 IGEGSFGLAYKGLL------QDGSLVVIKRHLQTQI----QNFLHEVKHIARVHHRHLVK 294
+GEG+FG + G D LV +K +T ++F E + + H ++VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHL---------YDSEGLPIGKLTMRQRLSIALGAA 345
G C E +++++Y+ +G++ L S P+G+LT+ Q L IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCF 402
G+ +L S H T N L+ + K+ D+G+ + V + + G T +
Sbjct: 133 SGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNS------DQNLILQVKRSC 455
+ PE + + ++ SDV+SFGV L E+ + G++ SN Q +LQ R+C
Sbjct: 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEVIECITQGRLLQRPRTC 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 223 NLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVK 282
NL++LT+ E IIGEG FG +G + V Q FL E
Sbjct: 4 NLQKLTLGE------------IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETA 51
Query: 283 HIARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
+ ++HH++LV+L+G H L ++ + + GN+ N L + G + +++ Q L +
Sbjct: 52 VMTKLHHKNLVRLLGVIL--HNGLYIVMELMSKGNLVNFL-RTRGRAL--VSVIQLLQFS 106
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC 401
L A+G+E+L S L H N+L+ E+ AKVSD+GL ++ GS ++
Sbjct: 107 LDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVK 162
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAH 436
+ PE K +S+ SDV+S+GV L E+ S GR +
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 85.6 bits (210), Expect = 5e-18
Identities = 62/278 (22%), Positives = 118/278 (42%), Gaps = 25/278 (8%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKR------HLQTQIQNFLHEVKHIARV-HHR 290
++ + +GEGSFG Y +D LV +K +++ FL E++ +A + H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
++VKL F ++ L+ +Y+ G++++ L + G L+ + L I LE+
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEY 116
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYT-AKVSDYGLLKLVTGSHHAGSTSAVDC-------F 402
LHS + H + N+LL+ + K+ D+GL KL+ S A+ +
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 403 LDPELNLSKN---YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK 459
+ PE+ L + S+ SD++S G+ L EL++G ++S + L++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 460 YVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ +L + + R S
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
|
Length = 384 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 245 IGEGSFGLAY----KGLL--QDGSLVVIK---RHLQTQIQNFLHEVKHIARVHHRHLVKL 295
+GEG+FG + LL QD LV +K ++ Q+F E + + + H+H+V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 296 VGFCEENHQQLLIYDYIPNGN----VQNH------LYDSEGLPIGKLTMRQRLSIALGAA 345
G C E L++++Y+ +G+ +++H L E + G+LT+ Q L+IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCF 402
G+ +L SL H T N L+ + K+ D+G+ + + + + G T +
Sbjct: 133 SGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ PE L + ++ SD++SFGV L E+ +
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 242 INIIGEGSFGLAYKGLL-----QDGSLVVIK--RHLQ--TQIQNFLHEVKHIARVHHRHL 292
I +GEG FG G V +K H +F E++ + + H ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 293 VKLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
VK G CE+ + LI +Y+P+G+++++L ++ +++ L + KG+++
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDY 124
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LDPE 406
L S H N+L+E K+SD+GL K++ PE
Sbjct: 125 LGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 407 -LNLSKNYSAGSDVYSFGVFLLELIS 431
L SK SA SDV+SFGV L EL +
Sbjct: 183 CLRTSKFSSA-SDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 14/196 (7%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG + G + V +K + + FL E + + ++ H LV+L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +Y+ G++ + L EG KL + Q + +A A+G+ +L S H
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESR--NYIHRD 128
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LDPELNLSKNYSAGSD 418
N+L+ EN K++D+GL +L+ + A F PE ++ SD
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK--FPIKWTAPEAANYGRFTIKSD 186
Query: 419 VYSFGVFLLELIS-GR 433
V+SFG+ L E+++ GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 26/267 (9%)
Query: 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+ +G G +G Y+G+ + SL V + L+ +++ FL E + + H +LV+L+G C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+I +++ GN+ ++L + + + + L +A + +E+L
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEK--KNFI 126
Query: 360 HMHFRTSNVLLEENYTAKVSDYGLLKLVTG---SHHAGSTSAVDCFLDPELNLSKNYSAG 416
H N L+ EN+ KV+D+GL +L+TG + HAG+ + + PE +S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIK 185
Query: 417 SDVYSFGVFLLELISGREAHGRN-HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATE 475
SDV++FGV L E+ + +G + + D + QV + G + E+ G +
Sbjct: 186 SDVWAFGVLLWEIAT----YGMSPYPGID---LSQVYELLEKGYRM-----ERPEGCPPK 233
Query: 476 MMELALQCVDVS-SRRPSMRQIAGELE 501
+ EL C + S RPS +I E
Sbjct: 234 VYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 245 IGEGSFGLAYKGLL------QDGSLVVIKR---HLQTQIQNFLHEVKHIARVHHRHLVKL 295
+GEG+FG + QD LV +K ++F E + + + H H+VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYD--------SEGLPIGKLTMRQRLSIALGAAKG 347
G C E +++++Y+ +G++ L +EG +LT Q L IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLD 404
+ +L S H T N L+ EN K+ D+G+ + V + + G T ++
Sbjct: 133 MVYLAS--QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD------QNLILQVKRSCDLG 458
PE + + ++ SDV+S GV L E+ + + SN++ Q +LQ R+C
Sbjct: 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC--- 247
Query: 459 KYVDKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQ 495
E+ +L L C R P MR
Sbjct: 248 --------------PKEVYDLMLGC---WQREPHMRL 267
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 51/210 (24%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 243 NIIGEGSFGLAYKGLLQD-GSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
++G GSFG Y L +D G L+ +K + +++ E++ ++ + H ++V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 297 GFCEEN-HQQLLIY-DYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIALGAAKGLEHL 351
G + L I+ +Y+ G++ + L LP I K T RQ L GL +L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT-RQILE-------GLAYL 117
Query: 352 HS--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV------TGSHHAGSTSAVDCFL 403
HS +V H + +N+L++ + K++D+G K + G+ T ++
Sbjct: 118 HSNGIV----HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY---WM 170
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGR 433
PE+ + Y +D++S G ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 44/284 (15%)
Query: 245 IGEGSFGLAYKG-LLQDG-----SLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+GEG+FG YKG L + V IK Q F E + ++ + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHL----------YDSEGLPIGK-LTMRQRLSIALG 343
L+G C + ++++Y+ +G++ L +S + L L IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 344 AAKGLEHL--HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS--HHAGSTSAV 399
A G+E+L H V H N L+ E T K+SD+GL + + + + S S +
Sbjct: 133 IAAGMEYLSSHHFV----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 400 DC-FLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDL 457
++ PE L ++ SD++SFGV L E+ S G + + + S+Q +I + RS L
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY---YGFSNQEVIEMI-RSRQL 244
Query: 458 GKYVDKTLGEQTVGAATEMMELALQCVD-VSSRRPSMRQIAGEL 500
L + L ++C + + +RRP + I L
Sbjct: 245 -------LP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG+ + G + V IK R +F+ E K + ++ H +LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +Y+ NG + N+L + + GKL L + + +E+L S H
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRD 125
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA---VDCFLDPELNLSKNYSAGSDV 419
N L+ E+ KVSD+GL + V + S V + PE+ +S+ SDV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK-WAPPEVFDYSRFSSKSDV 184
Query: 420 YSFGVFLLELISGREAHGRNHSNSD 444
+SFGV + E+ S + SNS+
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 244 IIGEGSFGLAYKGLLQDGSLVVIK---RHLQTQIQ-NFLHEVKHIARVHHRHLVKLVGFC 299
++G+G+FG +KG L+D + V +K L +++ FL E + + + H ++VKL+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+ ++ + +P G+ + L + +L +Q + AL AA G+ +L S
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLES--KNCI 115
Query: 360 HMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS--TSAVDCFLDPE-LNLSKNYSAG 416
H N L+ EN K+SD+G+ + ++ S + PE LN + YS+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSE 174
Query: 417 SDVYSFGVFLLELIS 431
SDV+S+G+ L E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 238 NFSEINIIGEGSFG---LAY-KGLLQDG--SLVVIK----RHLQTQIQNFLHEVKHIARV 287
N EI +G G FG LA KG+ ++G +LV++K + F E+ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS----EGLPIGKLTMRQRLSIALG 343
H+++V+L+G C E +I +Y G+++ L + E L L+ +Q++++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS--HHAGSTSAVDC 401
A G++HL + H N L+ KVS L K V S + +
Sbjct: 126 IALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGRE 434
+L PE ++S SDV+SFGV + E+ + E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 243 NIIGEGSFGLAYKGLLQDGS----LVVIKRHLQTQIQ-----NFLHEVKHIARVHHRHLV 293
+IG G FG +G L+ V IK L+ +FL E + + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+L G ++ ++I +Y+ NG++ L +++G K T+ Q + + G A G+++L
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSE 124
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---FLDPELNLS 410
+ H N+L+ N KVSD+GL + + S +T + PE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 411 KNYSAGSDVYSFGVFLLELIS 431
+ +++ SDV+SFG+ + E++S
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 2e-15
Identities = 67/271 (24%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HL----QTQIQNFLHEVKHIARVHHRH 291
+ I IG+GSFG Y DG L V+K L + + ++ L+EVK + +++H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGK-LTMRQRLSIALGAAKGLEH 350
++K EE + ++ +Y G++ + + GK Q L + L++
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 351 LHS---LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA-VDCFLDPE 406
LHS L H + N+ L N K+ D+G+ K+++ + T +L PE
Sbjct: 119 LHSRKIL-----HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466
L +K Y+ SD++S G L EL + + + L L++ + G+Y +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPF---EGENLLELALKILK----GQY--PPIP 224
Query: 467 EQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
Q ++E+ L + RPS+ QI
Sbjct: 225 SQY---SSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 65/278 (23%), Positives = 129/278 (46%), Gaps = 30/278 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKR----HLQTQIQNFLHEVKHIARVH 288
++ ++ +IG G FG ++G+L+ V IK + + Q Q+FL E + +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
H ++++L G + ++I +Y+ NG + +L D + G+ + Q + + G A G+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGM 120
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLD 404
++L + H N+L+ N KVSD+GL +++ T++ +
Sbjct: 121 KYLSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464
PE + +++ SDV+SFG+ + E++S E + SN +V ++ + G +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGFRLPAP 232
Query: 465 LGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELE 501
+ + + +L LQC +RRP I L+
Sbjct: 233 M-----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNF--------LHEVKHIARVH 288
+F +N IG+GSFG+ +K + + D + +K Q + + E + +A++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMK---QIDLSKMNRREREEAIDEARVLAKLD 57
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
++++ + + ++ +Y NG++ L G P L Q + GL
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP---LPEDQVWRFFIQILLGL 114
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSHHAGSTSAVDCFLDPEL 407
HLHS + H ++ N+ L+ K+ D G+ KL+ ++ A + +L PEL
Sbjct: 115 AHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460
K Y+ SDV++ GV L E +G+ +N+ LIL++ R G +
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPF---DANNQGALILKIIR----GVF 218
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG+ G + V IK + F+ E K + ++ H LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +Y+ NG + N+L + + Q L + +G+ +L S H
Sbjct: 72 RPIYIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRD 125
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-----FLDPELNLSKNYSAGS 417
N L+++ KVSD+GL + V + TS+V + PE+ L +S+ S
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 418 DVYSFGVFLLELIS 431
DV++FGV + E+ S
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 35/214 (16%)
Query: 244 IIGEGSFGLAYKGLL--QDGSL--VVIKR-----HLQTQIQNFLHEVKHIARVHHRHLVK 294
I+GEG FG +G L DGS V +K H ++I+ FL E + H +++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 295 LVGFCEENHQQ------LLIYDYIPNGNVQNHLYDS--EGLPIGKLTMRQRLSIALGAAK 346
L+G C E ++I ++ +G++ + L S GLP KL ++ L + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPLQTLLKFMVDIAL 124
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSHH-AGSTS------- 397
G+E+L + H N +L E+ T V+D+GL K + +G ++ G +
Sbjct: 125 GMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 398 AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
A++ D + Y++ SDV++FGV + E+ +
Sbjct: 183 AIESLAD------RVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 49/291 (16%)
Query: 243 NIIGEGSFGLAYKGLLQ-DG-----SLVVIKRHL-QTQIQNFLHEVKHIARV-HHRHLVK 294
++IGEG+FG + +++ DG ++ ++K + ++F E++ + ++ HH +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI-----------GKLTMRQRLSIALG 343
L+G CE + +Y P GN+ + L S L LT +Q L A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK--LVTGSHHAGSTSAVDC 401
A G+++L H NVL+ EN +K++D+GL + V G V
Sbjct: 128 VATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP-VRW 184
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRN----HSNSDQNLILQVKRSC 455
LN S Y+ SDV+SFGV L E++S G G + Q ++ R+C
Sbjct: 185 MAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNC 243
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQE 505
D E+ EL QC D RP QI+ +L + E
Sbjct: 244 D-----------------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG ++GL + + V +K + ++FL E + + ++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ + + G++ +L G L + Q + +A A G+ +L + H
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQ--NYIHRD 128
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA---VDCFLDPELNLSKNYSAGSDV 419
NVL+ EN KV+D+GL +++ + A + + PE L +S SDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK-WTAPEAALYNRFSIKSDV 187
Query: 420 YSFGVFLLELISGREAHGR 438
+SFG+ L E+++ +GR
Sbjct: 188 WSFGILLTEIVT----YGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 245 IGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQN----FLHEVKHIARVHHRHLVKLVGFC 299
IG G+FG + G L+ D + V +K +T + FL E + + + H ++V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+ ++ + + G+ L +EG +L +++ + + AA G+E+L S
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL-RTEG---PRLKVKELIQMVENAAAGMEYLES--KHCI 116
Query: 360 HMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---FLDPE-LNLSKNYSA 415
H N L+ E K+SD+G+ + +A + + PE LN + YS+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSS 175
Query: 416 GSDVYSFGVFLLELIS 431
SDV+SFG+ L E S
Sbjct: 176 ESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 50/293 (17%)
Query: 244 IIGEGSFGLAYKGLL-----QDGSLVVIKRHL-----QTQIQNFLHEVKHIARVHHRHLV 293
+GEG FG K + G V + L +++++ L E + +V+H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG-------------------KLTM 334
KL G C ++ LLI +Y G++++ L +S + LTM
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 335 RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV--TGSHH 392
+S A ++G+++L + L H NVL+ E K+SD+GL + V S+
Sbjct: 127 GDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 393 AGSTSAVDC-FLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRNHSNSDQNLIL 449
S + ++ E Y+ SDV+SFGV L E+++ G G + + L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI----APERLFN 240
Query: 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELE 501
+K + E+ + EM L L C +RP+ I+ ELE
Sbjct: 241 LLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 243 NIIGEGSFGLAYK------GLLQDGSLVVIKRHL-QTQIQNFLHEVKHIARV-HHRHLVK 294
++IGEG+FG K GL D ++ +K + + ++F E++ + ++ HH +++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI-----------GKLTMRQRLSIALG 343
L+G CE L +Y P+GN+ + L S L L+ +Q L A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK--LVTGSHHAGSTSAVDC 401
A+G+++L H N+L+ ENY AK++D+GL + V G V
Sbjct: 133 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-VRW 189
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
LN S Y+ SDV+S+GV L E++S
Sbjct: 190 MAIESLNYSV-YTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 237 NNFSEINIIGEGSFGLAYK----GLL--QDGSLV---VIKRHLQTQIQN-FLHEVKHIAR 286
NN + IG+G+FG ++ GLL + ++V ++K +Q F E +A
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD-----------------SEGLPI 329
H ++VKL+G C L+++Y+ G++ L GL
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 330 GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-- 387
L+ ++L IA A G+ +L H T N L+ EN K++D+GL + +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 388 TGSHHAGSTSAVDC-FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ A A+ ++ PE Y+ SDV+++GV L E+ S
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVG-F 298
+ IG+G FG G + G+ V +K ++ T Q FL E + ++ H +LV+L+G
Sbjct: 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPL 358
EE ++ +Y+ G++ ++L S G + L L +L + +E+L +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSV--LGGDCLLKFSLDVCEAMEYLEA--NNF 123
Query: 359 FHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSD 418
H NVL+ E+ AKVSD+GL K + + G + PE K +S SD
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAPEALREKKFSTKSD 181
Query: 419 VYSFGVFLLELIS-GREAHGR 438
V+SFG+ L E+ S GR + R
Sbjct: 182 VWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 242 INIIGEGSFG----LAYKGLLQD-GSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHL 292
I ++GEG FG Y G +V +K Q + E+ + ++H ++
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 293 VKLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
VK G C E + LI +Y+P G+++++L P KL + Q L A +G+ +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAY 122
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS----------AVD 400
LHS H NVLL+ + K+ D+GL K V H AV+
Sbjct: 123 LHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
C + +S SDV+SFGV L EL++
Sbjct: 181 CLKE------NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 243 NIIGEGSFGLAYKGLLQDGSL---------VVIKRHLQTQIQNFLHEVKHIARVHHRHLV 293
+++ EG+FG + G+L D V + Q+ L E + + H++++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 294 KLVGFCEENHQQ-LLIYDYIPNGNVQNHLYDSEGLPIGK---LTMRQRLSIALGAAKGLE 349
++ C E+ + ++Y Y+ GN++ L L+ +Q + +A+ A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVDCFLD---- 404
+LH + H N +++E K++D L + L +H C D
Sbjct: 132 YLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH--------CLGDNENR 181
Query: 405 ------PELNLSKNYSAGSDVYSFGVFLLELIS 431
E ++K YS+ SDV+SFGV L EL++
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 37/275 (13%)
Query: 245 IGEGSFGLAYKGLLQDG---SLVVIKR-----HLQTQIQNFLHEVKHIARVHHRHLVKLV 296
IG G FG G G + VV+K Q+ FL EV+ ++H ++++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP 356
G C E+ LL+ ++ P G+++N+L + G+ +A A GL LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 357 PLFHMHFRTSNVLLEENYTAKVSDYGLL-------KLVTGSHHAGSTSAVDCFLDPELN- 408
H N L + + K+ DYGL +T HA +L PEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELVE 175
Query: 409 ------LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN-SDQNLILQVKRSCDLGKYV 461
L K+ + S+++S GV + EL A + + + SD+ ++ QV R D+ +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELF---TAADQPYPDLSDEQVLKQVVREQDIK--L 230
Query: 462 DKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQI 496
K + + E+ C RP+ ++
Sbjct: 231 PKPQLDLKY--SDRWYEVMQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 242 INIIGEGSFGLAYKGL-LQDGSL----VVIKRHL----QTQIQNFLHEVKHIARVHHRHL 292
I ++G G+FG YKG+ + +G V IK + L E +A V H H+
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 293 VKLVGFC-EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
V+L+G C Q LI +P G + +++ + + + L+ + AKG+ +L
Sbjct: 72 VRLLGICLSSQVQ--LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 352 --HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG---SHHAGSTSAVDCFLDPE 406
LV H NVL++ K++D+GL KL+ +HA ++ E
Sbjct: 126 EEKRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS-GREAH 436
L + Y+ SDV+S+GV + EL++ G + +
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 49/286 (17%)
Query: 243 NIIGEGSFGLAYK------GLLQDGSLVVIKRHL-QTQIQNFLHEVKHIARV-HHRHLVK 294
++IGEG+FG K GL D ++ +K + + ++F E++ + ++ HH +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI-----------GKLTMRQRLSIALG 343
L+G CE L +Y P+GN+ + L S L L+ +Q L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK--LVTGSHHAGSTSAVDC 401
A+G+++L H N+L+ ENY AK++D+GL + V G V
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRW 177
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRN----HSNSDQNLILQVKRSC 455
LN S Y+ SDV+S+GV L E++S G G + Q L+ +C
Sbjct: 178 MAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGEL 500
D E+ +L QC + RPS QI L
Sbjct: 237 D-----------------DEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIKRHLQTQI--QNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG+ + G + V IK + + ++F+ E K + ++ H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +++ NG + N+L +G KL+ LS+ +G+E+L H
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLER--NSFIHRD 125
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA---VDCFLDPELNLSKNYSAGSDV 419
N L+ KVSD+G+ + V + S+ A V + PE+ YS+ SDV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-WSPPEVFNFSKYSSKSDV 184
Query: 420 YSFGVFLLELISGREAHGRNHSNSD 444
+SFGV + E+ + + SN +
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ--IQNFLHEVKHIARVHHRHLVK 294
F + IG+G FG YK + G V IK L+++ + ++E++ + + H ++VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
G + + ++ ++ G++++ L S LT Q + KGLE+LHS
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQT---LTESQIAYVCKELLKGLEYLHSN 117
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYS 414
+ H + +N+LL + K+ D+GL ++ + + ++ PE+ K Y
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 415 AGSDVYSFGVFLLELISGREAHGRNHS 441
+D++S G+ +EL G+ +
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 9/210 (4%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG + G + + V +K + +Q FL E + + H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
+I +Y+ G++ + L EG GK+ + + + + A+G+ ++ H
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER--KNYIHRD 128
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVY 420
R +NVL+ E+ K++D+GL +++ + + A + PE +++ SDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 421 SFGVFLLELISGREAHGRNHSNSDQNLILQ 450
SFG+ L E+++ + SNSD LQ
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 245 IGEGSFGLAYKGL------LQDGSLVVIKRHLQTQI---QNFLHEVKHIARVHHRHLVKL 295
+GEG+FG + +D LV +K + ++F E + + + H H+VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDS--------EGLPI---GKLTMRQRLSIALGA 344
G C + +++++Y+ +G++ L +G P G+L + Q L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDC 401
A G+ +L S H T N L+ N K+ D+G+ + V + + G T
Sbjct: 133 ASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE + + ++ SDV+SFGV L E+ +
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 63/271 (23%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 244 IIGEGSFGLAYKGLLQDGS----LVVIKR----HLQTQIQNFLHEVKHIARVHHRHLVKL 295
+IG G FG G L+ V IK + + Q ++FL E + + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
G ++ +++ +Y+ NG++ L +G + T+ Q + + G A G+++L +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDM- 125
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSK 411
H N+L+ N KVSD+GL +++ A T+ + PE +
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 412 NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471
+++ SDV+S+G+ + E++S E SN D V ++ + G + +
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLPAPM-----D 233
Query: 472 AATEMMELALQCVDVS-SRRPSMRQIAGELE 501
+ +L L C + RP QI L+
Sbjct: 234 CPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 244 IIGEGSFGLAYKGLLQ----DGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHLVKL 295
+IG G FG +G L+ V IK + + Q ++FL E + + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
G ++ ++I +++ NG + + L ++G + T+ Q + + G A G+++L +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEM- 125
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVDC-----FLDPELNL 409
H N+L+ N KVSD+GL + L + TS++ + PE
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444
+ +++ SDV+S+G+ + E++S E + SN D
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 8e-13
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRHL 292
+ +I IGEG++G YK + G LV +K+ ++ + + F + E+K + ++ H ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 293 VKLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGL---PIGKLTMRQRLSIALGAAKG 347
V+L + ++++Y+ +D GL P K T Q +G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQIKCYMKQLLEG 112
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL---D 404
L++LHS + H + SN+L+ + K++D+GL + T + A T+ V L
Sbjct: 113 LQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV-ITLWYRP 169
Query: 405 PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
PEL L + Y D++S G L EL G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 54/215 (25%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG + G + V +K + ++FL E + + ++ H LV+L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE- 72
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +Y+ G++ + L D EG L + + +A A G+ ++ + H
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMAYIERM--NYIHRD 127
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVY 420
R++N+L+ + K++D+GL +L+ + + A + PE L ++ SDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 421 SFGVFLLELIS-GREAH-GRNHSNSDQNLILQVKR 453
SFG+ L EL++ GR + G N ++ ++ QV+R
Sbjct: 188 SFGILLTELVTKGRVPYPGMN----NREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVK 294
+IG+G FG Y G L D I +++ +++ FL E + H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 295 LVGFCEENH-QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
L+G C + L++ Y+ +G+++N + P T++ + L AKG+E+L S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEYLAS 116
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV------TGSHHAGSTSAVDCFLDPEL 407
H N +L+E++T KV+D+GL + + + +H G+ V L
Sbjct: 117 --KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ--NLILQVKRSCDLGKYVDKTL 465
K ++ SDV+SFGV L EL++ R A +S +LQ +R +Y L
Sbjct: 175 QTQK-FTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQ-PEYCPDPL 231
Query: 466 GEQTVGAATEMMELALQCVD-VSSRRPSMRQIAGELEGI 503
E+ L C RP+ ++ +E I
Sbjct: 232 -----------YEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 48/206 (23%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 238 NFSEINIIGEGSFGLAYK-GLLQDGSLVVIK----RHL-QTQIQNFLHEVKHIARVHHRH 291
+F + +G+GS+G YK L D +K + Q + ++ ++E++ +A V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 292 LVKLVGFCE---ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRL-SIALGAAKG 347
++ + E + ++ ++ +Y P G++ + S+ KL Q + I + +G
Sbjct: 61 II---SYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPEL 407
L+ LH + H +++N+LL N K+ D G+ K++ + A + ++ PE+
Sbjct: 116 LQALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-AKTQIGTPHYMAPEV 172
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR 433
+ YS SD++S G L E+ +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 47/205 (22%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI-----QNFLHEVKHIARVHHRH 291
+ +I ++G G+FG+ + D LV+IK+ Q+ +E + + + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+++ E+ +++ +Y P G + ++ + + T+ L A L H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---LHHV 117
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTA-KVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS 410
H+ + + H +T N+LL+++ K+ D+G+ K+++ A + C++ PEL
Sbjct: 118 HTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG 175
Query: 411 KNYSAGSDVYSFGVFLLELISGREA 435
K Y+ SD+++ G L EL S + A
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 40/278 (14%)
Query: 245 IGEGSFGLAYKGLL-----QDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHLVKL 295
+GE +FG YKG L LV IK + Q F E +A +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLY------------DSEGLPIGKLTMRQRLSIALG 343
+G + ++++Y+ G++ L D +G L L IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS--HHAGSTSAVDC 401
A G+E+L S H N+L+ E K+SD GL + + + + S +
Sbjct: 133 IAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 402 -FLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGK 459
++ PE + +S+ SD++SFGV L E+ S G + + + S+Q +I V++
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY---YGFSNQEVIEMVRK------ 241
Query: 460 YVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQI 496
+ L + M L +C + SRRP + I
Sbjct: 242 ---RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVI--------KRHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
+G G+FG KG+ S + + H+ + FL E +A++ H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT--MRQRLSIALGAAKGLEHLHSL 354
G C+ +L+ + P G + +L +P+ L Q +A+G A LE H
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ---VAMGMAY-LESKH-- 115
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVDCFLD---PE-LNL 409
H NVLL + AK+SD+G+ + L GS + +T+A L PE +N
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 410 SKNYSAGSDVYSFGVFLLELIS 431
K +S+ SDV+S+GV L E S
Sbjct: 173 GK-FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 44/194 (22%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 254 YKGLLQDGSLVVIK--RHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL- 306
YKG+ + V+I+ + I +E+K++ R+ +++K+ GF + L
Sbjct: 37 YKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 307 ---LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV--PPLFHM 361
LI +Y G ++ L + L+ + +L +A+ KGL +L+ P +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 362 HFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPEL--NLSKNYSAGSDV 419
+ + + L+ ENY K+ +GL K+++ V + ++ ++ Y+ D+
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKDDI 205
Query: 420 YSFGVFLLELISGR 433
YS GV L E+ +G+
Sbjct: 206 YSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIKRHLQ--TQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG + G + V IK Q + FL E + ++ H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ- 72
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
+I +Y+ NG++ + L EG+ KLT+ + + +A A+G+ + H
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIE--RKNYIHRD 127
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVY 420
R +N+L+ E K++D+GL +L+ + + A + PE ++ SDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 421 SFGVFLLELISGREAHGR 438
SFG+ L E+++ +GR
Sbjct: 188 SFGILLTEIVT----YGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 56/241 (23%), Positives = 113/241 (46%), Gaps = 34/241 (14%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ--------------NFLHEVKHIARVHHR 290
+G+GSFG+ Y+G+ + V+K +T++ FL+E + +
Sbjct: 14 LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLY----DSEGLPIGKL-TMRQRLSIALGAA 345
H+V+L+G + L+I + + G+++++L + E P+ ++++ + +A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV--TGSHHAGSTSAVDC-F 402
G+ +L++ H N ++ E++T K+ D+G+ + + T + G + +
Sbjct: 130 DGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462
+ PE ++ SDV+SFGV L E+ + E + SN QV R G +D
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFVMEGGLLD 241
Query: 463 K 463
K
Sbjct: 242 K 242
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNF-----LHEVKHIARV-HHRH 291
+ I +G+G+FG Y + G LV IK+ ++ + ++ L EVK + ++ H +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK-MKKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+VKL EN + +++Y+ GN+ + D +G P + +R SI +GL H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR---SIIYQILQGLAHI 115
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD------- 404
H FH + N+L+ K++D+GL A + + D
Sbjct: 116 HKH--GFFHRDLKPENLLVSGPEVVKIADFGL---------AREIRSRPPYTDYVSTRWY 164
Query: 405 --PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
PE+ L S +YS+ D+++ G + EL + R
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-12
Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 34/295 (11%)
Query: 220 DTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLH 279
D++ K +TI ++ + E N+I G G +YKG + + + +
Sbjct: 676 DSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732
Query: 280 EVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLS 339
E+ + ++ H ++VKL+G C LI++YI N+ L + L+ +R
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRK 784
Query: 340 IALGAAKGLEHLHSLVPP-LFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA 398
IA+G AK L LH P + + ++++ + L L+ +SA
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA 843
Query: 399 VDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGRE----AHGRNHSNSDQNLILQVKR- 453
++ PE +K+ + SD+Y FG+ L+EL++G+ G + S I++ R
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS------IVEWARY 894
Query: 454 ---SCDLGKYVDKTLGEQTVGAATEM---MELALQCVDVS-SRRPSMRQIAGELE 501
C L ++D ++ E+ M LAL C + RP + LE
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 48/207 (23%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRH 291
N+ ++IG G+FG+ YKGL L+ G V IK+ + +++ + E+ + + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP--IGKLTMRQRLSIALGAAKGLE 349
+VK +G E + +I +Y NG+++ + P + + + Q L +GL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------QGLA 113
Query: 350 HLH--SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF-LDPE 406
+LH ++ H + +N+L ++ K++D+G+ + ++ + + PE
Sbjct: 114 YLHEQGVI----HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGR 433
+ S SD++S G ++EL++G
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 49/194 (25%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G+G FG + G + V IK + + FL E + + ++ H LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +++ G++ + L + +G L + Q + +A A G+ ++ + H
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERM--NYIHRD 127
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVY 420
R +N+L+ +N K++D+GL +L+ + + A + PE L ++ SDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 421 SFGVFLLELIS-GR 433
SFG+ L EL++ GR
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQR 337
H++++ L+G C ++ +I +Y GN++ +L YD +P ++T +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397
+S A+G+E+L S H NVL+ EN K++D+GL + V + T+
Sbjct: 140 VSCTYQVARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 398 AVDC---FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE + Y+ SDV+SFGV + E+ +
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G+G FG + G + V IK + + FL E + + ++ H LV+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
++ +Y+ G++ + L G L + Q + +A A G+ ++ + H
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 127
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVY 420
R +N+L+ EN KV+D+GL +L+ + + A + PE L ++ SDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 421 SFGVFLLELIS-GR 433
SFG+ L EL + GR
Sbjct: 188 SFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 45/226 (19%), Positives = 92/226 (40%), Gaps = 36/226 (15%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSL-----VVIKRHL-QTQIQNFLHEVKHI-ARV-H 288
++F IIGEGSF ++ + ++ KR L + + ++ K + R+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
H ++KL ++ + +Y PNG + ++ G L + A L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLAL 115
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC------- 401
E+LHS + H + N+LL+++ K++D+G K++ + S
Sbjct: 116 EYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 402 --------------FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
++ PEL K SD+++ G + ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 242 INIIGEGSFGLAYKGLL--------QDGSLVVIK----RHLQTQIQNFLHEVKHIARVHH 289
I +GEG FG K L G V +K I + E++ + ++H
Sbjct: 9 IRDLGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65
Query: 290 RHLVKLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
++VK G C E+ LI +++P+G+++ +L ++ K+ ++Q+L A+ KG
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKG 121
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSHHAGSTSAVDC---FL 403
+++L S H NVL+E + K+ D+GL K + T + +D +
Sbjct: 122 MDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 243 NIIGEGSFGLAYKGLLQD------GSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRH 291
N +G G+FG Y+G D G + V + L+ + + FL E ++ +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS--EGLPIGKLTMRQRLSIALGAAKG-- 347
+VKL+G C N Q +I + + G++ ++L D+ E LT+++ L I L AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 348 -LEHLHSLVPPLFHMHFRTSNVLL-EENYTA----KVSDYGLLKLVTGSHH---AGSTSA 398
LE +H H N L+ E+ Y A K+ D+GL + + S + G
Sbjct: 121 YLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 399 VDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE L ++ SDV+SFGV + E+++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHH 289
F +I ++G G+FG YKGL + +G V I ++ + L E +A V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
H+ +L+G C + Q LI +P G + +++ + + + + L+ + AKG+
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMN 123
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG---SHHAGSTSAVDCFLDPE 406
+L L H NVL++ K++D+GL KL+ +HA ++ E
Sbjct: 124 YLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS 431
L + Y+ SDV+S+GV + EL++
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 31/216 (14%)
Query: 245 IGEGSFGLAY----KGLLQ----------DGSLVVIKRHLQTQI-----QNFLHEVKHIA 285
+GEG FG + +GL + ++V + L+ + +FL E+K ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSE-------GLPIGKLTMRQRL 338
R+ + ++++L+G C + +I +Y+ NG++ L E I +++ L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 339 SIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTS 397
+A+ A G+++L SL H T N L+ +YT K++D+G+ + L +G ++
Sbjct: 133 YMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 398 AVDC--FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
AV ++ E L ++ SDV++FGV L E+ +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQI-----QNFLHEVKHIARVHHRH 291
+ I IGEGSFG Y + D VIK T++ + EV +A++ H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+V +EN + ++ +Y G++ + G+ + Q LS + + GL+H+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV---LFSEDQILSWFVQISLGLKHI 117
Query: 352 HSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLLKLVTGSHHAGSTSA-VDCFLDPELNL 409
H + H ++ N+ L +N AK+ D+G+ + + S T +L PE+
Sbjct: 118 HD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
++ Y+ +D++S G L EL + + N+ L+L++ + +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQG---------YFAPIS 223
Query: 470 VGAATEMMELALQCVDVSSR-RPSMRQI 496
+ ++ L Q VS R RPS+ I
Sbjct: 224 PNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 56/242 (23%), Positives = 115/242 (47%), Gaps = 36/242 (14%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ--------------NFLHEVKHIARVHHR 290
+G+GSFG+ Y+G +D +IK +T++ FL+E +
Sbjct: 14 LGQGSFGMVYEGNARD----IIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLY----DSEGLPIGKL--TMRQRLSIALGA 344
H+V+L+G + L++ + + +G+++++L ++E P G+ T+++ + +A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEMIQMAAEI 128
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV--TGSHHAGSTSAVDC- 401
A G+ +L++ H N ++ ++T K+ D+G+ + + T + G +
Sbjct: 129 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461
++ PE ++ SD++SFGV L E+ S E + SN QV + G Y+
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVMDGGYL 240
Query: 462 DK 463
D+
Sbjct: 241 DQ 242
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 50/268 (18%), Positives = 114/268 (42%), Gaps = 27/268 (10%)
Query: 238 NFSEINIIGEGSFGLA--YKGLLQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHR 290
++ I ++G+G+FG A Y+ +D SLVV K R + + ++ L+E+ ++ + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
+++ +++ L+ +Y G + + + +G L + +
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIVSAVSY 116
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVDCFLDPELNL 409
+H + H +T N+ L + K+ D+G+ K L + A + ++ PEL
Sbjct: 117 IHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
Y+ SD+++ G L EL++ + + + I+Q + + Y
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY--------- 225
Query: 470 VGAATEMMELALQCVDVS-SRRPSMRQI 496
++E++ L + +RP+ ++
Sbjct: 226 ---SSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQR 337
H++++ L+G C ++ ++ +Y GN++ +L +D+ LP +LT +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397
+S A A+G+E+L S H NVL+ E+ K++D+GL + V + T+
Sbjct: 137 VSCAYQVARGMEYLAS--QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 398 AVDC---FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE + Y+ SDV+SFGV L E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKRHL--------QTQIQNFLHEVKHIARVHHRHLVKL 295
+G GSFG Y+GL L DG +K Q ++ E+ ++++ H ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 296 VGFCEENHQQLLIY-DYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
+G E L I+ + +P G++ L Y S P+ +L RQ L GLE+LH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------LGLEYLH 119
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKN 412
H + +N+L++ N K++D+G+ K V A S ++ PE+ +
Sbjct: 120 D--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 413 -YSAGSDVYSFGVFLLELISGR 433
Y +D++S G +LE+ +G+
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQIQNFLH-----EVKHIARVHHR 290
N + + ++GEG++G+ K + G +V IK+ +++ + EVK + ++ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSE-GLPIG--KLTMRQRLSIALGAAKG 347
++V L + L+++Y+ + L S GLP + + Q L +
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL-------QA 112
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC--FLDP 405
+ + HS + H + N+L+ E+ K+ D+G + + + T V + P
Sbjct: 113 IAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 406 ELNL-SKNYSAGSDVYSFGVFLLELISGR 433
EL + NY DV++ G + EL+ G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
F+++ IG+GSFG +KG+ + +V IK + +I++ E+ +++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
K G ++ + +I +Y+ G+ + L G L Q +I KGL++LHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS 119
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-HAGSTSAVDCFLDPELNLSKN 412
H + +NVLL E+ K++D+G+ +T + + ++ PE+
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNH 440
Y + +D++S G+ +EL G H H
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 19/173 (10%)
Query: 276 NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQ-----NHLYDSEG---- 326
+FL EVK ++R+ ++++L+G C + +I +Y+ NG++ +HL D E
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 327 -----LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381
+ ++ L +AL A G+++L SL H T N L+ EN T K++D+
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADF 182
Query: 382 GLLK-LVTGSHHAGSTSAVDC--FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
G+ + L G ++ AV ++ E L ++ SDV++FGV L E++
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 76/289 (26%), Positives = 132/289 (45%), Gaps = 39/289 (13%)
Query: 242 INIIGEGSFG---LAYKGLLQD--GSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHL 292
I +G+G+FG L LQD G +V +K+ LQ +++F E++ + + H ++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK-LQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 293 VKLVGFC-EENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
VK G C + L L+ +Y+P G+++++L +L R+ L A KG+E+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEY 123
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-----AGSTSAVDCFLDP 405
L S H T N+L+E K+ D+GL K++ S + +
Sbjct: 124 LGSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS---------DQNLILQVKRSCD 456
L SK +S SDV+SFGV L EL + + ++ S D+ + V +
Sbjct: 182 SLTESK-FSVASDVWSFGVVLYELFTYSD---KSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQ 504
L K + G E+ + +C + S+RPS ++A ++E I+
Sbjct: 238 LLK--NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR--------HLQTQIQNFLHEVKHIARVH 288
E++ +GEG+ G K L++ ++ + LQ QI L E++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI---LRELEINKSCK 57
Query: 289 HRHLVKLVGFCEENHQQLL--IYDYIPNGNVQNHLYDSEGLPIGKLTMRQR----LSIAL 342
++VK G + + +Y G++ DS + K R IA
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 343 GAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG---SHHAGSTSAV 399
KGL +LHS + H + SN+LL K+ D+G V+G + AG+ +
Sbjct: 113 SVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGT 166
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
++ PE K YS SDV+S G+ LLE+ R
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 245 IGEGSFGLAYKGLLQD------GSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+G+GSFG+ Y+GL + + V IK + FL+E + + H+V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLY----DSEGLPIGKLTMRQR-LSIALGAAKGLE 349
L+G L++ + + G+++++L ++E P Q+ + +A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV--TGSHHAGSTSAVDC-FLDPE 406
+L + H N ++ E+ T K+ D+G+ + + T + G + ++ PE
Sbjct: 134 YLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS 431
++ SDV+SFGV L E+ +
Sbjct: 192 SLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 22/160 (13%)
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQR 337
H++++ L+G C ++ +I +Y GN++ +L Y+ +P +L+ +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397
+S A A+G+E+L S H NVL+ E+ K++D+GL + + HH
Sbjct: 143 VSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDI---HHIDYYK 197
Query: 398 AVDC------FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE + Y+ SDV+SFGV L E+ +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 49/214 (22%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK-------------RHLQTQIQNFLHEVKHIARVHH 289
+IG GSFG Y G+ G L+ +K R ++ + E+ + + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRK-RSMLDALAREIALLKELQH 65
Query: 290 RHLVKLVGFCEENHQQLLIY-DYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAK 346
++V+ +G + L I+ +Y+P G+V L Y + + + +RQ L K
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------K 117
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-------TGSHHAGSTSAV 399
GL +LH+ + H + +N+L++ K+SD+G+ K + + S
Sbjct: 118 GLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
++ PE+ +Y+ +D++S G ++E+++G+
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 53/212 (25%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK----------RHLQTQ---IQNFLHEVKHIARVHH 289
+IG+G++G Y L + G ++ +K RH Q ++ E++ + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 290 RHLVKLVGFCEENHQQLLIY-DYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAK 346
++V+ +GF E + L I+ +Y+P G++ + L Y + + Q L +
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-------E 119
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL---VTGSHHAGSTSAVDCFL 403
GL +LHS + H + N+L++ + K+SD+G+ K + + S ++
Sbjct: 120 GLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 404 DPEL--NLSKNYSAGSDVYSFGVFLLELISGR 433
PE+ + S+ YSA D++S G +LE+ +GR
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 61/241 (25%), Positives = 112/241 (46%), Gaps = 33/241 (13%)
Query: 275 QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSE----GLPIG 330
++FL EVK ++R+ ++ +L+G C + +I +Y+ NG++ L GL
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 331 KLTMRQR--LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LV 387
++ L +A A G+ +L SL H T N L+ +NYT K++D+G+ + L
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 388 TGSHHAGSTSAV--------DCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGR 438
+ ++ A + L L K ++ SDV++FGV L E+++ RE +
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVL-----LGK-FTTKSDVWAFGVTLWEILTLCRE---Q 232
Query: 439 NHSN-SDQNLILQVKR-SCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQ 495
+ + +DQ +I D G+ + + ++ EL L+C RP+ R+
Sbjct: 233 PYEHLTDQQVIENAGHFFRDDGRQI---YLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289
Query: 496 I 496
I
Sbjct: 290 I 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
F+++ IG+GSFG +KG+ + +V IK + +I++ E+ +++ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
K G + + +I +Y+ G+ + L P + + L L KGL++LHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEIL---KGLDYLHS 119
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF-LDPELNLSKN 412
H + +NVLL E K++D+G+ +T + +T F + PE+
Sbjct: 120 --EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNH 440
Y + +D++S G+ +EL G + H
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 52/225 (23%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 239 FSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQTQIQN-----FLHEVKHIARVHH 289
+ ++ IGEGSFG K +L +DG VIK +++ EV ++ + H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++V+ EEN ++ DY G++ + G+ + Q L + L+
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE---DQILDWFVQICLALK 115
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS-AVDCFLDPELN 408
H+H + H ++ N+ L ++ T K+ D+G+ +++ + T +L PE+
Sbjct: 116 HVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC 173
Query: 409 LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453
++ Y+ SD+++ G L E+ + + A + + +NL+L++ R
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAF---EAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 21/200 (10%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
IGEG++G+ YK G +V IK+ + + L E+K + ++H +++KL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPL 358
L+++++ + ++ L + + ++ S +GL HS +
Sbjct: 67 FRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIK---SYLYQLLQGLAFCHS--HGI 119
Query: 359 FHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH----HAGSTSAVDCFLDPELNL-SKNY 413
H + N+L+ K++D+GL + H T + PEL L K Y
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR---WYRAPELLLGDKGY 176
Query: 414 SAGSDVYSFGVFLLELISGR 433
S D++S G EL+S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 241 EINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQN--------FLHEVKHIARVHHRH 291
++ ++G G+FG YKG+ + DG V I ++ +N L E +A V +
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+ +L+G C + QL + +P G + +++ +++ ++ + L+ + AKG+ +L
Sbjct: 71 VCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYL 125
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV---TGSHHAGSTSAVDCFLDPELN 408
+ L H NVL++ K++D+GL +L+ +HA ++ E
Sbjct: 126 EEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 409 LSKNYSAGSDVYSFGVFLLELIS 431
L + ++ SDV+S+GV + EL++
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 54/227 (23%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQDGSLV----------VIKRHLQTQIQNFLHEVKHIARV 287
+F + +IG+G+FG +D + +++ ++N L+E + + +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKG---SVRNVLNERRILQEL 57
Query: 288 HHRHLVKL-VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLS-IALGAA 345
+H LV L F +E + L++ D + G+++ HL S+ + + ++ + I L
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVV-DLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA-- 112
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDP 405
LE+LHS + H + N+LL+E ++D+ + VT STS ++ P
Sbjct: 113 --LEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK 452
E+ + YS D +S GV E + G+ + R HS + ++ I +
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 45/222 (20%)
Query: 244 IIGEGSFGLAYKGLL-----QDGSLVVIKRHL-----QTQIQNFLHEVKHIARV-HHRHL 292
+GEG+FG K + + V + L + + + + E++ + + H+++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQRLSIA 341
+ L+G C + ++ +Y +GN+++ L D P LT + +S A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC 401
A+G+E L S H NVL+ E++ K++D+GL + + HH +D
Sbjct: 139 YQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLARDI---HH------IDY 187
Query: 402 F------------LDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ + PE + Y+ SDV+SFGV L E+ +
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHL------QTQIQNFLHEVKHIARVHHRH 291
F+++ IG GSFG Y ++ +V IK+ + Q+ + EV+ + ++ H +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQR--LSIALGAAKGLE 349
++ G H L+ +Y S+ L + K +++ +I GA +GL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSA-------SDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
+LHS H + N+LL E T K++D+G LV+ A S ++ PE+ L
Sbjct: 130 YLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVIL 184
Query: 410 SKN---YSAGSDVYSFGVFLLEL 429
+ + Y DV+S G+ +EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 49/211 (23%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNF-----LHEVKH----IA 285
++ ++G G FG +KG+ + +G + I ++T IQ+ E+ +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT-IQDRSGRQTFQEITDHMLAMG 64
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAA 345
+ H ++V+L+G C QL + P G++ +H+ L ++ L+ + A
Sbjct: 65 SLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRD----SLDPQRLLNWCVQIA 119
Query: 346 KGLEHL--HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-- 401
KG+ +L H +V H + N+LL+ + +++D+G+ L+ S
Sbjct: 120 KGMYYLEEHRMV----HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 402 -FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ E L Y+ SDV+S+GV + E++S
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQR 337
H++++ L+G C + +I +Y GN++ L +D +P +L+ +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397
+S A A+G+E+L S H NVL+ E+ K++D+GL + V + TS
Sbjct: 137 VSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 398 AVDC---FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE + Y+ SDV+SFG+ + E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 67/284 (23%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 244 IIGEGSFGLAYKGLL--QDGSLV-----VIKRHL--QTQIQNFLHEVKHIARVHHRHLVK 294
++G+G FG + L +DGS ++K + + I+ FL E + H +++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 295 LVGFCEENHQQ------LLIYDYIPNGNVQNHLYDSEGLPIGK----LTMRQRLSIALGA 344
L+G + + ++I ++ +G++ L S IG+ L ++ + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR---IGEEPFTLPLQTLVRFMIDI 122
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHH-AGSTSAVDCF 402
A G+E+L S H N +L EN T V+D+GL K+ +G ++ G S +
Sbjct: 123 ASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 403 LDPELNLSKN-YSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKY 460
+L+ N Y+ SDV++FGV + E+++ G+ + ++ N +++ R
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL------ 234
Query: 461 VDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGI 503
+Q ++ EL QC RPS + + +LE I
Sbjct: 235 ------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 53/212 (25%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 238 NFSEINIIGEGSFGLAYKGLL--QDGSLVVIKRHLQT-------QIQ-NFLHEVKHIARV 287
+ + + +G G+FG Y+GL +DG V ++ ++T Q + +FL E +++
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI--GKLTMRQRLSIALGAA 345
+H+++V+L+G E + ++ + + G++++ L ++ P LTM+ L A A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLE---ENYTAKVSDYGLLKLVTGSHH---AGSTSAV 399
KG ++L H N LL AK++D+G+ + + + + G
Sbjct: 127 KGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE L +++ +DV+SFGV L E+ S
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIARVHHRH 291
F+++ IG GSFG Y ++ +V IK+ + Q+ + EVK + R+ H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
++ G H L+ +Y + L + P+ ++ + +I GA +GL +L
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIA---AITHGALQGLAYL 141
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK 411
HS + H + N+LL E K++D+G + + A S ++ PE+ L+
Sbjct: 142 HS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAM 196
Query: 412 N---YSAGSDVYSFGVFLLEL 429
+ Y DV+S G+ +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQN--------FLHEVKHIARVHH 289
+ ++G G+FG YKG+ + +G V I ++ + F+ E +A + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
HLV+L+G C QL + +P+G + +++++ + IG + L+ + AKG+
Sbjct: 69 PHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKD-NIGSQLL---LNWCVQIAKGMM 123
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG---SHHAGSTSAVDCFLDPE 406
+L L H NVL++ K++D+GL +L+ G ++A ++ E
Sbjct: 124 YLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS 431
+ ++ SDV+S+GV + EL++
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 237 NNFSEINIIGEGSFG-----LAYKGLLQDGSLVVIKRHLQ-----TQIQNFLHEVKHIAR 286
NN S +G G+FG AY D + V + L+ ++ + + E+K ++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 287 V-HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLY-DSEGLPIGKLTMRQRLSIALGA 344
+ +H ++V L+G C L+I +Y G++ N L E LT+ LS +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF----LTLEDLLSFSYQV 150
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHA--GSTSAVDC 401
AKG+ L S H NVLL K+ D+GL + ++ S++ G+
Sbjct: 151 AKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE + Y+ SDV+S+G+ L E+ S
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ---IQN-FLHEVKHIARVHHRH 291
+ + IGEG+ G+ +K + G V +K+ L+ I N L E+K + H +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNG--NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+VKL+ +L+ +Y+P+ V K MR L KG+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL-------KGVA 113
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC--FLDPEL 407
++H+ + H + +N+L+ + K++D+GL +L + + V + PEL
Sbjct: 114 YMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 408 NL-SKNYSAGSDVYSFGVFLLELISGR 433
++ Y G D+++ G EL++G
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 19/199 (9%)
Query: 244 IIGEGSFGLAYKGLLQDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVKL 295
IGEG FG Y+G+ I ++T + FL E + + H H+VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHL-YDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
+G EN ++ + P G ++++L + L + L + + + L +L S
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALAYLESK 126
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS--HHAGSTSAVDCFLDPELNLSKN 412
H NVL+ K+ D+GL + + + A ++ PE +
Sbjct: 127 --RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 413 YSAGSDVYSFGVFLLELIS 431
+++ SDV+ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
F+++ IG+GSFG YKG+ + +V IK + +I++ E+ +++ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+ G + + +I +Y+ G+ + L G L +I KGL++LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS 119
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF-LDPELNLSKN 412
H + +NVLL E K++D+G+ +T + +T F + PE+
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNH 440
Y +D++S G+ +EL G + H
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 44/202 (21%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ-IQNFLHEVKHIARVHHRHL 292
+ + IGEG+ G YK G V IK+ L+ Q + ++E+ + H ++
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V + ++ +Y+ G++ + + + ++ Q + +GLE+LH
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV----RMNEPQIAYVCREVLQGLEYLH 133
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC--FLDPELNLS 410
S + H ++ N+LL ++ + K++D+G +T + S V ++ PE+
Sbjct: 134 SQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVVGTPYWMAPEVIKR 190
Query: 411 KNYSAGSDVYSFGVFLLELISG 432
K+Y D++S G+ +E+ G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 245 IGEGSFGLAYKGLL-QDGSL--VVIKRH-----LQTQIQNFLHEVKHIARVHHRHLVKLV 296
+GEG FG +G L QD S+ V +K ++++++FL E + H ++++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 297 GFCEENHQQ------LLIYDYIPNGNVQNHL-YDSEGLPIGKLTMRQRLSIALGAAKGLE 349
G C + + ++I ++ +G++ + L Y G L + + A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS--HHAGSTSAVDC-FLDPE 406
+L S H N +L EN V+D+GL K + + G + + ++ E
Sbjct: 127 YLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 407 LNLSKNYSAGSDVYSFGVFLLEL 429
+ Y+ SDV+SFGV + E+
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRH 291
++ + ++G+GS G+ YK + G + +K+ + + L E+K + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIALGAAKGL 348
+VK G + + ++ +Y+ G++ + L +P + + RQ L KGL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIA-RQIL-------KGL 112
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC------- 401
++LH+ + H + SN+L+ K++D+G+ K++ + C
Sbjct: 113 DYLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-------ENTLDQCNTFVGTV 164
Query: 402 -FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
++ PE ++YS +D++S G+ LLE G+
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 41/210 (19%)
Query: 245 IGEGSFGLAYK-GLLQDGSL----VVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLV- 296
+G+GSFG G L V+ K+ + ++++ L E ++R++H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 297 GFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA-LGAAKGLEHLHSL 354
F E L L+ +Y P G + +HL R R A + A LE+LHSL
Sbjct: 61 AFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAAEIVLA--LEYLHSL 112
Query: 355 ------VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVDC----FL 403
+ P N+LL+ + K++D+GL K L + + C +L
Sbjct: 113 GIIYRDLKP--------ENILLDADGHIKLTDFGLAKELSSEGSRTNT----FCGTPEYL 160
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGR 433
PE+ L K Y D +S GV L E+++G+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (139), Expect = 5e-09
Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRHL 292
+ ++ +GEG++G+ YK + G +V +K+ L + + L E+ + + H ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYD-SEGLPIG--KLTMRQRLSIALGAAKGLE 349
VKL+ + L+++Y +++ +L L K M Q L GL
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR-------GLA 112
Query: 350 HLHSLVPPLFH--MH--FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD- 404
+ HS H +H + N+L+ + K++D+GL + + +
Sbjct: 113 YCHS------HRILHRDLKPQNILINRDGVLKLADFGLARAFG--------IPLRTYTHE 158
Query: 405 --------PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
PE+ L SK+YS D++S G E+I+G+
Sbjct: 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 244 IIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ------------NFLHEVKHIARVHHRH 291
I+G G FG +G L+ S KR L I FL E + + H +
Sbjct: 12 ILGTGRFGELCRGCLKLPS----KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+V+L G + +++ +Y+ NG + + L E G+L Q + + G A G+++L
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYL 123
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL---KLVTGSHHAGSTSAVDCFLDPELN 408
+ H VL+ + K+S + L K S V + PE
Sbjct: 124 SEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV-LWAAPEAI 180
Query: 409 LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444
++S+ SDV+SFG+ + E++S E + S D
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 28/225 (12%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLL---------QDGSLVVIKRHLQTQI-QNFLHE 280
E+ +T F E +GE FG YKG L Q ++ +K + + + F HE
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 281 VKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLY-----------DSEGLPI 329
+R+ H ++V L+G + +I+ Y + ++ L D +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 330 GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389
L + I A G+E L S + H T NVL+ + K+SD GL + V
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 390 SHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ + G++ ++ PE + +S SD++S+GV L E+ S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 44/168 (26%), Positives = 87/168 (51%), Gaps = 17/168 (10%)
Query: 276 NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV---------QNHLYDSEG 326
+FL E+K ++R+ ++++L+ C + +I +Y+ NG++ Q ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 327 LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK- 385
+ I T+ +A A G+++L SL H T N L+ +NYT K++D+G+ +
Sbjct: 125 VTISYSTLI---FMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 386 LVTGSHHAGSTSAVDC--FLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
L +G ++ AV ++ E L ++ SDV++FGV L E+++
Sbjct: 180 LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNFLHEVKHIARVHHRHLVKLV 296
F + +GEGS+G YK + + G +V IK ++ +Q + E+ + + ++VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGK-LTMRQRLSIALGAAKGLEHLHSLV 355
G +N ++ +Y G+V + + K LT + +I KGLE+LHS
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSV-SDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDCFLDPELNLSKNYS 414
H + N+LL E AK++D+G+ +L + ++ PE+ Y+
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 415 AGSDVYSFGVFLLELISGR 433
+D++S G+ +E+ G+
Sbjct: 178 NKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 48/220 (21%), Positives = 91/220 (41%), Gaps = 20/220 (9%)
Query: 245 IGEGSFGLAYKGLLQD-GSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLVKLVG 297
+G+G FG ++ G + K+ + ++ Q L+E K + +V R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLY--DSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
E L+ + G+++ H+Y G P + + A GLEHLH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIICGLEHLHQRR 115
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSA 415
+ + + NVLL+++ ++SD GL + G + ++ PE+ + Y
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 416 GSDVYSFGVFLLELISGR---EAHGRNHSNSD-QNLILQV 451
D ++ G L E+I+GR + + L++
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVV-IKR----HLQTQIQNFLHEVKHIARVHHRHLVKLV 296
I +IG G+ + Y + + V IKR QT + EV+ +++ +H ++VK
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 297 GFCEENHQQLLIYDYIPNG---NVQNHLYDSEGLP--IGKLTMRQRLSIALGAAKGLEHL 351
+ L+ Y+ G ++ Y GL I +++ L KGLE+L
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL-------KGLEYL 118
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYG----LLKLVTGSHHAGSTSA-VDCFLDPE 406
HS H + N+LL E+ + K++D+G L + T C++ PE
Sbjct: 119 HS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 407 LNLSKN-YSAGSDVYSFGVFLLELISGR 433
+ + Y +D++SFG+ +EL +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 245 IGEGSFGLAYKG-LLQDGSLVV---IK----RHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
+G+GSFG+ +G G V+ +K L + +FL E + + H +L++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEG--LPIGKLTMRQRLSIALGAAKGLEHLHSL 354
G H +++ + P G++ + L I L A+ A G+ +L S
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLES- 115
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVD---CFLDPELNLS 410
H N+LL + K+ D+GL++ L H + + PE +
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 411 KNYSAGSDVYSFGVFLLELIS-GRE 434
+ +S SDV+ FGV L E+ + G E
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 47/221 (21%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQN-----FLHEVKHIARVHHRH 291
F ++N IGEG++G+ Y+ G +V +K+ ++ L E+ + + H +
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 292 LVKL---------------VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQ 336
+V+L + +CE++ LL N+ +S+ K M Q
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-------DNMPTPFSESQ----VKCLMLQ 116
Query: 337 RLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST 396
L +GL++LH + H + SN+LL + K++D+GL + T A
Sbjct: 117 LL-------RGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM 165
Query: 397 SAVDCFL---DPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
+ L PEL L Y+ D+++ G L EL++ +
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK------RHLQTQIQNFLHEVKHIARVHHRH 291
FS++ IG GSFG Y +++ +V IK + + Q+ + EV+ + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
++ G H L+ +Y + L + P+ ++ + ++ GA +GL +L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIA---AVTHGALQGLAYL 131
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK 411
HS + H + N+LL E K+ D+G ++ A ++ PE+ L+
Sbjct: 132 HS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAM 186
Query: 412 N---YSAGSDVYSFGVFLLEL 429
+ Y DV+S G+ +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 38/236 (16%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRH 291
+ ++ IGEG++G+ G V IK+ H QT Q L E+K + R H +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHEN 64
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQ--NHLYDSEGL---PIGKLTMRQRLS------I 340
++ I D I + + N +Y + L + KL Q LS
Sbjct: 65 IIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYF 111
Query: 341 ALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-HAGSTS-- 397
+GL+++HS + H + SN+LL N K+ D+GL ++ H H G +
Sbjct: 112 LYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 398 -AVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451
A + PE+ L SK Y+ D++S G L E++S R NLIL V
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 55/224 (24%), Positives = 113/224 (50%), Gaps = 27/224 (12%)
Query: 245 IGEGSFGLAYKGLLQD-GSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVG-FC 299
+G+G+FG YK ++ G+L VI+ + ++++++ E++ +A +H ++VKL+G F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 300 EENHQQLLIYDYIPNGNVQNHLYD-SEGL--PIGKLTMRQRLSIALGAAKGLEHLHSLVP 356
+ ++I ++ P G V + + GL P ++ RQ L + L++LHS+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQML-------EALQYLHSM-- 129
Query: 357 PLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDCFLDPELNLSKN--- 412
+ H + NVLL + K++D+G+ K V S ++ PE+ + +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 413 --YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454
Y +D++S G+ L+E+ H H + ++L++ +S
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKS 230
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 239 FSEINIIGEGSFGLAYKGLLQD-GSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRHL 292
F I IGEG++G YK +D G LV +K+ L + + F + E+K + +++HR++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 293 VKL----------VGFCEENHQQLLIYDYIPN---GNVQNHLYDSEGLPIGKLTMRQRLS 339
V L + F ++ L+++Y+ + G +++ L I M+Q L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-MKQLL- 126
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399
+GL + H H + SN+LL K++D+GL +L T+ V
Sbjct: 127 ------EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 400 DC--FLDPELNLSKN-YSAGSDVYSFGVFLLELISGR 433
+ PEL L + Y DV+S G L EL + +
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 47/210 (22%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 243 NIIGEGSFGLAYKGLLQDGSLVVIKR---------HLQTQIQNFLHEVKHIARVHHRHLV 293
++G+G++G Y GL G L+ +K+ + + + EV + + H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIALGAAKGLEH 350
+ +G C +++ + +++P G++ + L LP K T +Q L G+ +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYT-KQIL-------DGVAY 117
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL-------VTGSHHAGSTSAVDCFL 403
LH+ + H + +NV+L N K+ D+G + T S+ S ++
Sbjct: 118 LHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGR 433
PE+ Y SD++S G + E+ +G+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 280 EVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLY----DSEGLPIGKLTMR 335
E + +A+VH R +V L + L+ + G+++ H+Y ++ G P +
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 336 QRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAG 394
I+ GLEHLH + + + NVLL+ + ++SD GL ++L G
Sbjct: 103 TAQIIS-----GLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155
Query: 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ F+ PEL + Y D ++ GV L E+I+ R
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQ--IQ-----NFLHEVKH--I 284
+ + IG+GSFG K DG ++V K ++ + Q N L E+KH I
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 285 ARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL--YDSEGLPIGK----LTMRQRL 338
R + R + + N ++ +Y G++ + E I + + Q L
Sbjct: 62 VRYYDRIIDR------SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ-L 114
Query: 339 SIALGAAKGLEHLHSLVPP---LFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS 395
+AL H+ P + H + +N+ L+ N K+ D+GL K++
Sbjct: 115 LLAL------YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 396 TSA-VDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNH 440
T ++ PE +Y SD++S G + EL + RN
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 51/218 (23%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 230 LELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT---QIQNFLHEVKHIA 285
LE ++ + E ++G+G++G+ Y L + IK + +Q E+ +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEG-LPIGKLTM----RQRLSI 340
+ HR++V+ +G EN + + +P G++ L G L + T+ +Q L
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-- 118
Query: 341 ALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA--KVSDYGLLKLVTGSHHAGST-S 397
+GL++LH + H + NVL+ Y+ K+SD+G K + G + T +
Sbjct: 119 -----EGLKYLHDN--QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTETFT 170
Query: 398 AVDCFLDPEL--NLSKNYSAGSDVYSFGVFLLELISGR 433
++ PE+ + Y A +D++S G ++E+ +G+
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIARVHHRH 291
F ++ IG GSFG Y +V +K+ + Q+ + EVK + ++ H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
++ G + H L+ +Y + L + P+ ++ + +I GA +GL +L
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIA---AITHGALQGLAYL 137
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK 411
HS + H + N+LL E K++D+G + A S ++ PE+ L+
Sbjct: 138 HSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAM 192
Query: 412 N---YSAGSDVYSFGVFLLEL 429
+ Y DV+S G+ +EL
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 43/229 (18%)
Query: 232 LKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLH----EVKHIAR 286
L T F + +IGEG++G YK + G LV IK I + + E+K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK------IMDIIEDEEEEIKEEYN 54
Query: 287 V-----HHRHLVKLVG-FCEENHQ----QL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMR 335
+ +H ++ G F ++N QL L+ + G+V + L G
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-------LVKGLRKKG 107
Query: 336 QRLS------IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389
+RL I +GL +LH + H + N+LL +N K+ D+G+ +
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165
Query: 390 SHHAGSTS-AVDCFLDPEL-----NLSKNYSAGSDVYSFGVFLLELISG 432
+ +T ++ PE+ +Y A SDV+S G+ +EL G
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 24/205 (11%)
Query: 243 NIIGEGSFGLAYKGLLQDGS-LVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGF-- 298
NIIG GSFG+ Y+ + D S V IK+ LQ Q +N E+ + ++H +++ L +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYY 129
Query: 299 ---CEENHQQL---LIYDYIP---NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++N + + ++ ++IP + ++++ ++ LP L + + S L + L
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP---LFLVKLYSYQL--CRALA 184
Query: 350 HLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELN 408
++HS + H + N+L++ N +T K+ D+G K + + S + PEL
Sbjct: 185 YIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242
Query: 409 L-SKNYSAGSDVYSFGVFLLELISG 432
L + NY+ D++S G + E+I G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLV----VIKRHLQTQIQN-FLHEVKHIARVHHRH 291
++ + +G G+ G+ K L + + I+ + IQ L E+ + + + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEG----LPIGKLTMRQRLSIALGAAKG 347
+V G N + +Y+ G++ L + +G +GK IA+ KG
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--------IAVAVLKG 112
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPEL 407
L +LH + H + SN+L+ K+ D+G+ + S A + ++ PE
Sbjct: 113 LTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-AKTFVGTSSYMAPER 170
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR 433
+YS SD++S G+ L+EL +GR
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 49/220 (22%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 242 INIIGEGSFG--LAYKGLLQDGSLVVIKRHL---QTQIQNFLHEVKHIARVHHRHLVKLV 296
+ ++GEGSFG L + + D + + L + +++ E +A++ H ++V
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP 356
E + ++ +Y G++ + G + T+ L + G++H+H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI---LQWFVQMCLGVQHIHE--K 119
Query: 357 PLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAGSTSAVDCFLDPELNLSKNYSA 415
+ H ++ N+ L +N K+ D+G +L+T +A + ++ PE+ + Y+
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 416 GSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455
SD++S G L EL + + +NS +NLIL+V +
Sbjct: 180 KSDIWSLGCILYELCTLKHPF---QANSWKNLILKVCQGS 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 5e-07
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 232 LKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT--QIQNFLHEVKHIARV- 287
L+ F + ++G G++G YKG ++ G L IK T + + E+ + +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 288 HHRHLVKLVG-FCEEN-----HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
HHR++ G F ++N Q L+ ++ G+V + + +++G L I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYIC 117
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL---LKLVTGSHHAGSTSA 398
+GL HLH + H + NVLL EN K+ D+G+ L G + +
Sbjct: 118 REILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--TFIG 173
Query: 399 VDCFLDPEL-----NLSKNYSAGSDVYSFGVFLLELISG 432
++ PE+ N Y SD++S G+ +E+ G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 46/208 (22%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRH 291
NF ++ IGEG++G+ YK G +V +K+ L T+ + + E+ + ++H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+VKL+ ++ L+++++ + +++ + + P+ + + S +GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-----LKLVTGSHHAGSTSAVDCFLDPE 406
HS + H + N+L+ K++D+GL + + T +H + + PE
Sbjct: 117 HS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL----WYRAPE 170
Query: 407 LNL-SKNYSAGSDVYSFGVFLLELISGR 433
+ L K YS D++S G E+++ R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 17/150 (11%)
Query: 245 IGEGSFGLAYKGLLQDG---SLVVIKR-----HLQTQIQNFLHEVKHIARVHHRHLVKLV 296
IG G FG G + G + VV+K +Q Q++ FL E + + H +L++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQCL 61
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYD---SEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
G C E LL+ ++ P G+++ +L +E + T+++ +A A GL HLH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR---MACEIALGLLHLHK 118
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383
H N LL + T K+ DYGL
Sbjct: 119 --NNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 39/232 (16%)
Query: 242 INIIGEGSFG---------------LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKH--I 284
+ ++G+GSFG L +L+ +L V R ++ L EV H I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 285 ARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA 344
++H+ F E + LI D++ G++ L K M +
Sbjct: 61 VKLHY-------AFQTEG-KLYLILDFLRGGDLFTRL--------SKEVMFTEEDVKFYL 104
Query: 345 AK---GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVD 400
A+ L+HLHSL + + + N+LL+E K++D+GL K + A S
Sbjct: 105 AELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK 452
++ PE+ + ++ +D +SFGV + E+++G +IL+ K
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 47/212 (22%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSL--VVIKRH------LQTQIQNFLHEVK 282
+ K +F+ I +G GSFG ++ V IKR Q Q+ + E K
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 283 HIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP--IGKLTMRQRLSI 340
+ ++H V L G ++ L+ +++ G L ++ P +G Q + I
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143
Query: 341 ALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
E+L SL + + + N+LL+++ K++D+G K+V + +
Sbjct: 144 -------FEYLQSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTP 192
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
++ PE+ L+ + +D ++ G+F+ E++ G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 64/284 (22%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLV----VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLV- 296
I +G+G+FG YK ++ ++ VI + ++++++ E+ +A H ++VKL+
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP 356
F EN+ +LI ++ G V + + E LT Q + + L +LH
Sbjct: 70 AFYYENNLWILI-EFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE--N 122
Query: 357 PLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAGSTSAVDCFLDPELNL---SKN 412
+ H + N+L + K++D+G+ T + S ++ PE+ + SK+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 413 --YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR------------SCDLG 458
Y +DV+S G+ L+E+ H H + ++L++ + S +
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 459 KYVDKTLGEQTVGA---ATEMMELALQCVDVSSRRPSMRQIAGE 499
++ K L E+ V A T++++ V V+S +P +R++ E
Sbjct: 240 DFLKKCL-EKNVDARWTTTQLLQHPF--VTVNSNKP-IRELIAE 279
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 34/233 (14%)
Query: 223 NLKQLTILELKHATNNFSEINIIGEGSFGLAYK-GLLQDGSLVVIK-----RHLQTQIQN 276
N L + L T+ + I IG+G++G YK +DGSL +K + +I+
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 277 FLHEVKHIARVHHRHLVKLVG-FCEENH----QQLLIYDYIPNGNVQNHLYDSEGLPIGK 331
+ ++ + +H ++VK G F + + Q L+ + G+V L G
Sbjct: 68 EYNILQSLP--NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE-------LVKGL 118
Query: 332 LTMRQRLS------IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385
L QRL I GA GL+HLH+ + H + +N+LL K+ D+G+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 386 LVTGSHHAGSTSAVDCF-LDPEL-----NLSKNYSAGSDVYSFGVFLLELISG 432
+T + +TS F + PE+ +Y A DV+S G+ +EL G
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 43/194 (22%), Positives = 89/194 (45%), Gaps = 11/194 (5%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302
+G G FG + + V +K + ++ FL E + + H LVKL +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72
Query: 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
+I +++ G++ + L EG K + + + + A+G+ + H
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRD 127
Query: 363 FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKNYSAGSDVY 420
R +N+L+ + K++D+GL +++ + + A + PE +++ SDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 421 SFGVFLLELIS-GR 433
SFG+ L+E+++ GR
Sbjct: 188 SFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 235 ATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-TQIQNF----LHEVKHIARVH 288
++ + +GEG+FG YK ++ G +V +K+ L + F L E+K + ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 289 HRHLVKLVGFC-----EENHQQLLIYDYIPNGNVQNHLYDSEGL---PIGKLTMRQRLSI 340
H ++V L+ + ++ +Y P +H D GL P KLT Q
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTP---YMDH--DLSGLLENPSVKLTESQIKCY 120
Query: 341 ALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS----HHAGST 396
L +G+ +LH + H + +N+L++ K++D+GL + G G
Sbjct: 121 MLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 397 SAVDC--------FLDPELNLS-KNYSAGSDVYSFGVFLLELISGR 433
+ PEL L + Y+ D++ G E+ + R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-------HLQTQIQNF--LHEVKHIARV 287
+ + +GEG++ + YK + G +V IK+ + I NF L E+K + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI-NFTALREIKLLQEL 59
Query: 288 HHRHLVKLVG-FCEENHQQL-LIYDYIPNGNVQNHLYDSEGL---PIGKLTMRQRLSIAL 342
H +++ L+ F + + L+++++ D E + LT S L
Sbjct: 60 KHPNIIGLLDVFGHK--SNINLVFEFME--------TDLEKVIKDKSIVLTPADIKSYML 109
Query: 343 GAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC- 401
+GLE+LHS + H + +N+L+ + K++D+GL + GS + T V
Sbjct: 110 MTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTR 166
Query: 402 -FLDPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
+ PEL +++Y G D++S G EL+
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKR--------HLQTQIQNFLHEVKHIARV 287
N+ ++G+G+FG Y D G + +K+ + ++ E++ + +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 288 HHRHLVKLVGFCEENHQQLLIY-DYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIALG 343
H +V+ G C + + L I+ +Y+P G+V++ L L K T RQ L
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYT-RQIL----- 114
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVD-- 400
+G+E+LHS + H + +N+L + K+ D+G K L T +V
Sbjct: 115 --EGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 401 -CFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
++ PE+ + Y +DV+S G ++E+++
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 7/114 (6%)
Query: 323 DSEGLPIGK--LTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380
D EG + K LT+ +S + A+G+E L S H N+LL EN K+ D
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICD 216
Query: 381 YGLLKLVTGSH---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+GL + + G ++ PE K Y+ SDV+SFGV L E+ S
Sbjct: 217 FGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399
IA+ K LE+LHS + + H + SNVL+ N K+ D+G+ + S T
Sbjct: 108 IAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDA 164
Query: 400 DC-------FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
C ++PELN K Y SDV+S G+ ++EL +GR
Sbjct: 165 GCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 53/244 (21%), Positives = 87/244 (35%), Gaps = 66/244 (27%)
Query: 237 NNFSEINIIGEGSFG---LAYKGLLQDGSLVVIKR------HLQTQIQNFLHEVKHIARV 287
++F I +IG G+FG L G + +K + QI + E +A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 288 HHRHLVKLV-GFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLP-------IGKLTMRQRL 338
+VKL F +E H L L+ +Y+P G++ N L + P I +L +
Sbjct: 59 DSPWIVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL---- 112
Query: 339 SIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL--------------- 383
AL + L +H + P N+L++ + K++D+GL
Sbjct: 113 --ALDSVHKLGFIHRDIKP--------DNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 384 -------LKLVTGSHHAGSTSAVDCF--------LDPELNLSKNYSAGSDVYSFGVFLLE 428
V V + PE+ Y D +S GV L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 429 LISG 432
++ G
Sbjct: 223 MLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 40/128 (31%), Positives = 57/128 (44%), Gaps = 12/128 (9%)
Query: 309 YDYIPNGNVQNHLYD--SEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366
Y + V+N L D SEGL L LS A+G+E L S H
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL-----LSFTYQVARGMEFLAS--KNCVHRDLAAR 266
Query: 367 NVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFG 423
NVLL + K+ D+GL + + + GST ++ PE Y+ SDV+S+G
Sbjct: 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 424 VFLLELIS 431
+ L E+ S
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 5/103 (4%)
Query: 332 LTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391
LTM + + A+G+E L S H N+LL EN K+ D+GL + +
Sbjct: 171 LTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 228
Query: 392 ---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
GS ++ PE K Y+ SDV+SFGV L E+ S
Sbjct: 229 DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 222 QNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQ 275
++L + + L+ F + ++G G++G YKG ++ G L IK + +I+
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK 60
Query: 276 NFLHEVKHIARVHHRHLVKLVG-FCEE-----NHQQLLIYDYIPNGNVQNHLYDSEGLPI 329
++ +K + HHR++ G F ++ + Q L+ ++ G+V + + +++G
Sbjct: 61 LEINMLKKYS--HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--- 115
Query: 330 GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL---LKL 386
L I +GL HLH + H + NVLL EN K+ D+G+ L
Sbjct: 116 NALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173
Query: 387 VTGSHHAGSTSAVDCFLDPEL-----NLSKNYSAGSDVYSFGVFLLELISG 432
G + + ++ PE+ N Y SD++S G+ +E+ G
Sbjct: 174 TVGRRN--TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 245 IGEGSFGLAYKG--LLQDGSLVVIKR-HLQTQIQNF----LHEV---KHIARVHHRHLVK 294
IGEG++G +K L G V +KR +QT + + EV +H+ H ++V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 295 LVGFC-----EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
L C + + L+++++ + ++ +L + +P + + +GL+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC--FLDPEL 407
LHS + H + N+L+ + K++D+GL ++ S TS V + PE+
Sbjct: 125 FLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ 445
L +Y+ D++S G E+ R+ R S+ DQ
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHR 290
N F + ++GEG++G+ K ++ +V IK+ ++ + L E+K + +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
++V+L + L+++Y+ +N L E +P G + R S K +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHW 115
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS--AVDCFLDPELN 408
H + H + N+L+ N K+ D+G + ++ +A T A + PEL
Sbjct: 116 CHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 409 LSKNYSAGSDVYSFGVFLLELISGR 433
L Y D++S G L EL G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 43/204 (21%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQIQNF-----LHEVKHIARVHHR 290
+ + ++GEGS+G+ K ++ G +V IK+ L+++ + E++ + ++ H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
+LV L+ + L+++++ + L D E P G R R +G+E
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVR-KYLFQILRGIEF 115
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST-SAVDCFLDPELNL 409
HS + H + N+L+ ++ K+ D+G + + + A + PEL +
Sbjct: 116 CHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173
Query: 410 SK-NYSAGSDVYSFGVFLLELISG 432
Y D+++ G + E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 49/221 (22%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ---------IQNFLHEVKHIARVHHRHLV 293
+G G+F Y+ ++ G+L+ +K+ + ++ E++ +AR++H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 294 KLVG-FCEENHQQLLIYDYIPNGNVQNHLYD----SEGLPIGKLTMRQRLSIALGAAKGL 348
+++G CE++H L + +++ G+V + L E + I Q L +GL
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYT--EQLL-------RGL 116
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYG----LLKLVTGS-HHAGSTSAVDCF 402
+LH + H + +N+L++ +++D+G L TG+ G F
Sbjct: 117 SYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHG-RNHSN 442
+ PE+ + Y DV+S G ++E+ + + HSN
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 245 IGEGSFGLAYKGLLQ--DGSLVVIKRHLQTQIQN------FLHEVKHIARVHHRHLVKLV 296
+G G+FG KG+ + V + L+ + L E + ++ + ++V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-MRQRLSIALGAAKGLEHLHSLV 355
G CE +L+ + G + L ++ + +T + ++S+ + K LE + V
Sbjct: 63 GICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGM---KYLEE-TNFV 117
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS---HHAGSTS-------AVDCFLDP 405
H NVLL + AK+SD+GL K + + A + A +C
Sbjct: 118 ----HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC---- 169
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELIS 431
+N K +S+ SDV+SFGV + E S
Sbjct: 170 -MNYYK-FSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 5/111 (4%)
Query: 324 SEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383
E L LT+ + + AKG+E L S H N+LL EN K+ D+GL
Sbjct: 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGL 225
Query: 384 LKLVTGSH---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ + G ++ PE + Y+ SDV+SFGV L E+ S
Sbjct: 226 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI---------QNFLHEVKHIA 285
NF IG+G F + YK + L DG +V +K+ QI Q+ L E+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK---VQIFEMMDAKARQDCLKEIDLLK 57
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALG 343
++ H +++K + EN++ ++ + G++ + + + I + T+ + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF---VQ 114
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHAGSTSAVDCF 402
LEH+HS + H + +NV + K+ D GL + + + A S +
Sbjct: 115 LCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLEL 429
+ PE Y+ SD++S G L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 65/276 (23%), Positives = 112/276 (40%), Gaps = 50/276 (18%)
Query: 242 INIIGEGSFG-LAYKGLLQDGSLVVIKR-HLQT----------QIQNFLHEVKHIARVHH 289
+ ++G+GS+G ++ DG VIK+ +L+ Q L ++KH V +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 290 RH--------LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
R L ++GFCE G++ + L + +G L Q +
Sbjct: 65 RESWEGEDGLLYIVMGFCE-------------GGDLYHKLKEQKG---KLLPENQVVEWF 108
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST-SAVD 400
+ A L++LH + H +T NV L KV D G+ +++ ST
Sbjct: 109 VQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTP 166
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460
++ PEL +K Y+ SDV++ G + E+ + + A NS I++ K Y
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226
Query: 461 VDKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQI 496
LGE ++ E +RPS++ I
Sbjct: 227 -SPELGELIATMLSKRPE----------KRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 56/223 (25%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT------------------QIQNFL 278
++F I +G GSFG V++ RH + Q+++ L
Sbjct: 1 DDFEFIKTLGTGSFGR-----------VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL 49
Query: 279 HEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL--YDSEGLPIGKLTMRQ 336
+E + + + H LV L G +++ L+ +Y+P G + +HL P+ + Q
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ 109
Query: 337 RLSIALGAAKGLEHLHSLVPPLFHMHFRT---SNVLLEENYTAKVSDYGLLKLVTGSHHA 393
+ L LE+LHSL + +R N+LL+ + K++D+G K V
Sbjct: 110 ---VVLA----LEYLHSL-----DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----K 152
Query: 394 GSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
G T + C +L PE+ LSK Y D ++ G+ + E+++G
Sbjct: 153 GRTYTL-CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399
IA+ KGL +L SL + H + SN+L+ K+ D+G+ + S A +
Sbjct: 100 IAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVGT 156
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ ++ PE + Y SDV+S G+ +EL GR
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 45/211 (21%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ-----NFLHEVKHIA 285
ELK ++F +I+ +G G+ G+ +K + L++ ++ + +I+ + E++ +
Sbjct: 1 ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIAL 342
+ ++V G + + + +++ G++ L + +P +GK +++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--------VSI 110
Query: 343 GAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF 402
KGL +L + H + SN+L+ K+ D+G+ + S A S +
Sbjct: 111 AVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSY 168
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ PE +YS SD++S G+ L+E+ GR
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 19/198 (9%)
Query: 245 IGEGSFGLAYKGLLQDGSLV-----VIKRHL--QTQIQNFLHEVKHIARVHHRHLVKLVG 297
IG+GSFG + +D + + K H+ ++++ + L E +A+V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKL-TMRQRLSIA-LGAAKGLEHLHSLV 355
+ + L+ +I G + +HL G+ R R A L A LE+LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-----GRFDLSRARFYTAELLCA--LENLHKF- 112
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL-VTGSHHAGSTSAVDCFLDPELNLSKNYS 414
+ + + N+LL+ + D+GL KL + + +L PEL L Y+
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 415 AGSDVYSFGVFLLELISG 432
D ++ GV L E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 35/158 (22%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 278 LHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGK--LTMR 335
L E + + +V+ +V L E L+ + G+++ H+Y+ +G+ L M
Sbjct: 41 LLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN-----VGERGLEME 95
Query: 336 QRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS 395
+ + + G+ HLHS+ + + + NVLL++ ++SD GL +
Sbjct: 96 RVIHYSAQITCGILHLHSM--DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153
Query: 396 TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ + ++ PE+ + YS D ++ G + E+++GR
Sbjct: 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 46/222 (20%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQN 276
D + L++L +I+ + ++ IG+G+ G Y + + G V IK+ +LQ Q +
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60
Query: 277 --FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS---EGLPIGK 331
++E+ + + ++V + + ++ +Y+ G++ + + ++ EG
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----- 115
Query: 332 LTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391
Q ++ + L+ LHS + H ++ N+LL + + K++D+G +T
Sbjct: 116 ----QIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169
Query: 392 HAGSTS-AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
ST ++ PE+ K Y D++S G+ +E++ G
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIK--RHLQTQIQNF--LHEVKHIARVHHRH 291
+++ ++ +GEGS+ YKG + +G LV +K R + + F + E + + H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG--KLTMRQRLSIALGAAKGLE 349
+V L L+++Y+ Q GL KL + Q L +GL
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLS 117
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
++H + H + N+L+ + K++D+GL + + H S V + P L
Sbjct: 118 YIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 410 --SKNYSAGSDVYSFGVFLLELISGREA 435
S YS D++ G +E+I G A
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 3/110 (2%)
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406
G++HLHS + H + SN++++ + T K+ D+GL + S + PE
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAH-GRNHSNSDQNLILQVKRSC 455
+ L Y D++S G + E+I G G +H + +I Q+ C
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 243 NIIGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
N IG G+FG Y + L G L+ +K + I+ E+K + + H +LVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 297 GFCEENHQQLLIY-DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
G E + +++ I+ +Y G ++ L E I + + ++ L +GL +LHS
Sbjct: 66 GV-EVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQL--LEGLAYLHS-- 117
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAG----STSAVDCFLDPEL--- 407
+ H + +N+ L+ N K+ D+G +KL + G S + ++ PE+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR 433
K + +D++S G +LE+ +G+
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRT 365
+ +++ G++ H+ D G+ + + A GL+ LHS + + +
Sbjct: 72 FFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKL 124
Query: 366 SNVLLEENYTAKVSDYGLLKL-VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGV 424
NV+L+ + K++D+G+ K V G + A + ++ PE+ Y+ D +SFGV
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 425 FLLELISGREA-HG 437
L E++ G+ HG
Sbjct: 185 LLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 239 FSEINIIGEGSFG-LAYKGLLQDGSLVVIKRHLQTQIQN------FLHEVKHIARVHHRH 291
F + ++G+G FG + + G + KR + +I+ L+E + + +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+V L E L+ + G+++ H+Y+ G P + L A GLE L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNP--GFEEERALFYAAEILCGLEDL 118
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDCFLDPELNLS 410
H + + N+LL++ ++SD GL +K+ G G V ++ PE+ +
Sbjct: 119 HR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG-YMAPEVLNN 175
Query: 411 KNYSAGSDVYSFGVFLLELISGR 433
+ Y+ D + G + E+I G+
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 244 IIGEGSFGLAYKGLLQDG----SLVVIKRHLQTQIQN--FLHEVKHI--ARVHHRHLVKL 295
+IG GS+ L+ ++ V+K+ L ++ ++ KH+ +H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRLSIALGAAKGLEHLHSL 354
+ + + +Y+ G++ H+ LP +S+AL +LH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL------NYLHE- 114
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLS 410
+ + + NVLL+ K++DYG+ K G T++ C ++ PE+
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHG--RNHSNSDQN 446
++Y D ++ GV + E+++GR + N DQN
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 234 HATNNFSE---INIIGEGSFGLAYKGLLQ-DGSLVVIK----RHLQTQIQNFLHEVKHIA 285
A + SE +N IG G+ G YK + + G L +K H T + E++ +
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAA 345
V+H ++VK + N + ++ +++ G+++ E + + RQ LS
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF-LADVA-RQILS------ 179
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-AGSTSAVDCFLD 404
G+ +LH + H + SN+L+ K++D+G+ +++ + S+ ++
Sbjct: 180 -GIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMS 236
Query: 405 PE-----LNLSKNYSAGSDVYSFGVFLLELISGR 433
PE LN D++S GV +LE GR
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 45/211 (21%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ-----NFLHEVKHIA 285
ELK ++F I+ +G G+ G+ K + L++ ++ + +I+ + E++ +
Sbjct: 1 ELK--DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIAL 342
+ ++V G + + + +++ G++ L +++ +P +GK +++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK--------VSI 110
Query: 343 GAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF 402
+GL +L + H + SN+L+ K+ D+G+ + S A S +
Sbjct: 111 AVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSY 168
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ PE +YS SD++S G+ L+EL GR
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 52/230 (22%)
Query: 243 NIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNF-----------------LHEVKHI 284
+GEG++G K G +V IK+ +I N L E+K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 285 ARVHHRHLVKLVG-FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI----GKLTMRQRLS 339
+ H +++ LV + E D+I N+ + S+ + +LT Q
Sbjct: 75 NEIKHENIMGLVDVYVEG--------DFI---NLVMDIMASDLKKVVDRKIRLTESQVKC 123
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-------------LKL 386
I L GL LH H +N+ + K++D+GL K
Sbjct: 124 ILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 387 VTGSHHAGSTSAVDC--FLDPELNLSKN-YSAGSDVYSFGVFLLELISGR 433
T TS V + PEL + Y D++S G EL++G+
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 32/205 (15%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVH---HRHLVKL 295
IG G++G YK G V +K +QT + EV + R+ H ++V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 296 VGFC-----EENHQQLLIYDYIPNGNVQNHL--YDSEGLPIGKLT--MRQRLSIALGAAK 346
+ C + + L+++++ + +++ +L GLP + MRQ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR------- 119
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC--FLD 404
GL+ LH+ + H + N+L+ K++D+GL ++ S T V +
Sbjct: 120 GLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRA 175
Query: 405 PELNLSKNYSAGSDVYSFGVFLLEL 429
PE+ L Y+ D++S G E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 44/219 (20%), Positives = 103/219 (47%), Gaps = 14/219 (6%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQN 276
D + +++L TI+ + ++ IG+G+ G + + + G V IK+ +LQ Q +
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60
Query: 277 --FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM 334
++E+ + + + ++V + + ++ +Y+ G++ + + ++ +
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET------CMDE 114
Query: 335 RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
Q ++ + LE LH+ + H ++ NVLL + + K++D+G +T
Sbjct: 115 AQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 395 STS-AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
ST ++ PE+ K Y D++S G+ +E++ G
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 46/198 (23%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 245 IGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQIQN-FLHEVKHIARVHHRHLVKLVG 297
+G G+FG KG+ + D ++ V+K + +++ + E + + ++ + ++V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357
CE +L+ + G + L + ++T+ + + + G+++L
Sbjct: 63 VCEA-EALMLVMEMASGGPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEG--KN 115
Query: 358 LFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHAGSTSAVDCFLD---PELNLSKNY 413
H NVLL + AK+SD+GL K L + + SA L PE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 414 SAGSDVYSFGVFLLELIS 431
S+ SDV+S+G+ + E S
Sbjct: 176 SSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 244 IIGEGSFGLAYKGLL----QDGSLVVIKRHLQTQIQNFLHEVKHI--------ARVHHRH 291
+IG+GSFG K LL DG +K LQ + E KHI V H
Sbjct: 2 VIGKGSFG---KVLLAKHKADGKFYAVKV-LQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 292 LVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
LV L + + +L + DY+ G + HL P R R A A L +
Sbjct: 58 LVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARF-YAAEIASALGY 111
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPE 406
LHSL + + + N+LL+ ++D+GL K G H+ +TS C +L PE
Sbjct: 112 LHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTF-CGTPEYLAPE 166
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQ 450
+ + Y D + G L E++ G + R+ + N++ +
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 44/208 (21%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 244 IIGEGSFGLAYKGLLQDGSLVVIKRHLQ---------TQIQNFLHEVKHIARVHHRHLVK 294
++G+G+FG Y D + + +Q ++ E++ + + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 295 LVGFCEENHQQ--LLIY-DYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAKGLE 349
G C + + L I+ +Y+P G+V++ L Y + + + RQ L +G+
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL-------EGMS 120
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG----STSAVDCFLDP 405
+LHS + + H + +N+L + K+ D+G K + +G S + ++ P
Sbjct: 121 YLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGR 433
E+ + Y +DV+S G ++E+++ +
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 45/278 (16%)
Query: 245 IGEGSFGLAYKGL---LQDGS--------LVVIKRHLQTQIQNFLHEVKHIARVHHRHLV 293
+G+G+F +KG+ + D L V+ + + ++F ++++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
G C + +++ +Y+ G++ +L ++ + + +L +A A L L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLED 118
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV---DCFLD------ 404
L H + NVLL K + +KL G + V + L+
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKL----SDPGISITVLPKEILLERIPWVP 172
Query: 405 PE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463
PE + +N S +D +SFG L E+ SG + + S D LQ Y D+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGD---KPLSALDSQKKLQF--------YEDR 221
Query: 464 TLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGEL 500
+ TE+ L QC+D RPS R I +L
Sbjct: 222 H--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 40/193 (20%), Positives = 86/193 (44%), Gaps = 13/193 (6%)
Query: 245 IGEGSFGLAYKGLLQD-GSLVVIKR---HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCE 300
IGEGS G+ ++ G LV +K+ Q + + +EV + H ++V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFH 360
+ ++ +++ G + + + + ++ Q ++ L K L LH+ + H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHA--QGVIH 139
Query: 361 MHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAGSTSAVDCFLDPELNLSKNYSAGSDV 419
++ ++LL + K+SD+G V+ S ++ PEL Y D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199
Query: 420 YSFGVFLLELISG 432
+S G+ ++E++ G
Sbjct: 200 WSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 35/215 (16%)
Query: 243 NIIGE---GSFGLAYKGLLQDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKL 295
IIGE G+FG YK ++ L + +Q ++++F+ E+ ++ H ++V L
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 296 V-GFCEENHQQLLIYDYIPNGNVQNHLYDSE-GL--PIGKLTMRQRLSIALGAAKGLEHL 351
+ EN +LI ++ G + + + + E GL P + RQ L + L L
Sbjct: 68 YEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQML-------EALNFL 119
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT----------GSHHAGSTSAVDC 401
HS + H + N+LL + K++D+G+ G+ + + V C
Sbjct: 120 HS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAH 436
E Y +D++S G+ L+EL H
Sbjct: 178 ----ETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 60/242 (24%), Positives = 99/242 (40%), Gaps = 50/242 (20%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ----IQNFLHEV---KHIARVHH 289
+ E+ IGEG++G YK L G V +K+ + + L E+ K + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 290 RHLVKLVGFCE--ENHQQLLIY-----------DYIPNGNVQNHLYDSEGLPIGKLT--M 334
++V+L+ C ++L + Y+ GLP + M
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK-------CPKPGLPPETIKDLM 113
Query: 335 RQRLSIALGAAKGLEHLHS--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
RQ L G++ LHS +V H + N+L+ + K++D+GL ++ S
Sbjct: 114 RQLLR-------GVDFLHSHRIV----HRDLKPQNILVTSDGQVKIADFGLARIY--SFE 160
Query: 393 AGSTSAVDC--FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLIL 449
TS V + PE+ L +Y+ D++S G EL R R S +DQ + I
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIF 219
Query: 450 QV 451
V
Sbjct: 220 DV 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 22/200 (11%)
Query: 243 NIIGEGSFG----LAYKGLLQDGSLVVIKRH---LQTQIQNFLHEVKHIARVHHRHLVKL 295
+G GSFG +KG + ++ +K+ Q+Q+ E + + H +V +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 296 V-GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP--IGKLTMRQRLSIALGAAKGLEHLH 352
+ F +EN L+ +++ G + HL + P + K + L +A E+LH
Sbjct: 84 MCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAE-LVLAF------EYLH 135
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKN 412
S + + + N+LL+ KV+D+G K V + +L PE+ SK
Sbjct: 136 SK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKG 191
Query: 413 YSAGSDVYSFGVFLLELISG 432
+ D ++ GV L E I+G
Sbjct: 192 HGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 35/210 (16%)
Query: 245 IGEGSFG---LAYKGLLQDGSLVVIK----RHLQT--QIQNFLHEVKHIARVHHRHLVKL 295
I +G++G LA K G + IK + Q+ L E +++ ++VKL
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 296 V-GFCEENHQQLLIYDYIPNGNVQNHLYDSEG-LP--IGKLTMRQRLSIALGAAKGLEHL 351
F + + L+ +Y+P G++ L ++ G L + ++ + + I L LE+L
Sbjct: 59 YYSFQGKKNL-YLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAE---IVLA----LEYL 109
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK--LVTGSHHAGSTSAVDC-------F 402
HS + H + N+L++ N K++D+GL K LV + D +
Sbjct: 110 HSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+ PE+ L + +S D +S G L E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 46/222 (20%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQN 276
D + L++L +I+ + ++ IG+G+ G Y + + G V I++ +LQ Q +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 277 --FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS---EGLPIGK 331
++E+ + + ++V + + ++ +Y+ G++ + + ++ EG
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----- 116
Query: 332 LTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391
Q ++ + LE LHS + H ++ N+LL + + K++D+G +T
Sbjct: 117 ----QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 392 HAGS-TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
S ++ PE+ K Y D++S G+ +E+I G
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 295 LVGF--CEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
LVG C + +L L+ +Y+ G++ H+ LP A L L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-----EEHARFYAAEICIALNFL 112
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPEL 407
H + + + NVLL+ + K++DYG+ K G G T++ C ++ PE+
Sbjct: 113 HE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---GDTTSTFCGTPNYIAPEI 167
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446
+ Y D ++ GV + E+++GR N D N
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 45/205 (21%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 239 FSEINIIGEGSFG-LAYKGLLQDGSLVVIKRHLQTQIQN------FLHEVKHIARVHHRH 291
F + ++G+G FG + + G + K+ + +I+ L+E + + +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA--AKGLE 349
+V L E L+ + G+++ H+Y +G+ + ++ A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-----MGEAGFEEGRAVFYAAEICCGLE 116
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDCFLDPELN 408
LH + + + N+LL+++ ++SD GL + + G G V ++ PE+
Sbjct: 117 DLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG-YMAPEVV 173
Query: 409 LSKNYSAGSDVYSFGVFLLELISGR 433
++ Y+ D ++ G L E+I+G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL--VTGSHHAGST-SAVDCFLD 404
+ H+HS + H +++N+LL N K+ D+G K+ T S G T ++
Sbjct: 156 VHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELIS 431
PE+ K YS +D++S GV L EL++
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 34/214 (15%)
Query: 242 INIIGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKL 295
I IG+G++G +K L ++GS +K + +I+ + +K ++ H ++VK
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKF 80
Query: 296 VGFC----EENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLS------IALGA 344
G +N QL L+ + G+V + L G L +R+ I A
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTD-------LVKGFLKRGERMEEPIIAYILHEA 133
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF-L 403
GL+HLH V H + +N+LL K+ D+G+ +T + +TS F +
Sbjct: 134 LMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 404 DPEL-----NLSKNYSAGSDVYSFGVFLLELISG 432
PE+ L Y A DV+S G+ +EL G
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 45/206 (21%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 244 IIGEGSFGLAY----KGLLQDGSLVVIKRH---LQTQIQNFLHEVKHIARV-HHRHLVKL 295
++G+GSFG + KG Q ++ +K+ + ++ + E + ++ H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
+ + +Y+ G++ H+ + + T A GL+ LHS
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-----YAAEIICGLQFLHS-- 114
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL-VTGSHHAGSTSAVDCFLDPELNLSKNYS 414
+ + + N+LL+ + K++D+G+ K + G + ++ PE+ L + Y+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 415 AGSDVYSFGVFLLELISGREA-HGRN 439
D +SFGV L E++ G+ HG +
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 35/144 (24%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 298 FC--EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
FC + + +Y+ G++ H+ S G+ + A GL+ LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHK-- 114
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL-VTGSHHAGSTSAVDCFLDPELNLSKNYS 414
+ + + NVLL+++ K++D+G+ K + G A + ++ PE+ + Y+
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 415 AGSDVYSFGVFLLELISGREA-HG 437
D +SFGV L E++ G+ HG
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDP 405
+GL+++HS + H + SN+L+ EN K+ D+GL + + G S + P
Sbjct: 119 RGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYVST-RYYRAP 174
Query: 406 ELNLS-KNYSAGSDVYSFGVFLLELISGREAH-GRNHSN 442
E+ L+ + Y D++S G E++ G+ G++H N
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 27/110 (24%), Positives = 52/110 (47%), Gaps = 3/110 (2%)
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406
G++HLHS + H + SN++++ + T K+ D+GL + S + PE
Sbjct: 131 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAH-GRNHSNSDQNLILQVKRSC 455
+ L Y D++S G + E++ + GR++ + +I Q+ C
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 44/229 (19%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHL-QTQIQNF----LHEVKHIAR 286
+ + ++ IG+G+FG +K + +V +K+ L + + + F L E+K +
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQL 67
Query: 287 VHHRHLVKLVGFCEENHQQ--------LLIYDY--------IPNGNVQNHLYDSEGLPIG 330
+ H ++V L+ C L++++ + N NV+ L
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF------TLSEI 121
Query: 331 KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390
K M+ L+ GL ++H + H + +N+L+ ++ K++D+GL + +
Sbjct: 122 KKVMKMLLN-------GLYYIHR--NKILHRDMKAANILITKDGILKLADFGLAR----A 168
Query: 391 HHAGSTSAVDCFLD---------PELNLS-KNYSAGSDVYSFGVFLLEL 429
S + + + PEL L ++Y D++ G + E+
Sbjct: 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 2/86 (2%)
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406
G++HLHS + H + SN++++ + T K+ D+GL + + + PE
Sbjct: 135 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISG 432
+ L Y D++S G + EL+ G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 28/235 (11%)
Query: 245 IGEGSFGLAYKGLLQDGSL-------VVIKRHL-QTQIQNFLHEVKHI-ARVHHRHLVKL 295
+G G FG L++ S V KRH+ +T Q + K I +H +VKL
Sbjct: 1 LGVGGFGRVE--LVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 296 V-GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQ-RLSIALGAAKGLEHLHS 353
F ++ + +L+ +Y G + L D G R IA E+LH+
Sbjct: 59 YRTFKDKKYIYMLM-EYCLGGELWTILRD-----RGLFDEYTARFYIA-CVVLAFEYLHN 111
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNY 413
+ + + N+LL+ N K+ D+G K + + ++ PE+ L+K Y
Sbjct: 112 R--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 414 SAGSDVYSFGVFLLELISGREAHGRNHSNSDQ----NLILQVKRSCDLGKYVDKT 464
D +S G+ L EL++GR G + D N IL+ + Y+DK
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFG--EDDEDPMEIYNDILKGNGKLEFPNYIDKA 222
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 50/222 (22%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQN 276
D + L++L TI+ + ++ IG+G+ G Y + + G V IK+ +LQ Q +
Sbjct: 1 DEEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60
Query: 277 FL--HEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS---EGLPIGK 331
L +E+ + H ++V + + ++ +Y+ G++ + + ++ EG
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----- 115
Query: 332 LTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391
Q ++ + LE LHS + H ++ N+LL + + K++D+G +T
Sbjct: 116 ----QIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169
Query: 392 HAGSTS-AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
ST ++ PE+ K Y D++S G+ +E++ G
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 36/130 (27%), Positives = 57/130 (43%), Gaps = 11/130 (8%)
Query: 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366
LI DY+ G + HLY E ++ R+ IA L+HLH L + + +
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIVLALDHLHQL--GIIYRDIKLE 134
Query: 367 NVLLEENYTAKVSDYGLLKLVTGS--HHAGSTSAVDCFLDPEL--NLSKNYSAGSDVYSF 422
N+LL+ ++D+GL K A S ++ PE+ S + D +S
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194
Query: 423 GVFLLELISG 432
GV EL++G
Sbjct: 195 GVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 46/207 (22%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 239 FSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT----QIQNF-LHEVKHIARVHHRHL 292
+ +++ IGEGS+G+ +K ++ G +V IK+ +++ I+ L E++ + ++ H +L
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHL-YDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
V L+ + L+++Y + V N L + G+P + I + +
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFC 116
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-----FLDPE 406
H H + N+L+ + K+ D+G +++TG D + PE
Sbjct: 117 HKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTG----PGDDYTDYVATRWYRAPE 170
Query: 407 LNLSK-NYSAGSDVYSFGVFLLELISG 432
L + Y DV++ G EL++G
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 39/205 (19%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 244 IIGEGSFGLAYKGLLQDGSLVVIKRHLQ---------TQIQNFLHEVKHIARVHHRHLVK 294
++G+G+FG Y D + + +Q ++ E++ + + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 295 LVGFCEENHQQLL--IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
G + ++ L +++P G++++ L S G +T + I +G+ +LH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQIL----EGVSYLH 123
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG----STSAVDCFLDPELN 408
S + + H + +N+L + K+ D+G K + +G S + ++ PE+
Sbjct: 124 SNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 409 LSKNYSAGSDVYSFGVFLLELISGR 433
+ Y +D++S G ++E+++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 238 NFSEINIIGEGSFGLAYKG-LLQDGSLVVIKRHLQTQI---------QNFLHEVKHIARV 287
NF IG G F Y+ L DG V +K+ QI + + E+ + ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKK---VQIFDLMDAKARADCIKEIDLLKQL 59
Query: 288 HHRHLVKL-VGFCEENHQQLLIYDYIPNGNVQN---HLYDSEGLPIGKLTMRQRLSIALG 343
+H +++K F E+N +++ + G++ H + L K + + +
Sbjct: 60 NHPNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC-- 116
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG-STSAVDCF 402
LEH+HS + H + +NV + K+ D GL + + A S +
Sbjct: 117 --SALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLEL 429
+ PE Y+ SD++S G L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399
IA+ +GL +L++ V + H + SN+L+ K+ D+G+ + S A +
Sbjct: 108 IAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADTFVGT 165
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
++ PE Y+ SDV+S G+ ++EL G+
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 47/216 (21%), Positives = 102/216 (47%), Gaps = 37/216 (17%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRH 291
++++I IGEG++G+ YKG + G +V +K+ L+++ + + E+ + + H +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRL-SIALGAAKGLEH 350
+V L + + LI++++ + +++ +L + LP G+ + + S +G+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK------------LVTGSHHAGSTSA 398
HS + H + N+L++ K++D+GL + +VT + A
Sbjct: 117 CHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA----- 169
Query: 399 VDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
PE+ L S YS D++S G E+ + +
Sbjct: 170 ------PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVK 294
+ I IG G++G YK + G LV VIK + E+ + H ++V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
G + ++ +Y G++Q+ +Y + G L+ Q + KGL +LH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQD-IYQ---VTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYG 382
H + +N+LL E+ K++D+G
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 48/252 (19%)
Query: 239 FSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQIQNFLH---EVKHIARVHHRHLVK 294
+ ++ +G GS GL + + D V +K+ + T Q+ H E+K I R+ H ++VK
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNH-----LYDSEGLPIGKLTMRQRLSIALGAA---- 345
+Y+ + L + + I + M L+ L
Sbjct: 67 -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113
Query: 346 -----------KGLEHLHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTG--SH 391
+GL+++HS + H + +NV + E+ K+ D+GL ++V SH
Sbjct: 114 EHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 392 --HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI 448
+ + P L LS NY+ D+++ G E+++G+ H LI
Sbjct: 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
Query: 449 L---QVKRSCDL 457
L V R D
Sbjct: 232 LESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQD---GSLVVIKRHLQT------QIQNFLHEVKHIARVH 288
+ I +G G+FG + L++D +K Q Q+ +E + + V
Sbjct: 2 DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 289 HRHLVKLVGFCEENHQQLL--IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK 346
H +++L F E+ Q+ L + +Y+P G + ++L +S G+ + L A
Sbjct: 60 HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVC 112
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406
LE+LHS + + + N+LL++ K++D+G K + + +L PE
Sbjct: 113 ALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWTLCGTPEYLAPE 168
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISG 432
+ SK ++ D ++ G+ + E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNF---LHEVKHIARVH 288
++ +++ I +G G++G YK L G L +K +F E+ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
H ++V G + + +Y G++Q+ +Y G P+ +L Q + +GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTG-PLSEL---QIAYVCRETLQGL 119
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAGSTSAVDCFLDPEL 407
+LHS H + +N+LL +N K++D+G+ +T + S ++ PE+
Sbjct: 120 AYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 408 -NLSKN--YSAGSDVYSFGVFLLEL 429
+ KN Y+ D+++ G+ +EL
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQIQNFLHEVKHI-------ARVH 288
+F + +G+G +G + +D G +V +KR ++ + L+EV+H+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKR-MKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 289 HRHLVKLV-GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQ-RLSIA-LGAA 345
LVKL+ F ++ + L + +Y+P G+ + L + G L+ R +A + A
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAM-EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEA 113
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHA-GSTSAVDCFL 403
++ LH L H + N L++ + K++D+GL K +VT ++ GS ++
Sbjct: 114 --VDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD----YM 165
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISG 432
PE+ K Y D +S G L E + G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 33/180 (18%)
Query: 267 KRHLQTQIQ----NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN----VQ 318
K +Q I+ N + + H + + +KL +LI DYI +G+ ++
Sbjct: 42 KLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK 101
Query: 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK- 377
SE K +RQ L AL H H+++ H + NVL Y
Sbjct: 102 KEGKLSE--AEVKKIIRQ-LVEALNDL----HKHNII----HNDIKLENVL----YDRAK 146
Query: 378 ----VSDYGLLKLV-TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+ DYGL K++ T S + G+ +D F PE NY D ++ GV EL++G
Sbjct: 147 DRIYLCDYGLCKIIGTPSCYDGT---LDYF-SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQD-GSLVVIKR-HLQTQIQ----NFLHEVKHIARVHHRH 291
+ ++ IGEG++G +K ++ +V +KR L + + L E+ + + H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEG---LPIGKLTMRQRLSIALGAAKGL 348
+V+L + + L+++Y + +++ + G I K M Q L KGL
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLL-------KGL 112
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383
HS + H + N+L+ +N K++D+GL
Sbjct: 113 AFCHS--HNVLHRDLKPQNLLINKNGELKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD-CFLD 404
+GL+++HS + H + SN+LL N K+ D+GL + + + V +
Sbjct: 119 RGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 405 PELNLS-KNYSAGSDVYSFGVFLLELISGRE 434
PEL L+ Y+ DV+S G EL+ GR+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 59/227 (25%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRH 291
+ ++N I EG++G+ Y+ + G +V +K+ ++ + + F L E+ + ++ H +
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 292 LVKL----VGFCEENHQQL-LIYDYIPNGNVQNHLYD-----SEGLPIG--KLTMRQRLS 339
+V + VG N ++ ++ +Y V++ L + K M Q LS
Sbjct: 66 IVTVKEVVVG---SNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL------------LKLV 387
G+ HLH + H +TSN+LL K+ D+GL +V
Sbjct: 118 -------GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168
Query: 388 TGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGR 433
T + A PEL L K YS D++S G EL++ +
Sbjct: 169 TLWYRA-----------PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
F+ + IG+GSFG YK + + +V IK + +I++ E++ +++ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
K G + + +I +Y G+ + L GKL I GLE+LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC------LDLLKPGKLDETYIAFILREVLLGLEYLHE 116
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA-VDCF------LDPE 406
H + +N+LL E K++D+G V+G ST + + F + PE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFG----VSG--QLTSTMSKRNTFVGTPFWMAPE 168
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISG 432
+ Y +D++S G+ +EL G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 43/202 (21%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHLV 293
+ +++ +GEG++ +KG + +LV +K H + + EV + + H ++V
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
L L+++Y+ + +++ +L + L ++M +GL + H
Sbjct: 67 TLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNL----MSMHNVKIFMFQLLRGLSYCHK 121
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL--SK 411
+ H + N+L+ E K++D+GL + + S V + P L S
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 412 NYSAGSDVYSFGVFLLELISGR 433
YS D++ G L E+ +GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 42/202 (20%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHLV 293
+ ++ +GEG++ +KG + +LV +K H + + EV + + H ++V
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
L + L+++Y+ + +++ ++ D + ++M +GL + H
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNI----MSMHNVKIFLYQILRGLAYCHR 122
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL--SK 411
+ H + N+L+ E K++D+GL + + S V + P L S
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 412 NYSAGSDVYSFGVFLLELISGR 433
YS D++ G E+ SGR
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 244 IIGEGSFG----LAYKGLLQDGSLVVIKRHLQTQIQN--FLHEVKHI--ARVHHRHLVKL 295
+IG GS+ + K + ++ VIK+ L ++ ++ KH+ +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRLSIALGAAKGLEHLHSL 354
+ + + +++ G++ H+ LP +S+AL LH
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLAL------NFLHE- 114
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLS 410
+ + + NVLL+ K++DYG+ K G T++ C ++ PE+
Sbjct: 115 -RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---GDTTSTFCGTPNYIAPEILRG 170
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHG--RNHSNSDQN 446
++Y D ++ GV + E+++GR N DQN
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.001
Identities = 60/255 (23%), Positives = 100/255 (39%), Gaps = 82/255 (32%)
Query: 242 INIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNF----------LHEVKHIARVHHR 290
+ IG G++G+ + + G V IK+ I N L E+K + + H
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKK-----ISNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGN----VQNHLYDSEGLPIGK-LTMRQRLSIA---- 341
+++ L+ +L + N V L +++ + K + Q L+
Sbjct: 60 NIIGLL--------DILRPPSPEDFNDVYIVTE-LMETD---LHKVIKSPQPLTDDHIQY 107
Query: 342 -----LGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389
L +GL++LHS L P SN+L+ N K+ D+GL + V
Sbjct: 108 FLYQIL---RGLKYLHSANVIHRDLKP---------SNILVNSNCDLKICDFGLARGVDP 155
Query: 390 SHHAGSTSAVDCFLD----------PELNLS-KNYSAGSDVYSFGVFLLELISGREAH-G 437
FL PEL LS Y+ D++S G EL++ + G
Sbjct: 156 DEDEKG------FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209
Query: 438 RNHSNSDQ-NLILQV 451
R++ DQ NLI++V
Sbjct: 210 RDY--IDQLNLIVEV 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 36/144 (25%), Positives = 63/144 (43%), Gaps = 12/144 (8%)
Query: 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366
I D + G++ HL G + ++ A GLEH+H+ + + + +
Sbjct: 74 FILDLMNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPA 126
Query: 367 NVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDCFLDPE-LNLSKNYSAGSDVYSFGV 424
N+LL+E+ ++SD GL HA + ++ PE L Y + +D +S G
Sbjct: 127 NILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184
Query: 425 FLLELISGREAHGRNHSNSDQNLI 448
L +L+ G R H D++ I
Sbjct: 185 MLFKLLRGHSPF-RQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 20/162 (12%)
Query: 280 EVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD--SEGLP-----IGKL 332
E+ +A H +VK + + + LLI +Y G++ + E LP +G L
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
+ L+ L+ +HS + H +++N+ L K+ D+G K + S
Sbjct: 175 FYQIVLA--------LDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224
Query: 393 ---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
A S +L PEL K YS +D++S GV L EL++
Sbjct: 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 54/223 (24%), Positives = 107/223 (47%), Gaps = 16/223 (7%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKR-HLQTQ---IQNFLHEVKHIARVHHRHL 292
NF ++ +GEG++ YKG + G +V +K HL + + E+ + + H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V+L ++ +L+++Y+ + +++ ++ D+ G+ G L S KG+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYM-DTHGVR-GALDPNTVKSFTYQLLKGIAFCH 117
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-FLDPELNL-S 410
+ H + N+L+ + K++D+GL + + S V + P++ L S
Sbjct: 118 E--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 411 KNYSAGSDVYSFGVFLLELISGREAH-GRNHSNSDQ-NLILQV 451
+ YS D++S G + E+I+GR G N N DQ I ++
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTN--NEDQLLKIFRI 216
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 43/212 (20%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIK-RHLQT---QIQNFLHEVKHIARVHH---R 290
+ + +IG G++G Y+G + G +V +K +L T + + EV ++++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGK----LTMRQRLSIALGAAK 346
++ K G + + +I +Y G+V+ + + PI + + +R+ L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVL-------V 112
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA-VDCFLDP 405
L+++H + + H + +N+L+ K+ D+G+ L+ + ST ++ P
Sbjct: 113 ALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
Query: 406 ELNLS-KNYSAGSDVYSFGVFLLELISGREAH 436
E+ K Y +D++S G+ + E+ +G +
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 49/218 (22%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 229 ILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQN--------FLHE 280
I +L+ ++ + +IG G+FG + + S V L ++ + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFG-EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 281 VKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSI 340
+A + +V+L +++ ++ +Y+P G++ N L + +P K +
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVP-EKWAKFYTAEV 151
Query: 341 ALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKL-VTGSHHAGSTSA 398
L L+ +HS+ L H + N+LL+++ K++D+G +K+ TG +
Sbjct: 152 VLA----LDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 399 VDCFLDPELNLSKN----YSAGSDVYSFGVFLLELISG 432
++ PE+ S+ Y D +S GVFL E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 45/203 (22%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 239 FSEINIIGEGSFGLAYKGL--LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHL 292
+ +++ +GEG++ YKG L D +LV +K H + + EV + + H ++
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V L L+++Y+ + +++ +L D + M +GL + H
Sbjct: 67 VTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS----INMHNVKLFLFQLLRGLNYCH 121
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL--S 410
+ H + N+L+ E K++D+GL + + S V + P L S
Sbjct: 122 R--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 411 KNYSAGSDVYSFGVFLLELISGR 433
+YS D++ G E+ +GR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 17/153 (11%)
Query: 285 ARVHHRHLVKLVG-FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALG 343
H LV L F E+H + +Y G++ H++ + + + A
Sbjct: 57 NSERHPFLVNLFACFQTEDHV-CFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAAC 109
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC-- 401
GL++LH + + + N+LL+ K++D+GL K G G ++ C
Sbjct: 110 VVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF---GDRTSTFCGT 164
Query: 402 --FLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
FL PE+ +Y+ D + GV + E++ G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 5/97 (5%)
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK-LVTGSHHA--G 394
LS + AKG+ L S H N+LL K+ D+GL + + S++ G
Sbjct: 217 LSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ ++ PE + Y+ SDV+S+G+ L E+ S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 15/126 (11%)
Query: 376 AKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL--SKNYSAGSDVYSFGVFLLELISGR 433
AK+ D+GL K + A S + PEL L +K+Y SD+++ G + EL SG+
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 434 EAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSSR-RPS 492
+ +N+ LI ++KR DL G + E+ L +++S++ RPS
Sbjct: 241 TPFHK--ANNFSQLISELKRGPDL----------PIKGKSKELNILIKNLLNLSAKERPS 288
Query: 493 MRQIAG 498
Q G
Sbjct: 289 ALQCLG 294
|
Length = 1021 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 30/131 (22%), Positives = 60/131 (45%), Gaps = 14/131 (10%)
Query: 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366
+ +Y+ G++ H+ +GK Q + A + GL LH + + +
Sbjct: 78 FVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLD 130
Query: 367 NVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSF 422
NV+L+ K++D+G+ K G T+ C ++ PE+ + Y D +++
Sbjct: 131 NVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187
Query: 423 GVFLLELISGR 433
GV L E+++G+
Sbjct: 188 GVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 46/208 (22%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 238 NFSEINIIGEGSFG---LA-YKGLLQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHR 290
+F+ + ++G+GSFG LA KG + ++ ++K+ + Q ++ + E + +A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 291 HLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+ + C + +L + +Y+ G++ + +G+ + A A GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLF 115
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDP 405
LHS + + + NV+L+ K++D+G+ K + G T+ C ++ P
Sbjct: 116 FLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAP 170
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGR 433
E+ + Y D ++FGV L E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDCFLDP 405
GLEH+H+ + + + +N+LL+E+ ++SD GL HA + ++ P
Sbjct: 109 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAP 164
Query: 406 ELNLSKN--YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI 448
E+ L K Y + +D +S G L +L+ G R H D++ I
Sbjct: 165 EV-LQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 45/217 (20%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 229 ILELKHATNNFSEINIIGEGSFG----LAYKGLLQDGSLVVIKRHLQTQIQN---FLHEV 281
I +L+ ++ + +IG G+FG + +K + ++ ++ + + + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 282 KHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
+A + +V+L +++ ++ +Y+P G++ N L + +P K +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVP-EKWARFYTAEVV 152
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC 401
L L+ +HS+ H + N+LL+++ K++D+G + +AV
Sbjct: 153 L----ALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 402 --FLDPELNLSKN----YSAGSDVYSFGVFLLELISG 432
++ PE+ S+ Y D +S GVFL E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 275 QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM 334
+N L VKH +V L+ + + LI +Y+ G + HL + EG+ +
Sbjct: 51 RNILEAVKH------PFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTAC 103
Query: 335 RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
I+L LEHLH + + + N+LL+ K++D+GL K S H G
Sbjct: 104 FYLSEISLA----LEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEG 154
Query: 395 STSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+ + C ++ PE+ + + D +S G + ++++G
Sbjct: 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 39/193 (20%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 245 IGEGSFGLAYKGLLQ-DGSLVVIKR---HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCE 300
IGEGS G+ + G V +K+ Q + + +EV + HH ++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFH 360
+ ++ +++ G + + + + ++ Q ++ L + L +LH+ + H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHN--QGVIH 141
Query: 361 MHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAGSTSAVDCFLDPELNLSKNYSAGSDV 419
++ ++LL + K+SD+G V+ S ++ PE+ Y D+
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 420 YSFGVFLLELISG 432
+S G+ ++E+I G
Sbjct: 202 WSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 12/147 (8%)
Query: 245 IGEGSFGLAYKGLLQDGSLV--VIKRHLQTQI----QN-FLHEVKHIARVHHRHLVKLVG 297
IG G FG + + V V+ + L+ QN FL + + H ++++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGL-PIGKLTMRQRLSIALGAAKGLEHLHSLVP 356
C E LL+++Y G+++++L + +L + QR++ + A G+ H+H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMHKH-- 118
Query: 357 PLFHMHFRTSNVLLEENYTAKVSDYGL 383
H N L + T KV DYG+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 530 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.47 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.03 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.55 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.37 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.77 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.64 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.54 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.12 | |
| PLN02236 | 344 | choline kinase | 95.98 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.61 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.46 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.2 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 95.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.8 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.79 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.68 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.45 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.41 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.48 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.64 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=455.91 Aligned_cols=281 Identities=42% Similarity=0.705 Sum_probs=243.3
Q ss_pred cccccCHHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEE
Q 009644 223 NLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFC 299 (530)
Q Consensus 223 ~~~~~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~ 299 (530)
..+.|++.+++.+|++|...+.||+|+||.||+|.+.++..||||++.... ..+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 467899999999999999999999999999999999999999999877643 56799999999999999999999999
Q ss_pred eecC-ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcCCCeEE
Q 009644 300 EENH-QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-VPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 300 ~~~~-~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~ivHrDLk~~NILl~~~~~~K 377 (530)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+. .++||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999976432 789999999999999999999985 45899999999999999999999
Q ss_pred EeecCCcccccC-CCCcCcc-cccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHH---
Q 009644 378 VSDYGLLKLVTG-SHHAGST-SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK--- 452 (530)
Q Consensus 378 I~DFGla~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~--- 452 (530)
|+|||+|+.... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..........+.|..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977654 3333333 79999999999999999999999999999999999999988654333333444432
Q ss_pred hhccCCcccccccc-c-cch-hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 453 RSCDLGKYVDKTLG-E-QTV-GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 453 ~~~~~~~~~d~~l~-~-~~~-~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
....+.+++|+.+. . +.. ....++..++.+|++.++ +||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 33378899999986 3 443 688889999999999998 899999999999766543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=426.27 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=218.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.+.+.+..+.||+|.||+||+|+.. +...||||.+++. ..++|.+|+++++.++|||||+|+|+|.++++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456666789999999999999853 3567999988754 35689999999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLP---------IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT 375 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~ 375 (530)
+++|+|||..|||.+||+...... ...|+..+.+.||.|||.||+||.+ ..+|||||.++|+||+++..
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CcccccchhhhhceeccceE
Confidence 999999999999999998643211 2348999999999999999999999 59999999999999999999
Q ss_pred EEEeecCCcccccCCCCcC---cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHH
Q 009644 376 AKVSDYGLLKLVTGSHHAG---STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 376 ~KI~DFGla~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 451 (530)
+||+||||+|.....+... .+.-+.+|||||.+..++||++||||||||||||++| |+.||.+.... ..++.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HHHHHH
Confidence 9999999999876654332 2335678999999999999999999999999999999 99999876543 344444
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
... .+-+.+.+++.++.+||..||+.+| +||+++||-..|+...+.
T Consensus 719 ~~g---------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 RAG---------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HcC---------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 332 2234677888999999999999999 999999999999987654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=403.09 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=211.3
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecC-ceeEEeeccCC
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENH-QQLLIYDYIPN 314 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~~~ 314 (530)
..+.||+|+||+||+|.+++...||||++.... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999765559999987544 568999999999999999999999999887 79999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCcEEEcCCC-eEEEeecCCcccccCC-C
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP-LFHMHFRTSNVLLEENY-TAKVSDYGLLKLVTGS-H 391 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-ivHrDLk~~NILl~~~~-~~KI~DFGla~~~~~~-~ 391 (530)
|+|.++++... ...+++..++.++.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+++..... .
T Consensus 125 GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~--~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSE--GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC--CCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 99999998741 13799999999999999999999995 5 99999999999999997 9999999999887654 2
Q ss_pred CcCcccccccccCccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 392 HAGSTSAVDCFLDPELNL--SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
......||..|||||++. ...|+.|+|||||||+||||+||+.||..... ......+...... + ..+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~R-----p---~~p 268 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLR-----P---PIP 268 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCC-----C---CCC
Confidence 334467999999999999 56999999999999999999999999986643 2222332222111 1 123
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+...+..++.+||+.+| .||++.+|+..|+.+.....
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 3366789999999999999 99999999999999877533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=408.22 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=216.5
Q ss_pred CccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 239 FSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
+..++.||+|.||.||.|.++....||+|.+.... .++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 44568999999999999999888899999887643 4689999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCc-
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS- 395 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~- 395 (530)
|.+||+...+ ..+...+.+.++.|||+||+||++ +++|||||.++|||++++..+||+||||||...++.....
T Consensus 288 Ll~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 288 LLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999997332 378999999999999999999999 6999999999999999999999999999996555443222
Q ss_pred -ccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 396 -TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 396 -~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
..-+..|.|||.+..++|+.|||||||||+||||+| |+.|+..... ...+..+.+..++ +.+..++
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~~~le~GyRl---------p~P~~CP 430 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVLELLERGYRL---------PRPEGCP 430 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHHHHHhccCcC---------CCCCCCC
Confidence 224567999999999999999999999999999999 8888876543 3455555554333 2456778
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
..+.++|..||..+| +|||++.+...|+.+....
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 999999999999999 9999999999998877543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=372.39 Aligned_cols=244 Identities=22% Similarity=0.351 Sum_probs=206.7
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEcc----cccHHHHHHHHHHHHhcCCCCcceEEEEEeecC-ceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHL----QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENH-QQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~----~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~ 312 (530)
++.++.||+|..|+|||++++ ++..+|+|.+. ....+++.+|++++++.+||+||.+||.|..++ ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445689999999999999954 67889999873 334567899999999999999999999999998 599999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
.+|+|++++... +.+++...-+|+.++++||.|||+. .+||||||||+|||++..|++||||||.++.+.++ .
T Consensus 161 DgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 161 DGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-I 233 (364)
T ss_pred CCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-h
Confidence 999999999865 3789999999999999999999964 59999999999999999999999999999988766 5
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CchHHHHHHHHhhccCCccccccccccch
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHS--NSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
..+..||..|||||.+.+..|+.++||||||++++|+++|+.|+..... .....+...+- +..-+..+.
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---------~~ppP~lP~ 304 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---------DEPPPRLPE 304 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh---------cCCCCCCCc
Confidence 6778899999999999999999999999999999999999999986411 12222222222 211112222
Q ss_pred -hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 -GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 -~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.++.+++..|++.+| +|||+.|+++
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 367889999999999998 9999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=402.37 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=215.1
Q ss_pred cCCccceeeccCCcEEEEEEEEcC----CCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
....+.++||.|.||.||+|+++- ...||||.++. ++..+|+.|+.||.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345567899999999999999643 35799998874 4567899999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
+|||+||+|+.||+.+.+ .+++.+...+.++||.||+||.++ ++|||||.++|||++.+..+|++||||+|.+.
T Consensus 709 TEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999998764 799999999999999999999996 99999999999999999999999999999886
Q ss_pred CCCCcC-cc---cccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSHHAG-ST---SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~~~~-~~---~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
++.... ++ .-+.+|.|||.+..+++|.+||||||||||||.++ |.+||-..... ..+..+....+++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaIe~gyRLP----- 854 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIEQGYRLP----- 854 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHHHHhccCCC-----
Confidence 554221 11 13467999999999999999999999999999887 99998765433 4444444443332
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.+..++..|.+||+.||+.+- +||++.||+..|+++...
T Consensus 855 ----pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 855 ----PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 344577899999999999996 999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.09 Aligned_cols=200 Identities=23% Similarity=0.449 Sum_probs=182.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
..+|...+.||+|+||+||+|++ +++..||||.+... ..+....|+.+|+.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35677888899999999999994 56889999987654 3566889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC------CeEEEeecCC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN------YTAKVSDYGL 383 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~------~~~KI~DFGl 383 (530)
|||.+|+|.+|++... .+++.....++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999864 78999999999999999999999 699999999999999865 5689999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN 442 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 442 (530)
||.+.......+.+|++.|||||++...+|+.|+|+||.|++||||++|+.||......
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 99998777777888999999999999999999999999999999999999999865443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=384.24 Aligned_cols=242 Identities=20% Similarity=0.356 Sum_probs=211.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
..|...+.||+|||+.+|.++. ..|+.||+|++.+ ...+...+|++|.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999995 8899999998765 34567899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
|+|++|+|..+++... .+++.++..+..||+.||.|||+ .+|||||||..|++|++++++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998543 79999999999999999999999 5999999999999999999999999999998875
Q ss_pred C-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 S-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
+ ....+.+||+.|+|||++....++..+||||+||+||-|++|++||....-. .....++.. +.. .
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---ety~~Ik~~----~Y~------~ 237 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---ETYNKIKLN----EYS------M 237 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---HHHHHHHhc----Ccc------c
Confidence 5 5566788999999999999999999999999999999999999999865433 333333332 111 2
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+.....+..+|+.+.|+.+| +|||+++|+.
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22445678899999999999 9999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=355.56 Aligned_cols=254 Identities=21% Similarity=0.373 Sum_probs=207.7
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcc-----cccHHHHHHHHHHHHhcCCCCcceEEE-EEeecCc-eeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHL-----QTQIQNFLHEVKHIARVHHRHLVKLVG-FCEENHQ-QLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~H~nIv~l~g-~~~~~~~-~~LV 308 (530)
.+|+++++||+|+||.|||+. +.+|..+|.|.+. ....++...|+.+|++|+|||||++++ .+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999998 7789999999765 344578899999999999999999999 4555555 8999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP--LFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~--ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
||||..|+|.+.++..+.. ...+++..+++++.|++.||.++|+..+. |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999764332 23789999999999999999999995445 99999999999999999999999999999
Q ss_pred ccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 387 VTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 387 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
+..... ..+..||+.||+||.+....|+.||||||+||++|||+.-++||.+.. ...+-.++... +... +
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~KI~qg-d~~~-----~ 248 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKKIEQG-DYPP-----L 248 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHHHHcC-CCCC-----C
Confidence 876544 356679999999999999999999999999999999999999998762 22222222221 2211 1
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
+ ....+..+.+++..|+..++ .||+.-.++..+..
T Consensus 249 p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 P--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred c--HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 13456789999999999998 89996666655554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=404.69 Aligned_cols=271 Identities=27% Similarity=0.489 Sum_probs=220.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC--CC----EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD--GS----LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~--~~----~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
..+....+.||+|.||.||+|.+.+ +. .||+|.+.+. +..+|++|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456677899999999999999654 32 4889987653 456899999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLP--IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
++++|||++|+|..||++.+..+ ...++..+.+.++.|||+|+.||++ +++|||||.++|+||+....+||+||||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999999863322 2469999999999999999999999 6999999999999999999999999999
Q ss_pred cccccCCCCc-C--cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 384 LKLVTGSHHA-G--STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 384 a~~~~~~~~~-~--~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
||.+...... . ...-...|||||.+..+.||.|||||||||+|||++| |..||...... .+...+....++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~~~~ggRL-- 923 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLDVLEGGRL-- 923 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHHHHhCCcc--
Confidence 9965443322 1 1223467999999999999999999999999999999 88888765443 333333333222
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCccccccch
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEEID 520 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ee~~ 520 (530)
+.+..++..+.++|..||+.+| +||++..|++++..+.....+.....+.++-+
T Consensus 924 -------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~~ 978 (1025)
T KOG1095|consen 924 -------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADYE 978 (1025)
T ss_pred -------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccccC
Confidence 2456778899999999999999 99999999999999887655544444444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=362.50 Aligned_cols=247 Identities=20% Similarity=0.341 Sum_probs=207.1
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc----------HHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ----------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.+.|...+.||+|+||.|-+|. .++|+.||||.+.++. .....+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4567778999999999999999 6789999999876532 1235799999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CeEEEeec
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN---YTAKVSDY 381 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~---~~~KI~DF 381 (530)
.|+||||+++|+|.+++-.+. .+.+..-..++.|++.|+.|||+ .||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998764 57777778899999999999999 599999999999999866 88999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-cC
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNY---SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-DL 457 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-~~ 457 (530)
|+|+.........+.+||+.|.|||++.++.+ ..++|+||+||+||-+++|.+||....... ...+++.... ..
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKGRYAF 401 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcCcccc
Confidence 99999887777788899999999999986653 347899999999999999999998665432 2333333221 11
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. +..+.+...+..+++.+++..+| +|||+.|+++
T Consensus 402 ~-------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 G-------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c-------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 12445566789999999999999 9999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.61 Aligned_cols=237 Identities=20% Similarity=0.345 Sum_probs=199.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..++||+|+||+||.++. ++++.+|+|++.+. +.+...+|..||.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999994 55889999987654 346688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
+||+.||.|..+|.+.. .+++..+..++.+|+.||.|||+ ++||||||||+|||||++|+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998653 78999999999999999999999 699999999999999999999999999999654
Q ss_pred CC-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GS-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.. ....+.+||+.|||||++....|+..+|.||+|+++|||++|.+||...+.. ..+..+.... +..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---~~~~~I~~~k---------~~~ 244 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---KMYDKILKGK---------LPL 244 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---HHHHHHhcCc---------CCC
Confidence 33 4445568999999999999999999999999999999999999999866433 2333322211 111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCC
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRP 491 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RP 491 (530)
.+.-...+..+++.+.+..+| +|-
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhc
Confidence 111133567788888888998 785
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.12 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=216.5
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcc-----cccHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHL-----QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.+++...+.+.+...||+|+||+||+|++.+ .||||++. ..+.+.|.+|+..+++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4555556677788999999999999999863 59999865 3456889999999999999999999999998877
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.+|+.+|++-+|+.+|+..+ .+|...+.+.||.|||+||.|||. ++|||||||+.||++.+++++||+||||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999999765 379999999999999999999999 79999999999999999999999999998
Q ss_pred ccc---cCCCCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 385 KLV---TGSHHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 385 ~~~---~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
... ..........+...|||||++. ..+|+..|||||||+|+|||+||..||.... ...++..+.+.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~dqIifmVGrG---- 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---RDQIIFMVGRG---- 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---hhheEEEeccc----
Confidence 643 2233334456778899999986 4579999999999999999999999998332 22444444333
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
...+.+.....++.+++.+|+..||..++ +||++.+|+..|++++..
T Consensus 609 -~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 -YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 12233333455677899999999999998 999999999999998874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=369.79 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=207.9
Q ss_pred cCCccceeeccCCcEEEEEEEEcC--C--CE-EEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD--G--SL-VVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~--~--~~-vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
++....+.||+|+||.||+|.+.. + .. ||||.... .+..+|++|+++|++++|||||++||++....++
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445555899999999999999643 2 23 89997663 3457899999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++|||+|+||+|.+||....+ .++..+++.++.++|.||+|||+ +++|||||.++|||++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999998753 69999999999999999999999 699999999999999999999999999998
Q ss_pred cccCCCCcC-cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHh-hccCCcccc
Q 009644 386 LVTGSHHAG-STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKR-SCDLGKYVD 462 (530)
Q Consensus 386 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~d 462 (530)
.-....... ...-+..|+|||.+....|++++|||||||++||+++ |..||.+.... ....++.. ....
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI~~~~~r~----- 382 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKIVKNGYRM----- 382 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHHHhcCccC-----
Confidence 653211111 2235568999999999999999999999999999999 88898765432 33333311 1111
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+...+..+..++.+||..+| +||||.+|.+.|+.+.....
T Consensus 383 ----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 ----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1222445778888899999999 89999999999999877644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=394.02 Aligned_cols=257 Identities=24% Similarity=0.458 Sum_probs=205.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
...|...+.||+|+||.||+|.. .++..||+|++..... ....|++++++++|||||+++|+|.+.+..++||||+++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45677778999999999999995 5788999998764322 224578899999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
|+|.++++ .++|.++..++.|+|+||+|||+. .++|+||||||+||+++.++.+++. ||.+......
T Consensus 768 g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 768 KNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 99999995 478999999999999999999953 3799999999999999999988876 6665543221
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh---ccCCccccccccc---
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS---CDLGKYVDKTLGE--- 467 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~l~~--- 467 (530)
....++..|+|||++.+..++.++|||||||++|||+||+.||...... ......+.... .....++|+.+..
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 2235778899999999999999999999999999999999998643322 12233333221 1233445555432
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
...+...++.+++.+||+.+| +||||+||++.|+++...
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 334566788999999999999 999999999999998654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=354.81 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=203.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec-
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN- 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~- 302 (530)
..++|++.+.||+|+||.||+|.. .++..||+|++... ..+.+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999974 23467999987642 235689999999999 899999999998764
Q ss_pred CceeEEeeccCCCChHHHhhccCCC-------------------------------------------------------
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL------------------------------------------------------- 327 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~------------------------------------------------------- 327 (530)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4688999999999999999753210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccc
Q 009644 328 --PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCF 402 (530)
Q Consensus 328 --~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y 402 (530)
....+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....... .....++..|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 01247888999999999999999999 6999999999999999999999999999986543221 1223356789
Q ss_pred cCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHH
Q 009644 403 LDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELAL 481 (530)
Q Consensus 403 ~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 481 (530)
+|||++.+..++.++|||||||++|||++ |..||....... ........... . ..+...+..+.+++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~------~---~~~~~~~~~l~~li~ 311 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR------M---RAPENATPEIYRIML 311 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC------C---CCCCCCCHHHHHHHH
Confidence 99999999999999999999999999997 999997643321 11121111100 0 112233467899999
Q ss_pred HcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 482 QCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 482 ~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+||+.+| +|||+.+|++.|++++.
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.28 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=210.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.....+.++||+|-||.|..+....+..||||.+.... ..+|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34556668999999999999999888999999988643 46899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
|++|+|.+|+...... .+.....++|+.|||.||+||.+. ++|||||.++|||++.++++||+|||++|.+....
T Consensus 617 mEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~--nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESL--NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhh--chhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999876431 345667788999999999999996 99999999999999999999999999999775543
Q ss_pred Cc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 392 HA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.. +...-+.+|||||.+.-+++|++||||+|||++||+++ .+.||..... ...++......+-. -.....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~--~~~~~l 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQ--GRQVVL 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCC--Ccceec
Confidence 32 22335678999999999999999999999999999876 7788865432 23333322211100 011122
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+.-++.++.+++++||..+. +|||++++...|++.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3456677899999999999997 999999999988764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=353.09 Aligned_cols=257 Identities=22% Similarity=0.360 Sum_probs=215.9
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc--HHH--HHHHHHHHHhcC-CCCcceEEEEEeecC-ceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ--IQN--FLHEVKHIARVH-HRHLVKLVGFCEENH-QQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~~--~~~E~~il~~l~-H~nIv~l~g~~~~~~-~~~LV 308 (530)
-++|..+++||.|+||.||+|+ ...+..||||+++++. .++ =++|+..|++++ |||||++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4678888999999999999999 6678999999877543 333 368999999998 999999999998887 99999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||| ..+|++.++++. ..+++..+..|+.||.+||+|+|. +|+.|||+||+|||+..+..+||+|||+||.+.
T Consensus 89 fE~M-d~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhh-hhhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEecccccccccc
Confidence 9999 469999998874 379999999999999999999999 599999999999999999999999999999988
Q ss_pred CCCCcCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------
Q 009644 389 GSHHAGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------ 455 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------ 455 (530)
.....+....|..|+|||++. .+-|+.+.|+||+||+++|+.+-++.|.+..+.+....+..+....
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 777777788899999999876 6779999999999999999999999998876655555554443222
Q ss_pred -----cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 456 -----DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 456 -----~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.........+....++...+..+++.+|+..|| +|||+.|.++.
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222223333334467889999999999999 99999998863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=333.79 Aligned_cols=255 Identities=18% Similarity=0.341 Sum_probs=204.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccH-----HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQI-----QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
+.|+.+.++|+|+||.|||++. ++|+.||||++.++.. +-.++|++.|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788999999999999994 5699999999886543 336899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc-C
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT-G 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~-~ 389 (530)
||+..-|.+ |.... ..++...+..++.|++.|+.|+|+ +++|||||||+|||++.++.+||||||+||.+. .
T Consensus 82 ~~dhTvL~e-Le~~p----~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYP----NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHH-HHhcc----CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 998744444 44332 257888999999999999999999 599999999999999999999999999999887 4
Q ss_pred CCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------------
Q 009644 390 SHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------- 455 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------- 455 (530)
....+....|..|.|||.+.+ .+|+..+||||.||++.||++|++.|.+..+.+....+.......
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 444556678999999999886 789999999999999999999999998776655444444332111
Q ss_pred ----cCCccccc-cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 ----DLGKYVDK-TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ----~~~~~~d~-~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+++.-++ .+....+....-+.+++..|++.|| +|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 1122333445578999999999999 9999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.36 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=201.7
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecC--ceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENH--QQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~--~~~LV~E 310 (530)
.++...+.||+|+||.||++... +|...|||...... .+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45666789999999999999954 48999999876544 566899999999999999999999855544 6889999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCcccccC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~~ 389 (530)
|+++|+|.+++.+..+ .+++..+..+++||++||+|||+ ++||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987643 68999999999999999999998 69999999999999999 79999999999987763
Q ss_pred ----CCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 390 ----SHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 390 ----~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
........||+.|||||++..+.. ..++|||||||++.||+||++||... ......+..+......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~------- 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSL------- 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCC-------
Confidence 122334669999999999986433 35999999999999999999999753 1112222222222111
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
+..+...+.+..+++.+|+..+| +|||++++++.---
T Consensus 242 -P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 -PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 12333455788999999999999 99999999976443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.45 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=208.4
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~L 307 (530)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++.-.. ..-..+|+.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568888999999999999999 7789999999876433 23457999999999999999999998776 68999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|+|||++ +|..++.... -.|+..++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 8888886542 379999999999999999999999 69999999999999999999999999999987
Q ss_pred cCCCC--cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc---
Q 009644 388 TGSHH--AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV--- 461 (530)
Q Consensus 388 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 461 (530)
..... .+....|..|.|||.+.+ ..|+.+.|+||.||||.||++|++.|.+..+.+..+.+.+.-.......|.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 65543 345557899999999885 579999999999999999999999999887766667766654332211111
Q ss_pred -------------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 -------------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 -------------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+.+.+.........++|+...|..+| +|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111112122233556788888889998 9999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=356.86 Aligned_cols=241 Identities=24% Similarity=0.381 Sum_probs=204.7
Q ss_pred ccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHH
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQN 319 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~ 319 (530)
..++-||+|+-|.||+|+++ ++.||||++.+-. ..++..|++|+||||+.|.|+|....-++||||||+.|.|+.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 44578999999999999996 5679999865322 346788999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCccccc
Q 009644 320 HLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399 (530)
Q Consensus 320 ~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt 399 (530)
.|+... .++......+..+||.||.|||. ..|||||||+-||||..+-.+||+|||.++......+..++.||
T Consensus 202 VLka~~-----~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 202 VLKAGR-----PITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred HHhccC-----ccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 998764 78889999999999999999999 49999999999999999999999999999988777677788999
Q ss_pred ccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHH
Q 009644 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMEL 479 (530)
Q Consensus 400 ~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 479 (530)
..|||||++...+.++|+||||||||||||+||..||..-+.. .++ |......+. ...+..++..+.-|
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AII-wGVGsNsL~-------LpvPstcP~GfklL 343 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AII-WGVGSNSLH-------LPVPSTCPDGFKLL 343 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeE-EeccCCccc-------ccCcccCchHHHHH
Confidence 9999999999999999999999999999999999999754332 111 211110110 12455667889999
Q ss_pred HHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 480 ALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 480 i~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
+++||+..| .||++++|+..|+-.
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhc
Confidence 999999888 899999999888654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=349.90 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=206.5
Q ss_pred HHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH------HHHHHHHHHHHhc-CCCCcceEEEEEeecCc
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI------QNFLHEVKHIARV-HHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~------~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~ 304 (530)
+...++|...+.||+|+|++||+|+ ...++.+|||++.++.. +-...|-++|.+| +||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445789999999999999999999 56789999998776542 3467788999999 89999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
+|+|+||+++|+|.++|+.. +.|++.....++.+|+.||+|||+ .|||||||||+|||||+++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999876 379999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCCc--------------CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH
Q 009644 385 KLVTGSHHA--------------GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450 (530)
Q Consensus 385 ~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 450 (530)
+.+...... .+..||..|.+||++..+..+..+|+|+|||+||+|+.|++||....+. ...++
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqk 298 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQK 298 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHH
Confidence 987543211 3456999999999999999999999999999999999999999866432 33333
Q ss_pred HHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 451 VKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 451 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+... + - +++...+..+.+|+.+.+..+| +|+|..||-+
T Consensus 299 I~~l-~------y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 299 IQAL-D------Y---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHh-c------c---cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 2221 1 1 1233334678889999999998 9999988764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=336.94 Aligned_cols=242 Identities=21% Similarity=0.357 Sum_probs=198.1
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEee----cCceeEEeecc
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQLLIYDYI 312 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~ 312 (530)
..||+|++|.||+|.+ +|+.||+|.+.... .+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 68899999876432 3568899999999999999999999876 34678999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++.... .+++.....++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997642 688999999999999999999973 378899999999999999999999999998654322
Q ss_pred cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 393 AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..... ... .+.
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~-----~~~---~~~ 245 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIINKNN-----SLK---LPL 245 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCC-----CCC---CCC
Confidence 23457788999999875 6899999999999999999999999985432 222222211110 011 122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
..+..+.+++.+||+.+| +|||++||++.|+.++
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 345688999999999999 9999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=336.31 Aligned_cols=247 Identities=16% Similarity=0.290 Sum_probs=200.6
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ...+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999994 578999999865432 2357889999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988865322 258899999999999999999999 69999999999999999999999999999876543
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+....... ....+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~ 226 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------QEEYSE 226 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc---------cccCCc
Confidence 33344568899999999999999999999999999999999999998654332211111111110 001222
Q ss_pred hHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
.....+.+++.+||+.+| +||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 334678899999999999 9997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.29 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=200.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-----------------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-----------------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVK 294 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-----------------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~ 294 (530)
.++|...+.||+|+||.||++..++ +..||+|.+... ...+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3567888999999999999998533 236999987643 2457899999999999999999
Q ss_pred EEEEEeecCceeEEeeccCCCChHHHhhccCC--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009644 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEG--------------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFH 360 (530)
Q Consensus 295 l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivH 360 (530)
+++++.+.+..++||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ .+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence 99999999999999999999999999865321 111247888999999999999999999 59999
Q ss_pred cCCCCCcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 009644 361 MHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREA 435 (530)
Q Consensus 361 rDLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt--G~~p 435 (530)
|||||+|||+++++.+||+|||+++.+..... .....++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543221 122234678999999988899999999999999999987 5566
Q ss_pred CCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 436 HGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
|...... ............. ........+...+..+.+++.+||+.+| +|||+.+|.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQ--GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhc--cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6644322 2222221111000 0000011223345688999999999999 99999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=347.27 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=205.8
Q ss_pred hhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc--------cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT--------QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQ 304 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~ 304 (530)
...+|...+.||+|+||.|+.|. ..++..||+|.+.++ ..+...+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35688899999999999999998 556899999975543 1335668999999998 9999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGL 383 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGl 383 (530)
.++||||+.+|+|.+++... +.+.+.+...++.|++.|++|+|+ ++|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999883 278899999999999999999999 599999999999999999 9999999999
Q ss_pred cccc-cCCCCcCcccccccccCccccCCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh-ccCCc
Q 009644 384 LKLV-TGSHHAGSTSAVDCFLDPELNLSKN-YS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS-CDLGK 459 (530)
Q Consensus 384 a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 459 (530)
+... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.... .......+... ..+..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRKIRKGEFKIPS 244 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHHHhcCCccCCC
Confidence 9988 4555667788999999999999877 86 77999999999999999999998632 22333332221 12222
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHH
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIA 497 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl 497 (530)
+++ ..++.+++.+|+..+| +|+|+.+|+
T Consensus 245 ~~~----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 245 YLL----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CcC----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 211 5788999999999999 999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.96 Aligned_cols=273 Identities=20% Similarity=0.326 Sum_probs=216.0
Q ss_pred cccccCHHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc--CCCCcceEEEEEe
Q 009644 223 NLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV--HHRHLVKLVGFCE 300 (530)
Q Consensus 223 ~~~~~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l--~H~nIv~l~g~~~ 300 (530)
+...+++.-.+....+....+.||+|.||.||+|.++ |+.||||++...+.+.|.+|.+|.+.+ +|+||+.+++.-.
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 3456677777778889999999999999999999996 778999999999999999999999875 9999999998754
Q ss_pred ec----CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhc------CCCCeeecCCCCCcEEE
Q 009644 301 EN----HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS------LVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 301 ~~----~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~------~~~~ivHrDLk~~NILl 370 (530)
.+ .++|||++|.++|||+|||... .++....++++..+|.||+|||. .+|.|.|||||+.|||+
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 43 2689999999999999999874 79999999999999999999995 24789999999999999
Q ss_pred cCCCeEEEeecCCcccccCCC-----CcCcccccccccCccccCCCC----CC--chhhHHHHHHHHHHHHcC-------
Q 009644 371 EENYTAKVSDYGLLKLVTGSH-----HAGSTSAVDCFLDPELNLSKN----YS--AGSDVYSFGVFLLELISG------- 432 (530)
Q Consensus 371 ~~~~~~KI~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~s--~ksDVwSfGvvl~ElltG------- 432 (530)
.+++.+.|+|+|||-...... ......||.+|||||++...- |. ..+||||||.|+||++..
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 999999999999997654432 234456999999999985422 21 359999999999999753
Q ss_pred ---CCCCCCCCCCchHHHHHHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 433 ---REAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 433 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+.||.+--..+. . ++.+.... -.+-+.|.++. ...+....+.+++..||..+| -|-|+--|-+.|.++.+
T Consensus 430 eey~~Pyyd~Vp~DP-s-~eeMrkVV-Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDP-S-FEEMRKVV-CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hhhcCCcccCCCCCC-C-HHHHhcce-eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 466654322211 1 11111110 01112333333 456778899999999999999 89999999999988874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=351.82 Aligned_cols=259 Identities=23% Similarity=0.393 Sum_probs=216.9
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.+++....+....++||-|.||.||.|.|+. .-.||||.+++.. .++|+.|+.+|+.++|||+|+|+|+|.....+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3444445566667899999999999999765 4579999888654 579999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
||+|||.+|+|.+||++... ..++.--.+.++.||+.||+||.. +++|||||.++|+|+.++..+||+||||+|+
T Consensus 340 IiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999998653 357777889999999999999999 6999999999999999999999999999999
Q ss_pred ccCCCCcCc--ccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 387 VTGSHHAGS--TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 387 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
+..+..... ..-...|.|||.+....|+.|||||+|||+|||+.| |..||.+.+-...+.+.+ ...++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE---kgyRM------ 485 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE---KGYRM------ 485 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh---ccccc------
Confidence 877654321 224567999999999999999999999999999999 888887654332222222 22111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+.+..|+.++.+||++||+.+| +||++.|+-+.++.+..
T Consensus 486 ---~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 486 ---DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 2456778899999999999998 99999999999998864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.63 Aligned_cols=261 Identities=20% Similarity=0.327 Sum_probs=201.2
Q ss_pred CccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHh--cCCCCcceEEEEEeecC----ceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIAR--VHHRHLVKLVGFCEENH----QQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~H~nIv~l~g~~~~~~----~~~LV~Ey~ 312 (530)
.+..+.||+|+||.||||.+. ++.||||++...+.+.|.+|-+|.+. +.|+||++++++-.... .++||+||.
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 344578999999999999995 48999999999999999999999875 48999999999876555 899999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-------VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++|+|.+||..+ .++|....+|+..+++||+|||+. +++|+|||||++|||+.+|+++.|+|||+|.
T Consensus 291 ~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 291 PKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred cCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999876 799999999999999999999963 4789999999999999999999999999998
Q ss_pred cccCCCCc---CcccccccccCccccCCCC-CC-----chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH--------
Q 009644 386 LVTGSHHA---GSTSAVDCFLDPELNLSKN-YS-----AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI-------- 448 (530)
Q Consensus 386 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~-------- 448 (530)
.+...... ....||.+|||||++.+.. +. .+.||||+|.|||||+++..-+......+...-.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87644332 2356999999999986532 22 3589999999999999976554311111100000
Q ss_pred --HHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 449 --LQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 449 --~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
..++.. -..+...|.+++ .....+.-+.+.+..||+.|+ .|-|+.=|-+++.++....
T Consensus 445 t~e~mq~~-VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQEL-VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHH-HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 000000 011111222222 112345678899999999998 8999999999888876553
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.86 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=201.7
Q ss_pred cCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|+..+.||+|+||.||+|.++ .+..||+|..... ....|.+|+.++.+++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999853 3568999987643 235689999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999997643 268999999999999999999999 599999999999999999999999999876543
Q ss_pred CCCCc--CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 389 GSHHA--GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 389 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
..... ....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ........... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~------~-- 227 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFR------L-- 227 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC------C--
Confidence 22111 12234567999999999999999999999999999775 99999754322 22222221111 0
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+...+..+.+++.+||+.+| +|||+++|.+.|+++
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1123345678999999999998 999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=342.94 Aligned_cols=249 Identities=20% Similarity=0.335 Sum_probs=201.9
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 5889999987643 2356889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997542 68899999999999999999999 5999999999999999999999999999986543
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ........... ...+......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~--~~~~~~~~~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKYWKET--LQRPVYDDPR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHhcccc--ccCCCCCccc
Confidence 2234568899999999999999999999999999999999999997653322 11121111000 0001111111
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.....++.+++.+|+..+| +||++.++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2335678899999999887 89999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=316.14 Aligned_cols=256 Identities=19% Similarity=0.361 Sum_probs=211.4
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH-----HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI-----QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.+|...+.||+|.||.||+|+ ...|+.||||++.-... ...++|+..|+.++|+||+.++++|-..+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357777899999999999999 67799999998765433 357899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
||+ .+|...+++... .++..++..++.++.+||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 996 499999987653 78999999999999999999999 69999999999999999999999999999988655
Q ss_pred CCc-CcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc--------
Q 009644 391 HHA-GSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY-------- 460 (530)
Q Consensus 391 ~~~-~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 460 (530)
... .....|..|.|||.+.+ +.|+...||||.||++.||+-|.+-|.+..+.++...+...-.......+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 433 23357889999998774 67999999999999999999999988877766665666555332211111
Q ss_pred -------ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 461 -------VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 461 -------~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..+.+....+.+.....+++.+++..+| +|+|++|.++.
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1222233444556677999999999999 99999998763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.51 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=202.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
..++|+..+.||+|+||.||+|.. .++..||+|++... ..+.+.+|+.++..+ +||||++++++|..++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788889999999999999973 23557999987642 235688999999999 8999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCC--------------------------------------------------------
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL-------------------------------------------------------- 327 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~-------------------------------------------------------- 327 (530)
..++||||+++|+|.+++......
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999999753210
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 328 --------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 328 --------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 01247889999999999999999999 59999999999999999999999999999866433221
Q ss_pred ---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 394 ---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 394 ---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
....++..|+|||++.+..++.++|||||||++|||++ |..||....... ............ ..+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~---------~~~ 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGYRM---------LSP 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCccC---------CCC
Confidence 12234567999999999999999999999999999998 888886543221 222222211100 011
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
...+.++.+++.+||+.+| +|||+.||++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1224578999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.98 Aligned_cols=254 Identities=17% Similarity=0.323 Sum_probs=204.9
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.+.|+..++||.|..++||+|+ ...++.||||++.- ...+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678899999999999999999 56789999999763 235678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
||.+|++.+.++..-. ..+++..+..|.+++++||.|||. +|.||||||+.||||+++|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986532 248999999999999999999999 69999999999999999999999999988765433
Q ss_pred CC----c-CcccccccccCccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 391 HH----A-GSTSAVDCFLDPELNL--SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 391 ~~----~-~~~~gt~~y~aPE~~~--~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
.. . ....||++|||||++. -..|+.|+||||||++..||.+|..||.....-. -+....+.... .....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLqn~pp--~~~t~ 255 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQNDPP--TLLTS 255 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCCCC--Ccccc
Confidence 21 1 3446999999999955 3569999999999999999999999998664322 12222222111 11100
Q ss_pred ccc-ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 464 TLG-EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 464 ~l~-~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+. +........+.+++..|++.|| +|||++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111 1233344678899999999999 9999999985
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=345.47 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=202.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
..++|+..+.||+|+||.||+|+.. ++..||+|++... ..+.+.+|+++++.+ +|+||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457888999999999999998732 2357999987643 235688999999999 8999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCC---------------------------------------------------------
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEG--------------------------------------------------------- 326 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~--------------------------------------------------------- 326 (530)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999864311
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc---Cc
Q 009644 327 --------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA---GS 395 (530)
Q Consensus 327 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~---~~ 395 (530)
.....+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 011247888999999999999999999 69999999999999999999999999999865432211 12
Q ss_pred ccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 396 TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 396 ~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
..++..|+|||++....++.++|||||||++|||++ |+.||....... .......... ... .+...+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~~------~~~---~~~~~~~ 342 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRGY------QMS---RPDFAPP 342 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHccc------Ccc---CCCCCCH
Confidence 224567999999998999999999999999999997 999997543322 1111111110 000 1112246
Q ss_pred HHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 475 EMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
++.+++.+||+.+| +|||+.+|++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 78999999999999 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=325.88 Aligned_cols=246 Identities=23% Similarity=0.414 Sum_probs=202.0
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++|+..+.||+|+||.||++.++++..+|+|...... .++|.+|++++++++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4577889999999999999998888889999876433 46799999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA- 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~- 393 (530)
|+|.+++.... +.+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999997543 258899999999999999999999 69999999999999999999999999999865432221
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ............ ... +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~---~~~------~~~ 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFR---LYR------PKL 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCC---CCC------CCC
Confidence 12234567999999988899999999999999999999 8999865432 223333322211 111 111
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
....+.+++.+||..+| +|||+.++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 23578999999999999 999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.43 Aligned_cols=244 Identities=19% Similarity=0.379 Sum_probs=206.3
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..|.....||+|+.|.||.+. ..+++.||||++... ..+-.++|+.+|+..+|+|||+++..|..++.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777899999999999998 667889999986533 2345789999999999999999999999889999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
++|+|.+.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.++.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998765 58999999999999999999999 699999999999999999999999999998876655
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
...+..||++|||||++....|++|.||||||++++||+-|++||..........++. ... . +.+ ..+..
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa---~ng-~-----P~l-k~~~k 494 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNG-T-----PKL-KNPEK 494 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh---hcC-C-----CCc-CCccc
Confidence 4556679999999999999999999999999999999999999998644322222111 111 0 111 12334
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+..+.+++.+|++.|+ +||++.|+++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 45789999999999998 9999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=319.79 Aligned_cols=196 Identities=26% Similarity=0.429 Sum_probs=179.9
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+.++.||.|+||.|.+++ ..+|..+|+|++.+. +.++..+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467888999999999999999 456889999988764 3467789999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||.++|.|..+|++.. .+++.....+|.||+.||+|||+ .+|++|||||+|||||.+|.+||.|||.|+.+..
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999998764 79999999999999999999999 5999999999999999999999999999998765
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHS 441 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 441 (530)
. ..+.+||+.|+|||.+..+.|+.++|.|||||++|||+.|.+||.....
T Consensus 197 r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 R--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred c--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3 4567899999999999999999999999999999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=345.44 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=204.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+. +.+...+|++|+++++|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677788999999999999994 46788999987653 34568999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+.+ +|..+|.... .++++.+..|+.+++.||.|||+ .+|+|||+||.|||++.++++|+||||+||.+...
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9965 9999998753 79999999999999999999999 59999999999999999999999999999987654
Q ss_pred CC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 HH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.. ..+..||+.|||||...+..|+..+|.||+||++||+++|++||... +..+++..+... +. ..+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d--------~v--~~p 220 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKD--------PV--KPP 220 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcC--------CC--CCc
Confidence 32 34556999999999999999999999999999999999999999743 233444333321 11 123
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+..++...+..|| +|.|..+++.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 3556788889999999999 9999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=329.08 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=204.1
Q ss_pred cCCccceeeccCCcEEEEEEEEcCC------CEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDG------SLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~------~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
++|+..+.||+|+||.||+|..... ..+++|.+.... ...|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4677889999999999999985432 478999875432 356899999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCC-----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPI-----------GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT 375 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~ 375 (530)
++|||+++|+|.+++........ ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCCCc
Confidence 99999999999999976432111 368899999999999999999999 59999999999999999999
Q ss_pred EEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHH
Q 009644 376 AKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 376 ~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 451 (530)
+||+|||+++....... .....++..|+|||.+....++.++|||||||++|||++ |..||...... .....+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999986533221 122335678999999988899999999999999999998 99998754322 222222
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
... . ....+...+..+.+++.+||+.+| +||++.+|++.|+++
T Consensus 240 ~~~-~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 RSR-Q--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HcC-C--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 211 1 111223445789999999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=331.30 Aligned_cols=243 Identities=32% Similarity=0.549 Sum_probs=192.2
Q ss_pred cceeeccCCcEEEEEEEEc-----CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 241 EINIIGEGSFGLAYKGLLQ-----DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..+.||.|.||.||+|.+. .+..|+||.+... ..+.|.+|++.+++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 2567999998542 257899999999999999999999999988889999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.++|..... ..+++.++..++.|++.||+|||+ .+++|+||+++|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc---cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 999999999998622 378999999999999999999999 599999999999999999999999999998763221
Q ss_pred C---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 392 H---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 392 ~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
. .........|+|||.+....++.++||||||+++|||+| |+.||... ............... .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~~~~~~---------~ 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLKQGQRL---------P 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHHTTEET---------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc---------e
Confidence 1 122335667999999988889999999999999999999 67887654 223334444322111 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
.+...+..+.+++.+||+.+| +||||.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222345678999999999999 999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.85 Aligned_cols=241 Identities=19% Similarity=0.288 Sum_probs=199.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+|... +++.+|+|.+... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999954 6889999987532 2356889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997643 68899999999999999999999 6999999999999999999999999999987643
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .. ..+
T Consensus 154 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~~-~~---------~~~ 218 (291)
T cd05612 154 R--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILAG-KL---------EFP 218 (291)
T ss_pred C--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC-Cc---------CCC
Confidence 2 22345888999999999989999999999999999999999999764322 222222211 00 111
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCC-----HHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPS-----MRQIAGE 499 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~~ 499 (530)
......+.+++.+|++.+| +||+ ++++++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1224578899999999999 9995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=325.04 Aligned_cols=251 Identities=21% Similarity=0.436 Sum_probs=205.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...++..||+|..... ..+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 3578888999999999999999888889999987643 34678999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999976432 368899999999999999999999 59999999999999999999999999999876433211
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....++..|+|||++....++.++||||||+++|||+| |..||...... ............ + ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~-----~----~~~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGYRM-----P----RME 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCCC-----C----CCC
Confidence 12234567999999988889999999999999999999 99998654321 222222221111 1 111
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+..+.+++.+|+..+| +|||++++.+.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 234678899999999998 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=313.31 Aligned_cols=244 Identities=18% Similarity=0.296 Sum_probs=209.2
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH------HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~------~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|.||.||.|+ .+++-.||+|++.+++. ..+.+|++|-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4678899999999999999999 45678999999887654 4688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
+||.++|+|...|.+... ..+++.....++.|+|.||.|+|. +++||||+||+|+|++..+..||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999986543 368888889999999999999999 799999999999999999999999999987654
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......+....+..+... +
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-------------~ 241 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-------------F 241 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-------------C
Confidence 44556778999999999999999999999999999999999999999876533322222222211 2
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+........+++.+|+..+| +|.+..||+.
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 23345688999999999999 9999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=334.07 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=200.8
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCC----EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGS----LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.+|+..+.||+|+||.||+|.+. ++. .||+|..... ..+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888899999999999999853 333 3899987532 246789999999999999999999999875 5679
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998653 258899999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
...... .....+..|+|||++....++.++||||||+++|||++ |+.||...... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~------ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGERL------ 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhCCCCC------
Confidence 543221 12224567999999999999999999999999999998 99998754321 111111111000
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+..+...+.+++.+||..+| +|||+.+++..|..+...
T Consensus 231 ---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0112234578899999999998 999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=344.98 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=212.2
Q ss_pred cCCccceeeccCCcEEEEEEEEcC---CC--EEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD---GS--LVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~---~~--~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
+.....+.||.|-||.||+|.+.+ |. .||||..+. ...+.|+.|..+|++++|||||+++|+|.+. +.|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 344555789999999999999644 22 478887664 3467899999999999999999999999875 7899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|||.++.|.|..||..+.. .|+......++.||+.+|+|||+ +.+|||||..+|||+.+.-.+|++|||++|.+
T Consensus 468 vmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999987754 78899999999999999999999 69999999999999999999999999999998
Q ss_pred cCCCCcCccc--ccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 388 TGSHHAGSTS--AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 388 ~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
.++....... -+..|||||.+...+||.+||||-|||.+||+++ |..||.+-...+... ..... .
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~---~iEnG---------e 609 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG---HIENG---------E 609 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE---EecCC---------C
Confidence 7765443333 3457999999999999999999999999999987 999998654433211 11111 1
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
-.+.+++++..+..++.+||.++| +||++.++...|.++++.+..
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 113567888999999999999999 999999999999999886544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.59 Aligned_cols=236 Identities=17% Similarity=0.267 Sum_probs=194.3
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+.||+|+||.||++.. .+++.+|+|.+... ....+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 56889999987643 2346788999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCcC
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAG 394 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~~ 394 (530)
+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999997642 68999999999999999999999 59999999999999999999999999999754322 2223
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...||+.|+|||++.+..++.++|||||||++|||+||+.||..... .......... .. ..+.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~~~-~~---------~~p~~~~~ 220 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILME-EI---------RFPRTLSP 220 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHHcC-CC---------CCCCCCCH
Confidence 44589999999999999999999999999999999999999975432 1222221111 10 11223346
Q ss_pred HHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 475 EMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.+.+++.+|++.+| +|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 78899999999999 999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=338.64 Aligned_cols=240 Identities=19% Similarity=0.286 Sum_probs=198.7
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+|+.. +++.||+|.+... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999964 5789999987643 2356889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997643 67888999999999999999999 5999999999999999999999999999987643
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .. ..+
T Consensus 171 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~-~~---------~~p 235 (329)
T PTZ00263 171 RT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKILAG-RL---------KFP 235 (329)
T ss_pred Cc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHhcC-Cc---------CCC
Confidence 22 234688999999999999999999999999999999999999975432 1222222211 00 011
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
......+.+++.+||+.+| +||+ ++++++
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1223578899999999999 9986 677764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.04 Aligned_cols=255 Identities=18% Similarity=0.312 Sum_probs=197.4
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||+|.. .++..||+|.+... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5688889999999999999995 46789999987532 234678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ |+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 59999887543 257889999999999999999999 599999999999999999999999999997654322
Q ss_pred -CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc------------C
Q 009644 392 -HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------------L 457 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------------~ 457 (530)
......++..|+|||.+.+ ..++.++||||+||++|||+||++||......+....+........ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2233457888999998865 5689999999999999999999999976543332222222111000 0
Q ss_pred Cccccccc-----cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYVDKTL-----GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d~~l-----~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.. .........+..+++.+|++.+| +|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 00111234577899999999999 9999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.55 Aligned_cols=257 Identities=17% Similarity=0.263 Sum_probs=200.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||+++.. ++..+|+|.+... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999954 5778899976532 23578999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 588999999999999999999983 36999999999999999999999999999865432
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh--ccCCc---------
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS--CDLGK--------- 459 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~--~~~~~--------- 459 (530)
......++..|+|||++.+..++.++|||||||++|||+||+.||......+....+...... .....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 223345888999999999999999999999999999999999999654322111110000000 00000
Q ss_pred -----------------------cccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 460 -----------------------YVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 460 -----------------------~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+....... .......++.+++.+||+.+| +|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 011234678999999999999 99999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.87 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=203.7
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.+|...+.||+|+||.||+|... .+..+|+|...... ..++.+|++++++++|+||+++++++..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 35777789999999999999954 57889999876543 4578999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999975432 258999999999999999999999 69999999999999999999999999999876543221
Q ss_pred C--cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 G--STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 ~--~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. ....+..|+|||.+.+..++.++||||||+++|||++ |..||...... ........... . ..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~~------~---~~~~ 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKGYR------M---ERPE 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCC------C---CCCC
Confidence 1 1223557999999998999999999999999999998 89998754321 22222211100 0 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+..+.+++.+|++.+| +|||+.++++.|+++
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 344688999999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.90 Aligned_cols=251 Identities=24% Similarity=0.436 Sum_probs=205.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...+++.||+|.+... ..+++.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4568888999999999999999877888999987653 34679999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+++|.+++....+ ..+++.++..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999976432 268999999999999999999999 69999999999999999999999999999876532211
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....+..|+|||++.+..++.++||||||+++|||+| |+.||..... ......+...... ..+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~ 227 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYRM---------PCPP 227 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC---------CCCC
Confidence 11122357999999998999999999999999999999 9999865432 1222222221110 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.....+.+++.+|++.+| +||++.++++.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 334678999999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=334.85 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=199.8
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
...++|+.+..||+|+||.||+++. ..|..+|+|++.++ +.++.+.|-.+|....+|+||+||-.|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3457999999999999999999994 56899999998764 4567899999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
|||||++||++..+|.... .|++.....++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+.-
T Consensus 218 LiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~--gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQL--GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHc--CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999998763 899999999999999999999994 999999999999999999999999999853
Q ss_pred ccC-----------------------CCC-------------------------cCcccccccccCccccCCCCCCchhh
Q 009644 387 VTG-----------------------SHH-------------------------AGSTSAVDCFLDPELNLSKNYSAGSD 418 (530)
Q Consensus 387 ~~~-----------------------~~~-------------------------~~~~~gt~~y~aPE~~~~~~~s~ksD 418 (530)
+.. +.. ..++.||+-|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 000 11334899999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCC
Q 009644 419 VYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPS 492 (530)
Q Consensus 419 VwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt 492 (530)
.||+|||+|||+.|-+||......+....+...+.....+. ......+..++|.+|+. ++ +|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999998766554433332222211111 11223688899999888 65 7765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.68 Aligned_cols=255 Identities=18% Similarity=0.259 Sum_probs=197.5
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|++.+.||+|+||.||+++.+ +++.+|+|++... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999964 5788999986532 24568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++++.+..+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554322 268899999999999999999999 59999999999999999999999999999876432
Q ss_pred CC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------c
Q 009644 391 HH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------D 456 (530)
Q Consensus 391 ~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------~ 456 (530)
.. .....++..|+|||++.+..++.++|||||||++|||++|++||...........+....... .
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 223457889999999998899999999999999999999999997654322211111111000 0
Q ss_pred CCccccccccc-------cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 LGKYVDKTLGE-------QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ~~~~~d~~l~~-------~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.... .....+..+.+++.+|++.+| +|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 111234578999999999999 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=325.36 Aligned_cols=256 Identities=19% Similarity=0.320 Sum_probs=194.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-c-CCCEEEEEEcccc-----cHHHHHHHHHHHHhc---CCCCcceEEEEEe-----e
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-Q-DGSLVVIKRHLQT-----QIQNFLHEVKHIARV---HHRHLVKLVGFCE-----E 301 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l---~H~nIv~l~g~~~-----~ 301 (530)
++|+..+.||+|+||.||+|+. . ++..||+|.+... ....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999985 3 4678999976532 234567788887766 6999999999985 2
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 699999875432 258999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---cCC
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---DLG 458 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~ 458 (530)
|+++............++..|+|||.+....++.++|||||||++|||++|++||......+....+....... +..
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 99987654433344568889999999988899999999999999999999999998654322221111111000 000
Q ss_pred -------cccc----ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 -------KYVD----KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 -------~~~d----~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... ..+..........+.+++.+|++.+| +|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00001112234567899999999999 9999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=326.76 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=204.1
Q ss_pred cCCccceeeccCCcEEEEEEEEcC-CC--EEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD-GS--LVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~--~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|+..+.||+|+||.||+|...+ +. .+++|.+... ..+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999998654 32 4677776532 235789999999999 799999999999999999999
Q ss_pred eeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 309 YDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
|||+++|+|.+++...... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEE
Confidence 9999999999999753211 11358899999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
|+|||++..............+..|+|||++....++.++|||||||++|||+| |..||...... ...........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~~~~~~~ 236 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQGYR 236 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcCCC
Confidence 999999875322111112223456999999988899999999999999999998 99999754322 22222211100
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
. ..+......+.+++.+||+.+| +|||+++|++.|+.+.....+
T Consensus 237 ------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 237 ------M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred ------C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 1112234678899999999999 999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.18 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=207.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
...+|+..+.||+|+||.||+|...++..+++|.+.... ...+.+|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 345788889999999999999998888999999877543 45789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++....+ ..+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999986533 368999999999999999999999 699999999999999999999999999998764332
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. .....++..|+|||.+....++.++||||||+++|||++ |+.||..... ............. ..+
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~ 226 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYRM---------PCP 226 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCcC---------CCC
Confidence 2 122335667999999988899999999999999999998 8999865432 2222222211110 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
...+..+.+++.+|+..+| +|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 2344678899999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.59 Aligned_cols=247 Identities=24% Similarity=0.417 Sum_probs=201.3
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++|...+.||+|+||.||+|...++..+|+|.+.... .++|.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 3577789999999999999998777779999876543 46799999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA- 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~- 393 (530)
|+|.+++..... .+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999976432 68999999999999999999999 59999999999999999999999999999865433211
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
....++..|+|||+.....++.++||||||+++|||++ |..||...... ............ .....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~---------~~~~~ 225 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVSQGLRL---------YRPHL 225 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHhcCCCC---------CCCCC
Confidence 12234567999999988889999999999999999999 99998654321 222222211110 01112
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
....+.+++.+||+.+| +|||+.+|++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 24688999999999999 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.82 Aligned_cols=243 Identities=20% Similarity=0.326 Sum_probs=191.6
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||+|+. .+++.||+|.+... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3456678999999999999995 46889999987543 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+.. ...+..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 35677788999999999999999 599999999999999999999999999998764332
Q ss_pred C-cCcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 392 H-AGSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
. .....|+..|+|||++.. ...+.++|||||||++|||++|+.||....................
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 293 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--------- 293 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---------
Confidence 1 234468899999998743 2345689999999999999999999974433222222221111100
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.........++.+++.+||+.+| +|||+.|+++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122344678999999999998 99999999863
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.03 Aligned_cols=247 Identities=19% Similarity=0.321 Sum_probs=193.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++.. .+++.+|+|++... ....+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788999999999999999985 45889999987643 2346788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997642 68999999999999999999999 5999999999999999999999999999875432
Q ss_pred CCC------------------------------------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 009644 390 SHH------------------------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433 (530)
Q Consensus 390 ~~~------------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~ 433 (530)
... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 11235889999999999999999999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcc-c-CCC-CCCCHHHHHHH
Q 009644 434 EAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCV-D-VSS-RRPSMRQIAGE 499 (530)
Q Consensus 434 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl-~-~~p-~RPt~~eVl~~ 499 (530)
.||...... .....+..... .-.+++. ......+.+++.+++ . .++ .||+++||++.
T Consensus 234 ~Pf~~~~~~---~~~~~i~~~~~-~~~~p~~-----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQ---ETYKKVMNWKE-TLIFPPE-----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHH---HHHHHHHcCcC-cccCCCc-----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 999754322 22222221100 0001110 112245566665522 2 233 68999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=320.24 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=203.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+|.+.. ...||+|..... ...+|.+|+.++++++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568888999999999999999642 357899986543 23578999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... +.+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997643 268999999999999999999999 59999999999999999999999999999877
Q ss_pred cCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~------ 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRL------ 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC------
Confidence 422111 12234567999999998999999999999999999998 9999864432 1222222211110
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
+.+...+..+.+++.+|++.+| +||++++|++.|+++
T Consensus 228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112334678999999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=337.19 Aligned_cols=242 Identities=18% Similarity=0.271 Sum_probs=198.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC--CCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD--GSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+|...+ +..||+|.+... ..+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999998543 358999987532 34568899999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997653 68899999999999999999999 59999999999999999999999999999875
Q ss_pred cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 388 TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .. .
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~-~~---------~ 246 (340)
T PTZ00426 182 DTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILEG-II---------Y 246 (340)
T ss_pred CCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhcC-CC---------C
Confidence 432 23456889999999999888999999999999999999999999754321 222222211 00 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRP-----SMRQIAGE 499 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~~ 499 (530)
.+......+.+++.+|++.+| +|+ |++++++.
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112223567899999999998 884 88888753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.69 Aligned_cols=236 Identities=17% Similarity=0.272 Sum_probs=193.4
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+.||+|+||.||++.. .++..||+|.+... ....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999994 56889999987643 2346788999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCcC
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAG 394 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~~ 394 (530)
+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9999887542 68999999999999999999999 59999999999999999999999999998764222 2223
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... .. ..+.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~~~-~~---------~~p~~~~~ 220 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILME-EI---------RFPRTLSP 220 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHhcC-CC---------CCCCCCCH
Confidence 445889999999999999999999999999999999999999754322 111111111 00 01223346
Q ss_pred HHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 475 EMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.+.+++.+|++.+| +|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 78899999999999 898 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=323.14 Aligned_cols=252 Identities=25% Similarity=0.460 Sum_probs=203.3
Q ss_pred cCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.+|.+.+.||+|+||.||+|...+ +..||+|.+... ..+.|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 468999987643 2457999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 307 LIYDYIPNGNVQNHLYDSEG---------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
+||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeEE
Confidence 99999999999999976421 112358899999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHh
Q 009644 378 VSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 378 I~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~ 453 (530)
|+|||+++....... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... ........
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~~~ 239 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECITQ 239 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc
Confidence 999999986533221 122335678999999999999999999999999999999 99998754322 22222221
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
. . ....+...+..+.+++.+||+.+| +|||+.||++.|++
T Consensus 240 ~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 240 G-R--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred C-C--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 1 001122344688999999999999 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=323.70 Aligned_cols=247 Identities=17% Similarity=0.299 Sum_probs=199.9
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ...+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999995 468899999876432 2357789999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999998865422 258999999999999999999999 59999999999999999999999999999876443
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.......++..|+|||++.+..++.++||||||+++|||++|+.||...........+...... .....+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~~ 226 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE---------DQEEYSE 226 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh---------cccccCc
Confidence 3333446788999999999899999999999999999999999999765432221111111111 0011222
Q ss_pred hHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.....+.+++.+|+..+| +|| +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 345678899999999999 999 7778755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.97 Aligned_cols=254 Identities=21% Similarity=0.381 Sum_probs=201.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.+++|+..+.||+|+||.||+|... .+..+|+|..... ...+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999753 2457999987532 23568899999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGL-----PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
.++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999753211 01246788999999999999999999 699999999999999999999999
Q ss_pred ecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhc
Q 009644 380 DYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 380 DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|||+++........ ....++..|+|||++....++.++|||||||++|||++ |..||...... .........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~- 237 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFVMEG- 237 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcC-
Confidence 99999765432211 11234667999999998899999999999999999999 68888654321 222222111
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.. ...+...+..+.+++.+|++.+| +|||+.|+++.|++
T Consensus 238 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred Cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 01122334678999999999999 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=333.53 Aligned_cols=234 Identities=20% Similarity=0.317 Sum_probs=190.6
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||+|+||.||++... ++..||+|.+... ....+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999954 5788999987542 235678999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-CcCcc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-HAGST 396 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-~~~~~ 396 (530)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99997642 68999999999999999999999 599999999999999999999999999998643222 22334
Q ss_pred cccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHH
Q 009644 397 SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEM 476 (530)
Q Consensus 397 ~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 476 (530)
.||+.|+|||++.+..++.++|||||||++|||+||+.||..... .......... . . ..+......+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~~~~~~~~-~------~---~~~~~~~~~~ 220 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEMYRKILQE-P------L---RFPDGFDRDA 220 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHHHHHHHcC-C------C---CCCCcCCHHH
Confidence 588999999999999999999999999999999999999975432 1222221111 0 0 1122334678
Q ss_pred HHHHHHcccCCC-CCCC---HHHHHH
Q 009644 477 MELALQCVDVSS-RRPS---MRQIAG 498 (530)
Q Consensus 477 ~~li~~Cl~~~p-~RPt---~~eVl~ 498 (530)
.+++.+|++.+| +||+ +.+++.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 899999999999 9985 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=318.79 Aligned_cols=245 Identities=26% Similarity=0.429 Sum_probs=200.6
Q ss_pred CCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+|+..+.||+|+||.||+|..+++..+|+|..... ...+|.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46777899999999999999877778999987653 3457899999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc--
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA-- 393 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~-- 393 (530)
+|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999976432 68999999999999999999999 59999999999999999999999999999866432211
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ............. ..+...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~~~ 226 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYRL---------YRPKLA 226 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCcC---------CCCCCC
Confidence 11223457999999998999999999999999999999 7888865432 1222222221110 111224
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
+..+.+++.+||..+| +|||+.++++.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 5689999999999998 999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.08 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=206.1
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.|...+.||+|+||.||+|. ...++.||+|++.- .+.++..+|+.+|..++++||.++||.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 45566899999999999999 45688999998653 34567899999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
.+|++.+.|.... .+.+..+.-|.+++..||.|||+ .+.+|||||+.|||+..+|.+|++|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997642 44777788899999999999999 5999999999999999999999999999988766544
Q ss_pred c-CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 A-GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 ~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
. ....||+.|||||++....|+.|+||||||++.+||++|.+|+...+... ...-+.+-..|.+.+ .
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------vlflIpk~~PP~L~~---~ 234 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------VLFLIPKSAPPRLDG---D 234 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------EEEeccCCCCCcccc---c
Confidence 3 56779999999999998899999999999999999999999998665421 122233344455544 4
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+.+++..|++.+| .|||+.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 55678999999999999 9999999885
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.52 Aligned_cols=254 Identities=17% Similarity=0.339 Sum_probs=193.2
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Ccee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQQL 306 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~~~ 306 (530)
+|++.+.||+|+||.||+|+. .++..||+|++... ....+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999994 46889999987532 234688999999999999999999988543 2479
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 78999887542 68999999999999999999999 5999999999999999999999999999986
Q ss_pred ccCCCC----cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh------
Q 009644 387 VTGSHH----AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS------ 454 (530)
Q Consensus 387 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~------ 454 (530)
...... .....++..|+|||++.+ ..++.++|||||||++|||+||++||...........+......
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 532211 123458889999999865 67899999999999999999999999754322111111100000
Q ss_pred ------------ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 455 ------------CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 455 ------------~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..+.......+..........+.+++.+|++.+| +|||++|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000001111111234567899999999999 99999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.62 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=204.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCC--EEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGS--LVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~--~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+|..+ ++. .+++|..... ....+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357788899999999999999964 444 3577765432 235688999999999 89999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeE
Q 009644 308 IYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~ 376 (530)
||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCCCcE
Confidence 99999999999999754311 11358899999999999999999999 699999999999999999999
Q ss_pred EEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhc
Q 009644 377 KVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 377 KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
||+|||+++.............+..|+|||++....++.++|||||||++|||+| |..||...... ..........
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~ 240 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQGY 240 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcCC
Confidence 9999999874322111112223567999999988889999999999999999998 99998654322 2222221110
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCC
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRL 511 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~ 511 (530)
.. ..+......+.+++.+|++.+| +||++.++++.|+++.+......
T Consensus 241 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 241 RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence 00 1112234578899999999999 99999999999999887765433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.60 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=204.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~ 303 (530)
..++|.+.+.||+|+||.||+|.... +..||+|++... ..+.|.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678888999999999999998421 346999987642 2457899999999996 999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCC--------------------------------------------------------
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL-------------------------------------------------------- 327 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~-------------------------------------------------------- 327 (530)
..++||||+++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999998753210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 328 -----------------------------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 328 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
....+++.+++.++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nill~~ 272 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEEEeC
Confidence 01247888899999999999999999 59999999999999999
Q ss_pred CCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHH
Q 009644 373 NYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLI 448 (530)
Q Consensus 373 ~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~ 448 (530)
++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 99999999999986543322 122335677999999999999999999999999999997 989987543211 111
Q ss_pred HHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 449 LQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 449 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
......... ..+...+..+.+++.+||+.+| +|||+.+|++.|+++.+
T Consensus 351 ~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 122111110 1122345688999999999999 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.35 Aligned_cols=237 Identities=17% Similarity=0.269 Sum_probs=194.1
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+.||+|+||.||++.. .+++.+|+|.+... ....+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 46889999987643 2356889999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCcC
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAG 394 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~~ 394 (530)
+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999887542 68999999999999999999999 59999999999999999999999999998764322 2223
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...||..|+|||++.+..++.++|||||||++|||++|+.||...... ......... . . ..+.....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~~-~------~---~~p~~~~~ 220 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILME-D------I---KFPRTLSA 220 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhccC-C------c---cCCCCCCH
Confidence 345889999999999899999999999999999999999999754321 111111110 0 0 11223346
Q ss_pred HHHHHHHHcccCCC-CCC-----CHHHHHHH
Q 009644 475 EMMELALQCVDVSS-RRP-----SMRQIAGE 499 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RP-----t~~eVl~~ 499 (530)
.+.+++.+|++.+| +|| ++.++++.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 78899999999999 897 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=322.34 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=205.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|.+.+.||+|+||.||++... ++..+|+|.+... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888899999999999999842 2456888887643 2457899999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 307 LIYDYIPNGNVQNHLYDSEG--------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
+||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+||
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEe
Confidence 99999999999999975421 112358999999999999999999999 59999999999999999999999
Q ss_pred eecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhh
Q 009644 379 SDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 379 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
+|||+++....... .....++..|+|||++.+..++.++||||||+++|||+| |..||..... ..........
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~~~ 238 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQG 238 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC
Confidence 99999986543221 122234667999999998999999999999999999999 8998865432 1222222221
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
. .. ..+...+..+.+++.+||+.+| +|||+.+|.+.|+.+...
T Consensus 239 ~-~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 R-VL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred C-cC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 00 0111234578999999999999 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=338.90 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=193.1
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.|+.++.||+|+||.||+|+. .+++.+|+|++... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999984 56789999987643 23568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997643 57888999999999999999999 59999999999999999999999999997643110
Q ss_pred C------------------------------------------------CcCcccccccccCccccCCCCCCchhhHHHH
Q 009644 391 H------------------------------------------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSF 422 (530)
Q Consensus 391 ~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSf 422 (530)
. ......||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 0012358899999999998899999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHH--cccCCC-CCCCHHHHHHH
Q 009644 423 GVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQ--CVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 423 Gvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~--Cl~~~p-~RPt~~eVl~~ 499 (530)
||++|||+||+.||........ ............ .. .......++.+++.+ |+..++ .||++.++++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~-----~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET---QLKVINWENTLH-----IP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH---HHHHHccccccC-----CC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999976543221 111111000000 00 111223566777766 555555 69999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.98 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=213.2
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.-|+..+.||.|+.|.|-.|+ ..+|+.+|||.+.+. ......+|+-+|+-+.|||++++|+++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346777999999999999999 567999999987654 2356789999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|.|.+++.... .+++.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+.+||+|||+|..-..
T Consensus 92 Eyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~--~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAF--NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhh--cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999998763 789999999999999999999995 999999999999999999999999999988777
Q ss_pred CCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
+....+.+|.+.|.+||++.+.+|. .++||||.|||||.|+||+.||+++ ....+..+++... -+.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~G~----------f~M 231 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQRGV----------FEM 231 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHcCc----------ccC
Confidence 6667788999999999999999995 7899999999999999999999854 4456666666541 023
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+.+.+.+..+|+.++++.|| +|.|++||.+.
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 34455788999999999999 99999999873
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=321.19 Aligned_cols=251 Identities=21% Similarity=0.389 Sum_probs=197.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCC----EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGS----LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++|+..+.||+|+||.||+|.+. ++. .+++|..... ...++..|+..+++++||||++++|++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777899999999999999953 344 3677776532 23567788889999999999999998864 45779
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997643 268999999999999999999999 69999999999999999999999999999866
Q ss_pred cCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
..... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ........... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~---~~- 232 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLEKGERL---AQ- 232 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCcC---CC-
Confidence 43321 122335668999999998999999999999999999998 999987553221 11111111100 01
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
+......+.+++.+||..+| +|||+.|+++.|+.+...
T Consensus 233 -----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 233 -----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11123467889999999999 999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=322.28 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=202.3
Q ss_pred CCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
+|++.+.||+|+||.||+|... ....+++|..... ..+++.+|+.++++++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 2246888876543 24578899999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 009644 308 IYDYIPNGNVQNHLYDSEG-------------------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NI 368 (530)
+|||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~ni 158 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNV 158 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhheE
Confidence 9999999999999875321 112358899999999999999999999 5999999999999
Q ss_pred EEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCch
Q 009644 369 LLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSD 444 (530)
Q Consensus 369 Ll~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 444 (530)
|+++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 999999999999999986533221 112234567999999988889999999999999999999 9999865432
Q ss_pred HHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 445 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
............. ..+......+.+++.+|++.+| +||++.++++.|+++...
T Consensus 236 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ERLFNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1222222211110 0122334678899999999999 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.45 Aligned_cols=247 Identities=24% Similarity=0.413 Sum_probs=208.3
Q ss_pred cceeeccCCcEEEEEEEE-cCCC----EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 241 EINIIGEGSFGLAYKGLL-QDGS----LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~-~~~~----~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..++||+|+||+||+|.+ ..|+ +||+|++... ...+++.|+-+|.+++|||+++|+|+|..+. +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 347999999999999994 4443 6888876543 3578999999999999999999999998775 7899999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
|+.|+|.+|++..++ .+..+..+.+..|||+||.|||. +++|||||.++|||+.+...+||.|||+++.+..+.
T Consensus 779 mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999998654 78889999999999999999999 699999999999999999999999999999886554
Q ss_pred CcCc---ccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 392 HAGS---TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 392 ~~~~---~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.... ....+.|||-|.+....|+.+||||||||++||++| |..|+.+....+..+.++...+ -.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------------Ls 920 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------------LS 920 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------------CC
Confidence 3322 224567999999999999999999999999999999 9999987765544444333222 13
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.++.+..++.-++.+||..|+ .||+++++.+.+.++...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 566677899999999999998 899999999999887643
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.74 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=200.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999954 6889999987643 3456889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999865 268999999999999999999999 6999999999999999999999999999986643
Q ss_pred CC------------------------------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 390 SH------------------------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 390 ~~------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 122345888999999999999999999999999999999999999765
Q ss_pred CCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCC-HHHHHHH
Q 009644 440 HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPS-MRQIAGE 499 (530)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt-~~eVl~~ 499 (530)
.... ....+.... ... .++ ........+.+++.+|+. +| +||+ ++++++.
T Consensus 234 ~~~~---~~~~i~~~~--~~~---~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE---TYNKIINWK--ESL---RFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH---HHHHHhccC--Ccc---cCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4221 111111100 000 000 011134678899999997 77 9999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=322.25 Aligned_cols=256 Identities=24% Similarity=0.426 Sum_probs=205.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc------CCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.+|...+.||+|+||.||+|... ++..+++|...... .+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777899999999999999742 34568888876543 3568999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeE
Q 009644 308 IYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~ 376 (530)
||||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcE
Confidence 9999999999999975421 112358999999999999999999999 699999999999999999999
Q ss_pred EEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHH
Q 009644 377 KVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVK 452 (530)
Q Consensus 377 KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 452 (530)
||+|||+++....... .....++..|+|||++.+..++.++||||||+++|||+| |+.||...... .......
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~ 239 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECIT 239 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh
Confidence 9999999976543221 122335678999999999999999999999999999999 99998654322 2222221
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.. ... ......+..+.+++.+||+.+| +|||+.+|+++|+++...
T Consensus 240 ~~-~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QG-RVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CC-CCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11 110 1112234678999999999999 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.90 Aligned_cols=254 Identities=18% Similarity=0.312 Sum_probs=195.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||+|... +++.+|+|.+.... ...+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999954 68899999876322 3457889999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ ++|.+++.... ..++...+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 78888887543 268899999999999999999999 59999999999999999999999999999764322
Q ss_pred C-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---c---------
Q 009644 391 H-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---D--------- 456 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~--------- 456 (530)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ........... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhh
Confidence 2 2233457888999998865 45899999999999999999999999864321 11111111100 0
Q ss_pred CCccccccccccc----------hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 LGKYVDKTLGEQT----------VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ~~~~~d~~l~~~~----------~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
............. ......+.+++.+|++.+| +|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 0112467899999999999 9999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=321.20 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=200.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-----cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++|+..+.||+|+||.||+|.. .++..+++|..... ....|.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999984 24578999987642 23568899999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe
Q 009644 308 IYDYIPNGNVQNHLYDSEG------------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT 375 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~ 375 (530)
||||+++|+|.+++..... .....+++.+.+.++.|++.||+|||+ ++++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCCCc
Confidence 9999999999999864321 011257889999999999999999999 69999999999999999999
Q ss_pred EEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHH
Q 009644 376 AKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 376 ~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 451 (530)
+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|||++ |..||..... .......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 99999999986543221 122334567999999988889999999999999999999 8889865432 2222222
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
...... ..+......+.+++.+|++.+| +||++.+|.+.|+.
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 221100 1122334678899999999999 99999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=315.13 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=193.8
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
+.||+|+||.||+|.. .+++.+|+|..... ....|.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999995 46888999976532 245789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC---
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG--- 394 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~--- 394 (530)
.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997542 258899999999999999999999 599999999999999999999999999987654321111
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....+..|+|||.+.+..++.++||||||+++|||++ |..||...... ........... . ..+...+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~~~~------~---~~~~~~~ 222 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQGVR------L---PCPELCP 222 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHcCCC------C---CCcccCC
Confidence 1112346999999998899999999999999999998 88888643221 11111111100 0 1122334
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+.+++.+|++.+| +|||+.+|.+.|++
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 678999999999998 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.44 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=195.3
Q ss_pred ccceeeccCCcEEEEEEEEcCCC---EEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeec------Cce
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGS---LVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEEN------HQQ 305 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~---~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~~~ 305 (530)
.+.+.||+|+||.||+|...+.. .+|+|.... ...+.|.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45588999999999999965432 588987643 2356789999999999999999999987532 246
Q ss_pred eEEeeccCCCChHHHhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 306 LLIYDYIPNGNVQNHLYDSE-GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
+++|||+++|+|.+++.... ......+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 89999999999999885322 1112358999999999999999999999 69999999999999999999999999999
Q ss_pred ccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 385 KLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 385 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+....... .....++..|++||+.....++.++||||||+++|||++ |+.||..... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~--- 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGNRL--- 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence 87643321 112235567999999999999999999999999999999 7888865322 2222222221110
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.........+.+++.+||+.+| +|||+.+|++.|+++
T Consensus 234 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 ------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1122344678999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=324.30 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=204.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
..++|+..+.||+|+||.||++...+ ...+|+|..... ...++.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34678888999999999999998642 357899986642 234688999999999 8999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
..+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+|||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE 167 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEEcC
Confidence 99999999999999999975321 123468999999999999999999999 69999999999999999
Q ss_pred CCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHH
Q 009644 373 NYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLI 448 (530)
Q Consensus 373 ~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~ 448 (530)
++.+||+|||+++.+..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HHH
Confidence 99999999999987644321 111224567999999988899999999999999999998 88888654321 111
Q ss_pred HHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 449 LQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 449 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
........ ...+......+.+++.+|++.+| +|||+.++++.|+++.
T Consensus 245 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 21111100 01222345688999999999998 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=318.49 Aligned_cols=248 Identities=28% Similarity=0.456 Sum_probs=194.9
Q ss_pred eeeccCCcEEEEEEEEcC-CC--EEEEEEccc----ccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQD-GS--LVVIKRHLQ----TQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~-~~--~vavK~~~~----~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|...+ +. .+++|.... ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999654 33 467887653 2345788999999999 899999999999999999999999999
Q ss_pred CChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 315 GNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 315 GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
|+|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999754311 11257899999999999999999999 6999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
++.............+..|+|||++....++.++||||||+++|||++ |..||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~----- 230 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYRL----- 230 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhCCCCC-----
Confidence 864322111111223557999999988899999999999999999997 9999965432 1222222111110
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
+.+......+.+++.+|+..+| +|||+.++++.|++++
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1112234578899999999999 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=323.81 Aligned_cols=260 Identities=22% Similarity=0.403 Sum_probs=206.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|.+.+.||+|+||.||+++.. ++..+|+|..... ..+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778899999999999999741 2347899987542 345789999999999 899999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
...++||||+++|+|.+++...... +...+++.+++.++.|++.||+|||+ ++++||||||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nili~ 171 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVLVT 171 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEEEc
Confidence 9999999999999999999764321 12357889999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
+++.+||+|||+++........ ....++..|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~ 248 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL 248 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHH
Confidence 9999999999999876432211 12234567999999988889999999999999999998 7788764422 222
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
.......... ..+......+.+++.+||..+| +|||+.+|++.|+++.....+
T Consensus 249 ~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 249 FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 2222221110 1122345688999999999998 999999999999999877544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.37 Aligned_cols=198 Identities=20% Similarity=0.322 Sum_probs=172.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||++... ++..+|+|.+... ..+.+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999965 5778888875532 23568999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997642 578899999999999999999973 37999999999999999999999999999765332
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH 440 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 440 (530)
. .....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 M-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred c-cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1 223457889999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=324.56 Aligned_cols=243 Identities=19% Similarity=0.380 Sum_probs=209.7
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH------HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~------~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
..+|++.+.||+|.||.|-++. ...|+.||||.+.+... -.+.+|++||+.|+||||+++|.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3568888999999999999999 57899999998765432 3578999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||..+|.|++|+.+.. .|++.+..++++||+.|+.|+|. ++++|||||.+|||||.|+++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999998864 79999999999999999999999 599999999999999999999999999999888
Q ss_pred CCCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
......+.+|++.|.+||.+.+.+|. +.+|-||+||+||.|+.|..||++.+ ...++.++... ....
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~G----aYrE----- 272 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISRG----AYRE----- 272 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhcc----cccC-----
Confidence 77777888999999999999999985 78999999999999999999998653 33555555443 1111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
++.+....-|+.+++..+| +|.|+.+|...
T Consensus 273 --P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 --PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1223455678888888998 89999999753
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=315.56 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=193.7
Q ss_pred eeccCCcEEEEEEEE---cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 244 IIGEGSFGLAYKGLL---QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~---~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
.||+|+||.||+|.+ .++..+|+|++... ..+++.+|+.++++++||||++++|++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999974 35678999987533 24578999999999999999999999864 4678999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc--
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA-- 393 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~-- 393 (530)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999997542 68899999999999999999999 69999999999999999999999999999876443221
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ............ + ..+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~------~---~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGER------M---ECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCC------C---CCCC
Confidence 11223467999999988889999999999999999998 9999975432 222222222110 0 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+.++.+++.+||+.+| +||++.+|++.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 344678999999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=337.02 Aligned_cols=247 Identities=19% Similarity=0.311 Sum_probs=194.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|...+.||+|+||.||++.. .+++.||+|.+... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999984 56889999987543 2356888999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997542 68889999999999999999999 5999999999999999999999999999964321
Q ss_pred CCC------------------------------------------------cCcccccccccCccccCCCCCCchhhHHH
Q 009644 390 SHH------------------------------------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYS 421 (530)
Q Consensus 390 ~~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwS 421 (530)
... .....||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 01235888999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCCC---CCCHHHHHH
Q 009644 422 FGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSSR---RPSMRQIAG 498 (530)
Q Consensus 422 fGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p~---RPt~~eVl~ 498 (530)
|||++|||+||..||...... .............. ++ ........+.+++.+|+..+++ |+|+.|++.
T Consensus 234 lGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~-----~p-~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH---ETYRKIINWRETLY-----FP-DDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKS 304 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH---HHHHHHHccCCccC-----CC-CCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhc
Confidence 999999999999999755432 11122111100000 00 1112345778899999874433 679999886
Q ss_pred H
Q 009644 499 E 499 (530)
Q Consensus 499 ~ 499 (530)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.01 Aligned_cols=246 Identities=21% Similarity=0.268 Sum_probs=198.3
Q ss_pred CCccceeeccCCcEEEEEEEEc-C-CCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-D-GSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~-~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.|...+.||+|+||.||+|... + +..||+|...... ...+.+|+.+++.++|||||++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999843 3 5678888654322 345788999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++..... ....+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865321 11368899999999999999999999 5999999999999999999999999999987654322
Q ss_pred ---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 ---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 ---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. + ..+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~~~-~~----~----~~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVLYG-KY----D----PFP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CC----C----CCC
Confidence 2334589999999999999999999999999999999999999975422 2222222211 10 0 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+||+.+| +|||+.+++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2234678999999999999 9999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.27 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=195.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+++. .+++.||+|++... ....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788999999999999999995 46889999987643 2345788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997642 68999999999999999999999 5999999999999999999999999999875432
Q ss_pred CCC---------------------------------------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHH
Q 009644 390 SHH---------------------------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELI 430 (530)
Q Consensus 390 ~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ell 430 (530)
... .....||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 01234889999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCCCCCC---HHHHHH
Q 009644 431 SGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSSRRPS---MRQIAG 498 (530)
Q Consensus 431 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p~RPt---~~eVl~ 498 (530)
+|..||...... .....+... ...+ .. .........+.+++.+|+..+++|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~---~~~~~i~~~---~~~~--~~-~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQ---ETYRKIINW---KETL--QF-PDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHH---HHHHHHHcC---CCcc--CC-CCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhc
Confidence 999999755322 222222111 0000 00 01112345778888888863337886 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.60 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=202.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|.+.+.||+|+||.||+|...+...||+|..... ..+.|.+|++++++++||||+++++++.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 3568888999999999999999877778999987743 24678999999999999999999998754 56789999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999975422 257899999999999999999999 69999999999999999999999999999866433221
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....++..|+|||+..+..++.++||||||+++|||+| |..||...... ............ ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~~~~---------~~~~ 226 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRM---------PCPP 226 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhcCCCC---------CCcc
Confidence 12335567999999988899999999999999999999 88888654322 222211111000 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
..+..+.+++.+|++.+| +||++.++++.|++..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 345678999999999998 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.50 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=198.5
Q ss_pred CccceeeccCCcEEEEEEEE-----cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeE
Q 009644 239 FSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLL 307 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~L 307 (530)
|+..+.||+|+||.||++.+ .++..||+|..... ....|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37779999999999988653 35778999987643 245788999999999999999999998653 45789
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999753 58999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---cCCcc
Q 009644 388 TGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---DLGKY 460 (530)
Q Consensus 388 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 460 (530)
..... .....++..|+|||.+....++.++||||||+++|||+||..|+....... ........... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 43321 112234566999999988899999999999999999999999986443211 01100000000 00011
Q ss_pred ccccc-cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 461 VDKTL-GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 461 ~d~~l-~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
++... ...+...+..+.+++.+||+.+| +|||+++|++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 01223345789999999999998 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.56 Aligned_cols=252 Identities=16% Similarity=0.205 Sum_probs=195.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
.++|+..+.||+|+||.||++.. .+++.||+|... .+.+.+|++++++++||||+++++++..+...++|||++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 36799999999999999999994 568899999754 3457899999999999999999999999999999999994
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC--C
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH--H 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~--~ 392 (530)
++|..++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 167 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 167 TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 78998887543 58899999999999999999999 599999999999999999999999999997543221 1
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc----hHHHHHHHHh-hccCC---------
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS----DQNLILQVKR-SCDLG--------- 458 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~----~~~~~~~~~~-~~~~~--------- 458 (530)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+..+.. .....
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 223468999999999999999999999999999999999998875432110 0011111100 00000
Q ss_pred ------------cccccccc---ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 ------------KYVDKTLG---EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ------------~~~d~~l~---~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+... ......+..+.+++.+|++.+| +|||++|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0011234578899999999999 9999999985
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.30 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=205.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+|+. .+++.||+|.+.. .....+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788889999999999999994 5788999997542 22356889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++...... ...++...+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988643211 1257889999999999999999999 5999999999999999999999999999987643
Q ss_pred CCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ........... . .+.. .
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~-~-----~~~~--~ 229 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQC-D-----YPPL--P 229 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhcC-C-----CCCC--C
Confidence 322 12335777899999998888999999999999999999999998654322 11222222111 1 0111 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.......+.+++.+||+.+| +||++.+|++.|+++.
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 12234678999999999998 9999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=329.13 Aligned_cols=236 Identities=17% Similarity=0.286 Sum_probs=192.4
Q ss_pred eeeccCCcEEEEEEEE----cCCCEEEEEEccccc-------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 243 NIIGEGSFGLAYKGLL----QDGSLVVIKRHLQTQ-------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~~-------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+.||+|+||.||+++. .+++.||+|.+.... ...+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 357889999876422 24577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++.... .+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999997642 57888899999999999999999 599999999999999999999999999987543222
Q ss_pred -CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 -HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... .. ..+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~~~-~~---------~~~~ 221 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKG-KL---------NLPP 221 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHHcC-CC---------CCCC
Confidence 223345889999999999888999999999999999999999999754321 222222111 00 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.....+.+++.+|++.+| +|| ++.++++
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 234678899999999998 999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.47 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=205.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|.+.+.||+|+||.||++... +...+|+|.+... ...++..|++++.++ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888899999999999999742 2346999987643 235688899999999 799999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
+..++||||+++|+|.+++..... .+...+++.+++.++.|++.||+|||+ .+++||||||+||+++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT 174 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEEc
Confidence 999999999999999999976432 112358999999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
+++.+||+|||+++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence 9999999999999765432211 11123457999999988889999999999999999998 8888864322 122
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
......... .+.+......+.+++.+|+..+| +|||+.+|++.|+++.+...
T Consensus 252 ~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 252 FKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 222221110 01122334688899999999998 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.53 Aligned_cols=248 Identities=18% Similarity=0.295 Sum_probs=198.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
..++|+..+.||+|+||.||+++. .++..+|+|.+... ..+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356899999999999999999995 46889999987542 23457789999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++... .++...+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998653 57888899999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC--cCcccccccccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 388 TGSHH--AGSTSAVDCFLDPELNLSK----NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 388 ~~~~~--~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
..... .....||+.|+|||++... .++.++|||||||++|||++|+.||...... ........... ..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~--~~- 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHKN--SL- 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCC--cC-
Confidence 43321 2344589999999998643 4789999999999999999999999865432 22222211100 00
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-C--CCCHHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-R--RPSMRQIAGE 499 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~--RPt~~eVl~~ 499 (530)
..+ .....+..+.+++.+|++.+| + |||+.++++.
T Consensus 267 --~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 --TFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 111234678899999998777 5 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.82 Aligned_cols=264 Identities=21% Similarity=0.305 Sum_probs=196.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeec--------Cce
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN--------HQQ 305 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--------~~~ 305 (530)
...+|...+.||+|+||.||+|.. .+++.||+|++.... ....+|+.++++++||||+++++++... ..+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 346799999999999999999995 467899999875432 2345799999999999999999987432 246
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLL 384 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla 384 (530)
++||||++ ++|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 79999997 578777754211 11368999999999999999999999 5999999999999999654 7999999999
Q ss_pred ccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--------
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-------- 455 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-------- 455 (530)
+.+..........+++.|+|||++.+ ..++.++|||||||++|||+||.+||...........+.......
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 87755444445567889999999765 469999999999999999999999997654322222221111000
Q ss_pred -------cCCccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhh
Q 009644 456 -------DLGKYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGI 503 (530)
Q Consensus 456 -------~~~~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i 503 (530)
.........+.. .+...+.++.+++.+||..+| +|||+.|+++ .++++
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000000001111 122234678999999999999 9999999985 34444
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.66 Aligned_cols=250 Identities=25% Similarity=0.477 Sum_probs=201.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCC---EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGS---LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~---~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
+++|+..+.||+|+||.||+|... ++. .+++|..... ..+++.+|++++++++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456778899999999999999964 333 6899987543 24578999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++++|.+++.... +.+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999997643 268999999999999999999999 59999999999999999999999999999866
Q ss_pred cCCCCcC----cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 388 TGSHHAG----STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 388 ~~~~~~~----~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
....... ....+..|+|||++....++.++||||||+++|||++ |+.||..... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~----- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRL----- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCC-----
Confidence 4322111 1113456999999988889999999999999999998 9999865432 1222222211110
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.........+.+++.+|+..+| +||++.+|++.|+++
T Consensus 230 ----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112234678999999999998 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.51 Aligned_cols=242 Identities=19% Similarity=0.308 Sum_probs=192.4
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||+|+||+||++.. .+++.+|+|.+.... .+.+..|++++++++|+||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 468899999876432 24577899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-cCcc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-AGST 396 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-~~~~ 396 (530)
.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988864321 11368999999999999999999999 5999999999999999999999999999986644322 2234
Q ss_pred cccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHH
Q 009644 397 SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEM 476 (530)
Q Consensus 397 ~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 476 (530)
.++..|+|||++.+..++.++||||||+++|||++|+.||................. .... ..+...+..+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~ 228 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--------NDSV-TYPDKFSPAS 228 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc--------ccCC-CCcccCCHHH
Confidence 578899999999999999999999999999999999999976433211111111000 0000 1222345678
Q ss_pred HHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 477 MELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 477 ~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.+++.+|++.+| +|| +++++++
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 899999999999 999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.12 Aligned_cols=241 Identities=26% Similarity=0.443 Sum_probs=196.5
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChH
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~ 318 (530)
+.||+|+||.||+|...++..+|+|...... ...|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999865432 346889999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc--Ccc
Q 009644 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA--GST 396 (530)
Q Consensus 319 ~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~--~~~ 396 (530)
+++.... ..+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++........ ...
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9987543 257899999999999999999999 69999999999999999999999999999754332211 112
Q ss_pred cccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHH
Q 009644 397 SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATE 475 (530)
Q Consensus 397 ~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 475 (530)
.++..|+|||++....++.++||||||+++||+++ |..||...... ............ ..+...+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~ 222 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYRM---------SCPQKCPDD 222 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCCC---------CCCCCCCHH
Confidence 33567999999988899999999999999999999 99998754321 222222211110 112234568
Q ss_pred HHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 476 MMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 476 l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
+.+++.+|+..+| +|||+.+++++|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.27 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=201.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEee-cC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEE-NH 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~-~~ 303 (530)
.++|++.+.||+|+||.||+|... .++.||+|++... ..+.+.+|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888899999999999999732 2468999987532 235678899999999 89999999998864 45
Q ss_pred ceeEEeeccCCCChHHHhhccCCC--------------------------------------------------------
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL-------------------------------------------------------- 327 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~-------------------------------------------------------- 327 (530)
..+++|||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999998643210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccC
Q 009644 328 PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLD 404 (530)
Q Consensus 328 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~a 404 (530)
....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..... .....++..|+|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 01257899999999999999999999 5999999999999999999999999999987643221 122334567999
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHc
Q 009644 405 PELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC 483 (530)
Q Consensus 405 PE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~C 483 (530)
||++.+..++.++|||||||++|||++ |..||......+ ........... . ..+.....++.+++.+|
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------~---~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKEGTR------M---RAPEYATPEIYSIMLDC 312 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHhccCC------C---CCCccCCHHHHHHHHHH
Confidence 999999999999999999999999998 999987543222 11111111100 0 01122346789999999
Q ss_pred ccCCC-CCCCHHHHHHHHHhhHH
Q 009644 484 VDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 484 l~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
|+.+| +||++.||++.|+++++
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99998 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.30 Aligned_cols=252 Identities=22% Similarity=0.403 Sum_probs=200.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCC----EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGS----LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~----~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|+..+.||+|+||.||+|.+ .++. .||+|..... ...++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35688889999999999999984 3444 4789986532 245788999999999999999999999754 567
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997643 268999999999999999999999 6999999999999999999999999999987
Q ss_pred ccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 387 VTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 387 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
....... ....++..|+|||...+..++.++||||||+++|||++ |..||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~----- 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEKGERL----- 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCcC-----
Confidence 6432221 12234567999999988899999999999999999998 88988644321 122222111000
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+......+.+++.+||+.+| +||++.+++..|+++...
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 ----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1112334678899999999998 999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.44 Aligned_cols=248 Identities=25% Similarity=0.455 Sum_probs=201.0
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++|++.+.||+|+||.||+|...++..+|+|.+... ..+.|.+|+.++++++|+|++++++++.. ...+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 467888999999999999999888888999987643 34679999999999999999999998854 567899999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA- 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~- 393 (530)
++|.+++..... ..+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.+......
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999976432 258999999999999999999999 59999999999999999999999999999876432211
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
....++..|+|||+.....++.++||||||+++|||++ |..||..... ............. ..+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~~ 227 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGYRM---------PCPQD 227 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC---------CCCCc
Confidence 12234557999999988899999999999999999999 8888865432 1222222211110 11223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.+..+.+++.+|+..+| +|||+.++.+.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 34678999999999998 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.01 Aligned_cols=241 Identities=20% Similarity=0.354 Sum_probs=193.0
Q ss_pred eeccCCcEEEEEEEEc---CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 244 IIGEGSFGLAYKGLLQ---DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
.||+|+||.||+|.+. ++..||+|...... .+.|.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999853 34568999876432 3568899999999999999999999864 57889999999999
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc---
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA--- 393 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~--- 393 (530)
|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999997543 268999999999999999999999 59999999999999999999999999999865433211
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
....++..|+|||.+....++.++||||||+++||+++ |..||...... .....+..... ...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~---------~~~~~~ 222 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKR---------LDCPAE 222 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC---------CCCCCC
Confidence 11123467999999988889999999999999999996 99999754322 22222221111 012233
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
...++.+++.+||..+| +||++.+|.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 45788899999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.79 Aligned_cols=243 Identities=18% Similarity=0.296 Sum_probs=193.1
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||+|+||.||++.. .+|+.+|+|.+.... ...+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 468899999876422 23456799999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCccc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~ 397 (530)
.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.............
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 998865432 258899999999999999999999 599999999999999999999999999998765443333456
Q ss_pred ccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHH
Q 009644 398 AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMM 477 (530)
Q Consensus 398 gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 477 (530)
++..|+|||++.+..++.++|||||||++|||++|+.||...........+...... ..+. ........++.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~ 227 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE----DEVK----FEHQNFTEESK 227 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc----cccc----cccccCCHHHH
Confidence 788999999999888999999999999999999999999754322111111111100 0010 01112345789
Q ss_pred HHHHHcccCCC-CCCCHHHHHHHH
Q 009644 478 ELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 478 ~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
+++.+|++.+| +||++.|+++.+
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhh
Confidence 99999999999 999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.62 Aligned_cols=239 Identities=18% Similarity=0.336 Sum_probs=201.9
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
...++|..+++||+|+||+|+++..+ +++.+|||.+++. ..+..+.|.+|+... +||.+++++..|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999954 5789999987654 456788899998877 599999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
|.||||+.||++..+.+. +.+++..+..++..++.||+|||+ ++||+||||.+|||||.+|.+||+||||++
T Consensus 445 ~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEeccccccc
Confidence 999999999995554442 279999999999999999999999 699999999999999999999999999999
Q ss_pred ccc-CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 386 LVT-GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 386 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
... .+....+.+||+.|||||++.+..|+..+|.|||||+||||+.|+.||.++++.+....+. .. ++
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~---~d-------~~- 585 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV---ND-------EV- 585 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---cC-------CC-
Confidence 754 4455677889999999999999999999999999999999999999999776543322221 11 00
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
.++...+.+.+.++.+.+..+| +|--+
T Consensus 586 --~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 --RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1455566788899999999998 88866
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.84 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=198.7
Q ss_pred CccceeeccCCcEEEEEEEEcC----CCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc-----
Q 009644 239 FSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ----- 304 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~----- 304 (530)
|.+.+.||+|+||.||+|.... +..||+|++... ....+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998542 367999986532 23578999999999999999999999866544
Q ss_pred -eeEEeeccCCCChHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 305 -QLLIYDYIPNGNVQNHLYDSEG-LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 305 -~~LV~Ey~~~GsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
.+++|||+++|+|..++..... .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCcc
Confidence 7899999999999999865421 122368999999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 383 LLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 383 la~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
+++........ .....+..|+|||++....++.++||||||+++|||++ |..||..... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~-- 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRHGNR-- 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC--
Confidence 99876433211 11234567999999988899999999999999999999 8888865432 122222222111
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
...+......+.+++.+|++.+| +|||+.||++.|+++
T Consensus 234 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 -------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01222345688999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=331.13 Aligned_cols=237 Identities=17% Similarity=0.262 Sum_probs=193.0
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+.||+|+||.||++.. .++..+|+|.+... ....+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 56889999987643 2356788999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCcC
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAG 394 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~~ 394 (530)
+|.+++.... .+++.++..++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9999887542 689999999999999999999963 49999999999999999999999999998754322 2223
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...||..|+|||++.+..++.++|||||||++|||+||+.||...... ......... .. ..+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~~-~~---------~~p~~~~~ 221 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILME-EI---------RFPRTLSP 221 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhcC-CC---------CCCCCCCH
Confidence 345889999999999999999999999999999999999999754321 111111110 00 01122346
Q ss_pred HHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 475 EMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
++.+++.+|++.+| +|+ ++.++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 78899999999999 896 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.05 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=200.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
+++|...+.||+|+||.||+|...+ +..|++|..... ...+|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999653 567888876532 235689999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEee
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGL--PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSD 380 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~D 380 (530)
++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++++||||||+||+++.++ .+||+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999765321 12358999999999999999999999 5999999999999998754 699999
Q ss_pred cCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 381 YGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 381 FGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
||+++........ .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ...........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~ 239 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTGGGR 239 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCc
Confidence 9999876432211 11223457999999998999999999999999999997 99998754322 22222211111
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
. ..+...+..+.+++.+|++.+| +|||+.+|++.|++
T Consensus 240 ~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 240 L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0 1122334678999999999998 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.51 Aligned_cols=245 Identities=20% Similarity=0.298 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEE----cCCCEEEEEEcccc-------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 238 NFSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQT-------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~-------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
+|++.+.||+|+||.||+++. .++..+|+|.+.+. ..+.+..|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999884 35789999987542 234578899999999 599999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999997643 68899999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC--cCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 386 LVTGSHH--AGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 386 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
....... .....||..|+|||++.+. .++.++|||||||++|||+||+.||...........+...... .+
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~ 227 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CD 227 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CC
Confidence 6533221 2234588999999998765 4789999999999999999999999754332222211111111 01
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
+. .+......+.+++.+|++.+| +|| +++++++
T Consensus 228 ~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 122234678899999999999 999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=327.25 Aligned_cols=239 Identities=18% Similarity=0.340 Sum_probs=191.2
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHH---HhcCCCCcceEEEEEeecCceeEE
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHI---ARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il---~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
|++.+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|.+++ ++++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56778999999999999985 46889999987643 234566776655 466899999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|..++... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888642 68999999999999999999999 599999999999999999999999999987543
Q ss_pred CC-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GS-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ......... .. .
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~-~~---------~ 219 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVND-EV---------R 219 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC-CC---------C
Confidence 22 2223445889999999999999999999999999999999999999754321 222222111 00 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
.+......+.+++.+|++.+| +||+ +.++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112234678899999999999 9994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.26 Aligned_cols=249 Identities=24% Similarity=0.436 Sum_probs=203.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..++||+|+||.||+|..++++.+|+|.+.... .++|.+|+.++++++|+||+++++++. .+..+++|||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 46788889999999999999998889999999876533 467999999999999999999999874 457899999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++....+ ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999875432 368999999999999999999999 59999999999999999999999999999876532211
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....++..|+|||++....++.++||||||+++|||++ |+.||..... ............. ..+.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~ 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLERGYRM---------PRPD 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCCC---------CCCC
Confidence 12234567999999988889999999999999999999 9999975432 2222222211110 1112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+..+.+++.+|+..+| +|||++++...|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 234579999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.91 Aligned_cols=251 Identities=18% Similarity=0.282 Sum_probs=201.0
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC----
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH---- 303 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~---- 303 (530)
...++|.+.+.||+|+||.||++. ..+++.||+|.+... ....+.+|+.++..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345689999999999999999998 457899999987532 2456889999999999999999988775432
Q ss_pred ----ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 304 ----QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 304 ----~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCEEEE
Confidence 36799999999999999975432 12368999999999999999999999 699999999999999999999999
Q ss_pred ecCCcccccCCC---CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 380 DYGLLKLVTGSH---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 380 DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
|||+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......... .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~~~~~-~ 261 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTLAG-R 261 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcC-C
Confidence 999998754321 12334588999999999999999999999999999999999999975432 1222222111 0
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....+......+.+++.+||+.+| +||++.++++.
T Consensus 262 --------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 --------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 011223345678999999999999 99999999763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.99 Aligned_cols=257 Identities=20% Similarity=0.326 Sum_probs=201.4
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecC-----ceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENH-----QQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~LV~E 310 (530)
-.|...+++|+|+||.||+|.. .+++.||||+...... ---+|+++|+++.|||||++.-+|.... ...||||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 3466679999999999999995 4568999998665432 1136999999999999999999885432 3458999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCCcccccC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGla~~~~~ 389 (530)
|||. +|.++++...... ..++...+.-+..|+.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus 103 ymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9986 9999998532111 257777888899999999999999 599999999999999975 9999999999999877
Q ss_pred CCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---c---------
Q 009644 390 SHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---D--------- 456 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~--------- 456 (530)
.....+...+..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+....+.++-... +
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 766677778999999999875 579999999999999999999999999876655544444432211 0
Q ss_pred ---CCccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 ---LGKYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ---~~~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..++....... .......+..+++.+++.++| +|.++.|++.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111112 234456789999999999999 9999999885
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.33 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=202.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEccccc----HHHHHHHHHHHHhcC-CCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQ----IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~----~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~ 304 (530)
.++|.+.+.||+|+||.||+|++. .+..||+|++.... .+.+.+|++++.++. ||||++++|+|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 456778899999999999999864 23579999886432 346889999999997 9999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCC---------------------------------------------------------
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGL--------------------------------------------------------- 327 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~--------------------------------------------------------- 327 (530)
.++||||+++|+|.++++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999999753210
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 328 ------------------------------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 328 ------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
....+++..++.++.|++.||+|||+ ++++||||||+|||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcceEEEe
Confidence 01246788899999999999999999 6999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
+++.+||+|||+++....... .....++..|+|||.+....++.++|||||||++|||++ |+.||......+ ..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--~~ 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--QF 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--HH
Confidence 999999999999986533221 122345678999999988889999999999999999998 888886543221 11
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.......... ..+.....++.+++.+||..+| +||++++|++.|++++
T Consensus 352 ~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111110 1122334688999999999998 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.99 Aligned_cols=249 Identities=24% Similarity=0.439 Sum_probs=201.0
Q ss_pred cCCccceeeccCCcEEEEEEEEc-C---CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-D---GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~---~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.+|+..+.||+|+||.||+|... + +..+|+|.+... ..+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 2 336899986542 245789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997643 268999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCCcC----cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSHHAG----STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~~~~----~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
...... ...++..|+|||++.+..++.++||||||+++||+++ |..||...... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~------ 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGYRL------ 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCCcC------
Confidence 432211 1123457999999998899999999999999999887 99998754322 222222211110
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
......+..+.+++.+|++.+| +||+|.++++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1112234678899999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=318.06 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=202.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-----------------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-----------------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVK 294 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-----------------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~ 294 (530)
..+|++.+.||+|+||.||++...+ +..||+|.+... ..+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999988543 245889987643 3467889999999999999999
Q ss_pred EEEEEeecCceeEEeeccCCCChHHHhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 009644 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP------IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368 (530)
Q Consensus 295 l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NI 368 (530)
+++++..++..++||||+++++|.+++....... ...+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence 9999999999999999999999999997654211 1268999999999999999999999 5999999999999
Q ss_pred EEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCc
Q 009644 369 LLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRNHSNS 443 (530)
Q Consensus 369 Ll~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~ 443 (530)
++++++.+||+|||+++....... .....++..|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 999999999999999986543221 122335678999999988889999999999999999998 6677754322
Q ss_pred hHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 444 DQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
............... .......+...+.++.+++.+|++.+| +|||+.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -QQVIENAGHFFRDDG--RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHHhcccccc--ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 122222221100000 000011222334689999999999999 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=333.45 Aligned_cols=249 Identities=17% Similarity=0.270 Sum_probs=196.9
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
...++|+..+.||+|+||.||++... +++.+|+|.+.+. ..+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999954 5788999987542 2345788999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++... .++..++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999643 57888999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCC--cCcccccccccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 387 VTGSHH--AGSTSAVDCFLDPELNLSK----NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 387 ~~~~~~--~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
...... .....||+.|+|||++... .++.++|||||||++|||++|+.||...... ..............
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~- 267 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIMDHKNSLN- 267 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCcccC-
Confidence 643222 2344589999999998654 3789999999999999999999999755322 22222221110000
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC---CCCCHHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS---RRPSMRQIAGE 499 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p---~RPt~~eVl~~ 499 (530)
. .........+.+++..|+..++ .|||+.|+++.
T Consensus 268 ----~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----F-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----C-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0111234567788888887554 48899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.02 Aligned_cols=246 Identities=16% Similarity=0.255 Sum_probs=197.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++.. .+++.+|+|.+.... .+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999994 468899999876432 345788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999998653 268999999999999999999999 5999999999999999999999999999987644
Q ss_pred CCCc--CcccccccccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 390 SHHA--GSTSAVDCFLDPELNL------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 390 ~~~~--~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
.... ....+|..|+|||++. ...++.++|||||||++|||++|+.||....... ....+.........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~~~~~~~- 230 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNIMNFQRFLKF- 230 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHHHcCCCccCC-
Confidence 3221 2235788999999986 4567899999999999999999999997553321 12222111110010
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+.+++..|+. +| +|||+.++++
T Consensus 231 -----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 -----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0111234678889999997 77 9999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.53 Aligned_cols=236 Identities=19% Similarity=0.310 Sum_probs=191.5
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCC-CCcceEEEEEeecCceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHH-RHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H-~nIv~l~g~~~~~~~~~LV~ 309 (530)
+|+..+.||+|+||.||+|... +++.||+|.+... ..+.+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999954 5678999987642 34567889999999965 56888999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987542 68899999999999999999999 5999999999999999999999999999875322
Q ss_pred -CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 -SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
........||..|+|||++.+..++.++|||||||++|||+||+.||..... ......+... . . ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~-~------~---~~ 220 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIMEH-N------V---SY 220 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC-C------C---CC
Confidence 2222334588999999999999999999999999999999999999975432 2222222211 0 0 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
+......+.+++.+|++.+| +|++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 22234678899999999999 99976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=316.09 Aligned_cols=253 Identities=22% Similarity=0.396 Sum_probs=202.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|...+.||+|+||.||+|...+ +..+|+|...... ...+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999998643 3579999876432 34688999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGL-----PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||+|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999754321 12257889999999999999999999 6999999999999999999999999
Q ss_pred cCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 381 YGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 381 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
||+++....... .....++..|+|||.+....++.++||||||+++||++| |..||..... .......... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~-~ 238 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVIDG-G 238 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHhcC-C
Confidence 999986643321 122335678999999988889999999999999999998 8888864432 1222222211 0
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
. ...+...+..+.+++.+||+.+| +|||+.++++.|++
T Consensus 239 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 239 H--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 01122235688999999999998 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.73 Aligned_cols=236 Identities=18% Similarity=0.303 Sum_probs=192.2
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
+|...+.||+|+||.||+|... ++..+|+|.+.... .+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999954 57789999876432 23567788888877 6899999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987642 68899999999999999999999 5999999999999999999999999999975432
Q ss_pred -CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 -SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
........||+.|+|||++....++.++|||||||++|||+||+.||..... .......... .. ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~-~~---------~~ 220 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEH-NV---------AY 220 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CC---------CC
Confidence 2222345588999999999999999999999999999999999999975432 2222222211 00 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
+.....++.+++.+|++.+| +|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 22334678999999999999 99984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.66 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=199.7
Q ss_pred CCccceeeccCCcEEEEEEEEcC------CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
+|...+.||+|+||.||+|...+ +..||+|+..... .+.|.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667899999999999998532 4679999876432 3568899999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeE
Q 009644 308 IYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~ 376 (530)
++||+++++|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCCce
Confidence 9999999999999853211 011257888999999999999999999 599999999999999999999
Q ss_pred EEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHH
Q 009644 377 KVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVK 452 (530)
Q Consensus 377 KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 452 (530)
||+|||+++....... .....++..|+|||++....++.++||||||+++|||++ |..||..... ........
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i~ 240 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMIR 240 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 9999999886543221 122335678999999988899999999999999999998 8888865432 22233222
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.. .. ...+...+..+.+++..||+.+| +||++++|+..|+.
T Consensus 241 ~~-~~--------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NR-QV--------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cC-Cc--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 21 11 11223445678999999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=310.47 Aligned_cols=248 Identities=28% Similarity=0.466 Sum_probs=204.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|... ++.||+|...... .+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 356788899999999999999875 7889999877553 4679999999999999999999999998999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999976532 258999999999999999999999 5999999999999999999999999999987633221
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....+..|+|||++....++.++||||||+++|||++ |..||..... ............. ..+...
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~~~ 224 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYRM---------EAPEGC 224 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCC---------CCccCC
Confidence 2334567999999988899999999999999999997 9999865432 2222222211110 111233
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
+..+.+++.+|+..+| +|||+++++++|+.+
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 4688999999999998 999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=310.05 Aligned_cols=245 Identities=18% Similarity=0.336 Sum_probs=198.8
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++|+..+.||+|+||.||++.. .++..+++|.+... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999984 56889999976432 23568899999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++++|.+++.... .++...+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987642 57889999999999999999999 59999999999999999999999999999765
Q ss_pred cCCCCc----CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHHA----GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~------ 225 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTN------ 225 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHhccCCC------
Confidence 332111 2234677899999999988999999999999999999999998754221 111111111000
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
...+......+.+++.+||..+| +|||+.++++.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11222344678899999999998 99999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.43 Aligned_cols=231 Identities=17% Similarity=0.310 Sum_probs=188.9
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|+.+ +++.||+|.+... ..+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 5789999987642 235677888888877 799999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~~~ 393 (530)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999987653 68899999999999999999999 5999999999999999999999999999876432 2222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... . . ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~-~---~------~~~~~~~ 220 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILND-E---V------VYPTWLS 220 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcC-C---C------CCCCCCC
Confidence 3445889999999999999999999999999999999999999754322 222222211 0 0 0111234
Q ss_pred HHHHHHHHHcccCCC-CCCCH
Q 009644 474 TEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~ 493 (530)
..+.+++.+|++.+| +||++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCC
Confidence 578899999999999 99998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.98 Aligned_cols=240 Identities=18% Similarity=0.298 Sum_probs=191.4
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||++.. .++..||+|.+... ..+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999995 46789999987643 234578899999998 799999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc-CCCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT-GSHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~-~~~~~ 393 (530)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++... .....
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999887542 68999999999999999999999 599999999999999999999999999997532 22223
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc-----hHHHHHHHHhhccCCcccccccccc
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS-----DQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
....||..|+|||++.+..++.++|||||||++|||+||+.||....... .............. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~ 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------RI 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------CC
Confidence 34568899999999999999999999999999999999999996322111 11111111111110 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCC------HHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPS------MRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt------~~eVl~ 498 (530)
+......+.+++.+|++.+| +||| +.++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 22234678899999999999 9997 667653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.07 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=200.4
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++|...+.||+|+||.||+|...++..+|+|...... .+.|.+|++++++++|+|++++++++.. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 4577889999999999999998777789999866432 3678999999999999999999998854 567899999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA- 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~- 393 (530)
|+|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 85 GSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999976432 257899999999999999999999 59999999999999999999999999999865432211
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
....++..|+|||+..+..++.++||||||+++|||+| |..||...... ....+....... ..+..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~---------~~~~~ 227 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVERGYRM---------PCPQG 227 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCC---------CCCcc
Confidence 12235567999999988899999999999999999999 88898754321 222222221110 11223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.+..+.+++.+|+..+| +||++++|++.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34678999999999998 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=312.52 Aligned_cols=256 Identities=19% Similarity=0.321 Sum_probs=205.7
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++. ..++..+++|.+.. ...+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467788999999999999999 45788999997643 22357889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++++|.+++..... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875321 12368999999999999999999999 5999999999999999999999999999876643
Q ss_pred CCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
... .....++..|+|||++.+..++.++||||||+++|||++|..||...... .......... ...+.. .
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~------~~~~~~--~ 229 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQ------CDYPPL--P 229 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhc------CCCCCC--C
Confidence 322 12335778899999998889999999999999999999999998654321 1111111111 011111 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.......+.+++.+||..+| +||||.+|++.++++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 12345678999999999998 9999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=327.32 Aligned_cols=255 Identities=16% Similarity=0.294 Sum_probs=195.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-----
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH----- 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~----- 303 (530)
..++|+..+.||+|+||.||++.. .++..||+|.+... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999985 46889999987532 2456889999999999999999999986543
Q ss_pred -ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 304 -QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 304 -~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
..++||||+++ +|.+.+.. .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47899999964 66666642 47888999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH-----------
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV----------- 451 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~----------- 451 (530)
+++............+|..|+|||.+.+..++.++|||||||++|||+||+.||...........+...
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 998654443334456788999999999999999999999999999999999999755321111000000
Q ss_pred -----H----hhccCC---------ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 452 -----K----RSCDLG---------KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 452 -----~----~~~~~~---------~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
. ...... .+..+............+.+++.+|++.+| +|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000 000000000111223568899999999999 99999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=318.10 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=202.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~ 304 (530)
.++|...+.||+|+||.||++... .+..+|+|..... ..+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457888899999999999999742 2447899987643 235689999999999 79999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ ++|+|+||||+|||+++++.+|++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999976432 248999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 385 KLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 385 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+....... .....++..|+|||.+....++.++|||||||++|||+| |..||....... ...........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~~~~~~~---- 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKLIKEGYR---- 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHHHHcCCc----
Confidence 86543221 112235667999999998999999999999999999998 999987544321 11111111100
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
. ..+......+.+++.+|++.+| +|||+.||++.|+++
T Consensus 263 --~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --M---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0111234678999999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=315.00 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=205.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEee-cCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~~ 305 (530)
.++|+..+.||+|+||.||+|...+ +..|++|.+... ..+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999765 678899976542 24568899999999999999999998866 4678
Q ss_pred eEEeeccCCCChHHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGL---PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
++++||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEECCCC
Confidence 9999999999999999764221 11368999999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 383 LLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 383 la~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
+++.+...... ....++..|+|||++....++.++||||||+++||+++ |+.||..... ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~ 239 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGYRLA 239 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCCCCC
Confidence 99865432211 12234567999999988899999999999999999999 9999975432 22222222211110
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
.....+..+.+++.+||..+| +|||+.+|++.|+.+.+
T Consensus 240 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 ---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 112234678999999999998 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=310.92 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=199.8
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEe-ecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCE-ENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~-~~~~~~LV~Ey~~~ 314 (530)
++|+..+.||+|+||.||++... +..+++|..... ..+.|.+|+.++++++|+|++++++++. .++..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46788899999999999999875 678999987654 3457999999999999999999999764 45678999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~ 394 (530)
|+|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... .
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 85 GSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred CcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence 999999976432 257899999999999999999999 599999999999999999999999999988654322 2
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....+..|+|||++....++.++||||||+++|||++ |+.||..... ............ + ......+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~------~---~~~~~~~ 225 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYK------M---DAPDGCP 225 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC------C---CCCCCCC
Confidence 2334567999999988899999999999999999998 9999864422 222222221110 0 1122334
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+.+++.+|++.+| +|||+.++++.|+++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 688999999999998 999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=319.43 Aligned_cols=255 Identities=20% Similarity=0.348 Sum_probs=197.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|...+.||+|+||.||+|+.. +++.||+|.+... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999854 6788999986532 234678999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 58888887543 257889999999999999999999 699999999999999999999999999997653322
Q ss_pred C-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc-------------
Q 009644 392 H-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------------- 456 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------------- 456 (530)
. .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2 223456788999998764 5689999999999999999999999976544332222222111000
Q ss_pred ----CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 ----LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ----~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.........++.+++.+|++.+| +|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000001112234577899999999999 9999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.45 Aligned_cols=246 Identities=22% Similarity=0.396 Sum_probs=202.9
Q ss_pred ccceeeccCCcEEEEEEEEcC--CC--EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 240 SEINIIGEGSFGLAYKGLLQD--GS--LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~--~~--~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
...++||+|.||.|++|.|.. |+ .||||.+... ...+|++|+.+|.+|+|+|+++|||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 445789999999999999753 33 5899987653 35789999999999999999999999987 678899999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++.|+|.+.|++.. ...|-......++.|||.||.||.+ +++|||||.++|+||-..-.+||+||||.|.+....
T Consensus 192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999998722 2367888889999999999999999 699999999999999999999999999999886544
Q ss_pred CcC----cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 392 HAG----STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~~~----~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
... .......|+|||.+....|+.+||||+|||++|||+| |+.||.+...... .+.+... ...
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI---L~~iD~~---------erL 334 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI---LKNIDAG---------ERL 334 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH---HHhcccc---------ccC
Confidence 322 1224557999999999999999999999999999999 8899987654332 2222211 111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+..++..+.++++.||..+| +|||+..|.+.+-..
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 3566788999999999999998 999999998655443
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=313.72 Aligned_cols=248 Identities=24% Similarity=0.450 Sum_probs=199.7
Q ss_pred CCccceeeccCCcEEEEEEEEcC-C---CEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQD-G---SLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~-~---~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.|+..+.||+|+||.||+|.... + ..||+|..... ..++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999543 3 36999987643 3457999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... +.+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999997643 268999999999999999999999 5999999999999999999999999999876543
Q ss_pred CCCcCc----cc--ccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 390 SHHAGS----TS--AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 390 ~~~~~~----~~--gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
...... .. .+..|+|||++....++.++||||||+++|||++ |..||...... .....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~~~----- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDYRL----- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCcC-----
Confidence 221111 11 2346999999999999999999999999999887 99998754322 222222211111
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..+...+..+.+++.+||..+| +||++.+|+..|+++
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112334678899999999998 999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.33 Aligned_cols=236 Identities=17% Similarity=0.292 Sum_probs=191.8
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|+.. +++.||+|.+... ..+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 5789999987643 234577899998876 899999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-Cc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-HA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-~~ 393 (530)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 99999987543 68899999999999999999999 599999999999999999999999999997643222 22
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....|+..|+|||++.+..++.++|||||||++|||+||+.||..... ........... .. .+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~~~~----~~------~p~~~~ 220 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESILHDD----VL------YPVWLS 220 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC----CC------CCCCCC
Confidence 334588999999999999999999999999999999999999975532 22222222110 00 111234
Q ss_pred HHHHHHHHHcccCCC-CCC-------CHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRP-------SMRQIAG 498 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RP-------t~~eVl~ 498 (530)
.++.+++.+|++.+| +|| ++.++++
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 678899999999999 999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.97 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=200.4
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|.. .++..+++|.+.. ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467789999999999999995 4688999997652 3356789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999986422 368999999999999999999999 699999999999999999999999999998765432
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. .....++..|+|||+..+..++.++||||||+++|||++|+.||..... .......... . ......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~--------~~~~~~ 223 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKIIRG-V--------FPPVSQ 223 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC-C--------CCCCcc
Confidence 2 2233477889999999999999999999999999999999999975431 1222222111 0 011111
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+||+.+| +||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 334678999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=322.13 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=198.0
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc-----------------HHHHHHHHHHHHhcCCCCcceE
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ-----------------IQNFLHEVKHIARVHHRHLVKL 295 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~-----------------~~~~~~E~~il~~l~H~nIv~l 295 (530)
...++|++.+.||+|.||.|-+|+ ..+++.||+|++.+.. .+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345789999999999999999999 5678999999876432 2468899999999999999999
Q ss_pred EEEEeec--CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 009644 296 VGFCEEN--HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN 373 (530)
Q Consensus 296 ~g~~~~~--~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~ 373 (530)
+.+..+. +.+|||+|||..|.+...=-.. ..++..+...++++++.||+|||. ++||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~-----~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-----PELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCc-----ccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCC
Confidence 9998764 5799999999999875432111 138999999999999999999999 699999999999999999
Q ss_pred CeEEEeecCCcccccCC------CCcCcccccccccCccccCCCC---C-CchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 009644 374 YTAKVSDYGLLKLVTGS------HHAGSTSAVDCFLDPELNLSKN---Y-SAGSDVYSFGVFLLELISGREAHGRNHSNS 443 (530)
Q Consensus 374 ~~~KI~DFGla~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 443 (530)
|++||+|||.+...... .....+.||+.|+|||...++. + +.+.||||+||+||-|+.|+.||..+..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999999999866222 1223467999999999987632 3 4678999999999999999999986532
Q ss_pred hHHHHHHHHhhccCCcccccccc-ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 444 DQNLILQVKRSCDLGKYVDKTLG-EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
.....++... .+. ...++....+.++++++|+.|| +|.+..+|....
T Consensus 325 -~~l~~KIvn~---------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 -LELFDKIVND---------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHHHHHHhcC---------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 2222332221 111 1222456788999999999999 999999987544
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.38 Aligned_cols=256 Identities=21% Similarity=0.369 Sum_probs=206.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+|... +++.+|+|.+.. ...+.+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999965 788999997642 22467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++..... ....+++.++..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875322 12358999999999999999999999 5999999999999999999999999999876543
Q ss_pred CCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ........... .. +.. .
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~-----~~~--~ 229 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKC-DY-----PPL--P 229 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcC-CC-----CCC--C
Confidence 221 22334777899999998889999999999999999999999998654321 11111111110 00 000 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.......+.+++.+||..+| +|||+.+|++.|+++.
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11334578899999999998 9999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=315.71 Aligned_cols=257 Identities=24% Similarity=0.420 Sum_probs=197.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-----CCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEee--cCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-----DGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~ 306 (530)
++|+..+.||+|+||.||++..+ ++..||+|.+.... .+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999753 47789999876433 4578999999999999999999998754 34688
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997543 268999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCCc----CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc------
Q 009644 387 VTGSHHA----GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------ 456 (530)
Q Consensus 387 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------ 456 (530)
....... ....++..|+|||++.+..++.++||||||+++|||++|..++...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 6433221 1112334599999998889999999999999999999998775432110 0000000000
Q ss_pred -CCcccccc-ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 457 -LGKYVDKT-LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 457 -~~~~~d~~-l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
+.+.+... ........+..+.+++.+||..+| +|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 001122344679999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.43 Aligned_cols=256 Identities=20% Similarity=0.360 Sum_probs=201.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.+++|++.+.||+|+||.||+|..++ +..||+|...... ...+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45788999999999999999997532 4479999865332 3468899999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGL-----PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
.++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999753211 11245778899999999999999999 699999999999999999999999
Q ss_pred ecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhc
Q 009644 380 DYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 380 DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|||+++........ ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .........
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~- 237 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFVMDG- 237 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-
Confidence 99999865432211 11224567999999988899999999999999999999 78888653321 222211111
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
. ....+......+.+++.+|++.+| +|||+.++++.|++..
T Consensus 238 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 G--------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred C--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 001122234689999999999999 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=334.06 Aligned_cols=246 Identities=21% Similarity=0.276 Sum_probs=193.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+.++.||+|+||.||+++. .+++.+|+|.+... ..+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999994 45889999987643 2356889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997642 57888889999999999999999 5999999999999999999999999999753210
Q ss_pred CC--------------------------------------------CcCcccccccccCccccCCCCCCchhhHHHHHHH
Q 009644 390 SH--------------------------------------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVF 425 (530)
Q Consensus 390 ~~--------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvv 425 (530)
.. ......||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0012358889999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCC---CHHHHHHH
Q 009644 426 LLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRP---SMRQIAGE 499 (530)
Q Consensus 426 l~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP---t~~eVl~~ 499 (530)
+|||++|+.||........ ......... ....+ ........+.+++.+|+. +| +|+ |+.++++.
T Consensus 234 lyell~G~~Pf~~~~~~~~---~~~i~~~~~--~~~~~----~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h 301 (376)
T cd05598 234 LYEMLVGQPPFLADTPAET---QLKVINWET--TLHIP----SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeehhhCCCCCCCCCHHHH---HHHHhccCc--cccCC----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCC
Confidence 9999999999986543221 111111000 00000 111233566777777664 55 899 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.06 Aligned_cols=235 Identities=20% Similarity=0.333 Sum_probs=188.9
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|... +++.||+|.+... ..+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 5788999987643 234566677777654 899999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|.+++.... .++..++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999987642 68899999999999999999999 59999999999999999999999999999864322 222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... ......+... . + ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~---~----~---~~~~~~~ 220 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILND---R----P---HFPRWIS 220 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC---C----C---CCCCCCC
Confidence 344589999999999999999999999999999999999999975432 2222222111 0 0 1122234
Q ss_pred HHHHHHHHHcccCCC-CCCCHH-HHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMR-QIA 497 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~-eVl 497 (530)
.++.+++.+||+.+| +||++. +++
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 577899999999999 999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.05 Aligned_cols=235 Identities=18% Similarity=0.299 Sum_probs=187.1
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||++.. .+++.+|+|.+... ..+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 45788999987643 234577888888877 899999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~~~ 393 (530)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999887542 68999999999999999999999 5999999999999999999999999999975422 2222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----chHHHHHHHHhhccCCcccccccccc
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN-----SDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... ............... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~~ 224 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------RI 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------CC
Confidence 3445889999999999999999999999999999999999999532111 111111111111110 12
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
+......+.+++.+|++.+| +||+.
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 22334678899999999999 99983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.31 Aligned_cols=256 Identities=20% Similarity=0.336 Sum_probs=202.2
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccHH-----HHHHHHHHHHhcCCCCcceEEEEEee--cCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQ-----NFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~L 307 (530)
.++|+.++.|++|+||.||+|+ .++++.||+|++.-...+ .-++|+.+|.+++|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3567888999999999999999 567889999997744322 35899999999999999999998754 357999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|||||++ +|...+..-. ..+...++..+..|+++|++|||+ .-|+|||||++|+|+++.|.+||+|||+||.+
T Consensus 155 VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 8999887654 378999999999999999999999 59999999999999999999999999999988
Q ss_pred cCCCC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC---Ccc--
Q 009644 388 TGSHH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL---GKY-- 460 (530)
Q Consensus 388 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-- 460 (530)
..... .+....|..|.|||.+.+ ..|++..|+||+|||+.||+++++.|.+....+..+.+........- +.+
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 66532 344557889999999875 56999999999999999999999999887766555555554322110 000
Q ss_pred ---c-cccccccchh----------HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 ---V-DKTLGEQTVG----------AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ---~-d~~l~~~~~~----------~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ .-.+...+.+ ....-.+++...+..|| +|.|++|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 0011111110 22455778888889999 9999999875
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=316.72 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=198.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC---------------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD---------------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLV 296 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~---------------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~ 296 (530)
.++|++.+.||+|+||.||++...+ ...||+|..... ..+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 124889987643 235689999999999999999999
Q ss_pred EEEeecCceeEEeeccCCCChHHHhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 009644 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGL-------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVL 369 (530)
Q Consensus 297 g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NIL 369 (530)
+++...+..++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEE
Confidence 9999999999999999999999999653210 11247889999999999999999999 59999999999999
Q ss_pred EcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCch
Q 009644 370 LEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRNHSNSD 444 (530)
Q Consensus 370 l~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~~ 444 (530)
+++++.+||+|||+++....... .....++..|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999986543221 112234567999999988899999999999999999998 5667664322
Q ss_pred HHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 445 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
...+........... .......+...+..+.+++.+|++.+| +|||+++|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQG--RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhcc--ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 122222111100000 000001122234689999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=315.73 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=199.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-----------------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-----------------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVK 294 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-----------------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~ 294 (530)
.++|+..+.||+|+||.||++... ++..+|+|..... ..++|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888899999999999998632 2346889987643 2357899999999999999999
Q ss_pred EEEEEeecCceeEEeeccCCCChHHHhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 009644 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGL------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368 (530)
Q Consensus 295 l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NI 368 (530)
+++++..++..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheE
Confidence 999999999999999999999999999764321 11257888999999999999999999 5999999999999
Q ss_pred EEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCc
Q 009644 369 LLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRNHSNS 443 (530)
Q Consensus 369 Ll~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt--G~~p~~~~~~~~ 443 (530)
|+++++.+||+|||+++.+..... .....++..|++||....+.++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986543221 112224567999999888899999999999999999998 67787644322
Q ss_pred hHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 444 DQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+.......... ........+...+..+.+++.+||+.+| +|||+.+|++.|++
T Consensus 241 --~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 --QVIENTGEFFRDQ--GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHhhc--cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1121111100000 0000001122344688999999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.00 Aligned_cols=236 Identities=19% Similarity=0.337 Sum_probs=192.2
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||++... ++..+|+|.+... ....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5788999987643 234577899999888 799999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999987642 68999999999999999999999 59999999999999999999999999998753222 222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. ..+....
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~~~-~~---------~~~~~~~ 220 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSILED-EV---------RYPRWLS 220 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcC-CC---------CCCCcCC
Confidence 334578899999999999999999999999999999999999975432 2222222111 00 0112234
Q ss_pred HHHHHHHHHcccCCC-CCCCH-----HHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSM-----RQIAG 498 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~-----~eVl~ 498 (530)
..+.+++.+||+.+| +|||+ .++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 678999999999999 99999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.81 Aligned_cols=235 Identities=20% Similarity=0.357 Sum_probs=190.0
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|... +++.||+|.+... ..+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5788999987643 234567788888764 999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999997642 68899999999999999999999 59999999999999999999999999998754221 222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... +. .+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~-------~~---~~~~~~ 220 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDN-------PC---YPRWLT 220 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-------CC---CCccCC
Confidence 344588899999999999999999999999999999999999975432 22222222110 11 111234
Q ss_pred HHHHHHHHHcccCCC-CCCCHH-HHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMR-QIA 497 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~-eVl 497 (530)
.++.+++.+|++.+| +||++. ++.
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 578899999999999 999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=316.08 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=201.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|+..+.||+|+||.||++... ++..+|+|.+.... .++|.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888899999999999999853 46789999876432 35688999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 009644 306 LLIYDYIPNGNVQNHLYDSEG-----------------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NI 368 (530)
++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~ni 161 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNC 161 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHhhe
Confidence 999999999999999975321 111247888999999999999999999 6999999999999
Q ss_pred EEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCch
Q 009644 369 LLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSD 444 (530)
Q Consensus 369 Ll~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 444 (530)
++++++.+||+|||+++....... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--- 238 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999876533221 112224557999999988899999999999999999998 8888864422
Q ss_pred HHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 445 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.......... .. ...+...+..+.+++.+|++.+| +|||+.|+++.|++
T Consensus 239 ~~~~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRDG-NV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhcC-CC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1222222211 11 01122334688999999999998 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.66 Aligned_cols=253 Identities=17% Similarity=0.264 Sum_probs=199.6
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeec
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~ 302 (530)
.++....++|+..+.||+|+||.||+++.. +++.+|+|.+... ..+.+.+|..+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999954 5788999987542 234578899999999999999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
+..++||||+++|+|.+++... .++...+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998653 57888899999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCC--cCcccccccccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 383 LLKLVTGSHH--AGSTSAVDCFLDPELNLSK----NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 383 la~~~~~~~~--~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
+++....... .....||+.|+|||++... .++.++|||||||++|||++|+.||...... .....+.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 264 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN 264 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC
Confidence 9987643321 2344589999999998653 3789999999999999999999999754321 22222221111
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC---CCCCHHHHHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS---RRPSMRQIAGE 499 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p---~RPt~~eVl~~ 499 (530)
...+. ........+.+++.+|+..++ .||++.++++.
T Consensus 265 ~~~~~------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 SLTFP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cccCC------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11110 112334677889999997554 38899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=314.09 Aligned_cols=252 Identities=25% Similarity=0.444 Sum_probs=200.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.+|...+.||+|+||.||++... ++..+++|..... ..+.|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677789999999999999742 3457888876643 24579999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 308 IYDYIPNGNVQNHLYDSEG----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
+|||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCEE
Confidence 9999999999999976421 111358899999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHh
Q 009644 378 VSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 378 I~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~ 453 (530)
|+|||+++....... .....++..|+|||++.+..++.++|||||||++|||++ |.+||...... ........
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~ 239 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECITQ 239 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHHHc
Confidence 999999976543221 122234677999999999999999999999999999998 89998644321 22222211
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.... ..+...+..+.+++.+||+.+| +||++.+|++.|++
T Consensus 240 ~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 GREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1110 1112334678899999999999 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=309.74 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=194.5
Q ss_pred eeeccCCcEEEEEEEEcC----CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQD----GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++||+|+||.||+|.+.. +..+|+|...... .+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998432 2579999876433 357889999999999999999999876 4567999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~ 394 (530)
|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998653 68999999999999999999999 599999999999999999999999999998764332211
Q ss_pred ----cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 395 ----STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 395 ----~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
...++..|+|||.+....++.++||||||+++|||++ |..||..... ............. ..+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~ 220 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERL---------PRP 220 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcC---------CCC
Confidence 1113457999999998899999999999999999998 9999875432 2222222221110 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
...+..+.+++.+|+..+| +|||+.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 2334678899999999999 9999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=314.76 Aligned_cols=246 Identities=18% Similarity=0.320 Sum_probs=198.4
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
|+..+.||+|+||.||++.. .+++.+|+|.+.... ...+.+|+.++++++|+|++.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999995 468899999865432 23577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999865432 258899999999999999999999 699999999999999999999999999997654433
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
......++..|+|||++.+..++.++||||||+++|||++|+.||................... . . .....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--~----~---~~~~~ 227 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--Q----E---EYSEK 227 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--h----h---hcCcc
Confidence 3334468889999999999999999999999999999999999997643322111111111100 0 0 11222
Q ss_pred HHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
....+.+++.+|++.+| +||| ++|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 34568899999999998 9999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.37 Aligned_cols=196 Identities=21% Similarity=0.332 Sum_probs=170.4
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.|+.++.||+|+||.||+|+. .+++.+|+|.+... ..+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588889999999999999994 56788999987643 23568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999997642 57888999999999999999999 59999999999999999999999999997532100
Q ss_pred C------------------------------------------------CcCcccccccccCccccCCCCCCchhhHHHH
Q 009644 391 H------------------------------------------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSF 422 (530)
Q Consensus 391 ~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSf 422 (530)
. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0012357889999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 009644 423 GVFLLELISGREAHGRNH 440 (530)
Q Consensus 423 Gvvl~ElltG~~p~~~~~ 440 (530)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=330.44 Aligned_cols=246 Identities=20% Similarity=0.363 Sum_probs=211.1
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcc-----cccHHHHHHHHHHHHhcCCCCcceEEEEEeecCc-eeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHL-----QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ-QLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~-~~LV~ 309 (530)
++|..++.+|+|+||.++..+. .++..+++|.+. ....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788889999999999999883 457789998754 2334578899999999999999999999998888 99999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
+|++||+|.+.+...++ ..++++.+..++.|++.|+.|||+ +.|+|||||+.||+++.+..+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998763 368999999999999999999997 6999999999999999999999999999999877
Q ss_pred CC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.. ...+..||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+. ..++.++.... ....
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~~---------~~Pl 226 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRGL---------YSPL 226 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhcc---------CCCC
Confidence 66 55667799999999999999999999999999999999999999986543 34444433321 1123
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+.....++..++..|+..+| .||++.+++..
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 44456788999999999999 89999999976
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=314.11 Aligned_cols=255 Identities=17% Similarity=0.295 Sum_probs=193.7
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhc---CCCCcceEEEEEee-----cC
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARV---HHRHLVKLVGFCEE-----NH 303 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l---~H~nIv~l~g~~~~-----~~ 303 (530)
+|+..+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999995 46889999986532 123566788877766 79999999998864 24
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 589988875432 258999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc---CCc-
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD---LGK- 459 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~- 459 (530)
++............++..|+|||++.+..++.++|||||||++|||++|++||...........+........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 9876544333445578889999999988999999999999999999999999976543222211111110000 000
Q ss_pred ------ccc----ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 ------YVD----KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 ------~~d----~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... .............+.+++.+|++.+| +|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00111112344677899999999999 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=327.01 Aligned_cols=233 Identities=22% Similarity=0.295 Sum_probs=190.8
Q ss_pred eeeccCCcEEEEEEEE----cCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 243 NIIGEGSFGLAYKGLL----QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
+.||+|+||.||+++. .+++.+|+|++.... ...+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999876432 3457789999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CC
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HH 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~ 392 (530)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999997542 68999999999999999999999 59999999999999999999999999999865433 22
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
.....|+..|+|||.+....++.++|||||||++|||+||+.||..... .......... .. ..+...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~~~-~~---------~~p~~~ 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMILKA-KL---------GMPQFL 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHHcC-CC---------CCCCCC
Confidence 2334588899999999988899999999999999999999999975432 2222222111 00 112223
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQ 495 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~e 495 (530)
...+.+++.+|++.+| +|||+.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 4678899999999999 9999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.58 Aligned_cols=257 Identities=21% Similarity=0.413 Sum_probs=203.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|.+.+.||+|+||.||++... ....+|+|..... ...++.+|+++++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788899999999999999742 2346889986642 245688999999999 699999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
+..++||||+++|+|.+++..... .....+++.+++.++.|++.||.|||+ .+++||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~ 168 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVT 168 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEEEc
Confidence 999999999999999999976421 112358999999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
+++.+||+|||+++........ ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---EL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 9999999999999866432211 11223457999999988899999999999999999999 88888644321 22
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
......... . ..+......+.+++.+|+..+| +|||+.++++.|+++...
T Consensus 246 ~~~~~~~~~----~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 FKLLREGHR----M-----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHcCCC----C-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 222211100 0 1122334678899999999998 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=322.61 Aligned_cols=235 Identities=19% Similarity=0.340 Sum_probs=189.9
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|... ++..||+|.+... ..+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999954 5789999987643 234567788888765 899999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~~~ 393 (530)
|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999987642 68899999999999999999999 5999999999999999999999999999875322 2222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ........... + ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~-------~---~~~~~~~ 220 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDT-------P---HYPRWIT 220 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-------C---CCCCCCC
Confidence 344588999999999999999999999999999999999999975432 22222222110 1 1112234
Q ss_pred HHHHHHHHHcccCCC-CCCCHH-HHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMR-QIA 497 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~-eVl 497 (530)
.++.+++.+|++.+| +||++. ++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 678899999999999 999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=313.73 Aligned_cols=246 Identities=17% Similarity=0.285 Sum_probs=196.6
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
|+..+.||+|+||.||+|.. .+++.+|+|.+.... ...+.+|++++++++|+|++++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999995 468899999875432 23478899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998875422 268999999999999999999999 699999999999999999999999999997654333
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
......++..|+|||++.+..++.++|+||||+++|||++|+.||...........+...... ... .....
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~ 227 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE--TEE-------VYSAK 227 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc--ccc-------ccCcc
Confidence 333446788999999999899999999999999999999999999754322111111111110 000 11223
Q ss_pred HHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
....+.+++..|++.+| +||+ +.+++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 34577899999999999 9999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.65 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=188.4
Q ss_pred eeeccCCcEEEEEEEEcC---CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 243 NIIGEGSFGLAYKGLLQD---GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+.||+|+||.||+|...+ +..+|+|.+.... ...|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 3568899765432 246889999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC---
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH--- 392 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~--- 392 (530)
+|.+++...........++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999976432222356778888999999999999999 5999999999999999999999999999975433221
Q ss_pred cCcccccccccCccccCCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 393 AGSTSAVDCFLDPELNLSK-------NYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
.....++..|+|||++... .++.++||||||+++|||++ |+.||....... ........ ......++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~-~~~~~~~~~ 234 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTVRE-QQLKLPKPR 234 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHhhc-ccCCCCCCc
Confidence 1123356779999987532 35789999999999999996 999996543221 11111111 111111221
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
+ .......+.+++..|+. +| +|||+++|+..|+
T Consensus 235 ~---~~~~~~~~~~l~~~c~~-~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 L---KLPLSDRWYEVMQFCWL-QPEQRPSAEEVHLLLS 268 (269)
T ss_pred c---CCCCChHHHHHHHHHhc-CcccCCCHHHHHHHhc
Confidence 1 11233567889999994 57 9999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=309.36 Aligned_cols=245 Identities=24% Similarity=0.425 Sum_probs=191.0
Q ss_pred eeeccCCcEEEEEEEEcC----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEe-ecCceeEEeeccC
Q 009644 243 NIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCE-ENHQQLLIYDYIP 313 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~-~~~~~~LV~Ey~~ 313 (530)
+.||+|+||.||+|...+ ...+|+|..... ..+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 357899986532 2457889999999999999999999875 4556889999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
+|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999976432 56788889999999999999999 5999999999999999999999999999986543211
Q ss_pred ----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 393 ----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG-REAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 393 ----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.....++..|+|||.+....++.++||||||+++|||++| .+||.... ............. ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~~~------~~--- 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLLQGRR------LL--- 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhcCCC------CC---
Confidence 1122345679999999888999999999999999999995 45554322 1222222221100 00
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
.+...+..+.+++.+||..+| +||++.+|++.|+++..
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111224578899999999998 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.21 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=200.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec-C
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN-H 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~-~ 303 (530)
.++|+..+.||+|+||.||+|.. .+++.||||.+... ..+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788899999999999999973 34678999987642 235688999999999 789999999988654 5
Q ss_pred ceeEEeeccCCCChHHHhhccCCC--------------------------------------------------------
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL-------------------------------------------------------- 327 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~-------------------------------------------------------- 327 (530)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998753210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC---cCcccc
Q 009644 328 ------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSA 398 (530)
Q Consensus 328 ------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~g 398 (530)
....+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01246888899999999999999999 5999999999999999999999999999986533221 112234
Q ss_pred cccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHH
Q 009644 399 VDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMM 477 (530)
Q Consensus 399 t~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 477 (530)
+..|+|||.+.+..++.++||||||+++|||++ |..||....... ........... .. .+......+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~------~~---~~~~~~~~~~ 312 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTR------MR---APDYTTPEMY 312 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHhccCC------CC---CCCCCCHHHH
Confidence 567999999988999999999999999999997 888986543221 11111111110 00 0111235788
Q ss_pred HHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 478 ELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 478 ~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
+++..||+.+| +|||+.+|++.|+.+.+.
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.53 Aligned_cols=232 Identities=19% Similarity=0.280 Sum_probs=186.8
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHH-HHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVK-HIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~-il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|.. .+++.||+|.+.... ..++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 468899999876432 234555655 45779999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999987642 68899999999999999999999 59999999999999999999999999999754322 222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....||..|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~-~~---------~~~~~~~ 220 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDNILNK-PL---------RLKPNIS 220 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHHHHcC-CC---------CCCCCCC
Confidence 334588999999999999999999999999999999999999975432 1222222111 00 0112234
Q ss_pred HHHHHHHHHcccCCC-CCCCHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
..+.+++.+|++.+| +||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 678899999999998 999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=308.46 Aligned_cols=250 Identities=26% Similarity=0.462 Sum_probs=205.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|.+.+.||+|+||.||+|..+++..+|+|.+... ..+++.+|+.++++++|+||+++++++..+...++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678888999999999999999888888999987753 34679999999999999999999999999899999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+++|.+++....+ ..+++.++..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999976432 268999999999999999999999 59999999999999999999999999999876432111
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....+..|+|||.+.+..++.++||||||+++|||+| |+.||..... ............. ..+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~ 227 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYRM---------PRPP 227 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---------CCCC
Confidence 12224567999999998889999999999999999999 9999865432 2222222221110 0111
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+..+.+++.+|+..+| +||+++++.+.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 224678999999999998 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.32 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=201.4
Q ss_pred cCCccceeeccCCcEEEEEEEEcCC----CEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDG----SLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|...+.||+|+||.||+|...+. ..|++|..... ..+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577789999999999999986432 46888976533 34578999999999999999999999875 457899
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997643 258999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCCc--CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 389 GSHHA--GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 389 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
..... ....++..|+|||.+....++.++||||||+++||+++ |..||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~-------- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERL-------- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcC--------
Confidence 43221 12223457999999988889999999999999999996 99999755432 222222221111
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
..+...+..+.+++.+|+..+| +|||+.++++.|+++...+
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0112334678999999999999 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=322.37 Aligned_cols=235 Identities=19% Similarity=0.308 Sum_probs=188.6
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||++.. .+++.+|+|.+... ..+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 45788999987643 234578899999888 699999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~~~ 393 (530)
|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999887542 68999999999999999999999 5999999999999999999999999999975322 2223
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch---HHHHHHHHhhccCCccccccccccch
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD---QNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ ............. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p~ 224 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIPR 224 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCCC
Confidence 345688999999999999999999999999999999999999964322111 1111211111110 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
.....+.+++.+|++.+| +||++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 234577899999999999 99984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=326.96 Aligned_cols=254 Identities=18% Similarity=0.306 Sum_probs=195.2
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-----cee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH-----QQL 306 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~ 306 (530)
+|+..+.||+|+||.||++.. .+++.||+|++... ..+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 57899999987542 2357889999999999999999999998776 789
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 6888887653 268999999999999999999999 5999999999999999999999999999986
Q ss_pred ccCCCC--cCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC------
Q 009644 387 VTGSHH--AGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL------ 457 (530)
Q Consensus 387 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 457 (530)
...... .....++..|+|||++.+. .++.++|||||||++|||++|+.||...........+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543221 2233467889999998764 5799999999999999999999999765432222211111000000
Q ss_pred ---------Cccc-ccc---ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 458 ---------GKYV-DKT---LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 458 ---------~~~~-d~~---l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.... .+. +.........++.+++.+|++.+| +|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000 001112234678899999999999 99999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=307.74 Aligned_cols=247 Identities=26% Similarity=0.462 Sum_probs=200.8
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
.+|+..+.||+|+||.||+|...++..+|+|...... ..+|.+|++++++++|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4577789999999999999998778889999876543 46799999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC--
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-- 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-- 392 (530)
|+|.+++.... +.+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 84 GCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999997643 257899999999999999999999 5999999999999999999999999999876543221
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||++.+..++.++||||||+++|||++ |..||..... ........... ....+. .
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~---~~~~~~------~ 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGF---RLYKPR------L 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCC---CCCCCC------C
Confidence 112224567999999988899999999999999999998 8999865432 22222222111 111111 1
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
.+..+.+++.+||..+| +|||+.+|++.|.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 23678999999999998 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.29 Aligned_cols=255 Identities=18% Similarity=0.284 Sum_probs=205.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcCC-CEEEEEEcccc---cHHHHHHHHHHHHhcC-CCCcceEEEE-Eee------c
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQDG-SLVVIKRHLQT---QIQNFLHEVKHIARVH-HRHLVKLVGF-CEE------N 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~-~~vavK~~~~~---~~~~~~~E~~il~~l~-H~nIv~l~g~-~~~------~ 302 (530)
...++.+.++|.+|||+.||.+....+ ..+|+|++... ..+...+|+++|++|. |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345677889999999999999996665 99999986543 3466889999999996 9999999993 221 1
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
-+.+|.||||.+|.|-+++..+.. ..|++.++++|+.|+++|+++||...++|||||||.+||||+.++..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 357899999999999999986543 25999999999999999999999988899999999999999999999999999
Q ss_pred CcccccCCCC----------cCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH
Q 009644 383 LLKLVTGSHH----------AGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLIL 449 (530)
Q Consensus 383 la~~~~~~~~----------~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 449 (530)
.|........ ......|+.|+|||++. +...++|+|||++||+||-|+....||+....-. +.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Il 267 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----IL 267 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EE
Confidence 9865322211 11223788999999864 6788999999999999999999999998542211 11
Q ss_pred HHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.+... + +..+.....+.+||..||+.+| +||++-||+..+.++....
T Consensus 268 ng~Y~----------~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 268 NGNYS----------F-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ecccc----------C-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11111 0 1124567899999999999999 9999999999999987654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.58 Aligned_cols=257 Identities=23% Similarity=0.402 Sum_probs=203.9
Q ss_pred cCCccceeeccCCcEEEEEEEEcC--------CCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD--------GSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
.+|.+.+.||+|+||.||++...+ ...+|+|..... ..+++.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457888999999999999997421 236899976632 246789999999999 8999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
..+++|||+++|+|.+++..... .+...+++.+++.++.|++.||+|||+ ++++||||||+|||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nill~~ 169 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLVTE 169 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcC
Confidence 99999999999999999976421 123358899999999999999999999 69999999999999999
Q ss_pred CCeEEEeecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHH
Q 009644 373 NYTAKVSDYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLI 448 (530)
Q Consensus 373 ~~~~KI~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~ 448 (530)
++.+||+|||+++........ ....++..|+|||++.+..++.++||||||+++|||++ |..||..... ....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~ 246 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EELF 246 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHH
Confidence 999999999999866432211 11223457999999999999999999999999999998 8888865432 1222
Q ss_pred HHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 449 LQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 449 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
........ ...+......+.+++.+|++.+| +|||+.++++.|+++....
T Consensus 247 ~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 KLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 22221110 01122334678899999999998 9999999999999988544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.71 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=187.1
Q ss_pred eeccCCcEEEEEEEEcC---CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 244 IIGEGSFGLAYKGLLQD---GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
.||+|+||.||+|...+ ...+++|...... ...|.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997543 3468888765332 3468899999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC---c
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---A 393 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~ 393 (530)
|.+++...........++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 9999987543322345778889999999999999999 5999999999999999999999999999875432211 1
Q ss_pred CcccccccccCccccC-------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 394 GSTSAVDCFLDPELNL-------SKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
....++..|+|||++. ...++.++|||||||++|||++ |..||...... ........... ..+.++.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~-~~~~~~~- 234 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQD-IKLPKPQ- 234 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccC-ccCCCCc-
Confidence 2233456799999864 3456889999999999999999 77787644221 22222211111 1111111
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
........+.+++..|+. +| +|||+++|++.|.
T Consensus 235 --~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 --LDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLT 268 (269)
T ss_pred --ccccCCHHHHHHHHHHhc-CcccccCHHHHHHHhc
Confidence 122344567788888985 66 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=311.63 Aligned_cols=249 Identities=22% Similarity=0.401 Sum_probs=196.2
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--cHHHHHHHHHHHHhc-CCCCcceEEEEEeec------C
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN------H 303 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~------~ 303 (530)
.+++.|+..+.||+|+||.||+|.. .+++.+|+|..... ...++.+|+.++.++ +|+||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3567788889999999999999995 45788999986533 345788999999998 799999999998653 4
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 57899999999999999986432 268899999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCC-CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 384 LKLVTGSH-HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 384 a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
++...... ......++..|+|||++. ...++.++|||||||++|||++|+.||....... ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---~~~~~~~~-~~ 233 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRN-PA 233 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH---HHHHHhcC-CC
Confidence 98654322 222345788899999986 3468889999999999999999999996443211 11111110 00
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+.. ........+.+++.+||..+| +|||+.+|++
T Consensus 234 -----~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 -----PRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 111234578999999999998 9999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.82 Aligned_cols=255 Identities=17% Similarity=0.280 Sum_probs=195.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------ 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------ 302 (530)
..++|+..+.||+|+||.||++.. ..++.+|+|++... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357899999999999999999984 45788999987642 235678899999999999999999988643
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCc
Confidence 34789999996 467776642 57888999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH-HHH----------
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI-LQV---------- 451 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~-~~~---------- 451 (530)
+++............+|..|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 998765443344456889999999999999999999999999999999999999754321111110 000
Q ss_pred ---------HhhccCCcc-----ccccc----cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 452 ---------KRSCDLGKY-----VDKTL----GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 452 ---------~~~~~~~~~-----~d~~l----~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
......... ....+ ..........+.+++.+|+..+| +|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000 00111234578899999999999 99999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.84 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=184.9
Q ss_pred eeeccCCcEEEEEEEEcC-------------CCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 243 NIIGEGSFGLAYKGLLQD-------------GSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~-------------~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
+.||+|+||.||+|.+.+ ...|++|.+.... ...|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2257888765433 346888999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe-------EEEe
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT-------AKVS 379 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~-------~KI~ 379 (530)
+||||+++|+|..++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999887543 268999999999999999999999 69999999999999987654 8999
Q ss_pred ecCCcccccCCCCcCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 380 DYGLLKLVTGSHHAGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELI-SGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 380 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~Ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|..|+......+. ...... ..
T Consensus 155 d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~-~~ 226 (262)
T cd05077 155 DPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEG-QC 226 (262)
T ss_pred CCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhc-Cc
Confidence 99998765322 2234677899999886 567899999999999999998 58887764322111 111110 00
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
. ........+.+++.+||+.+| +||++.+|++.|
T Consensus 227 -~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 -M--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -c--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 011123578899999999999 999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.61 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=201.9
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCC----EEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGS----LVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.+|+..+.||+|+||.||+|... ++. .+|+|...... ..++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999854 333 58888766432 3578899999999999999999999987 78899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999976532 58999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCCcC---cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHHAG---STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~~~---~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
....... ...++..|+|||.+....++.++|+||||+++||+++ |+.||...... ........... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~---~--- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKGER---L--- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCCCC---C---
Confidence 5332211 1123457999999988899999999999999999999 99999765322 22222221110 0
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+......+.+++.+||..+| +|||+.++++.|+++...
T Consensus 231 ---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1112233578899999999998 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=317.12 Aligned_cols=253 Identities=23% Similarity=0.425 Sum_probs=199.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCC----EEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGS----LVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++|+..+.||+|+||.||+|.. .++. .+|+|...... ..++.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4677788999999999999985 3444 46888766432 24688999999999999999999998764 4679
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987643 258899999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~------ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLEKGERL------ 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHCCCCC------
Confidence 433221 12234567999999988999999999999999999998 88998654321 222222111110
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
.........+.+++..||..+| +||+++++++.|+++.+.+.
T Consensus 231 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 231 ---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 0112234578899999999998 99999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.45 Aligned_cols=237 Identities=20% Similarity=0.263 Sum_probs=188.8
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHH-HHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVK-HIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~-il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||++.. .+|+.+|+|++... ....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999994 56889999987643 2234566655 46778999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CCCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~~~ 393 (530)
|+|..++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999887542 68999999999999999999999 5999999999999999999999999999875432 2222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......... . .. ......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~~~-~--~~-------~~~~~~ 220 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHK-P--LV-------LRPGAS 220 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHHcC-C--cc-------CCCCCC
Confidence 3445889999999999999999999999999999999999999754321 222222211 0 00 111234
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..+.+++.+|++.+| +||++.+.+++
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 577899999999998 99988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=311.46 Aligned_cols=262 Identities=20% Similarity=0.353 Sum_probs=208.4
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEee-----cCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEE-----NHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~-----~~~ 304 (530)
...|..++.||+|+||.|..+. ..+|+.||+|++.. ...++-.+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4456667899999999999999 56789999998763 234678899999999999999999999865 346
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.|+|+|+| ..+|.+.++... .|+......+..|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc--cccccccchhheeeccCCCEEeccccce
Confidence 89999999 669999998753 589999999999999999999995 9999999999999999999999999999
Q ss_pred ccccC---CCCcCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-----
Q 009644 385 KLVTG---SHHAGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC----- 455 (530)
Q Consensus 385 ~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~----- 455 (530)
|.... ....+....|..|.|||.+. ...||.+.||||.||++.||++|++-|.+.+.......+.......
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98754 22234456788999999876 5789999999999999999999999998876655544444332111
Q ss_pred -------------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhHH
Q 009644 456 -------------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQE 505 (530)
Q Consensus 456 -------------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~~ 505 (530)
.........+....++.....++++.+++..|| +|+|++|.++. |.....
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 111111112222233555678999999999999 99999998863 555443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=310.38 Aligned_cols=260 Identities=18% Similarity=0.321 Sum_probs=203.6
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH-----HHHHHHHHHHHhcCCCC-cceEEEEEeecC-----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI-----QNFLHEVKHIARVHHRH-LVKLVGFCEENH----- 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~H~n-Iv~l~g~~~~~~----- 303 (530)
...|+.+++||+|+||+||+|+ ..+|+.||+|++.-... ....+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456667889999999999999 66789999998664322 34689999999999999 999999998877
Q ss_pred -ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 304 -QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 304 -~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
.+++|+||+. -+|..++....... ..++...+..++.|++.||+|||+ .+|+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 59999998764221 246778899999999999999999 599999999999999999999999999
Q ss_pred CcccccCC-CCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 383 LLKLVTGS-HHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 383 la~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+|+...-. .......+|..|.|||++.+. .|++..||||+||++.||+++++-|.+..+.+....+...........+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99976532 234455688899999998876 7999999999999999999999999887664444444444322211111
Q ss_pred ------ccc--cccc---------cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 461 ------VDK--TLGE---------QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 461 ------~d~--~l~~---------~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.+- .... ..........+++.+|++.+| +|.|++..+..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 0101 111112467899999999998 99999998875
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=321.52 Aligned_cols=249 Identities=16% Similarity=0.250 Sum_probs=194.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||.||+++. .+++.+|+|.+.+. ..+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999995 45889999987642 2345888999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997543 268899999999999999999999 5999999999999999999999999999976543
Q ss_pred CCCc--CcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 390 SHHA--GSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 390 ~~~~--~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
.... ....||..|+|||++.. ..++.++|||||||++|||++|+.||...... ..............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~--- 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKEHFQ--- 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCccc---
Confidence 3221 22358899999999863 45788999999999999999999999754321 11112111111000
Q ss_pred ccccccchhHHHHHHHHHHHcccCC--C-CCCCHHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVS--S-RRPSMRQIAGE 499 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~--p-~RPt~~eVl~~ 499 (530)
+.......+..+.+++.+|+..+ + .||++.++++.
T Consensus 229 --~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 --FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111123456777887766544 3 58899998865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.38 Aligned_cols=235 Identities=22% Similarity=0.349 Sum_probs=184.5
Q ss_pred eeccCCcEEEEEEEEcC-------------------------CCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceE
Q 009644 244 IIGEGSFGLAYKGLLQD-------------------------GSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKL 295 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~~-------------------------~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l 295 (530)
.||+|+||.||+|.+.. ...|++|.+.... ...|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 1247888876433 3468889999999999999999
Q ss_pred EEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-
Q 009644 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY- 374 (530)
Q Consensus 296 ~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~- 374 (530)
+++|.++...++||||+++|+|..++.... +.+++..++.++.|+++||+|||+ ++|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999987543 268899999999999999999999 6999999999999997643
Q ss_pred ------eEEEeecCCcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCchHH
Q 009644 375 ------TAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELI-SGREAHGRNHSNSDQN 446 (530)
Q Consensus 375 ------~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~Ell-tG~~p~~~~~~~~~~~ 446 (530)
.+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||..........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999998654322 12345677999998865 56899999999999999995 7999987543322111
Q ss_pred HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 447 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
. ...... .+......+.+++.+||+.+| +|||+.+|++.|.
T Consensus 233 ~---~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 F---YEKKHR-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HHhccC-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 111101 011122478899999999998 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.29 Aligned_cols=249 Identities=18% Similarity=0.294 Sum_probs=197.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|+..+.||+|+||.||+|+. .+++.+|+|+.... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788889999999999999995 56788999987543 334678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999987542 68899999999999999999999 599999999999999999999999999998664322
Q ss_pred C-cCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 392 H-AGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
. .....++..|+|||.+. ...++.++|||||||++|||++|+.||........ .... .......+...
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~----~~~~~~~~~~~- 232 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM----SKSNFQPPKLK- 232 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heee----ecCCCCCCCCc-
Confidence 1 22345778899999874 44578899999999999999999999864322111 0000 00011111111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
........+.+++.+||..+| +|||+++|++.
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 111234678899999999999 99999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=320.73 Aligned_cols=236 Identities=18% Similarity=0.306 Sum_probs=191.5
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~ 309 (530)
+|+..+.||+|+||.||++.. .+++.||+|.+... ..+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467779999999999999995 46889999987643 2345778999998885 678889999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999987642 68999999999999999999999 5999999999999999999999999999986432
Q ss_pred CC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.. ......||..|+|||++.+..++.++|||||||++|||+||+.||..... .......... .. ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~-~~---------~~ 220 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEH-NV---------SY 220 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CC---------CC
Confidence 22 22334588999999999999999999999999999999999999975532 2222222211 10 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
+......+.+++.+|++.+| +|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 22234678899999999998 99985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.25 Aligned_cols=249 Identities=20% Similarity=0.409 Sum_probs=202.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||++...++..+++|...... .+.|.+|++++++++|+||+++++++.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 45788889999999999999998778889999876533 4678999999999999999999999887 77899999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++....+ ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999976432 257889999999999999999999 59999999999999999999999999999765432211
Q ss_pred --CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 394 --GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 394 --~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
....++..|+|||++....++.++|+||||+++||++| |..||...... ............ ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~---------~~~~ 226 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYRM---------PRPE 226 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCCC---------CCcc
Confidence 12234567999999988889999999999999999999 89898754321 222222211111 1112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+..+.+++.+|++.+| +||++.++.+.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 334678899999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.94 Aligned_cols=254 Identities=17% Similarity=0.276 Sum_probs=195.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------C
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------H 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~ 303 (530)
.++|+..+.||+|+||.||++.. ..++.||+|++... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999984 45788999987532 245688999999999999999999987543 3
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||++ ++|.+++.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 5799999996 577777742 47888999999999999999999 6999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh----------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR---------- 453 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~---------- 453 (530)
++............++..|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 9876544333445688899999999999999999999999999999999999976543221111110000
Q ss_pred ----------hccCC-----cccccc----ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 454 ----------SCDLG-----KYVDKT----LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 454 ----------~~~~~-----~~~d~~----l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..... ...... ...........+.+++.+|++.+| +|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000 000111123568899999999999 99999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.34 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=202.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEccccc-HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQ-IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...+ +..+++|.+.... .+++.+|++++++++|+||+++++++..+...++++||++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3678888999999999999999654 7889999876543 6789999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-C
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-H 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-~ 392 (530)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 82 AGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999997543 268999999999999999999999 599999999999999999999999999998765433 2
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....... ....... ...+.+ ..+...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~~~------~~~~~~-~~~~~~ 225 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMIPN------KPPPTL-SDPEKW 225 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhhcc------CCCCCC-Cchhhc
Confidence 223346788999999988899999999999999999999999997543211 1111110 000111 112223
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+.+++.+|++.+| +|||+.||++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4578999999999999 9999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.82 Aligned_cols=193 Identities=18% Similarity=0.233 Sum_probs=166.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
...+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++||||+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~- 139 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY- 139 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence 3467999999999999999999964 4678999975433 3457999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
.|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 140 ~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 140 SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence 578999887543 268999999999999999999999 59999999999999999999999999999764433333
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHG 437 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~ 437 (530)
....||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 34568899999999999999999999999999999998655543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=306.71 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=199.2
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+|+..+.||+|+||.||++.. .++..+|+|.+.. ...+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999994 4688899997642 23467889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++....+ ..++......++.|++.||.|||+ .+|+|+||||+||++++++.++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999875432 257899999999999999999999 5999999999999999999999999999986643322
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||..... .......... ... ..+..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~~-~~~--------~~~~~ 223 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQG-SYK--------PLPSH 223 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHhcC-CCC--------CCCcc
Confidence 2234577889999999888899999999999999999999999975432 1222222111 110 11122
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....+.+++.+||+.+| +|||+.+|+..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 33568899999999999 99999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.90 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=197.2
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++..++++.....||+|+||.||+|.. .++..|++|..... ..+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345566777778999999999999994 45778999986644 34578999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKL--TMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLL 384 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla 384 (530)
|+||+++++|.+++..... .+ +...+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999986422 34 788889999999999999999 69999999999999986 679999999998
Q ss_pred ccccCCCC-cCcccccccccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 385 KLVTGSHH-AGSTSAVDCFLDPELNLSKN--YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 385 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
........ .....++..|+|||++.... ++.++||||||+++|||++|+.||........ . ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~-~~~~~~~-~~---- 229 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-A-MFKVGMF-KI---- 229 (268)
T ss_pred eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-h-Hhhhhhh-cc----
Confidence 76543222 22234778899999986543 78999999999999999999999865332111 1 1111000 00
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+.....++.+++.+||+.+| +|||+.|++.
T Consensus 230 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 ---HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011222344678899999999998 9999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.40 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=191.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++.. .+++.+|+|.+... ....+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999995 46889999987542 2356788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997642 68899999999999999999999 6999999999999999999999999999875432
Q ss_pred CCC------------------------------------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 009644 390 SHH------------------------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433 (530)
Q Consensus 390 ~~~------------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~ 433 (530)
... .....||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 11235889999999999999999999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCC---HHHHHH
Q 009644 434 EAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPS---MRQIAG 498 (530)
Q Consensus 434 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt---~~eVl~ 498 (530)
.||....... ....+...... -.+++ ......++.+++.+++. +| +|++ +.++++
T Consensus 234 ~Pf~~~~~~~---~~~~i~~~~~~-~~~p~-----~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQE---TYRKVMNWKET-LVFPP-----EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHH---HHHHHHcCCCc-eecCC-----CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9997654322 22222111000 00111 11123567777777654 55 7774 666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=322.76 Aligned_cols=238 Identities=19% Similarity=0.254 Sum_probs=188.6
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHH-HHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVK-HIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~-il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+++.. +++.+|+|.+.... ..++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 57789999876432 234455544 46778999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|.+++.... .+.......++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999997642 57888888999999999999999 59999999999999999999999999999754322 223
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .. .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~-~~---------~~~~~~~ 220 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNK-PL---------QLKPNIT 220 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHhC-Cc---------CCCCCCC
Confidence 3445889999999999999999999999999999999999999754321 222222111 00 1112334
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
..+.+++.+|++.+| +||++.+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 678899999999998 999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.14 Aligned_cols=254 Identities=17% Similarity=0.291 Sum_probs=197.5
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||++... ++..+|+|..... ....+.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999954 5777888876532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++.... .+++..+..++.|++.||.|||+. .+++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997642 688999999999999999999973 389999999999999999999999999987654321
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC-------------
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG------------- 458 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 458 (530)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 233457788999999988889999999999999999999999986443211111110000000000
Q ss_pred -------ccc-------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 459 -------KYV-------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 459 -------~~~-------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
... .+.+. .......+.+++.+|+..+| +|||+.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000 00133568899999999998 99999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.43 Aligned_cols=255 Identities=18% Similarity=0.341 Sum_probs=196.0
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|...+.||+|+||.||+|... +++.||+|.+... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999854 5788999986532 234678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 69999887643 257899999999999999999999 599999999999999999999999999997653322
Q ss_pred C-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---c----------
Q 009644 392 H-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---D---------- 456 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~---------- 456 (530)
. .....++..|+|||.+.+ ..++.++|||||||++|||+||++||...........+....... .
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1 223346788999998765 457899999999999999999999997654322111111110000 0
Q ss_pred ----CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 ----LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ----~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+..........+.+++.+|++.+| +|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000011112334578899999999999 9999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=308.07 Aligned_cols=246 Identities=19% Similarity=0.283 Sum_probs=194.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||+|.. .+++.+|+|..... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999984 56889999986532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999997542 46788889999999999999999 599999999999999999999999999998654322
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH-HHHHHHhhccCCccccccccccch
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN-LILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....++..|+|||++.+..++.++||||||+++|||++|+.||.......... .......... ...+.+. ..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~ 223 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD---EDPPVLP--VG 223 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc---cCCCCCC--CC
Confidence 233457889999999998899999999999999999999999996533221110 0011110000 0011111 11
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....++.+++.+|++.+| +||+++++++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 223578899999999999 99999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.16 Aligned_cols=232 Identities=20% Similarity=0.293 Sum_probs=185.9
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHH-HHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVK-HIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~-il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|+. .+++.+|+|.+.... ..++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999995 467899999876432 234555654 57889999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|..++.... .++..++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99998886542 67888999999999999999999 59999999999999999999999999998754222 222
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+... .. ..+....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~-~~---------~~~~~~~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNILHK-PL---------QLPGGKT 220 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHHhcC-CC---------CCCCCCC
Confidence 334588899999999988999999999999999999999999975432 1222222111 00 1122334
Q ss_pred HHHHHHHHHcccCCC-CCCCHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
..+.+++.+|++.+| +||+..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 678899999999998 999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=308.82 Aligned_cols=256 Identities=18% Similarity=0.299 Sum_probs=195.0
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|... ++..||+|.+... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999954 6889999986532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ ++|.+++..... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888865432 1368999999999999999999999 599999999999999999999999999997653221
Q ss_pred C-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh---------------
Q 009644 392 H-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS--------------- 454 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~--------------- 454 (530)
. .....++..|+|||.+.+ ..++.++||||||+++|||+||++||..................
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 1 122345778999998765 45789999999999999999999999755322111111000000
Q ss_pred -ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 455 -CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 455 -~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..........+.........++.+++.+|++.+| +|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000011111111112234677899999999999 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.80 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=198.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-----cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec--Cce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 305 (530)
..|+..+.||+|+||.||++.+ .++..||+|.+... ..+.+.+|++++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 34778999987633 235789999999999999999999998775 568
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999996542 258999999999999999999999 699999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc---------hHHHHHHHH
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS---------DQNLILQVK 452 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~---------~~~~~~~~~ 452 (530)
....... .....++..|+|||++.+..++.++||||||+++|||+|++.|........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7643221 112335667999999988889999999999999999999887653221100 000000000
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.. ..... .......+..+.+++.+|++.+| +|||+.++++.|+++
T Consensus 238 ~~-~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VL-EEGKR-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HcCcc-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 00000 01122345689999999999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.56 Aligned_cols=235 Identities=26% Similarity=0.390 Sum_probs=187.4
Q ss_pred eeeccCCcEEEEEEEEcCCC-----------EEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 243 NIIGEGSFGLAYKGLLQDGS-----------LVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~-----------~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
+.||+|+||.||+|...+.. .+++|...... ...|.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999975433 47778765433 4678999999999999999999999988 7789999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-------eEEEeecC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-------TAKVSDYG 382 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-------~~KI~DFG 382 (530)
||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986532 68899999999999999999999 5999999999999999888 89999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSK--NYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
+++.... .....++..|+|||++... .++.++||||||+++|||++ |..|+.......... .......
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~~~~~--- 224 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQDQHR--- 224 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHhcCCC---
Confidence 9987543 1223355679999998776 78999999999999999999 577775543211111 1111000
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
.+......+.+++.+||..+| +|||+.+|++.|+
T Consensus 225 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001112688899999999998 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.33 Aligned_cols=247 Identities=23% Similarity=0.433 Sum_probs=197.5
Q ss_pred CccceeeccCCcEEEEEEEEcC-CCEEEEEEcccccHH-----HHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQIQ-----NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~-----~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
|+..+.||+|+||.||++.... ++.+|+|........ ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677999999999999999654 568999987765432 2355999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc-cCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~-~~~~ 391 (530)
++++|.+++... ..+++.++..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccc-----cccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence 999999999843 278999999999999999999999 59999999999999999999999999999764 2222
Q ss_pred CcCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 HAGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......++..|+|||.+. ...++.++||||+|+++|+|++|..||.................... .... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~ 227 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-----PSSS-QQSR 227 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-----HHHT-TSHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc-----cccc-cccc
Confidence 334456788899999998 78899999999999999999999999986522222222222221100 0000 0011
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+|++.+| +|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 113789999999999999 9999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.73 Aligned_cols=244 Identities=18% Similarity=0.357 Sum_probs=198.8
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.+|+..+.||+|+||.||+|.. .++..+++|.+... ..+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999984 56889999987643 2456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998643 57899999999999999999999 5999999999999999999999999999886543221
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||....... ......... . +.+ ..+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~~~~--~-----~~~-~~~~~ 241 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNG--T-----PEL-QNPEK 241 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHhcCC--C-----CCC-CCccc
Confidence 223457788999999988889999999999999999999999997543211 111111110 0 000 11223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+.+++.+|+..+| +|||+.+|++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 34678899999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=305.40 Aligned_cols=244 Identities=19% Similarity=0.360 Sum_probs=197.0
Q ss_pred CCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
+|...+.||+|+||.||+|...+++.+|+|.+... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36677899999999999999888899999976522 124688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997642 57889999999999999999999 599999999999999999999999999987653
Q ss_pred CCC-------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 389 GSH-------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 389 ~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||....... . ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~-~~~~~~~~~~---- 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--A-MFYIGAHRGL---- 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--H-HHHhhhccCC----
Confidence 211 1122347788999999998889999999999999999999999997543211 1 1111111000
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+ ..+......+.+++.+||+.+| +||++.++++
T Consensus 227 ~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MP---RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC---CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01 1122334678999999999998 9999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=303.51 Aligned_cols=245 Identities=27% Similarity=0.479 Sum_probs=199.7
Q ss_pred eeeccCCcEEEEEEEEcC----CCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQD----GSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|.... +..+++|...... .+.+.+|++.+..++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999643 7789999876432 46789999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 315 GNVQNHLYDSEGL----PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 315 GsL~~~l~~~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+|.+++...... ....+++.++..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999875210 01378999999999999999999999 69999999999999999999999999999876543
Q ss_pred C---CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
. ......++..|+|||.+....++.++||||||+++|||++ |..||..... ............ .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---------~ 226 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYR---------L 226 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC---------C
Confidence 2 1223346778999999988899999999999999999999 6899876522 222232222110 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
..+...+..+.+++.+|+..+| +|||+.++++.|+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1222335688999999999998 9999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.41 Aligned_cols=242 Identities=22% Similarity=0.438 Sum_probs=195.2
Q ss_pred eeeccCCcEEEEEEEEcC--C--CEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQD--G--SLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~--~--~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|.+.+ + ..+|+|...... .+++.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 2 258999877543 4578999999999999999999999988 889999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC--
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-- 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-- 392 (530)
|+|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987532 368999999999999999999999 6999999999999999999999999999987644221
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....++..|+|||++....++.++||||||+++|||+| |..||...... ........... .. ..+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~--~~------~~~ 223 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDKEGE--RL------ERP 223 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCC--cC------CCC
Confidence 112335678999999988899999999999999999999 99998644322 22222221110 00 011
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
...+..+.+++.+|+..+| +|||+.+|++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2234678999999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=302.38 Aligned_cols=249 Identities=20% Similarity=0.354 Sum_probs=200.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|+..+.||+|+||.||+|.. .++..+++|..... ..+.+.+|++++++++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46788889999999999999995 45778999986643 356789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++.... ..++..++..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999987652 268899999999999999999999 599999999999999999999999999998654332
Q ss_pred -CcCcccccccccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 392 -HAGSTSAVDCFLDPELNLSK---NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
......++..|+|||.+... .++.++||||||+++|||+||+.||....... ........ ....+.+ .
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~~~~~----~~~~~~~-~ 227 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFLISKS----NFPPPKL-K 227 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhc----cCCCccc-c
Confidence 12234567789999998776 88999999999999999999999997543211 11111111 0011111 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.+++.+||..+| +|||+.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 222345678999999999999 9999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=308.04 Aligned_cols=255 Identities=18% Similarity=0.343 Sum_probs=197.2
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|... +++.+|+|++... ..+.+.+|++++++++|+|++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999965 5889999986532 23467899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|..++.... .+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765432 68999999999999999999999 59999999999999999999999999999876543
Q ss_pred C-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--------cCCcc
Q 009644 391 H-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--------DLGKY 460 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~ 460 (530)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+....... .....
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 3 1223346778999999865 568899999999999999999999997654322211111110000 00000
Q ss_pred ----cccccc------ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 ----VDKTLG------EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ----~d~~l~------~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+... .........+.+++.+|++.+| +|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 0011234678899999999998 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=302.55 Aligned_cols=242 Identities=28% Similarity=0.467 Sum_probs=195.5
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChH
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~ 318 (530)
+.||+|+||.||++...+++.|++|..... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999777899999986643 3457899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc---Cc
Q 009644 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA---GS 395 (530)
Q Consensus 319 ~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~---~~ 395 (530)
+++.... ..+++..++.++.+++.||+|||+ ++++||||||+||+++.++.+||+|||+++........ ..
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9997643 257899999999999999999999 69999999999999999999999999999865422111 11
Q ss_pred ccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 396 TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 396 ~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...+..|+|||.+.+..++.++||||||+++|||+| |..||....... ........... ..+...+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~ 222 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIESGYRM---------PAPQLCPE 222 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHhcCCCC---------CCCccCCH
Confidence 123456999999988899999999999999999999 788886543211 11111111000 01223346
Q ss_pred HHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 475 EMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.+.+++.+|+..+| +|||+.||++.|++
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 89999999999999 99999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.65 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=200.4
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.-|+.++.||.|+||.||.++ ..+.+.||||++.- ...+++++|+..|.+++|||++.+-|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 357777899999999999999 56788999998763 23568999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||| -|+-.|.+.-.. .++.+.++..|..+.+.||+|||+. +.||||||+.||||++.|.+||+|||.|.....
T Consensus 106 EYC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999 678888886554 2788899999999999999999995 999999999999999999999999999987643
Q ss_pred CCCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
..++.||+.|||||++. .+.|+-|+||||+|++..||...++|...... ......+... -.|.+.
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---MSALYHIAQN------esPtLq 246 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQN------ESPTLQ 246 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---HHHHHHHHhc------CCCCCC
Confidence 45778999999999976 67899999999999999999999999875432 2222222221 112222
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+-+..+..++..|++..| +|||.+++++
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 33455678899999999998 9999998763
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=303.04 Aligned_cols=245 Identities=19% Similarity=0.360 Sum_probs=200.3
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||.|+||.||.++ ..++..+++|.+.. ...+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999988 45688899997542 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999976532 368999999999999999999999 599999999999999999999999999998764433
Q ss_pred -CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 -HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......++..|+|||...+..++.++||||||+++|||++|+.||...... ......... ... ....
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~-~~~--------~~~~ 223 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQG-NYT--------PVVS 223 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcC-CCC--------CCcc
Confidence 223345788899999998888999999999999999999999999754322 222222111 110 1112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....++.+++.+|+..+| +||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 334678899999999998 99999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=307.37 Aligned_cols=246 Identities=26% Similarity=0.448 Sum_probs=194.8
Q ss_pred eeeccCCcEEEEEEEEcC-------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 243 NIIGEGSFGLAYKGLLQD-------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+.||+|+||.||+|...+ +..+++|..... ....|.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 246888876543 346789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-----eEEEeecCCc
Q 009644 312 IPNGNVQNHLYDSEGL--PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-----TAKVSDYGLL 384 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-----~~KI~DFGla 384 (530)
+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.+. .+|++|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999754221 12357899999999999999999999 5999999999999999877 8999999999
Q ss_pred ccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 385 KLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 385 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+....... ......+..|+|||++.+..++.++||||||+++|||+| |+.||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~--- 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGRL--- 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCcc---
Confidence 76543221 112234567999999999999999999999999999998 9999864422 1222222111100
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+...+..+.+++.+||..+| +||++.+|++.|++
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 ------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1122345678899999999998 99999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.82 Aligned_cols=195 Identities=18% Similarity=0.301 Sum_probs=159.9
Q ss_pred ceeeccCCcEEEEEEEEc---CCCEEEEEEccccc-HHHHHHHHHHHHhcCCCCcceEEEEEee--cCceeEEeeccCCC
Q 009644 242 INIIGEGSFGLAYKGLLQ---DGSLVVIKRHLQTQ-IQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLLIYDYIPNG 315 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~G 315 (530)
.++||+|+||.||+|+.. ++..+|+|.+.... ...+.+|++++++++||||+++++++.. +...++||||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 368999999999999864 45789999876543 3567899999999999999999998854 456889999995 5
Q ss_pred ChHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCeEEEeecCCcccc
Q 009644 316 NVQNHLYDSEG----LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL----EENYTAKVSDYGLLKLV 387 (530)
Q Consensus 316 sL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl----~~~~~~KI~DFGla~~~ 387 (530)
+|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 88888764321 111258899999999999999999999 599999999999999 45679999999999876
Q ss_pred cCCCC----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 388 TGSHH----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 388 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
..... .....+|..|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 43321 223457889999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=304.16 Aligned_cols=245 Identities=29% Similarity=0.470 Sum_probs=197.3
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
++|++.+.||+|+||.||+|.. ++..+|+|..... ..+.+.+|+.++++++|||++++++++..+ ..++||||+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 4578889999999999999985 5678999987654 346789999999999999999999998765 478999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCc
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS 395 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~ 395 (530)
+|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..... ...
T Consensus 84 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 84 NLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceecccc--CCC
Confidence 99999976432 257899999999999999999999 59999999999999999999999999998764322 122
Q ss_pred ccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 396 TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 396 ~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........... .+ .....+.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~-----~~~~~~~ 224 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVEKGYR----ME-----PPEGCPA 224 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhCCCC----CC-----CCCcCCH
Confidence 234567999999988899999999999999999998 99998754322 22222211110 00 1122346
Q ss_pred HHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 475 EMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.+.+++.+|++.+| +||++.+|++.|++
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 78899999999999 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=304.25 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCccceeeccCCcEEEEEEEEcC--CCEEEEEEccc-------------ccHHHHHHHHHHHHh-cCCCCcceEEEEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQD--GSLVVIKRHLQ-------------TQIQNFLHEVKHIAR-VHHRHLVKLVGFCEE 301 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~-------------~~~~~~~~E~~il~~-l~H~nIv~l~g~~~~ 301 (530)
+|+..+.||+|+||.||+|.... ++.+|+|.+.. ....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999655 67899997542 123457789888875 799999999999999
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. .+++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542211 13689999999999999999999963 48999999999999999999999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
|++.............++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~-~~---- 230 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEA-VY---- 230 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHhhc-cC----
Confidence 999876544333345578889999999988899999999999999999999999864422 1112211111 00
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
.+ . ........+.+++.+|++.+| +||++.||.+++++
T Consensus 231 ~~-~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EP-L--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred Cc-C--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00 0 011234678899999999999 99999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.82 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=200.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-----CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEee--cCce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-----DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~ 305 (530)
..|+..+.||+|+||.||+|.+. ++..+|+|.+.... .+.|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999854 35789999876442 4579999999999999999999999977 5578
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976532 58999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCCc----CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc------------hHHHHH
Q 009644 386 LVTGSHHA----GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS------------DQNLIL 449 (530)
Q Consensus 386 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~------------~~~~~~ 449 (530)
........ ....++..|++||......++.++||||||+++|||+||..|+....... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 11224456999999988899999999999999999999999986432211 001111
Q ss_pred HHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
....... . ..+.....++.+++.+|++.+| +||||.||+++|+.+
T Consensus 238 ~~~~~~~--------~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER--------L-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc--------C-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111100 0 0112234678999999999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.15 Aligned_cols=249 Identities=14% Similarity=0.230 Sum_probs=195.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+++.+ +++.+|+|.+.+. ....+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 4678999987542 2235788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997643 268899999999999999999999 5999999999999999999999999999976543
Q ss_pred CCC--cCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 390 SHH--AGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 390 ~~~--~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
... .....||..|+|||++. ...++.++|||||||++|||++|+.||...... .....+..... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~-----~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKE-----R 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCc-----c
Confidence 222 12345899999999986 356889999999999999999999999754321 22222221110 0
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC---CCCCHHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS---RRPSMRQIAGE 499 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p---~RPt~~eVl~~ 499 (530)
...+.........+.+++.+|+..++ .|+++.++++.
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111122334677888888776543 47899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=300.70 Aligned_cols=243 Identities=21% Similarity=0.406 Sum_probs=198.0
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc--------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
+|+..+.||+|+||.||+|... ++..|++|.+... ..+.+.+|++++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3566789999999999999965 7889999976532 335788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997642 58899999999999999999999 599999999999999999999999999998764
Q ss_pred CCCCcCcccccccccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKN-YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.........++..|++||.+.... ++.++|+||||+++|||++|+.||..... .............. .
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~--------~ 222 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSKELP--------P 222 (258)
T ss_pred ccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcccCC--------C
Confidence 433233445778899999987766 89999999999999999999999975431 11111111111111 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+......+.+++.+|++.+| +||++.+++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 122334678899999999998 9999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=343.73 Aligned_cols=258 Identities=19% Similarity=0.260 Sum_probs=202.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||.||+|.. .+++.||+|++... ..++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788899999999999999995 45889999987642 2357899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 310 DYIPNGNVQNHLYDSEGL------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
||+++|+|.+++...... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999998742110 11246778889999999999999999 5999999999999999999999999999
Q ss_pred cccccCCC-------------------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch
Q 009644 384 LKLVTGSH-------------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444 (530)
Q Consensus 384 a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 444 (530)
++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k- 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK- 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence 98652110 0112348899999999999999999999999999999999999997543211
Q ss_pred HHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCC-CHHHHHHHHHhhHHH
Q 009644 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRP-SMRQIAGELEGIQER 506 (530)
Q Consensus 445 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP-t~~eVl~~L~~i~~~ 506 (530)
.... .. . .++.-.......+..+.+++.+|++.+| +|| +++++.+.|+...+.
T Consensus 239 --i~~~-~~---i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 --ISYR-DV---I---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --hhhh-hh---c---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111 00 0 0000000111334578899999999998 895 778888888887664
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.69 Aligned_cols=249 Identities=16% Similarity=0.236 Sum_probs=195.0
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+++.. +++.+|+|.+.+. ....+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999954 5788999987642 2345788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998643 268899999999999999999999 6999999999999999999999999999987644
Q ss_pred CCCc--CcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 390 SHHA--GSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 390 ~~~~--~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
.... ....|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ........... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~--~--- 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHEE--R--- 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCCC--c---
Confidence 3222 22458899999999865 56889999999999999999999999754321 22222211100 0
Q ss_pred ccccccchhHHHHHHHHHHHcccCCCC---CCCHHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSSR---RPSMRQIAGE 499 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p~---RPt~~eVl~~ 499 (530)
..++......+..+.+++.+|+..+++ |++++++++.
T Consensus 227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 001111122346788888888876543 5688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=293.79 Aligned_cols=258 Identities=20% Similarity=0.325 Sum_probs=203.1
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Ccee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~~~ 306 (530)
.++|.+.+.||+|||+.||.++ ..++..+|+|++.- ++.+..++|++..++++|||++++++++..+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678888999999999999999 77889999998653 3456789999999999999999999987443 3589
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
|+++|...|+|.+.+...... ...+++.+++.|+.++++||++||+..+++.||||||.|||+.+.+.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999865322 2368999999999999999999999656799999999999999999999999999875
Q ss_pred ccCC----CC------cCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 387 VTGS----HH------AGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 387 ~~~~----~~------~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
..-. .. ......|..|.|||.+. +...++++|||||||+||+|+.|..||+....... .+..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-SlaL---- 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLAL---- 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEEE----
Confidence 4211 00 11223677899999986 44568999999999999999999999974432110 0000
Q ss_pred hccCCcccccccc-ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 454 SCDLGKYVDKTLG-EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 454 ~~~~~~~~d~~l~-~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.+....+. ......+..+.+++.+|++.+| +||++.+++..++.+.
T Consensus 254 -----Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 -----AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111110 1122256789999999999999 9999999999988754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.39 Aligned_cols=254 Identities=17% Similarity=0.213 Sum_probs=197.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc---CCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ---DGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..+|++.+.||+|+||.||++... .+..|++|..... ..+.+|++++++++||||+++++++......++||||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 457999999999999999999753 3567899987654 34568999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
. ++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 169 ~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 169 K-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 5 7899888433 268999999999999999999999 5999999999999999999999999999976643322
Q ss_pred ---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC-----C------
Q 009644 393 ---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL-----G------ 458 (530)
Q Consensus 393 ---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~-----~------ 458 (530)
.....||..|+|||++....++.++|||||||++|||++|+.||...........+..+...... .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 12345889999999999999999999999999999999999999765433222222211111000 0
Q ss_pred ---------ccccccc--cc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 459 ---------KYVDKTL--GE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 459 ---------~~~d~~l--~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....+.. .. ........+.+++.+|+..+| +|||+.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00 001123467889999999999 99999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.74 Aligned_cols=241 Identities=22% Similarity=0.379 Sum_probs=196.0
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.|+..+.||+|+||.||+|.. .++..||+|..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355668899999999999985 45778999986532 2356889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++++|.+++... .+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 85 ~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG------PLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988642 68899999999999999999999 6999999999999999999999999999986643321
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||++.+..++.++||||||+++|||+||+.|+....... ........ ..+. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~------~~~~---~~~~ 224 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFLIPKN------SPPT---LEGQ 224 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhhhhcC------CCCC---CCcc
Confidence 122346778999999998899999999999999999999999986443211 11111110 0111 1223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+..+.+++.+|++.+| +|||+.+|++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 34678899999999999 9999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.78 Aligned_cols=252 Identities=17% Similarity=0.283 Sum_probs=199.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||++.. .++..+|+|..... ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4677889999999999999995 46888999975532 245789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++.... .+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999987642 689999999999999999999973 489999999999999999999999999987553221
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch-----HHHHHHHHhhccCCcccccccc
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-----QNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.....++..|+|||++.+..++.++|||||||++|||+||+.||........ ............ . ..+.+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~- 233 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ--E-PPPRL- 233 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh--c-cCCCC-
Confidence 2234578889999999888999999999999999999999999985443211 111111111100 0 00111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
.....+..+.+++.+|++.+| +|||+.||++..
T Consensus 234 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 -PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111244678999999999999 999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=307.17 Aligned_cols=244 Identities=21% Similarity=0.369 Sum_probs=194.1
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
|+..+.||+|+||.||+|... ++..+++|..... ..+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999965 4677888876543 345788999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-Cc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-HA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-~~ 393 (530)
|+|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...... ..
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 99999886533 268999999999999999999999 599999999999999999999999999987653322 12
Q ss_pred CcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 394 GSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
....++..|+|||++. ...++.++|||||||++|||++|++||..... ............ +.. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~------~~~-~~ 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEP------PTL-AQ 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCC------CCC-CC
Confidence 3345788899999873 45578899999999999999999999875432 112222211110 000 01
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+......+.+++.+||+.+| +|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12234678999999999999 9999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.21 Aligned_cols=243 Identities=21% Similarity=0.372 Sum_probs=199.0
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||.|+||.||+|... +++.+|+|..... ....+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999954 6889999986533 245688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++... .+++..+..++.|++.||.|||+ ++++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 68899999999999999999999 599999999999999999999999999998765432
Q ss_pred -CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 -HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......++..|+|||++.+..++.++||||||+++|||+||+.||..... .......... ..+.+...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~------~~~~~~~~-- 221 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKN------NPPSLEGN-- 221 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhc------CCCCCccc--
Confidence 22334577789999999988899999999999999999999999975432 1111111111 11111111
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+|+..+| +|||++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 134578899999999998 9999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.36 Aligned_cols=253 Identities=16% Similarity=0.207 Sum_probs=193.6
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
.+|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++|+|||++++++..++..++|||++ .+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~ 244 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS 244 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence 36889999999999999999954 47889999643 234678999999999999999999999999999999999 57
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC---
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH--- 392 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~--- 392 (530)
+|.+++.... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 245 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 245 DLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9999887543 268999999999999999999999 5999999999999999999999999999987643321
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----chHHHHHHHHhhc-cCCccc---cc
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN-----SDQNLILQVKRSC-DLGKYV---DK 463 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~-----~~~~~~~~~~~~~-~~~~~~---d~ 463 (530)
.....||..|+|||++.+..++.++|||||||+||||++|..++...... ....+...+.... ....+. ..
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 12345899999999999999999999999999999999988765432211 0111111111110 000000 00
Q ss_pred cc-------------ccc-------chhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 464 TL-------------GEQ-------TVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 464 ~l-------------~~~-------~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.+ ... .......+.+++.+|++.|| +|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000 00122367899999999999 99999999863
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.18 Aligned_cols=236 Identities=25% Similarity=0.361 Sum_probs=185.3
Q ss_pred eeeccCCcEEEEEEEEcC--------CCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 243 NIIGEGSFGLAYKGLLQD--------GSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+.||+|+||.||+|.... ...+++|...... .+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 2247777765432 35788999999999999999999999998999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe--------EEEeecCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT--------AKVSDYGL 383 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~--------~KI~DFGl 383 (530)
+++|+|.+++..... .+++..++.++.|++.||+|||+ ++|+||||||+||+++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999986532 68899999999999999999999 69999999999999987764 69999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGR-EAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
+...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..... . ..........
T Consensus 155 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~--~~~~~~~~~~------ 222 (258)
T cd05078 155 SITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-Q--KKLQFYEDRH------ 222 (258)
T ss_pred ccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-H--HHHHHHHccc------
Confidence 8755322 22346778999999876 45899999999999999999995 55443221 1 1111111110
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
..+.....++.+++.+||+.+| +|||++++++.|+
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1112233578999999999999 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=303.38 Aligned_cols=241 Identities=20% Similarity=0.410 Sum_probs=195.5
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
|...+.||+|+||.||+|.. .++..+|+|.+... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56678999999999999985 45788999976432 124688999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999997642 68889999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC-------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 386 LVTGSHH-------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 386 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---- 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGEN---- 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhcc----
Confidence 7652211 1123467789999999988999999999999999999999999975422 1122211111
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+ ..+......+.+++.+||+.+| +||++.+|++
T Consensus 228 --~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --ASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111 1222344678899999999999 9999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=305.54 Aligned_cols=243 Identities=21% Similarity=0.373 Sum_probs=198.8
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..|+..+.||.|+||.||+|... ++..+|+|..... ..+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677789999999999999954 5788999986533 245788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++... .+++.+...++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999998642 57889999999999999999999 599999999999999999999999999997764432
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. .....++..|+|||++.+..++.++|+||||+++|||+||+.||....... ........ ..+ ....
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~------~~~---~~~~ 223 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFLIPKN------NPP---TLTG 223 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---HhhhhhcC------CCC---CCch
Confidence 2 222346778999999988889999999999999999999999987543211 11111110 001 1233
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.....+.+++.+||+.+| +||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 455788999999999999 99999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.55 Aligned_cols=255 Identities=18% Similarity=0.320 Sum_probs=194.1
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN----- 302 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~----- 302 (530)
...++|+..+.||+|+||.||+|.. .++..||+|++... ..+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999984 56789999987643 234678899999999999999999987543
Q ss_pred -CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 303 -HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 303 -~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEcCC
Confidence 3578999998 78998887532 68999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-----
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC----- 455 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~----- 455 (530)
|+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 163 g~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 163 GLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred ccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999875432 233457889999999876 578999999999999999999999997543221111111100000
Q ss_pred -------------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 456 -------------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 456 -------------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.+.......+..........+.+++.+|++.+| +|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000011123457899999999999 99999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=310.30 Aligned_cols=245 Identities=16% Similarity=0.360 Sum_probs=199.9
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..+|+..+.||.|+||.||+|. ..+++.|++|.+... ..+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3568899999999999999998 457889999976532 345788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++... .+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988643 58999999999999999999999 599999999999999999999999999988654332
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||........ ....... ... .+ ..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~~~~-~~~-----~~-~~~~ 239 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATN-GTP-----EL-QNPE 239 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhc-CCc-----cc-CCcc
Confidence 2 2233577889999999888899999999999999999999999976532211 1111111 000 00 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+||..+| +|||+.+|++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 334578899999999998 8999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.71 Aligned_cols=244 Identities=22% Similarity=0.423 Sum_probs=199.0
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||++.. .+++.+|+|.+... ..+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999985 46788999986532 345788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCCcccccCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGla~~~~~~ 390 (530)
+++++|.+++....+ ..+++..+..++.+++.||+|||+ .+++|+||+|+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999976432 258999999999999999999999 599999999999999854 56899999999876544
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.......++..|+|||.+....++.++||||||+++|||++|+.||...... ......... ... ..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~-~~~--------~~~~ 223 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIMSG-TFA--------PISD 223 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHHhc-CCC--------CCCC
Confidence 3333445778899999998888999999999999999999999999754322 222222211 000 1112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+||..+| +|||+.|+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 234678999999999998 9999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=310.30 Aligned_cols=194 Identities=19% Similarity=0.312 Sum_probs=158.9
Q ss_pred eeeccCCcEEEEEEEEcC---CCEEEEEEccccc-HHHHHHHHHHHHhcCCCCcceEEEEEee--cCceeEEeeccCCCC
Q 009644 243 NIIGEGSFGLAYKGLLQD---GSLVVIKRHLQTQ-IQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLLIYDYIPNGN 316 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~~-~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~Gs 316 (530)
.+||+|+||.||+|...+ +..+|+|.+.... ...+.+|++++++++||||+++++++.. +...++||||++ ++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence 689999999999999653 4689999876543 3468899999999999999999998853 457889999986 58
Q ss_pred hHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCeEEEeecCCccccc
Q 009644 317 VQNHLYDSEG----LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL----EENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 317 L~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl----~~~~~~KI~DFGla~~~~ 388 (530)
|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 8887753211 112358899999999999999999999 599999999999999 567799999999998764
Q ss_pred CCCC----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 389 GSHH----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 389 ~~~~----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
.... .....+|..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 3321 123357888999999876 45899999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=308.37 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=200.0
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--HHHHHHHHHHHHhc-CCCCcceEEEEEe----
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--IQNFLHEVKHIARV-HHRHLVKLVGFCE---- 300 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~E~~il~~l-~H~nIv~l~g~~~---- 300 (530)
+..+....++|+..+.||+|+||.||++.. .+++.+|+|...... ..++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345566788999999999999999999985 457889999865432 35688899999999 7999999999884
Q ss_pred -ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 301 -ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 301 -~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
.++..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999999998864321 11368889999999999999999999 599999999999999999999999
Q ss_pred ecCCcccccCCC-CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 380 DYGLLKLVTGSH-HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 380 DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
|||+++...... ......++..|+|||++. ...++.++|||||||++|||++|+.||....... .......
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~~~~ 243 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFKIPR 243 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhhccc
Confidence 999998764332 222345788899999875 3457899999999999999999999987543211 1111111
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
. ..+.+. .+......+.+++.+|++.+| +|||+.||++.
T Consensus 244 ~------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 N------PPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c------CCCccc-CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 001110 111123578899999999998 99999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=298.66 Aligned_cols=258 Identities=19% Similarity=0.293 Sum_probs=209.0
Q ss_pred HHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc-------c----HHHHHHHHHHHHhc-CCCCcceEEEEE
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-------Q----IQNFLHEVKHIARV-HHRHLVKLVGFC 299 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-------~----~~~~~~E~~il~~l-~H~nIv~l~g~~ 299 (530)
+..-++|...+.||+|..++|-++. ..+|...|+|++... . .+.-.+|+.||+++ .||||+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3445678888999999999999988 456788888875421 1 23456899999998 799999999999
Q ss_pred eecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 300 ~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
+.+...++|+|.|+.|.|.++|...- .+++++..+|++|+..|++|||. ++||||||||+|||++++.++||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEe
Confidence 99999999999999999999998763 79999999999999999999999 699999999999999999999999
Q ss_pred ecCCcccccCCCCcCcccccccccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 380 DYGLLKLVTGSHHAGSTSAVDCFLDPELNL------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 380 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
|||+|..+.........+||++|+|||.+. ...|+...|+||.||+||.|+.|.+||.....-.....+...+.
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 999999998887778889999999999875 34588899999999999999999999974321111111111111
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHHH
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQER 506 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~~ 506 (530)
...- +...+......+++.+|++.+| +|.|.+|+++ ....+...
T Consensus 246 qF~s---------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 246 QFRS---------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ccCC---------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 1111 2334456788999999999999 9999999986 34444433
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.23 Aligned_cols=243 Identities=19% Similarity=0.351 Sum_probs=191.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--------cHHHHHHHHHHHHhcCCCCcceEEEEEee--cCce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~ 305 (530)
.+|+..+.||+|+||.||+|.. .++..+++|..... ....+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788889999999999999985 45889999976421 23468889999999999999999998865 3567
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
+++|||+++++|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997642 57899999999999999999999 599999999999999999999999999997
Q ss_pred cccCCC----CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 386 LVTGSH----HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 386 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+....... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~~-----~ 226 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQP-----T 226 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcCC-----C
Confidence 653211 112234678899999999888999999999999999999999999754221 1111111110 0
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+. .+......+.+++ +|+..+| +||+++||++
T Consensus 227 ~~~---~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ---LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC---CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1222334556666 6887888 9999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.42 Aligned_cols=253 Identities=24% Similarity=0.426 Sum_probs=200.5
Q ss_pred cCCccceeeccCCcEEEEEEEEc------CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
++|+....||+|+||.||+|+.+ +...+++|...... .+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999954 24578999865432 357999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLP----IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
+||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999997653211 1258999999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 383 LLKLVTGSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 383 la~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .......... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~~-~~~~ 238 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQAG-KLEL 238 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHcC-CcCC
Confidence 9875432211 122335667999999988889999999999999999999 7888864322 2222222211 1110
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
. .....+..+.+++.+|+..+| +|||+.++++.|.+
T Consensus 239 ~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 239 P-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 112334688999999999998 99999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=306.07 Aligned_cols=256 Identities=22% Similarity=0.404 Sum_probs=201.0
Q ss_pred cCHHHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--cHHHHHHHHHHHHhc-CCCCcceEEEEEee-
Q 009644 227 LTILELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--QIQNFLHEVKHIARV-HHRHLVKLVGFCEE- 301 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~E~~il~~l-~H~nIv~l~g~~~~- 301 (530)
.++.++....+.|+..+.||+|+||.||+|.. .+++.+|+|..... ...++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 35556666778899999999999999999995 56788999986543 345688899999998 79999999999853
Q ss_pred -----cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeE
Q 009644 302 -----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 302 -----~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~ 376 (530)
....+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCE
Confidence 4578999999999999999976432 257888899999999999999999 599999999999999999999
Q ss_pred EEeecCCcccccCCC-CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH
Q 009644 377 KVSDYGLLKLVTGSH-HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450 (530)
Q Consensus 377 KI~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 450 (530)
||+|||+++...... ......++..|+|||.+. ...++.++|||||||++|||++|+.||...... .....
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~ 237 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFL 237 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhhh
Confidence 999999987654221 123345788899999875 356888999999999999999999999654321 11111
Q ss_pred HHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 451 VKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 451 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... ..+.. ........+.+++.+||..+| +|||+.|+++
T Consensus 238 ~~~~------~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRN------PPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhC------CCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111 00111 111234678999999999999 9999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.56 Aligned_cols=246 Identities=23% Similarity=0.382 Sum_probs=196.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+.|++.+.||+|+||.||+|... ++..+++|...... .+++.+|+.++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999964 47889999876443 457889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
++++|..++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998886543 268999999999999999999999 599999999999999999999999999987643321
Q ss_pred CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 392 HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
......++..|+|||++. ...++.++|||||||++|||++|+.||...... ......... . .+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~-~-----~~~~- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKS-E-----PPTL- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHHhcC-C-----CccC-
Confidence 122344678899999984 345788999999999999999999998754321 111111111 0 0110
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.....++.+++.+||+.+| +||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122334578899999999998 9999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=298.82 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=196.3
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee-cCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~~~LV~E 310 (530)
+|+..+.||+|+||.||++.. .+++.+|+|++... ..+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478889999999999999994 45788999986532 23568899999999999999999998764 446789999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999976432 258999999999999999999999 59999999999999999999999999999876432
Q ss_pred CC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 HH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.. .....++..|+|||++.+..++.++||||||+++|||++|+.||..... .......... .. ...+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~-~~--------~~~~ 223 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIEG-KL--------PPMP 223 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhc-CC--------CCCc
Confidence 22 2233477889999999999999999999999999999999999874431 1221111111 11 1112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+|++.+| +|||+.++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2344678999999999999 9999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=304.08 Aligned_cols=248 Identities=20% Similarity=0.309 Sum_probs=196.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|...+.||+|+||.||+|.. .++..+|+|.+.... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34677788999999999999985 468889999865432 34578899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999987542 68999999999999999999999 599999999999999999999999999987654322
Q ss_pred C-cCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 392 H-AGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
. .....++..|+|||++. ...++.++|||||||++|||++|+.||........ ....... ....+....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~-----~~~~~~~~~ 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKS-----NFQPPKLKD 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhcc-----CCCCCcccc
Confidence 1 22345788999999874 45688999999999999999999999865432211 1111111 111111111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.......+.+++.+|+..+| +|||+++|++
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 -KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11223468899999999999 9999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=325.81 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=198.9
Q ss_pred eeccCCcEEEEEEEEc-CCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHH
Q 009644 244 IIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQN 319 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~ 319 (530)
+||+|.||+||-|+.. +...+|||.+..+. .+-+..|+.+.++++|.|||+++|.|.+++++-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999944 45568999877654 3457889999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeEEEeecCCcccccCCCC-cCc
Q 009644 320 HLYDSEGLPIGKL--TMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKLVTGSHH-AGS 395 (530)
Q Consensus 320 ~l~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~~~~~~~~-~~~ 395 (530)
+|+..-+ ++ ++..+-.+.+||++||.|||+ +.|||||||-.|+|++ -.|.+||+|||-++.+..-.. ..+
T Consensus 662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHhccC----CCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9987643 45 788888999999999999999 6999999999999997 478999999999987755433 345
Q ss_pred ccccccccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 396 TSAVDCFLDPELNLSK--NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 396 ~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
..||..|||||++..+ .|+.++|||||||++.||.||++||....+.. ....++.. -+.-++.+.+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGm--------yKvHP~iPeels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGM--------YKVHPPIPEELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhhcc--------eecCCCCcHHHH
Confidence 6799999999999754 58899999999999999999999998654332 22222211 112234566778
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+...++++|+.++| +||++.++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 889999999999999 9999999986
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.94 Aligned_cols=249 Identities=19% Similarity=0.315 Sum_probs=197.8
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||++... ++..+|+|.+... ....+.+|++++.+++|+||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999965 6889999976532 245789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|..++..... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999999875321 23689999999999999999999963 489999999999999999999999999997654322
Q ss_pred CcCcccccccccCccccCCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 392 HAGSTSAVDCFLDPELNLSK------NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||.................. ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~ 227 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG---------DP 227 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc---------CC
Confidence 2233467789999998543 3588999999999999999999999754322211111111111 01
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+......+.+++.+|++.+| +||++.+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11222345678899999999998 9999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.08 Aligned_cols=249 Identities=16% Similarity=0.216 Sum_probs=189.6
Q ss_pred cceeeccC--CcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 241 EINIIGEG--SFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 241 ~~~~LG~G--~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.+++||+| +||+||++.. .+++.||+|++... ..+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999984 57899999987643 2245678999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999975422 258999999999999999999999 5999999999999999999999999987544321110
Q ss_pred --------cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 393 --------AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 393 --------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||....... ....... .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~--~~~~~~~~ 232 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN--GTVPCLLD 232 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhc--CCcccccc
Confidence 112235667999999875 468999999999999999999999997543211 1111110 00000000
Q ss_pred -------------------c------------------cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 463 -------------------K------------------TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 463 -------------------~------------------~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ............+.+++.+|++.+| +|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000111234578899999999999 9999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=306.57 Aligned_cols=248 Identities=19% Similarity=0.348 Sum_probs=198.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|++.+.||.|+||.||+|.. .++..+|+|..... ..+.|.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46788889999999999999996 46788999986543 345789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999987643 268999999999999999999999 599999999999999999999999999987653322
Q ss_pred C-cCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 392 H-AGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
. .....++..|+|||.+. ...++.++||||||+++|||++|+.||...... .......... .+.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~------~~~~ 228 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKILKSE------PPTL 228 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHHhcCC------CCCc
Confidence 1 22334788899999874 345788999999999999999999999754321 2222221110 0111
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..+......+.+++.+||+.+| +||++.+|++.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122234578899999999999 99999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.88 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=184.9
Q ss_pred eeccCCcEEEEEEEEcCC---CEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 244 IIGEGSFGLAYKGLLQDG---SLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
.||+|+||.||+|...++ ..+++|..... ..+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999985443 24566654432 24579999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC---Cc
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH---HA 393 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~---~~ 393 (530)
|.+++...... ...++...+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++....... ..
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999864321 1256777888999999999999999 599999999999999999999999999986432211 11
Q ss_pred CcccccccccCccccCC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 394 GSTSAVDCFLDPELNLS-------KNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ......+... ......++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~-~~~~~~~~~~ 234 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKD-QQVKLFKPQL 234 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhh-cccccCCCcc
Confidence 23346778999998743 345789999999999999997 4667754322 2222222221 1122223322
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
.. .....+.+++..||. +| +||++++|++.|.
T Consensus 235 ~~---~~~~~~~~l~~~c~~-~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 EL---PYSERWYEVLQFCWL-SPEKRATAEEVHRLLT 267 (268)
T ss_pred CC---CCcHHHHHHHHHHhh-CcccCCCHHHHHHHhc
Confidence 21 233567888899994 56 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.60 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=195.4
Q ss_pred CccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
|...+.||+|+||.||+|... .+..+|+|.+... ..+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456689999999999999853 3578999986542 3457889999999999999999999886532
Q ss_pred ceeEEeeccCCCChHHHhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSE-GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
..++++||+++|+|.+++.... ......+++.....++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECccc
Confidence 2478999999999998875432 1111257899999999999999999999 699999999999999999999999999
Q ss_pred CcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 383 LLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 383 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
+++....... .....++..|++||.+....++.++||||||+++|||++ |++||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~- 234 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGNRL- 234 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCcC-
Confidence 9986643221 112234567999999988889999999999999999999 8888865432 1222222211110
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.........+.+++.+|+..+| +|||+.++++.|+++
T Consensus 235 --------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 --------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112334689999999999998 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=342.49 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=196.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEee--cCcee
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQL 306 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~ 306 (530)
..++|.+.+.||+|+||.||++.. ..+..+|+|.+.. .....|..|+.++.+++|||||++++++.. ...++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 356899999999999999999995 4567888887653 234578999999999999999999998854 35689
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCeeecCCCCCcEEEcC---------
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV-----PPLFHMHFRTSNVLLEE--------- 372 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~ivHrDLk~~NILl~~--------- 372 (530)
|||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.. ++||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999975321 1136899999999999999999999842 35999999999999964
Q ss_pred --------CCeEEEeecCCcccccCCCCcCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 009644 373 --------NYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSN 442 (530)
Q Consensus 373 --------~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 442 (530)
...+||+|||+++.+..........+|+.|+|||++.. ..++.++|||||||+||||+||+.||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 23589999999987654433444568999999999854 4589999999999999999999999975432
Q ss_pred chHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 443 SDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...++..+..... ..+ ......+.+++..||..+| +||++.|++.
T Consensus 249 -~~qli~~lk~~p~------lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 -FSQLISELKRGPD------LPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -HHHHHHHHhcCCC------CCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1222222221110 011 1224678899999999999 9999999984
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.77 Aligned_cols=259 Identities=15% Similarity=0.247 Sum_probs=193.4
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--cHHHHHHHHHHHHhcCC------CCcceEEEEEee
Q 009644 231 ELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--QIQNFLHEVKHIARVHH------RHLVKLVGFCEE 301 (530)
Q Consensus 231 el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H------~nIv~l~g~~~~ 301 (530)
++...+++|++.+.||+|+||.||+|.. ..++.||||++... ...++..|++++.+++| .+++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3444578899999999999999999985 45788999987542 23456778888877754 458899998875
Q ss_pred c-CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC------
Q 009644 302 N-HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY------ 374 (530)
Q Consensus 302 ~-~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~------ 374 (530)
. .+.++|||++ +++|.+++.... .+++..+..|+.|++.||+|||+. .+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccc
Confidence 4 5788999988 778999887542 689999999999999999999972 3999999999999998765
Q ss_pred ----------eEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch
Q 009644 375 ----------TAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444 (530)
Q Consensus 375 ----------~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~ 444 (530)
.+||+|||++..... ......+|..|+|||++.+..|+.++|||||||++|||++|+.||......+.
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998864322 23345688999999999999999999999999999999999999976543322
Q ss_pred HHHHHHHHhhc-----------------cCCccccccccc------------cchhHHHHHHHHHHHcccCCC-CCCCHH
Q 009644 445 QNLILQVKRSC-----------------DLGKYVDKTLGE------------QTVGAATEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 445 ~~~~~~~~~~~-----------------~~~~~~d~~l~~------------~~~~~~~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
...+....... .....+.+.... ........+.+++.+||..|| +|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 22222211000 000000000000 000113457799999999999 999999
Q ss_pred HHHH
Q 009644 495 QIAG 498 (530)
Q Consensus 495 eVl~ 498 (530)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.25 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=199.2
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||++.. .+++.+++|.+.. ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999984 5688999997653 2345789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999875432 257899999999999999999999 599999999999999999999999999998664432
Q ss_pred Cc-CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 HA-GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.. ....++..|+|||+..+..++.++|+||||+++|||++|+.||..... .......... .. ...+.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~~~-~~--------~~~~~ 223 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLVLKIIRG-SY--------PPVSS 223 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHHHHHhcC-CC--------CCCcc
Confidence 21 223467789999999888999999999999999999999999875422 2222222211 00 11122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+|++.+| +||++.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 335678999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=308.99 Aligned_cols=245 Identities=17% Similarity=0.356 Sum_probs=199.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..+|...+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788889999999999999994 57899999987542 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998643 57889999999999999999999 599999999999999999999999999998654332
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ . ...... . .+.+ ..+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~-~~~~~~-~-----~~~~-~~~~ 239 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L-YLIATN-G-----TPEL-QNPE 239 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--e-eeeccC-C-----CCCC-CCcc
Confidence 2 2233577889999999988899999999999999999999999975432111 0 000000 0 0000 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+||+.+| +||++.+|++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234567899999999998 8999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.31 Aligned_cols=246 Identities=20% Similarity=0.341 Sum_probs=198.8
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee--cCceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~LV~ 309 (530)
+|+..+.||.|+||.||++.. .++..+|+|.+... ..+.+..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999984 56788999976532 34568899999999999999999998754 45678999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH-----SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
||+++++|.+++..... ....+++..++.++.|++.||.||| + .+++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPG--NTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCcccc--CcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999976421 1237899999999999999999999 6 69999999999999999999999999999
Q ss_pred ccccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 385 KLVTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 385 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
........ .....++..|+|||.+....++.++||||||+++|+|++|+.||.... ........... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~-~------- 226 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEG-K------- 226 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcC-C-------
Confidence 87654432 233457888999999998889999999999999999999999997543 12222222211 1
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+......+.+++.+|++.+| +|||+.+|++
T Consensus 227 -~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 -FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111223345688999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.82 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=209.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcC--------CCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEe
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQD--------GSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCE 300 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~ 300 (530)
...++..+.+.||+|.||.|++|.... ...||||.+... +.+.+..|+++|..+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 334555566799999999999998431 346899987643 456899999999999 6999999999999
Q ss_pred ecCceeEEeeccCCCChHHHhhccC---------CCCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 009644 301 ENHQQLLIYDYIPNGNVQNHLYDSE---------GLPIG--KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVL 369 (530)
Q Consensus 301 ~~~~~~LV~Ey~~~GsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NIL 369 (530)
.++..++|+||+..|+|.++|+..+ ..... .++..+.+.++.|||.||+||++ .++|||||.++|||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARNVL 450 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhhEE
Confidence 9999999999999999999999876 11111 38999999999999999999999 59999999999999
Q ss_pred EcCCCeEEEeecCCcccccCCCCcC--ccc--ccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCch
Q 009644 370 LEENYTAKVSDYGLLKLVTGSHHAG--STS--AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSD 444 (530)
Q Consensus 370 l~~~~~~KI~DFGla~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~ 444 (530)
+.++..+||+|||+|+......... ... -+..|||||.+....|+.|||||||||+||||+| |..||..-.. .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence 9999999999999999765443322 122 2446999999999999999999999999999999 8888875321 2
Q ss_pred HHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 445 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
..+....+...++ +.+..+..++.++++.||+.+| +||++.++++.++..+.
T Consensus 529 ~~l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 EELLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 2333344333221 2345567889999999999998 99999999999999654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.08 Aligned_cols=246 Identities=18% Similarity=0.403 Sum_probs=198.6
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
+|+..+.||+|+||.||+|. ..+++.+|+|.+... ..+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47778999999999999998 467889999987532 23578999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKL 386 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~ 386 (530)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997642 68899999999999999999999 5999999999999998775 699999999877
Q ss_pred ccCCCC-----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 387 VTGSHH-----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 387 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
...... .....++..|+|||.+.+..++.++||||+|+++|||++|..||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----- 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----
Confidence 643211 1223467789999999888899999999999999999999999975443222222222111100
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+......+.+++.+|+..+| +|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011223345688999999999998 9999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.58 Aligned_cols=247 Identities=19% Similarity=0.289 Sum_probs=209.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcC-CCCcceEEEEEeecCcee
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~ 306 (530)
....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.. ...+.+|+++|+++. |||||.+++++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999955 49999999876543 357899999999998 999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CeEEEeecC
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN----YTAKVSDYG 382 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~----~~~KI~DFG 382 (530)
+|||++.+|.|.+.+... .+++.....++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999864 28999999999999999999999 599999999999999643 579999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
++............+||+.|+|||++....|+..+||||.||++|.|++|.+||.......... .+... +. .+-
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~-~~-~f~- 258 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRG-DF-DFT- 258 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcC-CC-CCC-
Confidence 9998877555667789999999999999999999999999999999999999998765433322 22211 11 111
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+........+.+++..++..+| +|+|+.++++
T Consensus 259 ---~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 259 ---SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 12344456788899999999998 9999999998
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.44 Aligned_cols=245 Identities=28% Similarity=0.491 Sum_probs=198.2
Q ss_pred CccceeeccCCcEEEEEEEEcC-----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 239 FSEINIIGEGSFGLAYKGLLQD-----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
|++.+.||+|+||.||++...+ +..+|+|..... ..+.+..|++++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456899999999999999654 378999987644 3457899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999976432 128999999999999999999999 5999999999999999999999999999987654
Q ss_pred CCCcC--cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SHHAG--STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
..... ...++..|+|||.+....++.++||||+|+++|||++ |.+||..... .............
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~--------- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRL--------- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCC---------
Confidence 32211 1236678999999988889999999999999999998 7888765322 2222322221110
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
......+..+.+++.+|+..+| +|||+.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112245678999999999998 999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.45 Aligned_cols=251 Identities=21% Similarity=0.358 Sum_probs=195.7
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
+|+..+.||+|+||.||+|.. .+++.|++|.+.... ...+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999995 468899999876432 23567899999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997643 268999999999999999999999 599999999999999999999999999998765
Q ss_pred CCCC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-----------
Q 009644 389 GSHH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC----------- 455 (530)
Q Consensus 389 ~~~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~----------- 455 (530)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|.++|........ ........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhc
Confidence 4322 222345677999998754 5678999999999999999999887765433211 11111100
Q ss_pred -cCCccc------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -DLGKYV------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -~~~~~~------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...... ..............+.+++.+|+..+| +|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000 001111123345688999999999999 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.79 Aligned_cols=253 Identities=19% Similarity=0.336 Sum_probs=194.6
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|+. .+++.+|+|.+... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 578889999999999999985 46889999986532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+. ++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689998875432 368999999999999999999999 599999999999999999999999999987654322
Q ss_pred C-cCcccccccccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--------------
Q 009644 392 H-AGSTSAVDCFLDPELNLSKN-YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-------------- 455 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-------------- 455 (530)
. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||....... ..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 12233577899999876544 6889999999999999999999997543221 1111111000
Q ss_pred ----cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 ----DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ----~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+....+..........+.+++.+|++.+| +|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000111111111111233567899999999999 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.13 Aligned_cols=235 Identities=18% Similarity=0.297 Sum_probs=184.9
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhc---CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 245 IGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARV---HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 245 LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l---~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
||+|+||.||+|+. .+++.||+|++.... ...+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999995 458899999876432 23456677777665 699999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCc
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHA 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~ 393 (530)
|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999987542 68999999999999999999999 59999999999999999999999999999764322 223
Q ss_pred CcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 GSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....||..|+|||++.+. .++.++|||||||++|||+||+.||..... .......... .. . +.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~~~-~~-~-----~~~--~~~ 221 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIAFG-KV-R-----FPK--NVL 221 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHHcC-CC-C-----CCC--ccC
Confidence 345688999999998754 489999999999999999999999975432 1222222111 00 0 100 112
Q ss_pred HHHHHHHHHHcccCCC-CCCC----HHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPS----MRQIAG 498 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt----~~eVl~ 498 (530)
...+.+++.+|++.+| +||+ +.++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3577899999999999 8984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.57 Aligned_cols=243 Identities=24% Similarity=0.394 Sum_probs=193.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
...|+..+.||+|+||.||+|.. .+++.||+|.+... ..+++.+|++++++++||||++++++|.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35578889999999999999995 46889999976522 235688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+. |+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 68877776433 268999999999999999999999 599999999999999999999999999987654
Q ss_pred CCCCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
.. ....++..|+|||++. ...++.++||||||+++|||+||+.||..... .......... .. +.+
T Consensus 167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~-~~-----~~~ 234 (307)
T cd06607 167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQN-DS-----PTL 234 (307)
T ss_pred CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcC-CC-----CCC
Confidence 32 2334677899999874 46688999999999999999999999865422 1111111111 00 111
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
........+.+++.+||..+| +||++.+|+..
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 --SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 112234678999999999998 99999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=305.87 Aligned_cols=255 Identities=18% Similarity=0.375 Sum_probs=196.2
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|..+ +++.+|+|++... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999965 5889999986532 23468899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.++..... .+++.++..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765432 58999999999999999999999 59999999999999999999999999999876443
Q ss_pred CC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--------cCCcc
Q 009644 391 HH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--------DLGKY 460 (530)
Q Consensus 391 ~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~ 460 (530)
.. .....++..|+|||++.+ ..++.++||||||+++|||++|++||...........+....... ....+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22 122346778999999865 457889999999999999999999987543211111111100000 00000
Q ss_pred ----ccccc------cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 ----VDKTL------GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ----~d~~l------~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.. ..........+.+++.+||+.+| +||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 00112345678999999999999 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.06 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=201.7
Q ss_pred cCHHHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 227 LTILELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
++..++..++++|+..+.||+|+||.||++.. .+++.+|+|..... ....+.+|+.++.++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 44455666789999999999999999999995 56889999987643 235678899999999 899999999998653
Q ss_pred -----CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 303 -----HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 303 -----~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
+..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998864321 11368999999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCC-CcCcccccccccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 378 VSDYGLLKLVTGSH-HAGSTSAVDCFLDPELNLSK-----NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 378 I~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
|+|||+++...... ......++..|+|||.+... .++.++|||||||++|||++|+.||...... ..+...
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKI 245 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHH
Confidence 99999998654322 12234577889999987543 3689999999999999999999999754321 111221
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... ...... ........+.+++.+|++.+| +||++.++++
T Consensus 246 ~~~-~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRN-PPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcC-CCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 111111 111233578999999999998 9999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=299.07 Aligned_cols=243 Identities=16% Similarity=0.300 Sum_probs=192.3
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc--------ccHHHHHHHHHHHHhcCCCCcceEEEEEeec--Cce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ--------TQIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~--------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 305 (530)
++|+..+.||+|+||.||+|.. .++..||+|.+.. ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788889999999999999995 4588999997642 1235688899999999999999999988664 467
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++.... .+++...+.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987542 57888999999999999999999 599999999999999999999999999998
Q ss_pred cccCCC----CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 386 LVTGSH----HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 386 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+...... . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~-~----~ 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQ-P----T 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcC-C----C
Confidence 653211 112234778899999998888999999999999999999999999744211 111111111 0 0
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ...+......+.+++.+|+. +| +||++++|++
T Consensus 227 ~---~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 N---PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C---CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 11233344677888889985 55 9999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.63 Aligned_cols=239 Identities=23% Similarity=0.378 Sum_probs=197.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++.. .+++.+|+|.+... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688889999999999999995 46889999987542 3456889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .++...+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997652 68999999999999999999999 6999999999999999999999999999987654
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... . . ..+
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~------~---~~~ 218 (290)
T cd05580 154 R--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKILEG-K------V---RFP 218 (290)
T ss_pred C--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcC-C------c---cCC
Confidence 3 2334578889999999888899999999999999999999999975431 1111221111 0 0 111
Q ss_pred hhHHHHHHHHHHHcccCCC-CCC-----CHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRP-----SMRQIA 497 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl 497 (530)
......+.+++.+||..+| +|| +++|++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 2224678899999999998 898 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.91 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=197.2
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|.. .+++.+++|++.... ...+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999995 468899999876432 45789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+ +++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987643 268999999999999999999999 599999999999999999999999999998765432
Q ss_pred C--cCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc------------
Q 009644 392 H--AGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------------ 456 (530)
Q Consensus 392 ~--~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------------ 456 (530)
. .....++..|+|||.+.+. .++.++||||+|+++|||+||.++|....... ..........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccC
Confidence 1 2234578889999998654 46899999999999999999988876543221 1111111000
Q ss_pred CC---cccc-----ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 LG---KYVD-----KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ~~---~~~d-----~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+. .... ..+.+...+....+.+++.+|+..+| +|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0000 00111112334788999999999999 9999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=300.73 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=198.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~LV~ 309 (530)
++|+..+.||.|++|.||++.. .+++.+|+|.+... ....+.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4678889999999999999996 45788999986643 245689999999999999999999998653 4689999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++++|.+++..... ....++...+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998764322 12368899999999999999999999 5999999999999999999999999999876533
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CchHHHHHHHHhhccCCccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHS--NSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........+.... ......+. . .
T Consensus 158 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~-~ 233 (287)
T cd06621 158 SL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDE-P-G 233 (287)
T ss_pred cc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-CchhhccC-C-C
Confidence 22 1233467789999999989999999999999999999999999976532 1112222222211 11111000 0 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.+++.+||+.+| +|||+.||++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111234678999999999998 9999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.81 Aligned_cols=247 Identities=20% Similarity=0.410 Sum_probs=194.6
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-------------cHHHHHHHHHHHHhcCCCCcceEEEEEeecC
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-------------QIQNFLHEVKHIARVHHRHLVKLVGFCEENH 303 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-------------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~ 303 (530)
+|...+.||+|+||.||+|.. .+++.+|+|.+... ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 456678999999999999984 46889999975421 1245788999999999999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+++|+|.+++... +.+++..+..++.|++.||.|||+ ++++||||+|+||++++++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 268899999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCC---cCcccccccccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 384 LKLVTGSHH---AGSTSAVDCFLDPELNLSKN--YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 384 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
++....... .....++..|+|||.+.... ++.++||||||+++||+++|..||...... ......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~-~~~ 230 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNK-RSA 230 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhcc-ccC
Confidence 976543211 12234678899999987654 889999999999999999999998643221 111111111 001
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..++. .........+.+++.+|+..+| +|||+++|++
T Consensus 231 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111 1122345688999999999999 9999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.88 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=192.7
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHH-HHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKH-IARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~i-l~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||++... +|..||+|++... ...++..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999954 6899999987543 22456667765 556699999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ |+|.+++....... ..+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 78988886532221 3689999999999999999999982 28999999999999999999999999999876443
Q ss_pred CCcCcccccccccCccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 HHAGSTSAVDCFLDPELNLS----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... .......... . .+.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-~-----~~~~~ 229 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEE-P-----SPQLP 229 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhc-C-----CCCCC
Confidence 32233457788999998754 45789999999999999999999999643221 1111111111 0 01111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+..+.+++.+|+..+| +|||+.+|++
T Consensus 230 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 --AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11234578999999999999 9999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.74 Aligned_cols=259 Identities=18% Similarity=0.293 Sum_probs=193.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCc-----
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQ----- 304 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~----- 304 (530)
++|+..+.||+|+||.||+|.. .+++.||+|..... ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688889999999999999995 46889999976532 235688999999999 56999999999977665
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGL 383 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGl 383 (530)
.++||||+++ +|.+++..........+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 89998875433222368999999999999999999999 69999999999999998 89999999999
Q ss_pred cccccCCCC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc-----
Q 009644 384 LKLVTGSHH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD----- 456 (530)
Q Consensus 384 a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~----- 456 (530)
++....... .....++..|+|||++.+ ..++.++||||||+++|||++|..||...........+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 986533211 122345778999998764 4579999999999999999999999975432211111111000000
Q ss_pred ----------CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 ----------LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ----------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+..........+.+++.+|+..+| +|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000011112345678999999999999 9999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.56 Aligned_cols=252 Identities=18% Similarity=0.289 Sum_probs=193.1
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|+. .+|..+|+|.+... ....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999999995 46889999987532 224678899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ ++|.+++.... ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 58888876543 268999999999999999999999 599999999999999999999999999998654322
Q ss_pred C-cCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------cC
Q 009644 392 H-AGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------DL 457 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------~~ 457 (530)
. .....++..|+|||++.+. .++.++|||||||++|||+||+.|+....... .......... ..
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhc
Confidence 1 2233467789999988664 47899999999999999999998875433221 1111111000 00
Q ss_pred Ccccc-ccc------cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYVD-KTL------GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d-~~l------~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..... +.. .........++.+++.+|++.+| +|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 000 00112234678899999999999 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=302.00 Aligned_cols=255 Identities=19% Similarity=0.331 Sum_probs=197.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|... +++.|++|.+... ..+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999964 5789999976532 24578999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++++.+..+.... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 258999999999999999999999 59999999999999999999999999999876544
Q ss_pred C--CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------
Q 009644 391 H--HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------ 455 (530)
Q Consensus 391 ~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------ 455 (530)
. ......++..|+|||++... .++.++||||||+++|||++|++||......+............
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 3 22234467789999999887 88999999999999999999999997543221111111100000
Q ss_pred -----cCCcccccc-ccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -----DLGKYVDKT-LGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -----~~~~~~d~~-l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......++. ... .+...+.++.+++.+||..+| +|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 000 112235789999999999998 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.63 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=193.1
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||++.. .+++.+|+|.+... ....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999995 45789999987542 3456889999999996 99999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+. ++|.++...........+++..+..++.|++.||+|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 85 4655543211001113689999999999999999999973 489999999999999999999999999998765443
Q ss_pred CcCcccccccccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc-
Q 009644 392 HAGSTSAVDCFLDPELNLSK---NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE- 467 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~- 467 (530)
......++..|+|||++... .++.++||||||+++|||++|+.||.... ........... ...+.+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~---~~~~~~~~~ 234 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK---GDPPILSNS 234 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC---CCCCcCCCc
Confidence 33444578889999998765 68999999999999999999999997543 11111111100 00111111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
........+.+++.+|++.+| +|||+.+|++.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345688999999999999 99999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.93 Aligned_cols=245 Identities=20% Similarity=0.358 Sum_probs=206.5
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEcc-cccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHL-QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~-~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
-|.++.+||+|+||.||++. ...|+.+|+|.+. ....++..+|+.||.+...|++|++||.+.....+|+|||||..|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 46677899999999999999 4568999999876 456899999999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-CcC
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-HAG 394 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-~~~ 394 (530)
++.+.++.++ .+|++.++..+.++.++||+|||.. .-||||||+.||||+.+|.+||+|||.|..+++.- ...
T Consensus 114 SiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 114 SISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999998765 3899999999999999999999995 77999999999999999999999999998776543 234
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...||+.|||||++..-.|+.++||||+|++..||..|++||..-+.-.. +. -+.....| .-..+..-+.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IF------MIPT~PPP-TF~KPE~WS~ 257 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IF------MIPTKPPP-TFKKPEEWSS 257 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eE------eccCCCCC-CCCChHhhhh
Confidence 55699999999999999999999999999999999999999975543210 00 11111111 1123455567
Q ss_pred HHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 475 EMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
++.++++.|+-..| +|-|+.++++
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 89999999999998 9999998764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=294.17 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=204.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|++|.||++... +++.+++|+.... ..+.+.+|++.+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999965 4889999987654 246799999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS-LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
+++++|.+++... ..++...+..++.|++.||+|||+ . +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~--~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC--CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 268999999999999999999998 5 9999999999999999999999999999876543
Q ss_pred CCcC-cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 HHAG-STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.... ...++..|+|||.+....++.++||||||+++|||+||+.||.................. .. ...+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~--------~~~~ 224 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PP--------PSLP 224 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CC--------CCCC
Confidence 3222 344678899999999889999999999999999999999999765432222333332211 11 1111
Q ss_pred hh-HHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 470 VG-AATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 470 ~~-~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.. .+..+.+++.+|+..+| +|||+.++++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22 44689999999999998 99999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.97 Aligned_cols=242 Identities=22% Similarity=0.402 Sum_probs=197.1
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
-|+..+.||+|+||.||+|.. .++..+|+|..... ..+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999985 46789999986532 2356889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG------PLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998642 58899999999999999999999 6999999999999999999999999999876643221
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||.+.+..++.++|+|||||++|||++|..||..... .......... . .+ .....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~-----~~---~~~~~ 224 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKN-N-----PP---TLEGN 224 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcC-C-----CC---CCCcc
Confidence 1223467789999999888899999999999999999999999864332 1112211111 0 01 11223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....+.+++.+|++.+| +||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 34678899999999999 99999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=302.18 Aligned_cols=255 Identities=20% Similarity=0.352 Sum_probs=193.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||+|..+ +++.||+|.+.... ...+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999954 67899999865322 24577899999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ ++|.+++..... .+++.....++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 599998876432 67899999999999999999999 599999999999999999999999999987543221
Q ss_pred -CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch-HHHHHHHHhhc---------cCCc
Q 009644 392 -HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-QNLILQVKRSC---------DLGK 459 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-~~~~~~~~~~~---------~~~~ 459 (530)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+....... ....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122235778999998865 5589999999999999999999999965432111 01111000000 0000
Q ss_pred c--------cccccccc--chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 Y--------VDKTLGEQ--TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 ~--------~d~~l~~~--~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ....+... .......+.+++.+|++.+| +|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 01112577899999999999 9999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.68 Aligned_cols=249 Identities=18% Similarity=0.251 Sum_probs=197.9
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++... .++.|++|.+... ..+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999954 5788999987643 2346789999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999997642 68899999999999999999999 5999999999999999999999999999874211
Q ss_pred CC----------------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 390 SH----------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 390 ~~----------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
.. ......++..|+|||.+....++.++|+||||+++|||++|+.||..... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~ 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVIS 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Confidence 00 00112356789999999888999999999999999999999999975432 122222111
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
. . ...+. .....+..+.+++.+|++.+| +||++.++.+.|+.
T Consensus 231 ~-~---~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 D-D---IEWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c-c---cCCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 1 00111 111234678999999999999 99998777766665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.28 Aligned_cols=245 Identities=19% Similarity=0.290 Sum_probs=203.0
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEE-----cccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~-----~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
+++|++.+.||+|.|+.||++. ...|+.+|+|. +.....+++.+|++|.+.|+|||||+|.....+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4677888899999999999987 45677777664 44556788999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLKL 386 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~~ 386 (530)
|+|.+|+|..-+-... ..++...-+.++||+.+|.|.|. ++|||||+||.|+|+.+ .--+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999987665542 57788888999999999999999 69999999999999964 34689999999998
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-cCCccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-DLGKYVDKTL 465 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l 465 (530)
+.+........||++|||||++...+|+..+|||+.||+||-|+.|.+||.+.... .+.+++.... +...
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g~yd~~~------ 233 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAGAYDYPS------ 233 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhccccCCCC------
Confidence 88655566778999999999999999999999999999999999999999865432 3344443321 1111
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIA 497 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl 497 (530)
.+......+..+++.+++..+| +|.|+.|.+
T Consensus 234 -~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 234 -PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1334445678899999999999 999998866
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=295.43 Aligned_cols=249 Identities=20% Similarity=0.365 Sum_probs=200.6
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||.|+||.||+|.. .++..+++|++... ..+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999994 46788999987532 346789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 1368999999999999999999999 599999999999999999999999999998765432
Q ss_pred Cc-----CcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 392 HA-----GSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 392 ~~-----~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
.. ....++..|+|||++... .++.++|+||||+++|||++|+.||....... ........ .++.+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~------~~~~~ 227 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQN------DPPSL 227 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcC------CCCCc
Confidence 21 223477889999998776 78999999999999999999999997543321 11111111 01111
Q ss_pred cc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. ........+.+++.+|+..+| +|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 112345678999999999999 9999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=298.86 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=191.9
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCcceEEEEEeec--CceeEEee
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHLVKLVGFCEEN--HQQLLIYD 310 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~--~~~~LV~E 310 (530)
|+..+.||+|+||.||+|.. .++..+|+|..... ......+|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999994 46889999986642 1234567999999985 99999999999887 88999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ |+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||+|+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 68888887543 268999999999999999999999 59999999999999999 99999999999876544
Q ss_pred CCcCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh--------hcc---CC
Q 009644 391 HHAGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR--------SCD---LG 458 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~--------~~~---~~ 458 (530)
.......++..|+|||++. ...++.++|||||||++|||++|..||......+.......... ... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 3333445778899999765 45678999999999999999999999976433221111111000 000 00
Q ss_pred cc-----ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 KY-----VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ~~-----~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. ....+.......+..+.+++.+|++.+| +|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 0000011112345789999999999999 9999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=294.50 Aligned_cols=245 Identities=20% Similarity=0.379 Sum_probs=196.6
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|.. .++..+++|.+... ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477789999999999999995 46889999986532 346789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997642 57889999999999999999999 599999999999999999999999999998764432
Q ss_pred CcC-----cccccccccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 392 HAG-----STSAVDCFLDPELNLSKN---YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 392 ~~~-----~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
... ...++..|+|||++.... ++.++||||||+++|||++|+.||...... .......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~~------~~~ 225 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGAG------HKP 225 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhcC------CCC
Confidence 211 234677899999988766 889999999999999999999999754321 1111111111 011
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.++. .......+.+++.+|++.+| +|||+.+++.
T Consensus 226 ~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 11224677899999999998 9999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=296.70 Aligned_cols=250 Identities=20% Similarity=0.347 Sum_probs=199.0
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||++... +++.+++|.+... ..+.+.+|++++++++||||+++++++..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777789999999999999965 6888999986543 235689999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++.... ..++...+..++.|++.||+|||+. .+++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 2688999999999999999999992 399999999999999999999999999987654322
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.. ...++..|+|||.+.+..++.++||||||+++|||++|+.||........ ............ ..+.+. ...
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~---~~~~~~--~~~ 228 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE---PPPRLP--SGK 228 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC---CCCCCC--hhh
Confidence 21 25577889999999989999999999999999999999999975432111 111111111000 001110 011
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+.+++.+|+..+| +|||+.+++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 44678999999999999 9999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.28 Aligned_cols=243 Identities=16% Similarity=0.305 Sum_probs=194.4
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
|.....||+|+||.||++.. .++..||+|.+... ..+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33346799999999999985 46889999986542 235688999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-c
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-A 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-~ 393 (530)
++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ .
T Consensus 104 ~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 104 GALTDIVTHT------RMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999988542 57899999999999999999999 5999999999999999999999999999876533221 2
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....++..|+|||.+....++.++||||||+++|||++|+.||...... ......... .++.+.. .....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~------~~~~~~~-~~~~~ 245 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRDN------LPPRVKD-SHKVS 245 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc------CCCcccc-ccccC
Confidence 2345788899999998889999999999999999999999999754321 111211111 1111111 11223
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..+.+++.+|+..+| +|||++++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 568889999999999 99999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=299.45 Aligned_cols=255 Identities=18% Similarity=0.307 Sum_probs=194.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++++|...+.||+|+||.||+|.. .++..+++|.+.... ...+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357889999999999999999985 468899999875432 236788999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+. ++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 78877776432 257888899999999999999999 5999999999999999999999999999976433
Q ss_pred CC-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------
Q 009644 390 SH-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------ 455 (530)
Q Consensus 390 ~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------ 455 (530)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+.......
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence 22 1223346788999999865 45889999999999999999999999754321 11111111100
Q ss_pred cCCccccc--------cccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDK--------TLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~--------~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........ .+.. ........+.+++.+|+..+| +|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000 000123577899999999998 9999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=298.95 Aligned_cols=254 Identities=17% Similarity=0.304 Sum_probs=194.3
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
|+..+.||+|++|.||+|.. .+|..||+|++... ....+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999995 47899999986532 2356889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
+ ++|.+++..... ..+++..+..++.|++.||+|||+ ++++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 799999876432 268999999999999999999999 599999999999999999999999999997653221
Q ss_pred CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh-h---------------
Q 009644 392 HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR-S--------------- 454 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~-~--------------- 454 (530)
......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+..... .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223457789999987654 578999999999999999999999975432111111100000 0
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....................+.+++.+|++.+| +|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000011111111222334678899999999999 9999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.18 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=199.8
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
+|+..+.||.|+||.||++... ++..+|+|..... ..+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999964 5889999987642 34678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.+++... ..+++.++..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999764 268899999999999999999999 59999999999999999999999999999876544
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||................. ... ..+.
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~-------~~~~ 223 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADV-------LYPA 223 (258)
T ss_pred ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccc-------cCcc
Confidence 333344577789999999888899999999999999999999999986654322222211110 000 1222
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCH--HHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSM--RQIA 497 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~--~eVl 497 (530)
..+..+.+++.+||+.+| +||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 334788999999999999 99999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.70 Aligned_cols=236 Identities=22% Similarity=0.398 Sum_probs=195.6
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEE---EEE--cc--cccHHHHHHHHHHHHhcCCCCcceEEEEEeecCc--eeEEeecc
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVV---IKR--HL--QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ--QLLIYDYI 312 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~va---vK~--~~--~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~--~~LV~Ey~ 312 (530)
.+||+|+|-+||+|... +|-.|| +|. +. ....+.|..|+++|+.|+|||||++|.++.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 68999999999999953 455565 232 22 2345889999999999999999999999977655 67899999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCcccccCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~~~~ 391 (530)
..|+|..|+++.+ .++.+.+..+++||++||.|||+..|+|||||||..||+|+. .|.+||+|+|||..+...+
T Consensus 126 TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999998874 788999999999999999999998899999999999999975 5899999999999876654
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---cCCcccccccccc
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---DLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~l~~~ 468 (530)
.. +..||+.|||||++. ..|++.+||||||+.++||+|+..||..... ...++.++.... .+.++-
T Consensus 201 ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~------- 269 (632)
T KOG0584|consen 201 AK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVK------- 269 (632)
T ss_pred cc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccC-------
Confidence 43 367999999999985 8899999999999999999999999986643 234555554332 122222
Q ss_pred chhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSSRRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p~RPt~~eVl~ 498 (530)
..++.++|.+|+...++|||+.|+++
T Consensus 270 ----dPevr~fIekCl~~~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ----DPEVREFIEKCLATKSERLSAKELLK 295 (632)
T ss_pred ----CHHHHHHHHHHhcCchhccCHHHHhh
Confidence 25788999999998559999999985
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=295.51 Aligned_cols=244 Identities=25% Similarity=0.428 Sum_probs=197.3
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||+|... ++..+|+|.+... ..+.+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999954 5788999986542 345688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCcccccCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKLVTGS 390 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~~~~~ 390 (530)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999976432 257899999999999999999999 5999999999999999875 5799999999876443
Q ss_pred CCc-CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 HHA-GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
... ....++..|+|||+.....++.++||||||+++|||++|+.||..... ...+...... .+. ...
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-----~~~----~~~ 223 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQG-----YFA----PIS 223 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcc-----cCC----CCC
Confidence 221 223477889999999888899999999999999999999999864421 1222211111 111 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+|+..+| +|||+.+|++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2334578999999999998 9999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.84 Aligned_cols=241 Identities=16% Similarity=0.277 Sum_probs=194.6
Q ss_pred cceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 241 EINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
....||+|+||.||++.. .+++.+|+|.+... ..+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999985 46889999986532 34568899999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-cCc
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-AGS 395 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-~~~ 395 (530)
|.+++... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ ...
T Consensus 105 L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 105 LTDIVSQT------RLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 99987542 58899999999999999999999 5999999999999999999999999999876543221 223
Q ss_pred ccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHH
Q 009644 396 TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATE 475 (530)
Q Consensus 396 ~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 475 (530)
..++..|+|||++.+..++.++||||||+++|||++|+.||...... ......... .. +. ..........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~-~~-----~~-~~~~~~~~~~ 246 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDS-PP-----PK-LKNAHKISPV 246 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcc-CC-----CC-ccccCCCCHH
Confidence 45788999999998889999999999999999999999999754321 222222111 00 00 0111223457
Q ss_pred HHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 476 MMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 476 l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+.+++.+|++.+| +||+++++++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 8899999999998 99999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=300.25 Aligned_cols=255 Identities=19% Similarity=0.328 Sum_probs=194.8
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~LV 308 (530)
++|+..+.||+|+||.||+|... +++.+++|.+.... ...+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999965 57889999875322 23567899999999999999999998877 889999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||++ ++|.+++..... .+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 599998876432 68999999999999999999999 599999999999999999999999999998765
Q ss_pred CCC-CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh---------ccC
Q 009644 389 GSH-HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS---------CDL 457 (530)
Q Consensus 389 ~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---------~~~ 457 (530)
... ......++..|+|||.+.+. .++.++|+||||+++|||++|.+||...........+...... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 432 22234467789999988654 4689999999999999999999999754332111111100000 000
Q ss_pred C--------ccccccccc-cchh-HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 G--------KYVDKTLGE-QTVG-AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~--------~~~d~~l~~-~~~~-~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ......+.. .+.. ....+.+++.+|++.+| +|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000001111 1111 25678899999999999 9999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=296.78 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=197.9
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhc-CCCCcceEEEEEeecC------
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARV-HHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~------ 303 (530)
..+++|+..+.||+|+||.||+|... +++.+++|...... .+.+.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999964 57789999876433 46789999999999 7999999999997644
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998753311 1368999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCC-cCcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 384 LKLVTGSHH-AGSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 384 a~~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
+........ .....++..|+|||++.. ..++.++||||||+++|||++|+.||...... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~--- 233 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKIPRN--- 233 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHhhcc---
Confidence 876543221 223447888999998753 35778999999999999999999999743221 112221111
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.+ .........+.+++.+|+..+| +|||+.++++
T Consensus 234 ---~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 ---PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111 1112244678899999999999 9999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.42 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=196.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||++... ++..+|+|.+... ..+.+..|++++.+++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 4889999987643 2346889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+.+++|.+++....+ ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875432 368999999999999999999999 5999999999999999999999999999875432
Q ss_pred CCC------------------------------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 390 SHH------------------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 390 ~~~------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
... .....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 110 01224677899999999888999999999999999999999999754
Q ss_pred CCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCC----HHHHHH
Q 009644 440 HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPS----MRQIAG 498 (530)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt----~~eVl~ 498 (530)
.... ........ .. ... ........+.+++.+|+..+| +||| +.+++.
T Consensus 236 ~~~~---~~~~~~~~-~~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE---TFSNILKK-EV------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH---HHHHHhcC-Cc------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3221 11111110 00 000 111145789999999999998 9999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=298.25 Aligned_cols=242 Identities=18% Similarity=0.361 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc----ccHHHHHHHHHHHHhcC---CCCcceEEEEEeecCceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ----TQIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~----~~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.|+..+.||+|+||.||+|.. .++..+|+|.+.. ...+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999995 5688999998643 23467889999999996 999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++++|.+++... .+++.....++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998642 68899999999999999999999 5999999999999999999999999999987644
Q ss_pred CCC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 390 SHH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 390 ~~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ....... ....+.+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~------~~~~~~~~~ 224 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMMLIP------KSKPPRLED 224 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhccc------cCCCCCCCc
Confidence 322 223357788999998865 45789999999999999999999999754321 1111110 001111111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+|++.+| +||++.++++
T Consensus 225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 --NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1134678999999999998 9999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.41 Aligned_cols=258 Identities=18% Similarity=0.290 Sum_probs=193.1
Q ss_pred CCccceeeccCCcEEEEEEEEc---CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeec--Ccee
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ---DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQL 306 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~ 306 (530)
.|+..+.||+|+||.||+|... ++..+|+|.+... ..+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777899999999999999964 4789999987652 235678899999999999999999999888 7899
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----CCeEEEeecC
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE----NYTAKVSDYG 382 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~----~~~~KI~DFG 382 (530)
+||||++ ++|.+++..........++...+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999996 477777754332222368899999999999999999999 59999999999999999 9999999999
Q ss_pred CcccccCCCC----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch------HHHHHHH
Q 009644 383 LLKLVTGSHH----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD------QNLILQV 451 (530)
Q Consensus 383 la~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~------~~~~~~~ 451 (530)
+++....... .....++..|+|||.+.+ ..++.++||||||+++|||++|++||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643221 122346778999998765 4589999999999999999999999975543220 0000000
Q ss_pred Hhhc------------cCCccc-----------c-ccccc-cc--hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 452 KRSC------------DLGKYV-----------D-KTLGE-QT--VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 452 ~~~~------------~~~~~~-----------d-~~l~~-~~--~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... ...+.. + ..+.. .. .....++.+++.+|++.+| +|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 000000 0 00000 00 0234578899999999999 9999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.82 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=194.3
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeEEee
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLLIYD 310 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~LV~E 310 (530)
|+..+.||+|+||.||+|... +++.+|+|.+... ..+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999965 5789999987654 245688999999999999999999999887 88999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ ++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 58988886542 268999999999999999999999 59999999999999999999999999999876543
Q ss_pred CC--cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC---c-----
Q 009644 391 HH--AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG---K----- 459 (530)
Q Consensus 391 ~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~----- 459 (530)
.. .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+.......... .
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 222345677999997754 468999999999999999999999997654322111111111000000 0
Q ss_pred ---------cccccccccchh-HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 ---------YVDKTLGEQTVG-AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 ---------~~d~~l~~~~~~-~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+.... ....+.+++.+|+..+| +||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000010111 25678999999999999 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.63 Aligned_cols=246 Identities=20% Similarity=0.369 Sum_probs=201.4
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCC-EEEEEEcc---cccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGS-LVVIKRHL---QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-~vavK~~~---~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+-|+++..||.|+||.||++..++.. ..|.|.+. ....++|+-|++||+...||+||+|++.|...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34566678999999999999966544 44556544 345678999999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~ 391 (530)
.||..+..+..... .|+..++.-+++|++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred CCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999998877643 79999999999999999999999 6999999999999999999999999999865432 23
Q ss_pred CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 392 HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
...+..||++|||||+.. ..+|+.++||||||++|.||..+.+|...-. ...++.++.... +|.+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---pMRVllKiaKSe------PPTL- 255 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKIAKSE------PPTL- 255 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---hHHHHHHHhhcC------CCcc-
Confidence 456778999999999854 6789999999999999999999999976432 233444443321 1222
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
-.+......+.+++.+|+..+| .||++.++++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2344556788999999999999 8999999873
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.61 Aligned_cols=255 Identities=16% Similarity=0.315 Sum_probs=193.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|... +++.+|+|..... ..+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999954 6889999986532 23568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCcccccC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~~ 389 (530)
|++ ++|.+++..... ..+++..+..++.|++.||+|||+ ++++||||+|+||++++ ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 688888765432 246788888999999999999999 69999999999999985 56799999999976533
Q ss_pred CCC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc--------
Q 009644 390 SHH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK-------- 459 (530)
Q Consensus 390 ~~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 459 (530)
... .....++..|+|||++.+ ..++.++||||||+++|||+||++||......+........... ....
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSL 234 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccc
Confidence 221 122346778999998865 45789999999999999999999999764332211111111000 0000
Q ss_pred ---------cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 ---------YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 ---------~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+....+..........+.+++.+|++.+| +||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011111122334678899999999999 9999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.03 Aligned_cols=248 Identities=18% Similarity=0.299 Sum_probs=214.0
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH-----HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI-----QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.-|...+.||+|.|..|-+++ .-.|..||||++.+... .++.+|++.|+-++|||||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346666899999999999998 56899999999887654 468899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeEEEeecCCcccccC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~~~~~ 389 (530)
+-.+|+|.+|+..... .+++....+++.||+.|+.|+|.. .+|||||||+|+.+- +-|-+||.|||++-.+..
T Consensus 98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqL--HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQL--HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhh--hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999987653 689999999999999999999995 999999999998875 568999999999998888
Q ss_pred CCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.......+|...|-|||.+.+..|+ +++||||+||+||-|+.|++||......+...++...+.. .
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-------------v 238 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-------------V 238 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc-------------C
Confidence 8778888999999999999999997 6799999999999999999999977665544444433321 3
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhh
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGI 503 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i 503 (530)
+.....++.+||..|+..+| +|.|.+||+. .|+.+
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 44556899999999999999 9999999985 34443
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=300.97 Aligned_cols=245 Identities=17% Similarity=0.359 Sum_probs=198.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
++|...+.||+|+||.||+|.. .++..+++|.+... ..+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999984 46788999986532 2456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998753 57889999999999999999999 5999999999999999999999999999876543322
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||.+....++.++||||||+++||+++|+.||........ ....... . .+.. .....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~-~-----~~~~-~~~~~ 240 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATN-G-----TPEL-QNPEK 240 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehhcC-C-----CCCC-CCccc
Confidence 2233577789999999888899999999999999999999999975432111 1111100 0 0001 01122
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....+.+++.+||..+| +||++.+++..
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34578899999999998 99999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.53 Aligned_cols=253 Identities=18% Similarity=0.302 Sum_probs=201.8
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc--HHHHHHHHHHHHhcC-C-----CCcceEEEEEeecCceeEE
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVH-H-----RHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-H-----~nIv~l~g~~~~~~~~~LV 308 (530)
+|++.+.||+|+||.|.+|. .++++.||||+++... ..+-..|+.+|..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 78999999999999999999 5669999999987643 356678999999996 4 4899999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC--CeEEEeecCCccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN--YTAKVSDYGLLKL 386 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~--~~~KI~DFGla~~ 386 (530)
+|.+ .-+|+++|+.+.- ..++...+..|+.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.|..
T Consensus 267 fELL-~~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999 5599999997653 368999999999999999999999 599999999999999753 4799999999987
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---------cC
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---------DL 457 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---------~~ 457 (530)
...... ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+....+....+..+.... +.
T Consensus 341 ~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 341 ESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred cCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 654322 4456778999999999999999999999999999999998888776554444433321110 00
Q ss_pred Cccccc---------------------------------ccc-------c-cchhHHHHHHHHHHHcccCCC-CCCCHHH
Q 009644 458 GKYVDK---------------------------------TLG-------E-QTVGAATEMMELALQCVDVSS-RRPSMRQ 495 (530)
Q Consensus 458 ~~~~d~---------------------------------~l~-------~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~e 495 (530)
..+++. ..+ . .....-..+++++++|++.|| +|+|..|
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 111111 000 0 011233567999999999999 9999999
Q ss_pred HHH
Q 009644 496 IAG 498 (530)
Q Consensus 496 Vl~ 498 (530)
.++
T Consensus 499 al~ 501 (586)
T KOG0667|consen 499 ALN 501 (586)
T ss_pred Hhc
Confidence 886
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=287.50 Aligned_cols=244 Identities=19% Similarity=0.382 Sum_probs=201.7
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeEEe
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLLIY 309 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~LV~ 309 (530)
+|...+.||+|++|.||+|... ++..+++|...... .+.+.+|++++++++||||+++++.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667789999999999999965 68899999876543 56789999999999999999999999888 8899999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++++|.+++.... .+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997653 68999999999999999999999 5999999999999999999999999999987755
Q ss_pred CCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
... .....++..|+|||......++.++||||||+++|||++|..||..... ............. ..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~--------~~ 223 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGE--------PP 223 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCC--------Cc
Confidence 432 3344577889999999888899999999999999999999999976541 1111111111000 11
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+......+.+++.+|++.+| +||++.++++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1222335789999999999998 9999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.82 Aligned_cols=256 Identities=19% Similarity=0.351 Sum_probs=195.9
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+|+..+.||.|++|.||+|+.. ++..||+|.+... ..+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999964 6888999986543 2456788999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
+ |+|.+++..... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 7 589988875432 1368999999999999999999999 5999999999999999999999999999976543221
Q ss_pred -cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---------cCCcc-
Q 009644 393 -AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---------DLGKY- 460 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~- 460 (530)
.....++..|++||.+.+ ..++.++||||||+++|||++|+.||......+....+....... .....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 122346778999998765 457899999999999999999999997654322211111110000 00000
Q ss_pred ------ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 ------VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ------~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+.............+.+++.+|++.+| +||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000011112234678899999999999 9999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.02 Aligned_cols=249 Identities=19% Similarity=0.348 Sum_probs=202.4
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
..+++|+..+.||+|+||.||+|..+ ++..+++|.+.... .+.+.+|++++++++|+|++++++++...+..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34677888899999999999999965 68889999876544 5678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998753 268999999999999999999999 69999999999999999999999999998765432
Q ss_pred CC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 HH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.. .....++..|++||.+.+..++.++||||||+++|||++|+.||...... ......... ...... ..
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~~~-~~~~~~------~~ 239 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTK-GIPPLK------NP 239 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc-CCCCCc------ch
Confidence 21 12234677899999998888999999999999999999999998754321 111111111 111100 11
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+|++.+| +|||+.+|++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1234678999999999999 9999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=294.97 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=212.0
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEE
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFC 299 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~ 299 (530)
.++.....++.....+-+|.||.||+|.+.+ .+.|.+|.+... +...++.|.-.+..++|||+.++.|++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4455556678888889999999999997654 334556654432 345689999999999999999999998
Q ss_pred eec-CceeEEeeccCCCChHHHhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe
Q 009644 300 EEN-HQQLLIYDYIPNGNVQNHLYDSEG---LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT 375 (530)
Q Consensus 300 ~~~-~~~~LV~Ey~~~GsL~~~l~~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~ 375 (530)
.++ ..++++|.++.-|+|..||...++ .....++..+...++.|++.|++|||+. ++||.||.++|++||+..+
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~--~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH--GVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc--Ccccchhhhhcceehhhee
Confidence 654 578899999999999999983322 1234688889999999999999999994 9999999999999999999
Q ss_pred EEEeecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHH
Q 009644 376 AKVSDYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 376 ~KI~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 451 (530)
+||+|=.++|.+...+.. .....+..||+||.+....|+.+||||||||+||||+| |+.|+..-++.+..+.+...
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999999977554432 22335677999999999999999999999999999999 99998766554443333322
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
. ++ ..+.+++.++..++..||...| +||+++|++.-|.++...
T Consensus 515 y---Rl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 515 Y---RL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred c---ee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2 22 2456788999999999999998 999999999999987643
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=294.95 Aligned_cols=237 Identities=21% Similarity=0.337 Sum_probs=189.3
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||+|+||.||++.. .+++.+|+|.+.... .+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 468899999875422 34577899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCccc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~ 397 (530)
.+++..... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++............
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 999976532 258999999999999999999999 599999999999999999999999999998765433333345
Q ss_pred ccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHH
Q 009644 398 AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMM 477 (530)
Q Consensus 398 gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 477 (530)
++..|+|||++.+..++.++||||||+++|||++|+.||...........+...... . . ...+......+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~----~---~~~~~~~~~~~~ 226 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--M----A---VEYPDKFSPEAK 226 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--c----c---ccCCccCCHHHH
Confidence 677899999998888999999999999999999999999755432111111111100 0 0 012222356789
Q ss_pred HHHHHcccCCC-CCCCHHH
Q 009644 478 ELALQCVDVSS-RRPSMRQ 495 (530)
Q Consensus 478 ~li~~Cl~~~p-~RPt~~e 495 (530)
+++.+||+.+| +||+..+
T Consensus 227 ~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHccCChhHccCCCc
Confidence 99999999999 9995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.72 Aligned_cols=232 Identities=19% Similarity=0.283 Sum_probs=189.9
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||.|+||.||++... +++.+++|.+... ..+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 4889999986542 235688999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCccc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~ 397 (530)
.+++.... .++...+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++............
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 99997642 58899999999999999999999 699999999999999999999999999998775543233345
Q ss_pred ccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHH
Q 009644 398 AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMM 477 (530)
Q Consensus 398 gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 477 (530)
++..|++||.+....++.++|+||||+++|||++|..||...... .............. ...+......+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 224 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKGNGK--------LEFPNYIDKAAK 224 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhccCCC--------CCCCcccCHHHH
Confidence 778899999998888999999999999999999999999765431 12222222110000 012222356899
Q ss_pred HHHHHcccCCC-CCCC
Q 009644 478 ELALQCVDVSS-RRPS 492 (530)
Q Consensus 478 ~li~~Cl~~~p-~RPt 492 (530)
+++.+||+.+| +||+
T Consensus 225 ~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 225 DLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHccCChhhCcC
Confidence 99999999998 9999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.74 Aligned_cols=261 Identities=15% Similarity=0.216 Sum_probs=186.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC--CCEEEEE------------------Eccc--ccHHHHHHHHHHHHhcCCCCc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD--GSLVVIK------------------RHLQ--TQIQNFLHEVKHIARVHHRHL 292 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK------------------~~~~--~~~~~~~~E~~il~~l~H~nI 292 (530)
..++|++++.||+|+||.||++..+. +...+.| .... .....+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 1111111 1111 123467899999999999999
Q ss_pred ceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 293 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
+++++++...+..++|+|++ .++|.+++..............+...++.|++.||+|||+ .+||||||||+|||++.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECC
Confidence 99999999999999999999 5688887765321111234466778899999999999999 59999999999999999
Q ss_pred CCeEEEeecCCcccccCCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH
Q 009644 373 NYTAKVSDYGLLKLVTGSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450 (530)
Q Consensus 373 ~~~~KI~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 450 (530)
++.+||+|||+++.+..... .....||..|+|||++.+..++.++|||||||++|||++|..++...........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987654322 2234588999999999999999999999999999999998865433222111111111
Q ss_pred HHhhcc--CCccccc------------------cccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 451 VKRSCD--LGKYVDK------------------TLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 451 ~~~~~~--~~~~~d~------------------~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+..... ..++.+. .+.. ........+.+++.+|+..|| +|||+.|++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111100 0000000 0000 001122456778899999999 9999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=293.17 Aligned_cols=254 Identities=19% Similarity=0.335 Sum_probs=194.4
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhc---CCCCcceEEEEEeecCc-----
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARV---HHRHLVKLVGFCEENHQ----- 304 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l---~H~nIv~l~g~~~~~~~----- 304 (530)
|++.+.||+|+||.||+|..+ ++..+|+|..... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999975 4889999987532 123567788887766 59999999999988776
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.+++|||+. ++|.+++..... ..+++.++..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 589998875432 258999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh-cc-------
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS-CD------- 456 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-~~------- 456 (530)
.............++..|+|||++.+..++.++||||||+++|||++|.+||......+....+...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 8765443333444677899999999889999999999999999999999998754432211111111000 00
Q ss_pred ------CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 ------LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...................+.+++.+||+.+| +||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000011111122344677899999999998 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.28 Aligned_cols=245 Identities=21% Similarity=0.379 Sum_probs=200.5
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
+|+..+.||+|++|.||++... ++..+++|+.... ..+.+.+|++.+++++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999965 6888999987654 34678999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence 999999987653 268999999999999999999999 59999999999999999999999999999876544322
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....++..|+|||.+....++.++||||||+++|||++|+.||...... ........ ....... ......
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~------~~~~~~ 224 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIAT-NGPPGLR------NPEKWS 224 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHh-cCCCCcC------cccccC
Confidence 3445778899999998888999999999999999999999998754321 11111111 1111111 111124
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.+++.+|++.+| +|||+.++++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 678999999999998 9999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=295.85 Aligned_cols=242 Identities=16% Similarity=0.300 Sum_probs=195.6
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
|...+.||+|++|.||++.. .+++.+++|+.... ..+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999984 56888999976432 235688999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-c
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-A 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-~ 393 (530)
++|.+++... .+++.++..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++........ .
T Consensus 101 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 101 GALTDIVTHT------RMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred CCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999998762 58899999999999999999999 5999999999999999999999999998876543221 2
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....++..|+|||...+..++.++||||||+++|||++|+.||...... ......... . .+.. .......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~~~-~-----~~~~-~~~~~~~ 242 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDN-L-----PPKL-KNLHKVS 242 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHhc-C-----CCCC-cccccCC
Confidence 2334788899999998888999999999999999999999998754321 122222111 0 0111 1111234
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.+++.+|++.+| +|||+.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 688999999999999 9999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.61 Aligned_cols=255 Identities=18% Similarity=0.307 Sum_probs=195.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------ 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------ 302 (530)
..++|+..+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999994 57889999987532 235678899999999999999999998643
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
...++||||+. ++|.+.+.. .++..++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588887753 37888999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH-----------
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV----------- 451 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~----------- 451 (530)
+++............++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 998765433333345778899999999999999999999999999999999999754321111111000
Q ss_pred ---------Hhhc-----cCCccccccc----cc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 452 ---------KRSC-----DLGKYVDKTL----GE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 452 ---------~~~~-----~~~~~~d~~l----~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.... .......... .. ........+.+++.+|++.+| +|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000000000 00 112335678899999999999 99999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.43 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=193.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~L 307 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46788999999999999999995 468899999875322 23467899999999999999999998754 46899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+. ++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 58988887543 368999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc--C------
Q 009644 388 TGSHH-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD--L------ 457 (530)
Q Consensus 388 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~--~------ 457 (530)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|++||...........+........ .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 54321 222235677999999865 5679999999999999999999999975443222221111110000 0
Q ss_pred ----Ccc--cccccc---ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 ----GKY--VDKTLG---EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ----~~~--~d~~l~---~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... -..... .........+.+++.+|++.+| +|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000000 0011135677899999999999 9999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=297.51 Aligned_cols=248 Identities=19% Similarity=0.360 Sum_probs=193.5
Q ss_pred cCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|..++ ++.+|+|.+... ...++..|+.++.+.+ ||||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999764 889999987643 2345777888777775 9999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. ++|+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 57777765533 2689999999999999999999973 48999999999999999999999999999876544
Q ss_pred CCcCcccccccccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 HHAGSTSAVDCFLDPELNLSKN----YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.......++..|+|||.+.... ++.++||||||+++|||++|+.||...... .......... ... ..
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~-~~~-----~~- 239 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQE-EPP-----SL- 239 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcC-CCC-----CC-
Confidence 3333445677899999987554 789999999999999999999999643211 1111111111 000 00
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
........++.+++.+|+..+| +||++.+++..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111234678999999999999 99999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=293.94 Aligned_cols=238 Identities=19% Similarity=0.291 Sum_probs=185.3
Q ss_pred eeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHh---cCCCCcceEEEEEeecCceeEEeeccC
Q 009644 244 IIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIAR---VHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~---l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.||+|+||.||++.. .+++.+|+|.+.... ...+.+|..++.. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 458899999765421 1234455444433 479999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-P 152 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-c
Confidence 999999987542 68999999999999999999999 599999999999999999999999999987654322 2
Q ss_pred CcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 GSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....++..|+|||.+.. ..++.++|||||||++|||++|..||......... ........ .+.. .+...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~------~~~~---~~~~~ 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT------VNVE---LPDSF 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc------CCcC---Ccccc
Confidence 23457889999999864 56899999999999999999999999755433221 11111111 0111 12233
Q ss_pred HHHHHHHHHHcccCCC-CCC-----CHHHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRP-----SMRQIAGE 499 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RP-----t~~eVl~~ 499 (530)
..++.+++.+|+..+| +|| |++++++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 4678899999999998 999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=290.75 Aligned_cols=248 Identities=20% Similarity=0.257 Sum_probs=190.9
Q ss_pred HHHHHhhcCCccceee--ccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 230 LELKHATNNFSEINII--GEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 230 ~el~~~t~~f~~~~~L--G~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
.+.....++|++.+.+ |+|+||.||++.. .++..+|+|.......... |+.....+ +||||+++++++...+..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3444445677776666 9999999999994 5678899998765433222 33222222 799999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLL 384 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla 384 (530)
++||||+++|+|.+++.... .+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999997652 68999999999999999999999 5999999999999999998 9999999998
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
+..... ....++..|+|||++.+..++.++||||||+++|||++|+.||........ .. ........ . .
T Consensus 158 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~-~~~~~~~~--~----~ 226 (267)
T PHA03390 158 KIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DL-ESLLKRQQ--K----K 226 (267)
T ss_pred eecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hH-HHHHHhhc--c----c
Confidence 865432 233577889999999988999999999999999999999999975432221 11 11111100 0 0
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCC-HHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPS-MRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt-~~eVl~ 498 (530)
. .........+.+++.+|++.+| +||+ ++++++
T Consensus 227 ~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 L-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred C-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 1112344678999999999998 9995 688874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=297.12 Aligned_cols=252 Identities=14% Similarity=0.173 Sum_probs=181.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCC----CEEEEEEccccc--H------------HHHHHHHHHHHhcCCCCcceEEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDG----SLVVIKRHLQTQ--I------------QNFLHEVKHIARVHHRHLVKLVG 297 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~----~~vavK~~~~~~--~------------~~~~~E~~il~~l~H~nIv~l~g 297 (530)
.++|++.+.||+|+||.||+|...++ ..+|+|...... . .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999999996543 456666432111 0 11223334456678999999999
Q ss_pred EEeecC----ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 009644 298 FCEENH----QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN 373 (530)
Q Consensus 298 ~~~~~~----~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~ 373 (530)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCC
Confidence 775543 3467888774 46666665432 35778889999999999999999 599999999999999999
Q ss_pred CeEEEeecCCcccccCCC--------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH
Q 009644 374 YTAKVSDYGLLKLVTGSH--------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ 445 (530)
Q Consensus 374 ~~~KI~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 445 (530)
+.+||+|||+|+.+.... ......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~- 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN- 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-
Confidence 999999999998763221 11223588999999999999999999999999999999999999986533221
Q ss_pred HHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 446 NLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 446 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
.+....... ...+..... .....+..+.+++..|+..++ +||++.++++.|
T Consensus 242 -~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 -LIHAAKCDF-IKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred -HHHHhHHHH-HHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111000 000000000 112335778999999999998 999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=298.12 Aligned_cols=243 Identities=23% Similarity=0.380 Sum_probs=193.8
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.|+..+.||+|+||.||+|.. .++..+|+|.+... ...++.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 467778999999999999995 46889999986532 23468899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 996 58888776432 268999999999999999999999 5999999999999999999999999999875432
Q ss_pred CCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 391 HHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||...... ........... +. .
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~------~~--~ 244 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNES------PT--L 244 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhccC------CC--C
Confidence 22345778899999974 456899999999999999999999998754221 11222211100 00 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
........+.+++.+|++.+| +||++.+|++.+-
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 112234578999999999998 9999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.41 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=194.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-----
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH----- 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~----- 303 (530)
..++|+..+.||+|+||.||+|..+ +++.||+|.+... ....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578889999999999999999964 5789999987532 2346788999999999999999999987654
Q ss_pred -----ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 304 -----QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 304 -----~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
..++|+||+++ ++.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 7777776532 268999999999999999999999 59999999999999999999999
Q ss_pred eecCCcccccCCCCc--CcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 379 SDYGLLKLVTGSHHA--GSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 379 ~DFGla~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|||++|++||...........+.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999876443221 12235667999998764 457899999999999999999999997543322222222211110
Q ss_pred c---CCccc--------c------ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 D---LGKYV--------D------KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~---~~~~~--------d------~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ...+. + +.........+..+.+++.+|+..+| +|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 0 00001111235678999999999999 9999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.88 Aligned_cols=256 Identities=19% Similarity=0.331 Sum_probs=191.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
-++|+..+.||+|+||.||+|... +++.||+|.+.... ...+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999954 68899999765321 235678999999999999999999987654
Q ss_pred --ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 304 --QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 304 --~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
..++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCcEEECcC
Confidence 3599999996 58888876542 268999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCCc-----CcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 382 GLLKLVTGSHHA-----GSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 382 Gla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|++......... ....++..|+|||.+.+. .++.++||||||+++|||+||..||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866432211 123356789999987654 47899999999999999999999997654322222222221110
Q ss_pred cCC---cc-----ccc-cccc-c---------chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLG---KY-----VDK-TLGE-Q---------TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~---~~-----~d~-~l~~-~---------~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.-. .. .+. .+.. . .......+.+++.+|+..+| +|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00 000 0000 0 00113466799999999999 9999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.84 Aligned_cols=260 Identities=22% Similarity=0.366 Sum_probs=195.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~~ 305 (530)
+++|+..+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999984 56889999987532 235688899999999999999999987654 357
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++|+||+. ++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 5888877542 68999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCCc----CcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---cC
Q 009644 386 LVTGSHHA----GSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---DL 457 (530)
Q Consensus 386 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~ 457 (530)
........ ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 65432211 12346788999998654 568999999999999999999999996543211111111000000 00
Q ss_pred Ccccc-------------cc--ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhH
Q 009644 458 GKYVD-------------KT--LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQ 504 (530)
Q Consensus 458 ~~~~d-------------~~--l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~ 504 (530)
..+.+ +. ...........+.+++.+|++.+| +|||+.|+++. ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 00 000111234678899999999999 99999999885 55544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=289.10 Aligned_cols=244 Identities=18% Similarity=0.313 Sum_probs=194.3
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc--------ccHHHHHHHHHHHHhcCCCCcceEEEEEeec--Cce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ--------TQIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~--------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 305 (530)
.+|...+.||+|+||.||+|.. .++..+|+|.... .....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788889999999999999994 5688999997532 1235788999999999999999999998664 457
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++++|.+++.... .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987542 57889999999999999999999 599999999999999999999999999998
Q ss_pred cccCCC----CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 386 LVTGSH----HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 386 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
...... ......++..|+|||++.+..++.++|+||||+++|||++|+.||..... ...+.+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~---- 226 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQ-PT---- 226 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcC-CC----
Confidence 653211 11223477889999999888899999999999999999999999975422 1112221111 00
Q ss_pred cccccccchhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p~RPt~~eVl~ 498 (530)
. ...+......+.+++.+|+..+..|||..+++.
T Consensus 227 ~---~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~ 260 (264)
T cd06653 227 K---PMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLR 260 (264)
T ss_pred C---CCCCcccCHHHHHHHHHHhcCcccCccHHHHhc
Confidence 0 112334456789999999986559999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.57 Aligned_cols=261 Identities=17% Similarity=0.329 Sum_probs=195.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
.++|...+.||+|+||.||+|.. .+++.||+|++... ....+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999994 56889999987532 2346889999999999999999999986543
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++|+||+. ++|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999996 47776652 157899999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9765322 223346778999999876 468999999999999999999999997543211111111100000
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhHHHhh
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQEREI 508 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~~~~~ 508 (530)
.........+....+.....+.+++.+|++.+| +||++++++.. ++++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 000000001111111234568899999999999 99999999954 777655433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=288.80 Aligned_cols=245 Identities=20% Similarity=0.356 Sum_probs=200.0
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||++.. .+++.+++|..... ...++.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999984 46788999986532 345688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876321 12368999999999999999999999 59999999999999999999999999999876544
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
......++..|++||...+..++.++|+||||+++|||++|+.||...... ......... . .......
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~-~--------~~~~~~~ 224 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQRG-K--------YPPIPPI 224 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcC-C--------CCCCchh
Confidence 222345778899999999989999999999999999999999999754321 111111111 1 1112224
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+.+++.+|+..+| +|||+.++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 45679999999999998 9999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=293.76 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=194.8
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc----HHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ----IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~----~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
|...+.||+|+||.||+|... +++.|++|++.... .....+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999965 47789999866432 224567999999998 999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
+|+|.+++..... ..+++.++..++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 8899999876532 268999999999999999999999 5999999999999999999999999999987654433
Q ss_pred cCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh-------------ccCC
Q 009644 393 AGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS-------------CDLG 458 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-------------~~~~ 458 (530)
.....++..|+|||.+. ...++.++|+||||+++|||++|++||.................. ....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 33445778899999875 456789999999999999999999998755332211111100000 0000
Q ss_pred ----ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 ----KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ----~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+..........+.+++.+|++.+| +|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000011111111224678999999999998 9999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.55 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=196.4
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
|+..+.||+|++|.||++.. .+++.+++|.+.... ...+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45668999999999999995 468889999865432 356889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
+ ++|.+++.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 D-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred C-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 6 48888887643 268999999999999999999999 599999999999999999999999999998765433
Q ss_pred CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---------------
Q 009644 392 HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--------------- 455 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--------------- 455 (530)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+....+.......
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12233467789999998766 78999999999999999999999997554322111111100000
Q ss_pred --cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 --DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 --~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+............++.+++.+||+.+| +||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000011111223345788999999999999 9999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=301.22 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=192.6
Q ss_pred cCCcc-ceeeccCCcEEEEEEEE-cCCCEEEEEEcccccH-----------------HHHHHHHHHHHhcCCCCcceEEE
Q 009644 237 NNFSE-INIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQI-----------------QNFLHEVKHIARVHHRHLVKLVG 297 (530)
Q Consensus 237 ~~f~~-~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~-----------------~~~~~E~~il~~l~H~nIv~l~g 297 (530)
++|.. .+.||+|+||.||+|.. .+++.||+|....... ..+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 44543 46799999999999994 4688999998654321 14778999999999999999999
Q ss_pred EEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 298 ~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
++..++..++||||+. |+|.+++.... .++......++.|++.||+|||+ .+++||||+|+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEE
Confidence 9999999999999996 69999986542 68899999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCC---------------CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 009644 378 VSDYGLLKLVTGSH---------------HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHS 441 (530)
Q Consensus 378 I~DFGla~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 441 (530)
|+|||+++...... ......++..|+|||.+.+. .++.++||||||+++|||+||++||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654111 11122356789999998754 478999999999999999999999976543
Q ss_pred CchHHHHHHHHhhccC---------------CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 442 NSDQNLILQVKRSCDL---------------GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 442 ~~~~~~~~~~~~~~~~---------------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+......... .....+............+.+++.+|++.+| +|||++|++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2221111111110000 0000111111122335678899999999999 9999999985
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.62 Aligned_cols=262 Identities=18% Similarity=0.323 Sum_probs=198.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 304 (530)
.++|...+.||+|+||.||+|.. .++..||+|.+... ....+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999994 56889999986532 235678899999999999999999988654 35
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 7899888754 268999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCC-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 385 KLVTGSH-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 385 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
+...... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 8764331 2223346778999998764 568999999999999999999999997543211111111110000
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhHH
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQE 505 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~~ 505 (530)
......++............+.+++.+|++.+| +|||++++++. ++.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000001111111122345678999999999999 99999999976 665533
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=301.08 Aligned_cols=260 Identities=20% Similarity=0.371 Sum_probs=195.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc-----ccHHHHHHHHHHHHhc-CCCCcceEEEEEeec--Cce
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ-----TQIQNFLHEVKHIARV-HHRHLVKLVGFCEEN--HQQ 305 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~-----~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~--~~~ 305 (530)
..++|+..+.||+|+||.||+|... +++.+|+|++.. .....+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999954 578899997643 2335678899999999 999999999998653 468
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 6999888653 57888999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC------cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh----
Q 009644 386 LVTGSHH------AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS---- 454 (530)
Q Consensus 386 ~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~---- 454 (530)
....... .....++..|+|||.+.. ..++.++||||||+++|||+||+.||...........+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6643321 112346788999998754 56789999999999999999999999754332211111110000
Q ss_pred ----------c----cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhh
Q 009644 455 ----------C----DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGI 503 (530)
Q Consensus 455 ----------~----~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i 503 (530)
. ....................+.+++.+|++.+| +|||+.++++. ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 000000011111112245678999999999999 99999999974 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.15 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=194.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee----cCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~ 305 (530)
.++|+..+.||+|+||.||+|.. .++..||+|++... ..+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36888889999999999999994 46889999987643 23567889999999999999999998753 3468
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+. |+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 69999886542 58999999999999999999999 599999999999999999999999999997
Q ss_pred cccCCCCc-----CcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc----
Q 009644 386 LVTGSHHA-----GSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---- 455 (530)
Q Consensus 386 ~~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---- 455 (530)
........ ....++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432211 12346778999998765 568999999999999999999999997543321111111100000
Q ss_pred -------c-------CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -------D-------LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -------~-------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. .....+.............+.+++.+|++.+| +|||+++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 00000000011112345778999999999999 9999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=288.32 Aligned_cols=240 Identities=17% Similarity=0.234 Sum_probs=187.4
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHH-hcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIA-RVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~-~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|.. .+++.||+|...... ...+..|..++. ..+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 468899999876432 123455555444 45899999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~ 394 (530)
++|.+++.... .+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceeccc---cc
Confidence 99999997642 68899999999999999999999 5999999999999999999999999999876433 22
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 474 (530)
...++..|+|||.+.+..++.++||||||+++|||++|..||...... ......... ... . .. ........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-~~~-~-~~---~~~~~~~~ 222 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNILSR-RIN-W-PE---EVKEFCSP 222 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhc-ccC-C-CC---cccccCCH
Confidence 334677899999998888999999999999999999999999754321 222221111 000 0 00 01113346
Q ss_pred HHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 475 EMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 475 ~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
.+.+++.+|++.+| +||++.++.+.|.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 88999999999999 9998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=290.29 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=198.4
Q ss_pred cCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccccH------HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~------~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
+.|+.++.||.|.-|+||++.+.+ +...|+|++.+... .+...|-+||+.++||.++.||+.++.+...+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346677899999999999999765 48899999876543 45778999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
|||+||+|...++.+.+ ..+++..+..++.+++-||+|||-. |||.|||||+||||.++|++-|+||-|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHml--GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHML--GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhh--ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999998887644 4799999999999999999999995 999999999999999999999999998642210
Q ss_pred ---------------------------------C-C-----------------------CcCcccccccccCccccCCCC
Q 009644 390 ---------------------------------S-H-----------------------HAGSTSAVDCFLDPELNLSKN 412 (530)
Q Consensus 390 ---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~ 412 (530)
. . ...+..||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 011233788899999999999
Q ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCC
Q 009644 413 YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRP 491 (530)
Q Consensus 413 ~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP 491 (530)
.+.++|.|+|||++|||+.|..||.+....+....+ +.+. ..+++. ++.+..+.+||.+.+..|| +|-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~~--------l~Fp~~-~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQP--------LKFPEE-PEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcCC--------CcCCCC-CcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999999999987654432211 1111 111222 2455788999999999999 898
Q ss_pred C----HHHHH
Q 009644 492 S----MRQIA 497 (530)
Q Consensus 492 t----~~eVl 497 (530)
- +.||-
T Consensus 381 g~~rGA~eIK 390 (459)
T KOG0610|consen 381 GSKRGAAEIK 390 (459)
T ss_pred ccccchHHhh
Confidence 7 55553
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=283.65 Aligned_cols=242 Identities=22% Similarity=0.434 Sum_probs=198.1
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|++|.||++... +++.+++|..... ..+.+.+|++++++++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999854 5788999986543 345789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998765 268999999999999999999999 599999999999999999999999999998765433
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. .....++..|+|||......++.++||||||+++|||++|+.||..... .......... .. + ..+.
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~~-----~---~~~~ 221 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQD-DH-----P---PLPE 221 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcc-CC-----C---CCCC
Confidence 2 1234477889999998888889999999999999999999999875431 1111111111 00 1 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+|+..+| +|||+.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 334678899999999998 9999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.04 Aligned_cols=256 Identities=21% Similarity=0.365 Sum_probs=191.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
.++|+..+.||+|+||.||+|.. .+++.+|+|++.... ...+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999995 467899999865321 245788999999999999999999875433
Q ss_pred --ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 304 --QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 304 --~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
..++||||+. ++|...+.... ..+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcC
Confidence 4699999996 47777776432 268999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCCc------------CcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH
Q 009644 382 GLLKLVTGSHHA------------GSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI 448 (530)
Q Consensus 382 Gla~~~~~~~~~------------~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~ 448 (530)
|+++........ ....++..|+|||.+.+ ..++.++||||||+++|||++|++||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865432211 11235677999998765 45899999999999999999999999755432222221
Q ss_pred HHHHhhc---------cCCccc--------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 449 LQVKRSC---------DLGKYV--------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 449 ~~~~~~~---------~~~~~~--------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....... .+.... ++.+..........+.+++.+|++.+| +|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111100 000000 011111111223578899999999999 9999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.95 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=196.9
Q ss_pred CCccceeeccCCcEEEEEEEE----cCCCEEEEEEcccc-------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 238 NFSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQT-------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~-------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
+|+..+.||+|+||.||++.. .++..+|+|.+... ..+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467789999999999999884 35678999987532 234688999999999 699999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999987542 68899999999999999999999 699999999999999999999999999988
Q ss_pred cccCCCC--cCcccccccccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH-HHHHHHHhhccCCcc
Q 009644 386 LVTGSHH--AGSTSAVDCFLDPELNLSKN--YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGKY 460 (530)
Q Consensus 386 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 460 (530)
....... .....++..|+|||...+.. .+.++||||||+++|||++|..||......... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------ 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc------
Confidence 6543322 12234678899999987655 788999999999999999999999643322111 111111110
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.+ ..+......+.+++.+|++.+| +|||+.++.+.|+..
T Consensus 228 -~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 1112233578899999999998 999999888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.70 Aligned_cols=244 Identities=19% Similarity=0.287 Sum_probs=192.4
Q ss_pred CCccceeeccCCcEEEEEEEE----cCCCEEEEEEcccc-------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 238 NFSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQT-------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~-------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
+|+..+.||+|+||.||++.. .+|..+|+|.+... ..+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999985 36889999987642 235678899999999 699999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999997643 57889999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC--cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch-HHHHHHHHhhccCCcc
Q 009644 386 LVTGSHH--AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-QNLILQVKRSCDLGKY 460 (530)
Q Consensus 386 ~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 460 (530)
....... .....++..|+|||.+.. ..++.++||||||+++|||++|..||........ .......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~-- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---E-- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc---C--
Confidence 7543221 123447788999999875 3468899999999999999999999964332211 1111111111 0
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
...+......+.+++.+|++.+| +|| ++.++++
T Consensus 229 -----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01122334678899999999998 897 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=284.34 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=200.7
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|+..+.||+|+||.||++... ++..+++|++... ..+.+.+|++++++++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999954 5889999987643 345788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++++|.+++..... ....+++.++..++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999986431 11378999999999999999999999 599999999999999999999999999998764432
Q ss_pred -CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 -HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......++..|+|||......++.++||||+|+++|+|++|+.||..... .......... . ....+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~-~--------~~~~~~ 225 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELALKILKG-Q--------YPPIPS 225 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHHHHHHhcC-C--------CCCCCC
Confidence 12234577789999999888899999999999999999999999865431 1222221111 1 111222
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+|+..+| +|||+.++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 344688999999999998 9999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.98 Aligned_cols=237 Identities=19% Similarity=0.306 Sum_probs=185.3
Q ss_pred eeccCCcEEEEEEEE-cCCCEEEEEEcccccH------HHHHHHHHH---HHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 244 IIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQI------QNFLHEVKH---IARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~E~~i---l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.||+|+||.||++.. .+++.||+|.+..... ..+..|..+ ++..+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999998764321 124445443 444579999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++... +.+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++...... .
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-P 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-C
Confidence 99999988654 268999999999999999999999 599999999999999999999999999987654322 2
Q ss_pred CcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 GSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....++..|+|||.+.++ .++.++||||||+++|||++|+.||........... ...... .+.. .+...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~------~~~~---~~~~~ 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLT------MAVE---LPDSF 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhc------cCCC---CCCcC
Confidence 334578899999998754 689999999999999999999999976533222111 111111 0111 11123
Q ss_pred HHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
+..+.+++.+|+..+| +|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 4688999999999998 999 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.65 Aligned_cols=262 Identities=18% Similarity=0.326 Sum_probs=198.6
Q ss_pred cCHHHHHHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEe
Q 009644 227 LTILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCE 300 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~ 300 (530)
....++...+++|...+.||+|+||.||+|. ..+++.||+|++... ..+.+.+|++++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3445667788999999999999999999998 457889999987542 2356788999999999999999999886
Q ss_pred ec------CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 009644 301 EN------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY 374 (530)
Q Consensus 301 ~~------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~ 374 (530)
.. ...++++|++ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEcCCC
Confidence 43 3467888887 78998887642 58999999999999999999999 5999999999999999999
Q ss_pred eEEEeecCCcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 375 TAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 375 ~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 158 ~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 158 ELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred CEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999998865322 223456788999998765 5688999999999999999999999965432211111111000
Q ss_pred hc------------------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 454 SC------------------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 454 ~~------------------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.. .+..................+.+++.+|++.+| +|||+.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000001111111234578899999999999 99999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.78 Aligned_cols=238 Identities=17% Similarity=0.313 Sum_probs=192.5
Q ss_pred eeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChH
Q 009644 243 NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~ 318 (530)
..||+|+||.||++.. .++..||+|+.... ....+.+|+.++++++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 56889999986532 2356889999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-cCccc
Q 009644 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-AGSTS 397 (530)
Q Consensus 319 ~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-~~~~~ 397 (530)
+++... .+++.....++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 987542 57899999999999999999999 5999999999999999999999999999876543221 22345
Q ss_pred ccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHH
Q 009644 398 AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMM 477 (530)
Q Consensus 398 gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 477 (530)
++..|+|||.+....++.++|+||||+++|||++|+.||...... ......... .++.+.. .......+.
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~------~~~~~~~-~~~~~~~l~ 247 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN------LPPKLKN-LHKVSPSLK 247 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh------CCcccCC-cccCCHHHH
Confidence 778899999998888999999999999999999999998754321 111111111 1111111 112345678
Q ss_pred HHHHHcccCCC-CCCCHHHHHH
Q 009644 478 ELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 478 ~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+++.+|++.+| +||++.++++
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhc
Confidence 99999999999 9999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.97 Aligned_cols=262 Identities=16% Similarity=0.322 Sum_probs=197.9
Q ss_pred HHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC---
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH--- 303 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~--- 303 (530)
....++|+..+.||+|+||.||++. ..++..||+|+.... ..+.+.+|++++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3356789999999999999999998 457889999987532 2346889999999999999999999987653
Q ss_pred ---ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 304 ---QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 304 ---~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 77998887642 68899999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh-----
Q 009644 381 YGLLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS----- 454 (530)
Q Consensus 381 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~----- 454 (530)
||+++..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+......
T Consensus 162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 162 FGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999865432 223346778999999875 45889999999999999999999999754321111111100000
Q ss_pred -------------ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 455 -------------CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 455 -------------~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
..........+..........+.+++.+|++.+| +|||+.+++. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0000000011111112334568899999999999 9999999984 4555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.40 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=206.9
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
...|.+...||+|.|+.|..|+ ...+..||+|.+.+.+ .+.+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 5678888999999999999999 4468899999877654 356899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+.+|.+.+|+.... .+.......++.|+.++++|||+ +.|||||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999998764 56668888999999999999999 6999999999999999999999999999999887
Q ss_pred CCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.....+.+|++.|.|||++.+..|. +.+|+||+|++||-|+.|..||++..-.+....+...+. . .
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--r-----------I 274 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--R-----------I 274 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--c-----------c
Confidence 7777888999999999999988885 789999999999999999999986543322111111111 1 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+.-...++.+++.+.+-.+| +|++++++.+.
T Consensus 275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 12223577888888888998 99999999763
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.73 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=201.0
Q ss_pred HHHHHhh-cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccH------HHHHHHHHHHHhcCCCCcceEEEEEee
Q 009644 230 LELKHAT-NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLVKLVGFCEE 301 (530)
Q Consensus 230 ~el~~~t-~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~E~~il~~l~H~nIv~l~g~~~~ 301 (530)
.|....| +.|..-++||+||||.||-++. .+|+.+|.|++.++.. .-.++|-.+|.+++.+.||.+--.|+.
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 3443333 5678889999999999999984 5688899987765433 236789999999999999999999999
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
.+.++||+..|.+|+|.-+|..... ..+++..++.++.+|+.||++||+ .+||.|||||+|||||+.|+++|+|.
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeecc
Confidence 9999999999999999999987643 369999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
|||..+..........||.+|||||++.+..|+...|.||+||++|||+.|+.||..........-+.+......
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~----- 406 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP----- 406 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-----
Confidence 999998877776677899999999999999999999999999999999999999975433222111221111100
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCC
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPS 492 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt 492 (530)
.+++...+.+..++....+..+| +|--
T Consensus 407 ----~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 407 ----EEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ----hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 12334445566677666677776 6653
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=286.79 Aligned_cols=239 Identities=20% Similarity=0.319 Sum_probs=192.2
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||.|+||.||++... +++.+++|.+... ..+.+.+|++++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 4889999987643 235688999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC------
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH------ 391 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~------ 391 (530)
.+++.... .+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997642 68999999999999999999999 599999999999999999999999999987643321
Q ss_pred ---CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 392 ---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
......++..|++||......++.++||||||+++|||++|+.||...... ......... .. . .. .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~-~~----~--~~-~ 222 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILNG-KI----E--WP-E 222 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcC-Cc----C--CC-c
Confidence 112234667899999998888999999999999999999999999755321 222222110 00 0 00 0
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
.......+.+++.+|++.+| +|||+.++.+.|+
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11124678999999999998 9999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.32 Aligned_cols=242 Identities=22% Similarity=0.374 Sum_probs=191.5
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.|+..+.||+|+||.||+|+. .++..+++|.... ...+++.+|++++++++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466678999999999999995 4678899997642 123568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68888776432 258899999999999999999999 59999999999999999999999999998765432
Q ss_pred CCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 391 HHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
....++..|+|||.+. ...++.++|||||||++|||++|..||...... ......... .. +..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~-~~-----~~~-- 234 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQN-ES-----PAL-- 234 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHHhhc-CC-----CCc--
Confidence 2335677899999974 356889999999999999999999998654221 111111111 00 000
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
........+.+++.+||..+| +||++.+|++.-
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111234678899999999998 999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.14 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=192.0
Q ss_pred eeeccC--CcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEG--SFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G--~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
..||+| +||+||++.. .+++.||+|..... ..+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999995 57899999986532 235688999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC--
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-- 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-- 392 (530)
|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.+........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876432 258899999999999999999999 5999999999999999999999999986543321110
Q ss_pred ------cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--c------
Q 009644 393 ------AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--D------ 456 (530)
Q Consensus 393 ------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--~------ 456 (530)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .......... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 011224556999999876 347899999999999999999999997543221 1111110000 0
Q ss_pred -----------------CC----------ccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 457 -----------------LG----------KYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 457 -----------------~~----------~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
+. ...+..+.. ........+.+++.+||+.+| +|||++|+++ .++.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00 000001111 123345678999999999999 9999999985 4566555
Q ss_pred H
Q 009644 506 R 506 (530)
Q Consensus 506 ~ 506 (530)
.
T Consensus 317 ~ 317 (328)
T cd08226 317 Q 317 (328)
T ss_pred h
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.12 Aligned_cols=260 Identities=21% Similarity=0.370 Sum_probs=200.7
Q ss_pred CCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-----cee
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH-----QQL 306 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~ 306 (530)
+|+..+.||+|+||.||+|+.. ++..+++|++... ..+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 4889999986642 2457899999999999999999999987765 789
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58998887542 68999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCC----CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc-----
Q 009644 387 VTGSH----HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD----- 456 (530)
Q Consensus 387 ~~~~~----~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~----- 456 (530)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65432 12233467789999999877 889999999999999999999999976543221111111100000
Q ss_pred ------CCccc-------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhHH
Q 009644 457 ------LGKYV-------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQE 505 (530)
Q Consensus 457 ------~~~~~-------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~~ 505 (530)
....+ ...+..........+.+++.+||+.+| +|||+.+++.. ++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000 000111112235678999999999999 99999999974 666544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.05 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=175.3
Q ss_pred ccceeeccCCcEEEEEEE-EcCCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecC------ceeEE
Q 009644 240 SEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENH------QQLLI 308 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------~~~LV 308 (530)
...+.||+|+||.||+|+ ...|+.||||.+.. ...+.+.+|+++|++++|+|||++++.-++.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 344789999999999999 66799999998765 34577899999999999999999999876543 57899
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCC--eEEEeecCCc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE--ENY--TAKVSDYGLL 384 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~--~~~--~~KI~DFGla 384 (530)
||||.+|||...|.+.++. ..|++.+.+.+..+++.||.|||+ ++|+||||||.||++- ++| .-||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999876543 369999999999999999999998 5999999999999994 333 5799999999
Q ss_pred ccccCCCCcCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSN 442 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~ 442 (530)
|.+.++....+..||..|++||.+. .+.|+..+|.|||||++||.+||..||......
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9998888888889999999999998 488999999999999999999999999865543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=291.09 Aligned_cols=248 Identities=16% Similarity=0.184 Sum_probs=186.7
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
+.+|.|+++.||++.. +++.+|+|+.... ..+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455556666666555 6889999986532 346789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-----
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH----- 392 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~----- 392 (530)
.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999986432 257889999999999999999999 5999999999999999999999999999875532211
Q ss_pred ---cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------
Q 009644 393 ---AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------ 455 (530)
Q Consensus 393 ---~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------ 455 (530)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||....... ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 122335667999999865 358899999999999999999999997543221 2222211100
Q ss_pred --cCCc----cccccc-----cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 --DLGK----YVDKTL-----GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 --~~~~----~~d~~l-----~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... ..++.. .........++.+++.+||..+| +|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000000 00122334578899999999999 9999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=287.54 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=194.9
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
|+..+.||+|+||.||+|+.. +++.+++|..... ..+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455688999999999999954 5889999986643 2356788999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 69999998653 268999999999999999999999 5999999999999999999999999999987644321
Q ss_pred -cCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh----------------h
Q 009644 393 -AGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR----------------S 454 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~----------------~ 454 (530)
......+..|+|||.+... .++.++||||||+++|||++|++||...........+..... .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2223356679999998766 889999999999999999999999975432211111111000 0
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....................+.+++.+|++.+| +||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000101111224679999999999999 9999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=290.10 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=190.5
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
|...+.||+|+||.||+|+. .++..+++|.+... ..+++.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999995 46788999986532 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 68888776543 268999999999999999999999 5999999999999999999999999999865322
Q ss_pred CcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 392 HAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.....++..|+|||++. ...++.++||||||+++|||++|..||...... ......... ..... .
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~-~~~~~-------~ 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQN-DSPTL-------Q 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhc-CCCCC-------C
Confidence 22345778899999974 466889999999999999999999998754321 111121111 11111 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.......+.+++.+|++.+| +||++.+++..
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223468899999999999 99999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=294.26 Aligned_cols=256 Identities=18% Similarity=0.334 Sum_probs=194.7
Q ss_pred HHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEee-cCce
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQQ 305 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~~ 305 (530)
...+++|+..+.||+|+||.||++. ..++..+|+|++.. ...+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3467899999999999999999998 44788999997643 234678899999999999999999999865 5678
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+ +++|.+++... .+++.....++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++
T Consensus 86 ~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999999 56898888642 57888888999999999999999 599999999999999999999999999997
Q ss_pred cccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHH--------hhc-
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK--------RSC- 455 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~--------~~~- 455 (530)
..... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+.... ...
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 54321 223346778999998765 568999999999999999999999997543211111111000 000
Q ss_pred --cCCccc-------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 456 --DLGKYV-------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 456 --~~~~~~-------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
...... .....+........+.+++.+|++.+| +|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000001112234688999999999999 99999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=297.75 Aligned_cols=244 Identities=16% Similarity=0.262 Sum_probs=194.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccc-----ccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
...|++++.||+||.+.||++...+.+.+|+|++.. ...+.|.+|+..|.+| .|.+||+|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 356888999999999999999988888899887543 2356799999999999 5999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||= ..+|..+|+.... .+....+..+..|++.++.++|.. +|||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 440 E~G-d~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH~~--gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIHQH--GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHHHh--ceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 976 6699999987653 233237788999999999999994 999999999999997 46999999999998866
Q ss_pred CCC---cCcccccccccCccccCCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 390 SHH---AGSTSAVDCFLDPELNLSKN-----------YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 390 ~~~---~~~~~gt~~y~aPE~~~~~~-----------~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
+.. ..+..||..||+||.+.... .+.+|||||+||+||+|+.|++||... .+.+.+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~--- 583 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLH--- 583 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHH---
Confidence 543 34566999999999876433 457899999999999999999999732 22333222
Q ss_pred cCCccccccc--cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDKTL--GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~~l--~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+.||.. .-......++++++++.||..|| +|||+.++++
T Consensus 584 ---aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 ---AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2233311 00111122449999999999999 9999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=276.47 Aligned_cols=245 Identities=18% Similarity=0.348 Sum_probs=196.5
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.+.+..||+|+.|.|++.+.+ .|...|||.+.+. +.++++..++++.+-+ .|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344568999999999999954 5889999987653 3456777888877765 899999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
. .-+..+|+.-. +.+++.-+-++...+++||.||-+. .+|+|||+||+|||+|+.|++|+||||++..+.++..
T Consensus 174 s-~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 S-TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred H-HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 4 35566665543 2678888888999999999999874 5999999999999999999999999999988877776
Q ss_pred cCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 AGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....|.+.|||||.+. ...|+.++||||||++|+||.||+.||.....+ ......+... ..|.+++ .
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~------ePP~L~~-~ 318 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNE------EPPLLPG-H 318 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhc------CCCCCCc-c
Confidence 77778999999999986 346899999999999999999999999875432 2333333321 1133332 1
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+..+.+++..|+..|+ +||...++++
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2256788999999999998 9999998875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.66 Aligned_cols=242 Identities=19% Similarity=0.294 Sum_probs=197.2
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV 308 (530)
++|...+.||+|+||.||+|... +++.+++|..... ..+.+.+|.+++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999954 6889999987542 2356889999999998 99999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 68999999999999999999999 599999999999999999999999999988654
Q ss_pred CCCC---------------------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHH
Q 009644 389 GSHH---------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNL 447 (530)
Q Consensus 389 ~~~~---------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 447 (530)
.... .....++..|+|||......++.++||||||+++||+++|+.||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 3221 1122356789999999888899999999999999999999999975532 121
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCH----HHHHH
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSM----RQIAG 498 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~----~eVl~ 498 (530)
....... .. ..+......+.+++.+|++.+| +|||+ +++++
T Consensus 231 ~~~~~~~---~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILKL---EY-------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHhc---CC-------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 2221110 00 1122234678999999999998 99999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.00 Aligned_cols=253 Identities=18% Similarity=0.333 Sum_probs=194.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc----
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ---- 304 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~---- 304 (530)
..++|+..+.||+|+||.||+|+.. ++..+|+|++... ..+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999964 5788999986532 23567789999999999999999998766554
Q ss_pred --eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 305 --QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 305 --~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
.++|+||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 67999988642 68999999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------ 455 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------ 455 (530)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+.......
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 99865432 223346778999998765 467899999999999999999999997543321111111110000
Q ss_pred ------------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 ------------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ------------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.......+.+..........+.+++.+|++.+| +|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000001111111235688999999999999 9999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.52 Aligned_cols=250 Identities=19% Similarity=0.282 Sum_probs=188.9
Q ss_pred CCccceeeccCCcEEEEEEEEc-C--CCEEEEEEcccc-----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec----Cc
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQ-D--GSLVVIKRHLQT-----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN----HQ 304 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~-~--~~~vavK~~~~~-----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~----~~ 304 (530)
+|...+.||+|+||.||++... . +..+|+|++... ..+.+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999954 3 678999986532 235688999999999 599999999976432 45
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 68999886542 68999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCC-----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---
Q 009644 385 KLVTGSHH-----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--- 455 (530)
Q Consensus 385 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--- 455 (530)
+....... .....++..|+|||++.+ ..++.++|||||||++|||++|++||....... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~ 229 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTP 229 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCC
Confidence 86543211 122347888999998765 568999999999999999999999997543211 111111000
Q ss_pred ------------------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 ------------------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ------------------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+..........+.+++.+|++.+| +|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000001111112234678999999999999 9999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=282.73 Aligned_cols=245 Identities=18% Similarity=0.275 Sum_probs=190.0
Q ss_pred CCccceeeccCCcEEEEEEEEcC-CCEEEEEEccc--------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQ--------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~--------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
+|.+.+.||+|+||.||++.... +..+++|.... ....++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46777999999999999998543 33344444321 2234577899999999999999999999998999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++..... ....+++.++..++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998875321 12368999999999999999999999 59999999999999976 569999999998764
Q ss_pred CCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.... .....++..|+|||.+....++.++|+||||+++|+|++|..||.... ........... . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~-~--------~~~ 224 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEG-P--------TPS 224 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcC-C--------CCC
Confidence 3322 223446778999999988889999999999999999999999986432 11222211111 0 111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+......+.+++.+|+..+| +||++.++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 222345688999999999998 9999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=295.01 Aligned_cols=254 Identities=21% Similarity=0.372 Sum_probs=189.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeec---------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--------- 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--------- 302 (530)
..+|...+.||.|+||.||+|.. .++..||+|.+... ..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788899999999999999995 46889999986543 345688999999999999999999876543
Q ss_pred -----CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeE
Q 009644 303 -----HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTA 376 (530)
Q Consensus 303 -----~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~ 376 (530)
...++||||++ ++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceE
Confidence 35789999996 6898888542 58899999999999999999999 5999999999999997 46689
Q ss_pred EEeecCCcccccCCCC----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 377 KVSDYGLLKLVTGSHH----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 377 KI~DFGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
|++|||+++....... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976533211 112246778999998654 56889999999999999999999999754322111111100
Q ss_pred Hhh----------ccC-------CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 452 KRS----------CDL-------GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 452 ~~~----------~~~-------~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... ... .................++.+++.+|+..+| +|||+++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 000 0000000001112234678899999999999 9999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.69 Aligned_cols=231 Identities=22% Similarity=0.357 Sum_probs=189.8
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 245 IGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 245 LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
||+|+||.||++... +++.+++|.+... ....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 5889999986643 234788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC-CCcCcc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS-HHAGST 396 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~-~~~~~~ 396 (530)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++...... ......
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99997653 58999999999999999999999 69999999999999999999999999999876443 223334
Q ss_pred cccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHH
Q 009644 397 SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEM 476 (530)
Q Consensus 397 ~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 476 (530)
.++..|++||...+...+.++|+||||+++||+++|+.||..... .......... . . ..+......+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~-~------~---~~~~~~~~~l 220 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKD-P------L---RFPEFLSPEA 220 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcC-C------C---CCCCCCCHHH
Confidence 567789999999888899999999999999999999999965432 1222222110 0 0 1112224678
Q ss_pred HHHHHHcccCCC-CCCCHHH
Q 009644 477 MELALQCVDVSS-RRPSMRQ 495 (530)
Q Consensus 477 ~~li~~Cl~~~p-~RPt~~e 495 (530)
.+++.+|+..+| +|||+.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 999999999998 9999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=313.25 Aligned_cols=248 Identities=19% Similarity=0.326 Sum_probs=187.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------ 302 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------ 302 (530)
...++|++++.||+||||.|||++ .-||+.+|||++.-. ......+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456789999999999999999999 458999999987643 335688999999999999999996543110
Q ss_pred --------------------------------------------------------------------------------
Q 009644 303 -------------------------------------------------------------------------------- 302 (530)
Q Consensus 303 -------------------------------------------------------------------------------- 302 (530)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 009644 303 ---------------------------------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349 (530)
Q Consensus 303 ---------------------------------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~ 349 (530)
..+|+-||||+..+|+++++++... -......+++++|+.||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHH
Confidence 0246789999988888888765321 035677889999999999
Q ss_pred HhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc-------------------CCCCcCcccccccccCccccCC
Q 009644 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT-------------------GSHHAGSTSAVDCFLDPELNLS 410 (530)
Q Consensus 350 yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~ 410 (530)
|+|+ .+||||||||.||+|+++..+||+|||+|.... ++...+...||..|+|||++.+
T Consensus 712 YIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 712 YIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 599999999999999999999999999998721 0012234458889999999875
Q ss_pred C---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCC
Q 009644 411 K---NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS 487 (530)
Q Consensus 411 ~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~ 487 (530)
. .|+.|+|+||+||||+||+. ||.... +....+...+ ...++.. .++..+....-..++.++++.|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR-~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLR-KGSIPEP-----ADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcc-cCCCCCC-----cccccccchHHHHHHHHHhcCC
Confidence 4 59999999999999999986 465432 1112222222 2222211 2234445556678889999999
Q ss_pred C-CCCCHHHHHH
Q 009644 488 S-RRPSMRQIAG 498 (530)
Q Consensus 488 p-~RPt~~eVl~ 498 (530)
| +|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 8 9999999885
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=322.22 Aligned_cols=248 Identities=19% Similarity=0.317 Sum_probs=196.7
Q ss_pred HHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
...+-+++....||.|.||.||-|. ..+|...|+|-+.- +......+|..++..++|||+|+++|+-..++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3345567777899999999999999 67788999995432 22356788999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
|.||||.+|+|.+.+...+ ..++.-...+..|++.|+.|||+ .+|||||+||.||+|+.+|.+|++|||.|..
T Consensus 1311 IFMEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999987643 34555556678999999999999 4999999999999999999999999999988
Q ss_pred ccCCCC-----cCcccccccccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 387 VTGSHH-----AGSTSAVDCFLDPELNLSK---NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 387 ~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
+.+... .....||+.|||||++.+. ....+.||||+|||+.||+||+.||...+.+ ..+..++... ..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~g-h~- 1459 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAG-HK- 1459 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhcc-CC-
Confidence 755421 2345699999999999753 3567899999999999999999999755432 2333443322 11
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
| ..+.....+=.+++..|++.|| +|.++.|+++
T Consensus 1460 ----P---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ----P---QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----C---CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1 1233355667899999999998 8877775543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=277.66 Aligned_cols=236 Identities=19% Similarity=0.276 Sum_probs=194.3
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
-++|..+++||+|.||.|.+++ ...++.+|+|++++. +..+-+.|-++|...+||.+..|.-.|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678899999999999999999 557899999987653 345567899999999999999999889999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc-
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV- 387 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~- 387 (530)
|||..+|.|.-+|...+ .+++.....+...|+.||.|||+ ++||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999998754 68888888899999999999999 69999999999999999999999999999853
Q ss_pred cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 388 TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.........+||+.|+|||++....|..++|.|.+|||+|||++|+.||...+......++..... .
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--k----------- 386 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--K----------- 386 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--c-----------
Confidence 333455677899999999999999999999999999999999999999986654322222221111 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCC
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRP 491 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RP 491 (530)
++.....+...++...+..+| +|-
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhc
Confidence 222223455666666677787 774
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=278.54 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=191.6
Q ss_pred CccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeecc
Q 009644 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.+.+..||.|+||+|+|-. .+.|+..|||++... +.++++.|.+...+- +.||||++||.+..++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3445789999999999988 456899999987643 346788898866554 7899999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
. -||..+-+.--......+++.-.-+|..-.+.||.||-.. ..|||||+||+|||++..|.+||||||++..+.++-.
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 4 4766544321111112678888888999999999999874 5899999999999999999999999999987766555
Q ss_pred cCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 393 AGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....|...|||||.+.. ..|+.+|||||+|++|||+.||..|+..-.+ ....+.++... +. .++.. .....
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~g-dp-p~l~~--~~~~~ 297 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIG-DP-PILLF--DKECV 297 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcC-CC-CeecC--ccccc
Confidence 555668888999999863 3589999999999999999999999874322 22222222221 11 11111 11234
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+....+..++..|+..+. +||...++.+
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 456789999999999986 9999998765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.28 Aligned_cols=254 Identities=19% Similarity=0.278 Sum_probs=206.7
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEee
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEE 301 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~ 301 (530)
..+++...++|.++++||+|+||.|..++. ..++.+|.|++.+- ...-|..|-.+|..-+.+.|++++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 456667788999999999999999999995 45788999987652 33568889999999999999999999999
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
+.++|+|||||+||+|..+|.... .+++..+..++..|+-||.-||+. |+|||||||.|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998763 689999999999999999999996 9999999999999999999999999
Q ss_pred CCcccccCCCC--cCcccccccccCccccC----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 382 GLLKLVTGSHH--AGSTSAVDCFLDPELNL----S-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 382 Gla~~~~~~~~--~~~~~gt~~y~aPE~~~----~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
|.+-.+..+.. .....|||-|++||++. + +.|+..+|.||+||++|||+.|..||+.+.-.+.+..+...+..
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 99877764443 34566999999999975 3 67999999999999999999999999866544433333333333
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCCCCCC---HHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSSRRPS---MRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p~RPt---~~eVl~ 498 (530)
..++. ....+....+||.+-+...+.|-. ++++-.
T Consensus 300 l~FP~---------~~~VSeeakdLI~~ll~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 300 LSFPD---------ETDVSEEAKDLIEALLCDREVRLGRNGIEDIKN 337 (1317)
T ss_pred cCCCc---------ccccCHHHHHHHHHHhcChhhhcccccHHHHHh
Confidence 22221 122456778888877766555554 877754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.37 Aligned_cols=142 Identities=21% Similarity=0.333 Sum_probs=128.7
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|.+.+.||+|+||.||+|... +++.||+|++.... ...+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 68899999876432 356889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
||+.+|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997542 57889999999999999999999 599999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=284.84 Aligned_cols=249 Identities=20% Similarity=0.366 Sum_probs=194.6
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc--c--------cHHHHHHHHHHHHhcCCCCcceEEEEEe-ecCce
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ--T--------QIQNFLHEVKHIARVHHRHLVKLVGFCE-ENHQQ 305 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~--~--------~~~~~~~E~~il~~l~H~nIv~l~g~~~-~~~~~ 305 (530)
+|-.++.||+|||+.||++. +...+.||||+..- . ..+...+|.+|.+.|.||.||++|+|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 46667889999999999999 66678899997431 1 1245778999999999999999999986 45678
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecC
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYG 382 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFG 382 (530)
|-|+|||++.+|+-||+... .+++.++..|+.||+.||.||....++|||-||||.||||-+ .|.+||.|||
T Consensus 544 CTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 89999999999999998764 689999999999999999999998899999999999999964 5789999999
Q ss_pred CcccccCCCC--------cCcccccccccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH
Q 009644 383 LLKLVTGSHH--------AGSTSAVDCFLDPELNLSK----NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450 (530)
Q Consensus 383 la~~~~~~~~--------~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 450 (530)
|++.+.++.. .....||..|++||.+.-+ +.+.|+||||.||++|..+.|+.||+.+.... .+. +
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dIL-q 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DIL-Q 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHH-h
Confidence 9999865532 2334589999999987643 57889999999999999999999998765432 111 1
Q ss_pred HHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 451 VKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 451 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
-.......++--| ..+-...+..+++.+|+.+-. +|....++..
T Consensus 696 eNTIlkAtEVqFP----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKATEVQFP----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcceeccCC----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111111101 111223567889999999886 8888777654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=270.58 Aligned_cols=250 Identities=18% Similarity=0.298 Sum_probs=199.7
Q ss_pred hhcCCccc-eeeccCCcEEEEEEE-EcCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeec----CceeE
Q 009644 235 ATNNFSEI-NIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEEN----HQQLL 307 (530)
Q Consensus 235 ~t~~f~~~-~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~----~~~~L 307 (530)
.+++|++. ++||-|-.|.|-.+. ...++.+|+|++.... ...+|+++.-+. .|||||+++++|+.. ..+++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 35566543 679999999999988 4568889999887553 456889887666 699999999998653 45789
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLL 384 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla 384 (530)
|||.|+||.|...+.+... ..++++++..|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|
T Consensus 137 VmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcceEecccccc
Confidence 9999999999999987653 3699999999999999999999995 9999999999999974 557999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC--cccc
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG--KYVD 462 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~d 462 (530)
+.........+.+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||+........ .-++...... ++.+
T Consensus 212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhccCccCCC
Confidence 9876555566677899999999999999999999999999999999999999977653211 1111111111 1111
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+.....+....++++..+..+| +|-|+.+++.
T Consensus 289 ----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 289 ----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2345556777888888888898 9999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=294.42 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=210.1
Q ss_pred cCHHHHHHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc--ccHHHHHHHHHHHHhc-CCCCcceEEEEEee-
Q 009644 227 LTILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ--TQIQNFLHEVKHIARV-HHRHLVKLVGFCEE- 301 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~- 301 (530)
+.+..+...++-|++.+.||.|.+|.||+++ .++++.+|+|+... ...++...|.++++.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444555667889999999999999999999 67889999998654 3346778888999888 79999999999853
Q ss_pred ----cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 302 ----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 302 ----~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
++++|||||||.+||.-++++...+ ..+.|..+..|++.++.||.+||. +.++|||+|-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEE
Confidence 4689999999999999999987763 479999999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCCC-cCcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 378 VSDYGLLKLVTGSHH-AGSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 378 I~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
+.|||++..++.... ..+..||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.+.+...
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------- 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------- 235 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------
Confidence 999999988765543 345669999999999863 347789999999999999999999987654321
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+..-..|.+ ..+..-..++.+++..|+..+- +||++.++++
T Consensus 236 -aLF~IpRNPPPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 -ALFLIPRNPPPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hhccCCCCCCccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111222222222 2455667899999999999995 9999998873
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=268.22 Aligned_cols=221 Identities=14% Similarity=0.176 Sum_probs=177.0
Q ss_pred CCcEEEEEEE-EcCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhccCC
Q 009644 248 GSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEG 326 (530)
Q Consensus 248 G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~ 326 (530)
|.||.||+++ ..+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-
Confidence 8999999999 4568899999986543 34456666666789999999999999999999999999999999987642
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCcc
Q 009644 327 LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406 (530)
Q Consensus 327 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE 406 (530)
.+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++++|||.+...... .....++..|+|||
T Consensus 81 ----~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE 152 (237)
T cd05576 81 ----NIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPE 152 (237)
T ss_pred ----CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCc
Confidence 58999999999999999999999 69999999999999999999999999988765432 12234566799999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccC
Q 009644 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDV 486 (530)
Q Consensus 407 ~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~ 486 (530)
......++.++||||+|+++|||++|+.|+....... ... ... ..+......+.+++.+|++.
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------~~~------~~~---~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------NTH------TTL---NIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------ccc------ccc---CCcccCCHHHHHHHHHHccC
Confidence 9988889999999999999999999998875332110 000 000 01122345788999999999
Q ss_pred CC-CCCCHHHH
Q 009644 487 SS-RRPSMRQI 496 (530)
Q Consensus 487 ~p-~RPt~~eV 496 (530)
+| +||++.+.
T Consensus 216 dp~~R~~~~~~ 226 (237)
T cd05576 216 NPTERLGAGVA 226 (237)
T ss_pred CHHHhcCCCcc
Confidence 99 99997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=271.75 Aligned_cols=201 Identities=20% Similarity=0.338 Sum_probs=169.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-----CCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEee-cCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-----GSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~ 304 (530)
...|+.+..||+|.||.||++.-.+ ...+|+|++..+. .....+|+.+++.++|||++.|..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999996322 2368999877542 3567899999999999999999999877 778
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CeEEEee
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN----YTAKVSD 380 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~----~~~KI~D 380 (530)
.+|++||.+. +|.+.++-.+......++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999976 89988876554444578999999999999999999999 589999999999999877 8999999
Q ss_pred cCCcccccCCCC----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 381 YGLLKLVTGSHH----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 381 FGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
||++|.+.+.-. ......|..|.|||.+.+ ..||.+.||||.||++.||+|-++.|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999998865432 233457889999999886 56899999999999999999999888653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.05 Aligned_cols=238 Identities=17% Similarity=0.273 Sum_probs=195.3
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
++.|.....+|.|+|+.|-++. ..+++..++|++.+. ..+-.+|+.++... +||||+++++.+.++.+.|+|||++.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 5678888889999999999998 456788899998766 33445677776666 79999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-cCCCeEEEeecCCcccccCCCC
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl-~~~~~~KI~DFGla~~~~~~~~ 392 (530)
+|-|.+.+.... .+. .++..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++....+
T Consensus 400 g~ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccHHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 998888887653 233 7788899999999999999 699999999999999 69999999999999877654
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....+-|..|.|||+.....|++++|+||||++||||++|+.||...... ..+...+... .+....
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~------------~~s~~v 535 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMP------------KFSECV 535 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCC------------cccccc
Confidence 23345677899999999999999999999999999999999999866543 1222222111 122445
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+....+|+.+|++.+| +||+|.++..
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 5788999999999999 9999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=276.76 Aligned_cols=235 Identities=19% Similarity=0.316 Sum_probs=188.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~L 307 (530)
..+|..+.+||+|+||.|.++..+ ..+.+|||++.+.- .+--+.|-++|+-- +-|.+++++.+++.-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888899999999999999854 35689999876532 23345677777766 67899999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+.+|+|-.++..- +.+.+..+..+|.+||-||-|||+ ++||.||||..||+||.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999765 378888899999999999999999 69999999999999999999999999999853
Q ss_pred -cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 388 -TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 388 -~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
....+..+.+||+.|+|||.+...+|+..+|.|||||+||||+.|++||++.+..+.. ..+... ..
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---~aI~eh-nv--------- 567 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QAIMEH-NV--------- 567 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHc-cC---------
Confidence 3344456678999999999999999999999999999999999999999987644322 222211 00
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CC
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RR 490 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~R 490 (530)
.++...+.+.++++..-+...| +|
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccc
Confidence 1333445566666666665555 55
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=282.85 Aligned_cols=238 Identities=22% Similarity=0.366 Sum_probs=193.2
Q ss_pred eeeccCCcEEEEEEE-EcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 243 NIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
++||+|.||+||-|+ .++|+.||||++.+ ++...+.+|+.||.+++||.||.+--.|+..+..++|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 789999999999999 56799999998654 34567899999999999999999999999999999999999 667
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CeEEEeecCCcccccCCCCc
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN---YTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~---~~~KI~DFGla~~~~~~~~~ 393 (530)
..+.+...+. +.|++.....+..||+.||.|||. ++|+|+||||+|||+.+. -++||||||.||.+......
T Consensus 649 MLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILSSEK---GRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 6666654432 479999889999999999999999 699999999999999754 37999999999999887777
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
.+..||+.|+|||++..+.|+..-|+||.||++|--++|..||..+.+ +-.+++.. .++-|. ....+..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNA----aFMyPp--~PW~eis 792 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNA----AFMYPP--NPWSEIS 792 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhcc----ccccCC--CchhhcC
Confidence 788899999999999999999999999999999999999999975432 22233221 111111 1233444
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIA 497 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl 497 (530)
...++++...++..- +|-|.++-+
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 566777777776653 677766543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=258.14 Aligned_cols=234 Identities=23% Similarity=0.371 Sum_probs=191.2
Q ss_pred CcEEEEEEEEc-CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhc
Q 009644 249 SFGLAYKGLLQ-DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD 323 (530)
Q Consensus 249 ~fG~Vy~g~~~-~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~ 323 (530)
+||.||+|... +++.+++|+..... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48899999876543 57899999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCccccccccc
Q 009644 324 SEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL 403 (530)
Q Consensus 324 ~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~ 403 (530)
.. .+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+.............++..|+
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 43 38899999999999999999999 599999999999999999999999999998776543344455778899
Q ss_pred CccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHc
Q 009644 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC 483 (530)
Q Consensus 404 aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~C 483 (530)
+||......++.++||||||+++|||++|..||..... ........... ... . .........++.+++.+|
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~-~~~-~-----~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKP-KPP-F-----PPPEWKISPEAKDLIRKL 224 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhcc-CCC-C-----ccccccCCHHHHHHHHHH
Confidence 99999888899999999999999999999999875321 11222222211 000 0 000000346889999999
Q ss_pred ccCCC-CCCCHHHHHH
Q 009644 484 VDVSS-RRPSMRQIAG 498 (530)
Q Consensus 484 l~~~p-~RPt~~eVl~ 498 (530)
+..+| +||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 99998 9999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=244.73 Aligned_cols=208 Identities=21% Similarity=0.381 Sum_probs=173.6
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+|...++||+|.||+||+|+ .+.++.||+|+..-.. -...++|+-+++.++|+|||+++++...+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566899999999999999 5668899999865322 24689999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
|. .+|..|.....+ .++.+....++.|+.+||.|.|+ .++.||||||.|.|++.+|++|++|||+++.+.-.-
T Consensus 83 cd-qdlkkyfdslng----~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 94 588888876553 78999999999999999999999 499999999999999999999999999999876443
Q ss_pred Cc-CcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHH
Q 009644 392 HA-GSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVK 452 (530)
Q Consensus 392 ~~-~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 452 (530)
.. .....|..|.+|.++.+. -|++..|+||-||++.|+.. |++.|.+.+..+....+.+..
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence 22 233467889999998764 58999999999999999997 666677665545445555543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=259.68 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=192.8
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc---cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT---QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~---~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
+.++-..|+ +.||+|+|+.|--+. +.+|..+|||++.+. ...+..+|++++... .|+||++|+.+|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 445444443 689999999999988 788999999987754 356789999999998 6999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEee
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSD 380 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~D 380 (530)
.+|||||-|.+|+|..++.+.. .+++.+..++..+||.||.|||. ++|.||||||+|||-.+.. -+||+|
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999998764 68999999999999999999999 7999999999999997654 589999
Q ss_pred cCCcccccCCC--------CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch---
Q 009644 381 YGLLKLVTGSH--------HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD--- 444 (530)
Q Consensus 381 FGla~~~~~~~--------~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~--- 444 (530)
|.+..-..-.. ...+..|+..|||||+.. ...|+.++|.||+|||||-|++|.+||.+.-..+-
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 98875432111 112334667799999853 34688999999999999999999999976443211
Q ss_pred --------HH-HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 445 --------QN-LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 445 --------~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+ +.+.++.. --++.|. .....+.+..+++...+..++ +|-++.++++
T Consensus 303 rGe~Cr~CQ~~LFesIQEG--kYeFPdk----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEG--KYEFPDK----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhcc--CCcCChh----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 11111111 0111111 233344556677777777887 8999988886
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=278.84 Aligned_cols=238 Identities=16% Similarity=0.242 Sum_probs=200.3
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCC-EEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGS-LVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.+++.+..||-|+||.|-+...+... ..|+|.+.+ ++.++...|-.||...+.|.||++|-.|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 35666778999999999999865433 367776554 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
|-|-+|.|...|++.. .++......++..+.+|++|||+ ++||.|||||+|.+|+.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999998763 68888888999999999999999 6999999999999999999999999999999988
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....+.+||+.|.|||.+.++..+.++|.||+|+++|||+||.+||...+.-...+.+.+......++.
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr---------- 642 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR---------- 642 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc----------
Confidence 8888889999999999999999999999999999999999999999998876666666666554433322
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCC
Q 009644 470 VGAATEMMELALQCVDVSS-RRPS 492 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt 492 (530)
.......+++++....+| +|--
T Consensus 643 -~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 -RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -ccchhHHHHHHHHHhcCcHhhhc
Confidence 223455666665444555 7764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=281.06 Aligned_cols=256 Identities=18% Similarity=0.230 Sum_probs=176.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-----------------cCCCEEEEEEccccc---HHH--------------HHHH
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-----------------QDGSLVVIKRHLQTQ---IQN--------------FLHE 280 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-----------------~~~~~vavK~~~~~~---~~~--------------~~~E 280 (530)
..++|++.++||+|+||.||+|.. .+++.||||++.... .++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235679999865321 123 3446
Q ss_pred HHHHHhcCCCCc-----ceEEEEEee--------cCceeEEeeccCCCChHHHhhccCCC-------------------C
Q 009644 281 VKHIARVHHRHL-----VKLVGFCEE--------NHQQLLIYDYIPNGNVQNHLYDSEGL-------------------P 328 (530)
Q Consensus 281 ~~il~~l~H~nI-----v~l~g~~~~--------~~~~~LV~Ey~~~GsL~~~l~~~~~~-------------------~ 328 (530)
+..+.+++|.++ ++++++|.. .+..+|||||+++|+|.++++...+. .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 778888753 35689999999999999999753210 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC--cccccccccCcc
Q 009644 329 IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG--STSAVDCFLDPE 406 (530)
Q Consensus 329 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~--~~~gt~~y~aPE 406 (530)
...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......... ...+++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1245678889999999999999999 599999999999999999999999999997654332222 223477899999
Q ss_pred ccCCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCCCchH------HHHHHHHhhccC
Q 009644 407 LNLSKNY----------------------SAGSDVYSFGVFLLELISGRE-AHGRNHSNSDQ------NLILQVKRSCDL 457 (530)
Q Consensus 407 ~~~~~~~----------------------s~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~------~~~~~~~~~~~~ 457 (530)
.+..... ..+.||||+||++|||++|.. |+......... ....+.....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~-- 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG-- 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc--
Confidence 8754321 134799999999999999875 55422111000 0000100000
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCC---C-CCCCHHHHHH
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVS---S-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~---p-~RPt~~eVl~ 498 (530)
...+ +. ..........+++.+++..+ + +|+|++|+++
T Consensus 459 -~~~~--~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 -QKYD--FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -cCCC--cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0001 10 11223456778888888753 3 6999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.98 Aligned_cols=256 Identities=18% Similarity=0.196 Sum_probs=166.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-C----CCEEEEEEcccccHHH-HHHHHHHHHhcCCCCcceEEEE------Eeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-D----GSLVVIKRHLQTQIQN-FLHEVKHIARVHHRHLVKLVGF------CEEN 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~----~~~vavK~~~~~~~~~-~~~E~~il~~l~H~nIv~l~g~------~~~~ 302 (530)
..++|+..+.||+|+||.||+|... + +..||+|++......+ +..| .+....+.++..++.. +..+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 4578999999999999999999964 4 6889999876433222 2221 1222223333222221 2456
Q ss_pred CceeEEeeccCCCChHHHhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL---------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSN 367 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~N 367 (530)
...++||||+++++|.+++...... .........+..++.|++.||+|||+ ++|+||||||+|
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRDLKP~N 285 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRDVKPQN 285 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCcCCHHH
Confidence 6889999999999999998754210 00011233456799999999999999 699999999999
Q ss_pred EEEcC-CCeEEEeecCCcccccCCC--CcCcccccccccCccccCCC----------------------CCCchhhHHHH
Q 009644 368 VLLEE-NYTAKVSDYGLLKLVTGSH--HAGSTSAVDCFLDPELNLSK----------------------NYSAGSDVYSF 422 (530)
Q Consensus 368 ILl~~-~~~~KI~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDVwSf 422 (530)
||+++ ++.+||+|||+|+.+.... ......+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 6899999999998654322 22344578899999965322 24456799999
Q ss_pred HHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh-ccCCc---cccccccc-------cchhHHHHHHHHHHHcccCCC-CC
Q 009644 423 GVFLLELISGREAHGRNHSNSDQNLILQVKRS-CDLGK---YVDKTLGE-------QTVGAATEMMELALQCVDVSS-RR 490 (530)
Q Consensus 423 Gvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-~~~~~---~~d~~l~~-------~~~~~~~~l~~li~~Cl~~~p-~R 490 (530)
||+||||+++..++... ........... .+... ...+.... ..........+++.+|++.+| +|
T Consensus 366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999977654321 11111111110 00000 01111000 000011234589999999999 99
Q ss_pred CCHHHHHH
Q 009644 491 PSMRQIAG 498 (530)
Q Consensus 491 Pt~~eVl~ 498 (530)
||++|+++
T Consensus 442 ~ta~e~L~ 449 (566)
T PLN03225 442 ISAKAALA 449 (566)
T ss_pred CCHHHHhC
Confidence 99999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=266.67 Aligned_cols=255 Identities=16% Similarity=0.275 Sum_probs=200.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc--ccHHHHHHHHHHHHhcCC--C----CcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ--TQIQNFLHEVKHIARVHH--R----HLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~E~~il~~l~H--~----nIv~l~g~~~~~~~~~ 306 (530)
+++|.+...+|+|.||.|-.+.. ..+..||+|+++. ...+..+-|+++|.++.+ | -+|++.+++.-.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 68899999999999999999984 3468899998764 334566789999999932 2 3788889999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--------------
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-------------- 372 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-------------- 372 (530)
+|+|.+ +-|+.++|..+.. ..++...+..|+.|++++++|||+ .+++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 6699999987643 368899999999999999999999 59999999999999942
Q ss_pred ------CCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 009644 373 ------NYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446 (530)
Q Consensus 373 ------~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 446 (530)
+..+||.|||.|+.-... ......|..|.|||++.+-.++.++||||+||+|.|+.||...|......+...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 346899999999875443 345567889999999999999999999999999999999999998776555444
Q ss_pred HHHHHHhhccC----------------------------Ccccc--cccc---ccchhHHHHHHHHHHHcccCCC-CCCC
Q 009644 447 LILQVKRSCDL----------------------------GKYVD--KTLG---EQTVGAATEMMELALQCVDVSS-RRPS 492 (530)
Q Consensus 447 ~~~~~~~~~~~----------------------------~~~~d--~~l~---~~~~~~~~~l~~li~~Cl~~~p-~RPt 492 (530)
+.+.+....+. ....+ ..+. .....+..++.+|+.+++..|| +|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 44433221100 00000 0010 1233456789999999999999 9999
Q ss_pred HHHHHH
Q 009644 493 MRQIAG 498 (530)
Q Consensus 493 ~~eVl~ 498 (530)
+.|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=246.14 Aligned_cols=205 Identities=20% Similarity=0.309 Sum_probs=168.9
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc----ccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ----TQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~----~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
++...+....+..||+|+||.|-+-+ ..+|...|+|++.. +..++.++|+.+..+- ..|.+|++||.....+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34445666677899999999998888 56799999998653 3345678899876654 799999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++.||.|. .||..+-+.-- ...+.+++.-+-+|+..+..||.|||+. -.+||||+||+|||++.+|++|+||||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 58877655321 1123788888999999999999999985 589999999999999999999999999998
Q ss_pred cccCCCCcCcccccccccCccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNL----SKNYSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
.+.++-......|...|||||.+. ...|+.||||||+|+++.||.+++.||..-
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 877654444455777899999875 347999999999999999999999999754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=257.10 Aligned_cols=254 Identities=20% Similarity=0.373 Sum_probs=192.5
Q ss_pred CCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc-cc----HHHHHHHHHHHHhcCCCCcceEEEEEee--------cC
Q 009644 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-TQ----IQNFLHEVKHIARVHHRHLVKLVGFCEE--------NH 303 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~--------~~ 303 (530)
.|+...+||+|.||.||+++ .+.|+.||+|+..- .+ -...++|+.+|..+.|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999999 45577888886442 22 2456899999999999999999998853 23
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
.+++||.+|+. +|...|.... ..++..++.+++.++..||.|+|+ ..|+|||+|+.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 58999999976 8888887643 378999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCC-----cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 384 LKLVTGSHH-----AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 384 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
++.+..... ......|..|.+||.+.+ ..|+++.|||.-||++.||.||.+-+..+......+.+...-....-
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987643321 122335888999999875 67999999999999999999999999877655544555444322110
Q ss_pred Ccc-----------c-cccccc----cchhHH------HHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKY-----------V-DKTLGE----QTVGAA------TEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~-----------~-d~~l~~----~~~~~~------~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+ + -++++. ...+.. .+..+++...+..|| +|+++++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000 0 000111 011111 256788888889999 9999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=287.37 Aligned_cols=242 Identities=22% Similarity=0.372 Sum_probs=188.2
Q ss_pred CccceeeccCCcE-EEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 239 FSEINIIGEGSFG-LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 239 f~~~~~LG~G~fG-~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
|...+++|.|+.| .||+|.+ +|+.||||++..+...-..+|+..|+.- .|||||++++.-.++.+.|+..|.| ..+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 4555789999987 5899999 5789999999888777788999999988 6999999999999999999999999 569
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCeEEEeecCCcccccCCC
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-----NYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-----~~~~KI~DFGla~~~~~~~ 391 (530)
|.+++... +.............+..|++.||++||+. +||||||||.||||+. ...++|+|||+++.+..+.
T Consensus 589 L~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl--~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSL--KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhc--ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999874 11111112134567889999999999995 9999999999999976 2589999999999886554
Q ss_pred C----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 392 H----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG-REAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
. .....||.+|+|||++....-+.++||||+|||+|..++| ..||+.....+ .+++.... .+..+ .
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~~~~---~L~~L-----~ 736 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILTGNY---TLVHL-----E 736 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhcCcc---ceeee-----c
Confidence 3 2344589999999999988888999999999999999995 89998543221 11111111 01000 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIA 497 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl 497 (530)
. ..+ .+..+|+.++++.+| .||++.+|+
T Consensus 737 ~-~~d--~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 737 P-LPD--CEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred c-Cch--HHHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 111 177899999999999 899999997
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=272.41 Aligned_cols=200 Identities=22% Similarity=0.349 Sum_probs=171.8
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
-|..++.||-|+||.|.+++. +....+|.|.+.+. +......|-.||+.-+.+.||+||-.|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477788999999999999984 44667899876653 34578899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc--
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT-- 388 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~-- 388 (530)
|+++|++-.+|.+. +.+.+..+..++.++..|+++.|.+ |+|||||||.|||||.+|++||.||||+.-+.
T Consensus 710 YIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999865 3788888888999999999999995 99999999999999999999999999985331
Q ss_pred -------CCCC----------------------------------cCcccccccccCccccCCCCCCchhhHHHHHHHHH
Q 009644 389 -------GSHH----------------------------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLL 427 (530)
Q Consensus 389 -------~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ 427 (530)
...+ .....||+.|+|||++....|+.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1000 11233889999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCch
Q 009644 428 ELISGREAHGRNHSNSD 444 (530)
Q Consensus 428 ElltG~~p~~~~~~~~~ 444 (530)
||+.|++||..+...+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999987655443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=245.13 Aligned_cols=196 Identities=19% Similarity=0.340 Sum_probs=172.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccH------HHHHHHHHHHHhc-CCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQI------QNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|..+++||+|+|.+|..+++ +..+.+|+|+++++-. +=...|-.+.... +||.+|.++.+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 36799999999999999999994 5577899998765422 2245566666665 79999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|.||+++|+|.-++...+ +++++.+..+...|.-||.|||+ .+||.||||..|+|+|..|++|+.|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998887764 78999999999999999999999 69999999999999999999999999999854
Q ss_pred -cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 009644 388 -TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR 438 (530)
Q Consensus 388 -~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 438 (530)
.......+.+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+-
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 344556678899999999999999999999999999999999999999973
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=229.33 Aligned_cols=205 Identities=33% Similarity=0.571 Sum_probs=179.7
Q ss_pred eccCCcEEEEEEEEcC-CCEEEEEEcccccH----HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHH
Q 009644 245 IGEGSFGLAYKGLLQD-GSLVVIKRHLQTQI----QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQN 319 (530)
Q Consensus 245 LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~----~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~ 319 (530)
||+|++|.||++...+ ++.+++|....... +.+.+|++.++.+.|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 88999999876643 679999999999999999999999999899999999999999999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCcccccCCC-CcCccc
Q 009644 320 HLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVTGSH-HAGSTS 397 (530)
Q Consensus 320 ~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~~~~-~~~~~~ 397 (530)
++.... ..+++..+..++.+++++|+|||+ .+++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 987642 258899999999999999999999 59999999999999999 8999999999998764432 122344
Q ss_pred ccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHH
Q 009644 398 AVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEM 476 (530)
Q Consensus 398 gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 476 (530)
+...|++||..... .++.++|+|++|+++++| ..+
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~ 190 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PEL 190 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHH
Confidence 66779999998777 888999999999999999 367
Q ss_pred HHHHHHcccCCC-CCCCHHHHHHH
Q 009644 477 MELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 477 ~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.+++..|++.+| +||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 889999999998 99999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=234.89 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=199.0
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccHHHHHHHHHHHHhcC-CCCcceEEEEEeec--CceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARVH-HRHLVKLVGFCEEN--HQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~--~~~~LV~Ey 311 (530)
.++|++.+++|+|.|+.||.|. ..+.+.++||.+++-..+...+|+.||..+. ||||+++++...+. ..+.||+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4689999999999999999999 6778899999999988889999999999996 99999999998765 457799999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCcccccCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~~~ 390 (530)
+.+.+....-. .++..++..++.++++||.|+|+ .||.|||+||.|+++|. .-.++|.|+|+|.+....
T Consensus 117 v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 117 VNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99887665442 67888899999999999999999 59999999999999996 457999999999988766
Q ss_pred CCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH-HHHHHHHhhccCCc-------cc
Q 009644 391 HHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGK-------YV 461 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~-------~~ 461 (530)
........+..|--||.+.. ..|+..-|+|||||+|..|+..+.||....++.++ -.+..+....++.. -+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 65555566777899998864 56889999999999999999999999876654332 12222211111000 02
Q ss_pred cccccc----------------cc-hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGE----------------QT-VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~----------------~~-~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
|+.+.+ .. .-...+.++++.+.+..|. +|||+.|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 222111 00 0113577888888889997 9999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=231.98 Aligned_cols=194 Identities=28% Similarity=0.465 Sum_probs=169.6
Q ss_pred CccceeeccCCcEEEEEEEEcC-CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 239 FSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
|...+.||+|++|.||++...+ +..+++|..... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566899999999999999765 789999987754 45688999999999999999999999999899999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC--
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-- 391 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-- 391 (530)
+++|.+++..... .+++.....++.+++.++.|||+ .+++|+|++|.||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976531 27899999999999999999999 599999999999999999999999999998765432
Q ss_pred CcCcccccccccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 009644 392 HAGSTSAVDCFLDPELN-LSKNYSAGSDVYSFGVFLLELISGREAHGR 438 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 438 (530)
......++..|++||.. ....++.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334466779999998 677788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=254.99 Aligned_cols=193 Identities=18% Similarity=0.327 Sum_probs=167.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccH--H---------HHHHHHHHHHhcC---CCCcceEEEEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQI--Q---------NFLHEVKHIARVH---HRHLVKLVGFCEE 301 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~--~---------~~~~E~~il~~l~---H~nIv~l~g~~~~ 301 (530)
.+|..++.+|+|+||.|+.+.++ +...|++|.+.++.. + ..-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888899999999999999965 456788998776542 1 2456999999997 9999999999999
Q ss_pred cCceeEEeeccC-CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 302 NHQQLLIYDYIP-NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 302 ~~~~~LV~Ey~~-~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
++.+||+||-.. +-+|.+++.... .+++.+...|+.|++.|+++||+ .+|||||||-+|+.++.+|.+||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEee
Confidence 999999999664 458999997653 78999999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCC
Q 009644 381 YGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHG 437 (530)
Q Consensus 381 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~ 437 (530)
||.|....+ .......||..|.|||++.+.+|- ..-|||++|++||.++....||+
T Consensus 714 fgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876543 345667899999999999998885 55899999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=239.17 Aligned_cols=201 Identities=18% Similarity=0.363 Sum_probs=165.6
Q ss_pred ccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-----ceeEE
Q 009644 240 SEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH-----QQLLI 308 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-----~~~LV 308 (530)
+..+.||-|+||.||... -++|+.|+.|++..- ..+.+.+|+.+|.-++|.|++..++...... +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 344789999999999988 567999999987642 3467899999999999999999998776543 56889
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
+|.| ..+|...+-.. ..++...+.-+..||++||.|||+. +|.||||||.|.|+++|..+||||||++|...
T Consensus 136 TELm-QSDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-HhhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEeccCceEEecccccccccc
Confidence 9999 45787777543 2688888888999999999999994 99999999999999999999999999999765
Q ss_pred CCCC--cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH
Q 009644 389 GSHH--AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI 448 (530)
Q Consensus 389 ~~~~--~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~ 448 (530)
.+.. ......|.+|.|||.+.+ ..|+.+.||||.||++.|++..+..|......+...++
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 4432 233346788999999886 56999999999999999999999888766554444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=233.39 Aligned_cols=251 Identities=18% Similarity=0.301 Sum_probs=187.6
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------Cc
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------HQ 304 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~~ 304 (530)
.+|.-+..+|.|.- .|-.+. .-.++.||+|+.... ..++..+|..++..++|+||++++.++... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888877 444444 234788999976532 345678899999999999999999999654 35
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.|+||||| .++|.+.+.- .++-..+..|..|++.|++|||+ .+|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchhh
Confidence 78999999 5699988872 57788899999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH------------H
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV------------K 452 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~------------~ 452 (530)
+....+...+....|..|.|||++.+..|.+.+||||.||++.||++|+..|.+....+....+... .
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 8765554445566888999999999988999999999999999999999988754322221111110 0
Q ss_pred hh-------------ccCCcccccc-c---cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 453 RS-------------CDLGKYVDKT-L---GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 453 ~~-------------~~~~~~~d~~-l---~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. ....+.+... . .+.+........+++.+++-.+| +|-++++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 0001111111 1 11112233456788999999998 9999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=258.28 Aligned_cols=250 Identities=19% Similarity=0.317 Sum_probs=199.9
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
...++|+.+..+|.|.||.|||++ ...++..|+|.++- ...+-..+|+-+++..+|||||.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 345789999999999999999999 56788889887653 33455678999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
|||.+|+|++.-+.. +.+++.++..+++...+||+|||+ .+-+|||||-.|||+++.+.+|++|||.+..++.
T Consensus 92 EycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchhhhhh
Confidence 999999999977654 379999999999999999999999 5889999999999999999999999999876644
Q ss_pred CC-CcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 390 SH-HAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 390 ~~-~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
.- ...+..||++|||||+.. .+.|..++|||+.|++..|+-.-++|..+.+... .....-+.. +-.+.+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~-----~qpp~l 237 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSG-----FQPPTL 237 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccC-----CCCCcc
Confidence 32 234667999999999864 5679999999999999999998888865443211 111111111 112222
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ....-...+-++++.|+..+| +|||++.++.
T Consensus 238 k-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 K-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred c-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2 223334567889999999998 9999988653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=224.28 Aligned_cols=250 Identities=15% Similarity=0.248 Sum_probs=177.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhc-CCCCcceEEEE-EeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARV-HHRHLVKLVGF-CEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l-~H~nIv~l~g~-~~~~~~~~LV~E 310 (530)
.+.|.+.+.||+|.||.+-++..+ ..+.+++|.+.... ..+|.+|..---.| .|.||+.-|++ |+..+.+.+++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 356888899999999999999964 46778889876544 57899998765555 69999998875 567778889999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCeEEEeecCCccccc
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE--ENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~--~~~~~KI~DFGla~~~~ 388 (530)
|++.|+|..-+... .+.+.....++.|+++|+.|+|+ +++||||||.+|||+- +..++|+||||+.+...
T Consensus 103 ~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999998877543 46677788899999999999999 6999999999999994 34589999999988654
Q ss_pred CCCCcCcccccccccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSK-----NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
..-. ...-+..|.+||..... ...+.+|||.||++++.++||+.||........ ....+..-..... +
T Consensus 175 ~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w~~rk~----~ 247 (378)
T KOG1345|consen 175 TTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQWLKRKN----P 247 (378)
T ss_pred ceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHHhcccC----c
Confidence 3211 12234458999976532 236789999999999999999999985443222 2222222111111 1
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
.++.........+..+-++-+...+ +|--..++.+.-
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 2222112223455566666667777 554555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=240.82 Aligned_cols=259 Identities=18% Similarity=0.269 Sum_probs=200.6
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH--HHHHHHHHHHHhcC------CCCcceEEEEEeecCc
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI--QNFLHEVKHIARVH------HRHLVKLVGFCEENHQ 304 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~------H~nIv~l~g~~~~~~~ 304 (530)
.....|.+....|+|-|++|.+|. ...|+.||||++...+. +.=+.|++||.+|+ --|+++|+..|...++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 345678888899999999999999 44578999999887654 45678999999994 3589999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGL 383 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGl 383 (530)
+|||+|-+ .-+|.+.|+...... .|....+..++.|+.-||.+|-.+ +|+|.||||.|||+++. ..+||||||.
T Consensus 509 LClVFE~L-slNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~c--~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKKC--GVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHhc--CeeecccCccceEeccCcceeeeccCcc
Confidence 99999988 559999998764322 577888999999999999999997 99999999999999975 5789999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-----cCC
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-----DLG 458 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-----~~~ 458 (530)
|....... ......+..|.|||.+.+..|+...|+||.||+||||.||+..|.+...+....+...++... .-.
T Consensus 584 A~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 584 ASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 97765432 222334556999999999999999999999999999999999998766554443333322111 000
Q ss_pred cc------------------------------cc------------ccccccchhHHHHHHHHHHHcccCCC-CCCCHHH
Q 009644 459 KY------------------------------VD------------KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQ 495 (530)
Q Consensus 459 ~~------------------------------~d------------~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~e 495 (530)
.+ +. +.+++........+.+|+..|+..+| +|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 00 01 11222333455677888899999998 8999888
Q ss_pred HHH
Q 009644 496 IAG 498 (530)
Q Consensus 496 Vl~ 498 (530)
.++
T Consensus 743 AL~ 745 (752)
T KOG0670|consen 743 ALK 745 (752)
T ss_pred Hhc
Confidence 764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=266.35 Aligned_cols=192 Identities=14% Similarity=0.181 Sum_probs=138.9
Q ss_pred hcCC-CCcceEEEEE-------eecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 009644 286 RVHH-RHLVKLVGFC-------EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357 (530)
Q Consensus 286 ~l~H-~nIv~l~g~~-------~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 357 (530)
.++| +||++++++| .....+++++||+ .++|.++|.... ..+++.+++.++.||++||+|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHS--QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHh--CC
Confidence 4455 6888888887 2334577889988 669999997532 368999999999999999999999 69
Q ss_pred eeecCCCCCcEEEcC-------------------CCeEEEeecCCcccccCCC-----------------CcCccccccc
Q 009644 358 LFHMHFRTSNVLLEE-------------------NYTAKVSDYGLLKLVTGSH-----------------HAGSTSAVDC 401 (530)
Q Consensus 358 ivHrDLk~~NILl~~-------------------~~~~KI~DFGla~~~~~~~-----------------~~~~~~gt~~ 401 (530)
|+||||||+||||+. ++.+|++|||+++...... ......+|+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4556777777776421100 0011236788
Q ss_pred ccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHH
Q 009644 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELAL 481 (530)
Q Consensus 402 y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 481 (530)
|||||++.+..|+.++|||||||+||||++|.+|+.... ......... ..++. .........+++.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~-----~~~~~----~~~~~~~~~~~~~ 246 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR-----VLPPQ----ILLNWPKEASFCL 246 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh-----hcChh----hhhcCHHHHHHHH
Confidence 999999999999999999999999999999988764211 111111111 01111 1112234568888
Q ss_pred HcccCCC-CCCCHHHHHH
Q 009644 482 QCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 482 ~Cl~~~p-~RPt~~eVl~ 498 (530)
+||+.+| +||||.||++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 9999999 9999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=228.48 Aligned_cols=130 Identities=20% Similarity=0.307 Sum_probs=110.6
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccccc--HHHHHHHHHHHHhcC-----C---CCcceEEEEEee---
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVH-----H---RHLVKLVGFCEE--- 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-----H---~nIv~l~g~~~~--- 301 (530)
..+|-+.++||-|.|++||++. ..+.+.||+|+.+..+ .+..+.|+.+|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3678889999999999999999 5677899999876543 456788999999983 3 469999999964
Q ss_pred -cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 302 -NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 302 -~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
+.+.++|+|++ +.+|..+|..... ..++...+..|+.|++.||.|||.. -+|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence 45899999999 7799999886543 3688899999999999999999985 399999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=207.43 Aligned_cols=169 Identities=16% Similarity=0.222 Sum_probs=127.8
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~ 394 (530)
|+|.+++.... ..+++.++..++.|++.||+|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~--~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQ--A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc--C------CcccEeEcCccceee--ccceEeeccc----
Confidence 78999998643 2699999999999999999999994 4 999999999999999 9999876432
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH-
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA- 473 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~- 473 (530)
...++..|||||++.+..++.++|||||||++|||+||+.||....... ............ . ++..........
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~--~-~~~~~~~~~~~~~ 137 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA--D-DPRDRSNLESVSA 137 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc--C-CccccccHHHHHh
Confidence 2257889999999999999999999999999999999999996543211 111121111110 0 000000111122
Q ss_pred -HHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 474 -TEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 474 -~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+.+++.+|+..+| +|||+.|+++.+..+...
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 268999999999998 999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=221.32 Aligned_cols=199 Identities=24% Similarity=0.374 Sum_probs=166.3
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc-cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT-QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
+....+.|..+++||+|.|++||++... ....||+|.+... ......+|++.|..+ .+.||+++.+++..++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 4455678899999999999999999843 4678999987654 456789999999999 699999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLL 384 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla 384 (530)
.+|+||+++.+..++.. .++..++..+++.+..||+|+|. +||||||+||+|+|.+. .+.-.|.|||+|
T Consensus 111 ~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEechhH
Confidence 99999999999988886 46788899999999999999999 69999999999999985 467789999998
Q ss_pred ccccCC---------------C------------------------------CcCcccccccccCccccCC-CCCCchhh
Q 009644 385 KLVTGS---------------H------------------------------HAGSTSAVDCFLDPELNLS-KNYSAGSD 418 (530)
Q Consensus 385 ~~~~~~---------------~------------------------------~~~~~~gt~~y~aPE~~~~-~~~s~ksD 418 (530)
...... . ......||++|.|||++.. ..-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 721100 0 0011238999999999874 45688999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC
Q 009644 419 VYSFGVFLLELISGREAHGRNH 440 (530)
Q Consensus 419 VwSfGvvl~ElltG~~p~~~~~ 440 (530)
|||.||+++-+++++.||....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeeccceeehhhccccccccCc
Confidence 9999999999999999997654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=206.86 Aligned_cols=242 Identities=22% Similarity=0.340 Sum_probs=185.1
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
..+|.+...|..|+|+++.+. +++|++.- ...++|..|.-.|+-+.||||+.++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 356888899999999997554 55555432 234689999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe--ecCCcccccCCCCcC
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS--DYGLLKLVTGSHHAG 394 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~--DFGla~~~~~~~~~~ 394 (530)
|+..|++..+. ..+..+..+++.++|+|++|||+..+-|.---|.+..+++|++.+++|+ |--++. . ..
T Consensus 274 lynvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--q----e~ 344 (448)
T KOG0195|consen 274 LYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q----EV 344 (448)
T ss_pred HHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--e----cc
Confidence 99999976542 5678899999999999999999974445555799999999999999885 211111 1 11
Q ss_pred cccccccccCccccCCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 395 STSAVDCFLDPELNLSKNYS---AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s---~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
...-.+.||+||.+...+-+ .++|+|||.+++||+.|.+.||..-..-+..-.+. ++. +.. ..++.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------leg-lrv---~ippg 413 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------LEG-LRV---HIPPG 413 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------hcc-ccc---cCCCC
Confidence 22235679999999866543 56999999999999999999997654322211111 111 011 13445
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.+..+.+++.-|...|| +||.+..|+-.|+++.
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 56788899999999999 9999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-22 Score=205.34 Aligned_cols=267 Identities=18% Similarity=0.239 Sum_probs=198.3
Q ss_pred CCccceeeccCCcEEEEEEEEcCC--CEEEEEEccccc---HHHHHHHHHHHHhcCC----CCcceEEEEE-eecCceeE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDG--SLVVIKRHLQTQ---IQNFLHEVKHIARVHH----RHLVKLVGFC-EENHQQLL 307 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~--~~vavK~~~~~~---~~~~~~E~~il~~l~H----~nIv~l~g~~-~~~~~~~L 307 (530)
+|.+.+.||+|+||.||++..... ..+|+|...... ...+..|..++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999996543 478888755432 1267889999998863 6889999988 57778999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-----CeEEEeecC
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-----YTAKVSDYG 382 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-----~~~KI~DFG 382 (530)
||+.+ +.+|.++..... .+.++..+.+.|+.|++.+|++||+ .+++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999776543 2479999999999999999999999 599999999999999865 469999999
Q ss_pred Ccc--cccCCC----C-----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 383 LLK--LVTGSH----H-----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 383 la~--~~~~~~----~-----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
+++ .+.... . .....||..|.++....+...+.+.|+||++.++.|+..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 332111 0 12234899999999999999999999999999999999999999655433222222222
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccccc
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEE 518 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ee 518 (530)
........ .... .+..+.++...+-..+- ++|....+...|++..........+.++.+
T Consensus 253 ~~~~~~~~-----~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~ 312 (322)
T KOG1164|consen 253 PRKLLTDR-----FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE 312 (322)
T ss_pred hhhhcccc-----ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence 22211111 1111 22344444444434554 899999999999998877655555555543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=212.98 Aligned_cols=159 Identities=14% Similarity=0.183 Sum_probs=124.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc--CCCEEEEEEcccc--------cHHHHHHHHHHHHhcCCCCcce-EEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ--DGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVK-LVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~--~~~~vavK~~~~~--------~~~~~~~E~~il~~l~H~nIv~-l~g~~~~~~ 303 (530)
..++|...+.||+|+||+||+|... +++.+|||+.... ..+.|.+|+++|++++|+|++. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4577999999999999999999854 5777899975422 2356899999999999999985 4432 4
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCcEEEcCCCeEEEeecC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-RTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDL-k~~NILl~~~~~~KI~DFG 382 (530)
..++||||+++++|.. +. . .. ...++.++++||+|||+ .+|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~-~-------~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR-P-------HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hC-c-------cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5799999999999963 21 1 11 14578899999999999 59999999 9999999999999999999
Q ss_pred CcccccCCCCc---------CcccccccccCccccCCC
Q 009644 383 LLKLVTGSHHA---------GSTSAVDCFLDPELNLSK 411 (530)
Q Consensus 383 la~~~~~~~~~---------~~~~gt~~y~aPE~~~~~ 411 (530)
+|+.+...... ....++..|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99976443211 123366779999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-21 Score=194.34 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=191.8
Q ss_pred CccceeeccCCcEEEEEEEEcCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCC-CcceEEEEEeecCceeEEeec
Q 009644 239 FSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHR-HLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~-nIv~l~g~~~~~~~~~LV~Ey 311 (530)
|...+.||.|+||.||++... ..+++|.+... ....|.+|+.+++.+.|+ +++++++++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999976 67888876532 256799999999999988 799999999777778999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCcccccCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKLVTGS 390 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~~~~~ 390 (530)
+.++++.+++...... ..+.......+..|++.+++|+|+ .+++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654211 258889999999999999999999 5899999999999999988 7999999999865443
Q ss_pred C-------CcCcccccccccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHHHHhhc-c-C
Q 009644 391 H-------HAGSTSAVDCFLDPELNLS---KNYSAGSDVYSFGVFLLELISGREAHGRNHSN-SDQNLILQVKRSC-D-L 457 (530)
Q Consensus 391 ~-------~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~-~~~~~~~~~~~~~-~-~ 457 (530)
. ......++..|++||.+.. ..++...|+||+|++++++++|..||...... ............. . .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 3 1244568899999999987 57889999999999999999999997655431 0111112111111 0 0
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
....... ........+.+++..|+..++ .|.++.+....
T Consensus 236 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPS---NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcc---ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 001223567888888998888 89998887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=179.47 Aligned_cols=210 Identities=18% Similarity=0.253 Sum_probs=171.9
Q ss_pred hhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccccH-HHHHHHHHHHHhcCC-CCcceEEEEEeecCceeEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQI-QNFLHEVKHIARVHH-RHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~~~-~~~~~E~~il~~l~H-~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
...+|..++.||+|+||.+|.|. ..+|..||+|.-+.... ..+.-|..+...++| ..|..+..|..+...-.+||+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 35789999999999999999999 78899999998665432 467789999999865 5677777788888899999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CeEEEeecCCccccc
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN---YTAKVSDYGLLKLVT 388 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~---~~~KI~DFGla~~~~ 388 (530)
+ +.+|.+...-... .++..+++-++-|++.-++|+|. +++|||||||+|+|..-+ ..+.++|||+|+.+.
T Consensus 93 L-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred c-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 8 8899988865432 78999999999999999999999 699999999999999743 468899999999775
Q ss_pred CCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 389 GSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 389 ~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
+..+ .....||..|.+-....+..-+.+-|+=|+|.+|...-.|..||.+-......+..+++
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 4322 12345888898877777777788999999999999999999999876655444444444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-21 Score=203.20 Aligned_cols=215 Identities=24% Similarity=0.404 Sum_probs=166.7
Q ss_pred HHhcCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009644 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF 363 (530)
Q Consensus 284 l~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDL 363 (530)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..+++.-...+.++++.||+|||+. +-..|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNS-PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcC-cceeeeee
Confidence 356789999999999999999999999999999999998743 3789999999999999999999984 33399999
Q ss_pred CCCcEEEcCCCeEEEeecCCcccccCCC---CcCcccccccccCccccCCC---C----CCchhhHHHHHHHHHHHHcCC
Q 009644 364 RTSNVLLEENYTAKVSDYGLLKLVTGSH---HAGSTSAVDCFLDPELNLSK---N----YSAGSDVYSFGVFLLELISGR 433 (530)
Q Consensus 364 k~~NILl~~~~~~KI~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~----~s~ksDVwSfGvvl~ElltG~ 433 (530)
+++|++++..+.+||+|||+........ ..........|.|||.+... . .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987764311 11111233459999998753 1 467799999999999999999
Q ss_pred CCCCCCCCCch-HHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 434 EAHGRNHSNSD-QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 434 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.||........ ..++.++.. .......|.+.... +....+..++..||..+| +||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh--cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99987543322 345555444 12223333333222 334478999999999999 999999999988877653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-20 Score=178.39 Aligned_cols=209 Identities=16% Similarity=0.268 Sum_probs=174.8
Q ss_pred cCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc-ccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccC
Q 009644 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ-TQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~-~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
-+|.+.++||+|+||..+.|. +-+++.||||.-.. +..-.+..|.+..+.| ..+.|...|-|-.++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 468899999999999999999 66789999997553 3345677788888887 5689999998888888999999998
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-----CeEEEeecCCccccc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-----YTAKVSDYGLLKLVT 388 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-----~~~KI~DFGla~~~~ 388 (530)
+-+|.|+..-.. ..++.++++.+|.|+..-++|+|+ +.+|.|||||+|+||... ..+.|.|||+|+.+.
T Consensus 107 GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 789998876554 279999999999999999999999 699999999999999743 468999999999875
Q ss_pred CCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHH
Q 009644 389 GSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK 452 (530)
Q Consensus 389 ~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~ 452 (530)
+..+ ..+..||.+||+-....+..-+.+-|.=|+|-++...+.|..||.+-.........+++.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 4332 234569999999999889999999999999999999999999998765544444444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=180.15 Aligned_cols=136 Identities=14% Similarity=0.119 Sum_probs=106.7
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccccc------------HHHH-----------------HHHHHHHHhcCCCCc
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ------------IQNF-----------------LHEVKHIARVHHRHL 292 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~------------~~~~-----------------~~E~~il~~l~H~nI 292 (530)
...||+|+||.||+|...+|+.||+|++.... ...| ..|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36899999999999998789999999875431 0122 349999999988776
Q ss_pred ceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCcEEEc
Q 009644 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL-HSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 293 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~ivHrDLk~~NILl~ 371 (530)
.....+... ..+|||||++++++....... ..++..+...++.|++.+|.|+ |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE
Confidence 444333222 238999999988776553322 2678899999999999999999 67 5999999999999998
Q ss_pred CCCeEEEeecCCcccc
Q 009644 372 ENYTAKVSDYGLLKLV 387 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~ 387 (530)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=213.24 Aligned_cols=246 Identities=19% Similarity=0.241 Sum_probs=179.2
Q ss_pred cceeeccCCcEEEEEEEE-cCCCEEEEEEcc----c-ccH----HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 241 EINIIGEGSFGLAYKGLL-QDGSLVVIKRHL----Q-TQI----QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~----~-~~~----~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
..+++|.|++|.|+.... ......+.|... . ... ..+..|..+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998777763 333333433221 1 111 125567777888999999888777766666666699
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++. +|..++... +.++..++..++.|+..|++|||+. +|.|||+|++|+++..++.+||+|||.+..+.-.
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~--GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSM--GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhc--CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999999765 2678888999999999999999995 9999999999999999999999999999765432
Q ss_pred CC-----cCcccccccccCccccCCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 391 HH-----AGSTSAVDCFLDPELNLSKNYSAG-SDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 391 ~~-----~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
.. .....|...|+|||.+....|.+. .||||.|+++..|++|+.||.......... ........ ..+...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~--~~~~~~ 549 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQ--RNIFEG 549 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccccc--cccccC
Confidence 22 234557888999999999999865 899999999999999999997654433221 01111000 000000
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.....++.++++.+| +|-|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 011222334566778888999999 9999999986
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=174.01 Aligned_cols=137 Identities=14% Similarity=0.126 Sum_probs=109.2
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccccc-----------------------------HHHHHHHHHHHHhcCCCCc
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----------------------------IQNFLHEVKHIARVHHRHL 292 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~~l~H~nI 292 (530)
...||+|+||.||+|...+|+.||||...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 36899999999999997789999999865421 1123578999999999987
Q ss_pred ceEEEEEeecCceeEEeeccCCCChHHH-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 293 VKLVGFCEENHQQLLIYDYIPNGNVQNH-LYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 293 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~-l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
.....+... ..+|||||++++++... +.. ..++..+...++.|++.++.+||+. .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE
Confidence 555444333 24899999988865443 322 2567888999999999999999982 3999999999999999
Q ss_pred CCCeEEEeecCCccccc
Q 009644 372 ENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~ 388 (530)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=179.62 Aligned_cols=169 Identities=14% Similarity=0.201 Sum_probs=132.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc------HHH------HHHHHHHHHhcCCCCcceEEEEEee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ------IQN------FLHEVKHIARVHHRHLVKLVGFCEE 301 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~------~~~------~~~E~~il~~l~H~nIv~l~g~~~~ 301 (530)
...++|...+.+|.|+||.||.... ++..+|+|.+.+.. .+. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4468999999999999999999665 56789999876432 122 5789999999999999999988653
Q ss_pred c--------CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 009644 302 N--------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN 373 (530)
Q Consensus 302 ~--------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~ 373 (530)
. +..+|||||+++.+|.++. .++. ....+++.+|..+|+ .+++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCC
Confidence 3 3578999999999998863 2222 245689999999999 599999999999999998
Q ss_pred CeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHH
Q 009644 374 YTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELI 430 (530)
Q Consensus 374 ~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ell 430 (530)
+ ++|+|||..+........ ..+.....|..++|+||||+++.-..
T Consensus 172 g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988754322111 11344556778999999999887553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=169.14 Aligned_cols=181 Identities=14% Similarity=0.083 Sum_probs=135.0
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEcccccH-------HHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeecc
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI-------QNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~-------~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+...|++|+||+||.+.- ++..++.+.+..... ..|.+|+++|++++ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997665 567777776654332 24789999999994 5889999986 3468999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-RTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDL-k~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
.+.+|.+.+.. ....++.|++.+|+++|+ .+|+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR------------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh------------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99888654311 113477899999999999 59999999 7999999999999999999998543322
Q ss_pred Cc--------------CcccccccccCccccCC-CCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 009644 392 HA--------------GSTSAVDCFLDPELNLS-KNYS-AGSDVYSFGVFLLELISGREAHGRNH 440 (530)
Q Consensus 392 ~~--------------~~~~gt~~y~aPE~~~~-~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~ 440 (530)
.. .-...++.|++|+...- ...+ ...+.++-|.-+|.++|++.++..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 00113555677765332 1333 56788899999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-19 Score=167.49 Aligned_cols=134 Identities=18% Similarity=0.183 Sum_probs=104.0
Q ss_pred ccceeeccCCcEEEEEEEEcCCCEEEEEEcccc---cHHHHHHHHHHHHhc-----CCCCcceEEEEEeecC---cee-E
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT---QIQNFLHEVKHIARV-----HHRHLVKLVGFCEENH---QQL-L 307 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l-----~H~nIv~l~g~~~~~~---~~~-L 307 (530)
...+.||+|+||.||. ...++.. +||+.... ..+.+.+|+.+++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3447899999999996 3334444 68876543 456789999999999 5799999999998863 333 7
Q ss_pred Eeec--cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCeeecCCCCCcEEEcC----CCeEEEee
Q 009644 308 IYDY--IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL-EHLHSLVPPLFHMHFRTSNVLLEE----NYTAKVSD 380 (530)
Q Consensus 308 V~Ey--~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~ivHrDLk~~NILl~~----~~~~KI~D 380 (530)
|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5589999999653 34444 35678888888 99999 59999999999999974 34899999
Q ss_pred cCCcc
Q 009644 381 YGLLK 385 (530)
Q Consensus 381 FGla~ 385 (530)
|+.++
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-20 Score=193.09 Aligned_cols=183 Identities=26% Similarity=0.333 Sum_probs=154.0
Q ss_pred eeccCCcEEEEEEE----EcCCCEEEEEEccccc-----HHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeeccC
Q 009644 244 IIGEGSFGLAYKGL----LQDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~----~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.+|+|.||.|+..+ .+.+..+|.|...+.. ......|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 2345667777654321 224567888899897 9999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|...+.... .++......+...++-+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l--~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL--GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh--HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999998887653 567777777888899999999994 9999999999999999999999999999976543322
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR 438 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~ 438 (530)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8899999999987 677899999999999999999999985
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=191.50 Aligned_cols=249 Identities=17% Similarity=0.252 Sum_probs=181.5
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC---CCCcceEEEEEeecCceeEE
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~~LV 308 (530)
.+.....|.+.+.||+|+||+||+|...+|+.||+|.-.....=+|.--.+++.+|+ -+-|..+...+.-.+.-+||
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 334456788889999999999999998789999999877655444444445555555 22344444444555667899
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-------CCeEEEeec
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-------NYTAKVSDY 381 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-------~~~~KI~DF 381 (530)
+||.+.|+|.+++... +.+++.....++.|++.-+++||.+ +|||+||||+|+||.. +.-++|+||
T Consensus 773 ~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~--~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAM--GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhc--ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999843 3789999999999999999999995 9999999999999952 446899999
Q ss_pred CCcccc---cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 382 GLLKLV---TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 382 Gla~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
|.+-.+ .+........+|..+-.+|+..++.++...|-|.+..+++-|+.|+.-= ++. ...
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~--g~~ 909 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKN--GSS 909 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcC--Ccc
Confidence 998644 3333444556788899999999999999999999999999999997421 111 011
Q ss_pred ccccccccccc-hhHHHHHHHHHHHcccCC-CCCCCHHHHHHHHHhhHHH
Q 009644 459 KYVDKTLGEQT-VGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQER 506 (530)
Q Consensus 459 ~~~d~~l~~~~-~~~~~~l~~li~~Cl~~~-p~RPt~~eVl~~L~~i~~~ 506 (530)
..++..+..+. .+...++.++++. .+ +.=|...++...+++++..
T Consensus 910 ~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 910 WMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred eeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHHH
Confidence 11222222322 2233455665554 44 3678888888888887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-19 Score=193.67 Aligned_cols=244 Identities=18% Similarity=0.281 Sum_probs=175.0
Q ss_pred CCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc----HHHHHHHHHH--HHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ----IQNFLHEVKH--IARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----~~~~~~E~~i--l~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++...+.||++.|=+|.+|+.+.|. |+||++.+.. .+.|.++++- ....+|||.+.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556689999999999999988776 8889865432 3455544433 4455899999988877777788899999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc--cC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV--TG 389 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~--~~ 389 (530)
..+ +|+|.|..+. -+..-+..-|+.|+..||.-+|. .+|+|+|||.+|||++.=.-+.|+||..-+.. ..
T Consensus 103 vkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 955 8999887542 46677778899999999999999 59999999999999999889999999876543 22
Q ss_pred CCCc------CcccccccccCccccCCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHH
Q 009644 390 SHHA------GSTSAVDCFLDPELNLSK----------N-YSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 390 ~~~~------~~~~gt~~y~aPE~~~~~----------~-~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 451 (530)
+... .+...-.+|+|||.+... . .+++-||||+||++.||++ |+++|.-. ++....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence 2111 112233469999986531 2 6788999999999999998 78887521 111111
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
...... ....+.... ...+.+++..+++.+| +|-++++.++.-.+
T Consensus 249 ~~~~~~---~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 249 SGNADD---PEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ccCccC---HHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 110000 000011100 1257789999999999 99999999988554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=159.25 Aligned_cols=131 Identities=19% Similarity=0.315 Sum_probs=111.7
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc-----------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+.||+|++|.||+|.. ++..+++|...... ...+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 56778888744211 13578899999999999998888887777888999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+++++|.+++... .. .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988642 12 788899999999999999 5999999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=163.69 Aligned_cols=138 Identities=12% Similarity=0.109 Sum_probs=108.6
Q ss_pred CCccceeeccCCcEEEEEEE--EcCCCEEEEEEccccc---------------------------HHHHHHHHHHHHhcC
Q 009644 238 NFSEINIIGEGSFGLAYKGL--LQDGSLVVIKRHLQTQ---------------------------IQNFLHEVKHIARVH 288 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~--~~~~~~vavK~~~~~~---------------------------~~~~~~E~~il~~l~ 288 (530)
-|++.+.||+|+||.||+|. ..+|+.||+|...... ...+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 5689999999865321 012568999999997
Q ss_pred CC--CcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCC
Q 009644 289 HR--HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP-LFHMHFRT 365 (530)
Q Consensus 289 H~--nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-ivHrDLk~ 365 (530)
+. .+.+++++ ...++||||+++++|....... ..+...+...++.|++.+|+|||+ .+ ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCCh
Confidence 53 34444543 2358999999998887654322 135566678899999999999999 48 99999999
Q ss_pred CcEEEcCCCeEEEeecCCcccc
Q 009644 366 SNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 366 ~NILl~~~~~~KI~DFGla~~~ 387 (530)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.7e-18 Score=167.48 Aligned_cols=229 Identities=19% Similarity=0.273 Sum_probs=143.8
Q ss_pred CccceeeccCCcEEEEEEEEc-CCCEEEEEEccc------ccHHHHHHHHHHHHhcC----------CCCcceEEEEEe-
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ------TQIQNFLHEVKHIARVH----------HRHLVKLVGFCE- 300 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~------~~~~~~~~E~~il~~l~----------H~nIv~l~g~~~- 300 (530)
+...+.||.|+++.||.++.. .++.+|+|...- ...+++.+|.-....+. |-.++--++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345589999999999999965 488999997542 23456666664444432 212222222221
Q ss_pred --------ecC--------ceeEEeeccCCCChHHHhhc---cCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009644 301 --------ENH--------QQLLIYDYIPNGNVQNHLYD---SEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHM 361 (530)
Q Consensus 301 --------~~~--------~~~LV~Ey~~~GsL~~~l~~---~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHr 361 (530)
... +.+++|+-+ .+||.+++.. .... ...+....++.+..|+++-+++||+ .++||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHS--YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHH--TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhh--cceEec
Confidence 111 346788877 6788887642 2111 1134455667788999999999999 599999
Q ss_pred CCCCCcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCC--------CCCCchhhHHHHHHHHHHHHcCC
Q 009644 362 HFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS--------KNYSAGSDVYSFGVFLLELISGR 433 (530)
Q Consensus 362 DLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSfGvvl~ElltG~ 433 (530)
||+|+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.|.+|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999876654322111 334467999997643 25789999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CC
Q 009644 434 EAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RR 490 (530)
Q Consensus 434 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~R 490 (530)
.||.......... ..+..+. +.+..+..|+...++.+| +|
T Consensus 248 lPf~~~~~~~~~~----------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE----------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG----------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc----------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998653221110 0223334 667788899999999887 66
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=180.87 Aligned_cols=135 Identities=16% Similarity=0.222 Sum_probs=110.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccc----c------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ----T------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~----~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
...|...+.||+|+||.||+|.+.+...++.++..+ . ..+.+.+|++++.+++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445566789999999999999976554333222211 1 124588999999999999999988888877788
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999998875 245789999999999999 599999999999999 67799999999997
Q ss_pred c
Q 009644 386 L 386 (530)
Q Consensus 386 ~ 386 (530)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=154.98 Aligned_cols=141 Identities=15% Similarity=0.124 Sum_probs=110.0
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc-------------------------HHHHHHHHHHHH
Q 009644 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-------------------------IQNFLHEVKHIA 285 (530)
Q Consensus 231 el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~il~ 285 (530)
++......|...+.||+|+||.||++...+|+.||||+..... ...+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333334477779999999999999998889999999744211 113567889999
Q ss_pred hcCCC--CcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009644 286 RVHHR--HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF 363 (530)
Q Consensus 286 ~l~H~--nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDL 363 (530)
++.|+ .+...++. ...++||||+++++|...... .....++.+++.++.++|+ .+++||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK--HGIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH--CCCCcCCC
Confidence 99887 44555442 355899999999998765321 2345688999999999999 59999999
Q ss_pred CCCcEEEcCCCeEEEeecCCccccc
Q 009644 364 RTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 364 k~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=155.22 Aligned_cols=127 Identities=18% Similarity=0.307 Sum_probs=105.2
Q ss_pred eeccCCcEEEEEEEEcCCCEEEEEEcccc-----------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 244 IIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.||+|+||.||+|.+ ++..+++|..... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 5678899874421 1245778999999999887666666666667779999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
++++|.+++.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875421 1 789999999999999 5999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=158.86 Aligned_cols=194 Identities=15% Similarity=0.209 Sum_probs=136.6
Q ss_pred CCCCcceEEEEEeec---------------------------CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHH
Q 009644 288 HHRHLVKLVGFCEEN---------------------------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSI 340 (530)
Q Consensus 288 ~H~nIv~l~g~~~~~---------------------------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i 340 (530)
+|||||++.++|.+. ..+|+||.-.+ .+|.+++..+ ..+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence 599999999987532 24789998874 4899999765 4677777889
Q ss_pred HHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCC--eEEEeecCCcccccCC-------CCcCcccccccccCccccC
Q 009644 341 ALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE--ENY--TAKVSDYGLLKLVTGS-------HHAGSTSAVDCFLDPELNL 409 (530)
Q Consensus 341 ~~qia~gL~yLH~~~~~ivHrDLk~~NILl~--~~~--~~KI~DFGla~~~~~~-------~~~~~~~gt~~y~aPE~~~ 409 (530)
..|+++|+.|||. .+|.|||+|++|||+. ++. .+.|+|||++-.-... .......|...-||||+..
T Consensus 347 laQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 4999999999999994 343 5789999987432210 0112233566789999975
Q ss_pred CCC--C----CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHc
Q 009644 410 SKN--Y----SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC 483 (530)
Q Consensus 410 ~~~--~----s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~C 483 (530)
..+ . -.|+|.|+.|.+.||+++...||+....- .+- ....-...++..+..++..+.+++...
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~--------~r~Yqe~qLPalp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLD--------TRTYQESQLPALPSRVPPVARQLVFDL 493 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eec--------hhhhhhhhCCCCcccCChHHHHHHHHH
Confidence 432 1 25899999999999999999999863211 100 001111122233444456677888888
Q ss_pred ccCCC-CCCCHHHHHHHHH
Q 009644 484 VDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 484 l~~~p-~RPt~~eVl~~L~ 501 (530)
++.+| +||+..-....|.
T Consensus 494 L~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hcCCccccCCccHHHhHHH
Confidence 88998 9998776555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-17 Score=168.20 Aligned_cols=121 Identities=19% Similarity=0.316 Sum_probs=105.9
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
.+++.|++|...+|.++|..... ....++...+.++.|++.|++| . +.+|||+||.||....+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y--k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY--K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh--c---cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975432 2367888899999999999999 3 899999999999999999999999999
Q ss_pred cccccCCC-------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 009644 384 LKLVTGSH-------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431 (530)
Q Consensus 384 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt 431 (530)
........ ......||..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87765443 2344558999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-16 Score=173.16 Aligned_cols=205 Identities=21% Similarity=0.280 Sum_probs=138.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
..+|+.++.|-.|+||.||..+.+. .+..|.|.-++... ++- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li---lRn--ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI---LRN--ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchh---hhc--cccccCCccee---------------------
Confidence 4688999999999999999998653 45677744222211 110 22222333332
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC---
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH--- 391 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~--- 391 (530)
|+-...++... .++.. ++.+++|||+ .+|+|||+||+|.||+.-|++|+.|||+++......
T Consensus 136 gDc~tllk~~g-----~lPvd--------mvla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 GDCATLLKNIG-----PLPVD--------MVLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred chhhhhcccCC-----CCcch--------hhHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 55555554432 23322 2678999999 599999999999999999999999999987532110
Q ss_pred -------------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 392 -------------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 392 -------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
.....+||+.|+|||++....|...+|.|++|+++||.+-|+.||.++..++.. .++... ..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf---g~visd--~i 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF---GQVISD--DI 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH---hhhhhh--hc
Confidence 012346899999999999999999999999999999999999999877544322 121111 11
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCC
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRP 491 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP 491 (530)
.+. +.+.....+..+++.+.++.+| .|-
T Consensus 276 ~wp-----E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWP-----EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccc-----ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111 1222334566777777777777 664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-15 Score=133.85 Aligned_cols=133 Identities=18% Similarity=0.205 Sum_probs=112.7
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEccccc-HHHHHHHHHHHHhcCC--CCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-IQNFLHEVKHIARVHH--RHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~H--~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
+.+.||+|.++.||++...+ ..+++|...... ..++.+|+.++..++| .++.+++++....+..+++|||++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 34789999999999999855 678999876543 3578999999999976 5999999998888889999999988776
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 318 QNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 318 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
..+ +......++.+++.+|++||.. .++++|+|++|+||++++.+.+++.|||.++.
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4456677899999999999985 24799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-15 Score=140.07 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=97.9
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccccc-----HHHH----------------------HHHHHHHHhcCCC--Cc
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----IQNF----------------------LHEVKHIARVHHR--HL 292 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----~~~~----------------------~~E~~il~~l~H~--nI 292 (530)
.+.||+|+||.||+|...+++.||||+..... ...+ ..|.+.+.++++. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36899999999999998789999999765321 1111 3466666666443 34
Q ss_pred ceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 293 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
.+.+++ ...++||||++++++........ ... .+...++.+++.++.++|.. .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-
Confidence 555543 24589999999965432211110 011 56778999999999999983 3999999999999999
Q ss_pred CCeEEEeecCCccccc
Q 009644 373 NYTAKVSDYGLLKLVT 388 (530)
Q Consensus 373 ~~~~KI~DFGla~~~~ 388 (530)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-14 Score=142.23 Aligned_cols=131 Identities=14% Similarity=0.189 Sum_probs=102.7
Q ss_pred eeec-cCCcEEEEEEEEcCCCEEEEEEcccc----------------cHHHHHHHHHHHHhcCCCCc--ceEEEEEeecC
Q 009644 243 NIIG-EGSFGLAYKGLLQDGSLVVIKRHLQT----------------QIQNFLHEVKHIARVHHRHL--VKLVGFCEENH 303 (530)
Q Consensus 243 ~~LG-~G~fG~Vy~g~~~~~~~vavK~~~~~----------------~~~~~~~E~~il~~l~H~nI--v~l~g~~~~~~ 303 (530)
..|| .||.|+||+.... +..+++|..... ....+.+|++++.+++|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999998875 667888865421 12357889999999998875 77777754432
Q ss_pred -c---eeEEeeccCC-CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 304 -Q---QLLIYDYIPN-GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 304 -~---~~LV~Ey~~~-GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
. .++||||+++ .+|.+++... .++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 3599999997 6899887642 34443 35689999999999 59999999999999999889999
Q ss_pred eecCCccc
Q 009644 379 SDYGLLKL 386 (530)
Q Consensus 379 ~DFGla~~ 386 (530)
+|||.++.
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.9e-13 Score=140.28 Aligned_cols=141 Identities=16% Similarity=0.218 Sum_probs=100.9
Q ss_pred CCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHH------------------------------------------
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ------------------------------------------ 275 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~------------------------------------------ 275 (530)
.|+. +.||.|++|.||+|++++|+.||||+..+...+
T Consensus 119 ~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 3443 689999999999999999999999986532111
Q ss_pred -HHHHHHHHHHhcC----CCCcceEEEEEe-ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHH-HH
Q 009644 276 -NFLHEVKHIARVH----HRHLVKLVGFCE-ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK-GL 348 (530)
Q Consensus 276 -~~~~E~~il~~l~----H~nIv~l~g~~~-~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~-gL 348 (530)
+|.+|++.+.+++ |.+-+.+-.++. .....+|||||+++++|.++...... .. .+..++..++. .+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFL 270 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHH
Confidence 2555666666652 333333333332 23457899999999999987653211 12 23456666665 46
Q ss_pred HHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 349 ~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
..+|. .+++|+|++|.||++++++.+++.|||++..+.
T Consensus 271 ~ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 77888 599999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.4e-15 Score=160.32 Aligned_cols=249 Identities=16% Similarity=0.191 Sum_probs=176.6
Q ss_pred cCCccceeeccCCcEEEEEEEEcC--CCEEEEEEccccc-----HHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD--GSLVVIKRHLQTQ-----IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV 308 (530)
..|...+.||+|+|+.|-...... ...+|+|...... ..+...|..+-..+. |+|++++++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666779999999998877433 3445666544321 223345777777776 99999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCC-eEEEeecCCccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH-SLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKL 386 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~ 386 (530)
+||..+|++.+.+..... ...+....-.+..|+..|+.|+| . .++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988832111 13455566778999999999999 6 6999999999999999999 999999999987
Q ss_pred ccC-CCC---cCcccc-cccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 387 VTG-SHH---AGSTSA-VDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 387 ~~~-~~~---~~~~~g-t~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+.. ... .....| ++.|+|||...+..| .+..|+||.|+++.-+++|..|+......... ...+.......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~--- 250 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNKGRF--- 250 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccccccc---
Confidence 655 221 223446 888999999887544 57799999999999999999998755433211 11111111000
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.............++..+++..++ .|.+.+++..
T Consensus 251 ----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 ----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 001122223456677777776666 8888887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=135.73 Aligned_cols=200 Identities=19% Similarity=0.274 Sum_probs=140.0
Q ss_pred HHHHhcCCCCcceEEEEEeec-----CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 009644 282 KHIARVHHRHLVKLVGFCEEN-----HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP 356 (530)
Q Consensus 282 ~il~~l~H~nIv~l~g~~~~~-----~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 356 (530)
..|..+.|.|||+++.|+.+. ....++.|||..|+|..+|++..... ..+......+++.||..||.|||++.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 345566799999999998654 35778999999999999998764322 357778888999999999999999989
Q ss_pred CeeecCCCCCcEEEcCCCeEEEeecCCcccc-----cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 009644 357 PLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-----TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431 (530)
Q Consensus 357 ~ivHrDLk~~NILl~~~~~~KI~DFGla~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt 431 (530)
+|+|+++..+-|++..++-+||.----...- ..........+.++|.+||+-.....+.++|||+||...+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887532111100 00011122235678999999888888899999999999999998
Q ss_pred CCCCCCCCCC-CchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 432 GREAHGRNHS-NSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 432 G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+..-.....+ ......+..+.. .+.. ..-.+++..|++..| .||+|.+++-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~--~len--------------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII--GLEN--------------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhhee--eccC--------------ccccCcCcccccCCCCCCcchhhhhc
Confidence 8754221111 111111111100 0000 111356778999998 8999998763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.3e-11 Score=129.31 Aligned_cols=143 Identities=13% Similarity=0.179 Sum_probs=95.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccccH----------------------------------------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQI---------------------------------------- 274 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~---------------------------------------- 274 (530)
...|+. +.||+|++|+||+|++++ |+.||||+..+.-.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999999887 99999998753210
Q ss_pred ---HHHHHHHHHHHhcC----CCCcceEEEEEee-cCceeEEeeccCCCChHHHhhcc-CCCCCCCCCHHHHHHHHHHHH
Q 009644 275 ---QNFLHEVKHIARVH----HRHLVKLVGFCEE-NHQQLLIYDYIPNGNVQNHLYDS-EGLPIGKLTMRQRLSIALGAA 345 (530)
Q Consensus 275 ---~~~~~E~~il~~l~----H~nIv~l~g~~~~-~~~~~LV~Ey~~~GsL~~~l~~~-~~~~~~~l~~~~~~~i~~qia 345 (530)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-. .+.....+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 02455665555552 4444544444433 45678999999999998753211 11000112222233333333
Q ss_pred HHHHHhhcCCCCeeecCCCCCcEEEcCCC----eEEEeecCCccccc
Q 009644 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENY----TAKVSDYGLLKLVT 388 (530)
Q Consensus 346 ~gL~yLH~~~~~ivHrDLk~~NILl~~~~----~~KI~DFGla~~~~ 388 (530)
+. .+++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 277 ------f~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FR--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------Hh--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 23 4999999999999999888 99999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.1e-12 Score=136.46 Aligned_cols=246 Identities=18% Similarity=0.205 Sum_probs=172.9
Q ss_pred CCccceeecc--CCcEEEEEEEE---cCCCEEEEEEccc-----ccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCcee
Q 009644 238 NFSEINIIGE--GSFGLAYKGLL---QDGSLVVIKRHLQ-----TQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 238 ~f~~~~~LG~--G~fG~Vy~g~~---~~~~~vavK~~~~-----~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 306 (530)
.|...+.+|. |.+|.||.+.. .++..+|+|+-.. .....=.+|+.-..++ .|+|.++.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455578999 99999999986 4577888886221 1122335566666777 5999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeec
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK----GLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDY 381 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DF 381 (530)
+-+|++ +.+|..+...... -++......+..+... ||.++|+ +.++|-|+||.||++..+ ...++.||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCC--CcccccccchhheecccccceeecCCc
Confidence 999999 4788888876532 3556666677777777 9999999 699999999999999999 88999999
Q ss_pred CCcccccCCCCcCcc------cccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 382 GLLKLVTGSHHAGST------SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 382 Gla~~~~~~~~~~~~------~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|+...+......... .+-..|++||.. .+-++..+|+||+|.+..|..++..++....... |....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~~r- 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQLR- 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccccc-
Confidence 999887654422111 345569999986 6678999999999999999999887765432111 00000
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
-..+.+ ++.......+...+.++++.++ .|++.+.+. .|.-+.
T Consensus 340 -~~~ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~ 383 (524)
T KOG0601|consen 340 -QGYIPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIH 383 (524)
T ss_pred -cccCch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-cccccc
Confidence 000000 1222222344446777788887 777776654 444443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-11 Score=113.58 Aligned_cols=128 Identities=18% Similarity=0.117 Sum_probs=95.8
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCc-ceEEEEEeecCceeEEeeccCCCChH
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHL-VKLVGFCEENHQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~GsL~ 318 (530)
++.|+.|.++.||++... +..+++|...... ...+..|+.++..+.+.++ .+++.+.. ...++||||+++.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 367899999999999875 6789999876543 3457889999999865554 45555433 3457999999998875
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV---PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 319 ~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+.. .. ...++.+++++|+.||+.. ..++|+|++|.||+++ ++.+++.|||.+..
T Consensus 80 ~~~---------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 01 1235678999999999851 1369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.2e-10 Score=108.89 Aligned_cols=138 Identities=22% Similarity=0.343 Sum_probs=108.5
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc----HHHHHHHHHHHHhcCC--CCcceEEEEEeec---CceeEEeeccC
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ----IQNFLHEVKHIARVHH--RHLVKLVGFCEEN---HQQLLIYDYIP 313 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~H--~nIv~l~g~~~~~---~~~~LV~Ey~~ 313 (530)
+.|+.|.++.||++...+|..+++|...... ...+..|.+++..+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 6789999999999998777889999866432 4578899999999975 4467788887664 25689999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL--------------------------------------- 354 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------- 354 (530)
+.++.+.+.. ..++..+...++.++++.|.+||+.
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888775531 1467777778888888888888852
Q ss_pred ---------------CCCeeecCCCCCcEEEcC--CCeEEEeecCCccc
Q 009644 355 ---------------VPPLFHMHFRTSNVLLEE--NYTAKVSDYGLLKL 386 (530)
Q Consensus 355 ---------------~~~ivHrDLk~~NILl~~--~~~~KI~DFGla~~ 386 (530)
...++|+|+.+.||+++. ++.+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134699999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.5e-10 Score=105.08 Aligned_cols=132 Identities=16% Similarity=0.144 Sum_probs=96.4
Q ss_pred eeeccCCcEEEEEEEEcC-------CCEEEEEEcccc------------------------c-HHHH----HHHHHHHHh
Q 009644 243 NIIGEGSFGLAYKGLLQD-------GSLVVIKRHLQT------------------------Q-IQNF----LHEVKHIAR 286 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~-------~~~vavK~~~~~------------------------~-~~~~----~~E~~il~~ 286 (530)
..||.|.-+.||.|.-.+ +..+|+|..... . .+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998543 478999964310 0 1122 379999999
Q ss_pred cC--CCCcceEEEEEeecCceeEEeeccCCCChHH-HhhccCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeecC
Q 009644 287 VH--HRHLVKLVGFCEENHQQLLIYDYIPNGNVQN-HLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL-HSLVPPLFHMH 362 (530)
Q Consensus 287 l~--H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~-~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~ivHrD 362 (530)
+. .-++...+++ ...+|||||+.++.+.. .+++. .++..+...+..+++.+|..| |. .++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKE--CNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHh--CCeecCC
Confidence 84 3566777765 45689999997654422 22221 344556677889999999999 77 4999999
Q ss_pred CCCCcEEEcCCCeEEEeecCCcccc
Q 009644 363 FRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 363 Lk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|++.|||+++ +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.7e-11 Score=125.17 Aligned_cols=194 Identities=20% Similarity=0.250 Sum_probs=148.8
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE--cCCCEEEEEEcccccH---HH--HHHHHHHHHhc-CCCCcceEEEEEeecCce
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLL--QDGSLVVIKRHLQTQI---QN--FLHEVKHIARV-HHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~--~~~~~vavK~~~~~~~---~~--~~~E~~il~~l-~H~nIv~l~g~~~~~~~~ 305 (530)
..+.+|..+..||.|.|+.||+... .++..+++|...+... ++ -+.|+-+...+ .|.++++.+..+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788999999999999999874 3577888887654322 11 24566666665 588889988888877888
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCCc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLL 384 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGla 384 (530)
++--||++++++...+.-. ..+....++++..|++.++.++|+ +.++|+|+||+||++..+ +..+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccccccc
Confidence 8999999999988766322 257788889999999999999999 699999999999999886 78899999998
Q ss_pred ccccCCCCcCccc-ccccc-cCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 009644 385 KLVTGSHHAGSTS-AVDCF-LDPELNLSKNYSAGSDVYSFGVFLLELISGREAH 436 (530)
Q Consensus 385 ~~~~~~~~~~~~~-gt~~y-~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~ 436 (530)
..+.-. ..... ....| .+++......+..+.|++|||..+.|.++|...-
T Consensus 415 t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 415 TRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccccee--cccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 643211 11122 22334 3566666778899999999999999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.2e-09 Score=114.95 Aligned_cols=162 Identities=19% Similarity=0.223 Sum_probs=120.4
Q ss_pred EcCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCH
Q 009644 258 LQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM 334 (530)
Q Consensus 258 ~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~ 334 (530)
..++.+|.|.....+. .+...+-++.|+.++||||++++......+..|||+|-+. .|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 4456677766554332 2445677888999999999999999999999999999874 67777764 334
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-cCcccccccccCccccCCCCC
Q 009644 335 RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-AGSTSAVDCFLDPELNLSKNY 413 (530)
Q Consensus 335 ~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 413 (530)
....-.+.||+.||.|||+. .+++|++|.-..|+++..|..||++|-++........ .........|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 55666789999999999864 4999999999999999999999999988765433221 01111122356666543322
Q ss_pred CchhhHHHHHHHHHHHHcC
Q 009644 414 SAGSDVYSFGVFLLELISG 432 (530)
Q Consensus 414 s~ksDVwSfGvvl~ElltG 432 (530)
-..|.|-||+++||++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.8e-09 Score=95.56 Aligned_cols=140 Identities=16% Similarity=0.236 Sum_probs=102.1
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEcccc-c----------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-Q----------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~----------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
....|-+|+-+.|+++.+. |+..+||....+ . .++-.+|+++|.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999984 677777753321 1 245778999999886444443333455556667999
Q ss_pred eccCC-CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEeecCCcc
Q 009644 310 DYIPN-GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSDYGLLK 385 (530)
Q Consensus 310 Ey~~~-GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~DFGla~ 385 (530)
||+++ -++.+++...... .........++..|-+-+.-||. ++|||+||.++||+|..++ .+-+.|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99965 3888888765332 12222336788888899999999 5999999999999997654 45899999985
Q ss_pred c
Q 009644 386 L 386 (530)
Q Consensus 386 ~ 386 (530)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.8e-09 Score=96.47 Aligned_cols=128 Identities=17% Similarity=0.293 Sum_probs=95.5
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEcccc-----c------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----Q------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..+++|+-+.+|.+.+.+ ..+++|...++ . ...-.+|+.++.+++--.|.--.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999998754 34777753322 1 13467899999998654444444445566677899999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
.++-.|.+.+... ...++..+-.-+.-||. .+|+|+||.++||++..+. +.+.||||+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888753 13456666667778999 5999999999999998775 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=9.5e-11 Score=130.12 Aligned_cols=201 Identities=18% Similarity=0.224 Sum_probs=145.1
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEE------cccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKR------HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~------~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
...+.|.+.+-+-+|.++.++.+.-. .|...+.|. +.....+....+-.++-..+||-++...--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567777788889999999987632 232333332 22223334444444444456677776555555667889
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
|+++|..+++|...|+... ..+..-.......+..+++|||+. .++|||++|.|.|...++..+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~--~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSS--LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccc--hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999988653 334444455666778899999993 699999999999999999999999984322
Q ss_pred cc------CC--------------------------CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 009644 387 VT------GS--------------------------HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGRE 434 (530)
Q Consensus 387 ~~------~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~ 434 (530)
.. .. .......+|+.|.+||...+......+|.|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 00 00122347888999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 009644 435 AHGRNHS 441 (530)
Q Consensus 435 p~~~~~~ 441 (530)
||.....
T Consensus 1034 p~na~tp 1040 (1205)
T KOG0606|consen 1034 PFNAETP 1040 (1205)
T ss_pred CCCCcch
Confidence 9986543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.1e-07 Score=94.77 Aligned_cols=138 Identities=17% Similarity=0.151 Sum_probs=99.0
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc----HH----------HHHHHHHHHHhcCC--CCcceEEEEEee-----
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ----IQ----------NFLHEVKHIARVHH--RHLVKLVGFCEE----- 301 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----~~----------~~~~E~~il~~l~H--~nIv~l~g~~~~----- 301 (530)
+.+-+-....|++..+ +|+.+.||+..... .+ .+.+|...+.++.. -.....+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 56789999764322 11 37789998888843 233445555543
Q ss_pred cCceeEEeeccCCC-ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-------C
Q 009644 302 NHQQLLIYDYIPNG-NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-------N 373 (530)
Q Consensus 302 ~~~~~LV~Ey~~~G-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-------~ 373 (530)
....+||||++++- +|.+++..... ...+...+..++.+++..+.-||. .+|+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCC
Confidence 23468999999876 89998864211 134566777899999999999999 59999999999999975 4
Q ss_pred CeEEEeecCCccc
Q 009644 374 YTAKVSDYGLLKL 386 (530)
Q Consensus 374 ~~~KI~DFGla~~ 386 (530)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.8e-08 Score=91.95 Aligned_cols=122 Identities=16% Similarity=0.231 Sum_probs=80.8
Q ss_pred EEEEEEEcCCCEEEEEEcccc-------------------------c----HHHHHHHHHHHHhcCCC--CcceEEEEEe
Q 009644 252 LAYKGLLQDGSLVVIKRHLQT-------------------------Q----IQNFLHEVKHIARVHHR--HLVKLVGFCE 300 (530)
Q Consensus 252 ~Vy~g~~~~~~~vavK~~~~~-------------------------~----~~~~~~E~~il~~l~H~--nIv~l~g~~~ 300 (530)
.||.|...+|..+|+|..... . .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999964310 0 12356899999999755 566776553
Q ss_pred ecCceeEEeeccC--CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 301 ENHQQLLIYDYIP--NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL-HSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 301 ~~~~~~LV~Ey~~--~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
...|||||++ +..+.. |... .++......++.+++..+..+ |. .+|+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~------~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV------DLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC------GGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhh-HHhc------cccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEE
Confidence 3479999998 544443 3322 122334456777777766664 67 499999999999999988 999
Q ss_pred EeecCCcccc
Q 009644 378 VSDYGLLKLV 387 (530)
Q Consensus 378 I~DFGla~~~ 387 (530)
|.|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.2e-07 Score=90.38 Aligned_cols=262 Identities=14% Similarity=0.096 Sum_probs=151.2
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEE------eecC-ceeEEeecc
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFC------EENH-QQLLIYDYI 312 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~------~~~~-~~~LV~Ey~ 312 (530)
....||+|+-+.+|----- +.. +.|+....-...-.+-++.|.+. .||-+..=+.+= -+++ ..-+.|..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 3468999999999964311 112 33443322111111122233333 455433211111 1111 244566666
Q ss_pred CCC-ChHHHhhc-cCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 313 PNG-NVQNHLYD-SEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 313 ~~G-sL~~~l~~-~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
++- -+..+++- .+........|...++.++.+|.+.+-||.. |.+-+|+.++|+|+++++.+.+.|=..-..-.++
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--CCcccccCccceeeecCceEEEEcccceeeccCC
Confidence 543 22222221 1122234689999999999999999999994 8999999999999999999999874433222333
Q ss_pred CCcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCch-----HHHHHHHHhh--cc-
Q 009644 391 HHAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISG-REAHGRNHSNSD-----QNLILQVKRS--CD- 456 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~-----~~~~~~~~~~--~~- 456 (530)
.......|...|.+||... +-.-+...|-|.+||++++++.| +.||.+...... ..-+...... .+
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~ 250 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ 250 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhc
Confidence 3334455778899999754 33446789999999999999986 889875322110 1011111000 00
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCC--C-CCCCHHHHHHHHHhhHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVS--S-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~--p-~RPt~~eVl~~L~~i~~~ 506 (530)
-.....+...-...-....+..+-.+|+... + -|||++.-+..|.++.+.
T Consensus 251 ~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 251 RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0001111110011122346677888898765 4 699999998888877554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-06 Score=91.73 Aligned_cols=168 Identities=19% Similarity=0.246 Sum_probs=125.1
Q ss_pred cEEEEEEE-EcCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEee----cCceeEEeeccCC-CChHHH
Q 009644 250 FGLAYKGL-LQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQLLIYDYIPN-GNVQNH 320 (530)
Q Consensus 250 fG~Vy~g~-~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~~LV~Ey~~~-GsL~~~ 320 (530)
-.+.||+. ..||..+++|++.... ...-..-++.++++.|+|+|++..++.. +..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35788988 5688899999883221 1123345788999999999999998863 4568899999986 577766
Q ss_pred hhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 321 LYDSEGL----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 321 l~~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
-...... .....++..++.++.|+..||.++|+ .|+.-+-|.+++||++.+.+++|+..|....+..+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5432211 11246788899999999999999999 59999999999999999999999988877655433
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA 435 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p 435 (530)
.. |-+. --.+-|.=.||.+++-|.||..-
T Consensus 447 ~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT-------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC-------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 20 1111 12356888999999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.7e-07 Score=88.93 Aligned_cols=130 Identities=16% Similarity=0.155 Sum_probs=91.1
Q ss_pred ccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-------------------------cHHHHHHHHHHHHhcCCC--Cc
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-------------------------QIQNFLHEVKHIARVHHR--HL 292 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-------------------------~~~~~~~E~~il~~l~H~--nI 292 (530)
.+.+.||-|.-+.||.|....|.++|+|..... ......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 345789999999999999999999999963310 012356799999998654 66
Q ss_pred ceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 293 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
.+.+++ +...+||||+++-.|...- ++....-.++..|..-+.-+-. .||||+|+.+-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEec
Confidence 666654 4567999999886654421 1122222333333333333333 39999999999999999
Q ss_pred CCeEEEeecCCcc
Q 009644 373 NYTAKVSDYGLLK 385 (530)
Q Consensus 373 ~~~~KI~DFGla~ 385 (530)
+|.+.+.||=-+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.4e-08 Score=107.57 Aligned_cols=146 Identities=18% Similarity=0.233 Sum_probs=99.3
Q ss_pred HHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc----------CcccccccccCccccCCC
Q 009644 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA----------GSTSAVDCFLDPELNLSK 411 (530)
Q Consensus 342 ~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~----------~~~~gt~~y~aPE~~~~~ 411 (530)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+......... ........|.|||++...
T Consensus 106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4455999999986 79999999999999999999999999987655431110 011133459999999998
Q ss_pred CCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-C
Q 009644 412 NYSAGSDVYSFGVFLLELISG-REAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-R 489 (530)
Q Consensus 412 ~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~ 489 (530)
..+.++|+||+|+++|-+..| +.-+.......... ...... +.....+..+.+.++.+=+.+.+..++ -
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~---~~~~~~------~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS---FSRNLL------NAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhh---hhhccc------ccccccccccCcHHHHHHHHHHhcCCccc
Confidence 889999999999999999954 44443222111111 111111 111112334555677777777777776 8
Q ss_pred CCCHHHHH
Q 009644 490 RPSMRQIA 497 (530)
Q Consensus 490 RPt~~eVl 497 (530)
||++.++.
T Consensus 256 rp~~~~l~ 263 (700)
T KOG2137|consen 256 RPTLDLLL 263 (700)
T ss_pred Ccchhhhh
Confidence 99877764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.6e-07 Score=103.02 Aligned_cols=52 Identities=25% Similarity=0.346 Sum_probs=41.9
Q ss_pred hhHHHhhhhcc---CCCChhhhHHHHHHhhhhhCCCC--CCCCCCCCCCCcC---ccccccccC
Q 009644 26 PLLLLIQLLQS---TSTDHKVYAEALLACKSALGTPG--QSSGRIGRYPCIR---QRACLNCYE 81 (530)
Q Consensus 26 ~~~~~~~~~~~---~~~~~~~~~~~~~~~k~~~~~~~--~~~g~~~~~pc~~---~~~~~~c~~ 81 (530)
|+||.+|+.+- ...|.+.|++||+++|..++.+. +|.| |||.| .|.|+.|+.
T Consensus 352 pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~g----~~C~p~~~~w~Gv~C~~ 411 (623)
T PLN03150 352 AIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNG----DPCVPQQHPWSGADCQF 411 (623)
T ss_pred ceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCCC----CCCCCcccccccceeec
Confidence 88998887432 22567789999999999998764 7988 69986 699999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-08 Score=107.49 Aligned_cols=193 Identities=17% Similarity=0.090 Sum_probs=142.6
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCCC-cceEEEEEeecCceeEEee
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRH-LVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~LV~E 310 (530)
++..+..+...+-+++|+++++||.+--..+....+.+... ....-++++|.+++||| .+..++-+..+...+++++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 33445556666778999999999988433333445555443 34556889999999999 7777777777888999999
Q ss_pred ccCCC-ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 311 YIPNG-NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~G-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
++..| +-..-.... ...+...+...+.+.-.++|+|||+. .=+||| ||+..+ ...|..||+....+..
T Consensus 315 i~s~~rs~~~~~~~s----e~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVS----EIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhcCCccccccCChh----hHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCc
Confidence 99887 222111111 11344455566777788999999983 458998 777765 6889999999988776
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHG 437 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~ 437 (530)
........+++.|+|||+.....+..+.|+||.|+---++.-|.+|-.
T Consensus 384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 655666778999999999999999999999999987778877776643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.6e-06 Score=83.08 Aligned_cols=105 Identities=19% Similarity=0.314 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcC--CCCcceEEEEEeecC----ceeEEeeccCCC-ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 009644 275 QNFLHEVKHIARVH--HRHLVKLVGFCEENH----QQLLIYDYIPNG-NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347 (530)
Q Consensus 275 ~~~~~E~~il~~l~--H~nIv~l~g~~~~~~----~~~LV~Ey~~~G-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~g 347 (530)
....+|...+.++. .=.+.+.+++..... ..+||+|++++. +|.+++.... ..+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence 35778888887774 334566666665532 357999999874 7999887642 25566778899999999
Q ss_pred HHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEeecCCccc
Q 009644 348 LEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSDYGLLKL 386 (530)
Q Consensus 348 L~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~DFGla~~ 386 (530)
+.-||. .+|+|+|+++.|||++.+. .+.+.||+-++.
T Consensus 131 i~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 5999999999999999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.1e-06 Score=94.87 Aligned_cols=142 Identities=15% Similarity=0.241 Sum_probs=95.0
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc---------------------------------HH--------
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ---------------------------------IQ-------- 275 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---------------------------------~~-------- 275 (530)
..|+. +.|+.++-|.||+|++++|+.||||+..+.- .+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34544 6899999999999999999999999754210 01
Q ss_pred --HHHHHHHHHHhc----C-CCCcceEEEEEe-ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 009644 276 --NFLHEVKHIARV----H-HRHLVKLVGFCE-ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347 (530)
Q Consensus 276 --~~~~E~~il~~l----~-H~nIv~l~g~~~-~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~g 347 (530)
++.+|...+.++ + .++ +.+=.++. -.+...|+|||++|-.+.+...-... .++.+. ++..++++
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~---ia~~~~~~ 276 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKE---LAELLVRA 276 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHH---HHHHHHHH
Confidence 255666666665 2 333 33334443 35667899999999988887532221 344333 23222222
Q ss_pred -HHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 348 -LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 348 -L~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
+.-+-. .+++|.|..|.||+++.++.+-+.|||+...+..
T Consensus 277 f~~q~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHh--cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 111112 3899999999999999999999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.6e-05 Score=75.71 Aligned_cols=135 Identities=14% Similarity=0.103 Sum_probs=99.1
Q ss_pred eccCCcEEEEEEEEcCCCEEEEEEcc---------cccHHHHHHHHHHHHhcCC--CCcceEEEEEe-ec----CceeEE
Q 009644 245 IGEGSFGLAYKGLLQDGSLVVIKRHL---------QTQIQNFLHEVKHIARVHH--RHLVKLVGFCE-EN----HQQLLI 308 (530)
Q Consensus 245 LG~G~fG~Vy~g~~~~~~~vavK~~~---------~~~~~~~~~E~~il~~l~H--~nIv~l~g~~~-~~----~~~~LV 308 (530)
-|+||-+-|++-.+. |..+-+|+-. +.-...|.+|...|.++.. -.+.+.. ++. .. -.-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467899999997774 4468888744 2234579999999998843 2244444 332 11 235799
Q ss_pred eeccCC-CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe--EEEeecCCcc
Q 009644 309 YDYIPN-GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT--AKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~-GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~--~KI~DFGla~ 385 (530)
+|-+++ -+|.+++.+..- ...+...+..+..+++..+.-||+ .++.|+|+-+.||+++.++. +++.||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 588888865321 245777788999999999999999 59999999999999986666 9999997665
Q ss_pred c
Q 009644 386 L 386 (530)
Q Consensus 386 ~ 386 (530)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.4e-05 Score=77.75 Aligned_cols=139 Identities=14% Similarity=0.115 Sum_probs=85.4
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc-HHHHHHHHHHHHhcCCCC--cceEEEEEeecCceeEEeeccCCCC-hH
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-IQNFLHEVKHIARVHHRH--LVKLVGFCEENHQQLLIYDYIPNGN-VQ 318 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~Gs-L~ 318 (530)
..||+|..+.||+. .+..+++|...... .....+|.++++.+..-. +.+.+++....+...+|||+++|.+ +.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 57999999999984 24457788765532 456788999999986433 4677888877777889999998863 11
Q ss_pred HHh------------------hccCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHhhc--CCCCeeecCCCCC
Q 009644 319 NHL------------------YDSEGLPIGKLTMRQRL-SIAL----------GAAK-GLEHLHS--LVPPLFHMHFRTS 366 (530)
Q Consensus 319 ~~l------------------~~~~~~~~~~l~~~~~~-~i~~----------qia~-gL~yLH~--~~~~ivHrDLk~~ 366 (530)
..+ ..-...+.......... .+.. .+.. ..++|.. ..+.++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 111 00001000011111100 0100 0111 1223322 1246789999999
Q ss_pred cEEEcCCCeEEEeecCCcc
Q 009644 367 NVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 367 NILl~~~~~~KI~DFGla~ 385 (530)
||++++++ +.|.||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.3e-06 Score=89.32 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=90.4
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc---------------------------------H-------HHHHHHHH
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ---------------------------------I-------QNFLHEVK 282 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---------------------------------~-------~~~~~E~~ 282 (530)
+.||.-+.|.||+|++++|+.||||+..+.- . -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999744210 0 03667776
Q ss_pred HHHhc----CCCCc---ceEEEEEe-ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 009644 283 HIARV----HHRHL---VKLVGFCE-ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354 (530)
Q Consensus 283 il~~l----~H~nI---v~l~g~~~-~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 354 (530)
...++ .|-+. |.+=.++. -.....|+||||+|..+.+.-.-... .++...+..-+.++..- .-++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~-qIf~-- 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLE-QIFK-- 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHH-HHHh--
Confidence 55554 45551 11222222 23467899999999877665332211 35555444333332211 1122
Q ss_pred CCCeeecCCCCCcEEEcC----CCeEEEeecCCccccc
Q 009644 355 VPPLFHMHFRTSNVLLEE----NYTAKVSDYGLLKLVT 388 (530)
Q Consensus 355 ~~~ivHrDLk~~NILl~~----~~~~KI~DFGla~~~~ 388 (530)
.|++|+|-.|.||++.. ++.+.+-|||+...+.
T Consensus 320 -~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 -TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 38999999999999984 6789999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-05 Score=77.02 Aligned_cols=141 Identities=13% Similarity=0.143 Sum_probs=86.9
Q ss_pred eeccCCc-EEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeeccCCCChHHHh
Q 009644 244 IIGEGSF-GLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL 321 (530)
Q Consensus 244 ~LG~G~f-G~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l 321 (530)
.|-.|.+ ..||+.... +..+.+|........+..+|++++..+. +--+.+++++...++..++|||++++.+|....
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~ 83 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALW 83 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhh
Confidence 4555655 788998764 4678888876554456778999988883 444667888777766789999999987776432
Q ss_pred h----------------ccCCCCC--CCCC--HHHHHHHHH--------------------HHHHHHHHhhc-----CCC
Q 009644 322 Y----------------DSEGLPI--GKLT--MRQRLSIAL--------------------GAAKGLEHLHS-----LVP 356 (530)
Q Consensus 322 ~----------------~~~~~~~--~~l~--~~~~~~i~~--------------------qia~gL~yLH~-----~~~ 356 (530)
. .-...+. ..+. ....+.-.. .+...+..|-. ..+
T Consensus 84 ~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 163 (244)
T cd05150 84 EELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL 163 (244)
T ss_pred cccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence 0 0000110 0111 000010000 01111222211 124
Q ss_pred CeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 357 PLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 357 ~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
.++|+|+.|.|||++++....|.||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 69999999999999998888999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=8e-05 Score=71.30 Aligned_cols=136 Identities=13% Similarity=0.193 Sum_probs=91.4
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccH------H------HHHHHHHHHHhcC---CCCcceEEEE
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI------Q------NFLHEVKHIARVH---HRHLVKLVGF 298 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~------~------~~~~E~~il~~l~---H~nIv~l~g~ 298 (530)
...++|...+++-......|.+-.. +|..+++|....... . ...+++..+.++. -.....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457888888888888888877777 467888997554321 1 1233444444442 2333333333
Q ss_pred Eee-----cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 009644 299 CEE-----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN 373 (530)
Q Consensus 299 ~~~-----~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~ 373 (530)
... ....+|+|||++|-.|.++.. ++. .++..+++++.-||+. |++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~--G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKH--GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHc--CCccCCCCcCcEEEECC
Confidence 322 234568999999988776532 222 2456677889999994 99999999999999966
Q ss_pred CeEEEeecCCccc
Q 009644 374 YTAKVSDYGLLKL 386 (530)
Q Consensus 374 ~~~KI~DFGla~~ 386 (530)
+ +++.||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 4 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.3e-05 Score=72.88 Aligned_cols=151 Identities=15% Similarity=0.173 Sum_probs=100.2
Q ss_pred ccCHHHHHHhhcCCccce---eeccCCcEEEEEEEEcCCCEEEEEEccccc----------------------HH----H
Q 009644 226 QLTILELKHATNNFSEIN---IIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ----------------------IQ----N 276 (530)
Q Consensus 226 ~~~~~el~~~t~~f~~~~---~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~----------------------~~----~ 276 (530)
..+...+....+...+.. .|.+|.-+.||+|.-.++..+|+|+..... .. .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345555555555554444 455677778999998889999999754211 00 1
Q ss_pred -HHHHHHHHHhc--CCCCcceEEEEEeecCceeEEeeccCCCC-hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 009644 277 -FLHEVKHIARV--HHRHLVKLVGFCEENHQQLLIYDYIPNGN-VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352 (530)
Q Consensus 277 -~~~E~~il~~l--~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs-L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 352 (530)
..+|...|.++ .+-.+.+-+++. .-.|||||+.... -.-.|++ -.+...+...+..++++++.-|-
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHH
Confidence 24577888877 344555556554 3369999996531 1111111 12333356677788888888776
Q ss_pred cCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 353 ~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
.. -++||+||..=|||+. ++.+.|+|||-|....
T Consensus 184 ~~-a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KE-AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred Hh-cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 52 3999999999999999 8899999999886543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.03 E-value=9.3e-05 Score=71.14 Aligned_cols=142 Identities=18% Similarity=0.234 Sum_probs=85.1
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCC--CcceEEEEEee---cCceeEEeeccCCC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHR--HLVKLVGFCEE---NHQQLLIYDYIPNG 315 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~--nIv~l~g~~~~---~~~~~LV~Ey~~~G 315 (530)
++.|+.|..+.||+....+ ..+++|..... ......+|..++..+... .+.+++.+... ....+++|+++++.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 4689999999999999877 58999987665 456778899998888433 35677765533 23568999999988
Q ss_pred ChHH----------------Hhh---ccCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc-
Q 009644 316 NVQN----------------HLY---DSEGLPIGKLTMRQ---------RLSI------------ALGAAK-GLEHLHS- 353 (530)
Q Consensus 316 sL~~----------------~l~---~~~~~~~~~l~~~~---------~~~i------------~~qia~-gL~yLH~- 353 (530)
.+.. .+. ... .+...+.... .... ...+.. .++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 7777 111 110 0101111110 0000 111222 2333332
Q ss_pred ----CCCCeeecCCCCCcEEEc-CCCeEEEeecCCcc
Q 009644 354 ----LVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLK 385 (530)
Q Consensus 354 ----~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~ 385 (530)
....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 224799999999999999 66777899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00012 Score=84.60 Aligned_cols=75 Identities=13% Similarity=0.283 Sum_probs=56.6
Q ss_pred ceeeccCCcEEEEEEEEcCC---CEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCc--ceEEEEEeec---CceeEE
Q 009644 242 INIIGEGSFGLAYKGLLQDG---SLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHL--VKLVGFCEEN---HQQLLI 308 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nI--v~l~g~~~~~---~~~~LV 308 (530)
.+.++.|.++.+|+....++ ..+++|+.... ....+.+|.++++.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999876554 35677765432 2346889999999995 6665 8888888764 467899
Q ss_pred eeccCCCC
Q 009644 309 YDYIPNGN 316 (530)
Q Consensus 309 ~Ey~~~Gs 316 (530)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0002 Score=67.77 Aligned_cols=132 Identities=21% Similarity=0.350 Sum_probs=93.6
Q ss_pred ccccccCHHHHHHhhcCCccceeeccCCc-EEEEEEEEcCCCEEEEEEccc------------------------ccHHH
Q 009644 222 QNLKQLTILELKHATNNFSEINIIGEGSF-GLAYKGLLQDGSLVVIKRHLQ------------------------TQIQN 276 (530)
Q Consensus 222 ~~~~~~~~~el~~~t~~f~~~~~LG~G~f-G~Vy~g~~~~~~~vavK~~~~------------------------~~~~~ 276 (530)
..+..|+. .+.+++.++.||.|.- |.||+... +|..+|+|.... .....
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 34556655 2378899999999999 99999998 467999998221 01134
Q ss_pred HHHHHHHHHhc---CCCCc--ceEEEEEeec------------------CceeEEeeccCCCChHHHhhccCCCCCCCCC
Q 009644 277 FLHEVKHIARV---HHRHL--VKLVGFCEEN------------------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT 333 (530)
Q Consensus 277 ~~~E~~il~~l---~H~nI--v~l~g~~~~~------------------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~ 333 (530)
|..|.+...+| ++.++ |+.+||..-. ....||.||.+... .++
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~ 166 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ 166 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc
Confidence 88899888877 35566 9999997322 02346777775532 123
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 334 MRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 334 ~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
... +.+|.+-|..+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 167 ~~~----~~~~~~dl~~~~k~--gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRD----IPQMLRDLKILHKL--GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhH----HHHHHHHHHHHHHC--CeeeccCcccccc-----CCEEEecccC
Confidence 333 34566677889995 9999999999986 4589999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.1e-05 Score=71.05 Aligned_cols=101 Identities=19% Similarity=0.204 Sum_probs=80.0
Q ss_pred HHHHHHHHhcCC-CCcceEEEEEeecCceeEEeeccCCCChHHH---hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 009644 278 LHEVKHIARVHH-RHLVKLVGFCEENHQQLLIYDYIPNGNVQNH---LYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353 (530)
Q Consensus 278 ~~E~~il~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~---l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 353 (530)
..|.-++..+.+ +++.+++|+|-. ++|.||...+++... +... -.-+|..+.+||.++++.+++|++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-----~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-----LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-----cccCHHHHHHHHHHHHHHHHHHhc
Confidence 357788888876 699999999943 679999987766422 1111 146899999999999999999987
Q ss_pred C-CCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 354 L-VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 354 ~-~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
. ...+.-.|++++|+-+++++++|+.|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4 224777999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00029 Score=66.91 Aligned_cols=129 Identities=16% Similarity=0.191 Sum_probs=91.4
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccccc-------------------HHHHHHHHHHHHhcC------CCCcceEE
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-------------------IQNFLHEVKHIARVH------HRHLVKLV 296 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-------------------~~~~~~E~~il~~l~------H~nIv~l~ 296 (530)
...||+|+.-.||. .++....+||+..... ..++.+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999997 3344556778766544 567778887776665 88999999
Q ss_pred EEEeecCceeEEeeccCC------CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 297 GFCEENHQQLLIYDYIPN------GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 297 g~~~~~~~~~LV~Ey~~~------GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
|+.+++.-.-+|+|.+.+ -+|.+++... .++. .....+.+. .+||-+ ..|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f---~~~l~~--~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEF---KRYLLD--HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHH---HHHHHH--cCCeecCCCcccEEE
Confidence 999999888999997653 2577777543 3444 333333333 456666 489999999999999
Q ss_pred cCCC----eEEEee-cCCc
Q 009644 371 EENY----TAKVSD-YGLL 384 (530)
Q Consensus 371 ~~~~----~~KI~D-FGla 384 (530)
..+. .+.|.| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 6432 567776 4533
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00027 Score=69.02 Aligned_cols=72 Identities=10% Similarity=0.172 Sum_probs=46.5
Q ss_pred eeeccCCcE-EEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCC---CcceEEEEEeec---CceeEEeeccCC
Q 009644 243 NIIGEGSFG-LAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHR---HLVKLVGFCEEN---HQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG-~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~---nIv~l~g~~~~~---~~~~LV~Ey~~~ 314 (530)
+.|+.|+.. .||+. +..+++|..... ...++.+|.+++..+... -+.++++..... ...+++||++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 567877776 58874 234677765543 345788999999888532 344455544332 235789999988
Q ss_pred CChH
Q 009644 315 GNVQ 318 (530)
Q Consensus 315 GsL~ 318 (530)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00053 Score=69.55 Aligned_cols=77 Identities=10% Similarity=0.098 Sum_probs=58.3
Q ss_pred ccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCC---CCcceEEEEEee---cCceeEEeecc
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHH---RHLVKLVGFCEE---NHQQLLIYDYI 312 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H---~nIv~l~g~~~~---~~~~~LV~Ey~ 312 (530)
...+.||.|..+.||+-...+++ +.+|..... ....|..|.+.|+.+.- -.+.+++++|.. .+..+||||++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 34568999999999998765554 666764442 34578999999998853 368888988854 36689999999
Q ss_pred CCCCh
Q 009644 313 PNGNV 317 (530)
Q Consensus 313 ~~GsL 317 (530)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00034 Score=64.41 Aligned_cols=126 Identities=14% Similarity=0.185 Sum_probs=83.6
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEcc-cccHHHHHHHHHHHHhcCCCCcc-eEEEEEeecCceeEEeeccCCCChH
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHL-QTQIQNFLHEVKHIARVHHRHLV-KLVGFCEENHQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~-~~~~~~~~~E~~il~~l~H~nIv-~l~g~~~~~~~~~LV~Ey~~~GsL~ 318 (530)
..+.||+|++|.||+|.+.++ .+|+|+.. ......+..|+++|..+.--++. +++.|-.+ ++.|||..+-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchh
Confidence 447899999999999999654 67777655 44567899999999998765543 34444322 3559999887887
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC-C-CcEEEcCCCeEEEeecCCccc
Q 009644 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFR-T-SNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 319 ~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk-~-~NILl~~~~~~KI~DFGla~~ 386 (530)
+.-.. .+-.....++ .. +|.=+. .+|-|..|. | .||++. +..+-|+||--|+.
T Consensus 101 ~~~~~--------~~rk~l~~vl----E~-a~~LD~-~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG--------GDRKHLLRVL----EK-AYKLDR-LGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc--------ccHHHHHHHH----HH-HHHHHH-hccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence 65432 1233333333 32 232221 377787775 3 455555 44999999998874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0004 Score=79.49 Aligned_cols=195 Identities=17% Similarity=0.232 Sum_probs=133.4
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEeecCc----eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 009644 277 FLHEVKHIARVHHRHLVKLVGFCEENHQ----QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352 (530)
Q Consensus 277 ~~~E~~il~~l~H~nIv~l~g~~~~~~~----~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 352 (530)
-..|.+.+.++.|+|++.+++|-.+... ..+..|++..-++...+..- +.++....+.+..++..||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH
Confidence 4456677888899999999998765432 23456788888888877654 26788888889999999999999
Q ss_pred cCCCCeeecCCCCC---cEEEcCCCeEEEe--ecCCcccccCCCCcCcccccccccCccccCCCCCCch--hhHHHHHHH
Q 009644 353 SLVPPLFHMHFRTS---NVLLEENYTAKVS--DYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAG--SDVYSFGVF 425 (530)
Q Consensus 353 ~~~~~ivHrDLk~~---NILl~~~~~~KI~--DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k--sDVwSfGvv 425 (530)
+. ...|.-|..+ +-..+..+...++ ||+.++.+..............|.+||......+..+ .|+|.+|..
T Consensus 304 ~~--~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 SL--SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred Hh--ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 94 4445444444 4444556667777 9988887655444333344556888888776655544 799999999
Q ss_pred HHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHH
Q 009644 426 LLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGEL 500 (530)
Q Consensus 426 l~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L 500 (530)
+..+..|..+-..... ... +++ ........+...+|+..++ +|++..+++...
T Consensus 382 ~~~~~~~~~i~~~~~~------~~~---------~l~-------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------PVS---------LLD-------VLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc------hhh---------hhc-------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999998765332110 000 000 0111156677788998887 899999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0021 Score=62.44 Aligned_cols=72 Identities=15% Similarity=0.121 Sum_probs=48.3
Q ss_pred ceeeccCCcEEEEEEEEcC--CCEEEEEEcccccH--HHHHHHHHHHHhcCC-CCcceEEEEEeecCceeEEeeccCCCC
Q 009644 242 INIIGEGSFGLAYKGLLQD--GSLVVIKRHLQTQI--QNFLHEVKHIARVHH-RHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~--~~~vavK~~~~~~~--~~~~~E~~il~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
++.|..|-...+|+....+ +..+++|....... -+..+|+.++..+.. .-..++++.+. ..++|||+++.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 3578888889999988654 56788887654321 123478888888843 33455554433 248999998876
Q ss_pred h
Q 009644 317 V 317 (530)
Q Consensus 317 L 317 (530)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0054 Score=64.50 Aligned_cols=72 Identities=14% Similarity=0.254 Sum_probs=53.5
Q ss_pred eeeccCCcEEEEEEEEcCC-CEEEEEEccc----------ccHHHHHHHHHHHHhcC---CCCcceEEEEEeecCceeEE
Q 009644 243 NIIGEGSFGLAYKGLLQDG-SLVVIKRHLQ----------TQIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~-~~vavK~~~~----------~~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~~LV 308 (530)
+.||.|.+..||+....+| +.++||...+ -..+.+..|.+.|..+. -.++.+++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 6799999999999998777 4899997431 13456778888888762 34677788773 3557899
Q ss_pred eeccCCCC
Q 009644 309 YDYIPNGN 316 (530)
Q Consensus 309 ~Ey~~~Gs 316 (530)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0012 Score=66.58 Aligned_cols=143 Identities=15% Similarity=0.169 Sum_probs=86.5
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCCC--cceEEEE------EeecCceeEEeeccC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRH--LVKLVGF------CEENHQQLLIYDYIP 313 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~g~------~~~~~~~~LV~Ey~~ 313 (530)
.+.|..|....+|+....++ .+++|........+...|++++..+++.. +.+++.. ....+..++|+||++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 56788888889999876544 68888876544566778888888885432 4454442 123445689999998
Q ss_pred CCChHH----H----------hhcc-CCCC-----CCCCCHHHHH----------HHHHHHHHHHHHhhc-----CCCCe
Q 009644 314 NGNVQN----H----------LYDS-EGLP-----IGKLTMRQRL----------SIALGAAKGLEHLHS-----LVPPL 358 (530)
Q Consensus 314 ~GsL~~----~----------l~~~-~~~~-----~~~l~~~~~~----------~i~~qia~gL~yLH~-----~~~~i 358 (530)
|..+.. . ++.. .+.. .....|.... .....+...+.++.. ...++
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 876532 0 1110 0000 0011222111 011112334444442 12479
Q ss_pred eecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 359 FHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 359 vHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
+|+|+.|.|||++++....|.||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCceEEEeehhhhc
Confidence 999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.006 Score=62.29 Aligned_cols=143 Identities=17% Similarity=0.153 Sum_probs=78.7
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCC--CcceEEE------EEeecCceeEEeeccC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHR--HLVKLVG------FCEENHQQLLIYDYIP 313 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~--nIv~l~g------~~~~~~~~~LV~Ey~~ 313 (530)
.+.|+.|....+|+....+| .+++|+......+....|.+++..|... .+.+.+. +....+..++++||++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 35567787789999887655 5788876532334455566666666322 2334332 1123456789999998
Q ss_pred CCChH-----------HHh---hcc-CCCC-----CCCCCH-HHHHH------------HH-HHHHHHHHHhhc-----C
Q 009644 314 NGNVQ-----------NHL---YDS-EGLP-----IGKLTM-RQRLS------------IA-LGAAKGLEHLHS-----L 354 (530)
Q Consensus 314 ~GsL~-----------~~l---~~~-~~~~-----~~~l~~-~~~~~------------i~-~qia~gL~yLH~-----~ 354 (530)
|..+. +.| +.. .+.+ ...+.| .+... .. ..+..-++.+.. .
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 86431 111 110 0000 001111 11111 01 111112233321 2
Q ss_pred CCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 355 ~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
..+++|+|+.+.|||++.+...-|.||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999977667899999774
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=63.98 Aligned_cols=136 Identities=14% Similarity=0.122 Sum_probs=77.3
Q ss_pred eeccCCcEEEEEEEEcCCCEEEEEEcccccH---HHHHHHHHHHHhcCCCCc-ceEEEEEeecCceeEEeeccCCCChHH
Q 009644 244 IIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI---QNFLHEVKHIARVHHRHL-VKLVGFCEENHQQLLIYDYIPNGNVQN 319 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~GsL~~ 319 (530)
.+..|-.+.+|+... ++..+++|....... -+..+|.++++.+....+ .++++... -++||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677888998874 566788887543221 245789999998854333 44554432 368999998866532
Q ss_pred H--------------hhccCCCC--CCCCCHHHH-HHHHHHH---------HHHHHHhhcC------CCCeeecCCCCCc
Q 009644 320 H--------------LYDSEGLP--IGKLTMRQR-LSIALGA---------AKGLEHLHSL------VPPLFHMHFRTSN 367 (530)
Q Consensus 320 ~--------------l~~~~~~~--~~~l~~~~~-~~i~~qi---------a~gL~yLH~~------~~~ivHrDLk~~N 367 (530)
. +.+-...+ ...++.... .....++ ..-+..+-.. ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111111 112222211 1111111 1112222111 1358999999999
Q ss_pred EEEcCCCeEEEeecCCcc
Q 009644 368 VLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 368 ILl~~~~~~KI~DFGla~ 385 (530)
|++++++ +.+.||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.015 Score=59.10 Aligned_cols=143 Identities=14% Similarity=0.102 Sum_probs=83.0
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCC--CcceEEEEE------eecCceeEEeecc
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHR--HLVKLVGFC------EENHQQLLIYDYI 312 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~--nIv~l~g~~------~~~~~~~LV~Ey~ 312 (530)
++.++.|....+|+....++ .+++|..... ..++...|.+++..|... .+.+++... ..++..++++||+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 45677787789999876555 5677865432 244566777777777422 244444421 2245678999999
Q ss_pred CCCChHH-----------H---hhcc-CCCCCC------CCCHHHHH------------HHHHHHHHHHHHhhc-----C
Q 009644 313 PNGNVQN-----------H---LYDS-EGLPIG------KLTMRQRL------------SIALGAAKGLEHLHS-----L 354 (530)
Q Consensus 313 ~~GsL~~-----------~---l~~~-~~~~~~------~l~~~~~~------------~i~~qia~gL~yLH~-----~ 354 (530)
+|..+.. . ++.. .+.+.. .-.|.... .....+.+.++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8754321 1 1110 010000 01111110 011223345555542 1
Q ss_pred CCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 355 ~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
..+++|+|+.+.||++++++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2589999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0046 Score=62.61 Aligned_cols=72 Identities=25% Similarity=0.269 Sum_probs=48.9
Q ss_pred eeeccCCcEEEEEEEEcC-------CCEEEEEEcccc--cHHHHHHHHHHHHhcCCCC-cceEEEEEeecCceeEEeecc
Q 009644 243 NIIGEGSFGLAYKGLLQD-------GSLVVIKRHLQT--QIQNFLHEVKHIARVHHRH-LVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~-------~~~vavK~~~~~--~~~~~~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+.+..|-...+|+....+ ++.+++|..... ...+..+|.+++..+.... ..++++++.. .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 566677778999988655 478888886543 2235678888888885333 3456665542 3689999
Q ss_pred CCCChH
Q 009644 313 PNGNVQ 318 (530)
Q Consensus 313 ~~GsL~ 318 (530)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.00025 Score=82.88 Aligned_cols=159 Identities=13% Similarity=0.047 Sum_probs=112.4
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEe--ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 009644 277 FLHEVKHIARVHHRHLVKLVGFCE--ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354 (530)
Q Consensus 277 ~~~E~~il~~l~H~nIv~l~g~~~--~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 354 (530)
...|...++...|+++...+.-.. ++.+.+.+++|+..|.+.+.+-+..... ..+...-+.....+...+..-.|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-CcchhchHHHHHHHHHhccchhhhc
Confidence 344555666678998877665443 3456789999999999999987643211 1233322322223324445554542
Q ss_pred ---CCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHH
Q 009644 355 ---VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELI 430 (530)
Q Consensus 355 ---~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ell 430 (530)
..--+|++||+-|.+|..+..+|++++|+.+.... ....+...+++.|+.|+....-.++.++|+|+.|+-+|+..
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23578999999999999999999999999994332 22334445777899999988889999999999999999998
Q ss_pred cCCCCC
Q 009644 431 SGREAH 436 (530)
Q Consensus 431 tG~~p~ 436 (530)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887664
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.022 Score=57.13 Aligned_cols=31 Identities=19% Similarity=0.365 Sum_probs=25.6
Q ss_pred CCeeecCCCCCcEEEcCCCe-EEEeecCCccc
Q 009644 356 PPLFHMHFRTSNVLLEENYT-AKVSDYGLLKL 386 (530)
Q Consensus 356 ~~ivHrDLk~~NILl~~~~~-~KI~DFGla~~ 386 (530)
+.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997554 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.008 Score=60.56 Aligned_cols=76 Identities=17% Similarity=0.319 Sum_probs=51.3
Q ss_pred CccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC---CCCcceEEEEEeecCceeEEeeccCCC
Q 009644 239 FSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
.+..+.++-|....+|+.. .+++.+.||.-.......|..|.+-|+.|. --.+.+.+++....+..+|||||++.+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3445778989999999977 567889999877666677899999888883 445778899888777789999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.004 Score=62.70 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=92.3
Q ss_pred ccCHHHHHHhhc---CCccceeeccCCcEEEEEEEEcCCCEEEEEEccc---------cc----------------HHHH
Q 009644 226 QLTILELKHATN---NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ---------TQ----------------IQNF 277 (530)
Q Consensus 226 ~~~~~el~~~t~---~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~---------~~----------------~~~~ 277 (530)
.+.|..++...+ -++..+.||-|.-+.||.+-..+|++.++|...- .. .-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 344555554443 3567799999999999999999999999885320 00 0124
Q ss_pred HHHHHHHHhcC-CC-CcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 009644 278 LHEVKHIARVH-HR-HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355 (530)
Q Consensus 278 ~~E~~il~~l~-H~-nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 355 (530)
.+|...|+.|. |- -+.+.+++ +..++|||++.+-.|.+.-+- .+..++..-+..+ +.-|-.
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~---Iv~la~-- 220 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGL---IVRLAN-- 220 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHH---HHHHHH--
Confidence 56888888884 22 23344433 456899999988777654321 2223322222222 223333
Q ss_pred CCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 356 PPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 356 ~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
.|+||+|..--||+++++..++++||=-
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechH
Confidence 5999999999999999999999999954
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.0099 Score=63.22 Aligned_cols=70 Identities=10% Similarity=0.226 Sum_probs=46.4
Q ss_pred EEEEEEcCCCEEEEEEcc-cccHHHHHHHHHHHHhcCCCCcceEEEEEeecC-ceeEEeeccCCCChHHHhhcc
Q 009644 253 AYKGLLQDGSLVVIKRHL-QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENH-QQLLIYDYIPNGNVQNHLYDS 324 (530)
Q Consensus 253 Vy~g~~~~~~~vavK~~~-~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~~~GsL~~~l~~~ 324 (530)
.+.|..++|... ..-+. .......+-....++.+.|+|+...+.+..... ...+|||++ +-||.+.+...
T Consensus 5 ~~~a~~~~~~~c-~nglplt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcCCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 355555555433 22111 122344566678889999999999998876543 467899999 66999988754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.11 Score=54.75 Aligned_cols=70 Identities=19% Similarity=0.293 Sum_probs=49.0
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEccc------c----cHHHHHHHHHHHHhcC---CCCcceEEEEEeecCceeEE
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQ------T----QIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~------~----~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~~LV 308 (530)
.+.||.|....||+.... +..++||.-.. . ...+-..|.+.|..+. ..++.+++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 468999999999998764 45688997441 1 2233344566666553 3578889988874 45789
Q ss_pred eeccCC
Q 009644 309 YDYIPN 314 (530)
Q Consensus 309 ~Ey~~~ 314 (530)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.093 Score=54.36 Aligned_cols=139 Identities=10% Similarity=0.111 Sum_probs=78.3
Q ss_pred eeeccCCcEEEEEEEEcC-----CCEEEEEEccccc--HHHHHHHHHHHHhcCCCCc-ceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQD-----GSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHL-VKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
..|-.|-...+|+....+ +..+++|...... .-+-.+|..++..+...++ .++++.+..+ .|+||+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 455557778889887532 3578888765432 1123678888888854333 3566665332 58999977
Q ss_pred CChHHH-----------------hhccCCCCCC--CCCHHHHHHHHHH-----------------HHHHHHHh----hc-
Q 009644 315 GNVQNH-----------------LYDSEGLPIG--KLTMRQRLSIALG-----------------AAKGLEHL----HS- 353 (530)
Q Consensus 315 GsL~~~-----------------l~~~~~~~~~--~l~~~~~~~i~~q-----------------ia~gL~yL----H~- 353 (530)
.+|... ++... .+.. ...+.++..+..+ +..-+..| ..
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~-~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLD-MPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 665421 11111 0100 1112222222211 11112222 21
Q ss_pred -CCCCeeecCCCCCcEEEcC-CCeEEEeecCCccc
Q 009644 354 -LVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKL 386 (530)
Q Consensus 354 -~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~ 386 (530)
....++|+|+++.|||+++ ++.+.+.||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1136899999999999986 47899999987753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.16 Score=52.64 Aligned_cols=70 Identities=14% Similarity=0.304 Sum_probs=46.2
Q ss_pred eeccCCcEEEEEEEEcCC-CEEEEEEccc----------ccHHHHHHHHHHHHhcC--CC-CcceEEEEEeecCceeEEe
Q 009644 244 IIGEGSFGLAYKGLLQDG-SLVVIKRHLQ----------TQIQNFLHEVKHIARVH--HR-HLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~~~~~-~~vavK~~~~----------~~~~~~~~E~~il~~l~--H~-nIv~l~g~~~~~~~~~LV~ 309 (530)
.||.|....||++...+| +.|+||.-.+ -..++-.-|.+.|.... -| .+.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 5799996331 11234556777776652 23 45555543 444556999
Q ss_pred eccCCC
Q 009644 310 DYIPNG 315 (530)
Q Consensus 310 Ey~~~G 315 (530)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.15 Score=51.96 Aligned_cols=134 Identities=18% Similarity=0.268 Sum_probs=74.4
Q ss_pred EEEEEEEEcCCCEEEEEEcc-----cccHHHHHHHHHHHHhcCC--CCcceEEEEEeecC--ceeEEeeccCCCCh----
Q 009644 251 GLAYKGLLQDGSLVVIKRHL-----QTQIQNFLHEVKHIARVHH--RHLVKLVGFCEENH--QQLLIYDYIPNGNV---- 317 (530)
Q Consensus 251 G~Vy~g~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~H--~nIv~l~g~~~~~~--~~~LV~Ey~~~GsL---- 317 (530)
-.+|..... ++..++. .. ........+|.++++.+.- --+...+++|.++. ..+.||+|.++..+
T Consensus 39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 334443332 6667776 22 1233456678888887743 22355677777665 77899999987322
Q ss_pred --------------HHHhhccCCC------CCC--------CC-CHHHHHHHH--------HHHHHHHHHhhcC------
Q 009644 318 --------------QNHLYDSEGL------PIG--------KL-TMRQRLSIA--------LGAAKGLEHLHSL------ 354 (530)
Q Consensus 318 --------------~~~l~~~~~~------~~~--------~l-~~~~~~~i~--------~qia~gL~yLH~~------ 354 (530)
.++|..-... ..+ .+ .|......+ -....-..||+..
T Consensus 117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 1222110000 000 00 111111000 0112224455442
Q ss_pred CCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 355 ~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
.+.++|+|+.+.|++++.+..+=|.||+++..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 14699999999999999998899999999865
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.14 Score=49.52 Aligned_cols=75 Identities=15% Similarity=0.292 Sum_probs=53.7
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc---CCCCcceEEEEEeecCceeEEeeccCCCChH
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV---HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l---~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~ 318 (530)
+.+--|.--..|.... +...+-||+-......-|..|+.-|..+ +--++.+++.+-.+.++.||||||++-|.+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3443343334444332 4567889987777778899998877666 3456778888888899999999999987665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.42 Score=48.32 Aligned_cols=64 Identities=13% Similarity=0.160 Sum_probs=39.4
Q ss_pred EEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCC--CcceEEEE------EeecCceeEEeeccCCCCh
Q 009644 252 LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHR--HLVKLVGF------CEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 252 ~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~--nIv~l~g~------~~~~~~~~LV~Ey~~~GsL 317 (530)
.||+....+| .+++|+... .......|...+..|... .+.+++.. ...++..+.++||++|.++
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~-~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY-PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876555 578888643 234455677777766332 34444432 1234568899999988554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.064 Score=55.84 Aligned_cols=61 Identities=15% Similarity=0.091 Sum_probs=42.5
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
..|+-+|+.+-++..++.... .++.-+.+++.-.++|+--+--. .+++|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~v-DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLIV-DNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHHh-hcceecccCCCcEEEEe
Confidence 456777898999999987653 23345555666556665443322 38999999999999953
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.021 Score=39.95 Aligned_cols=37 Identities=27% Similarity=0.398 Sum_probs=24.6
Q ss_pred hhhHHHHHHhhhhhCC-C----CCCCCCCCCCCCcCcccccccc
Q 009644 42 KVYAEALLACKSALGT-P----GQSSGRIGRYPCIRQRACLNCY 80 (530)
Q Consensus 42 ~~~~~~~~~~k~~~~~-~----~~~~g~~~~~pc~~~~~~~~c~ 80 (530)
++|++||+++|+.... + .+|...-..+||. |.|+.|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~--W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCS--WSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCC--STTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCee--eccEEeC
Confidence 4699999999999873 3 5687631247787 9999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.23 Score=51.19 Aligned_cols=134 Identities=15% Similarity=0.158 Sum_probs=89.9
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEccccc-------------------------H---HH-HHHHHHHHHhcCCCCcc
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-------------------------I---QN-FLHEVKHIARVHHRHLV 293 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-------------------------~---~~-~~~E~~il~~l~H~nIv 293 (530)
-.|..|.-+.||.+.-.+|..+|||+...+- . +- ...|++.|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 5788899999999999999999999643210 0 11 24588888888654432
Q ss_pred eEEEEEeecCceeEEeeccCCCC-hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 009644 294 KLVGFCEENHQQLLIYDYIPNGN-VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 294 ~l~g~~~~~~~~~LV~Ey~~~Gs-L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~ 372 (530)
----... ....|||+|+.... -.-.|++ ..++...+..+-.+++.-|.-|... -++||.||.--|+|+.
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEE-
Confidence 1111111 13469999995321 1122221 2567777777888888888887653 2899999999999986
Q ss_pred CCeEEEeecCCccc
Q 009644 373 NYTAKVSDYGLLKL 386 (530)
Q Consensus 373 ~~~~KI~DFGla~~ 386 (530)
+|.+.|+|-+-+..
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 46899999887653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.33 Score=49.95 Aligned_cols=71 Identities=18% Similarity=0.230 Sum_probs=44.8
Q ss_pred eeeccCCcEEEEEEEEcC----CCEEEEEEccccc--HHHHHHHHHHHHhcCCCCc-ceEEEEEeecCceeEEeeccCCC
Q 009644 243 NIIGEGSFGLAYKGLLQD----GSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHL-VKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
+.|..|-...+|+....+ +..+++|...... .-+-.+|..+++.+..-++ .++++++. ++ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 456557778889887543 2368888755422 1133578888888865444 45666653 22 589999766
Q ss_pred Ch
Q 009644 316 NV 317 (530)
Q Consensus 316 sL 317 (530)
.|
T Consensus 96 ~l 97 (330)
T PLN02421 96 TL 97 (330)
T ss_pred CC
Confidence 54
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.12 Score=49.64 Aligned_cols=149 Identities=17% Similarity=0.146 Sum_probs=91.7
Q ss_pred CcEEEEEEEEcCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhcc
Q 009644 249 SFGLAYKGLLQDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS 324 (530)
Q Consensus 249 ~fG~Vy~g~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~ 324 (530)
+-.+.-+|.-+-|.. .+|++... ...-|..+.+++++++ .|+++.. ..+..+-++.|+|-.-.
T Consensus 74 gNsTl~~~kt~iG~L-~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~-------- 140 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPL-FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIK-------- 140 (308)
T ss_pred CceEEEEeccccchh-hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCcc--------
Confidence 344444444333433 34443322 2345788999999886 4677762 12334558899884211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccC
Q 009644 325 EGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD 404 (530)
Q Consensus 325 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~a 404 (530)
..... .|..+ .+.|.-.|+...+.+|+|..|+||+-|..|.+||.|=+.--. .+..|..
T Consensus 141 ------i~~~N---~i~ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-----------~~V~~vN 199 (308)
T PF07387_consen 141 ------INFSN---FITAG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-----------NQVNMVN 199 (308)
T ss_pred ------cchhH---HHHHh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhh-----------heeeEEe
Confidence 11111 12222 366778897657999999999999999999999999774321 1112333
Q ss_pred ccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 009644 405 PELNLSKNYSAGSDVYSFGVFLLELISGRE 434 (530)
Q Consensus 405 PE~~~~~~~s~ksDVwSfGvvl~ElltG~~ 434 (530)
-| ....|.++.+=+|=.-++++.....
T Consensus 200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 200 IE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred ee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11 3456788888888888888877543
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.31 Score=51.23 Aligned_cols=71 Identities=11% Similarity=0.164 Sum_probs=48.1
Q ss_pred ceeeccCCcEEEEEEEEcC-CCEEEEEEccc---------ccHHHHHHHHHHHHhcC--CC-CcceEEEEEeecCceeEE
Q 009644 242 INIIGEGSFGLAYKGLLQD-GSLVVIKRHLQ---------TQIQNFLHEVKHIARVH--HR-HLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~---------~~~~~~~~E~~il~~l~--H~-nIv~l~g~~~~~~~~~LV 308 (530)
.+.||.|.-..||++...+ ++.|+||.-.. -..++..-|.+.|+... -| ++.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3689999999999999743 56799996331 12355666777777662 23 45666654 44456789
Q ss_pred eeccCC
Q 009644 309 YDYIPN 314 (530)
Q Consensus 309 ~Ey~~~ 314 (530)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.14 Score=48.89 Aligned_cols=30 Identities=17% Similarity=0.338 Sum_probs=21.3
Q ss_pred CeeecCCCCCcEEE-cCCCeEEEeecCCccc
Q 009644 357 PLFHMHFRTSNVLL-EENYTAKVSDYGLLKL 386 (530)
Q Consensus 357 ~ivHrDLk~~NILl-~~~~~~KI~DFGla~~ 386 (530)
.+.|+|+.+.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 57899999999999 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.023 Score=49.41 Aligned_cols=50 Identities=16% Similarity=0.282 Sum_probs=41.2
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV 287 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l 287 (530)
..|+. +.||.|+.|.||+|++++|+.||||+..+.-.+.+...+.++..+
T Consensus 12 ~~fd~-~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 12 DEFDP-EPLASASIAQVHRARLKDGEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred HHCCc-chhhheehhhheeeeecccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 34443 689999999999999999999999998887777777777777654
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.48 E-value=0.24 Score=51.06 Aligned_cols=74 Identities=16% Similarity=0.161 Sum_probs=56.4
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
....|++|++. +++|.-. ..-.+.+.+.|+.+.+.-+.-+... -+.=|||+.-.||||+ +|++.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~i---------k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII---------KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeeee---------ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEe
Confidence 34556777766 5554321 1357889999999888777666653 4788999999999999 999999999
Q ss_pred CCcccc
Q 009644 382 GLLKLV 387 (530)
Q Consensus 382 Gla~~~ 387 (530)
-++|.-
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.41 E-value=1.9 Score=44.30 Aligned_cols=69 Identities=16% Similarity=0.085 Sum_probs=43.8
Q ss_pred CCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCC--CcceEE---E--EEeecCceeEEeeccCCCC
Q 009644 248 GSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHR--HLVKLV---G--FCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 248 G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~--nIv~l~---g--~~~~~~~~~LV~Ey~~~Gs 316 (530)
+.-..||+....++..+++|..... .......|++.+..+... .++... | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4456799988878888999987533 345667788887776321 122211 1 1223456778999997754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.64 E-value=1 Score=45.82 Aligned_cols=30 Identities=17% Similarity=0.195 Sum_probs=27.1
Q ss_pred CCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 356 ~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
.+++|+|+.+.|+|+++++.+.+.||-.+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 479999999999999999899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 530 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-38 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-91
Identities = 101/301 (33%), Positives = 163/301 (54%), Gaps = 16/301 (5%)
Query: 217 SPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQ- 275
S + ++ +++L+ ATNNF +IG G FG YKG+L+DG+ V +KR Q
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78
Query: 276 --NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT 333
F E++ ++ H HLV L+GFC+E ++ +LIY Y+ NGN++ HLY S LP ++
Sbjct: 79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMS 137
Query: 334 MRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL--VTGSH 391
QRL I +GAA+GL +LH+ + H ++ N+LL+EN+ K++D+G+ K
Sbjct: 138 WEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 392 HAGSTSAVDCF--LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI- 448
H ST +DPE + + SDVYSFGV L E++ R A ++ NL
Sbjct: 196 HL-STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 449 --LQVKRSCDLGKYVDKTLGEQ-TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504
++ + L + VD L ++ + + + A++C+ +SS RPSM + +LE
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
Query: 505 E 505
Sbjct: 315 R 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-83
Identities = 90/314 (28%), Positives = 150/314 (47%), Gaps = 43/314 (13%)
Query: 219 IDTQNLKQLTILELKHATNNFSE------INIIGEGSFGLAYKGLLQDGSLVVIKRHLQT 272
+ + ELK+ TNNF E N +GEG FG+ YKG + + + V +K+
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 273 QIQN-------FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSE 325
F E+K +A+ H +LV+L+GF + L+Y Y+PNG++ + L +
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 326 GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385
G P L+ R IA GAA G+ LH H +++N+LL+E +TAK+SD+GL +
Sbjct: 126 GTP--PLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 386 LV-TGSHHAGSTSAVDCF--LDPELNLSKNYSAG-----SDVYSFGVFLLELISGREAHG 437
+ ++ V + PE G SD+YSFGV LLE+I+G A
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPE------ALRGEITPKSDIYSFGVVLLEIITGLPA-- 233
Query: 438 RNHSNSDQNL------ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCV-DVSSRR 490
+ Q L I ++ + Y+DK + + + M +A QC+ + ++R
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEK--TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 491 PSMRQIAGELEGIQ 504
P ++++ L+ +
Sbjct: 292 PDIKKVQQLLQEMT 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 7e-81
Identities = 99/298 (33%), Positives = 157/298 (52%), Gaps = 15/298 (5%)
Query: 219 IDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQN-- 276
+ LK+ ++ EL+ A++NFS NI+G G FG YKG L DG+LV +KR + + Q
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 277 --FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM 334
F EV+ I+ HR+L++L GFC ++LL+Y Y+ NG+V + L + L
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP-PLDW 130
Query: 335 RQRLSIALGAAKGLEHLH-SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393
+R IALG+A+GL +LH P + H + +N+LL+E + A V D+GL KL+
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 394 GSTSAVDCF--LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLIL-- 449
+T+ + PE + S +DV+ +GV LLELI+G+ A +D +++L
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 450 ---QVKRSCDLGKYVDKTLGEQ-TVGAATEMMELALQCVDVS-SRRPSMRQIAGELEG 502
+ + L VD L +++++AL C S RP M ++ LEG
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-50
Identities = 59/308 (19%), Positives = 112/308 (36%), Gaps = 40/308 (12%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHE--VKHIARVH 288
L + + + G FG +K L V +K Q++ +E V + +
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMK 76
Query: 289 HRHLVKLVGFCEE----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA 344
H ++++ +G + + LI + G++ + L + ++ + IA
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETM 130
Query: 345 AKGLEHLHSLV--------PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST 396
A+GL +LH + P + H ++ NVLL+ N TA ++D+GL AG T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 397 SAV---DCFLDPE-----LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI 448
++ PE +N ++ D+Y+ G+ L EL S A
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 449 LQVKRS---CDLGKYVDKTLGE-------QTVGAATEMMELALQCVDVS-SRRPSMRQIA 497
++ + D+ + V Q + E +C D R S +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 498 GELEGIQE 505
+ +Q
Sbjct: 311 ERITQMQR 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 55/291 (18%), Positives = 116/291 (39%), Gaps = 49/291 (16%)
Query: 238 NFSEINI---IGEGSFGLAYKGLLQDGSLVVIKRHLQTQ------IQNFLHEVKHIARVH 288
+F ++N + E G +KG Q G+ +V+K L+ + ++F E +
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKV-LKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 289 HRHLVKLVGFCEENHQQLL--IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK 346
H +++ ++G C+ I ++P G++ N L++ + Q + AL A+
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMAR 122
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406
G+ LH+L P + + +V+++E+ TA++S + + ++ PE
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWVAPE 178
Query: 407 L---NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-------QNLILQVKRSCD 456
+D++SF V L EL++ + SN + + L +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-ADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQER 506
+ +L C++ ++RP I LE +Q++
Sbjct: 238 -----------------PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 34/280 (12%)
Query: 238 NFSEINI---IGEGSFGLAYKGLLQDGSLVVIKR-HLQTQIQNFLHEVKHIARVHHRHLV 293
++ EI + +G G+FG+ K + V IK+ +++ + F+ E++ ++RV+H ++V
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIV 64
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
KL G C L+ +Y G++ N L+ +E P+ T +S L ++G+ +LHS
Sbjct: 65 KLYGACLNPV--CLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 354 LVPPLFHMHF--RTSNVLLEENYT-AKVSDYGLLKLVTGSHHAGSTSAVD--CFLDPELN 408
+ P +H + N+LL T K+ D+G + T+ ++ PE+
Sbjct: 121 MQPKAL-IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVF 175
Query: 409 LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--DLGKYVDKTLG 466
NYS DV+S+G+ L E+I+ R+ ++ V L K + K
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRPPLIKNLPK--- 231
Query: 467 EQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
+ L +C S+RPSM +I + +
Sbjct: 232 --------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 6e-41
Identities = 71/298 (23%), Positives = 133/298 (44%), Gaps = 50/298 (16%)
Query: 238 NFSEINI---IGEGSFGLAYKGLLQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHH 289
+ ++NI IG GSFG ++ GS V +K ++ FL EV + R+ H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++V +G + ++ +Y+ G++ L+ S +L R+RLS+A AKG+
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMN 151
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS-------AVDCF 402
+LH+ PP+ H + ++ N+L+++ YT KV D+GL +L + + ++ A
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA---- 207
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-------QNLILQVKRSC 455
PE+ + + SDVYSFGV L EL + ++ N + + + L++ R+
Sbjct: 208 --PEVLRDEPSNEKSDVYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKCKRLEIPRNL 264
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGRLH 512
+ ++ + C +RPS I L + + + +
Sbjct: 265 N-----------------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-40
Identities = 64/292 (21%), Positives = 120/292 (41%), Gaps = 39/292 (13%)
Query: 238 NFSEINI---IGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHR 290
S++ +G+G FG A K + G ++V+K ++ + FL EVK + + H
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
+++K +G ++ + I +YI G ++ + + + QR+S A A G+ +
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAY 123
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD------ 404
LHS+ + H + N L+ EN V+D+GL +L+ D
Sbjct: 124 LHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 405 ---------PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455
PE+ ++Y DV+SFG+ L E+I A ++ + L V+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD-PDYLPRTMDFGLNVRGFL 240
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQER 506
D + ++C D+ +RPS ++ LE ++
Sbjct: 241 DR---------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 61/299 (20%)
Query: 238 NFSEINI---IGEGSFGLAYKG-LLQDGSLVVIKR----------HLQTQIQNFLHEVKH 283
+EI IG+G FGL +KG L++D S+V IK + + Q F EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALG 343
++ ++H ++VKL G ++ +++P G++ + L D + +L + L
Sbjct: 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLD 130
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEE-----NYTAKVSDYGLLKLVTGSHHAGSTSA 398
A G+E++ + PP+ H R+ N+ L+ AKV+D+GL + S +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGL 186
Query: 399 VDCF--LDPEL--NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD---------Q 445
+ F + PE ++Y+ +D YSF + L +++G +S +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-DEYSYGKIKFINMIREE 245
Query: 446 NLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
L + C + + C +RP I EL +
Sbjct: 246 GLRPTIPEDCP-----------------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 8e-38
Identities = 60/324 (18%), Positives = 112/324 (34%), Gaps = 51/324 (15%)
Query: 226 QLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVK--H 283
+ E +N + +IG G +G YKG L D V +K QNF++E
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR 60
Query: 284 IARVHHRHLVKLVGFCEE-----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRL 338
+ + H ++ + + E + LL+ +Y PNG++ +L
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSC 114
Query: 339 SIALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391
+A +GL +LH+ P + H + NVL++ + T +SD+GL +TG+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 392 HAGSTSAVDC--------------FLDPELNLS--KNYSAGSDVYSFGVFLLELISGREA 435
+ L+ +NL ++ D+Y+ G+ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 436 HGRNHSNSD-----QNLILQVKRSCDLGKYVDK-----TLGE---QTVGAATEMMELALQ 482
S + Q + D+ V + E + A + E
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 483 CVDVS-SRRPSMRQIAGELEGIQE 505
C D R + + + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMM 318
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-37
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 59/296 (19%)
Query: 238 NFSEINI---IGEGSFGLAYKGLLQDGSLVVIKR-------HLQTQIQNFLHEVKHIARV 287
+F+E+ + IG G FG Y+ G V +K + I+N E K A +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
H +++ L G C + L+ ++ G + L ++ ++ A+ A+G
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARG 117
Query: 348 LEHLHSLVPPLFHMHF--RTSNVLLEE--------NYTAKVSDYGLLKLVTGSHHAGSTS 397
+ +LH +H ++SN+L+ + N K++D+GL + H S
Sbjct: 118 MNYLHDEAIVPI-IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMS 173
Query: 398 AVDCF--LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-------QNLI 448
A + + PE+ + +S GSDV+S+GV L EL++G R L
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-RGIDGLAVAYGVAMNKLA 232
Query: 449 LQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
L + +C +L C + RPS I +L I
Sbjct: 233 LPIPSTCP-----------------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 31/282 (10%)
Query: 238 NFSEINI---IGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHH 289
+I + IG GSFG YKG V +K T Q+Q F +EV + + H
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+++ +G+ ++ + ++ +HL+ SE K M++ + IA A+G++
Sbjct: 80 VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMD 134
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD---CFLDPE 406
+LH+ + H +++N+ L E+ T K+ D+GL + + + ++ PE
Sbjct: 135 YLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 407 L---NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463
+ S YS SDVY+FG+ L EL++G+ + N +N DQ +I V R +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQ-IIEMVGR-----GSLSP 245
Query: 464 TLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQ 504
L + M L +C+ RPS +I E+E +
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 44/299 (14%)
Query: 238 NFSEINI---IGEGSFGLAYKGLLQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHH 289
F ++ I IG+G FG Y G V I+ + Q++ F EV + H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++V +G C +I + + + D++ L + + IA KG+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMG 144
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD------CFL 403
+LH+ + H ++ NV + ++D+GL + + C L
Sbjct: 145 YLHA--KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 404 DPEL---------NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454
PE+ +S SDV++ G EL + ++ +I Q+
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEA-IIWQM--- 255
Query: 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGRLH 512
G + L + +G E+ ++ L C RP+ ++ LE + +R H
Sbjct: 256 ---GTGMKPNLSQIGMGK--EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 61/351 (17%), Positives = 134/351 (38%), Gaps = 54/351 (15%)
Query: 192 EGESSVPSPSAELERGDISPYPGAVSPIDTQN--LKQLTILELKHATNNFSEINIIGEGS 249
S + +L + G+ P+ Q + + + E IG+G
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQE------------SIGKGR 54
Query: 250 FGLAYKGLLQDGSLVVIKRHLQTQIQNFLHE--VKHIARVHHRHLVKLVGFCEENH---- 303
FG ++G + G V +K + +++ E + + H +++ + +++
Sbjct: 55 FGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113
Query: 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV------PP 357
Q L+ DY +G++ ++L +T+ + +AL A GL HLH + P
Sbjct: 114 QLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 358 LFHMHFRTSNVLLEENYTAKVSDYGL-LKLVTGSHHAGSTSAVDC---------FLDPEL 407
+ H ++ N+L+++N T ++D GL ++ + + LD +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227
Query: 408 NLS-KNYSAGSDVYSFGVFLLELISGREAHGR---------NHSNSDQNLILQVKRSCDL 457
N+ +D+Y+ G+ E+ G + SD ++ K C+
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
Query: 458 GKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQERE 507
+ Q+ A M ++ +C + + R + +I L + ++E
Sbjct: 288 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 65/342 (19%), Positives = 126/342 (36%), Gaps = 54/342 (15%)
Query: 199 SPSAELERGDISPYPGAVSPIDTQN--LKQLTILELKHATNNFSEINIIGEGSFGLAYKG 256
+L S G+ P+ Q KQ+ +++ IG+G +G + G
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVK------------QIGKGRYGEVWMG 56
Query: 257 LLQDGSLVVIKRHLQTQIQNFLHEVK--HIARVHHRHLVKLVGFCEENH----QQLLIYD 310
+ G V +K T+ ++ E + + H +++ + + Q LI D
Sbjct: 57 KWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV------PPLFHMHFR 364
Y NG++ ++L + L + L +A + GL HLH+ + P + H +
Sbjct: 116 YHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 365 TSNVLLEENYTAKVSDYGLLKLVTGSHHAG---STSAVDCF-------LDPELNL-SKNY 413
+ N+L+++N T ++D GL + + V LD LN
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 414 SAGSDVYSFGVFLLELISGREAHG---------RNHSNSDQNLILQVKRSCDLGKYVDKT 464
+D+YSFG+ L E+ + G + SD + + C
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 465 LGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
+ +M +L +C + + R + ++ L + E
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 47/236 (19%), Positives = 96/236 (40%), Gaps = 42/236 (17%)
Query: 225 KQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVK-- 282
+ +T+LE +G+G +G ++G Q G V +K +++ E +
Sbjct: 8 RDITLLE------------CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELY 54
Query: 283 HIARVHHRHLVKLVGFCEENHQQ----LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRL 338
+ + H +++ + + LI Y G++ ++L + L L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCL 108
Query: 339 SIALGAAKGLEHLHSLV------PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
I L A GL HLH + P + H ++ N+L+++N ++D GL + + S +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 393 ---AGSTSAVDCF-------LDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHG 437
G+ V LD + + + D+++FG+ L E+ ++G
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 67/291 (23%), Positives = 126/291 (43%), Gaps = 45/291 (15%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVV-IK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
+ +G G +G Y+G+ + SL V +K + +++ FL E + + H +LV+L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPL 358
C +I +++ GN+ ++L + +++ L +A + +E+L
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK----- 336
Query: 359 FHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LDPELNL 409
+F N L+ EN+ KV+D+GL +L+TG + A F PE
Sbjct: 337 --KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPESLA 392
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
+S SDV++FGV L E+ + + S + +++ + E+
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRM---------ERP 441
Query: 470 VGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI---------QEREIGR 510
G ++ EL C + S RPS +I E + E+E+G+
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 492
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 70/295 (23%), Positives = 114/295 (38%), Gaps = 46/295 (15%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSL-VVIK----RHLQTQIQNFLHEVKHIA 285
L H + IG G+FG + G L+ + V +K FL E + +
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAA 345
+ H ++V+L+G C + ++ + + G+ L +EG +L ++ L + AA
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEG---ARLRVKTLLQMVGDAA 223
Query: 346 KGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
G+E+L S N L+ E K+SD+G+ + +A S
Sbjct: 224 AGMEYLES-------KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ 276
Query: 401 C---FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKR 453
+ PE YS+ SDV+SFG+ L E S G N SN Q +
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFS----LGASPYPNLSNQ------QTRE 326
Query: 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQERE 507
+ G + + L QC +RPS I EL+ I++R
Sbjct: 327 FVEKGGRLPC-----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 38/275 (13%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+G+G FG + G + V IK + + FL E + + ++ H LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
E ++ +Y+ G++ + L G L + Q + +A A G+ ++
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER------ 298
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL-----DPELNL 409
M++ R +N+L+ EN KV+D+GL +L+ + + T+ PE L
Sbjct: 299 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 354
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
++ SDV+SFG+ L EL + N + ++ QV+R +
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRM---------PCP 403
Query: 470 VGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ +L QC RP+ + LE
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 38/275 (13%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+G+G FG + G + V IK + + FL E + + ++ H LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
E ++ +Y+ G++ + L G L + Q + +A A G+ ++
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER------ 381
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL-----DPELNL 409
M++ R +N+L+ EN KV+D+GL +L+ + + T+ PE L
Sbjct: 382 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAAL 437
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
++ SDV+SFG+ L EL + N + ++ QV+R +
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRM---------PCP 486
Query: 470 VGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ +L QC RP+ + LE
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 49/293 (16%)
Query: 242 INIIGEGSFGLAYKGLL-----QDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHL 292
I +GEG FG G V +K I + E++ + ++H ++
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 293 VKLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
VK G C E+ LI +++P+G+++ +L ++ K+ ++Q+L A+ KG+++
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDY 141
Query: 351 LHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--- 402
L S + NVL+E + K+ D+GL K + +
Sbjct: 142 LGS-------RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 403 -LDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR------S 454
PE L SK + SDV+SFGV L EL++ + + S+ + +
Sbjct: 195 WYAPECLMQSK-FYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 455 CDLGKYVDKTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGI 503
L + + G E+ +L +C S R S + + E +
Sbjct: 250 TRLVNTLKE--GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/292 (20%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 242 INIIGEGSFGLAYKGLL-----QDGSLVVIK---RHLQTQIQNFLHEVKHIARVHHRHLV 293
+ +G+G+FG G +V +K + +++F E++ + + H ++V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 294 KLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
K G C ++ LI +Y+P G+++++L + ++ + L KG+E+L
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYL 161
Query: 352 HSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF---- 402
+ + T N+L+E K+ D+GL K++
Sbjct: 162 GT-------KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 403 LDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV---KRSCDLG 458
PE L SK +S SDV+SFGV L EL + E + + + L
Sbjct: 215 YAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 459 KYVDKTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQER 506
+ + + G E+ + +C + ++RPS R +A ++ I+++
Sbjct: 274 ELLKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 45/215 (20%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL-----VVIK----RHLQTQIQNFLHEVKHIARVHHRHL 292
I ++G G+FG YKGL V IK + L E +A V + H+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
+L+G C + LI +P G + +++ + + + + L+ + AKG+ +L
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE 134
Query: 353 SLVPPLFHMHF-------RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS-------- 397
R NVL++ K++D+GL KL+
Sbjct: 135 D-------RRLVHRDLAAR--NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 398 -AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
A E L + Y+ SDV+S+GV + EL++
Sbjct: 186 MA------LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 61/291 (20%), Positives = 120/291 (41%), Gaps = 41/291 (14%)
Query: 242 INIIGEGSFGLAYKGLL-----QDGSLVVIK---RHLQTQIQNFLHEVKHIARVHHRHLV 293
+ +G+G+FG G +V +K + +++F E++ + + H ++V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 294 KLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
K G C ++ LI +Y+P G+++++L + ++ + L KG+E+L
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYL 130
Query: 352 HSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF---- 402
+ + T N+L+E K+ D+GL K++
Sbjct: 131 GT-------KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 403 LDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV---KRSCDLG 458
PE L SK +S SDV+SFGV L EL + E + + + L
Sbjct: 184 YAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 459 KYVDKTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQE 505
+ + + G E+ + +C + ++RPS R +A ++ I++
Sbjct: 243 ELLKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 67/284 (23%), Positives = 117/284 (41%), Gaps = 52/284 (18%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+ IG G FGL + G + V IK R ++F+ E + + ++ H LV+L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
E L+ +++ +G + ++L G L + L +G+ +L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE------ 122
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST--------SAVDCFLDPE 406
N L+ EN KVSD+G+ + V + ST ++ PE
Sbjct: 123 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------PE 175
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKYVD 462
+ YS+ SDV+SFGV + E+ S G+ N SNS+ ++ + L
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS----EGKIPYENRSNSE--VVEDISTGFRL----- 224
Query: 463 KTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQE 505
+ A+T + ++ C + RP+ ++ +L I E
Sbjct: 225 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 52/306 (16%)
Query: 242 INIIGEGSFGLAYKGLL-----QDGSLVVIK--RHLQT-QIQNFLHEVKHIARVHHRHLV 293
I+ +G+G+FG G+LV +K +H Q ++F E++ + +H +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 294 KLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
K G +Q L+ +Y+P+G +++ L +L + L + KG+E+L
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYL 143
Query: 352 HSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSH-----HAGSTS---- 397
S N+L+E K++D+GL KL+ S
Sbjct: 144 GS-------RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 398 -AVDCFLDPE-LNLSKNYSAGSDVYSFGVFLLELIS--GREAHGRNHSNSDQNLILQVKR 453
A PE L+ + +S SDV+SFGV L EL + + V
Sbjct: 197 YA------PESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 454 SCDLGKYVDKTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQEREIG 509
L + +++ G E+ EL C RPS + +L+ + G
Sbjct: 250 LSRLLELLEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 510 RLHSEF 515
F
Sbjct: 308 CETHAF 313
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 43/299 (14%)
Query: 242 INIIGEGSFGLAYKGLLQD-----GSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHL 292
I +GEG FG G +V +K + E+ + ++H H+
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 293 VKLVGFCEENHQQ--LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
+K G CE+ L+ +Y+P G+++++L + + Q L A +G+ +
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAY 149
Query: 351 LHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSH---HAGSTSAVDCF 402
LH+ H+ NVLL+ + K+ D+GL K V H F
Sbjct: 150 LHA-------QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 403 -LDPE-LNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLI-LQVKRSCDLG 458
PE L K + SDV+SFGV L EL++ + + I L
Sbjct: 203 WYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 459 KYVDKTLG---EQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGRLHS 513
+ +++ G + E+ L C + S RP+ + L+ + E+ G+ S
Sbjct: 262 ELLER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 67/302 (22%), Positives = 126/302 (41%), Gaps = 67/302 (22%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVV-IK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
+ +G G +G Y+G+ + SL V +K + +++ FL E + + H +LV+L+G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPL 358
C +I +++ GN+ ++L + +++ L +A + +E+L
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK----- 129
Query: 359 FHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST--------SAVDCFLDP 405
+F N L+ EN+ KV+D+GL +L+TG + +A P
Sbjct: 130 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA------P 181
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKYV 461
E +S SDV++FGV L E+ + +G S + +++
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDLSQ--VYELLEK-------- 227
Query: 462 DKTLG---EQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI---------QEREI 508
E+ G ++ EL C + S RPS +I E + E+E+
Sbjct: 228 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
Query: 509 GR 510
G+
Sbjct: 284 GK 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 34/206 (16%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+ +G G FG+ G + V IK + F+ E K + + H LV+L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+ +I +Y+ NG + N+L + + +Q L + + +E+L S
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES------ 138
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSH---HAGS------TSAVDCFLDP 405
F N L+ + KVSD+GL + V GS + P
Sbjct: 139 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP-------P 190
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELIS 431
E+ + +S+ SD+++FGV + E+ S
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 53/278 (19%), Positives = 113/278 (40%), Gaps = 44/278 (15%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+G G FG + + V +K + ++ FL E + + H LVKL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+ +I +++ G++ + L EG K + + + + A+G+ +
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ------ 302
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LDPELNLS 410
++ R +N+L+ + K++D+GL +++ + + A F PE
Sbjct: 303 -RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA--KFPIKWTAPEAINF 359
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKYVDKTLG 466
+++ SDV+SFG+ L+E+++ +GR SN + +I ++R +
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT----YGRIPYPGMSNPE--VIRALERGYRM--------- 404
Query: 467 EQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ E+ + ++C RP+ I L+
Sbjct: 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 48/207 (23%), Positives = 95/207 (45%), Gaps = 36/207 (17%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+ +G G FG + G + V +K + FL E + ++ H+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+ +I +Y+ NG++ + L G KLT+ + L +A A+G+ +
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE------ 127
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGS---HHAGS------TSAVDCFLDP 405
++ R +N+L+ + + K++D+GL +L+ + G+ T+ P
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA-------P 179
Query: 406 E-LNLSKNYSAGSDVYSFGVFLLELIS 431
E +N ++ SDV+SFG+ L E+++
Sbjct: 180 EAINYGT-FTIKSDVWSFGILLTEIVT 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 63/289 (21%), Positives = 121/289 (41%), Gaps = 58/289 (20%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+ +G G FG+ G + V +K + F E + + ++ H LVK G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
+ + ++ +YI NG + N+L L Q L + +G+ L S
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES------ 122
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST--------SAVDCFLDPE 406
F N L++ + KVSD+G+ + V + S SA PE
Sbjct: 123 -HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA------PE 175
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKYVD 462
+ YS+ SDV++FG+ + E+ S G+ ++NS+ ++L+V +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS----LGKMPYDLYTNSE--VVLKVSQ--------- 220
Query: 463 KTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQERE 507
G + A+ + ++ C ++ +RP+ +Q+ +E ++E++
Sbjct: 221 ---GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 45/215 (20%)
Query: 242 INIIGEGSFGLAYKGLLQDGS-----LVVIK----RHLQTQIQNFLHEVKHIARVHHRHL 292
I ++G G+FG YKGL V IK + L E +A V + H+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
+L+G C + LI +P G + +++ + + + + L+ + AKG+ +L
Sbjct: 80 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE 134
Query: 353 SLVPPLFHMHF-------RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS-------- 397
R NVL++ K++D+GL KL+
Sbjct: 135 D-------RRLVHRDLAAR--NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 398 -AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
A E L + Y+ SDV+S+GV + EL++
Sbjct: 186 MA------LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 56/286 (19%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIKR-HLQTQIQNFLHEVKHIARVHHRHLVKLVGFC- 299
+ IG+G FG G + G+ V +K Q FL E + ++ H +LV+L+G
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
EE ++ +Y+ G++ ++L L L +L + +E+L
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG------ 135
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS-----TSAVDCFLDPELNL 409
+F NVL+ E+ AKVSD+GL K + + G T+ PE
Sbjct: 136 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA-------PEALR 187
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKYVDKTL 465
K +S SDV+SFG+ L E+ S GR D ++ +V++
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS----FGRVPYPRIPLKD--VVPRVEK------------ 229
Query: 466 G---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQERE 507
G + G + E+ C ++ RPS Q+ +LE I+ E
Sbjct: 230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 45/215 (20%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL-----VVIK----RHLQTQIQNFLHEVKHIARVHHRHL 292
+ ++G G FG +KG+ V IK + + Q + I + H H+
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V+L+G C + L+ Y+P G++ +H+ G L + L+ + AKG+ +L
Sbjct: 78 VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLE 132
Query: 353 SLVPPLFHMHF-------RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS-------- 397
R NVLL+ +V+D+G+ L+ S
Sbjct: 133 E-------HGMVHRNLAAR--NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 398 -AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
A E Y+ SDV+S+GV + EL++
Sbjct: 184 MA------LESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 65/328 (19%), Positives = 128/328 (39%), Gaps = 61/328 (18%)
Query: 217 SPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGS----LVVIK----R 268
S ++ + ++ + + + ++ +IG G FG Y G L D +K
Sbjct: 5 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 64
Query: 269 HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL-IYDYIPNGNVQNHLYDSEGL 327
++ FL E + H +++ L+G C + L + Y+ +G+++N + +
Sbjct: 65 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-- 122
Query: 328 PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-------RTSNVLLEENYTAKVSD 380
T++ + L AKG+++L S F R N +L+E +T KV+D
Sbjct: 123 --HNPTVKDLIGFGLQVAKGMKYLAS-------KKFVHRDLAAR--NCMLDEKFTVKVAD 171
Query: 381 YGLLKLVTGSHHAGSTSAVDCFL-----DPELNLSKNYSAGSDVYSFGVFLLELISGREA 435
+GL + + + + L E ++ ++ SDV+SFGV L EL++
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT---- 227
Query: 436 HGR----NHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRR 490
G + + D + + + + L Q + E+ L+C R
Sbjct: 228 RGAPPYPDVNTFD--ITVYLLQGRRL---------LQPEYCPDPLYEVMLKCWHPKAEMR 276
Query: 491 PSMRQIAGELEGIQEREIGRLHSEFGEE 518
PS ++ + I + GE
Sbjct: 277 PSFSELVSRISAI-------FSTFIGEH 297
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 71/353 (20%), Positives = 132/353 (37%), Gaps = 62/353 (17%)
Query: 187 RIRRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIG 246
I + S L + +S ++ + ++ + + + ++ +IG
Sbjct: 39 SIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIG 98
Query: 247 EGSFGLAYKGLLQDGS----LVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
G FG Y G L D +K ++ FL E + H +++ L+G
Sbjct: 99 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 299 CEENHQQLL-IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357
C + L + Y+ +G+++N + + T++ + L AKG++ L S
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---- 210
Query: 358 LFHMHF-------RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL-----DP 405
F R N +L+E +T KV+D+GL + + + L
Sbjct: 211 ---KKFVHRDLAAR--NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 406 E-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKY 460
E L K ++ SDV+SFGV L EL++ G + + D+ Y
Sbjct: 266 ESLQTQK-FTTKSDVWSFGVLLWELMT----RGAPPYPDVNTF------------DITVY 308
Query: 461 VDKTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQEREIG 509
+ + G Q + E+ L+C + RPS ++ + I IG
Sbjct: 309 LLQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 72/328 (21%), Positives = 127/328 (38%), Gaps = 79/328 (24%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL---VVIKR----HLQTQIQNFLHEV---KHIARVHHRH 291
++IGEG+FG K ++ L IKR + ++F E+ + HH +
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHPN 87
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQRLSI 340
++ L+G CE L +Y P+GN+ + L + L+ +Q L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 341 ALGAAKGLEHLHSLVPPLFHMHF-------RTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393
A A+G+++L F R N+L+ ENY AK++D+GL + +
Sbjct: 148 AADVARGMDYLSQ-------KQFIHRDLAAR--NILVGENYVAKIADFGLSR-GQEVYVK 197
Query: 394 GSTS-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSN 442
+ A E Y+ SDV+S+GV L E++S G +
Sbjct: 198 KTMGRLPVRWMA------IESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGMTC 247
Query: 443 SDQNLILQVKRSCDLGKYVDKTLG---EQTVGAATEMMELALQC-VDVSSRRPSMRQIAG 498
++ L ++ + G E+ + E+ +L QC + RPS QI
Sbjct: 248 AE--LYEKLPQ------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 499 ELEGIQEREIGRLHSEFGEEIDAVKLGS 526
L + E +++ E+ +
Sbjct: 294 SLNRMLEERKTYVNTTLYEKFTYAGIDC 321
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 52/285 (18%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIKR-HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCE 300
+ IG+G FG G + G+ V +K Q FL E + ++ H +LV+L+G
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 301 ENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359
E L ++ +Y+ G++ ++L L L +L + +E+L
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG------ 307
Query: 360 HMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS-----TSAVDCFLDPE-LN 408
+F NVL+ E+ AKVSD+GL K + + G T+ PE L
Sbjct: 308 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA-------PEALR 359
Query: 409 LSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLGKYVDKT 464
K +S SDV+SFG+ L E+ S GR D ++ +V++ +
Sbjct: 360 EKK-FSTKSDVWSFGILLWEIYS----FGRVPYPRIPLKD--VVPRVEKGYKM------- 405
Query: 465 LGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREI 508
+ G + ++ C + + RP+ Q+ +LE I+ E+
Sbjct: 406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 61/306 (19%), Positives = 123/306 (40%), Gaps = 57/306 (18%)
Query: 242 INIIGEGSFGLAYKGLLQDGS------LVVIK----RHLQTQIQNFLHEVKHIARVHHRH 291
+G+GSFG+ Y+G+ + V IK + FL+E + + H
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----YDSEGLPIGKLTMRQRLSIALGAAK 346
+V+L+G + L+I + + G+++++L + + ++ + + +A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 347 GLEHLHSLVPPLFHMHF--R---TSNVLLEENYTAKVSDYGLLKLV-TGSHHAGSTSAVD 400
G+ +L++ F R N ++ E++T K+ D+G+ + + ++ +
Sbjct: 150 GMAYLNA-------NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL- 201
Query: 401 CFL-----DPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRN--HSNSDQNLILQVK 452
L PE L ++ SDV+SFGV L E+ + S++ ++ V
Sbjct: 202 --LPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT----LAEQPYQGLSNEQVLRFVM 254
Query: 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQE---REI 508
L ++ + EL C RPS +I ++ E RE+
Sbjct: 255 EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
Query: 509 GRLHSE 514
+SE
Sbjct: 306 SFYYSE 311
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 242 INIIGEGSFGLAYKGLLQDGS----LVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
IIG G G G L+ V IK + + Q ++FL E + + H +++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+L G +++ +Y+ NG++ L + G+ T+ Q + + G G+ +L
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 354 LVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LD 404
+ + NVL++ N KVSD+GL +++ A T+
Sbjct: 170 -------LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + +S+ SDV+SFGV + E+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 75/386 (19%), Positives = 143/386 (37%), Gaps = 88/386 (22%)
Query: 182 MCVKRRIRRSEGESSVPSPSAELERGDISPYPGAVSP----IDTQNLKQLTILELKHATN 237
+ ++R++ S SS + + L R A +P + L + E +
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPR--D 81
Query: 238 NFSEINIIGEGSFGLAYKGLLQD--------GSLVVIK----RHLQTQIQNFLHEV---K 282
+ +GEG FG V +K + + + + E+ K
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 283 HIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGK 331
I + H++++ L+G C ++ +I +Y GN++ +L YD +P +
Sbjct: 142 MIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 332 LTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKL 386
+T + +S A+G+E+L S NVL+ EN K++D+GL +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLAS-------QKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 387 V--TGSHHAGSTS-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHG 437
+ + + A PE + Y+ SDV+SFGV + E+ + G
Sbjct: 253 INNIDYYKKTTNGRLPVKWMA------PEALFDRVYTHQSDVWSFGVLMWEIFT----LG 302
Query: 438 RN----HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPS 492
+ + L +K + ++ E+ + C V S+RP+
Sbjct: 303 GSPYPGIPV--EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPT 351
Query: 493 MRQIAGELEGIQEREIGRLHSEFGEE 518
+Q+ +L+ I L EE
Sbjct: 352 FKQLVEDLDRI-------LTLTTNEE 370
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 51/232 (21%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 219 IDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGS----LVVIK----RHL 270
+D+ L ++ + + H +IG+G FG+ Y G D + IK
Sbjct: 3 LDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE 62
Query: 271 QTQIQNFLHEVKHIARVHHRHLVKLVGFC-EENHQQLLIYDYIPNGNVQNHLYDSEGLPI 329
Q++ FL E + ++H +++ L+G ++ Y+ +G++ + +
Sbjct: 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---- 118
Query: 330 GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLL 384
T++ +S L A+G+E+L F N +L+E++T KV+D+GL
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAE-------QKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 385 KLVTGSHHAGSTSAVDCFL-----DPELNLSKNYSAGSDVYSFGVFLLELIS 431
+ + + L E + ++ SDV+SFGV L EL++
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 62/324 (19%), Positives = 124/324 (38%), Gaps = 75/324 (23%)
Query: 242 INIIGEGSFGLAYKGLLQD--------GSLVVIK----RHLQTQIQNFLHEV---KHIAR 286
+GEG+FG V +K + + + + E+ K I +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMR 335
H++++ L+G C ++ +I +Y GN++ +L YD +P ++T +
Sbjct: 100 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 336 QRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLV--T 388
+S A+G+E+L S NVL+ EN K++D+GL + +
Sbjct: 158 DLVSCTYQLARGMEYLAS-------QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 389 GSHHAGSTS-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN-- 439
+ + A PE + Y+ SDV+SFGV + E+ + G +
Sbjct: 211 DYYKKTTNGRLPVKWMA------PEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPY 260
Query: 440 --HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQI 496
+ L +K + ++ E+ + C V S+RP+ +Q+
Sbjct: 261 PGIPV--EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 497 AGELEGIQEREIGRLHSEFGEEID 520
+L+ I + + + ++
Sbjct: 310 VEDLDRILTLTTNEEYLDLSQPLE 333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-22
Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 41/212 (19%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL----VVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
I+GEG FG Y+G+ + V +K + F+ E + + H H+V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
KL+G EE +I + P G + ++L ++ L + + +L K + +L S
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES 131
Query: 354 LVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGS---HHAGS------TSAV 399
++ N+L+ K+ D+GL + + + + S
Sbjct: 132 -------INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS-- 182
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + ++ SDV+ F V + E++S
Sbjct: 183 -----PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 62/303 (20%), Positives = 123/303 (40%), Gaps = 68/303 (22%)
Query: 242 INIIGEGSFGLAYKGLLQD-----GSLVV----IKRHLQTQIQNFLHEVKHIARVHHRHL 292
+GEG+FG + + ++V +K ++ Q+F E + + + H+H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHL----------YDSEGLPIGKLTMRQRLSIAL 342
V+ G C E L++++Y+ +G++ L E + G L + Q L++A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 343 GAAKGLEHLHSLVPPLFHMHF--R---TSNVLLEENYTAKVSDYGLLKLVTGSH--HAGS 395
A G+ +L +HF R T N L+ + K+ D+G+ + + + G
Sbjct: 166 QVAAGMVYLAG-------LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 396 TS-------AVDCFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNS 443
+ PE + K ++ SDV+SFGV L E+ + +G+ SN
Sbjct: 219 RTMLPIRWMP------PESILYRK-FTTESDVWSFGVVLWEIFT----YGKQPWYQLSN- 266
Query: 444 DQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEG 502
I + + +L E+ E+ + C +R S++ + L+
Sbjct: 267 -TEAIDCITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316
Query: 503 IQE 505
+ +
Sbjct: 317 LAQ 319
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 59/301 (19%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL----VVIK------RHLQTQIQNFLHEVKHIARVHHRH 291
+ +G+GSFG+ +G S V +K + +F+ EV + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
L++L G ++ + P G++ + L +G + A+ A+G+ +L
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 137
Query: 352 HSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF---- 402
S F N+LL K+ D+GL++ + +
Sbjct: 138 ES-------KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDLG 458
PE ++ +S SD + FGV L E+ + +G+ + S IL
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQ---ILH-------- 235
Query: 459 KYVDKTLGE---QTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQEREIGRLHSE 514
+DK GE + ++ + +QC RP+ + L Q + + +E
Sbjct: 236 -KIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD---MRAE 290
Query: 515 F 515
F
Sbjct: 291 F 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 62/315 (19%), Positives = 103/315 (32%), Gaps = 72/315 (22%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL------QDGSLVVIK----RHLQTQIQNFLHEV---KH 283
N S +G G+FG + V +K T+ + + E+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-------------YDSEGLPIG 330
+ H ++V L+G C L+I +Y G++ N L
Sbjct: 83 LGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 331 KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLK 385
L + LS + AKG+ L S + N+LL K+ D+GL +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS-------KNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 386 LVTGSHHAGSTSAVDCFL-----DPELNLSKNYSAGSDVYSFGVFLLELIS-------GR 433
+ + + L PE + Y+ SDV+S+G+FL EL S G
Sbjct: 194 DIKNDSNYVVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 434 EAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPS 492
+K G + A EM ++ C +RP+
Sbjct: 252 PVD--------SKFYKMIKE----GFRMLS-----PEHAPAEMYDIMKTCWDADPLKRPT 294
Query: 493 MRQIAGELEGIQERE 507
+QI +E
Sbjct: 295 FKQIVQLIEKQISES 309
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 63/304 (20%), Positives = 124/304 (40%), Gaps = 69/304 (22%)
Query: 242 INIIGEGSFGLAYKGLLQD-----GSLVV----IKRHLQTQIQNFLHEVKHIARVHHRHL 292
+GEG+FG + + ++V +K ++F E + + + H H+
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQRLSIA 341
VK G C + +++++Y+ +G++ L G+L + Q L IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 342 LGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGS--HHAG 394
A G+ +L S HF T N L+ N K+ D+G+ + V + + G
Sbjct: 140 SQIASGMVYLAS-------QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 395 STS-------AVDCFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSN 442
+ PE + K ++ SDV+SFGV L E+ + +G+ SN
Sbjct: 193 GHTMLPIRWMP------PESIMYRK-FTTESDVWSFGVILWEIFT----YGKQPWFQLSN 241
Query: 443 SDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELE 501
++ +I + + G+ + E+ E+ ++ L C +R ++++I L
Sbjct: 242 TE--VIECITQ----GRVL-----ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 502 GIQE 505
+ +
Sbjct: 291 ALGK 294
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 69/342 (20%), Positives = 135/342 (39%), Gaps = 47/342 (13%)
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKH-ATNNFSEINIIGE 247
+ S + SP +L + S +P K +I +LK N + I +G
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81
Query: 248 GSFGLAYKGLLQDGS------LVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVG 297
G+FG Y+G + V +K + +FL E I++ +H+++V+ +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI--GKLTMRQRLSIALGAAKGLEHLHSLV 355
++ + ++ + + G++++ L ++ P L M L +A A G ++L
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-- 199
Query: 356 PPLFHMHF--R---TSNVLLE---ENYTAKVSDYGLLKLV-TGSHHAGSTSA---VDCFL 403
HF R N LL AK+ D+G+ + + ++ A V ++
Sbjct: 200 -----NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV-KWM 253
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462
PE + +++ +D +SFGV L E+ S G + + SN + ++ V +
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQE--VLEFVTSGGRM----- 305
Query: 463 KTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGI 503
+ + + QC RP+ I +E
Sbjct: 306 ----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 242 INIIGEGSFGLAYKGLLQDGS-----LVVIK----RHLQTQIQNFLHEVKHIARVHHRHL 292
+IG G FG YKG+L+ S V IK + + Q +FL E + + H ++
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
++L G + ++I +Y+ NG + L + + G+ ++ Q + + G A G+++L
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA 164
Query: 353 SLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----L 403
+ M++ N+L+ N KVSD+GL +++ A T++
Sbjct: 165 N-------MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + +++ SDV+SFG+ + E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 66/328 (20%), Positives = 127/328 (38%), Gaps = 79/328 (24%)
Query: 242 INIIGEGSFGLAYKGLLQD--------GSLVVIK----RHLQTQIQNFLHEV---KHIAR 286
+GEG+FG + V +K + + + + E+ K I +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMR 335
H++++ L+G C ++ +I +Y GN++ +L Y+ P +L+ +
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 336 QRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLV--T 388
+S A A+G+E+L S NVL+ E+ K++D+GL + +
Sbjct: 192 DLVSCAYQVARGMEYLAS-------KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 389 GSHHAGSTS-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN-- 439
+ + A PE + Y+ SDV+SFGV L E+ + G +
Sbjct: 245 DYYKKTTNGRLPVKWMA------PEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPY 294
Query: 440 --HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQI 496
+ L +K + ++ E+ + C V S+RP+ +Q+
Sbjct: 295 PGVPVEE--LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343
Query: 497 AGELEGI----QEREIGRLHSEFGEEID 520
+L+ I +E+G H + D
Sbjct: 344 VEDLDRIVALTSNQEMGYYHHHHHHDYD 371
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 62/320 (19%), Positives = 108/320 (33%), Gaps = 78/320 (24%)
Query: 242 INIIGEGSFGLAYKGLLQD------GSLVVIK----RHLQTQIQNFLHEV---KHIARVH 288
+G G+FG + V +K ++ + + E+ HI
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-- 89
Query: 289 HRHLVKLVGFC-EENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQ 336
H ++V L+G C + ++I ++ GN+ +L E L LT+
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 337 RLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSH 391
+ + AKG+E L S N+LL E K+ D+GL + +
Sbjct: 150 LICYSFQVAKGMEFLAS-------RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 392 HAGSTS---------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN--- 439
A PE + Y+ SDV+SFGV L E+ S G +
Sbjct: 203 DYVRKGDARLPLKWMA------PETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYP 252
Query: 440 HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAG 498
D+ ++K + EM + L C S+RP+ ++
Sbjct: 253 GVKIDEEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 499 ELEGIQEREIGRLHSEFGEE 518
L + L + ++
Sbjct: 304 HLGNL-------LQANAQQD 316
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 60/302 (19%)
Query: 242 INIIGEGSFGLAYKGLLQD------GSLVVIK----RHLQTQIQNFLHEV---KHIARVH 288
+G G+FG + V +K + + + E+ H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--Q 108
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL---------YDSEGLPIGKLTMRQRLS 339
H ++V L+G C L+I +Y G++ N L + + + R L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 340 IALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
+ A+G+ L S + NVLL + AK+ D+GL + + +
Sbjct: 169 FSSQVAQGMAFLAS-------KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 395 STSAVDCFL-----DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH---SNSDQN 446
+ L PE Y+ SDV+S+G+ L E+ S G N +
Sbjct: 222 VKG--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNPYPGILVNSK 275
Query: 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQE 505
VK + Q A + + C + RP+ +QI L+ +
Sbjct: 276 FYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326
Query: 506 RE 507
+
Sbjct: 327 ED 328
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 242 INIIGEGSFGLAYKGLLQDGS----LVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
++G G FG G L+ S V IK + + Q ++FL E + + H +++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+L G ++ +++ +Y+ NG++ + L + + T+ Q + + G A G+++L
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD 165
Query: 354 LVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LD 404
M + N+L+ N KVSD+GL +++ A T+
Sbjct: 166 -------MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + +++ SDV+S+G+ L E++S
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 41/212 (19%)
Query: 242 INIIGEGSFGLAYKGLLQDGS----LVVIK----RHLQTQIQNFLHEVKHIARVHHRHLV 293
IGEG FG ++G+ V IK + + FL E + + H H+V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
KL+G E + +I + G +++ L + L + + A + L +L S
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES 134
Query: 354 LVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGS---HHAGS------TSAV 399
F NVL+ N K+ D+GL + + S + +
Sbjct: 135 -------KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA-- 185
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + +++ SDV+ FGV + E++
Sbjct: 186 -----PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 59/269 (21%), Positives = 114/269 (42%), Gaps = 27/269 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHR 290
+ + IGEGSFG A +DG VIK R + + EV +A + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
++V+ EEN ++ DY G++ + +G+ Q L + L+H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKH 140
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA-VDCFLDPELNL 409
+H + H ++ N+ L ++ T ++ D+G+ +++ + +L PE+
Sbjct: 141 VHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 410 SKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468
+K Y+ SD+++ G L EL + + A + +NL+L++ G + +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----KNLVLKIIS----GSF--PPVSLH 248
Query: 469 TVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ ++ L Q + RPS+ I
Sbjct: 249 ---YSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 69/312 (22%), Positives = 115/312 (36%), Gaps = 72/312 (23%)
Query: 242 INIIGEGSFGLAYKGLLQDG------SLVVIK----RHLQTQIQNFLHEVKHIARVHHRH 291
+GEG FG K + V +K +++++ L E + +V+H H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHL-------------------YDSEGLPIGKL 332
++KL G C ++ LLI +Y G+++ L + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLV 387
TM +S A ++G+++L M N+L+ E K+SD+GL + V
Sbjct: 148 TMGDLISFAWQISQGMQYLAE-------MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 388 TGSHHAGSTS---------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR 438
S A E Y+ SDV+SFGV L E+++ G
Sbjct: 201 YEEDSYVKRSQGRIPVKWMA------IESLFDHIYTTQSDVWSFGVLLWEIVT----LGG 250
Query: 439 NH--SNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQ 495
N + L +K + E+ + EM L LQC +RP
Sbjct: 251 NPYPGIPPERLFNLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 496 IAGELEGIQERE 507
I+ +LE + +
Sbjct: 302 ISKDLEKMMVKR 313
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 68/300 (22%)
Query: 242 INIIGEGSFGLAYKGLLQDGS------LVVIK----RHLQTQIQNFLHEVKHIARVHHRH 291
+ +GE FG YKG L + V IK + + F HE AR+ H +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKLTMRQRLSI 340
+V L+G ++ +I+ Y +G++ L D + L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 341 ALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSH--HA 393
A G+E+L S H T NVL+ + K+SD GL + V +
Sbjct: 134 VAQIAAGMEYLSS-------HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 394 GSTS-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSN 442
S A PE + +S SD++S+GV L E+ S +G +SN
Sbjct: 187 LGNSLLPIRWMA------PEAIMYGKFSIDSDIWSYGVVLWEVFS----YGLQPYCGYSN 236
Query: 443 SDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELE 501
Q+++ ++ L + L ++C + SRRP + I L
Sbjct: 237 --QDVVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 8e-21
Identities = 42/209 (20%), Positives = 85/209 (40%), Gaps = 40/209 (19%)
Query: 245 IGEGSFGLAYKGLLQDGS---LVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVG 297
+G G+FG +G+ + V IK + + + E + + ++ + ++V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357
C+ +L+ + G + L ++ + + + G+++L
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---- 128
Query: 358 LFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS----------AVDCF 402
+F NVLL + AK+SD+GL K + + A
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA---- 181
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + +S+ SDV+S+GV + E +S
Sbjct: 182 --PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 62/307 (20%), Positives = 104/307 (33%), Gaps = 69/307 (22%)
Query: 242 INIIGEGSFGLAYKGLLQDGS------LVVIK----RHLQTQIQNFLHEV---KHIARVH 288
++G G+FG S V +K + ++ + + E+ +
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS-- 107
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL------------------YDSEGLPIG 330
H ++V L+G C + LI++Y G++ N+L E +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 331 KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLK 385
LT L A AKG+E L NVL+ K+ D+GL +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF-------KSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 386 LVTGSHHAGSTSAVDCFL-----DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRN- 439
+ + + L PE Y+ SDV+S+G+ L E+ S G N
Sbjct: 221 DIMSDSNYVVRG--NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----LGVNP 274
Query: 440 --HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQI 496
D N ++ G +D+ A E+ + C S +RPS +
Sbjct: 275 YPGIPVDANFYKLIQN----GFKMDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNL 325
Query: 497 AGELEGI 503
L
Sbjct: 326 TSFLGCQ 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 70/351 (19%), Positives = 121/351 (34%), Gaps = 61/351 (17%)
Query: 183 CVKRRIRRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEI 242
I + S + + Y + DT + E++
Sbjct: 338 RALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELG 395
Query: 243 NIIGEGSFGLAYKGLLQDGS----LVVIKR----HLQTQIQNFLHEVKHIARVHHRHLVK 294
IGEG FG ++G+ V IK + + FL E + + H H+VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
L+G EN +I + G +++ L + L + + A + L +L S
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES- 509
Query: 355 VPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS--------AVDC 401
F NVL+ N K+ D+GL + + S + ++ A
Sbjct: 510 ------KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA--- 560
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQVKRSCDL 457
PE + +++ SDV+ FGV + E++ HG N+ V +
Sbjct: 561 ---PESINFRRFTSASDVWMFGVCMWEILM----HGVKPFQGVKNN------DVIGRIEN 607
Query: 458 GKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQERE 507
G+ + + L +C SRRP ++ +L I E E
Sbjct: 608 GERL-----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 60/297 (20%), Positives = 117/297 (39%), Gaps = 56/297 (18%)
Query: 242 INIIGEGSFGLAYKGLLQDGS------LVVIK----RHLQTQIQNFLHEVKHIARVHHRH 291
I +G G+FG Y+G + V +K + +FL E I++ +H++
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI--GKLTMRQRLSIALGAAKGLE 349
+V+ +G ++ + ++ + + G++++ L ++ P L M L +A A G +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 350 HLHSLVPPLFHMHF-------RTSNVLLE---ENYTAKVSDYGLLKLV-TGSHHAGSTSA 398
+L HF R N LL AK+ D+G+ + + S++ A
Sbjct: 155 YLEE-------NHFIHRDIAAR--NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 399 ---VDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQNLILQV 451
V ++ PE + +++ +D +SFGV L E+ S G + SN Q ++ V
Sbjct: 206 MLPV-KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSN--QEVLEFV 258
Query: 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGIQERE 507
+ + + + QC RP+ I +E +
Sbjct: 259 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 63/312 (20%), Positives = 118/312 (37%), Gaps = 72/312 (23%)
Query: 242 INIIGEGSFGLAYKGLLQDG------SLVVIK----RHLQTQIQNFLHEVKHIARVHHRH 291
+ IGEG+FG ++ ++V +K +F E +A + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHL-------------------YDSEGLPIGKL 332
+VKL+G C L+++Y+ G++ L L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFHMHF--R---TSNVLLEENYTAKVSDYGLLKLV 387
+ ++L IA A G+ +L F R T N L+ EN K++D+GL + +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSE-------RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 388 -TGSHHAGSTSAVDCFL-----DPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR-- 438
+ ++ + + PE + ++ Y+ SDV+++GV L E+ S +G
Sbjct: 225 YSADYYKADGNDA---IPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS----YGLQP 276
Query: 439 --NHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQ 495
++ + +I V+ G + E+ L C + + RPS
Sbjct: 277 YYGMAH--EEVIYYVRD----GNIL-----ACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 496 IAGELEGIQERE 507
I L+ + ER
Sbjct: 326 IHRILQRMCERA 337
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 62/299 (20%), Positives = 112/299 (37%), Gaps = 68/299 (22%)
Query: 242 INIIGEGSFGLAYKGLLQDGS----LVVIK-----RHLQTQIQNFLHEVKHIARVHHRHL 292
I+GEG FG +G L+ V +K Q +I+ FL E + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 293 VKLVGFCEENHQQLLIYDYI-----PNGNVQNHL-YDSEGLPIGKLTMRQRLSIALGAAK 346
++L+G C E Q + + G++ +L Y + ++ L + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 347 GLEHLHSLVPPLFHMHF-------RTSNVLLEENYTAKVSDYGLLKLVTGS--HHAGSTS 397
G+E+L + +F R N +L ++ T V+D+GL K + + G +
Sbjct: 159 GMEYLSN-------RNFLHRDLAAR--NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 398 -------AVDCFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSDQ 445
A E L Y++ SDV++FGV + E+ + G N +
Sbjct: 210 KMPVKWIA------IESLADRV-YTSKSDVWAFGVTMWEIAT----RGMTPYPGVQNHE- 257
Query: 446 NLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGI 503
+ + L +Q E+ E+ C RP+ + +LE +
Sbjct: 258 -MYDYLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 51/276 (18%), Positives = 109/276 (39%), Gaps = 32/276 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHR 290
++ + IG GS+G K DG ++V K + + Q + EV + + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 291 HLVKLVG-FCEENHQQLLIY-DYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAK 346
++V+ + + L I +Y G++ + + E + L +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL---DEEFVLRVMTQLTL 122
Query: 347 GLEHLHSLVPPLFH-MH--FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA-VDCF 402
L+ H +H + +NV L+ K+ D+GL +++ T +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVKRSCDLGKYV 461
+ PE +Y+ SD++S G L EL + + + L +++ GK+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIRE----GKF- 233
Query: 462 DKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ + + + E+ E+ + +++ RPS+ +I
Sbjct: 234 -RRIPYRY---SDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 3e-20
Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 33/267 (12%)
Query: 185 KRRIRRSEGESSVPSPSAELERGDISPYPGA----VSPIDTQNLKQLTILELKHATNNFS 240
+RRI + P P+ P P SP + L LK +
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 241 EINIIGEGSFGLAYKGLLQDGS---LVVIKR----HLQTQIQNFLHEVKHIARVHHRHLV 293
+I +G G+FG +G+ + V IK + + + E + + ++ + ++V
Sbjct: 341 DI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+L+G C+ +L+ + G + L ++ + + + G+++L
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE 454
Query: 354 LVPPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LD 404
+F NVLL + AK+SD+GL K + + + +
Sbjct: 455 -------KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELIS 431
PE + +S+ SDV+S+GV + E +S
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 69/300 (23%)
Query: 242 INIIGEGSFGLAYKGLLQDGS----LVVIK-----RHLQTQIQNFLHEVKHIARVHHRHL 292
++G+G FG + L+ V +K + I+ FL E + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 293 VKLVGFCEEN------HQQLLIYDYIPNGNVQNHLYDS-EGLPIGKLTMRQRLSIALGAA 345
KLVG + ++I ++ +G++ L S G L ++ + + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 346 KGLEHLHSLVPPLFHMHF-------RTSNVLLEENYTAKVSDYGLLKLV--TGSHHAGST 396
G+E+L S +F R N +L E+ T V+D+GL + + + G
Sbjct: 148 CGMEYLSS-------RNFIHRDLAAR--NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 397 S-------AVDCFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSD 444
S A E L + Y+ SDV++FGV + E+++ G+ N++
Sbjct: 199 SKLPVKWLA------LESLADNL-YTVHSDVWAFGVTMWEIMT----RGQTPYAGIENAE 247
Query: 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC-VDVSSRRPSMRQIAGELEGI 503
+ + L +Q E+ +L QC +RPS + ELE I
Sbjct: 248 --IYNYLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 52/291 (17%), Positives = 96/291 (32%), Gaps = 49/291 (16%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRH 291
+F I +G G FG+ ++ D IKR + + + + EVK +A++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 292 LVKLVGFCEENH---------QQLLIY---DYIPNGNVQNHLYDSEGLPIGKLTMRQRLS 339
+V+ E + ++ +Y N+++ + + + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE--ERERSVCLH 122
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399
I L A+ +E LHS L H + SN+ + KV D+GL+ + +
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 400 DCFLD-------------PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446
PE +YS D++S G+ L EL+ ++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST------QMERV 234
Query: 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
L R+ + + + S RP I
Sbjct: 235 RTLTDVRNLKFPPLFTQKY--------PCEYVMVQDMLSPSPMERPEAINI 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 44/205 (21%), Positives = 83/205 (40%), Gaps = 30/205 (14%)
Query: 244 IIGEGSFGLAYKGLLQDGSL---VVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKL 295
+G G+FG KG Q + V +K + L E + ++ + ++V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
+G CE +L+ + G + +L + + + + + + G+++L
Sbjct: 84 IGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE-- 135
Query: 356 PPLFHMHF-----RTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF----LDPE 406
+F NVLL + AK+SD+GL K + + + PE
Sbjct: 136 -----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 407 LNLSKNYSAGSDVYSFGVFLLELIS 431
+S+ SDV+SFGV + E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 51/311 (16%), Positives = 101/311 (32%), Gaps = 77/311 (24%)
Query: 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQ-----------TQIQNFLHEVKHIARVHHR 290
+G+G+F +KG+ ++ + ++F ++++ H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
HLV G C + +L+ +++ G++ +L ++ + + +L +A A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHF 128
Query: 351 LHSLVPPLFHMHF-----RTSNVLLE--------ENYTAKVSDYGLLKLVTGSHH----- 392
L N+LL K+SD G+ V
Sbjct: 129 LEE-------NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 393 ---AGSTSAVDCFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGR----NHSNSD 444
PE + KN + +D +SFG L E+ SG G +
Sbjct: 182 PWVP-----------PECIENPKNLNLATDKWSFGTTLWEICSG----GDKPLSALDSQ- 225
Query: 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ + + + E+ L C+D RPS R I +L +
Sbjct: 226 -----RKLQFYEDRHQLPAPKA-------AELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
Query: 504 QEREIGRLHSE 514
++ S
Sbjct: 274 FTPDLVPRGSH 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 28/234 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKL 295
+F EI +IG G FG +K DG VIKR ++ + EVK +A++ H ++V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREVKALAKLDHVNIVHY 69
Query: 296 VGFCEENH---------------QQLLIY-DYIPNGNVQNHLYDSEGLPIGKLTMRQRLS 339
G + + L I ++ G ++ + G + K L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK---VLALE 126
Query: 340 IALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV 399
+ KG++++HS L + + SN+ L + K+ D+GL+ + +
Sbjct: 127 LFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453
++ PE S++Y D+Y+ G+ L EL H + + ++
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAEL-----LHVCDTAFETSKFFTDLRD 233
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 57/296 (19%), Positives = 103/296 (34%), Gaps = 37/296 (12%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR---HLQTQIQNFLHEVKHIARVHHRHLV 293
++ I +GEG F L DG +KR H Q + E +H +++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 294 KLVGFCEE----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+LV +C H+ L+ + G + N + + LT Q L + LG +GLE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD----- 404
+H+ H + +N+LL + + D G + +
Sbjct: 149 AIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 405 -----PELNLSKNYSAG---SDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVKRSC 455
PEL +++ +DV+S G L ++ G L +Q + S
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGR 510
+ +L + V +RP + + +LE +Q G+
Sbjct: 267 PQSPRHSS-----------ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 44/218 (20%), Positives = 85/218 (38%), Gaps = 20/218 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK------RHLQTQIQNFLHEVKHIARVHH 289
NF IG G F Y+ L DG V +K + + E+ + +++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAKG 347
+++K E+++ ++ + G++ + + + I + R +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE---RTVWKYFVQLCSA 148
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD--CFLDP 405
LEH+HS + H + +NV + K+ D GL + S + S V ++ P
Sbjct: 149 LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSP 205
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGR---EAHGRNH 440
E Y+ SD++S G L E+ + + N
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 21/207 (10%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARV-HHR 290
+F ++ +G GS+G +K +DG L +KR L EV +V H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
V+L EE L + ++Q H L Q L H
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS----LPEAQVWGYLRDTLLALAH 172
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS---TSAVDCFLDPEL 407
LHS L H+ + +N+ L K+ D+GLL + + ++ PEL
Sbjct: 173 LHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDP---RYMAPEL 227
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGRE 434
L +Y +DV+S G+ +LE+ E
Sbjct: 228 -LQGSYGTAADVFSLGLTILEVACNME 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 52/293 (17%), Positives = 106/293 (36%), Gaps = 46/293 (15%)
Query: 242 INIIGEGSFGLAYKGL-LQDGSLVVIKR---HLQTQIQNFLHEVKHIARV-HHRHLVKLV 296
++ EG F Y+ + G +KR + + + + + EV + ++ H ++V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 297 GFC-------EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+ + L+ + G + L E G L+ L I + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQ 150
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD----- 404
H+H PP+ H + N+LL T K+ D+G ++ ++ ++
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 405 --------PEL-NLSKNYSAG--SDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453
PE+ +L N+ G D+++ G L L + + L++
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-------EDGAKLRIVN 263
Query: 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
GKY Q T L + V+ R S+ ++ +L+ I
Sbjct: 264 ----GKYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 57/301 (18%), Positives = 116/301 (38%), Gaps = 64/301 (21%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHL 292
++F EI ++G+G+FG K D IK RH + ++ L EV +A ++H+++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 293 VKLVG-FCEENHQQLL---------IY---DYIPNGNVQNHLYDSEGLPIGKLT----MR 335
V+ + E + ++ +Y NG + + + SE L + R
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFR 123
Query: 336 QRLSIALGAAKGLEHLHSLVPPLFHMHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHH 392
Q L L ++HS + H R N+ ++E+ K+ D+GL K V S
Sbjct: 124 QILE-------ALSYIHSQ--GIIH---RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 393 AGSTSAVDCFLD---------------PE-LNLSKNYSAGSDVYSFGVFLLELISGREAH 436
+ + E L+ + +Y+ D+YS G+ E+ +
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IY 226
Query: 437 GRNHSNSDQNLILQVKRSCDLGKYV-DKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQ 495
+ N++ +++ + + +++ L + D ++RP R
Sbjct: 227 PFSTGMERVNILKKLRS----VSIEFPPDFDDNKMKVEKKIIRLLID-HDP-NKRPGART 280
Query: 496 I 496
+
Sbjct: 281 L 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKLVG 297
IG GSF YKGL + V + +++ Q F E + + + H ++V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 298 FCE---ENHQQLLIY-DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
E + + +++ + + +G ++ +L + ++ S KGL+ LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 354 LVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKLVTGSHHAGSTSAVD--CFLDPELNLS 410
PP+ H + N+ + + K+ D GL L S + + + F+ PE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEM-YE 203
Query: 411 KNYSAGSDVYSFGVFLLELISGR 433
+ Y DVY+FG+ +LE+ +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 47/227 (20%), Positives = 88/227 (38%), Gaps = 31/227 (13%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARV-H 288
T F E+ IG G FG +K + DG + IKR QN L EV A +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 289 HRHLVKLVG-FCEENHQQLLIY-DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK 346
H H+V+ + E++H +LI +Y G++ + + ++ + + + L +
Sbjct: 70 HSHVVRYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH----------HAGST 396
GL ++HS+ L HM + SN+ + + + S+ H
Sbjct: 127 GLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 397 SAVD------CFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGREAH 436
S+ FL E L + + +D+++ + ++
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 35/249 (14%), Positives = 77/249 (30%), Gaps = 28/249 (11%)
Query: 209 ISPYPGAVSPIDTQNLKQLTI-LELKHATNNFSEINIIGEGSFGLAYKG------LLQDG 261
+S YP L + E + + +++GEG+F Y+ ++
Sbjct: 38 VSSYPNTFE--WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95
Query: 262 SLVVIKRHLQTQIQNFLHEVKHIAR---VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQ 318
V+K F + + R +K + +L+ + G +
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 319 NHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA-- 376
N + + P + +S A+ +E +H + H + N +L +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQD 213
Query: 377 ---------KVSDYGL---LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGV 424
+ D G +KL + F E+ +K ++ D +
Sbjct: 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAA 273
Query: 425 FLLELISGR 433
+ ++ G
Sbjct: 274 TVYCMLFGT 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 23/208 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIK----RHLQT--QIQNFLHEVKHIARVHH 289
+F +G+G FG Y Q ++ +K L+ EV+ + + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++++L G+ + + LI +Y P G V L K ++ + A L
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALS 123
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDP 405
+ HS + H + N+LL K++D+G S + C +L P
Sbjct: 124 YCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TDL---CGTLDYLPP 176
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGR 433
E+ + + D++S GV E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 48/252 (19%), Positives = 94/252 (37%), Gaps = 29/252 (11%)
Query: 195 SSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAY 254
+ S SA+L+R + P + + E + + + +G GSFG +
Sbjct: 18 KTWSSGSAKLQR--LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVH 75
Query: 255 KGL-LQDGSLVVIKRHLQTQIQNFL-HEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312
+ Q G +K + +++ F E+ A + +V L G E + + +
Sbjct: 76 RMKDKQTGFQCAVK---KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 313 PNGNVQNHL--YDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS--LVPPLFHMHFRTSNV 368
G++ + + Q L +GLE+LH+ ++ H + NV
Sbjct: 133 EGGSLGQLIKQMGCLPEDRALYYLGQAL-------EGLEYLHTRRIL----HGDVKADNV 181
Query: 369 LLEEN-YTAKVSDYGLLKLVTGSHHAGSTSAVDCF------LDPELNLSKNYSAGSDVYS 421
LL + A + D+G + S D + PE+ + K A D++S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 422 FGVFLLELISGR 433
+L +++G
Sbjct: 242 SCCMMLHMLNGC 253
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 40/217 (18%), Positives = 81/217 (37%), Gaps = 41/217 (18%)
Query: 237 NNFSEINIIGEGSFG---LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIAR------- 286
++F +G+G FG LA + Q+ ++ +K ++Q++ + R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLARE--KQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSH 70
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA-- 344
+ H +++++ + + + L+ ++ P G LY +L R A
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGE----LYK-------ELQKHGRFDEQRSATF 119
Query: 345 ----AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
A L + H + H + N+L+ K++D+G T
Sbjct: 120 MEELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--- 172
Query: 401 C----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
C +L PE+ K + D++ GV E + G
Sbjct: 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 53/337 (15%), Positives = 96/337 (28%), Gaps = 96/337 (28%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRH 291
+F I +G G FG+ ++ D IKR + + + + EVK +A++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 292 LVKLVGF-------------------CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG-- 330
+V+ E L + +V+ D
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 331 -------------------KLTMRQRLSIALGA---------------AKGLEHLHSLVP 356
K ++ ++ A+ +E LHS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 357 PLFHMHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD--------- 404
MH R SN+ + KV D+GL+ + +
Sbjct: 184 --GLMH-RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 405 ----PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460
PE NYS D++S G+ L EL+ ++ I+ R+
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ------MERVRIITDVRNLKFPLL 294
Query: 461 VDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ ++ + + S + RP I
Sbjct: 295 FTQKYPQEH--------MMVQDMLSPSPTERPEATDI 323
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 50/202 (24%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRHLV 293
F+++ IG+GSFG +KG+ + +V IK + +I++ E+ +++ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
K G ++ + +I +Y+ G+ L + G L Q +I KGL++LHS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL-DLLEP-----GPLDETQIATILREILKGLDYLHS 137
Query: 354 LVPPLFHMH--FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA-VDCFLDPELNLS 410
+H + +NVLL E+ K++D+G+ +T + +T ++ PE+
Sbjct: 138 ----EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 411 KNYSAGSDVYSFGVFLLELISG 432
Y + +D++S G+ +EL G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQN 276
+ LK+L K F + +GEGS+G YK + + G +V IK+ +++ +Q
Sbjct: 11 PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE 70
Query: 277 FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQ 336
+ E+ + + H+VK G +N ++ +Y G+V + + LT +
Sbjct: 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDE 126
Query: 337 RLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGST 396
+I KGLE+LH + H + N+LL AK++D+G+ +T + +T
Sbjct: 127 IATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184
Query: 397 S-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
A PE+ Y+ +D++S G+ +E+ G
Sbjct: 185 VIGTPFWMA------PEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 40/218 (18%)
Query: 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLV 296
+F +++G G+ G + D V +KR L EV+ + H ++++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 297 GFCEENHQQLLI--------YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
++ Q + +Y+ Q P ++Q S GL
Sbjct: 85 CTEKDRQFQYIAIELCAATLQEYV----EQKDFAHLGLEP--ITLLQQTTS-------GL 131
Query: 349 EHLHSL--VPPLFHMHFRTSNVLLEE-----NYTAKVSDYGLLKLVTGSHHAGSTSAVDC 401
HLHSL V H + N+L+ A +SD+GL K + H+ S +
Sbjct: 132 AHLHSLNIV----HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 402 ----FLDPEL---NLSKNYSAGSDVYSFGVFLLELISG 432
++ PE+ + +N + D++S G +IS
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 44/206 (21%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL---VVIK---RHLQTQ---IQNFLHEVKHIARVHHRHL 292
++ +G G Y +D L V IK + + ++ F EV + +++ H+++
Sbjct: 16 VDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V ++ EE+ L+ +YI + ++ G L++ ++ G++H H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH 128
Query: 353 S--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV---DCFLDPEL 407
+V H + N+L++ N T K+ D+G+ K ++ + T+ V + PE
Sbjct: 129 DMRIV----HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQ 183
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR 433
+ +D+YS G+ L E++ G
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRH 291
+++ +IG G+ + V IKR QT + L E++ +++ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQN---HLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
+V + L+ + G+V + H+ G L +I +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 349 EHLHSLVPPLFHMH--FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD------ 400
E+LH +H + N+LL E+ + +++D+G+ +
Sbjct: 135 EYLHK----NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 401 CFLDPE-LNLSKNYSAGSDVYSFGVFLLELISGR 433
C++ PE + + Y +D++SFG+ +EL +G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 38/211 (18%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIKR---HLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
++G+G++G+ Y G L + + IK Q E+ + H+++V+ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEG-LPIG----KLTMRQRLSIALGAAKGLEHLHS- 353
EN + + +P G++ L G L +Q L +GL++LH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------EGLKYLHDN 141
Query: 354 -LVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTS-------AVDCFLD 404
+V H + NVL+ + K+SD+G K + G + T A
Sbjct: 142 QIV----HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA------ 191
Query: 405 PE--LNLSKNYSAGSDVYSFGVFLLELISGR 433
PE + Y +D++S G ++E+ +G+
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 44/225 (19%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR---HLQTQI 274
D + L++L +I+ + ++ IG+G+ G Y + + G V I++ Q +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 275 QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM 334
+ ++E+ + + ++V + + ++ +Y+ G++ + + +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTE-----TCMDE 115
Query: 335 RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
Q ++ + LE LHS + H ++ N+LL + + K++D+G +T
Sbjct: 116 GQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 395 STS-------AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
ST A PE+ K Y D++S G+ +E+I G
Sbjct: 174 STMVGTPYWMA------PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 44/222 (19%), Positives = 74/222 (33%), Gaps = 39/222 (17%)
Query: 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEE 301
I+G GS G G V +KR L L E+K + H ++++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT 80
Query: 302 NHQQLLI--------YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+ + D + + NV + + +RQ S G+ HLHS
Sbjct: 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS-------GVAHLHS 133
Query: 354 L------VPP---LFHM--HFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD-- 400
L + P L F EN +SD+GL K + + T+ +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 401 ---CFLDPEL-------NLSKNYSAGSDVYSFGVFLLELISG 432
+ PEL + + D++S G ++S
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 45/213 (21%), Positives = 79/213 (37%), Gaps = 36/213 (16%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
+G G FG + + G V IK + + E++ + +++H ++V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 299 CEE------NHQQLLIYDYIPNGNVQNHLYDSE---GLP--IGKLTMRQRLSIALGAAKG 347
+ N LL +Y G+++ +L E GL + + S
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-------A 133
Query: 348 LEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLVTGSHHA----GSTSAVD 400
L +LH + H + N++L + K+ D G K + G+
Sbjct: 134 LRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL---- 187
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+L PEL K Y+ D +SFG E I+G
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 39/200 (19%), Positives = 74/200 (37%), Gaps = 25/200 (12%)
Query: 245 IGEGSFGLAYKG--LLQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKL--V 296
I G G Y +G VV+K + E + +A V H +V++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 297 GFCEENHQQLLIY---DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+ H + Y +Y+ +++ KL + + ++ L L +LHS
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS 200
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNY 413
+ L + + N++L E K+ D G + + + T F PE+ +
Sbjct: 201 I--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPG---FQAPEI-VRTGP 253
Query: 414 SAGSDVYSFGVFLLELISGR 433
+ +D+Y+ G L L
Sbjct: 254 TVATDIYTVGRTLAALTLDL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 37/266 (13%), Positives = 81/266 (30%), Gaps = 56/266 (21%)
Query: 207 GDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFG---LAYKGLLQDGSL 263
G + +S + E N++ I + +G F L K D
Sbjct: 1 GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK----DNKF 56
Query: 264 VVIK-------------RHLQTQIQNFLHEVKHIAR-------VHHRHLVKLVGFCEENH 303
+K + + + + + + G
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD 116
Query: 304 QQLLIYDYIPNGNVQNHLYDSEGL---PIGKLTMRQRLSIALGAAKGLEHLHS------- 353
+ +IY+Y+ N ++ L + ++ I ++H+
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176
Query: 354 -LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH---HAGSTSAVDCFLDPELNL 409
+ P SN+L+++N K+SD+G + + G+ F+ PE
Sbjct: 177 DVKP---------SNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY----EFMPPEFFS 223
Query: 410 SKNYSAG--SDVYSFGVFLLELISGR 433
+++ G D++S G+ L +
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 48/266 (18%), Positives = 93/266 (34%), Gaps = 54/266 (20%)
Query: 190 RSEGESSVPSPSAELERGDISPYPGAVSPI-DTQNLKQLTILELKHATNNFSEINIIGEG 248
G++ VP +A P + D ++ ++ +G+G
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRF------------LGKG 52
Query: 249 SFGLAYKG-LLQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
F ++ + K H + ++ E+ + H+H+V GF
Sbjct: 53 GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVGFHGF 109
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKGLEHL 351
E+N ++ + ++ LT +RQ + G ++L
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVL-------GCQYL 157
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPEL 407
H + H + N+ L E+ K+ D+GL V + G V C ++ PE+
Sbjct: 158 HRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV---EYDGERKKVLCGTPNYIAPEV 212
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR 433
K +S DV+S G + L+ G+
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 45/246 (18%)
Query: 210 SPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFG---LAYKGLLQDGSLVVI 266
P PGA S Q Q K +F I+GEGSF LA + L I
Sbjct: 7 EPRPGAGSLQHAQPPPQPR----KKRPEDFKFGKILGEGSFSTVVLARE--LATSREYAI 60
Query: 267 KRHLQTQIQNFLHEVKHI-------ARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQN 319
K + I ++V ++ +R+ H VKL +++ + Y NG +
Sbjct: 61 KILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 320 HLYDSEGLPIGKLTMRQRLSIA-LGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLE 371
++ R A + +A LE+LH L P N+LL
Sbjct: 120 YIRKIGSFDET----CTRFYTAEIVSA--LEYLHGKGIIHRDLKP---------ENILLN 164
Query: 372 ENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLL 427
E+ +++D+G K+++ ++ ++ PEL K+ SD+++ G +
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANSF-VGTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 428 ELISGR 433
+L++G
Sbjct: 224 QLVAGL 229
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 41/247 (16%), Positives = 94/247 (38%), Gaps = 26/247 (10%)
Query: 198 PSPSAELERGDISPYPGAVSPIDTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKG 256
S+ ++ G + Y + Q L +++ IGEGS G+
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 257 L-LQDGSLVVIKR---HLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312
G V +K Q + + +EV + H ++V++ + ++ +++
Sbjct: 65 REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372
G + + + +L Q ++ + L +LH+ + H ++ ++LL
Sbjct: 125 QGGALTD-IVSQ-----VRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTL 176
Query: 373 NYTAKVSDYGLLKLVTGSHHAGSTS-------AVDCFLDPELNLSKNYSAGSDVYSFGVF 425
+ K+SD+G ++ + A PE+ Y+ D++S G+
Sbjct: 177 DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA------PEVISRSLYATEVDIWSLGIM 230
Query: 426 LLELISG 432
++E++ G
Sbjct: 231 VIEMVDG 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 40/210 (19%), Positives = 76/210 (36%), Gaps = 41/210 (19%)
Query: 245 IGEGSFGLAYKG-LLQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+G+G F ++ + K H + ++ E+ + H+H+V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVG 79
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKG 347
GF E+N ++ + ++ LT +RQ + G
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVL-------G 127
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FL 403
++LH + H + N+ L E+ K+ D+GL V C ++
Sbjct: 128 CQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYI 182
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGR 433
PE+ K +S DV+S G + L+ G+
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 47/259 (18%), Positives = 96/259 (37%), Gaps = 52/259 (20%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
I+G+G+ ++G + G L IK + + E + + +++H+++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 299 CEENHQQL--LIYDYIPNGNVQNHLYDSE---GLP--IGKLTMRQRLSIALGAAKGLEHL 351
EE + LI ++ P G++ L + GLP + +R + G+ HL
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG-------GMNHL 128
Query: 352 HS-------LVPPLFHMHFRTSNVLL----EENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
+ P N++ + K++D+G + + S +
Sbjct: 129 RENGIVHRNIKP---------GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 401 CFLDPEL--------NLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQV 451
+L P++ + K Y A D++S GV +G ++ ++ ++
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 452 KRSCDLGKYVDKTLGEQTV 470
GK G Q
Sbjct: 240 IT----GKPSGAISGVQKA 254
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 35/240 (14%), Positives = 80/240 (33%), Gaps = 39/240 (16%)
Query: 220 DTQNLKQLTILELKHATNNFSEINIIGEG--SFGLAYKGL-LQDGSLVVIKR-----HLQ 271
+NL + + + +IG+G G V ++R
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 272 TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGK 331
+ E+ +H ++V +++ ++ ++ G+ ++ +
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD---------LIC 118
Query: 332 LTMRQRLS---IAL---GAAKGLEHLHSLVPPLFHMH--FRTSNVLLEENYTAKVSDYGL 383
++ IA G K L+++H + ++H + S++L+ + +S
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 384 LKLVTGSHHAGSTSAVD--------CFLDPEL--NLSKNYSAGSDVYSFGVFLLELISGR 433
+ +L PE+ + Y A SD+YS G+ EL +G
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 21/226 (9%), Positives = 59/226 (26%), Gaps = 40/226 (17%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK------RHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
+ G + + ++ +K + +++++ AR+ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 297 GFC-------------------------EENHQQLLIYDYIPNGNVQN--HLYDSEGLPI 329
+ L+ + +++ D +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 330 GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389
G + + + +L S L H HF N+ + + + D L V
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 390 SHHAGSTSAVDCFLDPELNLSKN--YSAGSDVYSFGVFLLELISGR 433
A S + E + ++ + + G+ + +
Sbjct: 247 RGPASSVPV--TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 38/202 (18%), Positives = 72/202 (35%), Gaps = 24/202 (11%)
Query: 245 IGEGSFGLAYKGLLQDGSL---VVIK---RHL---QTQIQNFLHEVKHIARVHHRHLVKL 295
+G G G Y+ +D V +K L E + R+ H+V +
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS-- 353
F E + Q + I ++ L G L + ++I L+ H+
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH--HAGSTSAVDCFLDPELNLSK 411
H + N+L+ + A + D+G+ T G+T ++ PE
Sbjct: 155 AT----HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 412 NYSAGSDVYSFGVFLLELISGR 433
+ + +D+Y+ L E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/201 (22%), Positives = 72/201 (35%), Gaps = 28/201 (13%)
Query: 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE 372
+ + E L LT+ + + AKG+E L S H N+LL E
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSE 228
Query: 373 NYTAKVSDYGLLKLV-TGSHHAGSTSAVDCFLD-----PELNLSKNYSAGSDVYSFGVFL 426
K+ D+GL + + + A L PE + Y+ SDV+SFGV L
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDA---RLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 427 LELISGREAHGRN---HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC 483
E+ S G + D+ ++K + EM + L C
Sbjct: 286 WEIFS----LGASPYPGVKIDEEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDC 332
Query: 484 -VDVSSRRPSMRQIAGELEGI 503
S+RP+ ++ L +
Sbjct: 333 WHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 19/91 (20%), Positives = 38/91 (41%), Gaps = 12/91 (13%)
Query: 243 NIIGEGSFGLAYKGLL------QDGSLVVIKR----HLQTQIQNFLHEVKH-IARVHHRH 291
+G G+FG + V +K ++ + + E+K I HH +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 292 LVKLVGFC-EENHQQLLIYDYIPNGNVQNHL 321
+V L+G C + ++I ++ GN+ +L
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 39/229 (17%)
Query: 226 QLTILELKHAT-NNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQ 271
Q LE + T N F + ++G+G FG A K L + + KR
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK---RIKKRK-- 226
Query: 272 TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIG 330
L+E + + +V+ R +V L + E L L+ + G+++ H+Y +G
Sbjct: 227 -GEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYH-----MG 279
Query: 331 KLTMRQRLSIALGA--AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388
+ + ++ A GLE LH + + + N+LL+++ ++SD GL V
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 389 GSHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
G T ++ PE+ ++ Y+ D ++ G L E+I+G+
Sbjct: 338 ----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 48/235 (20%)
Query: 226 QLTILELKHAT-NNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQ 271
Q LE + + F + ++G G FG A K L + + KR
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK---RLKKRK-- 227
Query: 272 TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIG 330
Q + E K +A+VH R +V L + E L L+ + G+++ H+Y +
Sbjct: 228 -GYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNP 284
Query: 331 KLTM-RQRLSIALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYG 382
R A GLEHLH L P NVLL+++ ++SD G
Sbjct: 285 GFQEPRAIFYTA-QIVSGLEHLHQRNIIYRDLKP---------ENVLLDDDGNVRISDLG 334
Query: 383 LLKLVTGSHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
L + F+ PEL L + Y D ++ GV L E+I+ R
Sbjct: 335 LAVELKAGQTKTKGY---AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 47/259 (18%), Positives = 96/259 (37%), Gaps = 52/259 (20%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
I+G+G+ ++G + G L IK + + E + + +++H+++VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 299 CEENHQQL--LIYDYIPNGNVQNHLYDSE---GLP--IGKLTMRQRLSIALGAAKGLEHL 351
EE + LI ++ P G++ L + GLP + +R + G+ HL
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG-------GMNHL 128
Query: 352 HS-------LVPPLFHMHFRTSNVLL----EENYTAKVSDYGLLKLVTGSHHAGSTSAVD 400
+ P N++ + K++D+G + + S +
Sbjct: 129 RENGIVHRNIKP---------GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 401 CFLDPEL--------NLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQV 451
+L P++ + K Y A D++S GV +G ++ ++ ++
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 452 KRSCDLGKYVDKTLGEQTV 470
GK G Q
Sbjct: 240 IT----GKPSGAISGVQKA 254
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 44/227 (19%)
Query: 232 LKHATNNFSEI----NIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQT--QIQNFLHE 280
++H+T FS+ ++G+GSFG G +K R ++ ++ L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 281 VKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD--------SEGLPIGKL 332
V+ + ++ H +++KL F E+ L+ + G L+D SE
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVD--AAR 130
Query: 333 TMRQRLSIALGAAKGLEHLHSL-VPPLFHMH--FRTSNVLL---EENYTAKVSDYGLLKL 386
+RQ LS G+ ++H + +H + N+LL ++ ++ D+GL
Sbjct: 131 IIRQVLS-------GITYMHKNKI-----VHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
S ++ PE+ L Y DV+S GV L L+SG
Sbjct: 179 FEASKKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 40/208 (19%), Positives = 87/208 (41%), Gaps = 24/208 (11%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ--IQNFLHEVKHIARVHHRHLVK 294
+ + +G+G+FG YK + G+L K +++ +++++ E++ +A H ++VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
L+G + + ++ ++ P G V + LT Q + + L LHS
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELD---RGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSA----------VDCFLD 404
+ H + NVL+ +++D+G+ + + V C
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISG 432
+ Y +D++S G+ L+E+
Sbjct: 195 KD----TPYDYKADIWSLGITLIEMAQI 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 43/213 (20%), Positives = 86/213 (40%), Gaps = 34/213 (15%)
Query: 242 INIIGEGSFGLAYKGLLQDGSL---VVIK---RHLQTQ---IQNFLHEVKHIARVHHRHL 292
I+G G + +D V +K L F E ++ A ++H +
Sbjct: 17 GEILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 293 VKL--VGFCEENHQQLLIY----DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK 346
V + G E + +Y+ +++ ++ G +T ++ + + A +
Sbjct: 75 VAVYDTG--EAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQ 127
Query: 347 GLEHLHS--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG-STSAV---D 400
L H ++ H + +N+++ KV D+G+ + + S ++ T+AV
Sbjct: 128 ALNFSHQNGII----HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+L PE + A SDVYS G L E+++G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 39/270 (14%), Positives = 87/270 (32%), Gaps = 40/270 (14%)
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
G + +A+ ER + D + + +K +S + IG G
Sbjct: 10 LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSG 67
Query: 249 SFGLAYKGLLQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHH--RHLVKLVGFCEE 301
++ L + + IK + ++ +E+ ++ ++ +++L + E
Sbjct: 68 GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EI 126
Query: 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIG--KLTMRQRLSIALGAAKGLEHLHSL--VPP 357
Q + + N ++ + L + + K + L + +H V
Sbjct: 127 TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIHQHGIV-- 177
Query: 358 LFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSHHAGSTSAV-------------DCFL 403
H + +N L+ + K+ D+G+ + + S V
Sbjct: 178 --HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGR 433
S SDV+S G L + G+
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 14/198 (7%)
Query: 192 EGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFG 251
+ +P+ +G + P P ++ + FS++ IG GSFG
Sbjct: 9 HHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFG 68
Query: 252 LAYKGL-LQDGSLVVIK------RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304
Y +++ +V IK + + Q+ + EV+ + ++ H + ++ G H
Sbjct: 69 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128
Query: 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFR 364
L+ +Y D + L + ++ GA +GL +LHS + H +
Sbjct: 129 AWLVMEYCLGS-----ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVK 181
Query: 365 TSNVLLEENYTAKVSDYG 382
N+LL E K+ D+G
Sbjct: 182 AGNILLSEPGLVKLGDFG 199
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-09
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 42/211 (19%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+G+GSF Y+ + G V IK + ++QN EVK ++ H +++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN---EVKIHCQLKHPSILE 75
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKG 347
L + E+++ L+ + NG + +L + + M Q ++ G
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIIT-------G 124
Query: 348 LEHLHSL-VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----F 402
+ +LHS + H SN+LL N K++D+GL + H T C +
Sbjct: 125 MLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CGTPNY 178
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ PE+ + SDV+S G L+ GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 49/243 (20%), Positives = 90/243 (37%), Gaps = 39/243 (16%)
Query: 213 PGAVSPIDTQNLKQLTILELKHATNNFSEI----NIIGEGSFGLAYKGL-LQDGSLVVIK 267
G + +L+ + + + SE+ +G G++G IK
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 268 ----RHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLY 322
+ T L EV + + H +++KL F E+ L+ + G L+
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LF 124
Query: 323 DSEGLPIGKLTMRQRLSIALGAA------KGLEHLHSL-VPPLFHMH--FRTSNVLL--- 370
D ++ R + + A G+ +LH + +H + N+LL
Sbjct: 125 D-------EIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI-----VHRDLKPENLLLESK 172
Query: 371 EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELI 430
E++ K+ D+GL + ++ PE+ L K Y DV+S GV L L+
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILL 231
Query: 431 SGR 433
+G
Sbjct: 232 AGY 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 50/236 (21%), Positives = 95/236 (40%), Gaps = 29/236 (12%)
Query: 217 SPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ- 273
S ++L ++ + L+ F + ++G G++G YKG ++ G L IK +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 274 IQNFLHEVKHIARV-HHRHLVK-----LVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEG 326
+ E+ + + HHR++ + QL L+ ++ G+V + + +
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KN 120
Query: 327 LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386
L I +GL HLH + H + NVLL EN K+ D+G+
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 387 VTGSHHAGSTSA----------VDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+ + +T + C +P+ Y SD++S G+ +E+ G
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPD----ATYDFKSDLWSLGITAIEMAEG 230
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 50/261 (19%), Positives = 101/261 (38%), Gaps = 34/261 (13%)
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
RR + + S Y V I Q Q ++ H +++ +G G
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTG 168
Query: 249 SFGLAYKGL-LQDGSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304
+FG+ ++ G+ + ++ + E++ ++ + H LV L E++++
Sbjct: 169 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228
Query: 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKGLEHLHSLVPP 357
++IY+++ G L++ K++ MRQ GL H+H
Sbjct: 229 MVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCK-------GLCHMHEN--N 275
Query: 358 LFHMHFRTSNVLL--EENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSK 411
H+ + N++ + + K+ D+GL + + V F PE+ K
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP----KQSVKVTTGTAEFAAPEVAEGK 331
Query: 412 NYSAGSDVYSFGVFLLELISG 432
+D++S GV L+SG
Sbjct: 332 PVGYYTDMWSVGVLSYILLSG 352
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 47/217 (21%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK----------RHLQTQIQNFLHEVKHIARVHHRHLV 293
+GEGS+G + L + +K + + ++ E++ + R+ H++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKNVI 69
Query: 294 KL--VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGA 344
+L V + EE + ++ +Y G + + DS +P + Q +
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDS--VPEKRFPVCQAHGYFCQLID----- 120
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG--STSAVDC- 401
GLE+LHS + H + N+LL T K+S G+ + + TS
Sbjct: 121 --GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QG 173
Query: 402 ---FLDPE-LNLSKNYS-AGSDVYSFGVFLLELISGR 433
F PE N +S D++S GV L + +G
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 52/241 (21%), Positives = 105/241 (43%), Gaps = 34/241 (14%)
Query: 233 KHATNNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKRHLQTQIQNF--LHEVKHIARVHH 289
+ + F + G+G+FG G G V IK+ +Q L ++ +A +HH
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 290 RHLVKLVGF----CEENHQQL---LIYDYIP---NGNVQNHLYDSEGLPIG--KLTMRQR 337
++V+L + E + + + ++ +Y+P + +N+ P K+ + Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGST 396
+ + + LH + H + NVL+ E + T K+ D+G K ++ S +
Sbjct: 139 I-------RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NV 189
Query: 397 SAVDCFL---DPELNL-SKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQ-NLILQ 450
+ + C PEL +++Y+ D++S G E++ G G N + Q + I++
Sbjct: 190 AYI-CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--AGQLHEIVR 246
Query: 451 V 451
V
Sbjct: 247 V 247
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 29/235 (12%), Positives = 61/235 (25%), Gaps = 50/235 (21%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK---------------RHLQTQIQNFLHEVKH--IA 285
++G+ + + G + + L +K+ A
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 286 RVHHRHLVKL-------------VGFCEENHQQLLIYDYIP-----NGNVQNHLYDSEGL 327
+VH R + V E + L + P L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 328 PIGKLTMRQRLSIALGAAKGLEHLHS--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385
L RL + L + L LH LV H + R +++L++ ++ + L
Sbjct: 205 H-KSLVHHARLQLTLQVIRLLASLHHYGLV----HTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 386 LVTGSHHAGSTSAVD--CFLDPELNLSKN-----YSAGSDVYSFGVFLLELISGR 433
S + + + D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 25/236 (10%), Positives = 64/236 (27%), Gaps = 51/236 (21%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLV 293
++G+ + + G + + Q++ + ++ + + ++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI------------------------ 329
K+ + V+ D L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 330 -GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388
L RL + L + L LH L H + R +++L++ ++ + L
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 389 GSHHAGSTSAVDCFLDPELNLSKN-----------YSAGSDVYSFGVFLLELISGR 433
+ + F PEL + + D ++ G+ + +
Sbjct: 258 ARVVSSVSRG---FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 56/234 (23%)
Query: 230 LELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF-------LHE 280
L++K + +++ +GEG F YK +V IK+ L + + L E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 281 VKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNH----LYDSEGLPIG----KL 332
+K + + H +++ L+ L++D++ + L + K
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFME------TDLEVIIKDNSLVLTPSHIKA 116
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKLV 387
M L +GLE+LH H +H R +N+LL+EN K++D+GL K
Sbjct: 117 YMLMTL-------QGLEYLHQ------HWILH-RDLKPNNLLLDENGVLKLADFGLAKSF 162
Query: 388 TGSHHAGSTSAVDCFLD-------PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
GS + T V PEL ++ Y G D+++ G L EL+
Sbjct: 163 -GSPNRAYTHQV-----VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRH 291
+ ++ +GEG++G+ YK G +V +KR L + + + E+ + +HH +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG----KLTMRQRLSIALGAAKG 347
+V L+ L+++++ +++ L D + K+ + Q L +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLL-------RG 131
Query: 348 LEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF 402
+ H H H +H R N+L+ + K++D+GL + G T V
Sbjct: 132 VAHCHQ------HRILH-RDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEV-VT 182
Query: 403 L---DPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
L P++ + SK YS D++S G E+I+G+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 43/239 (17%), Positives = 87/239 (36%), Gaps = 44/239 (18%)
Query: 222 QNLKQLTILELKHAT-----NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------- 268
+ KQ L + N+ + +G G+ G +K + G ++ +K+
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 269 HLQTQIQ---NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSE 325
+I + + + ++V+ G N + + + +
Sbjct: 65 EENKRILMDLDVVLKS-----HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 326 GLP---IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH--FRTSNVLLEENYTAKVSD 380
+P +GK + + K L +L +H + SN+LL+E K+ D
Sbjct: 120 PIPERILGK--------MTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGQIKLCD 168
Query: 381 YGLLKLVTGSHHAGSTSAVDCF------LDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+G+ + A SA +DP +Y +DV+S G+ L+EL +G+
Sbjct: 169 FGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 44/211 (20%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKR-------HLQTQIQNFLHEVKHIARVH 288
++F +I+ +G G+ G+ +K G ++ K ++ QI E++ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR---ELQVLHECN 89
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP---IGKLTMRQRLSIALGAA 345
++V G + + + +++ G++ L + +P +GK +++
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--------VSIAVI 141
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH---HAGSTSAVDCF 402
KGL +L + H + SN+L+ K+ D+G+ + S G+ S +
Sbjct: 142 KGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS----Y 196
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ PE +YS SD++S G+ L+E+ GR
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 47/221 (21%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHR 290
+ +I IGEGS+G+ +K G +V IK+ L E++ + ++ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS-EGLPIG--KLTMRQRLSIALGAAKG 347
+LV L+ + L+++Y + V + L G+P K Q L +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL-------QA 114
Query: 348 LEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF 402
+ H H +H R N+L+ ++ K+ D+G +L+ T D +
Sbjct: 115 VNFCHK------HNCIH-RDVKPENILITKHSVIKLCDFGFARLL--------TGPSDYY 159
Query: 403 LD---------PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
D PEL + Y DV++ G EL+SG
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 50/237 (21%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHR 290
+ ++ IGEG++G +K + +V +KR L + L E+ + + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG----KLTMRQRLSIALGAAK 346
++V+L + + L++++ +++ + DS + K + Q L K
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLL-------K 112
Query: 347 GLEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC 401
GL HS +H R N+L+ N K++++GL + G ++ V
Sbjct: 113 GLGFCHS------RNVLH-RDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV-V 163
Query: 402 FL---DPELNL-SKNYSAGSDVYSFGVFLLELISGREA--HGRNHSNSDQ-NLILQV 451
L P++ +K YS D++S G EL + G DQ I ++
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRL 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 47/232 (20%), Positives = 91/232 (39%), Gaps = 57/232 (24%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHR 290
+ + ++ IG+G+FG +K + G V +K+ ++ + + F L E+K + + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 291 HLVKLVGFCEENHQQL--------LIYDYIPNGNVQNH----LYDSEGLPIG----KLTM 334
++V L+ C L++D+ H L + + K M
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 335 RQRLSIALGAAKGLEHLHSLVPPLFHMH--FRTSNVLLEENYTAKVSDYGL---LKLVTG 389
+ L GL ++H +H + +NVL+ + K++D+GL L
Sbjct: 131 QMLL-------NGLYYIHR----NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 390 SHHAGSTSAVDCFLD-------PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
S T+ V PEL L ++Y D++ G + E+ +
Sbjct: 180 SQPNRYTNRV-----VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 52/243 (21%), Positives = 105/243 (43%), Gaps = 33/243 (13%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVK---HIARVHHRH 291
+++ + +G G + ++ + + + VV+K + + E+K ++ +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPN 92
Query: 292 LVKL--VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++ L + + L+++++ N + LY + + M + L K L+
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEIL-------KALD 144
Query: 350 HLHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTS----AVDCFLD 404
+ HS+ + H + NV++ E+ ++ D+GL + +H G A F
Sbjct: 145 YCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE----FYHPGQEYNVRVASRYFKG 198
Query: 405 PELNL-SKNYSAGSDVYSFGVFLLELISGREA--HGRNHSNSDQ-NLILQVKRSCDLGKY 460
PEL + + Y D++S G L +I +E HG H N DQ I +V + DL Y
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG--HDNYDQLVRIAKVLGTEDLYDY 256
Query: 461 VDK 463
+DK
Sbjct: 257 IDK 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 45/249 (18%), Positives = 97/249 (38%), Gaps = 32/249 (12%)
Query: 200 PSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGL-L 258
+ + I+ Y I + + Q ++ + + + +G G+FG+ ++ +
Sbjct: 14 VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73
Query: 259 QDGSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315
G + I +E+ + ++HH L+ L E+ ++ +LI +++ G
Sbjct: 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 316 ------NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVL 369
+++ SE MRQ GL+H+H + H+ + N++
Sbjct: 134 ELFDRIAAEDYKM-SE--AEVINYMRQACE-------GLKHMHEH--SIVHLDIKPENIM 181
Query: 370 LE--ENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFG 423
E + + K+ D+GL + V F PE+ + +D+++ G
Sbjct: 182 CETKKASSVKIIDFGLATKLNP----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 424 VFLLELISG 432
V L+SG
Sbjct: 238 VLGYVLLSG 246
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 38/208 (18%)
Query: 245 IGEGSFG---LAYKGLLQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
IG+G+F LA + G V IK + T +Q EV+ + ++H ++VKL
Sbjct: 23 IGKGNFAKVKLARH--ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK------GLEH 350
E LI +Y G ++D L R+ +K +++
Sbjct: 81 EVIETEKTLYLIMEYASGGE----VFD-------YLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH----AGSTSAVDCFLDPE 406
H + H + N+LL+ + K++D+G T G+ + PE
Sbjct: 130 CHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP----PYAAPE 183
Query: 407 LNLSKNYS-AGSDVYSFGVFLLELISGR 433
L K Y DV+S GV L L+SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 43/213 (20%), Positives = 85/213 (39%), Gaps = 46/213 (21%)
Query: 245 IGEGSFGLAYKG-LLQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+G G+FG + G VIK Q ++ E++ + + H +++K+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 300 EENHQQLLIYDYIPNGNVQNHLYD---SEGLPIGKLT-------MRQRLSIALGAAKGLE 349
E+ H ++ + G L + S L+ M+Q ++ L
Sbjct: 90 EDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMN-------ALA 138
Query: 350 HLHSL-VPPLFHMHF--RTSNVLL---EENYTAKVSDYGLLKLVTGSHH----AGSTSAV 399
+ HS V +H + N+L + K+ D+GL +L H AG+
Sbjct: 139 YFHSQHV-----VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA--- 190
Query: 400 DCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
++ PE+ ++ + D++S GV + L++G
Sbjct: 191 -LYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 43/212 (20%), Positives = 83/212 (39%), Gaps = 44/212 (20%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+GEG++G + V +K + +N E+ ++H ++VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK-------GLEHLH 352
E + Q L +Y G L+D ++ + A + G+ +LH
Sbjct: 75 REGNIQYLFLEYCSGG----ELFD-------RIEPDIGMPEPD-AQRFFHQLMAGVVYLH 122
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD-------- 404
+ + H + N+LL+E K+SD+GL + ++ + L+
Sbjct: 123 GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------ERLLNKMCGTLPY 173
Query: 405 --PELNLSKNYS-AGSDVYSFGVFLLELISGR 433
PEL + + DV+S G+ L +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 32/265 (12%)
Query: 187 RIRRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIG 246
R R + S G + T + + ++++ +IG
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 247 EGSFGLAYKGLLQD-GSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305
GSFG+ Y+ L D G LV IK+ LQ + E++ + ++ H ++V+L F + ++
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLRYFFYSSGEK 122
Query: 306 L------LIYDYIPNGNVQNHLYD----SEGLPIG--KLTMRQRLSIALGAAKGLEHLHS 353
L+ DY+P V + LP+ KL M Q + L ++HS
Sbjct: 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF-------RSLAYIHS 174
Query: 354 LVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL---DPELNL 409
+ H + N+LL + K+ D+G K + + S + C PEL
Sbjct: 175 F--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYI-CSRYYRAPELIF 229
Query: 410 -SKNYSAGSDVYSFGVFLLELISGR 433
+ +Y++ DV+S G L EL+ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 42/220 (19%), Positives = 91/220 (41%), Gaps = 45/220 (20%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHR 290
+ + ++GEGS+G+ K G +V IK+ + + E+K + ++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD-SEGLPIG--KLTMRQRLSIALGAAKG 347
+LV L+ C++ + L+++++ + + + L GL + + Q + G
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII-------NG 136
Query: 348 LEHLHSLVPPLFH--MH--FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL 403
+ HS H +H + N+L+ ++ K+ D+G + + + + +
Sbjct: 137 IGFCHS------HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------AAPGEVYD 182
Query: 404 D---------PELNL-SKNYSAGSDVYSFGVFLLELISGR 433
D PEL + Y DV++ G + E+ G
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 58/305 (19%), Positives = 102/305 (33%), Gaps = 62/305 (20%)
Query: 184 VKRRIRRSEGESSVPSPSAELERGDISPYPGA---VSPIDTQNLKQLTILELKHAT-NNF 239
V+ + + + + P E ++ S T+ + + H T N+F
Sbjct: 132 VQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDF 191
Query: 240 SEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNFLHE---VKH 283
S IIG G FG A K L + + + L+E +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQ---GETLALNERIMLSL 245
Query: 284 IARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIAL 342
++ +V + + +L I D + G++ HL R A
Sbjct: 246 VSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA- 299
Query: 343 GAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS 395
GLEH+H+ L P +N+LL+E+ ++SD GL +
Sbjct: 300 EIILGLEHMHNRFVVYRDLKP---------ANILLDEHGHVRISDLGLACDFSK----KK 346
Query: 396 TSAVDC----FLDPE-LNLSKNYSAGSDVYSFGVFLLELISGR---EAHGRNHSNSDQNL 447
A ++ PE L Y + +D +S G L +L+ G H + +
Sbjct: 347 PHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
Query: 448 ILQVK 452
L +
Sbjct: 406 TLTMA 410
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 45/243 (18%), Positives = 87/243 (35%), Gaps = 66/243 (27%)
Query: 232 LKHATNNFSEI----NIIGEGSFGLAYKGL-LQDGSLVVIK----------------RHL 270
++ E +G G++G S IK +++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 271 QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI- 329
+ + +E+ + + H +++KL E+ L+ ++ G L++ I
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQ----II 138
Query: 330 --GKLT-------MRQRLSIALGAAKGLEHLHSL-VPPLFHMH--FRTSNVLL---EENY 374
K M+Q LS G+ +LH + +H + N+LL
Sbjct: 139 NRHKFDECDAANIMKQILS-------GICYLHKHNI-----VHRDIKPENILLENKNSLL 186
Query: 375 TAKVSDYGLLKLVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELI 430
K+ D+GL + + G+ ++ PE+ L K Y+ DV+S GV + L+
Sbjct: 187 NIKIVDFGLSSFFSKDYKLRDRLGTAY----YIAPEV-LKKKYNEKCDVWSCGVIMYILL 241
Query: 431 SGR 433
G
Sbjct: 242 CGY 244
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 41/257 (15%)
Query: 195 SSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAY 254
S+ P +L D V D + +Q I ++ +IG GSFG+ +
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREI--------AYTNCKVIGNGSFGVVF 57
Query: 255 KGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL------LI 308
+ L + V IK+ LQ + E++ + V H ++V L F N + L+
Sbjct: 58 QAKLVESDEVAIKKVLQDKRFK-NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 309 YDYIPNGNVQNHL--YDSEGLPIG----KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMH 362
+Y+P V Y + KL M Q L + L ++HS+ + H
Sbjct: 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL-------RSLAYIHSI--GICHRD 166
Query: 363 FRTSNVLL-EENYTAKVSDYGLLK-LVTGSHHAGSTSAVDCFL---DPELNL-SKNYSAG 416
+ N+LL + K+ D+G K L+ G + S + C PEL + NY+
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYI-CSRYYRAPELIFGATNYTTN 222
Query: 417 SDVYSFGVFLLELISGR 433
D++S G + EL+ G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 34/222 (15%), Positives = 76/222 (34%), Gaps = 38/222 (17%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR-----HLQTQIQNFLHEVKHIARV--HH 289
+S + IG G ++ L + + IK + ++ +E+ ++ ++ H
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG--KLTMRQRLSIALGAAKG 347
+++L + E Q + + N ++ + L + + K + L
Sbjct: 69 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE-------A 120
Query: 348 LEHLHS--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSHHAGSTSAV----- 399
+ +H +V H + +N L+ + K+ D+G+ + + S V
Sbjct: 121 VHTIHQHGIV----HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 400 --------DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
S SDV+S G L + G+
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 43/215 (20%), Positives = 89/215 (41%), Gaps = 36/215 (16%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHRH 291
+ + IGEG++G+ YK G +K+ L+ + + + E+ + + H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG----KLTMRQRLSIALGAAKG 347
+VKL + +L+++++ +++ L D + K + Q L G
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQLL-------NG 112
Query: 348 LEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF 402
+ + H +H R N+L+ K++D+GL + + V
Sbjct: 113 IAYCHD------RRVLH-RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT-- 163
Query: 403 L---DPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
L P++ + SK YS D++S G E+++G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 43/212 (20%), Positives = 83/212 (39%), Gaps = 44/212 (20%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
+GEG++G + V +K + +N E+ ++H ++VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK-------GLEHLH 352
E + Q L +Y G L+D ++ + A + G+ +LH
Sbjct: 75 REGNIQYLFLEYCSGG----ELFD-------RIEPDIGMPEPD-AQRFFHQLMAGVVYLH 122
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD-------- 404
+ + H + N+LL+E K+SD+GL + ++ + L+
Sbjct: 123 GI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------ERLLNKMCGTLPY 173
Query: 405 --PELNLSKNYS-AGSDVYSFGVFLLELISGR 433
PEL + + DV+S G+ L +++G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 36/212 (16%), Positives = 79/212 (37%), Gaps = 39/212 (18%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLH-----------EVKHIARVHHRHL 292
+G G+FG + + + VV+K + ++ E+ ++RV H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK------ 346
+K++ E L+ + +G L+ + RL L +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGL---DLFA-------FIDRHPRLDEPLASYIFRQLVS 141
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH----AGSTSAVDCF 402
+ +L + H + N+++ E++T K+ D+G + G+ +
Sbjct: 142 AVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI----EY 195
Query: 403 LDPELNLSKNYS-AGSDVYSFGVFLLELISGR 433
PE+ + Y +++S GV L L+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 32/227 (14%), Positives = 74/227 (32%), Gaps = 48/227 (21%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHL-----QTQIQNFLHEVKHIARV--HH 289
+S + IG G ++ L + + IK + ++ +E+ ++ ++ H
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG--KLTMRQRLSIALGAAKG 347
+++L + + ++ + N ++ + L + + K + L
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------A 139
Query: 348 LEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV-TGSHHAGSTSAV 399
+ +H L P +N L+ + K+ D+G+ + + S V
Sbjct: 140 VHTIHQHGIVHSDLKP---------ANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 400 -------------DCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
S SDV+S G L + G+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 47/226 (20%)
Query: 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQ-------TQIQ--NFLHEVK 282
+++ F ++ +G G++ YKGL G V +K L T I+ + + E+K
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 283 H--IAR----VHHRHLVKLV-GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMR 335
H I R +H + + LV F + + ++ + D GN L L + K
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYM--DSRTVGNTPRGL----ELNLVKYFQW 115
Query: 336 QRLSIALGAAKGLEHLHSLVPPLFH--MH--FRTSNVLLEENYTAKVSDYGLLKLVTGSH 391
Q L +GL H + +H + N+L+ + K+ D+GL +
Sbjct: 116 QLL-------QGLAFCHE------NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162
Query: 392 HAGSTSAVDCFL---DPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
+ S+ V L P++ + S+ YS D++S G L E+I+G+
Sbjct: 163 NTFSSEVVT--LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 27/214 (12%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-------HLQTQIQNFLHEVKHIARVH 288
++ I +G G++G+ K + G ++ +KR Q ++ L V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR--TVD 64
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
V G + + + + Y + IA+ K L
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDK--FYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 349 EHLHSLVPPLFHMHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--- 402
EHLHS L +H R SNVL+ K+ D+G+ + A A
Sbjct: 123 EHLHS---KLSVIH-RDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMA 177
Query: 403 ---LDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
++PELN K YS SD++S G+ ++EL R
Sbjct: 178 PERINPELN-QKGYSVKSDIWSLGITMIELAILR 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 46/234 (19%), Positives = 86/234 (36%), Gaps = 62/234 (26%)
Query: 245 IGEGSFG---LAYKGLLQDGSLVVIK----------------------RHLQTQIQNFLH 279
IG+GS+G LAY D + +K R
Sbjct: 21 IGKGSYGVVKLAYN--ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 280 EVKHIAR-------VHHRHLVKLVGFCEENHQQLL--IYDYIPNGNVQNHLYDSEGLPIG 330
++ + + + H ++VKLV ++ ++ L +++ + G V
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------K 132
Query: 331 KLTM-------RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383
L+ + + G+E+LH + H + SN+L+ E+ K++D+G+
Sbjct: 133 PLSEDQARFYFQDLIK-------GIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 384 LKLVTGSHHAGSTSA-VDCFLDPEL--NLSKNYS-AGSDVYSFGVFLLELISGR 433
GS S + F+ PE K +S DV++ GV L + G+
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 47/230 (20%), Positives = 89/230 (38%), Gaps = 55/230 (23%)
Query: 234 HATNNFSEI----NIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQT-QIQNFLHEVKH 283
+ F+E ++G+GSFG K +K + L EV+
Sbjct: 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI---GKLT------- 333
+ ++ H +++KL E++ ++ + G L+D I + +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDE----IIKRKRFSEHDAARI 126
Query: 334 MRQRLSIALGAAKGLEHLHSL-VPPLFHMH--FRTSNVLL---EENYTAKVSDYGLLKLV 387
++Q S G+ ++H + +H + N+LL E++ K+ D+GL
Sbjct: 127 IKQVFS-------GITYMHKHNI-----VHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 388 TGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ G+ ++ PE+ L Y DV+S GV L L+SG
Sbjct: 175 QQNTKMKDRIGTAY----YIAPEV-LRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 39/219 (17%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNF----LHEVKHIARVHHR 290
+ + I +GEG++G YK + V IKR L+ + + + EV + + HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG--KLTMRQRLSIALGAAKGL 348
++++L NH+ LI++Y N +++ ++ + + + K + Q + G+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI-------NGV 145
Query: 349 EHLHSLVPPLFH--MHFR---TSNVLLEENYTA-----KVSDYGLLKLVTGSHHAGSTSA 398
HS +H R N+LL + + K+ D+GL + G T
Sbjct: 146 NFCHS------RRCLH-RDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHE 197
Query: 399 VDCFL---DPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
+ L PE+ L S++YS D++S E++
Sbjct: 198 I-ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 42/210 (20%), Positives = 81/210 (38%), Gaps = 41/210 (19%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+G G+FG G G V +K + +I+ E++++ H H++K
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIK 75
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK------GL 348
L ++ +Y+ G L+D + R+ +
Sbjct: 76 LYQVISTPTDFFMVMEYVSGG----ELFD-------YICKHGRVEEMEARRLFQQILSAV 124
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA----GSTSAVDCFLD 404
++ H + H + NVLL+ + AK++D+GL +++ GS +
Sbjct: 125 DYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP----NYAA 178
Query: 405 PELNLSKNYS-AGSDVYSFGVFLLELISGR 433
PE+ + Y+ D++S GV L L+ G
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 46/227 (20%), Positives = 90/227 (39%), Gaps = 40/227 (17%)
Query: 231 ELKHATNNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNF 277
+++ +F + +IG G+FG A K L + ++KR + F
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW---EMLKRA---ETACF 121
Query: 278 LHEVKHIARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTM-R 335
E + + + L + ++ L L+ DY G++ L E +L
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEM 176
Query: 336 QRLSIA-LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
R +A + A ++ +H L H + N+L++ N +++D+G +
Sbjct: 177 ARFYLAEMVIA--IDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 395 STSAV---DCFLDPELNLSKN-----YSAGSDVYSFGVFLLELISGR 433
S+ AV D ++ PE+ + Y D +S GV + E++ G
Sbjct: 233 SSVAVGTPD-YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 28/198 (14%), Positives = 58/198 (29%), Gaps = 46/198 (23%)
Query: 245 IGEGSFGLAYKGLLQDGSL---VVIK------RHLQTQIQNFLHEVKHIARVHHRHLVKL 295
G ++ D +L V + +Q L ++R+ + ++
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
+ L++ ++I G++Q D+ P+G + Q L+ A AA S+
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPVGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSA 415
P S V + + ++ +
Sbjct: 156 HP--------SRVRVSIDGDVVLAYPATMPDAN--------------------------P 181
Query: 416 GSDVYSFGVFLLELISGR 433
D+ G L L+ R
Sbjct: 182 QDDIRGIGASLYALLVNR 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 49/222 (22%), Positives = 88/222 (39%), Gaps = 50/222 (22%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQ-------TQIQNFLHEVKHIARV 287
+ +++ +GEG++ YKG +LV +K L+ T I+ EV + +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNH----LYDSEGLPIG----KLTMRQRLS 339
H ++V L L+++Y+ + D G I KL + Q L
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLL- 110
Query: 340 IALGAAKGLEHLHSLVPPLFH--MH--FRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGS 395
+GL + H +H + N+L+ E K++D+GL +
Sbjct: 111 ------RGLAYCHR------QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTY 157
Query: 396 TSAVDCFL---DPELNL-SKNYSAGSDVYSFGVFLLELISGR 433
+ V L P++ L S +YS D++ G E+ +GR
Sbjct: 158 DNEV-VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 45/229 (19%), Positives = 89/229 (38%), Gaps = 42/229 (18%)
Query: 231 ELKHATNNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNF 277
E++ ++F + +IG G+F A K + + ++KR ++ F
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW---DMLKRG---EVSCF 108
Query: 278 LHEVKHIARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTM-R 335
E + R + +L F ++ L L+ +Y G++ L ++
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEM 163
Query: 336 QRLSIA-LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
R +A + A ++ +H L H + N+LL+ +++D+G +
Sbjct: 164 ARFYLAEIVMA--IDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219
Query: 395 STSAV---DCFLDPELNLSKNYSAGSDVY-------SFGVFLLELISGR 433
S AV D +L PE+ + G+ Y + GVF E+ G+
Sbjct: 220 SLVAVGTPD-YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 44/213 (20%), Positives = 80/213 (37%), Gaps = 24/213 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HL------QTQIQNFLHEVKHIARVH 288
+ ++ IG G++G K + G ++ +KR Q Q+ L V
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR--SSD 79
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
++V+ G + + + + + + + I L K L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG----LLKLVTGSHHAGSTSAVDCFLD 404
HL + H + SN+LL+ + K+ D+G L+ + + AG ++
Sbjct: 139 NHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG-CRP---YMA 193
Query: 405 PE----LNLSKNYSAGSDVYSFGVFLLELISGR 433
PE + Y SDV+S G+ L EL +GR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 31/204 (15%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
IG G+FG+A LV +K + +Q E+ + + H ++V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKEV 84
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK------GLEHLH 352
+I +Y G LY+ ++ R S G+ + H
Sbjct: 85 ILTPTHLAIIMEYASGGE----LYE-------RICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 353 SLVPPLFHMHFRTSNVLLEENYTA--KVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS 410
S+ + H + N LL+ + K+ D+G K ST ++ PE+ L
Sbjct: 134 SM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 411 KNYS-AGSDVYSFGVFLLELISGR 433
+ Y +DV+S GV L ++ G
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 49/214 (22%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIAR-------VHHRHLVKLV 296
+G G+FG G G V +K + +I++ L V I R H H++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK------GLEH 350
++ +Y+ G L+D + RL G+++
Sbjct: 83 QVISTPSDIFMVMEYVSGG----ELFD-------YICKNGRLDEKESRRLFQQILSGVDY 131
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD------ 404
H + + H + NVLL+ + AK++D+GL +++ FL
Sbjct: 132 CHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD----------GEFLRTSCGSP 179
Query: 405 ----PELNLSKNYS-AGSDVYSFGVFLLELISGR 433
PE+ + Y+ D++S GV L L+ G
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDP 405
G++HLHS + H + SN++++ + T K+ D+GL + S + P
Sbjct: 138 CGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQ-NLILQV 451
E+ L Y D++S G + E+I G G +H DQ N +++
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQ 241
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 50/269 (18%), Positives = 102/269 (37%), Gaps = 47/269 (17%)
Query: 186 RRIRRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINII 245
+ + + + + + + ++T+ N F + ++
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM-------NEFEYLKLL 156
Query: 246 GEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHL 292
G+G+FG A K L ++ V++ + ++ + L E + + H L
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKE---VIVAKD---EVAHTLTENRVLQNSRHPFL 210
Query: 293 VKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
L + + H +L + +Y G + HL R R A L++L
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGA-EIVSALDYL 264
Query: 352 HSLVPPLFHMHFR---TSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLD 404
HS ++ +R N++L+++ K++D+GL K G+T C +L
Sbjct: 265 HSE----KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATMKTFCGTPEYLA 317
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGR 433
PE+ +Y D + GV + E++ GR
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 48/230 (20%), Positives = 94/230 (40%), Gaps = 49/230 (21%)
Query: 231 ELKHATNNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNF 277
+L+ ++ + +IG G+FG A K L + +IKR F
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF---EMIKRS---DSAFF 116
Query: 278 LHEVKHIARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQ 336
E +A + +V+L + ++ + L ++ +Y+P G++ N +
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM------------SNY 163
Query: 337 RLSIALG---AAK---GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390
+ A+ L+ +HS+ H + N+LL+++ K++D+G +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 391 HHAGSTSAV---DCFLDPELNLSK----NYSAGSDVYSFGVFLLELISGR 433
+AV D ++ PE+ S+ Y D +S GVFL E++ G
Sbjct: 222 GMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 9e-06
Identities = 40/249 (16%), Positives = 72/249 (28%), Gaps = 52/249 (20%)
Query: 235 ATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIK-----------RHLQTQIQNFLHEV-- 281
T IGEG FG ++ + D + V IK Q + L E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 282 ---------------KHIARVHHRHLVK------LVGFCEENHQQLLIYDYIPNGNVQNH 320
+ ++ H V+ L+ + + + P+ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 321 LY----------DSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370
L+ D E + ++ SI L + + H NVLL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-RFEHRDLHWGNVLL 195
Query: 371 EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELI 430
++ K+ K T S +D LS+ G V+ +L
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIID------YTLSRLERDGIVVFCDVSMDEDLF 249
Query: 431 SGREAHGRN 439
+G + +
Sbjct: 250 TGDGDYQFD 258
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 48/244 (19%), Positives = 103/244 (42%), Gaps = 50/244 (20%)
Query: 237 NNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKH 283
++F + IG+GSFG A K + + ++R+ +++N E++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ---KCVERN---EVRNVFKELQI 68
Query: 284 IARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA- 341
+ + H LV L + ++ + + ++ D + G+++ HL + +L I
Sbjct: 69 MQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----TVKLFICE 123
Query: 342 LGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
L A L++L + + P N+LL+E+ ++D+ + ++
Sbjct: 124 LVMA--LDYLQNQRIIHRDMKP---------DNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 395 STSAVDCFLDPELNLSKN---YSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQ--NLI 448
+ + ++ PE+ S+ YS D +S GV EL+ GR H R+ ++S + +
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232
Query: 449 LQVK 452
Sbjct: 233 ETTV 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 9e-06
Identities = 45/236 (19%), Positives = 92/236 (38%), Gaps = 63/236 (26%)
Query: 235 ATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQ---IQNF----LHEV---K 282
AT+ + + IG G++G YK G V +K + + EV +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 283 HIARVHHRHLVKL----VGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIG----KLT 333
+ H ++V+L + ++ L+++++ +++ +L + + K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 334 MRQRLSIALGAAKGLEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKL-- 386
MRQ L +GL+ LH+ + +H R N+L+ T K++D+GL ++
Sbjct: 126 MRQFL-------RGLDFLHA------NCIVH-RDLKPENILVTSGGTVKLADFGLARIYS 171
Query: 387 --VTGSHH-------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ + A PE+ L Y+ D++S G E+ +
Sbjct: 172 YQMALTPVVVTLWYRA-----------PEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 40/238 (16%), Positives = 82/238 (34%), Gaps = 52/238 (21%)
Query: 228 TILELKHATNNFSEI----NIIGEGSFGLAYKGL-LQDGSLV---VI-KRHLQTQ----I 274
IL++ F ++ +IG+G F + + + + G ++ +
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 275 QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD---SEGLPIGK 331
++ E + H H+V+L+ + ++++++ + L
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFV 126
Query: 332 LT-------MRQRLSIALGAAKGLEHLHSL-VPPLFHMHF--RTSNVLL---EENYTAKV 378
+ MRQ L L + H + +H + VLL E + K+
Sbjct: 127 YSEAVASHYMRQILE-------ALRYCHDNNI-----IHRDVKPHCVLLASKENSAPVKL 174
Query: 379 SDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+G+ + S F+ PE+ + Y DV+ GV L L+SG
Sbjct: 175 GGFGVAIQLGESGLVAGGR---VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 49/232 (21%), Positives = 94/232 (40%), Gaps = 61/232 (26%)
Query: 237 NNFSEINIIGEGSFGLAYKG--LLQDGSLVVIKR-HLQTQIQNF----LHEV---KHIAR 286
+ + IGEG++G +K L G V +KR +QT + + EV +H+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 287 VHHRHLVKL----VGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIG----KLTMRQR 337
H ++V+L + +L L+++++ ++ +L + K M Q
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 338 LSIALGAAKGLEHLHSLVPPLFH--MHFR---TSNVLLEENYTAKVSDYGLLKL----VT 388
L +GL+ LHS H +H R N+L+ + K++D+GL ++ +
Sbjct: 130 L-------RGLDFLHS------HRVVH-RDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 389 GSHH-------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ A PE+ L +Y+ D++S G E+ +
Sbjct: 176 LTSVVVTLWYRA-----------PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 58/225 (25%)
Query: 237 NNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKH 283
+ F I +G GSFG A K L + V+K QI++ L+E +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ---KVVKLK---QIEHTLNEKRI 94
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRL---S 339
+ V+ LVKL ++N ++ +Y+ G + +HL G+ + R
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQ 149
Query: 340 IALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
I L E+LHS L P N+L+++ +V+D+G K V G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKP---------ENLLIDQQGYIQVTDFGFAKRVKGR-- 194
Query: 393 AGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
T + C L PE+ LSK Y+ D ++ GV + E+ +G
Sbjct: 195 ---TWTL-CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 49/270 (18%), Positives = 89/270 (32%), Gaps = 55/270 (20%)
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
VP S D+ A Q + L +G G
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPL------------LGSG 54
Query: 249 SFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLH---------EVKHIARVHHR--HLVKLV 296
FG Y G+ + D V IK + +I ++ EV + +V +++L+
Sbjct: 55 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 297 GFCEENHQQLLIYDYI-PNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKGL 348
+ E +LI + P ++ + + + G L Q L +
Sbjct: 115 DWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLE-------AV 162
Query: 349 EHLHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSH---HAGSTSAVDCFLD 404
H H+ + H + N+L+ K+ D+G L+ + G+ +
Sbjct: 163 RHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR----VYSP 216
Query: 405 PELNLSKNYSAGS-DVYSFGVFLLELISGR 433
PE Y S V+S G+ L +++ G
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 41/240 (17%), Positives = 83/240 (34%), Gaps = 51/240 (21%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK--------RHLQTQIQNFLHEVKHIARVHHRHLVKL 295
IG+GS+G+ + Q ++ IK + ++ EV+ + ++HH ++ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV 355
E+ L+ + G++ + L GK M + + E +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 356 PPLF-------------------------HMHFRT--------SNVLLE--ENYTAKVSD 380
F ++H + N L +++ K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 381 YGLLKLVTGSHHAGSTSAVD-----CFLDPEL--NLSKNYSAGSDVYSFGVFLLELISGR 433
+GL K ++ F+ PE+ +++Y D +S GV L L+ G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 46/237 (19%), Positives = 85/237 (35%), Gaps = 40/237 (16%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVK 294
+ + IG G+ G+ V IK+ + H R + R LV
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK-----LSRPFQNQTHAKRAY-RELVL 114
Query: 295 LVGFCEENHQQLL-IYDYIPNGNVQNHLYDSEGLPIGKL--TMRQRLS------IALGAA 345
+ +N LL ++ +Y L L ++ L +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD- 404
G++HLHS + H + SN++++ + T K+ D+GL A +
Sbjct: 175 CGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGL---------ARTAGTSFMMTPY 223
Query: 405 --------PELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQ-NLILQV 451
PE+ L Y D++S G + E++ + GR++ DQ N +++
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQ 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 51/291 (17%), Positives = 97/291 (33%), Gaps = 70/291 (24%)
Query: 185 KRRIRRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEI-- 242
+ IR + S + + P + Q++ L A F +
Sbjct: 38 RAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYD 97
Query: 243 --NIIGEGSFGLAYKGL-LQDGSLVVIK-----------RHLQTQIQNFLHEV---KHIA 285
++IG G + + + G +K L+ + E + +A
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI---GKLT-------MR 335
H H++ L+ E + L++D + G L+D + L+ MR
Sbjct: 158 G--HPHIITLIDSYESSSFMFLVFDLMRKGE----LFDY----LTEKVALSEKETRSIMR 207
Query: 336 QRLSIALGAAKGLEHLHSL-VPPLFHMHFRT---SNVLLEENYTAKVSDYGLLKLVTGSH 391
L + LH+ + +H R N+LL++N ++SD+G +
Sbjct: 208 SLLE-------AVSFLHANNI-----VH-RDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 392 H----AGSTSAVDCFLDPE------LNLSKNYSAGSDVYSFGVFLLELISG 432
G+ +L PE Y D+++ GV L L++G
Sbjct: 255 KLRELCGTPG----YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 43/215 (20%), Positives = 78/215 (36%), Gaps = 43/215 (20%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLH---------EVKHIARVH----HR 290
+G+G FG + G L D V IK + ++ + EV + +V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK---- 346
+++L+ + E +L+ + L+D +T + L
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ---DLFD-------YITEKGPLGEGPSRCFFGQV 148
Query: 347 --GLEHLHSL-VPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSH---HAGSTSAV 399
++H HS V H + N+L+ AK+ D+G L+ G+
Sbjct: 149 VAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTR--- 202
Query: 400 DCFLDPELNLSKNYSAGS-DVYSFGVFLLELISGR 433
+ PE Y A V+S G+ L +++ G
Sbjct: 203 -VYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 51/263 (19%), Positives = 92/263 (34%), Gaps = 42/263 (15%)
Query: 189 RRSEGESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEG 248
E P P A KQ + S+ I+G G
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY----TVSKTEILGGG 100
Query: 249 SFGLAYKGLLQDGSLV----VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304
FG +K L +IK + +E+ + ++ H +L++L E +
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160
Query: 305 QLLIYDYIPNG------NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-VPP 357
+L+ +Y+ G +++ +E L M+Q G+ H+H + +
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNL-TE--LDTILFMKQICE-------GIRHMHQMYI-- 208
Query: 358 LFHMHF--RTSNVLL--EENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNL 409
+H + N+L + K+ D+GL + V+ FL PE+
Sbjct: 209 ---LHLDLKPENILCVNRDAKQIKIIDFGLARRYKP----REKLKVNFGTPEFLAPEVVN 261
Query: 410 SKNYSAGSDVYSFGVFLLELISG 432
S +D++S GV L+SG
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 42/210 (20%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+GEGSFG + V +K + +++ E+ ++ + H H++K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIK 73
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK------GL 348
L +++ +Y L+D + ++R++ G +
Sbjct: 74 LYDVITTPTDIVMVIEY-----AGGELFD-------YIVEKKRMTEDEGRRFFQQIICAI 121
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA----GSTSAVDCFLD 404
E+ H + H + N+LL++N K++D+GL ++T + GS +
Sbjct: 122 EYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSP----NYAA 175
Query: 405 PELNLSKNYS-AGSDVYSFGVFLLELISGR 433
PE+ K Y+ DV+S G+ L ++ GR
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 42/243 (17%), Positives = 83/243 (34%), Gaps = 60/243 (24%)
Query: 244 IIGEGSFGLAYKGLLQDGSLVV----IKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
IG GS+G + + + I ++ + F E++ + + H ++++L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPI---GKLT-------MRQRLSIALGAAKGLE 349
E+N L+ + G L++ + M+ LS +
Sbjct: 76 EDNTDIYLVMELCTGG----ELFER----VVHKRVFRESDAARIMKDVLS-------AVA 120
Query: 350 HLHSL-VPPLFHMHFRT---SNVLL---EENYTAKVSDYGLLKLVTGSHH----AGSTSA 398
+ H L V H R N L + K+ D+GL G+
Sbjct: 121 YCHKLNV-----AH-RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP-- 172
Query: 399 VDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVKRSCDL 457
++ P++ L Y D +S GV + L+ G D ++L+++
Sbjct: 173 --YYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPT----DSEVMLKIRE---- 221
Query: 458 GKY 460
G +
Sbjct: 222 GTF 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 51/240 (21%), Positives = 90/240 (37%), Gaps = 54/240 (22%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFC 299
++G G+F + G L IK+ + + +E+ + ++ H ++V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 300 EENHQQLLIYDYIPNGNVQNHLYDSEGLPI---GKLT-------MRQRLSIALGAAKGLE 349
E L+ + G L+D I G T ++Q LS ++
Sbjct: 76 ESTTHYYLVMQLVSGGE----LFDR----ILERGVYTEKDASLVIQQVLS-------AVK 120
Query: 350 HLHSL-VPPLFHMH--FRTSNVLL---EENYTAKVSDYGLLKLVTGSH---HAGSTSAVD 400
+LH + +H + N+L EEN ++D+GL K+ G+ V
Sbjct: 121 YLHENGI-----VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV- 174
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460
PE+ K YS D +S GV L+ G + ++ L ++K G Y
Sbjct: 175 ---APEVLAQKPYSKAVDCWSIGVITYILLCGYPPF---YEETESKLFEKIKE----GYY 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 54/256 (21%), Positives = 102/256 (39%), Gaps = 60/256 (23%)
Query: 234 HATNNFSEI----NIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQT-QIQNFLHEVKH 283
+ F+E ++G+GSFG K +K + L EV+
Sbjct: 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD--------SEGLPIGKLTMR 335
+ ++ H +++KL E++ ++ + G L+D SE ++
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSE--HDAARIIK 128
Query: 336 QRLSIALGAAKGLEHLHSL-VPPLFHMH--FRTSNVLL---EENYTAKVSDYGLLKLVTG 389
Q S G+ ++H + +H + N+LL E++ K+ D+GL
Sbjct: 129 QVFS-------GITYMHKHNI-----VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 390 SHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSD 444
+ G+ ++ PE+ L Y DV+S GV L L+SG +G+N +
Sbjct: 177 NTKMKDRIGTAY----YIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKN----E 227
Query: 445 QNLILQVKRSCDLGKY 460
+++ +V+ GKY
Sbjct: 228 YDILKRVET----GKY 239
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 35/216 (16%), Positives = 78/216 (36%), Gaps = 57/216 (26%)
Query: 245 IGEGSFGLAYKGL-LQDGSLV---VIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCE 300
+G G FG+ ++ + +K E+ + HR+++ L E
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 301 ENHQQLLIYDYIPNGNVQNHLYD---SEGLPIGKLT-------MRQRLSIALGAAKGLEH 350
+ ++I+++I + +++ + +L + Q L+
Sbjct: 72 SMEELVMIFEFISGLD----IFERINTSA---FELNEREIVSYVHQVCE-------ALQF 117
Query: 351 LHSL-VPPLFHMHF--RTSNVLL--EENYTAKVSDYGL---------LKLVTGSHHAGST 396
LHS + HF R N++ + T K+ ++G +L+ +
Sbjct: 118 LHSHNI-----GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA--PE-- 168
Query: 397 SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+ PE++ S +D++S G + L+SG
Sbjct: 169 -----YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 61/239 (25%)
Query: 233 KHATNNFSEI----NIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQ 275
H+T+ F E I+G G A K + G +Q +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 276 NFLHEV---KHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKL 332
L EV + ++ H ++++L E N L++D + G L+D L
Sbjct: 69 ATLKEVDILRKVS--GHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFD-------YL 115
Query: 333 TMRQRLS------IALGAAKGLEHLHSL-VPPLFHMHF--RTSNVLLEENYTAKVSDYGL 383
T + LS I + + LH L + +H + N+LL+++ K++D+G
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNI-----VHRDLKPENILLDDDMNIKLTDFGF 170
Query: 384 LKLVTGSHH----AGSTSAVDCFLDPE------LNLSKNYSAGSDVYSFGVFLLELISG 432
+ G+ S +L PE + Y D++S GV + L++G
Sbjct: 171 SCQLDPGEKLREVCGTPS----YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 42/221 (19%), Positives = 76/221 (34%), Gaps = 59/221 (26%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK---------RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+G G F + K G K + EV + +V H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKG 347
L E +LI + + G + + L L+ ++Q L G
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILD-------G 127
Query: 348 LEHLHSL-VPPLFHMHF--RTSNVLL----EENYTAKVSDYGL---------LKLVTGSH 391
+ +LH+ + HF + N++L K+ D+GL K + G+
Sbjct: 128 VNYLHTKKI-----AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT- 181
Query: 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
F+ PE+ + +D++S GV L+SG
Sbjct: 182 -PE-------FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 46/252 (18%), Positives = 83/252 (32%), Gaps = 72/252 (28%)
Query: 215 AVSPIDTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK----- 267
+ P Q ++ I E +G G F + K G K
Sbjct: 1 GMEPFKQQKVEDFYDIGE------------ELGSGQFAIVKKCREKSTGLEYAAKFIKKR 48
Query: 268 ----RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD 323
+ EV + +V H +++ L E +LI + + G + + L
Sbjct: 49 QSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ 108
Query: 324 SEGLPIGKLT-------MRQRLSIALGAAKGLEHLHSL-VPPLFHMHF--RTSNVLL--- 370
L+ ++Q L G+ +LH+ + HF + N++L
Sbjct: 109 K-----ESLSEEEATSFIKQILD-------GVNYLHTKKI-----AHFDLKPENIMLLDK 151
Query: 371 -EENYTAKVSDYGL---------LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVY 420
K+ D+GL K + G+ F+ PE+ + +D++
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKNIFGT--PE-------FVAPEIVNYEPLGLEADMW 202
Query: 421 SFGVFLLELISG 432
S GV L+SG
Sbjct: 203 SIGVITYILLSG 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 50/259 (19%), Positives = 96/259 (37%), Gaps = 69/259 (26%)
Query: 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLH---------EVKH 283
+ +++F +++GEG++G+ G +V IK+ I+ F E+K
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK-----IEPFDKPLFALRTLREIKI 62
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQN--------HLYDSEGLPIGKLTMR 335
+ H +++ + ++ + +N L ++ + ++
Sbjct: 63 LKHFKHENIITI-------------FNIQRPDSFENFNEVYIIQELMQTD---LHRVIST 106
Query: 336 QRLSIA---------LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL-K 385
Q LS L + ++ LH + H + SN+L+ N KV D+GL
Sbjct: 107 QMLSDDHIQYFIYQTL---RAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 386 LVTGSHHAGSTSAVDCFLD----------PELNLS-KNYSAGSDVYSFGVFLLELISGRE 434
+ + + + PE+ L+ YS DV+S G L EL R
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
Query: 435 A-HGRNHSNSDQ-NLILQV 451
GR++ Q LI +
Sbjct: 222 IFPGRDY--RHQLLLIFGI 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 56/259 (21%), Positives = 98/259 (37%), Gaps = 76/259 (29%)
Query: 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLH---------EVKH 283
++ ++ IGEG++G+ + V IK+ I F H E+K
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK-----ISPFEHQTYCQRTLREIKI 78
Query: 284 IARVHHRHLVKLV-----GFCEENHQQLLIYDYIP-------------NGNVQNHLYDSE 325
+ R H +++ + E+ ++ D + N ++ LY
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY--- 135
Query: 326 GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385
Q L +GL+++HS + H + SN+LL K+ D+GL
Sbjct: 136 ----------QIL-------RGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGL-- 174
Query: 386 LVTGSHHAGSTSAVDCFLD----------PELNLS-KNYSAGSDVYSFGVFLLELISGRE 434
+ A FL PE+ L+ K Y+ D++S G L E++S R
Sbjct: 175 ----ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 435 A-HGRNHSNSDQ-NLILQV 451
G+++ DQ N IL +
Sbjct: 231 IFPGKHY--LDQLNHILGI 247
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 59/221 (26%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQ-----IQNFLHEVKHIARVHHRHLVK 294
+G G F + K G K R L + + EV + + H +++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKG 347
L E +LI + + G + + L + LT ++Q L G
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILD-------G 120
Query: 348 LEHLHSL-VPPLFHMHF--RTSNVLL----EENYTAKVSDYGL---------LKLVTGSH 391
+ +LHS + HF + N++L N K+ D+G+ K + G+
Sbjct: 121 VHYLHSKRI-----AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT- 174
Query: 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
F+ PE+ + +D++S GV L+SG
Sbjct: 175 -PE-------FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 43/224 (19%), Positives = 80/224 (35%), Gaps = 49/224 (21%)
Query: 237 NNFSEINIIGEGSFG---LAYKGLLQD-GSLVVIKRHLQTQIQNFLHEVKHI-------A 285
F + ++G+G +G K + G + +K + I + H
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 286 RVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRL---SI 340
V H +V L+ + + +L LI +Y+ G + L G I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEI 130
Query: 341 ALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393
++ L HLH L P N++L K++D+GL K H
Sbjct: 131 SMA----LGHLHQKGIIYRDLKP---------ENIMLNHQGHVKLTDFGLCKE--SIHDG 175
Query: 394 GSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
T C ++ PE+ + ++ D +S G + ++++G
Sbjct: 176 TVTHTF-CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 3e-04
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 58/225 (25%)
Query: 237 NNFSEINIIGEGSFG-------------LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKH 283
+F + +G GSFG A K L ++ +V++ Q+++ E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE---IVVRLK---QVEHTNDERLM 59
Query: 284 IARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRL---S 339
++ V H ++++ G ++ Q +I DYI G + + L S + +
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAE 114
Query: 340 IALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
+ L LE+LHS L P N+LL++N K++D+G K V
Sbjct: 115 VCLA----LEYLHSKDIIYRDLKP---------ENILLDKNGHIKITDFGFAKYVPDV-- 159
Query: 393 AGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
T + C ++ PE+ +K Y+ D +SFG+ + E+++G
Sbjct: 160 ---TYTL-CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 36/219 (16%), Positives = 75/219 (34%), Gaps = 57/219 (26%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK-----RHLQTQIQNFLHEV---KHIARVHHRHLVKL 295
+G G F + + + G K R Q LHE+ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK--SCPRVINL 94
Query: 296 VGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLT-------MRQRLSIALGAAKGL 348
E + +LI +Y G + + ++ ++Q L G+
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILE-------GV 144
Query: 349 EHLHSL-VPPLFHMHF--RTSNVLL---EENYTAKVSDYGL---------LKLVTGSHHA 393
+LH + +H + N+LL K+ D+G+ L+ + G+
Sbjct: 145 YYLHQNNI-----VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT--P 197
Query: 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+L PE+ + +D+++ G+ L++
Sbjct: 198 E-------YLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 50/227 (22%), Positives = 83/227 (36%), Gaps = 59/227 (25%)
Query: 237 NNFSEINIIGEGSFG---LA-YKGLLQDGSL----VVIKRHLQTQIQNFLHEVKHI---- 284
N+F + ++G+G+FG L K G ++ K + I EV H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVI---IAK--DEVAHTVTES 56
Query: 285 ---ARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRL-- 338
H L L + + H +L + +Y G + HL R R
Sbjct: 57 RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYG 111
Query: 339 -SIALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390
I LE+LHS + N++L+++ K++D+GL K G
Sbjct: 112 AEIVSA----LEYLHSRDVVYRDIKL---------ENLMLDKDGHIKITDFGLCKE--GI 156
Query: 391 HHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
+ C +L PE+ +Y D + GV + E++ GR
Sbjct: 157 SDGATMKTF-CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 59/228 (25%)
Query: 237 NNFSEINIIGEGSFG---LAYKGLLQDG-----------SLVVIKRHLQTQIQNFLHEVK 282
+ F + ++G+GSFG L K D + + ++ ++T+++ +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME------R 77
Query: 283 HI-ARVHHRHLVKLVGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRL- 338
I V+H +VKL + + +L LI D++ G++ L T +
Sbjct: 78 DILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFY 131
Query: 339 --SIALGAAKGLEHLHS-------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389
+AL L+HLHS L P N+LL+E K++D+GL K
Sbjct: 132 LAELALA----LDHLHSLGIIYRDLKP---------ENILLDEEGHIKLTDFGLSKE--S 176
Query: 390 SHHAGSTSAVDC----FLDPELNLSKNYSAGSDVYSFGVFLLELISGR 433
H + C ++ PE+ + ++ +D +SFGV + E+++G
Sbjct: 177 IDHEKKAYSF-CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 54/260 (20%), Positives = 106/260 (40%), Gaps = 41/260 (15%)
Query: 194 ESSVPSPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFG-- 251
E A++ +G +P + I + + +F+ + ++G+GSFG
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGN---RDRMKLTDFNFLMVLGKGSFGKV 357
Query: 252 -----------LAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRH--LVKLVGF 298
A K L +D VVI+ ++ + E K + + + L +L
Sbjct: 358 MLSERKGTDELYAVKILKKD---VVIQDD---DVECTMVE-KRVLALPGKPPFLTQLH-S 409
Query: 299 CEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357
C + +L + +Y+ G++ H+ G+ + A A GL L S
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSK--G 462
Query: 358 LFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELNLSKNY 413
+ + + NV+L+ K++D+G+ K G T+ C ++ PE+ + Y
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD---GVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 414 SAGSDVYSFGVFLLELISGR 433
D ++FGV L E+++G+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 46/211 (21%), Positives = 82/211 (38%), Gaps = 45/211 (21%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLV---VIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGF 298
+GEGSF + K + + +I + ++ Q E+ + H ++VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV 74
Query: 299 CEENHQQLLIYDYIPNG------NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
+ L+ + + G + H ++E I MR+ +S + H+H
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI----MRKLVS-------AVSHMH 123
Query: 353 SL-VPPLFHMHFRT---SNVLL---EENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---- 401
+ V +H R N+L +N K+ D+G +L + T C
Sbjct: 124 DVGV-----VH-RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP---CFTLH 174
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
+ PEL Y D++S GV L ++SG
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 52/219 (23%)
Query: 245 IGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQ-------IQNFLHEVKHIARVHHRHL 292
+G G+ G + V I+ R N E++ + +++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 293 VKLVGFCEENHQQLLIYDYIPNGN-----VQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
+K+ F + ++ + + G V N E KL Q L
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRL-KE--ATCKLYFYQMLL-------A 251
Query: 348 LEHLHSL-VPPLFHMHFRT---SNVLL---EENYTAKVSDYGLLKLVTGSHH----AGST 396
+++LH + +H R NVLL EE+ K++D+G K++ + G+
Sbjct: 252 VQYLHENGI-----IH-RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 397 SAVDCFLDPEL---NLSKNYSAGSDVYSFGVFLLELISG 432
+ +L PE+ + Y+ D +S GV L +SG
Sbjct: 306 T----YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 66/267 (24%), Positives = 98/267 (36%), Gaps = 65/267 (24%)
Query: 199 SPSAELERGDISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLL 258
S E E + +P P P +Q + ++F + +IG+GSFG K LL
Sbjct: 3 SQPQEPELMNANPAP---PPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFG---KVLL 56
Query: 259 ----QDGSL----VVIKRHLQTQIQNFLHEVKHI--------ARVHHRHLVKLVGFCEEN 302
+ V+ K+ + ++ E KHI V H LV L F +
Sbjct: 57 ARHKAEEVFYAVKVLQKKAI---LKK--KEEKHIMSERNVLLKNVKHPFLVGLH-FSFQT 110
Query: 303 HQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTM-RQRL---SIALGAAKGLEHLHS---- 353
+L + DYI G + HL R R IA L +LHS
Sbjct: 111 ADKLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASA----LGYLHSLNIV 161
Query: 354 ---LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPE 406
L P N+LL+ ++D+GL K H +TS C +L PE
Sbjct: 162 YRDLKP---------ENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTF-CGTPEYLAPE 209
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGR 433
+ + Y D + G L E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 9e-04
Identities = 46/227 (20%), Positives = 88/227 (38%), Gaps = 54/227 (23%)
Query: 236 TNNFSEI----NIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQ-IQNFLHEVKHIA 285
+ FS+ +G+G+F + + + G K + L + Q E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI---GKLT-------MR 335
++ H ++V+L +E L++D + G L++ I + ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFED----IVAREFYSEADASHCIQ 112
Query: 336 QRLSIALGAAKGLEHLHSL-VPPLFHMHF--RTSNVLL---EENYTAKVSDYGLLKLVTG 389
Q L + + HS + +H + N+LL + K++D+GL V
Sbjct: 113 QILE-------SIAYCHSNGI-----VHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 390 SHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG 432
S AG+ +L PE+ YS D+++ GV L L+ G
Sbjct: 161 SEAWHGFAGTPG----YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 530 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.57 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.4 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.28 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 94.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.22 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.57 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.39 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 92.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.32 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 90.52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 89.01 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.28 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=449.90 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=212.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|.+.+.||+|+||.||+|++. ++..||||++... ..++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356788899999999999999864 4678999998653 3467999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 307 LIYDYIPNGNVQNHLYDSE--------GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~--------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
||||||++|+|.++|+... ..+...+++.+++.|+.|||.||+|||+ ++||||||||+||||++++.+||
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCcEEE
Confidence 9999999999999997642 1223479999999999999999999999 69999999999999999999999
Q ss_pred eecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhh
Q 009644 379 SDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 379 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+...+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQG 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcC
Confidence 99999987654332 223458999999999999999999999999999999999 8999976532 2334443332
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.. ...+..++.++.+++.+||+.+| +||||+||++.|+++.+.
T Consensus 247 ~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 247 RV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 11233455789999999999999 999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=451.13 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=207.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++|...++||+|+||.||+|+++ ++..||||++... ..++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777789999999999999864 4778999998653 34679999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 308 IYDYIPNGNVQNHLYDSEGL----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
|||||++|+|.++|+..... ....+++.+++.|+.|||.||+|||+ ++||||||||+||||++++.+|
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCCCcEE
Confidence 99999999999999864321 12469999999999999999999999 6999999999999999999999
Q ss_pred EeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHh
Q 009644 378 VSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 378 I~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~ 453 (530)
|+|||+|+.+..... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ...+..+..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~ 275 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCITQ 275 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 999999997644322 234568999999999999999999999999999999999 8999976532 233344333
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.... +.+..++.++.+++.+||+.+| +||||+||++.|+.+.+.
T Consensus 276 g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2111 1233455788999999999999 999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-56 Score=449.10 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=210.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.+++..+.||+|+||.||+|.+. +++.||||++... ..++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999963 4678999997643 3578999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe
Q 009644 307 LIYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT 375 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~ 375 (530)
||||||++|+|.++|...... ....+++.+++.|+.|||+||+|||+ ++||||||||+||||++++.
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGC
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEECCCCC
Confidence 999999999999999754211 11368999999999999999999999 59999999999999999999
Q ss_pred EEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHH
Q 009644 376 AKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 376 ~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~ 451 (530)
+||+|||+|+....... .....||+.|||||++.++.|+.++|||||||+||||+| |+.||.... ...++..+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHHH
Confidence 99999999987644322 234568999999999999999999999999999999999 899997653 23444444
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
..... .+.+..++..+.+++.+||+.+| +||||+||++.|+.+
T Consensus 261 ~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 RNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33211 11233456789999999999999 999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=442.17 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=205.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.+++.+.+.||+|+||+||+|++++ .||||++.. ...+.|.+|+++|++++|||||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577888999999999999999753 589998753 234679999999999999999999999865 56899999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
||++|+|.++|+... ..+++.+++.|+.|||.||+|||+ ++||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999998654 269999999999999999999999 69999999999999999999999999999876432
Q ss_pred C---CcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
. ......||+.|||||++. .+.|+.++|||||||+||||+||+.||...... ......+... ...+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~-----~~~p~ 258 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRG-----YASPD 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTT-----CCCCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcC-----CCCCC
Confidence 2 233456999999999985 456999999999999999999999999754432 1222222221 12233
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+...+..++..+.+++.+||+.+| +||||.||++.|+.+..
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 333445566789999999999999 99999999999987753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=432.53 Aligned_cols=260 Identities=20% Similarity=0.334 Sum_probs=204.2
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHH--HHhcCCCCcceEEEEEeecC----ceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKH--IARVHHRHLVKLVGFCEENH----QQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~i--l~~l~H~nIv~l~g~~~~~~----~~~LV~E 310 (530)
++|.+.+.||+|+||.||+|++ +|+.||||++.....+++..|.++ +.+++|||||+++|+|.+++ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4567779999999999999998 588999999987776666655554 56789999999999998764 5799999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL------VPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
||++|+|.++|+.. .+++.++++++.|++.||+|||+. .++||||||||+||||++++++||+|||+|
T Consensus 82 y~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999864 689999999999999999999973 248999999999999999999999999999
Q ss_pred ccccCCCC-----cCcccccccccCccccCCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc----------
Q 009644 385 KLVTGSHH-----AGSTSAVDCFLDPELNLSK------NYSAGSDVYSFGVFLLELISGREAHGRNHSNS---------- 443 (530)
Q Consensus 385 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~---------- 443 (530)
+....... .....||+.|||||++.+. .|+.++|||||||+||||+||++|+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 87654322 1234599999999998754 46789999999999999999988765332111
Q ss_pred -hHHHHHHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 444 -DQNLILQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 444 -~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
......... .....++.++. ...+....+.+++.+||+.+| +||||.||++.|+++.+.+
T Consensus 236 ~~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 011111111 11223333433 234566789999999999999 9999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=433.63 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=215.7
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhcC-CCCcceEEE
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARVH-HRHLVKLVG 297 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~-H~nIv~l~g 297 (530)
..+++...++|++.+.||+|+||.||+|.+.. ++.||||++... ..+.|.+|+++|.+++ |||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34555667899999999999999999998643 357999987653 3457999999999995 599999999
Q ss_pred EEeec-CceeEEeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009644 298 FCEEN-HQQLLIYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRT 365 (530)
Q Consensus 298 ~~~~~-~~~~LV~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~ 365 (530)
+|.+. +.++||||||++|+|.++|+.... .....+++.+++.++.|||+||+|||+ ++||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCccCc
Confidence 99764 578999999999999999976422 112358999999999999999999999 6999999999
Q ss_pred CcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 009644 366 SNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHS 441 (530)
Q Consensus 366 ~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~ 441 (530)
+|||+++++.+||+|||+|+.+..... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997654332 234458899999999999999999999999999999998 9999976543
Q ss_pred CchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 442 NSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.. .....+...... ..+...+.++.+++.+||+.+| +||||+||++.|+++++.
T Consensus 294 ~~--~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 294 DE--EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SH--HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH--HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 32 222223222111 1223345688999999999999 999999999999998865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=428.92 Aligned_cols=253 Identities=17% Similarity=0.200 Sum_probs=210.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
.+.|+..++||+|+||.||+|+. .+|+.||||++..... +.+|+.++++++|||||++++++.+++..|||||||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 35678889999999999999995 5689999999865432 35799999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCcccccCCCC-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~~~~~~~- 392 (530)
|+|.++|.... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 135 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 135 GSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999998753 79999999999999999999999 5999999999999999987 699999999997654321
Q ss_pred -----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 393 -----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 393 -----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.....||+.|||||++.+..|+.++|||||||++|||+||+.||...........+ .... +.+..
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~~~-------~~~~~ 277 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---ASEP-------PPIRE 277 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HHSC-------CGGGG
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---HcCC-------CCchh
Confidence 12346999999999999999999999999999999999999999866544332222 2110 11112
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.+...+..+.+++.+||+.+| +|||+.|+++.|...+...
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 334456788999999999999 9999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=435.07 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=201.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|++++.||+|+||.||+|+. .+|+.||||++... ..+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 56899999987532 34679999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
||++|+|.++|....+ ..+++.++..++.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999976532 257899999999999999999999 69999999999999999999999999999876543
Q ss_pred CC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 HH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.. .....||+.|||||++.+..|+.++|||||||+||||+||+.||.... .......+... .. ...+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~-~~--------~~~~ 246 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKIISG-SF--------PPVS 246 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT-CC--------CCCC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcC-CC--------CCCC
Confidence 22 234469999999999999999999999999999999999999997643 22333333322 11 1122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+.++.+++.+||+.|| +|||++|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3345688999999999999 9999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=426.76 Aligned_cols=244 Identities=16% Similarity=0.311 Sum_probs=206.8
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..|+..+.||+|+||.||+|+. .+|+.||||++... ..+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688899999999999999995 46899999987532 3456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 68999999999999999999999 699999999999999999999999999999875443
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
......||+.|||||++.+..|+.++|||||||++|||++|++||..... ......+.... .+.+ .....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~------~~~~-~~~~~ 295 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL------PPRL-KNLHK 295 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSS------CCCC-SCGGG
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCC------CCCC-Ccccc
Confidence 34556799999999999999999999999999999999999999975432 23333333221 1111 12233
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+.++.+++.+||+.|| +|||++|+++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 45688999999999999 9999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=412.69 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=195.3
Q ss_pred ccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee----cCceeEEe
Q 009644 240 SEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQLLIY 309 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~~LV~ 309 (530)
+..++||+|+||.||+|.. .++..||+|++... ..+.|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4557899999999999995 45889999987543 34679999999999999999999999865 34689999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCccccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVT 388 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~ 388 (530)
|||++|+|.+++.... .+++..+..++.||+.||+|||+..++||||||||+||||+. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998753 689999999999999999999995234999999999999984 7999999999998644
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
. .......||+.|||||++. +.|+.++|||||||+||||+||+.||..... ...+...+.... . .+. .
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~-~----~~~---~ 251 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV-K----PAS---F 251 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC-C----CGG---G
T ss_pred C-CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCC-C----CCC---C
Confidence 3 2334567999999999885 5699999999999999999999999975432 222222222211 0 111 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+...+.++.+++.+||+.+| +|||++|+++
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22233578999999999999 9999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=411.57 Aligned_cols=241 Identities=19% Similarity=0.318 Sum_probs=191.1
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||+||+|+. .+++.||+|++.+. ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999994 57899999987543 2457899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+ +|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 789999998653 79999999999999999999999 6999999999999999999999999999988765
Q ss_pred CCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
........||+.|||||++.+..| +.++||||+||++|||+||+.||.... .......+.... . ..
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~~~-~---------~~ 231 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISNGV-Y---------TL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTC-C---------CC
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCC-C---------CC
Confidence 555556789999999999998876 579999999999999999999997543 223333333221 0 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+...+.++.+++.+|++.+| +|||++|+++
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 12234678899999999999 9999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=421.46 Aligned_cols=241 Identities=18% Similarity=0.286 Sum_probs=206.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||+||+|+. .+++.||+|++.+. ..+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999994 56899999997643 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998753 79999999999999999999999 6999999999999999999999999999998753
Q ss_pred CC---CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SH---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+... ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~-~~--------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIKL-EY--------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT-CC---------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcC-CC---------
Confidence 32 2345679999999999999999999999999999999999999997543 22333333322 11
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIA 497 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl 497 (530)
..+...+.++.+++.+|++.|| +|||++|+.
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1122234678999999999999 999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=425.53 Aligned_cols=245 Identities=16% Similarity=0.309 Sum_probs=207.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.+.|+..+.||+|+||.||+|+. .+|+.||||++.. ...+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 35699999999999999999995 4689999998753 2345689999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
|++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999753 68999999999999999999999 599999999999999999999999999999875443
Q ss_pred -CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 -HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+.... .+.+ ....
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~------~~~~-~~~~ 371 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL------PPRL-KNLH 371 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC------CCCC-SCTT
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCC------CCCC-cccc
Confidence 34556799999999999999999999999999999999999999975432 23333332221 1111 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+..+.+++.+||+.|| +|||+.|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 344688999999999999 9999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=415.42 Aligned_cols=237 Identities=21% Similarity=0.287 Sum_probs=193.5
Q ss_pred cCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
++|++.+.||+|+||+||+|+.. .++.||+|++... ....+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 4678999987542 23468899999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|||||++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998753 68999999999999999999999 59999999999999999999999999999875
Q ss_pred cCC-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 388 TGS-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 388 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
... .......||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+... ..
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~-~~--------- 243 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMILKA-KL--------- 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC---------
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHHHcC-CC---------
Confidence 433 234456799999999999999999999999999999999999999975432 2333333221 10
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
..+...+.++.+++.+||+.+| +|||+
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122334678999999999999 99984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=400.01 Aligned_cols=244 Identities=20% Similarity=0.324 Sum_probs=186.4
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC--------
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH-------- 303 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-------- 303 (530)
++|+.++.||+|+||+||+|+. .+++.||||++... ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999995 56899999987532 2357899999999999999999999987544
Q ss_pred ----ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 304 ----QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 304 ----~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
..|+|||||++|+|.+++...... ....+..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999865321 245677789999999999999999 699999999999999999999999
Q ss_pred ecCCcccccCCCC-------------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 009644 380 DYGLLKLVTGSHH-------------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446 (530)
Q Consensus 380 DFGla~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 446 (530)
|||+|+.+..... .....||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 9999987654321 123459999999999999999999999999999999997 665221 1111
Q ss_pred HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 447 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+..... .. .+.........+.+++.+||+.+| +|||+.|+++
T Consensus 236 ~~~~~~~-~~--------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVRN-LK--------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHT-TC--------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhc-CC--------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 11 111222334566789999999999 9999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=401.02 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=200.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee------cC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE------NH 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~------~~ 303 (530)
.++|++++.||+|+||+||+|+. .+|+.||||++... ..+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999995 56899999997642 24568899999999999999999999764 35
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..|||||||+ |+|.+++.... .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 78999997643 79999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCC-----CCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 384 LKLVTGS-----HHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 384 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
|+.+... .......||+.|||||++.+. .|+.++||||+||++|||++|++||...........+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876432 123455799999999998765 5699999999999999999999999866443333333322211110
Q ss_pred Cc------------------cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GK------------------YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~------------------~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. .....+..........+.+|+.+||..|| +|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000001112234678899999999999 9999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=387.57 Aligned_cols=201 Identities=20% Similarity=0.309 Sum_probs=172.8
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc-cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCc
Q 009644 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT-QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 231 el~~~t~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~ 304 (530)
.+....+.|++.+.||+|+||+||+|+.+ .++.||+|++... ...++.+|+++|+.+ +|||||++++++.+++.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34456788999999999999999999853 4678999987644 456788999999998 69999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGL 383 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGl 383 (530)
.++||||+++|+|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999984 58899999999999999999999 599999999999999877 7999999999
Q ss_pred cccccCCC-----------------------------CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCC
Q 009644 384 LKLVTGSH-----------------------------HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGR 433 (530)
Q Consensus 384 a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~ 433 (530)
|+...... ......||+.|+|||++.+. .|+.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 98653321 11234599999999998775 5899999999999999999999
Q ss_pred CCCCCCCC
Q 009644 434 EAHGRNHS 441 (530)
Q Consensus 434 ~p~~~~~~ 441 (530)
.||....+
T Consensus 245 ~Pf~~~~~ 252 (361)
T 4f9c_A 245 YPFYKASD 252 (361)
T ss_dssp SSSSCCSS
T ss_pred CCCCCCCC
Confidence 99975543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=409.79 Aligned_cols=248 Identities=19% Similarity=0.343 Sum_probs=208.5
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|++.+.||+|+||.||+|+. .+|+.||+|.+.... .+.+.+|+++|+.++|||||++++++.+++.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999995 568999999876432 45688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC--CeEEEeecCCcccccC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN--YTAKVSDYGLLKLVTG 389 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~--~~~KI~DFGla~~~~~ 389 (530)
|++|+|.++|.... +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999997543 269999999999999999999999 599999999999999854 8999999999998876
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
........||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.... . . ++. ...
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~~-~-~-~~~---~~~ 380 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCD-W-N-MDD---SAF 380 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTC-C-C-CCS---GGG
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhCC-C-C-CCc---ccc
Confidence 5555566799999999999999999999999999999999999999976532 23333332211 0 0 010 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+..+.+++.+||+.|| +|||+.|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2344678899999999999 9999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=376.47 Aligned_cols=281 Identities=34% Similarity=0.556 Sum_probs=230.2
Q ss_pred ccccccCHHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccH----HHHHHHHHHHHhcCCCCcceEEE
Q 009644 222 QNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI----QNFLHEVKHIARVHHRHLVKLVG 297 (530)
Q Consensus 222 ~~~~~~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~----~~~~~E~~il~~l~H~nIv~l~g 297 (530)
.....+++.++...+++|+..+.||+|+||.||+|...+++.||+|++..... ..+.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34578899999999999999999999999999999988899999999765432 36899999999999999999999
Q ss_pred EEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcCCCeE
Q 009644 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-VPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 298 ~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~ivHrDLk~~NILl~~~~~~ 376 (530)
++...+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. .++|+||||||+|||+++++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 999999999999999999999999875432 23599999999999999999999992 2299999999999999999999
Q ss_pred EEeecCCcccccCCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-----CCCCchHHHHH
Q 009644 377 KVSDYGLLKLVTGSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGR-----NHSNSDQNLIL 449 (530)
Q Consensus 377 KI~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~-----~~~~~~~~~~~ 449 (530)
||+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||+||+.||.. ...........
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999987643322 2334489999999999888899999999999999999999999952 11111111111
Q ss_pred HHHhhccCCccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 450 QVKRSCDLGKYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
............+..+.. ........+.+++.+||+.+| +|||++||++.|++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 111222334444544444 667778899999999999999 999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=376.22 Aligned_cols=276 Identities=35% Similarity=0.606 Sum_probs=229.4
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 228 TILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 228 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
++.++...+++|+..+.||+|+||.||+|..++++.||+|+.... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 334455678899999999999999999999888999999987643 35679999999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+++|+|.+++..... +...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999976432 22368999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH---HHhhccCC
Q 009644 385 KLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ---VKRSCDLG 458 (530)
Q Consensus 385 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~---~~~~~~~~ 458 (530)
+....... .....+|..|+|||++.+..++.++||||||+++|||+||+.||.............+ ......+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 86543221 2234478999999999888999999999999999999999999976554333222222 22223445
Q ss_pred ccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 459 KYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 459 ~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+++.+.. ........+.+++.+||+.+| +|||+.||++.|+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 555655544 567788899999999999999 999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=404.85 Aligned_cols=244 Identities=20% Similarity=0.295 Sum_probs=200.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHH---HHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHE---VKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E---~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
++|++.+.||+|+||.||+|+. .+|+.||+|++.+.. ...+.+| +.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6799999999999999999995 468999999986432 2233444 56667779999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
||||||++|+|.++|.... .+++..+..++.||+.||+|||+ .+||||||||+||||+.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999998753 79999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
+.... ..+.+||+.|||||++.. ..|+.++||||+||+||||++|++||..........+....... ..
T Consensus 342 ~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~-------- 411 (689)
T 3v5w_A 342 FSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AV-------- 411 (689)
T ss_dssp CSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CC--------
T ss_pred cCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CC--------
Confidence 65433 345689999999999974 57999999999999999999999999765443333332222221 11
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
..+...+.++.+++.+|++.+| +|++ ++||.+
T Consensus 412 -~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1222344678999999999999 9998 677764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=358.10 Aligned_cols=277 Identities=31% Similarity=0.566 Sum_probs=228.2
Q ss_pred cccccCHHHHHHhhcCCccc------eeeccCCcEEEEEEEEcCCCEEEEEEcccc-------cHHHHHHHHHHHHhcCC
Q 009644 223 NLKQLTILELKHATNNFSEI------NIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-------QIQNFLHEVKHIARVHH 289 (530)
Q Consensus 223 ~~~~~~~~el~~~t~~f~~~------~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~H 289 (530)
....|++.++..++++|... +.||+|+||.||+|.. +++.||+|++... ..+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35688999999999999877 8999999999999987 5789999986532 24678999999999999
Q ss_pred CCcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 009644 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVL 369 (530)
Q Consensus 290 ~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NIL 369 (530)
|||+++++++.+.+..++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEE
Confidence 99999999999999999999999999999999754321 268999999999999999999999 59999999999999
Q ss_pred EcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH-
Q 009644 370 LEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ- 445 (530)
Q Consensus 370 l~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~- 445 (530)
+++++.+||+|||+++....... .....++..|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999987643221 223458899999998754 5899999999999999999999999865443322
Q ss_pred HHHHHHHh-hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 446 NLILQVKR-SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 446 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
........ ...+...+++.+..........+.+++.+||+.+| +|||+.+|++.|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22222221 11233445555555667778899999999999999 99999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=362.40 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=211.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|...+.||+|+||.||+|.. .++..||+|.+.. ...+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788889999999999999996 4588999998754 3356799999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999998743 268999999999999999999999 599999999999999999999999999998764332
Q ss_pred Cc---------------CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH--HHHHHHhh
Q 009644 392 HA---------------GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN--LILQVKRS 454 (530)
Q Consensus 392 ~~---------------~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~--~~~~~~~~ 454 (530)
.. ....||+.|+|||++.+..++.++||||||+++|||++|..|+.......... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-- 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-- 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--
Confidence 21 13458899999999999999999999999999999999999987543321110 000000
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCC
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRL 511 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~ 511 (530)
+.. .+...+..+.+++.+||+.+| +|||+.++++.|+++.....+..
T Consensus 241 -------~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 241 -------DRY---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp -------HHT---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred -------ccc---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 000 122333578899999999999 99999999999999987655433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=373.01 Aligned_cols=258 Identities=22% Similarity=0.407 Sum_probs=212.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|...+.||+|+||.||+|... ++..||+|.+... ..+.+.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999852 3457999997643 346789999999999 899999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
+..++||||+++|+|.+++..... .+...+++.+++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEC
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEEEC
Confidence 999999999999999999986532 122358999999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
.++.+||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999987654322 223346778999999999999999999999999999999 999997654322 2
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
......... ...+......+.+++.+||+.+| +|||+.|+++.|++++...
T Consensus 315 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 FKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 222222111 01223345688999999999999 9999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=357.49 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=206.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHh--cCCCCcceEEEEEeec----CceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIAR--VHHRHLVKLVGFCEEN----HQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~H~nIv~l~g~~~~~----~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|+. +++.||+|++.......+..|.+++.. ++||||+++++++... ...++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 56899999999999999999998 688999999988878888888888887 7999999999997543 4589999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH--------SLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
||+++|+|.+++... .+++..+..++.|++.||+||| + ++|+||||||+|||++.++.+||+||
T Consensus 86 e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999643 6899999999999999999999 6 69999999999999999999999999
Q ss_pred CCcccccCCCC-----cCcccccccccCccccCCC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCCC
Q 009644 382 GLLKLVTGSHH-----AGSTSAVDCFLDPELNLSK------NYSAGSDVYSFGVFLLELISG----------REAHGRNH 440 (530)
Q Consensus 382 Gla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~ElltG----------~~p~~~~~ 440 (530)
|+++....... .....+|+.|+|||++.+. .++.++||||||+++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 99987644322 1233689999999999876 455799999999999999999 88886543
Q ss_pred CCch-HHHHHHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 441 SNSD-QNLILQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 441 ~~~~-~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.... ............ ..+.+.. ........+.+++.+||+.+| +|||+.+|++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3221 122222111111 1111111 334567889999999999999 999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=361.81 Aligned_cols=259 Identities=26% Similarity=0.433 Sum_probs=203.5
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
...++|++.+.||+|+||.||+|+. +++.||+|++... ..+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999987 5788999987543 245789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP--LFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~--ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~--~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR--NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTS--SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcC--CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999986421 11389999999999999999999994 6 99999999999999999999999999986
Q ss_pred ccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 387 VTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 387 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
...... .....||..|+|||++.+..++.++||||||+++|||+||+.||..... ..............
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~~------- 258 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKRL------- 258 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCCC-------
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC-------
Confidence 543322 2345689999999999999999999999999999999999999975432 22222222111110
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+......+.+++.+||+.+| +|||+.+|++.|+.+.+...
T Consensus 259 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 259 -EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred -CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1223344678999999999999 99999999999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=364.51 Aligned_cols=263 Identities=20% Similarity=0.274 Sum_probs=206.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccH--HHHHHHHHHHHhcCCCCcceEEEEEeecC----ceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI--QNFLHEVKHIARVHHRHLVKLVGFCEENH----QQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~H~nIv~l~g~~~~~~----~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|+.. ++.||||++..... ..+..|+.++++++||||+++++++.... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 468899999999999999999875 78999999875543 34567888899999999999999998754 369999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL--------VPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
||+++|+|.+++... .+++..+..++.|++.||+|||+. .++|+||||||+|||++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999763 589999999999999999999982 129999999999999999999999999
Q ss_pred CCcccccCCCC---cCcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH---
Q 009644 382 GLLKLVTGSHH---AGSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ--- 450 (530)
Q Consensus 382 Gla~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~--- 450 (530)
|+++....... .....+|..|+|||++.+ ..++.++|||||||++|||+||+.||..............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654332 223458999999999876 3556789999999999999999999976433211111000
Q ss_pred ------HHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 451 ------VKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 451 ------~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.... .......+.+.. ........+.+++.+||+.+| +|||+.||++.|+++.+.
T Consensus 256 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEV-VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHH-HTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhh-hhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 011111222222 223456779999999999999 999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=365.19 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=206.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999995 67899999987543 3456889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999997653 68999999999999999999999 5999999999999999999999999999987765
Q ss_pred CCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
........||+.|+|||++.+..++ .++|||||||++|||++|+.||..... ......+... .. ..
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~-~~---------~~ 233 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVLRG-KY---------RI 233 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC---------CC
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CC---------CC
Confidence 5555566799999999999888775 799999999999999999999976532 2222222221 00 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+...+..+.+++.+|+..+| +|||++|+++
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22234678899999999999 9999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=377.47 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=209.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|...+.||+|+||.||+|... +++.||+|.+... ..+.|.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999975 6889999987643 23468899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999998653 268999999999999999999999 59999999999999999999999999999865433
Q ss_pred CCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 HHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
... ....++..|+|||.+....++.++|||||||++|||+| |..||..... ......+......
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~--------- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGRL--------- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCCC---------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---------
Confidence 211 12235677999999988899999999999999999999 9999975432 2222222222111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +|||+++|++.|+++.+.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1122344678999999999999 999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=364.93 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=208.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|++.+.||+|+||.||+|... .+..||||.+... ..+.|.+|++++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999964 3456999987643 34579999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999997643 268999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 388 TGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 388 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
..... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~----- 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRL----- 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC-----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCC-----
Confidence 54321 122335678999999988899999999999999999999 9999975432 2333333322111
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +|||+.+|++.|+++...
T Consensus 274 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 ----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1223345688999999999999 999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=353.22 Aligned_cols=253 Identities=24% Similarity=0.426 Sum_probs=212.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...+++.||+|++... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 3578889999999999999999888899999997754 35779999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC--
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-- 391 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-- 391 (530)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999997643 268999999999999999999999 599999999999999999999999999998664332
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......++..|+|||.+....++.++||||||+++|||++ |+.||..... ............ . ..+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~---~------~~~~ 230 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFR---L------YKPR 230 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCC---C------CCCT
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCcc---C------CCCC
Confidence 1233446778999999998999999999999999999999 9999975432 233333322211 0 1112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.....+.+++.+|++.+| +|||+.++++.|+++.+.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 234678999999999999 999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=355.18 Aligned_cols=245 Identities=16% Similarity=0.352 Sum_probs=204.7
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|+..+.||+|+||.||+|. ..+++.||+|++.. ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4679999999999999999999 46789999998653 2356789999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999764 58999999999999999999999 599999999999999999999999999998765433
Q ss_pred C-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 H-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
. .....||+.|+|||++.+..++.++||||||+++|||+||+.||...... ........... ... ..+.
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~-~~~------~~~~ 240 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGT-PEL------QNPE 240 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHHCS-CCC------SCGG
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCC-CCC------CCcc
Confidence 2 33456899999999999999999999999999999999999999754321 22222211111 000 1123
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+.+++.+||+.+| +|||++|+++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 345678999999999999 9999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=352.29 Aligned_cols=270 Identities=16% Similarity=0.229 Sum_probs=219.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|+.++.++ +|+|++++++++.++...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 46799999999999999999994 67889999987643 345688999999999 8999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe-----EEEeecCCcccc
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT-----AKVSDYGLLKLV 387 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~-----~KI~DFGla~~~ 387 (530)
+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 89 -GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999998653 268999999999999999999999 59999999999999987765 999999999876
Q ss_pred cCCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 388 TGSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 388 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
..... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||....................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 238 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--- 238 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH---
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc---
Confidence 54322 2344588999999999999999999999999999999999999987654443333333322110
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCccccc
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGE 517 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~e 517 (530)
...........+..+.+++.+||+.+| +|||+++|++.|+++.+.........++.
T Consensus 239 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 239 --STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp --HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred --CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 000111122345688999999999999 99999999999999988765555555443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=354.15 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=210.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...++..||+|++... ..+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 5678899999999999999999988889999998754 45789999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 103 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999998643 268999999999999999999999 5999999999999999999999999999987643321
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....+|..|+|||.+.+..++.++||||||+++|||+| |+.||..... ............ . ..+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~--~-------~~~~ 244 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLR--L-------YRPH 244 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCC--C-------CCCT
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccC--C-------CCCC
Confidence 223346778999999998899999999999999999999 9999975432 222222222211 0 0112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.....+.+++.+||+.+| +|||+.++++.|+++.+.+
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 224678999999999999 9999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=351.79 Aligned_cols=254 Identities=23% Similarity=0.417 Sum_probs=211.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...++..||+|.+... ..+++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 4678899999999999999999988889999997654 35779999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998753 258999999999999999999999 5999999999999999999999999999987654322
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ............ .. .+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---~~------~~~ 228 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHR---LY------RPH 228 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCC---CC------CCT
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCC---CC------CCC
Confidence 223345677999999988889999999999999999999 9999975432 222222222211 00 111
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
..+..+.+++.+||+.+| +|||+.++++.|+++.+.+
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 224578999999999999 9999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=371.34 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=199.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+|+.. ++..||+|.+... ..++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 5678999987643 34679999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999998643 268999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCCc----CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 388 TGSHHA----GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 388 ~~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~----- 269 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRL----- 269 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEEC-----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC-----
Confidence 543211 12234668999999999999999999999999999998 9999975432 2233332222111
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +|||+.+|++.|+++...
T Consensus 270 ----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 ----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1122345688999999999999 999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.14 Aligned_cols=273 Identities=14% Similarity=0.149 Sum_probs=211.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccccH--------------HHHHHHHHHHHhcCCCCcceE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQTQI--------------QNFLHEVKHIARVHHRHLVKL 295 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~~~--------------~~~~~E~~il~~l~H~nIv~l 295 (530)
.++|++.+.||+|+||.||+|...+ ++.||+|....... ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 5689999999999999999999754 36899998654321 124456666777889999999
Q ss_pred EEEEeec----CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 296 VGFCEEN----HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 296 ~g~~~~~----~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
++++... ...++||||+ +|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEEe
Confidence 9998765 4589999999 999999998643 269999999999999999999999 5999999999999999
Q ss_pred --CCCeEEEeecCCcccccCCCCc--------CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 009644 372 --ENYTAKVSDYGLLKLVTGSHHA--------GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHS 441 (530)
Q Consensus 372 --~~~~~KI~DFGla~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 441 (530)
.++.+||+|||+++.+...... ....||..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876433211 223489999999999999999999999999999999999999985433
Q ss_pred CchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCccccc
Q 009644 442 NSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGE 517 (530)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~e 517 (530)
...............+..++++.+. ....+..+.+++..||..+| +||++.+|++.|++++..........++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 3222111111111222233332221 12334688999999999999 99999999999999998765555555543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=375.29 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=209.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-ceeEEeecc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEENH-QQLLIYDYI 312 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~-~~~LV~Ey~ 312 (530)
..++|+..+.||+|+||.||+|... ++.||||.+... ..+.|.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3467888999999999999999985 779999988754 4578999999999999999999999987665 789999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp TTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999987532 247899999999999999999999 59999999999999999999999999999864332
Q ss_pred cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+. ...+...... ..+..
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~~~~---------~~p~~ 410 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYKM---------DAPDG 410 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHHTTCCC---------CCCTT
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCC---------CCCCc
Confidence 222356788999999999999999999999999999999 9999986654332 2222222111 12234
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.+..+.+++.+||+.+| +|||+.+|++.|+.+...+
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 45788999999999999 9999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=359.00 Aligned_cols=269 Identities=14% Similarity=0.165 Sum_probs=217.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|+++++++ +||||+++++++..++..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 46789999999999999999995 57889999987643 345688999999999 9999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe-----EEEeecCCcccc
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT-----AKVSDYGLLKLV 387 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~-----~KI~DFGla~~~ 387 (530)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 88 -~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 88 -GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred -CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999998643 279999999999999999999999 59999999999999998887 999999999876
Q ss_pred cCCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 388 TGSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 388 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..............+...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-T 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-S
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-C
Confidence 44322 13456899999999999999999999999999999999999999876554444433333221100 0
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCccccc
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGE 517 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~e 517 (530)
.........+ .+.+++..||+.+| +||++++|++.|+++.+.........++.
T Consensus 240 ----~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 240 ----PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp ----CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred ----CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 0000111123 89999999999999 99999999999999887654444434433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=363.32 Aligned_cols=268 Identities=22% Similarity=0.360 Sum_probs=214.6
Q ss_pred cCHHHHHHhhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceE
Q 009644 227 LTILELKHATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKL 295 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l 295 (530)
+...+++...++|+..+.||+|+||.||+|.+. +++.||||++... ..+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445566667889999999999999999999842 3578999998653 235689999999999 89999999
Q ss_pred EEEEeecC-ceeEEeeccCCCChHHHhhccCCCC----------------------------------------------
Q 009644 296 VGFCEENH-QQLLIYDYIPNGNVQNHLYDSEGLP---------------------------------------------- 328 (530)
Q Consensus 296 ~g~~~~~~-~~~LV~Ey~~~GsL~~~l~~~~~~~---------------------------------------------- 328 (530)
++++.+.+ ..++||||+++|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998754 4899999999999999998653210
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 329 ---------------IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 329 ---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1128999999999999999999999 5999999999999999999999999999986643321
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.||....... ............ ..+
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~---------~~~ 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRM---------RAP 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCC---------CCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCC---------CCC
Confidence 233457888999999999999999999999999999999 999997654332 222222221110 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
......+.+++.+||+.+| +|||+.||++.|+++++..
T Consensus 319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 2234678999999999999 9999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.78 Aligned_cols=255 Identities=20% Similarity=0.394 Sum_probs=212.0
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
...++|+..+.||+|+||.||+|..+++..||||.+... ..+.|.+|++++++++||||+++++++. .+..++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345778899999999999999999988889999987753 4678999999999999999999999987 5678999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999985432 257899999999999999999999 599999999999999999999999999998764322
Q ss_pred C--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 392 H--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
. .....++..|+|||++....++.++|||||||++|||+| |+.||..... ......+...... ..
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~---------~~ 406 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRM---------PR 406 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCC---------CC
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---------CC
Confidence 1 123345678999999998999999999999999999999 9999975432 2333333322111 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
+...+..+.+++.+||+.+| +|||+++|++.|+++...
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 23345688999999999999 999999999999998643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.15 Aligned_cols=268 Identities=20% Similarity=0.327 Sum_probs=211.4
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc--CCCCcceEEEEEeec----
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV--HHRHLVKLVGFCEEN---- 302 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l--~H~nIv~l~g~~~~~---- 302 (530)
........++|+..+.||+|+||.||+|+.. ++.||+|++.......+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3344455678999999999999999999985 889999998877777777888877765 899999999999877
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCeE
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL------VPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~ivHrDLk~~NILl~~~~~~ 376 (530)
...++||||+++|+|.+++... .+++.++..++.|++.||+|||+. .++|+||||||+|||++.++.+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6789999999999999999753 689999999999999999999983 1299999999999999999999
Q ss_pred EEeecCCcccccCCCCc-----CcccccccccCccccCCCCCCch------hhHHHHHHHHHHHHcC----------CCC
Q 009644 377 KVSDYGLLKLVTGSHHA-----GSTSAVDCFLDPELNLSKNYSAG------SDVYSFGVFLLELISG----------REA 435 (530)
Q Consensus 377 KI~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~s~k------sDVwSfGvvl~ElltG----------~~p 435 (530)
||+|||+++........ ....||..|+|||++.+..++.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999766433221 23468999999999987766654 9999999999999999 666
Q ss_pred CCCCCCCch-HHHHHHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 436 HGRNHSNSD-QNLILQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 436 ~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
|........ ............ ..+.... ........+.+++.+||+.+| +|||+.+|++.|+++.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCchhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 654332221 111111111111 1122211 233667889999999999999 9999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=352.77 Aligned_cols=256 Identities=16% Similarity=0.270 Sum_probs=211.0
Q ss_pred cccCHHHHHHhhcC----------CccceeeccCCcEEEEEEEEc-CCCEEEEEEccc---ccHHHHHHHHHHHHhcCCC
Q 009644 225 KQLTILELKHATNN----------FSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHR 290 (530)
Q Consensus 225 ~~~~~~el~~~t~~----------f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~ 290 (530)
..+++.+++.+++. |+..+.||+|+||.||+|+.. +|+.||||++.. ...+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888877764 677789999999999999965 789999998753 2356789999999999999
Q ss_pred CcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 291 nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
||+++++++...+..++||||+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 68999999999999999999999 599999999999999
Q ss_pred cCCCeEEEeecCCcccccCCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH
Q 009644 371 EENYTAKVSDYGLLKLVTGSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLIL 449 (530)
Q Consensus 371 ~~~~~~KI~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~ 449 (530)
+.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~ 251 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMK 251 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence 999999999999998765432 23445689999999999999999999999999999999999999975432 22222
Q ss_pred HHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...... .+.+ .........+.+++.+||+.+| +|||+.|+++
T Consensus 252 ~~~~~~------~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRDSP------PPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHSS------CCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCC------CCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222211 1111 1122334678999999999999 9999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.18 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=212.9
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEe
Q 009644 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCE 300 (530)
Q Consensus 231 el~~~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~ 300 (530)
.+....++|+..+.||+|+||.||+|+.. +++.||+|.+.... .+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445688999999999999999999964 34789999976532 457899999999999999999999999
Q ss_pred ecCceeEEeeccCCCChHHHhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009644 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLP-------------------IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHM 361 (530)
Q Consensus 301 ~~~~~~LV~Ey~~~GsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHr 361 (530)
+++..++||||+++|+|.+++....... ...+++.+++.++.|++.||+|||+ .+|+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 9999999999999999999998642110 1368999999999999999999999 599999
Q ss_pred CCCCCcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 009644 362 HFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHG 437 (530)
Q Consensus 362 DLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~ 437 (530)
||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643321 223457888999999988899999999999999999999 999997
Q ss_pred CCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 438 RNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.... ......+... .. ...+...+..+.+++.+||+.+| +|||+.+|++.|+++.+..
T Consensus 279 ~~~~---~~~~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMAH---EEVIYYVRDG-NI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSCH---HHHHHHHHTT-CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCh---HHHHHHHhCC-Cc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 5432 2233332221 11 11222344688999999999999 9999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=359.46 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=202.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCE----EEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSL----VVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~----vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|+..+.||+|+||.||+|+.. +++. ||+|.+.. ...+.|.+|+.++++++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357889999999999999999953 3443 57887643 23467999999999999999999999998764 78
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999998754 268999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 387 VTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 387 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
....... ....+|..|+|||++.+..++.++|||||||++|||+| |+.||......... .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~~~~----- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL----- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC-----
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHcCCCC-----
Confidence 6543322 22335778999999999999999999999999999999 99999765433322 222211110
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+......+.+++.+||+.+| +|||+.+|++.|+++...
T Consensus 239 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1222344678999999999999 999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=349.96 Aligned_cols=260 Identities=23% Similarity=0.415 Sum_probs=203.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-----cCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeec--Cce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 305 (530)
.++|+..+.||+|+||.||+|++ .+++.||+|++.... .+.|.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999985 357899999876543 35789999999999999999999998653 568
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999987532 58999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------chHHHHHHHH
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN---------SDQNLILQVK 452 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~---------~~~~~~~~~~ 452 (530)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7654321 12234667799999999999999999999999999999999988642110 0000000110
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
... ........+...+..+.+++.+||+.+| +|||+.|+++.|+++.+.
T Consensus 243 ~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELL-----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHH-----HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHH-----hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000 0000011233445789999999999999 999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=358.59 Aligned_cols=243 Identities=18% Similarity=0.285 Sum_probs=204.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+++.. +++.||+|.+.+. ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999964 6899999987643 346789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999998643
Q ss_pred C-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 G-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .. .
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~-~~---------~ 223 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILME-EI---------R 223 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC---------C
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHHHcC-CC---------C
Confidence 2 2233456689999999999999999999999999999999999999975432 2222222221 10 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.+......+.+++.+||+.+| +|| +++||++
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 122334678999999999999 999 8999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=363.43 Aligned_cols=247 Identities=17% Similarity=0.256 Sum_probs=206.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.+.|++.+.||+|+||.||++... +|+.||+|.+... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 567999999999999999999964 6889999987643 246789999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----eEEEeec
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY----TAKVSDY 381 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~----~~KI~DF 381 (530)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999754 268999999999999999999999 5999999999999998877 7999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
|+++............||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+... .. . .
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~-~~-~-~ 237 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITAV-SY-D-F 237 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTT-CC-C-C
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CC-C-C
Confidence 999887665445566799999999999999999999999999999999999999976432 2222222221 00 0 0
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
++ .........+.+++.+|+..+| +|||+.|+++
T Consensus 238 ~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 1122334678999999999999 9999999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=364.08 Aligned_cols=260 Identities=22% Similarity=0.392 Sum_probs=213.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|.+.+.||+|+||.||+|... ++..||+|++... ..+.+.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467889999999999999999852 2357999987643 236789999999999 999999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
+..++||||+++|+|.+++...... +...+++.+++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEEEc
Confidence 9999999999999999999865321 12358999999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
+++.+||+|||+++....... .....+|..|+|||++.+..++.++|||||||++|||+| |..||..... ...
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~~ 302 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL 302 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999987644321 233446788999999999999999999999999999999 9999975432 233
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
...+...... ..+......+.+++.+||+.+| +|||+.||++.|+++......
T Consensus 303 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 303 FKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 3333222111 1122344688999999999999 999999999999999877544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=349.79 Aligned_cols=264 Identities=17% Similarity=0.304 Sum_probs=212.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC--ceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH--QQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~--~~~LV 308 (530)
.++|.+.+.||+|+||.||+|... +++.||+|++... ..+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357889999999999999999965 4889999997643 3567889999999999999999999997765 77999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCeEEEeecCCc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL----EENYTAKVSDYGLL 384 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl----~~~~~~KI~DFGla 384 (530)
|||+++|+|.+++...... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999865321 248999999999999999999999 599999999999999 78889999999999
Q ss_pred ccccCCCCcCcccccccccCccccC--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc-hHHHHHHHHhhc
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNL--------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS-DQNLILQVKRSC 455 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~-~~~~~~~~~~~~ 455 (530)
+............+|..|+|||++. +..++.++|||||||++|||+||+.||....... ............
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 9876655555667899999999875 5788999999999999999999999997544322 223333332221
Q ss_pred cCC---cc---c------c---ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 456 DLG---KY---V------D---KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 456 ~~~---~~---~------d---~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
... .. . . +............+.+++.+||+.+| +|||++|+++...+-
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 100 00 0 0 00012345667788999999999999 999999999987764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=349.12 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=198.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+|.... +..||+|..... ..+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678899999999999999999643 456999986642 3457899999999999999999999985 457889
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998653 268999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 388 TGSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 388 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
..... .....+++.|+|||.+....++.++||||||+++|||++ |..||....... ....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~~~~~-------- 235 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGER-------- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCC--------
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHHcCCC--------
Confidence 54322 122345678999999988899999999999999999997 999997654332 2222222111
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
...+...+..+.+++.+|++.+| +|||+.++++.|+++.+.+.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 236 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 01223345688999999999999 99999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=356.53 Aligned_cols=247 Identities=17% Similarity=0.271 Sum_probs=205.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.+.|...+.||+|+||.||++... ++..||+|.+... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999964 6889999986542 256799999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----eEEEeec
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY----TAKVSDY 381 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~----~~KI~DF 381 (530)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999754 268999999999999999999999 5999999999999999887 8999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
|+++............+|+.|+|||++....++.++|||||||++|||++|+.||..... .......... .. ...
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~-~~-~~~ 237 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAV-NY-EFE 237 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHT-CC-CCC
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHhc-CC-CcC
Confidence 999887654444556789999999999999999999999999999999999999975432 2222222211 00 000
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ ......+..+.+++.+||+.+| +|||+.|+++
T Consensus 238 ~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 D----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1122334678899999999999 9999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=358.73 Aligned_cols=248 Identities=17% Similarity=0.252 Sum_probs=206.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|...+.||+|+||.||+|... ++..+|+|.+... ....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 578999999999999999999954 5788999987643 3456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCeEEEeecCCcccccCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE--NYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~--~~~~KI~DFGla~~~~~~ 390 (530)
++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999997543 268999999999999999999999 59999999999999997 789999999999887655
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.......+|+.|+|||++.+..++.++||||||+++|||++|..||..... ......+..... . .+. ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~--~-~~~---~~~~ 228 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEY--T-FDE---EAFK 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCC--C-CCH---HHHT
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcCCC--C-CCh---hhhc
Confidence 444455689999999999988899999999999999999999999976432 233333322210 0 000 0112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+..+.+++.+|+..+| +|||+.|+++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 334678999999999999 9999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=352.21 Aligned_cols=258 Identities=16% Similarity=0.334 Sum_probs=207.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|.. .++..||+|.+.. ...+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999995 4688999998632 2246789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 389 GSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 389 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ......... . ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~-~----~~~~~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---SIAIKHIQD-S----VPNVTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---HHHHHHHSS-C----CCCHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhc-c----CCCcch
Confidence 4322 22345899999999999999999999999999999999999999754321 111111111 0 111101
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCC-CHHHHHHHHHhhHHHhh
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRP-SMRQIAGELEGIQEREI 508 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RP-t~~eVl~~L~~i~~~~~ 508 (530)
......+..+.+++.+|++.+| +|| +++++.+.|++++....
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1223345688999999999999 998 99999999999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=380.61 Aligned_cols=254 Identities=23% Similarity=0.414 Sum_probs=212.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..++|+..+.||+|+||.||+|.... +..||||.+... ..++|.+|+++|++++||||++++++|......++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 35678888999999999999999765 788999998654 467899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++..... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999986432 368999999999999999999999 599999999999999999999999999998765432
Q ss_pred C--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 392 H--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
. .....++..|+|||++....++.++|||||||++|||+| |..||....... ....+...... ..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~---------~~ 440 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDYRM---------ER 440 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCCC---------CC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCC---------CC
Confidence 2 123345678999999998899999999999999999999 999997654332 22222221111 12
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+...+..+.+++.+||+.+| +|||+.+|++.|+.+..
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 23445788999999999999 99999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=350.97 Aligned_cols=269 Identities=19% Similarity=0.324 Sum_probs=217.0
Q ss_pred cCHHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHh--cCCCCcceEEEEEeecC-
Q 009644 227 LTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIAR--VHHRHLVKLVGFCEENH- 303 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~H~nIv~l~g~~~~~~- 303 (530)
.+........++|...+.||+|+||.||+|.. +++.||+|.+.....+.+.+|.+++.. ++||||+++++++....
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33444455678899999999999999999998 588999999988888889999999988 79999999999998775
Q ss_pred ---ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCeeecCCCCCcEEEcC
Q 009644 304 ---QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH--------SLVPPLFHMHFRTSNVLLEE 372 (530)
Q Consensus 304 ---~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~ivHrDLk~~NILl~~ 372 (530)
..++||||+++|+|.+++... .+++.++..++.|++.||+||| + .+|+||||||+|||++.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEECC
Confidence 789999999999999999753 5899999999999999999999 6 69999999999999999
Q ss_pred CCeEEEeecCCcccccCCCC-----cCcccccccccCccccCCC------CCCchhhHHHHHHHHHHHHcC---------
Q 009644 373 NYTAKVSDYGLLKLVTGSHH-----AGSTSAVDCFLDPELNLSK------NYSAGSDVYSFGVFLLELISG--------- 432 (530)
Q Consensus 373 ~~~~KI~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSfGvvl~ElltG--------- 432 (530)
++.+||+|||+++....... .....+|..|+|||.+... .++.++||||||+++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 99999999999987654331 2344688999999998765 234789999999999999999
Q ss_pred -CCCCCCCCCCc-hHHHHHHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 433 -REAHGRNHSNS-DQNLILQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 433 -~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
+.||....... ........... ....+.+.. ........+.+++.+||+.+| +|||+.+|++.|+++.+.+
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCccccCcCcccHHHHHHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 77886543221 11111111111 112222222 234567789999999999999 9999999999999998764
Q ss_pred h
Q 009644 508 I 508 (530)
Q Consensus 508 ~ 508 (530)
.
T Consensus 339 ~ 339 (342)
T 1b6c_B 339 G 339 (342)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=350.01 Aligned_cols=256 Identities=18% Similarity=0.356 Sum_probs=203.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||+|+..+++.||+|++.... .+.+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999998889999999876432 3568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|++ |+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 997 58888887643 268999999999999999999999 59999999999999999999999999999876433
Q ss_pred C-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc--------
Q 009644 391 H-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY-------- 460 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 460 (530)
. ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...........+...........+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 2 2234457899999999876 56899999999999999999999999876554443333322211110000
Q ss_pred --------cc-ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 --------VD-KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 --------~d-~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+ ............++.+++.+|++.+| +|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00001122234678899999999999 9999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=364.91 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=209.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|+..+.||+|+||.||+|.+. ++..||||++... ...++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999953 3568999997532 345789999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEee
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGL--PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSD 380 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~D 380 (530)
++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999875421 12368999999999999999999999 5999999999999999544 599999
Q ss_pred cCCcccccCCC---CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 381 YGLLKLVTGSH---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 381 FGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
||+++...... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||..... ......+.....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~~~~~ 304 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTSGGR 304 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC
Confidence 99998653221 2233457889999999999999999999999999999998 9999975432 233333332211
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
. ..+...+..+.+++.+||+.+| +|||+.+|++.|+.+...
T Consensus 305 ~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 M---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 1122334678999999999999 999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=344.36 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=211.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...+++.||+|.+... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 3578888999999999999999888889999997754 45789999999999999999999999999999999999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC--
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-- 391 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-- 391 (530)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999998653 268999999999999999999999 599999999999999999999999999998764322
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ............. ..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~~~---------~~~~ 228 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL---------YKPR 228 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC---------CCCT
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCCcC---------CCCc
Confidence 1223446778999999988899999999999999999999 8999875432 2233333222110 0112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.....+.+++.+||+.+| +|||+.++++.|+++.+.
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 234678999999999999 999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=351.85 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=211.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
..++|...+.||+|+||.||+|.. .++..||+|.+... ..+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788999999999999999985 23478999997643 34678999999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGL-------------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRT 365 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~ 365 (530)
.++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+|+||||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dikp 178 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAA 178 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCCCSG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccccch
Confidence 99999999999999999865321 01248999999999999999999999 5999999999
Q ss_pred CcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 009644 366 SNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHS 441 (530)
Q Consensus 366 ~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~ 441 (530)
+|||+++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987644322 223346778999999988889999999999999999999 9999976543
Q ss_pred CchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 442 NSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.. .......... ...+...+..+.+++.+||+.+| +|||+.+|++.|+++...
T Consensus 259 ~~---~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER---LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG---HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH---HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32 2222222110 01223345688999999999999 999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=359.79 Aligned_cols=245 Identities=19% Similarity=0.332 Sum_probs=206.8
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||.||++... +++.||+|.+... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999954 5789999987543 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999998642 68999999999999999999999 5999999999999999999999999999998766
Q ss_pred CCCcCcccccccccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLS---KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||................... .
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------~ 237 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----------V 237 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----------C
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----------c
Confidence 555566779999999999864 458999999999999999999999998665544444433332211 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCC-HHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPS-MRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt-~~eVl~ 498 (530)
..+......+.+++.+||+.+| +||+ +++|.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1223344688999999999999 9998 666653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.28 Aligned_cols=272 Identities=16% Similarity=0.214 Sum_probs=212.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEE-eecCceeEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFC-EENHQQLLIYDY 311 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~-~~~~~~~LV~Ey 311 (530)
..++|+..+.||+|+||.||+|+. .+++.||+|..... ..+.+.+|++++.+++|+|++..++++ ..++..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 357899999999999999999995 67889999975433 334688999999999988877777766 566778999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCccccc
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~~~~ 388 (530)
+ +|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 999999998543 268999999999999999999999 599999999999999 789999999999998765
Q ss_pred CCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 389 GSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 389 ~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
.... .....+|..|+|||.+.+..++.++|||||||++|||++|+.||................... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~--- 235 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-M--- 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-H---
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-c---
Confidence 4322 124458899999999999999999999999999999999999998654432222222221110 0
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccccc
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEE 518 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ee 518 (530)
...........+..+.+++.+||+.+| +|||+++|++.|+++.+.........++.+
T Consensus 236 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 236 -STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp -HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred -cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 000000112234688999999999999 999999999999999988766665555544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=344.04 Aligned_cols=271 Identities=16% Similarity=0.213 Sum_probs=215.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEE-eecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFC-EENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~-~~~~~~~LV~Ey~ 312 (530)
.++|+..+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|+.++++++|++++..++++ ..+...++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 57899999999999999999995 67889999986543 345789999999999988877766665 5667789999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCcccccC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~~~~~ 389 (530)
+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 -~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 88 -GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999997543 268999999999999999999999 599999999999999 4889999999999987654
Q ss_pred CCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 390 SHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 390 ~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||................... .
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~ 235 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----M 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----H
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-----c
Confidence 322 234458899999999999999999999999999999999999998644322222222221110 0
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccccc
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEE 518 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ee 518 (530)
...........+..+.+++.+||+.+| +|||+++|++.|+++...........++.+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 000001112334678999999999999 999999999999999888766666555544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=347.20 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=212.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
..++|+..+.||+|+||.||+|.. .++..||+|.+... ..+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356889999999999999999985 34678999987643 246789999999999 9999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL-------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILL 178 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEE
Confidence 999999999999999999865321 11248999999999999999999999 599999999999999
Q ss_pred cCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHH
Q 009644 371 EENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQN 446 (530)
Q Consensus 371 ~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~ 446 (530)
+.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999987654332 223346778999999988999999999999999999999 999997654332 1
Q ss_pred HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 447 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
.......... . ..+...+..+.+++.+|++.+| +|||+.|+++.|+++.....
T Consensus 257 ~~~~~~~~~~--~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 FYKMIKEGFR--M-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHTCC--C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHhccCCC--C-------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 2222222111 0 0122334688999999999999 99999999999999887643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=374.09 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=206.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..++|...+.||+|+||.||+|...++..||||.+... ..++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35678889999999999999999988888999998753 35789999999999999999999999976 6789999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++....+ ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 261 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp TTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999975422 258999999999999999999999 5999999999999999999999999999987653321
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....++..|+|||.+....++.++||||||+++|||+| |+.||..... ......+...... ..+
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~---------~~~ 403 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM---------PCP 403 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC---------CCC
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---------CCC
Confidence 123346778999999998999999999999999999999 9999975432 2333333322111 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
...+..+.+++.+||+.+| +|||+++|++.|+++...
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 3445688999999999999 999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.96 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=194.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|... ++.||+|..... ..+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367888999999999999999975 788999986532 246789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---eeecCCCCCcEEEcC--------CCeEE
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP---LFHMHFRTSNVLLEE--------NYTAK 377 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~---ivHrDLk~~NILl~~--------~~~~K 377 (530)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. + |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~--~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDE--AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHS--SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC--CCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998642 689999999999999999999994 6 999999999999986 77899
Q ss_pred EeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
|+|||+++...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..
T Consensus 157 l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~~ 231 (271)
T 3dtc_A 157 ITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVAMN-KL 231 (271)
T ss_dssp ECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHTS-CC
T ss_pred EccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhhcC-CC
Confidence 99999998664432 2345688999999999989999999999999999999999999975432 1222222211 11
Q ss_pred CccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 458 ~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
. ...+...+..+.+++.+||+.+| +|||+.|+++.|+++
T Consensus 232 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A-------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 01223344688999999999999 999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.47 Aligned_cols=242 Identities=18% Similarity=0.279 Sum_probs=204.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+.... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36789999999999999999995 678899999876432 34688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+ +|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 88 ~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999997653 68999999999999999999999 599999999999999999999999999998876
Q ss_pred CCCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ ...+......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~~~ 226 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCVYV 226 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSCCC
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCCCC
Confidence 6555566679999999999988776 7899999999999999999999975432211 0111111111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+...+..+.+++.+|++.+| +|||++|+++
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 223345678999999999999 9999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=359.18 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=205.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
..++|+..+.||+|+||.||+|.. .++..||+|.+... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356799999999999999999995 46889999987542 346788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN---YTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~---~~~KI~DFGla~ 385 (530)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999997542 68999999999999999999999 599999999999999864 469999999998
Q ss_pred cccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... . ....
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~-~-~~~~--- 251 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGA-Y-DYPS--- 251 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-C-CCCT---
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCC-C-CCCc---
Confidence 77655444556799999999999999999999999999999999999999975432 23333332221 0 0001
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+.+++.+||+.+| +|||+.|+++
T Consensus 252 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 252 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122334678999999999999 9999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.93 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=196.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC-CC---EEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD-GS---LVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~---~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
..++|+..+.||+|+||.||+|.... +. .||+|.+... ..+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999543 32 7999987542 356799999999999999999999999877654
Q ss_pred ------eEEeeccCCCChHHHhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 306 ------LLIYDYIPNGNVQNHLYDSEGL-PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 306 ------~LV~Ey~~~GsL~~~l~~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCCCCEEE
Confidence 8999999999999999754321 11258999999999999999999999 59999999999999999999999
Q ss_pred eecCCcccccCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhh
Q 009644 379 SDYGLLKLVTGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 379 ~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
+|||+++........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ........
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~~ 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNYLIGG 255 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTT
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHHHhcC
Confidence 999999876443221 22346678999999999999999999999999999999 899997654332 22222221
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.. ...+...+..+.+++.+||+.+| +|||+.++++.|++++...
T Consensus 256 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 256 NR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 11223344688999999999999 9999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=345.39 Aligned_cols=255 Identities=18% Similarity=0.310 Sum_probs=198.8
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+..+.||+|+||.||+|...+++.||+|++... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 478899999999999999999888999999987532 236788999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++ +|.+++.... +.+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 974 9999987643 268999999999999999999999 599999999999999999999999999998764322
Q ss_pred -CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc--------cc
Q 009644 392 -HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK--------YV 461 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 461 (530)
......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+........... ..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 2233457899999999875 4589999999999999999999999976532222111111111100000 00
Q ss_pred cccc--------cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTL--------GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l--------~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
++.. ..........+.+++.+|++.+| +|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 11122345678899999999999 9999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=342.58 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=202.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc----------HHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ----------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.++|+..+.||+|+||.||+|+. .+++.||+|.+.... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788999999999999999996 578899999875321 167899999999999999999999987654
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCe-----EE
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP--LFHMHFRTSNVLLEENYT-----AK 377 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~--ivHrDLk~~NILl~~~~~-----~K 377 (530)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQ--NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTS--SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhC--CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 69999999999999987653 2689999999999999999999994 6 999999999999987776 99
Q ss_pred EeecCCcccccCCCCcCcccccccccCcccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELN--LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|+|||+++.... ......+|..|+|||.+ ....++.++||||||+++|||++|+.||........ .........
T Consensus 170 l~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~- 245 (287)
T 4f0f_A 170 VADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREE- 245 (287)
T ss_dssp ECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHHS-
T ss_pred eCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhcc-
Confidence 999999985433 23345688999999998 455678999999999999999999999976544322 222222221
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
... + ..+...+..+.+++.+||+.+| +|||++|+++.|+++
T Consensus 246 ~~~----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 GLR----P---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCC----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCC----C---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1 1222345688999999999999 999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.90 Aligned_cols=256 Identities=15% Similarity=0.259 Sum_probs=206.7
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccccH------HHHHHHHHHHHhcCCCCcceEEEEEee
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQI------QNFLHEVKHIARVHHRHLVKLVGFCEE 301 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~~------~~~~~E~~il~~l~H~nIv~l~g~~~~ 301 (530)
+.+++..+++|+..+.||+|+||.||+|+..+ ++.||+|++.+... +.+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44555667899999999999999999999654 78899998765322 248899999999999999999999999
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999998643 268999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCC--cCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 382 GLLKLVTGSHH--AGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 382 Gla~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
|+++....... .....||+.|+|||++. ...|+.++|||||||++|||++|+.||......+....+......
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 99987654332 23356999999999986 567999999999999999999999999865332222222111111
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-C--CCCHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-R--RPSMRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~--RPt~~eVl~ 498 (530)
.... .........+.+++.+|+..++ + ||+++|+++
T Consensus 300 ~~~p--------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 FQFP--------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCC--------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccCC--------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111 1112234678899999997776 5 899999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=352.78 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=208.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
..++|...+.||+|+||.||+|... ++..||+|.+... ..+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999952 3557999987643 346789999999999 9999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL------------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRT 365 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~ 365 (530)
..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+|+||||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp 200 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAA 200 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCSG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCh
Confidence 999999999999999999865321 01248999999999999999999999 5999999999
Q ss_pred CcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 009644 366 SNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHS 441 (530)
Q Consensus 366 ~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~ 441 (530)
+|||++.++.+||+|||+++....... .....+|..|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987643322 223346778999999988999999999999999999998 9999976543
Q ss_pred CchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 442 NSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
.. ............ ..+......+.+++.+||+.+| +|||+.+|++.|+.+.+....
T Consensus 281 ~~--~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 281 DA--NFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp SH--HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred HH--HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 32 222222221110 1122334688999999999999 999999999999998766443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.71 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=205.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|...+.||+|+||.||+|...+ +..||+|.+... ..+.|.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678889999999999999998543 235999987653 346789999999999999999999998754 5689
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998653 268999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 388 TGSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 388 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
..... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||........ ..........
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~~~~~~~------- 233 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVLEKGDRL------- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHHHHTCCC-------
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHHhcCCCC-------
Confidence 54322 223346778999999988899999999999999999998 9999976543332 2222221110
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+......+.+++.+||+.+| +|||+.|+++.|+++.+.+.
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 1112234678999999999999 99999999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=367.06 Aligned_cols=249 Identities=17% Similarity=0.284 Sum_probs=205.4
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeec
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEEN 302 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~ 302 (530)
.+++...++|+..+.||+|+||.||+|+.. +++.||+|++.+.. .+.+.+|..+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 445556789999999999999999999965 58899999876532 23588999999999999999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
...++||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999753 58999999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCC--CcCcccccccccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh--
Q 009644 383 LLKLVTGSH--HAGSTSAVDCFLDPELNLSKN----YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS-- 454 (530)
Q Consensus 383 la~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~-- 454 (530)
+++...... ......||+.|+|||++.... ++.++|||||||++|||++|+.||...... .....+...
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 290 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN 290 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhccc
Confidence 998765433 223566999999999987655 889999999999999999999999865322 222222211
Q ss_pred -ccCCccccccccccchhHHHHHHHHHHHcccCCC-C--CCCHHHHHH
Q 009644 455 -CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-R--RPSMRQIAG 498 (530)
Q Consensus 455 -~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~--RPt~~eVl~ 498 (530)
.... ........+.+++.+|+..++ + ||+++||++
T Consensus 291 ~~~~p---------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 SLTFP---------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HCCCC---------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccCC---------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111 111234678999999999777 7 999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.09 Aligned_cols=260 Identities=22% Similarity=0.410 Sum_probs=211.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|...+.||+|+||.||+|... ++..||+|++... ..+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 578899999999999999999863 4678999997643 345789999999999 999999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
+..++||||+++|+|.+++...... +...+++.+++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVT 191 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEEEc
Confidence 9999999999999999999865321 12248999999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|||+| |+.||..... ...
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~ 268 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL 268 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HHH
Confidence 999999999999987654322 223346778999999988889999999999999999999 9999975432 222
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
.......... ..+......+.+++.+||+.+| +|||+.|+++.|+++......
T Consensus 269 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 269 FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 2222222110 1222344678999999999999 999999999999999876544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=342.05 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=208.5
Q ss_pred cCCccce-eeccCCcEEEEEEEEc---CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEIN-IIGEGSFGLAYKGLLQ---DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~-~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|...+ .||+|+||.||+|... ++..||+|.+... ..+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999853 5778999997652 346789999999999999999999999 55678999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999997543 268999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
.... .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~~~~------- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKR------- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCC-------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhcCCc-------
Confidence 3322 122345788999999988889999999999999999999 99999765432 22222222110
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
...+...+..+.+++.+||+.+| +|||+.++++.|++++.....
T Consensus 232 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 232 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 01223445689999999999999 999999999999999887554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.16 Aligned_cols=244 Identities=21% Similarity=0.334 Sum_probs=195.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----------------------------HHHHHHHHHHHH
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----------------------------IQNFLHEVKHIA 285 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~ 285 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999995 468899999875432 246889999999
Q ss_pred hcCCCCcceEEEEEee--cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009644 286 RVHHRHLVKLVGFCEE--NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHF 363 (530)
Q Consensus 286 ~l~H~nIv~l~g~~~~--~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDL 363 (530)
+++||||+++++++.+ ....++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCC
Confidence 9999999999999986 5678999999999999886543 268999999999999999999999 59999999
Q ss_pred CCCcEEEcCCCeEEEeecCCcccccCCCC-cCcccccccccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 009644 364 RTSNVLLEENYTAKVSDYGLLKLVTGSHH-AGSTSAVDCFLDPELNLSKN---YSAGSDVYSFGVFLLELISGREAHGRN 439 (530)
Q Consensus 364 k~~NILl~~~~~~KI~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~ElltG~~p~~~~ 439 (530)
||+|||++.++.+||+|||+++....... .....+|+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999987654322 23456899999999987665 378899999999999999999999754
Q ss_pred CCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 440 HSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. .......... .. .. + ........+.+++.+||+.+| +|||+.|+++
T Consensus 244 ~~---~~~~~~~~~~-~~-~~--~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI---MCLHSKIKSQ-AL-EF--P----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH---HHHHHHHHHC-CC-CC--C----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH---HHHHHHHhcc-cC-CC--C----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 2222222211 11 00 0 112234678999999999999 9999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=355.13 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=202.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCE----EEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSL----VVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~----vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|+..+.||+|+||.||+|... +++. ||+|.+... ..+.+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357888999999999999999954 4443 777875432 2346788999999999999999999986 45688
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... +.+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999998653 268899999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 387 VTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 387 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
...... .....++..|+|||++.+..++.++||||||+++|||+| |+.||........ ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~----- 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLEKGERL----- 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHHTTCBC-----
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHHcCCCC-----
Confidence 654332 223346778999999998999999999999999999999 9999986544332 2222221110
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+......+.+++.+||+.+| +|||+.++++.|+++...
T Consensus 237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111223467889999999999 999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.47 Aligned_cols=243 Identities=17% Similarity=0.298 Sum_probs=199.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+|+.. +++.||+|++... ..+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999954 5889999987643 345688999999998 79999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998753 68999999999999999999999 59999999999999999999999999999864
Q ss_pred cCC-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 388 TGS-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 388 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... .
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~-~--------- 241 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILNDE-V--------- 241 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC-C---------
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC-C---------
Confidence 322 233445689999999999888899999999999999999999999976532 23333332211 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCH------HHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSM------RQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~------~eVl~ 498 (530)
..+......+.+++.+|++.+| +||++ .||++
T Consensus 242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122234678899999999999 99998 66664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=350.57 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=201.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHH--hcCCCCcceEEEEEee-----cCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIA--RVHHRHLVKLVGFCEE-----NHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~--~l~H~nIv~l~g~~~~-----~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|+. +++.||+|++.....+.+..|.+++. .++||||+++++.+.. ....++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 46789999999999999999987 68899999988777777777777654 4899999999986543 2357899
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-------VPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
|||+++|+|.+++... ..++..+..++.|++.||+|||+. .++|+||||||+|||++.++.+||+||
T Consensus 91 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp ECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 9999999999999764 458999999999999999999982 129999999999999999999999999
Q ss_pred CCcccccCCC---------CcCcccccccccCccccCC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH
Q 009644 382 GLLKLVTGSH---------HAGSTSAVDCFLDPELNLS-------KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ 445 (530)
Q Consensus 382 Gla~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~ 445 (530)
|+++.+.... ......||..|+|||++.+ ..++.++|||||||++|||+||..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998764322 1123458999999999876 45678999999999999999998776543321110
Q ss_pred --------------HHHHHHHhhccCCccccccccc---cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 446 --------------NLILQVKRSCDLGKYVDKTLGE---QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 446 --------------~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
......... ....+.+.. .....+..+.+++.+||+.+| +|||++|+++.|++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSR----EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTT----SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHHhhhcc----cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 000000000 011111111 233466789999999999999 999999999999999865
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=354.14 Aligned_cols=255 Identities=13% Similarity=0.187 Sum_probs=210.5
Q ss_pred hhcCCccceeeccCCcEEEEEEE------EcCCCEEEEEEcccccHHHHHHHHHHHHhcC---CCCcceEEEEEeecCce
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGL------LQDGSLVVIKRHLQTQIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~------~~~~~~vavK~~~~~~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~ 305 (530)
..++|...+.||+|+||.||+|. ..+++.||+|++......++..|++++.+++ |+||+++++++..++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 35779999999999999999993 4568899999998888889999999999997 99999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----------CC
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-----------NY 374 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-----------~~ 374 (530)
++||||+++|+|.+++..........+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCccccccccC
Confidence 999999999999999986433333479999999999999999999999 59999999999999998 89
Q ss_pred eEEEeecCCccccc---CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 375 TAKVSDYGLLKLVT---GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 375 ~~KI~DFGla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
.+||+|||+++.+. .........||..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------- 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------- 292 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence 99999999997653 2223344568999999999999999999999999999999999999986432211
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CC-CCHHHHHHHHHhhHHHhh
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RR-PSMRQIAGELEGIQEREI 508 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~R-Pt~~eVl~~L~~i~~~~~ 508 (530)
.. +...+... .....+.+++..|++.+| +| |++.++.+.|+++++...
T Consensus 293 ---~~----~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 ---CK----PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ---EE----ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---ee----echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00 11111111 124567788889999887 55 799999999999887643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.04 Aligned_cols=245 Identities=21% Similarity=0.327 Sum_probs=195.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecC-------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENH------- 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------- 303 (530)
.++|+..+.||+|+||.||+|+.. +++.||+|++.. ...+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999965 789999998752 23467999999999999999999999986543
Q ss_pred --------------------------------------------------ceeEEeeccCCCChHHHhhccCCCCCCCCC
Q 009644 304 --------------------------------------------------QQLLIYDYIPNGNVQNHLYDSEGLPIGKLT 333 (530)
Q Consensus 304 --------------------------------------------------~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~ 333 (530)
..++||||+++|+|.+++...... ...+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchh
Confidence 279999999999999999875322 3567
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-------------CcCcccccc
Q 009644 334 MRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH-------------HAGSTSAVD 400 (530)
Q Consensus 334 ~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~-------------~~~~~~gt~ 400 (530)
+..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......+|+
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999999 599999999999999999999999999998765432 123345899
Q ss_pred cccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHH
Q 009644 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELA 480 (530)
Q Consensus 401 ~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li 480 (530)
.|+|||++.+..++.++||||||+++|||++|..|+. ............ ............+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNL---------KFPLLFTQKYPQEHMMV 306 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTT---------CCCHHHHHHCHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhcc---------CCCcccccCChhHHHHH
Confidence 9999999999999999999999999999999876642 111111111111 11112233446778999
Q ss_pred HHcccCCC-CCCCHHHHHH
Q 009644 481 LQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 481 ~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+||+.+| +|||+.|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 99999999 9999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=354.61 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=193.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|+..+.||+|+||.||+++.. +++.||+|++.... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999964 78899999876432 467899999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe--EEEeecCCcccccCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT--AKVSDYGLLKLVTGS 390 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~--~KI~DFGla~~~~~~ 390 (530)
++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999997653 68999999999999999999999 59999999999999987765 999999999865444
Q ss_pred CCcCcccccccccCccccCCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCchH-HHHHHHHhhccCCcccccccccc
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAG-SDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSfGvvl~ElltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ..+...... .. ... .
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~--~~~-----~ 243 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KY--SIP-----D 243 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-CC--CCC-----T
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-CC--CCC-----C
Confidence 34445668999999999988888766 89999999999999999999865443322 222222211 10 000 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.......+.+++.+||+.+| +|||+.|+++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11234678899999999999 9999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=354.46 Aligned_cols=249 Identities=16% Similarity=0.256 Sum_probs=190.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..++|+..+.||+|+||.||+|+.. +++.||+|++... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 3567999999999999999999965 5788999987654 3456889999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCcccccC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~~~~~ 389 (530)
++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 131 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 131 TGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999997642 68999999999999999999999 59999999999999975 88999999999987655
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .. .... ...
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~-~~-~~~~----~~~ 275 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNC-EY-YFIS----PWW 275 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTT-CC-CCCT----TTT
T ss_pred ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhC-CC-ccCC----chh
Confidence 44444566899999999999999999999999999999999999999755432 1222222221 10 0111 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+|++.+| +|||+.|+++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2345688999999999999 9999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=339.52 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=203.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~LV 308 (530)
.++|+..+.||+|+||.||+|+.. ++.||+|++... ..+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357888999999999999999985 788999987642 345799999999999999999999999877 788999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++..... ..+++.++..++.|++.||+|||+..++|+||||||+|||+++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999986532 25899999999999999999999942239999999999999999999999998876533
Q ss_pred CCCCcCcccccccccCccccCCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSA---GSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
. ....+|+.|+|||.+.+..++. ++||||||+++|||+||+.||..... ............ .+
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~-----~~-- 230 (271)
T 3kmu_A 165 S----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEGL-----RP-- 230 (271)
T ss_dssp C----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSCC-----CC--
T ss_pred c----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcCC-----CC--
Confidence 2 3345788999999988665544 89999999999999999999975432 222222221110 01
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
..+...+..+.+++.+||+.+| +|||++++++.|+++.+
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 -TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1222344678999999999999 99999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=343.84 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=196.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||+|... ..+|+|.+.. ...+.|.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467899999999999999999864 3599998753 2346799999999999999999999976 4556899999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999997543 268999999999999999999999 59999999999999999999999999999865432
Q ss_pred C---CcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
. ......+|..|+|||.+. ...++.++||||||+++|||++|+.||...... .......... . ..+.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~-~----~~~~ 246 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRG-S----LSPD 246 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHT-S----CCCC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhccc-c----cCcc
Confidence 1 223345889999999986 667899999999999999999999999765432 2222222221 1 1112
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+.......+..+.+++.+||+.+| +|||+.++++.|+++.+
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 222333455789999999999999 99999999999998763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=352.85 Aligned_cols=250 Identities=16% Similarity=0.243 Sum_probs=202.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.+.|+..+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35789999999999999999995 46899999987532 3567999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe---EEEeecCC
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT---AKVSDYGL 383 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~---~KI~DFGl 383 (530)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888654211 1258999999999999999999999 59999999999999986554 99999999
Q ss_pred cccccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 384 LKLVTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 384 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......... .. . .+
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~-~~-~-~~ 252 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKG-KY-K-MN 252 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHT-CC-C-CC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcC-CC-C-CC
Confidence 987754432 334568999999999999999999999999999999999999997532 1222222221 10 0 00
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ ......+..+.+++.+||+.+| +|||+.|+++
T Consensus 253 ~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 P---RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0112234678999999999999 9999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.72 Aligned_cols=248 Identities=19% Similarity=0.341 Sum_probs=205.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|++.+.||+|+||.||+|... +++.+|+|.+... ....+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999964 6889999987643 345688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCeEEEeecCCcccccC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE--NYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~--~~~~KI~DFGla~~~~~ 389 (530)
+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997543 268999999999999999999999 59999999999999974 57899999999988765
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
........+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... . . .++ ...
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~-~-~-~~~---~~~ 274 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCD-W-E-FDE---DAF 274 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCC-C-C-CCS---STT
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-C-C-CCc---ccc
Confidence 5444455689999999999999999999999999999999999999975432 22233322211 0 0 111 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+||+.+| +|||+.|+++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 2345688999999999999 9999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=350.85 Aligned_cols=246 Identities=17% Similarity=0.260 Sum_probs=200.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|++.+.||+|+||.||+|... +++.||+|++.... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 78899999875432 3568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999987542 68999999999999999999999 59999999999999999999999999999865422
Q ss_pred C---CcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ........... .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~----~----- 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY----L----- 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCTT----S-----
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccccc----C-----
Confidence 2 1234568999999999987765 7889999999999999999999976543322 11111111100 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+.+++.+||+.+| +|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0112334678899999999999 9999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=354.37 Aligned_cols=264 Identities=21% Similarity=0.367 Sum_probs=212.6
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEee
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEE 301 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~ 301 (530)
++...++|...+.||+|+||.||+|... ++..||+|.+... ....+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3445678999999999999999999854 3678999987643 23568999999999999999999999999
Q ss_pred cCceeEEeeccCCCChHHHhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeE
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEG-----LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~ 376 (530)
++..++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999975321 111357899999999999999999999 599999999999999999999
Q ss_pred EEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHH
Q 009644 377 KVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVK 452 (530)
Q Consensus 377 KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~ 452 (530)
||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||..... ........
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHHHH
Confidence 9999999986643321 122346778999999988899999999999999999999 8888875432 22222222
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
.. . ....+...+..+.+++.+||+.+| +|||+.|+++.|+++......
T Consensus 255 ~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 255 EG-G--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp TT-C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred cC-C--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 21 1 111223345678999999999999 999999999999998665433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=345.40 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=200.0
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
++|+..+.||+|+||.||+|... ++.||+|.+... ..+.|.+|++++++++||||+++++++.+ ..++||||+++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 56888899999999999999985 678999998654 35679999999999999999999998873 578999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCcEEEcCCCe-EEEeecCCcccccCCCCc
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV-PPLFHMHFRTSNVLLEENYT-AKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-~~ivHrDLk~~NILl~~~~~-~KI~DFGla~~~~~~~~~ 393 (530)
+|.+++...... ..+++..++.++.|+++||+|||+.. ++|+||||||+|||++.++. +||+|||+++..... .
T Consensus 85 ~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~ 160 (307)
T 2eva_A 85 SLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--M 160 (307)
T ss_dssp BHHHHHHCSSSE--ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CHHHHHhccCCC--CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--c
Confidence 999999865321 25789999999999999999999842 48999999999999988875 899999999765432 2
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....+|..|+|||++.+..++.++||||||+++|||+||+.||....... .......... ... ......+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~-~~~--------~~~~~~~ 230 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNG-TRP--------PLIKNLP 230 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTT-CCC--------CCBTTCC
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcC-CCC--------CcccccC
Confidence 23458899999999999999999999999999999999999997544322 1222222211 110 1122334
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+.+++.+||+.+| +|||++++++.|+.+...
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 678999999999999 999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.37 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=209.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|...++..||+|.+... ..+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4678899999999999999999888889999987654 45789999999999999999999999874 46889999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
+|+|.+++....+ ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 91 ~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999975421 158999999999999999999999 5999999999999999999999999999987654322
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ............. ..+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~---------~~~~ 233 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRM---------VRPD 233 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC---------CCCT
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCC---------CCcc
Confidence 123346678999999988889999999999999999999 8999875432 2233333222110 1122
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+..+.+++.+|++.+| +|||++++++.|+++...
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 334688999999999999 999999999999998765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.92 Aligned_cols=242 Identities=17% Similarity=0.300 Sum_probs=198.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+++.. +++.||+|++.+.. .+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999965 57789999876432 24578999999887 89999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999998753 68999999999999999999999 59999999999999999999999999999863
Q ss_pred -cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc-----hHHHHHHHHhhccCCccc
Q 009644 388 -TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS-----DQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 388 -~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 461 (530)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 279 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 279 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence 23333455679999999999999999999999999999999999999996432211 11111111111110
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
..+......+.+++.+||+.+| +||++
T Consensus 280 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1222344678999999999999 99995
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=343.58 Aligned_cols=253 Identities=24% Similarity=0.410 Sum_probs=203.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-----cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec--Cce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~ 305 (530)
+.|+..+.||+|+||.||+|++ .+++.||+|++... ..+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 35789999987643 346799999999999999999999999876 668
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999976542 68999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----------CCch-HHHHH
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH-----------SNSD-QNLIL 449 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~-----------~~~~-~~~~~ 449 (530)
....... .....+|..|+|||.+.+..++.++||||||+++|||+||..|+.... .... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7654332 233447778999999998899999999999999999999998864210 0000 01111
Q ss_pred HHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
...... ....+...+..+.+++.+||+.+| +|||+.++++.|++++
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111110 011233445789999999999999 9999999999999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=363.97 Aligned_cols=248 Identities=18% Similarity=0.268 Sum_probs=203.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
..++|+..+.||+|+||.||+|.. .+++.+|+|.+... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999984 56889999986543 245689999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE---ENYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~---~~~~~KI~DFGla~ 385 (530)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998653 68999999999999999999999 5999999999999998 46789999999998
Q ss_pred cccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 386 LVTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 386 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
....... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.... .......+.... .....+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~--~~~~~~- 235 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGA--YDFPSP- 235 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC--CCCCTT-
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCC--CCCCcc-
Confidence 7654332 234568999999999999999999999999999999999999997543 223333332221 011111
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+..+.+++.+|++.+| +|||+.|+++
T Consensus 236 ---~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 ---EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 112334678999999999999 9999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.48 Aligned_cols=258 Identities=18% Similarity=0.305 Sum_probs=200.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--------HHHHHHHHHHHHhc---CCCCcceEEEEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--------IQNFLHEVKHIARV---HHRHLVKLVGFCEEN 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~E~~il~~l---~H~nIv~l~g~~~~~ 302 (530)
..++|+..+.||+|+||.||+|+. .+++.||+|++.... ...+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999994 578899999875321 34677888887776 499999999999775
Q ss_pred C-----ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 303 H-----QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 303 ~-----~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
. ..++||||+. |+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEE
Confidence 5 4789999996 699999986532 248999999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~ 457 (530)
|+|||+++............+|+.|+|||++.+..++.++|||||||++|||++|+.||...........+.........
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99999998776554445567899999999999999999999999999999999999999765432222222211111000
Q ss_pred Cccc--------------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYV--------------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~--------------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+. ...+..........+.+++.+|++.+| +|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 000011122345678999999999999 9999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=350.17 Aligned_cols=253 Identities=23% Similarity=0.452 Sum_probs=202.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|...+.||+|+||.||+|.... +..||+|.+... ....+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998643 235999987643 3456899999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999998653 268999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 387 VTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 387 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||..... ......+......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~---- 269 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRL---- 269 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcC----
Confidence 644321 112235678999999999999999999999999999999 9999975432 2233332222111
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +||++.+|++.|+++...
T Consensus 270 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1122344678999999999999 999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=346.08 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=201.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-C-------CEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-G-------SLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-~-------~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.++|...+.||+|+||.||+|.... + ..||+|.+... ..+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578889999999999999998543 3 46999987543 35679999999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe--------E
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT--------A 376 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~--------~ 376 (530)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999998653 248999999999999999999999 59999999999999998887 9
Q ss_pred EEeecCCcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 377 KVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 377 KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
||+|||+++..... ....++..|+|||.+.+ ..++.++||||||+++|||++|..|+...... ...........
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~~~~ 235 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYEDRH 235 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTC
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHhhccC
Confidence 99999999765322 23347788999999887 77999999999999999999966555433221 12112111111
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
.. +......+.+++.+||+.+| +|||+.++++.|+++......
T Consensus 236 ~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 236 QL-----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp CC-----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 11 11113467899999999999 999999999999999876444
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=348.93 Aligned_cols=241 Identities=20% Similarity=0.332 Sum_probs=203.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+++.. +++.||+|.+... ..+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999964 6899999987643 346788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .. ..
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~-~~---------~~ 222 (318)
T 1fot_A 158 DV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILNA-EL---------RF 222 (318)
T ss_dssp SC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHC-CC---------CC
T ss_pred Cc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC-CC---------CC
Confidence 32 3345689999999999999999999999999999999999999975432 2222222221 10 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
+......+.+++.+|+..+| +|| ++++|++
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 22234678999999999998 999 8888874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=343.44 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=213.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
..++|+..+.||+|+||.||+|.... +..||+|.+... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 35678899999999999999999654 788999987654 346799999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999986432 368999999999999999999999 599999999999999999999999999998765433
Q ss_pred C--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 392 H--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~~~~~~---------~~ 233 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKDYRM---------ER 233 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTTCCC---------CC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhccCCC---------CC
Confidence 2 223346778999999998999999999999999999999 999987654332 22222221110 12
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
+...+..+.+++.+|+..+| +|||+.++++.|+++....
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 22334688999999999999 9999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=354.43 Aligned_cols=272 Identities=15% Similarity=0.198 Sum_probs=213.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC---------CCEEEEEEcccccHHHHHHHHHHHHhcCCCCcce------------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD---------GSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVK------------ 294 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~---------~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~------------ 294 (530)
.++|...+.||+|+||.||+|+... ++.||+|..... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 3678999999999999999999653 788999997654 46889999999999999988
Q ss_pred ---EEEEEee-cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 295 ---LVGFCEE-NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 295 ---l~g~~~~-~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
+++++.. +...++||||+ +|+|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFV 192 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEE
Confidence 6778776 67889999999 9999999986521 268999999999999999999999 599999999999999
Q ss_pred cCCC--eEEEeecCCcccccCCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 009644 371 EENY--TAKVSDYGLLKLVTGSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH 440 (530)
Q Consensus 371 ~~~~--~~KI~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 440 (530)
+.++ .+||+|||+++.+..... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 999999999987643221 123358899999999999999999999999999999999999998654
Q ss_pred CCchHHHHHHHHh-hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccccc
Q 009644 441 SNSDQNLILQVKR-SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGEE 518 (530)
Q Consensus 441 ~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ee 518 (530)
.... ........ ......+.+... .....+..+.+++.+||+.+| +|||+++|++.|+++.+.........++.+
T Consensus 273 ~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 273 PNTE-DIMKQKQKFVDKPGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp TCHH-HHHHHHHHHHHSCCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred cCHH-HHHHHHHhccCChhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 2221 11111111 111111111111 111234689999999999999 999999999999999987665555555443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=378.15 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=205.0
Q ss_pred cCCccce-eeccCCcEEEEEEEEc---CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEIN-IIGEGSFGLAYKGLLQ---DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~-~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
+++...+ .||+|+||.||+|.+. ++..||||++... ..++|.+|+++|++++|||||+++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444445 7999999999999864 4567999997642 45789999999999999999999999976 568999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997543 368999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCCc----CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSHHA----GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~~~----~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
..... ....++..|+|||++....++.++|||||||++|||+| |+.||...... .....+......
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~------ 558 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM------ 558 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCC------
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC------
Confidence 33211 12235578999999998999999999999999999998 99999865432 233333322111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
..+...+..+.+++.+||+.+| +|||+.+|++.|+.+......
T Consensus 559 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 559 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 1233455789999999999999 999999999999998766433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=357.35 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=199.8
Q ss_pred ccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCCC
Q 009644 240 SEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~G 315 (530)
...+.||+|+||.||+|.. .++..||+|++... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999995 56889999987653 3467899999999999999999999999999999999999999
Q ss_pred ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE--cCCCeEEEeecCCcccccCCCCc
Q 009644 316 NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL--EENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 316 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl--~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 172 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp EEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999987643 268999999999999999999999 599999999999999 56789999999999987655545
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
....+|+.|+|||++....++.++|||||||++|||++|+.||..... ......+.... . ...+ .......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~-~-~~~~----~~~~~~~ 316 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACR-W-DLED----EEFQDIS 316 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTC-C-CSCS----GGGTTSC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc-C-CCCh----hhhccCC
Confidence 556689999999999999999999999999999999999999976532 22222222210 0 0001 1122334
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHH--HHHhh
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAG--ELEGI 503 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i 503 (530)
..+.+++.+|++.+| +|||+.|+++ .+++.
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 688999999999999 9999999987 45554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.68 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=210.6
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcC-C-----CEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQD-G-----SLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~-~-----~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
...++|...+.||+|+||.||+|.... + ..||+|.+... ..+.+.+|+.+++++ +||||+++++++..+
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999999643 2 47999987653 346789999999999 899999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL---------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN 373 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~ 373 (530)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEEGG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEECCC
Confidence 9999999999999999999754210 01257999999999999999999999 599999999999999999
Q ss_pred CeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHH
Q 009644 374 YTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLIL 449 (530)
Q Consensus 374 ~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~ 449 (530)
+.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||........ ...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHH
Confidence 9999999999986643322 223346778999999988899999999999999999999 9999976543322 112
Q ss_pred HHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
........ ..+...+..+.+++.+||+.+| +|||+.+|++.|+++....
T Consensus 279 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 279 LVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 22211110 0122234678999999999999 9999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.64 Aligned_cols=245 Identities=19% Similarity=0.347 Sum_probs=203.3
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCc
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~ 304 (530)
....++|...+.||+|+||.||+|+.+ +++.||+|++... ..+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 5889999987643 345688999999987 99999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999998653 68999999999999999999999 59999999999999999999999999999
Q ss_pred ccccC-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 385 KLVTG-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 385 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... +
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~-------~ 235 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMDN-------P 235 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC-------C
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHhCC-------C
Confidence 86432 2234456789999999999999999999999999999999999999975432 23333332211 0
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHH-HHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMR-QIA 497 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~-eVl 497 (530)
..+......+.+++.+|+..+| +||++. +|.
T Consensus 236 ---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1122234678999999999999 999997 664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=351.25 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=200.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCE----EEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSL----VVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~----vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|+..+.||+|+||.||+|... +++. |++|.+.. ...+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999953 4443 57776542 34578999999999999999999999998764 78
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999987542 68999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 387 VTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 387 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
...... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......... .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~~~~~----- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL----- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC-----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCCC-----
Confidence 643322 122345778999999999999999999999999999999 99999765443322 222211110
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
..+......+.+++.+||+.+| +|||+.|+++.|+++....
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1122334678999999999999 9999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=351.19 Aligned_cols=266 Identities=27% Similarity=0.417 Sum_probs=210.6
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCE--EEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSL--VVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~--vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|+..+.||+|+||.||+|+. .++.. +|+|.+... ..+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6788899999999999999995 45554 488876532 345689999999999 999999999999999999999
Q ss_pred eeccCCCChHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 309 YDYIPNGNVQNHLYDSEG-----------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
|||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEEcCCCeEE
Confidence 999999999999976420 112368999999999999999999999 5999999999999999999999
Q ss_pred EeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
|+|||+++............++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ............
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~ 259 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYR 259 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGGGTCC
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHHHhhcCCC
Confidence 999999975433222333456778999999988889999999999999999998 9999975432 222222221110
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccc
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFG 516 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ 516 (530)
...+......+.+++.+||..+| +|||+.++++.|+++.+...........
T Consensus 260 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 311 (327)
T 1fvr_A 260 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 311 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCT
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccchh
Confidence 01222344688999999999999 9999999999999998875544444433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=358.13 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEEcC--C--CEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEee-cCceeEE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQD--G--SLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQQLLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~--~--~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~~~LV 308 (530)
.|...+.||+|+||.||+|...+ + ..||+|.+.. ...+.|.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999998532 2 3588998753 235679999999999999999999999754 5678999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997643 268899999999999999999999 599999999999999999999999999998664
Q ss_pred CCCC-----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 389 GSHH-----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 389 ~~~~-----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
.... .....++..|+|||.+.+..++.++||||||+++|||+| |.+||.......... ....... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~---~-- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRR---L-- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCC---C--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCC---C--
Confidence 3221 122346778999999999999999999999999999999 677776554433222 2221111 0
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+...+..+.+++.+||+.+| +|||+.|+++.|+++...-.
T Consensus 316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1122334678999999999999 99999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=346.30 Aligned_cols=240 Identities=24% Similarity=0.349 Sum_probs=193.1
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||+||+|+.. +++.||||++... ....+..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 7899999986532 234566677666666 9999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+ +|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 779999988754 269999999999999999999999 5999999999999999999999999999987755
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
........||+.|+|||++.+ .++.++|||||||++|||++|..|+... ......... ...+ ...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~-----~~~~---~~~ 274 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQG-----YLPP---EFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTT-----CCCH---HHH
T ss_pred CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhcc-----CCCc---ccc
Confidence 544455568999999999865 7999999999999999999997776532 111111111 1111 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.+++.+|++.+| +|||++|+++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2345688999999999999 9999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.83 Aligned_cols=253 Identities=17% Similarity=0.286 Sum_probs=198.9
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|... +++.||+|++... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999964 6889999987532 23678899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++ +|.+++.... +.+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 6666665533 268999999999999999999999 59999999999999999999999999999876533
Q ss_pred C-CcCcccccccccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---cCCcc-----
Q 009644 391 H-HAGSTSAVDCFLDPELNLSKN-YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---DLGKY----- 460 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~----- 460 (530)
. ......+|..|+|||++.+.. ++.++|||||||++|||++|..||...... ......+.... ....+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcc
Confidence 2 233456789999999987765 899999999999999999998886544322 22222222110 00000
Q ss_pred ----c-------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 ----V-------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ----~-------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ...+..........+.+++.+|++.+| +|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 000111223345678999999999999 9999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.98 Aligned_cols=243 Identities=16% Similarity=0.275 Sum_probs=194.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE----cCCCEEEEEEcccc-------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQT-------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~ 304 (530)
.++|+..+.||+|+||.||+++. .+++.||+|++... ....+.+|++++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999996 47899999987643 23457889999999999999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999998653 68899999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 385 KLVTGSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 385 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+... ..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~-~~------ 238 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKILKC-KL------ 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHT-CC------
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhC-CC------
Confidence 8643322 23345689999999999999999999999999999999999999975432 2222222221 00
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
..+......+.+++.+||..+| +|| ++.|+++
T Consensus 239 ---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1122334678999999999999 999 6777765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.70 Aligned_cols=256 Identities=16% Similarity=0.247 Sum_probs=205.3
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEe
Q 009644 228 TILELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCE 300 (530)
Q Consensus 228 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~ 300 (530)
.+.+.+...++|+..+.||+|+||.||+++. .+++.||+|++.+.. .+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445556678999999999999999999996 468999999986432 235889999999999999999999999
Q ss_pred ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 301 ~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999998653 268999999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCCC--cCcccccccccCccccC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 381 YGLLKLVTGSHH--AGSTSAVDCFLDPELNL-------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 381 FGla~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
||+++....... .....||+.|+|||++. ...|+.++|||||||++|||++|+.||...........+...
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 999987654332 23456899999999986 467899999999999999999999999765432221111111
Q ss_pred HhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CC---CCHHHHHH
Q 009644 452 KRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RR---PSMRQIAG 498 (530)
Q Consensus 452 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~R---Pt~~eVl~ 498 (530)
....... ......+.++.+++.+|+. +| +| |+++||++
T Consensus 286 ~~~~~~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 KEHLSLP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccCcCCC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111 1112334688999999998 65 55 79999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.64 Aligned_cols=247 Identities=19% Similarity=0.286 Sum_probs=205.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999995 45889999987543 2457889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe---EEEeecCCccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT---AKVSDYGLLKL 386 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~---~KI~DFGla~~ 386 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999987653 68999999999999999999999 59999999999999986654 99999999987
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
...........+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~--~~~~~~--- 229 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGA--YDYPSP--- 229 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC--CCCCTT---
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHhcc--ccCCch---
Confidence 7655544556789999999999999999999999999999999999999975432 22222222211 011111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.+++.+|++.+| +|||+.|+++
T Consensus 230 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 -EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112334678899999999999 9999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.03 Aligned_cols=268 Identities=22% Similarity=0.362 Sum_probs=214.2
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEE
Q 009644 228 TILELKHATNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLV 296 (530)
Q Consensus 228 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~ 296 (530)
...+.....++|...+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4445555678999999999999999999984 24578999987653 235689999999999 799999999
Q ss_pred EEEeecC-ceeEEeeccCCCChHHHhhccCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 009644 297 GFCEENH-QQLLIYDYIPNGNVQNHLYDSEGLP-----------IGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFR 364 (530)
Q Consensus 297 g~~~~~~-~~~LV~Ey~~~GsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk 364 (530)
+++...+ ..++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+|||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dik 175 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLA 175 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCCS
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccCc
Confidence 9987754 5899999999999999998653210 1138899999999999999999999 599999999
Q ss_pred CCcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 009644 365 TSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNH 440 (530)
Q Consensus 365 ~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~ 440 (530)
|+||+++.++.+||+|||+++....... .....+|..|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987643322 223446788999999999999999999999999999998 999997654
Q ss_pred CCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 441 SNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
... ............ ..+......+.+++.+||+.+| +|||+.+|++.|+++++...
T Consensus 256 ~~~--~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDE--EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSH--HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhH--HHHHHhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 332 222222221110 1112234678999999999999 99999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=344.46 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=205.4
Q ss_pred hcCCccce-eeccCCcEEEEEEEEc---CCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEIN-IIGEGSFGLAYKGLLQ---DGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~-~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
.++|...+ .||+|+||.||+|... ++..||+|.+.... .+.+.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999642 36789999876432 46799999999999999999999999 566789
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999998642 68999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 387 VTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 387 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
...... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGER----- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC-----
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-----
Confidence 644322 122335678999999988889999999999999999999 9999975432 222222222110
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
...+...+..+.+++.+||+.+| +|||+.+|++.|+++.....
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 239 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 01223345689999999999999 99999999999999987644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=338.84 Aligned_cols=248 Identities=22% Similarity=0.370 Sum_probs=206.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEee-------------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEE------------- 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~------------- 301 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 467899999999999999999975 78999999876443 467889999999999999999998854
Q ss_pred ---cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 302 ---NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 302 ---~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
....++||||+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEEcCCCCEEE
Confidence 4458999999999999999976432 268999999999999999999999 59999999999999999999999
Q ss_pred eecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 379 SDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 379 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
+|||+++............++..|+|||.+.+..++.++||||||+++|||++|..|+.. ........... ..
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~~~~~~~~-~~- 236 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKFFTDLRDG-II- 236 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHHHHHHHTT-CC-
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHHHHHhhcc-cc-
Confidence 999999887655444556689999999999999999999999999999999999988642 11111111111 11
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
+......+.+++.+||+.+| +|||+.|+++.|+.+...
T Consensus 237 ----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 237 ----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11223568899999999999 999999999999988654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=351.92 Aligned_cols=266 Identities=18% Similarity=0.254 Sum_probs=207.8
Q ss_pred cccCHHHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc--ccHHHHHHHHHHHHhcC-----CCCcceEE
Q 009644 225 KQLTILELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ--TQIQNFLHEVKHIARVH-----HRHLVKLV 296 (530)
Q Consensus 225 ~~~~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~E~~il~~l~-----H~nIv~l~ 296 (530)
..+++.+.....++|.+.+.||+|+||.||+|+. .+++.||+|++.. ...+.+..|+++++++. ||||++++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3444455555678999999999999999999996 5688999999864 33466888999999996 99999999
Q ss_pred EEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----
Q 009644 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---- 372 (530)
Q Consensus 297 g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---- 372 (530)
+++...+..++||||+ +++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEcccccc
Confidence 9999999999999999 9999999986532 258999999999999999999999 59999999999999975
Q ss_pred ---------------------CCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 009644 373 ---------------------NYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS 431 (530)
Q Consensus 373 ---------------------~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt 431 (530)
++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999865432 344568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHHHHhhcc-----------CCccccc-----cccc-----------------cchhHHHHHHH
Q 009644 432 GREAHGRNHSNSDQNLILQVKRSCD-----------LGKYVDK-----TLGE-----------------QTVGAATEMME 478 (530)
Q Consensus 432 G~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~d~-----~l~~-----------------~~~~~~~~l~~ 478 (530)
|+.||...........+........ ....++. ..+. ........+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999976543222222221111000 0000000 0000 00111256789
Q ss_pred HHHHcccCCC-CCCCHHHHHH
Q 009644 479 LALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 479 li~~Cl~~~p-~RPt~~eVl~ 498 (530)
++.+||+.+| +|||++|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 9999999999 9999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.54 Aligned_cols=265 Identities=18% Similarity=0.310 Sum_probs=200.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|++.+.||+|+||.||+|.. .+++.||+|++.. ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999995 5789999998753 2346789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999753211 1268999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ........... .....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~------- 258 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQC-DYPPL------- 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTT-CSCCC-------
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhcc-cCCCC-------
Confidence 3322 23345788999999999999999999999999999999999999754332 12222222211 11111
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCC
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLH 512 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~ 512 (530)
........+.+++.+||+.+| +|||+.+|++.|+++.+.......
T Consensus 259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 112234678999999999999 999999999999999887665443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.29 Aligned_cols=243 Identities=19% Similarity=0.353 Sum_probs=181.7
Q ss_pred eeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeeccCCCChHHH
Q 009644 243 NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNH 320 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~ 320 (530)
+.||+|+||.||+|... +++.||+|++.......+.+|+.++..+. ||||+++++++.++...++||||+++|+|.++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 78999999999999964 68899999998877788999999999997 99999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEeecCCcccccCCCC-cCcc
Q 009644 321 LYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSDYGLLKLVTGSHH-AGST 396 (530)
Q Consensus 321 l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~DFGla~~~~~~~~-~~~~ 396 (530)
+.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 97 l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 169 (325)
T 3kn6_A 97 IKKKK-----HFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169 (325)
T ss_dssp HHHCS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence 98753 68999999999999999999999 5999999999999997665 899999999986544322 2345
Q ss_pred cccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----chHHHHHHHHhhccCCccccccccccchhH
Q 009644 397 SAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN----SDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 397 ~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
.+|..|+|||++.+..++.++||||||+++|||++|+.||...... ............ .. .. + .+.....
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-~~-~~-~---~~~~~~~ 243 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DF-SF-E---GEAWKNV 243 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-CC-CC-C---SHHHHTS
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-CC-CC-C---cccccCC
Confidence 5789999999999999999999999999999999999999764321 111222222211 00 00 0 0112234
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+..+.+++.+|++.+| +|||++|+++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 5688999999999999 9999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=336.35 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=203.0
Q ss_pred CCccceeeccCCcEEEEEEEEcC-CC---EEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce-eEE
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQD-GS---LVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ-LLI 308 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~-~~---~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~-~LV 308 (530)
.|...+.||+|+||.||+|...+ +. .+|+|.+... ..+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998533 33 6999987642 346789999999999999999999999776554 899
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+.+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999998643 268999999999999999999999 599999999999999999999999999998654
Q ss_pred CCC-----CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSH-----HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ............
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~------ 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLAQGRRL------ 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHHTTCCC------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhhcCCCC------
Confidence 322 1233446788999999999999999999999999999999666654433222 222222221110
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+...+..+.+++.+|++.+| +|||+.++++.|+++.+...
T Consensus 248 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 ---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1122334678999999999999 99999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.07 Aligned_cols=268 Identities=18% Similarity=0.303 Sum_probs=214.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC--ceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH--QQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~--~~~LV 308 (530)
.++|.+.+.||+|+||.||+|... +++.||+|++... ..+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357889999999999999999965 4889999997643 3467889999999999999999999998765 67999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCeEEEeecCCc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL----EENYTAKVSDYGLL 384 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl----~~~~~~KI~DFGla 384 (530)
|||+++|+|.+++...... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999865321 248999999999999999999999 599999999999999 78888999999999
Q ss_pred ccccCCCCcCcccccccccCccccCC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-chHHHHHHHHhhc
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLS--------KNYSAGSDVYSFGVFLLELISGREAHGRNHSN-SDQNLILQVKRSC 455 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~-~~~~~~~~~~~~~ 455 (530)
+............+|..|+|||++.. ..++.++|||||||++|||+||+.||...... .............
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 88765555555678999999999764 56788999999999999999999999754332 2223333333221
Q ss_pred cCCcc------c------c---ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 456 DLGKY------V------D---KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 456 ~~~~~------~------d---~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
....+ . . +............+.+++.+||+.+| +|||+.++++.+++++...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 10000 0 0 00112335667788999999999999 9999999999999988753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.02 Aligned_cols=241 Identities=17% Similarity=0.303 Sum_probs=197.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+++.. +++.||+|++... ..+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357889999999999999999964 5789999987643 235688999999988 89999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999998653 68999999999999999999999 59999999999999999999999999999864
Q ss_pred cC-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------chHHHHHHHHhhccCCcc
Q 009644 388 TG-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN------SDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 388 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~------~~~~~~~~~~~~~~~~~~ 460 (530)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ ..
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~--- 236 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI--- 236 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CC---
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CC---
Confidence 32 22344557899999999999999999999999999999999999999753221 111111111111 10
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
..+......+.+++.+||+.+| +||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122344678999999999999 99995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.35 Aligned_cols=247 Identities=17% Similarity=0.258 Sum_probs=205.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457899999999999999999964 6889999986542 256799999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----eEEEeec
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY----TAKVSDY 381 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~----~~KI~DF 381 (530)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997642 68999999999999999999999 5999999999999999887 7999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
|+++............+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ...
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~---~~~ 237 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITSVS---YDF 237 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTC---CCC
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcc---ccc
Confidence 999877655444556689999999999999999999999999999999999999975432 22222222110 001
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
++ .........+.+++.+|++.+| +|||+.|+++
T Consensus 238 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 238 DE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Ch---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 1112334678999999999999 9999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=351.88 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=203.5
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|+..+.||+|+||.||+++.. +++.||+|.+... ..+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999964 6899999987643 3467889999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998753 68999999999999999999999 5999999999999999999999999999987643
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .. ..+
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~-~~---------~~p 258 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSG-KV---------RFP 258 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC---------CCC
T ss_pred C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHcC-CC---------CCC
Confidence 2 2345689999999999999999999999999999999999999975432 2233332221 10 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
......+.+++.+||+.+| +||+ +++|++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2334678999999999999 9998 788764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=376.12 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=210.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..++|++.+.||+|+||.||+|.+.++..||||++... ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35678889999999999999999988888999998753 35789999999999999999999999976 6789999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++....+ ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999975422 258999999999999999999999 5999999999999999999999999999987643221
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....++..|+|||.+....++.++|||||||+||||+| |+.||..... ......+...... ..+
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~---------~~~ 486 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM---------PCP 486 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC---------CCC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---------CCC
Confidence 123346678999999998999999999999999999999 8999975432 2333333322111 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
......+.+++.+||+.+| +|||+++|++.|+.+...
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 3345688999999999999 999999999999998643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=353.04 Aligned_cols=259 Identities=15% Similarity=0.174 Sum_probs=198.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc----CCCEEEEEEccccc--------------HHHHHHHHHHHHhcCCCCcceEEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQTQ--------------IQNFLHEVKHIARVHHRHLVKLVG 297 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~~--------------~~~~~~E~~il~~l~H~nIv~l~g 297 (530)
.++|...+.||+|+||.||+|... ++..+|+|...... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367899999999999999999975 56789999865431 134678889999999999999999
Q ss_pred EEee----cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 009644 298 FCEE----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN 373 (530)
Q Consensus 298 ~~~~----~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~ 373 (530)
++.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccC
Confidence 9987 67899999999 999999997653 68999999999999999999999 599999999999999988
Q ss_pred C--eEEEeecCCcccccCCCC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 009644 374 Y--TAKVSDYGLLKLVTGSHH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS 443 (530)
Q Consensus 374 ~--~~KI~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 443 (530)
+ .+||+|||+++.+..... .....+|..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999987643221 123458899999999999999999999999999999999999996533222
Q ss_pred hHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhH
Q 009644 444 DQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQ 504 (530)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~ 504 (530)
.................+..... ....+..+.+++.+||+.+| +|||+.+|++.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHhhcccccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 21111111111111111111000 11344689999999999999 9999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.68 Aligned_cols=253 Identities=18% Similarity=0.284 Sum_probs=204.4
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
++|+..+.||+|+||.||++... +++.||+|.+... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999965 6889999986532 3577999999999999999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----eEEEeecC
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY----TAKVSDYG 382 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~----~~KI~DFG 382 (530)
+||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999997653 68999999999999999999999 5999999999999998877 89999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
+++............++..|+|||.+....++.++||||||+++|||++|+.||..... .......... .. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~--~~~ 231 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAV-NY--DFD 231 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTT-CC--CCC
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhc-cc--CCc
Confidence 99876554444455688999999999999999999999999999999999999975432 2222222211 00 000
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
. .........+.+++.+|+..+| +|||+.|+++ .++.+..
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 232 E---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp H---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred c---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0 1122334678999999999999 9999999997 4555543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.69 Aligned_cols=250 Identities=17% Similarity=0.308 Sum_probs=203.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcC-CCCcceEEEEEee--cCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVH-HRHLVKLVGFCEE--NHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~--~~~~~LV~Ey~ 312 (530)
++|+..+.||+|+||.||+|+. .+++.||+|.+.....+.+.+|++++++++ ||||+++++++.+ ....++||||+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 6789999999999999999984 578899999998888889999999999997 9999999999987 56789999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCcccccCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~~~~~~ 391 (530)
++++|.+++. .++..++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 116 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999884 47889999999999999999999 5999999999999999776 89999999998776555
Q ss_pred CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc---cC-------Ccc
Q 009644 392 HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC---DL-------GKY 460 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~---~~-------~~~ 460 (530)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .......... .. ...
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccc
Confidence 5556678899999999876 679999999999999999999999996544321 1111111000 00 000
Q ss_pred ccc----------------cc-cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 VDK----------------TL-GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ~d~----------------~l-~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.++ .. ..........+.+++.+|++.+| +|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00 00122245788999999999999 9999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.95 Aligned_cols=260 Identities=17% Similarity=0.328 Sum_probs=189.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46788899999999999999995 46889999987532 24678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 311 YIPNGNVQNHLYDSEG-LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
|++ |+|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 997 699999875421 112358999999999999999999999 5999999999999999999999999999987643
Q ss_pred CC-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc-------
Q 009644 390 SH-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY------- 460 (530)
Q Consensus 390 ~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 460 (530)
.. ......+|..|+|||++.+ ..++.++|||||||++|||+||+.||...........+...........+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 32 2334568899999999876 46899999999999999999999999865432222222221111000000
Q ss_pred -ccccc------------c-ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 -VDKTL------------G-EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 -~d~~l------------~-~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.. . .........+.+++.+|++.+| +|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 0 0111234678999999999999 9999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.06 Aligned_cols=244 Identities=18% Similarity=0.302 Sum_probs=202.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC-CCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCcee
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 306 (530)
..++|+..+.||+|+||.||+|+... ++.||+|++... ..+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999654 788999987643 345688999999988 8999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999998653 68999999999999999999999 5999999999999999999999999999986
Q ss_pred ccC-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 387 VTG-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 387 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ..
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~-~~-------- 238 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEH-NV-------- 238 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC--------
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHHhC-CC--------
Confidence 432 2234456689999999999999999999999999999999999999975432 2333333221 10
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
..+......+.+++.+|+..+| +||+ +++|++
T Consensus 239 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122344688999999999999 9995 466654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.93 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=201.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCC----CEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEe-ecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDG----SLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCE-ENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~-~~~~~~ 306 (530)
..+|+..+.||+|+||.||+|...+. ..+|+|.+... ..+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34688889999999999999985432 25888886542 3467899999999999999999999864 456789
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999997643 268999999999999999999999 5999999999999999999999999999986
Q ss_pred ccCCCC-----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 387 VTGSHH-----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 387 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
...... .....+|..|+|||.+.+..++.++||||||+++|||++ |.+||........ ......... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~~~~---~ 251 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRR---L 251 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHTTCC---C
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhcCCC---C
Confidence 643321 223346778999999999999999999999999999999 5555554433222 122221110 0
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
..+...+..+.+++.+||+.+| +|||++|+++.|+++....
T Consensus 252 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0112234678999999999999 9999999999999998653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.35 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=205.8
Q ss_pred CccceeeccCCcEEEEEEEEc-----CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeec--CceeE
Q 009644 239 FSEINIIGEGSFGLAYKGLLQ-----DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEEN--HQQLL 307 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~--~~~~L 307 (530)
|+..+.||+|+||.||++.+. +++.||+|++.... .+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 57889999977532 45689999999999999999999999874 57899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999764 58999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc--------hHHHHHHHHhhc
Q 009644 388 TGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS--------DQNLILQVKRSC 455 (530)
Q Consensus 388 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~--------~~~~~~~~~~~~ 455 (530)
..... .....++..|+|||.+.+..++.++||||||+++|||+||+.||....... ..........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE-- 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH--
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH--
Confidence 54322 223346778999999998899999999999999999999999986431100 0000000000
Q ss_pred cCCcccccc-ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcC
Q 009644 456 DLGKYVDKT-LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGR 510 (530)
Q Consensus 456 ~~~~~~d~~-l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~ 510 (530)
.+... ....+...+..+.+++.+||+.+| +|||+.|+++.|+++.+.....
T Consensus 263 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 263 ----LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ----HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 00000 011233445789999999999999 9999999999999998775543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.49 Aligned_cols=243 Identities=19% Similarity=0.375 Sum_probs=205.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999964 78999999876432 35788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++... +.+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999754 268999999999999999999999 599999999999999999999999999999876
Q ss_pred CCCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.........||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....+.... . .
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~-~---------~ 234 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGI-F---------Y 234 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHHTTC-C---------C
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCC-c---------C
Confidence 5554556679999999999988776 68999999999999999999999865432 2222222211 0 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+......+.+++.+||+.+| +|||+.|+++
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 112233578999999999999 9999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.24 Aligned_cols=251 Identities=17% Similarity=0.289 Sum_probs=193.2
Q ss_pred hcCCccc-eeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEee----cCceeEE
Q 009644 236 TNNFSEI-NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEE----NHQQLLI 308 (530)
Q Consensus 236 t~~f~~~-~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~----~~~~~LV 308 (530)
.++|... +.||+|+||.||++... +++.||+|++.. ...+.+|++++.++ +||||+++++++.. ....++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 3566665 68999999999999954 688999999864 34677899987554 89999999999875 5678999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~ 385 (530)
|||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 138 ~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999986432 258999999999999999999999 59999999999999998 7899999999998
Q ss_pred cccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH-HHHHHHHhhccCCcccccc
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~ 464 (530)
............+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+... .. ....+
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-~~-~~~~~- 289 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-QY-EFPNP- 289 (400)
T ss_dssp ECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-CC-CCCTT-
T ss_pred ccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-cc-cCCCc-
Confidence 765544445566899999999999999999999999999999999999999765433211 111111111 10 00000
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
........+.+++.+||+.+| +|||+.|+++.
T Consensus 290 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112344678999999999999 99999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=342.57 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=199.2
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc----CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC-
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ----DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH- 303 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~----~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~- 303 (530)
...++|...+.||+|+||.||+|... .+..||+|.+... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578899999999999999999854 2347999987532 3467899999999999999999999997754
Q ss_pred ----ceeEEeeccCCCChHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 304 ----QQLLIYDYIPNGNVQNHLYDSEG-LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 304 ----~~~LV~Ey~~~GsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
..++||||+++|+|.+++..... .....+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTSCEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEE
Confidence 35999999999999999954321 122368999999999999999999999 59999999999999999999999
Q ss_pred eecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhh
Q 009644 379 SDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 379 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~ 265 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYLLHG 265 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHHTT
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHHcC
Confidence 99999987643321 122346778999999999999999999999999999999 888887654332 22222221
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.. ...+...+..+.+++.+||..+| +|||+.++++.|+++.+.
T Consensus 266 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 266 HR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 01223344688999999999999 999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.30 Aligned_cols=258 Identities=17% Similarity=0.296 Sum_probs=198.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ---- 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~---- 304 (530)
.++|++.+.||+|+||.||+++. .+++.||+|++... ....+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999995 67889999987643 23568899999999999999999999876654
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999998653 68999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 385 KLVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 385 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+....... .....||..|+|||++.+..++.++||||||+++|||+||+.||..... .............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~--- 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDPI--- 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCCC---
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCC---
Confidence 87644321 1234479999999999999999999999999999999999999975432 1222222111100
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHH-HHHHHHhhHHHhhc
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQ-IAGELEGIQEREIG 509 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~e-Vl~~L~~i~~~~~~ 509 (530)
.+ .......+..+.+++.+||+.+| +||+..+ +...+.++......
T Consensus 238 -~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 238 -PP--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp -CH--HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred -Cc--ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 00 00122344678999999999999 9996555 44566666554433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=364.96 Aligned_cols=244 Identities=18% Similarity=0.271 Sum_probs=195.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 56889999987643 235678899999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997653 689999999999999999999972 399999999999999999999999999998643
Q ss_pred CC-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GS-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... .. .
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~-~~---------~ 367 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILME-EI---------R 367 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC---------C
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHhC-CC---------C
Confidence 32 233456689999999999999999999999999999999999999975432 2222222221 10 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
.+......+.+++.+||+.+| +|| |++|+++
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 122234678999999999999 999 9999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=339.88 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=197.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+..+.||+|+||.||+|... +++.||+|++.... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999964 58899999875432 3568899999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999887543 68999999999999999999999 59999999999999999999999999999876533
Q ss_pred C-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------------
Q 009644 391 H-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------- 455 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------- 455 (530)
. ......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+.......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2234568889999999875 678999999999999999999999997654332222221111000
Q ss_pred -cCCcccccc----ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -DLGKYVDKT----LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -~~~~~~d~~----l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......++. +..........+.+++.+||+.+| +|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 000112345678999999999999 9999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.59 Aligned_cols=243 Identities=20% Similarity=0.320 Sum_probs=199.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|... ++..||+|.+.... ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999854 56789999875432 35688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999986544
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... . . ..
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~------~---~~ 226 (279)
T 3fdn_A 161 SSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRV-E------F---TF 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT-C------C---CC
T ss_pred ccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHhC-C------C---CC
Confidence 322 2345688999999999999999999999999999999999999975432 2222222221 0 0 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+......+.+++.+||+.+| +|||+.|+++.
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22234678899999999999 99999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.72 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=201.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEeec-CceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-HQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-~~~~LV~Ey~~ 313 (530)
.++|+..+.||+|+||.||+|... ++.||+|.+... ..+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 467899999999999999999874 789999998754 456799999999999999999999997554 57899999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~ 393 (530)
+|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 99 ~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 171 (278)
T 1byg_A 99 KGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 171 (278)
T ss_dssp TEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccccccccc--c
Confidence 9999999976431 137899999999999999999999 59999999999999999999999999999865432 2
Q ss_pred CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||....... .......... . ..+...
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~------~---~~~~~~ 239 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYK------M---DAPDGC 239 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCC------C---CCCTTC
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC------C---CCcccC
Confidence 23356788999999988999999999999999999998 999997654322 2222221110 0 122334
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
+..+.+++.+||+.+| +|||+.++++.|+++...+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 5688999999999999 9999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.85 Aligned_cols=242 Identities=22% Similarity=0.375 Sum_probs=198.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.+.|+..+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34588899999999999999995 57889999987532 235789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+. |+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99996 78888886543 268999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
.. ....+|+.|+|||++. ...++.++|||||||++|||++|+.||..... ........... . +..
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~-~-----~~~ 273 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNE-S-----PAL 273 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC-C-----CCC
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcC-C-----CCC
Confidence 32 3456899999999984 57799999999999999999999999975432 12222222211 1 111
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.+++.+||+.+| +|||++++++
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 112234678899999999999 9999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.38 Aligned_cols=259 Identities=16% Similarity=0.203 Sum_probs=200.8
Q ss_pred hcCCccceeeccC--CcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEG--SFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G--~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|++.+.||+| +||.||+|+.. +++.||+|++... ..+.+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999965 6899999987643 23568889999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986532 268999999999999999999999 59999999999999999999999999998654
Q ss_pred cCCC--------CcCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--
Q 009644 388 TGSH--------HAGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-- 455 (530)
Q Consensus 388 ~~~~--------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-- 455 (530)
.... ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||...................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 1223357888999999987 679999999999999999999999997654433211110000000
Q ss_pred cCC---------------------c----------cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 456 DLG---------------------K----------YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 456 ~~~---------------------~----------~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
+.. . ..+.............+.+++.+||+.+| +|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0 00000001122334678999999999999 99999999853
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=344.23 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=205.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-----cCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEe--ecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCE--ENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~--~~~~~ 305 (530)
.++|+..+.||+|+||.||+|++ .++..||+|++.... .+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36788999999999999999984 357889999876543 356899999999999999999999986 45668
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++..... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999986432 68999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc------------hHHHHH
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS------------DQNLIL 449 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~------------~~~~~~ 449 (530)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7644322 223347778999999988889999999999999999999999986421100 000111
Q ss_pred HHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 450 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
..... .....+...+..+.+++.+||+.+| +|||+.|+++.|+.+......
T Consensus 256 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 256 LLEEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred Hhhcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 11110 0011233445789999999999999 999999999999999776443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=334.55 Aligned_cols=246 Identities=15% Similarity=0.272 Sum_probs=204.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|+..+.||+|+||.||+|... ++..+|+|++.. ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467899999999999999999964 467899998764 3457899999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCccccc
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~~~~ 388 (530)
+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999997653 68999999999999999999999 599999999999999 788999999999998776
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.........+|+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ........... . .... ..
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~-~-~~~~----~~ 230 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGT-F-TFPE----KD 230 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC-C-CCCH----HH
T ss_pred CccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCC-C-CCCc----hh
Confidence 5555556678999999999865 499999999999999999999999975432 22222222211 0 0000 01
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.......+.+++.+|++.+| +|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11234688999999999999 9999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=335.24 Aligned_cols=249 Identities=17% Similarity=0.271 Sum_probs=196.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|...+.||+|+||.||++.. .++..+|+|++... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35788899999999999999995 46889999987543 34789999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCcccc
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLV 387 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~~~ 387 (530)
|+++|+|.+++...... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653211 1268999999999999999999999 599999999999999 45688999999999876
Q ss_pred cCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 388 TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
..........++..|+|||.+. ..++.++||||||+++|||++|+.||..... ............. ...
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~-------~~~ 246 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPN-------YAV 246 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC-------CCC
T ss_pred CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCcc-------ccc
Confidence 6554455566899999999975 6789999999999999999999999975432 2222222211110 001
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.+++.+|++.+| +|||+.||++
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111124678899999999999 9999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=350.18 Aligned_cols=239 Identities=16% Similarity=0.291 Sum_probs=202.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----------cHHHHHHHHHHHHhcCCCCcceEEEEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----------QIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~ 302 (530)
..++|+..+.||+|+||.||+|+. .+++.||+|.+... ..+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999994 56889999987643 223577899999999999999999999999
Q ss_pred CceeEEeeccCCC-ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 303 HQQLLIYDYIPNG-NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 303 ~~~~LV~Ey~~~G-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
+..++||||+..| +|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 9999997653 68999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
|+++............||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ....
T Consensus 175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~ 240 (335)
T 3dls_A 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAA 240 (335)
T ss_dssp TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTC
T ss_pred ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------Hhhc
Confidence 99988766555555668999999999988877 88999999999999999999999642110 0000
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
. ..+......+.+++.+||+.+| +|||+.++++.
T Consensus 241 ~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 I-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred c-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111234678999999999999 99999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=367.09 Aligned_cols=249 Identities=19% Similarity=0.322 Sum_probs=207.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|+.. +|+.||+|++... ....+.+|+++|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999964 6899999987643 245688999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999976432 258999999999999999999999 599999999999999999999999999998876
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......... ..
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~---------~~ 408 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE---------EY 408 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC---------CC
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc---------cC
Confidence 554444567999999999999999999999999999999999999999865433222222222211110 12
Q ss_pred chhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
+......+.+++.+|++.+| +|| +++||++
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 22334688999999999999 999 7788875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.09 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=200.3
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--------cHHHHHHHHHHHHhcCCCCcceEEEEEeec
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--------QIQNFLHEVKHIARVHHRHLVKLVGFCEEN 302 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~ 302 (530)
+....++|+..+.||+|+||.||+|.. .++..||+|++... ..+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345567899999999999999999995 56788999987533 346789999999999999999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCC-----------------------------------CCCCCCHHHHHHHHHHHHHH
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL-----------------------------------PIGKLTMRQRLSIALGAAKG 347 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~qia~g 347 (530)
+..++||||+++|+|.+++...... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998531100 01124577788999999999
Q ss_pred HHHhhcCCCCeeecCCCCCcEEEcCCC--eEEEeecCCcccccCCCC-----cCcccccccccCccccCC--CCCCchhh
Q 009644 348 LEHLHSLVPPLFHMHFRTSNVLLEENY--TAKVSDYGLLKLVTGSHH-----AGSTSAVDCFLDPELNLS--KNYSAGSD 418 (530)
Q Consensus 348 L~yLH~~~~~ivHrDLk~~NILl~~~~--~~KI~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~s~ksD 418 (530)
|+|||+ .+|+||||||+|||++.++ .+||+|||+++.+..... .....+|+.|+|||.+.. ..++.++|
T Consensus 181 l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 181 LHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 5999999999999998766 899999999986643221 234458899999999865 67899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHH
Q 009644 419 VYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIA 497 (530)
Q Consensus 419 VwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl 497 (530)
|||||+++|||++|+.||..... ............ ....+ ........+.+++.+|++.+| +|||+.+++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKL--CFENP----NYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCC--CTTSG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhccc--ccCCc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 99999999999999999975532 222222222110 01111 112234678999999999999 999999998
Q ss_pred H
Q 009644 498 G 498 (530)
Q Consensus 498 ~ 498 (530)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=348.02 Aligned_cols=264 Identities=20% Similarity=0.297 Sum_probs=199.8
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--------------HHHHHHHHHHHHhcCCCCcc
Q 009644 228 TILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--------------IQNFLHEVKHIARVHHRHLV 293 (530)
Q Consensus 228 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--------------~~~~~~E~~il~~l~H~nIv 293 (530)
...++....++|...+.||+|+||.||+|...++..||+|++.... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888899999999999999999999998889999999875321 26789999999999999999
Q ss_pred eEEEEEee-----cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 009644 294 KLVGFCEE-----NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNV 368 (530)
Q Consensus 294 ~l~g~~~~-----~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NI 368 (530)
++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCChHHE
Confidence 99999854 335799999997 78998887543 268999999999999999999999 5999999999999
Q ss_pred EEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHH
Q 009644 369 LLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNL 447 (530)
Q Consensus 369 Ll~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 447 (530)
|++.++.+||+|||+++............+|..|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp EECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999986655444455668889999999876 7799999999999999999999999986543222111
Q ss_pred HHHHHhhcc-------------------CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 448 ILQVKRSCD-------------------LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 448 ~~~~~~~~~-------------------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+........ ...................+.+++.+|++.+| +|||+.|+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111100000 00000011111222335678999999999999 9999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.81 Aligned_cols=246 Identities=19% Similarity=0.261 Sum_probs=195.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHH-HHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKH-IARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~i-l~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|+..+.||+|+||.||+++.+ ++..||+|++.+.. ...+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999964 57889999876432 3456777776 467899999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999998653 68899999999999999999999 59999999999999999999999999999864
Q ss_pred cC-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 388 TG-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 388 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~-~~--------- 256 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNK-PL--------- 256 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHHS-CC---------
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhc-cc---------
Confidence 33 2334456799999999999999999999999999999999999999975432 2222322221 10
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
..+......+.+++.+|++.+| +||++.+.++++.
T Consensus 257 ~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 257 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 1112234678999999999999 9999865444443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.55 Aligned_cols=257 Identities=20% Similarity=0.364 Sum_probs=190.9
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc-----ccHHHHHHHHHHHHhcC-CCCcceEEEEEeecC--c
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVH-HRHLVKLVGFCEENH--Q 304 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~--~ 304 (530)
...++|+..+.||+|+||.||+|.. .+++.||+|++.. ...+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999995 5689999998743 23456889999999997 999999999997544 6
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 6999998753 68999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCC----------------------CCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 009644 385 KLVTGS----------------------HHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHS 441 (530)
Q Consensus 385 ~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~ 441 (530)
+.+... .......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 11223458999999999876 6799999999999999999999999986543
Q ss_pred CchHHHHHHHHhhccC---Cccc------------------ccccccc-------------chhHHHHHHHHHHHcccCC
Q 009644 442 NSDQNLILQVKRSCDL---GKYV------------------DKTLGEQ-------------TVGAATEMMELALQCVDVS 487 (530)
Q Consensus 442 ~~~~~~~~~~~~~~~~---~~~~------------------d~~l~~~-------------~~~~~~~l~~li~~Cl~~~ 487 (530)
......+......... .... ....... .......+.+++.+||..+
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 2222222111100000 0000 0000000 0123457899999999999
Q ss_pred C-CCCCHHHHHHH
Q 009644 488 S-RRPSMRQIAGE 499 (530)
Q Consensus 488 p-~RPt~~eVl~~ 499 (530)
| +|||++|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9 99999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=346.34 Aligned_cols=253 Identities=17% Similarity=0.308 Sum_probs=206.7
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----------HHHHHHHHHHHHhc-CCCCcceEE
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----------IQNFLHEVKHIARV-HHRHLVKLV 296 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----------~~~~~~E~~il~~l-~H~nIv~l~ 296 (530)
.......++|+..+.||+|+||.||+|... +|+.||||++.... .+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999975 68999999865322 34678999999999 899999999
Q ss_pred EEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeE
Q 009644 297 GFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTA 376 (530)
Q Consensus 297 g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~ 376 (530)
+++......++||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999998653 68999999999999999999999 599999999999999999999
Q ss_pred EEeecCCcccccCCCCcCcccccccccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHH
Q 009644 377 KVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450 (530)
Q Consensus 377 KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~ 450 (530)
||+|||++..+..........||+.|+|||++. ...++.++|||||||++|||+||+.||..... ......
T Consensus 240 kl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~ 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRM 316 (365)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH
T ss_pred EEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHHH
Confidence 999999998876555555667899999999875 34688999999999999999999999975432 222222
Q ss_pred HHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 451 VKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 451 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+... .. ....+ ........+.+++.+|++.+| +|||+.|+++
T Consensus 317 i~~~-~~-~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEG-QY-QFSSP----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHT-CC-CCCHH----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhC-CC-CCCCc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2211 00 00000 111234578999999999999 9999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=360.42 Aligned_cols=253 Identities=18% Similarity=0.285 Sum_probs=193.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------C
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------H 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~ 303 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999984 46889999987532 346788999999999999999999999654 3
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+++ +|.+.+.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999965 56666642 48899999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------cC
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------DL 457 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------~~ 457 (530)
++............+|+.|+|||++.+..|+.++|||||||++|||++|+.||...........+....... .+
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 988765544555678999999999999999999999999999999999999998654322222211111000 00
Q ss_pred -----------C--------ccccccc----cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 -----------G--------KYVDKTL----GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 -----------~--------~~~d~~l----~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ......+ ..........+.+++.+||..+| +|||++|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000 00111225678999999999999 9999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=374.99 Aligned_cols=244 Identities=22% Similarity=0.346 Sum_probs=199.2
Q ss_pred eeeccCCcEEEEEEEEc---CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQ---DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|.+. .+..||||++... ..++|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 4578999987643 24689999999999999999999999965 468899999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC--
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-- 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-- 392 (530)
|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997642 68999999999999999999999 5999999999999999999999999999987654321
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....+|..|+|||++....++.++|||||||++|||+| |+.||..... ......+...... ..+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~---------~~p 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM---------GCP 594 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC---------CCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---------CCC
Confidence 122335678999999999999999999999999999998 9999976532 2233333222111 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
...+..+.+++.+||+.+| +|||+.+|++.|+++...
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 3445789999999999999 999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.25 Aligned_cols=255 Identities=15% Similarity=0.215 Sum_probs=199.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+.... .+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999964 68899999876432 36788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999998764
Q ss_pred CCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 389 GSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 389 ~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~-------~~~ 255 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---SVMGAHINQAIP-------RPS 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---HHHHHHHHSCCC-------CGG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---HHHHHHhccCCC-------Ccc
Confidence 4321 2234588899999999999999999999999999999999999975421 111111111110 011
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCC-CHHHHHHHHHhhHHHh
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRP-SMRQIAGELEGIQERE 507 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RP-t~~eVl~~L~~i~~~~ 507 (530)
......+..+.+++.+||+.+| +|| |++++++.|+++++..
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1223344678899999999999 999 9999999999886553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=333.25 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=182.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|.+.... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36789999999999999999995 578999999876432 36789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998643 268999999999999999999999 599999999999999999999999999998764
Q ss_pred CCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ... .... . .
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~~~---~---~ 230 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---NKV----VLAD---Y---E 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------C----CSSC---C---C
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---HHH----hhcc---c---C
Confidence 322 223345888999999999889999999999999999999999999765432211 100 0000 0 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+......+.+++.+|++.+| +|||++++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 122334678899999999999 9999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.47 Aligned_cols=249 Identities=16% Similarity=0.296 Sum_probs=192.7
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----------HHHHHHHHHHHHhcCCCCcceEEEEEee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----------IQNFLHEVKHIARVHHRHLVKLVGFCEE 301 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~H~nIv~l~g~~~~ 301 (530)
...++|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467899999999999999999995 457899999876432 1247899999999999999999999854
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CeEEE
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN---YTAKV 378 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~---~~~KI 378 (530)
+..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEE
Confidence 45789999999999999987542 68999999999999999999999 599999999999999754 45999
Q ss_pred eecCCcccccCCCCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 379 SDYGLLKLVTGSHHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 379 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
+|||+++............||+.|+|||++. ...++.++|||||||++|||+||+.||........ ........
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~~- 360 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITSG- 360 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHTT-
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhcC-
Confidence 9999999876554445567899999999985 36788999999999999999999999976543321 11111111
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. .. ...........+.+++.+|++.+| +|||+.|+++
T Consensus 361 ~~-~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KY-NF----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC-CC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-CC----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00 011122334678999999999999 9999999886
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.78 Aligned_cols=250 Identities=15% Similarity=0.323 Sum_probs=203.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeecc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..++|+..+.||+|+||.||++... +++.||+|.+.... ..+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 3567999999999999999999964 58899999876543 2356789999888 7999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CeEEEeecCCccccc
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN----YTAKVSDYGLLKLVT 388 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~----~~~KI~DFGla~~~~ 388 (530)
++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++...
T Consensus 99 ~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 99 KGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999997642 68999999999999999999999 599999999999998543 359999999998765
Q ss_pred CCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... ......+|+.|+|||++.+..++.++|||||||++|||++|..||..........+...+... ... . ...
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~~-~----~~~ 245 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-KFS-L----SGG 245 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-CCC-C----CST
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-Ccc-c----Ccc
Confidence 432 234456899999999998888999999999999999999999999865443333444333322 110 0 011
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........+.+++.+|+..+| +|||+.++++
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 223345688999999999999 9999999886
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=344.92 Aligned_cols=255 Identities=17% Similarity=0.323 Sum_probs=195.2
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccHH----HHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQ----NFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~----~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|...+.||+|+||.||+|... +++.||+|++...... .+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999964 6889999987643322 356799999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
++ |+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 96 699999886532 68999999999999999999999 599999999999999999999999999998654322
Q ss_pred -CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccC---Ccccc----
Q 009644 392 -HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL---GKYVD---- 462 (530)
Q Consensus 392 -~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~d---- 462 (530)
......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......... .....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2233457899999999876 67899999999999999999999999865433222222222111100 00000
Q ss_pred ----------ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 463 ----------KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 463 ----------~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+..........+.+++.+|++.+| +|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00001112334678899999999999 9999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=331.41 Aligned_cols=243 Identities=18% Similarity=0.338 Sum_probs=195.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|.+.+.||+|+||.||+|... +++.||+|.+... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999965 6899999987643 245788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999998765
Q ss_pred CCCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.........++..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ............. .
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~----------~ 229 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVF----------Y 229 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC----------C
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCcc----------c
Confidence 5444445568889999999987766 689999999999999999999997542 2222222222110 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+......+.+++.+|++.+| +|||+.++++
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112234678899999999999 9999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=359.01 Aligned_cols=246 Identities=19% Similarity=0.330 Sum_probs=202.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|++.+.||+|+||.||+|... +++.||+|++.. ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999964 688999998753 34567999999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCeEEEeecCCccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE---ENYTAKVSDYGLLKL 386 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~---~~~~~KI~DFGla~~ 386 (530)
||+++|+|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999997653 68999999999999999999999 5999999999999995 466899999999987
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
...........||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+.... .. . + .
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~-~~-~-~--~- 243 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGK-YA-F-D--L- 243 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-CC-S-C--S-
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-CC-C-C--C-
Confidence 765554555678999999999865 699999999999999999999999976532 23333332221 00 0 0 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+..+.+++.+||+.+| +|||+.|+++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122345678999999999999 9999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=346.05 Aligned_cols=245 Identities=14% Similarity=0.248 Sum_probs=193.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCC--CCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHH--RHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H--~nIv~l~g~~~~~~~~~LV 308 (530)
.++|++.+.||+|+||.||++...+++.||+|++... ..+.+.+|++++.+++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568999999999999999999888999999986532 24678999999999976 9999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
||+ .+|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp ECC-CSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EeC-CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 994 5889999998753 68999999999999999999999 5999999999999997 5789999999998764
Q ss_pred CCCC---cCcccccccccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 389 GSHH---AGSTSAVDCFLDPELNLS-----------KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 389 ~~~~---~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~ 236 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDP 236 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHCT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHhcC
Confidence 4322 234468999999999854 67899999999999999999999999754321 1111111111
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.. .. ..+......+.+++.+||+.+| +|||+.|+++.
T Consensus 237 ~~-----~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NH-----EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TS-----CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc-----cc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 00 00 1122223578899999999999 99999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.46 Aligned_cols=269 Identities=19% Similarity=0.241 Sum_probs=215.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhcCC-CCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARVHH-RHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|++.+.||+|+||.||+|.. .+++.||||+.... ...++..|++++..++| +++..+..++...+..++||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 46899999999999999999995 56899999986533 33568899999999976 56666767777888899999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCcccccC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~~~~~ 389 (530)
+++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 86 -g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 86 -GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp -CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred -CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999998543 269999999999999999999999 599999999999999 6889999999999987654
Q ss_pred CCCc--------CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 390 SHHA--------GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 390 ~~~~--------~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
.... ....||..|+|||++.+..++.++|||||||+||||++|+.||...........+..+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~--- 234 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-VA--- 234 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-HH---
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-cc---
Confidence 3221 24568999999999999999999999999999999999999998765544444433332221 00
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccc
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFG 516 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ 516 (530)
..+.......+.++.+++..||+.+| +||++.+|++.|+++.....-.....++
T Consensus 235 -~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~d 289 (483)
T 3sv0_A 235 -TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD 289 (483)
T ss_dssp -SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCH
T ss_pred -ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcC
Confidence 00001112334688999999999999 9999999999999998766554444444
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=341.63 Aligned_cols=263 Identities=18% Similarity=0.292 Sum_probs=191.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---HHHHHHHHHHHHhcC-CCCcceEEEEEe--------ec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVH-HRHLVKLVGFCE--------EN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~E~~il~~l~-H~nIv~l~g~~~--------~~ 302 (530)
..+|++.+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45789999999999999999995 468899999875433 456899999999996 999999999994 33
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
...++||||+. |+|.+++...... +.+++.++..++.|++.||+|||+..++|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 45789999995 8999998763221 36999999999999999999999941229999999999999999999999999
Q ss_pred CcccccCCCCc-------------CcccccccccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 009644 383 LLKLVTGSHHA-------------GSTSAVDCFLDPELN---LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446 (530)
Q Consensus 383 la~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 446 (530)
+++........ ....+|+.|+|||++ .+..++.++||||||+++|||+||+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 99876443211 133478899999998 56778999999999999999999999996432211
Q ss_pred HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccc
Q 009644 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFG 516 (530)
Q Consensus 447 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ 516 (530)
.. ...... + ........+.+++.+||+.+| +|||+.|+++.|+++.+.......++..
T Consensus 261 ~~---~~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~~ 319 (337)
T 3ll6_A 261 IV---NGKYSI-----P----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319 (337)
T ss_dssp --------CCC-----C----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCCH
T ss_pred hh---cCcccC-----C----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccHH
Confidence 10 000000 0 111122357889999999999 9999999999999998765544444433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.43 Aligned_cols=245 Identities=21% Similarity=0.360 Sum_probs=203.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|...+.||+|+||.||+|+.. +|+.||+|++... ..+.+.+|++++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367889999999999999999964 6899999997643 245788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++...... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999764321 2368999999999999999999999 599999999999999999999999999998765
Q ss_pred CCCCc-CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch-HHHHHHHHhhccCCcccccccc
Q 009644 389 GSHHA-GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD-QNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 389 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
..... ....||+.|+|||++.+..|+.++|||||||++|||+||+.||........ ..+...+... ..
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-~~--------- 410 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-AV--------- 410 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-CC---------
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-cc---------
Confidence 44332 334799999999999999999999999999999999999999986543222 2222222211 10
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSM 493 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~ 493 (530)
..+...+..+.+++.+|++.+| +||++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1223345688999999999999 99976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=343.00 Aligned_cols=257 Identities=21% Similarity=0.365 Sum_probs=205.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE------cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~------~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|...+.||+|+||.||+|+. .++..||+|.+... ...++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 34678999997532 345789999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCeEEEee
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGL--PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE---ENYTAKVSD 380 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~---~~~~~KI~D 380 (530)
++||||+++|+|.+++...... ....+++.+++.++.|++.||.|||+ .+|+||||||+|||++ ++..+||+|
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999875421 12358999999999999999999999 5999999999999998 455799999
Q ss_pred cCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 381 YGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 381 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
||+++....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||..... ......+.....
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~ 263 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTSGGR 263 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTTCC
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHhcCCC
Confidence 999986543221 223446888999999988999999999999999999998 9999875432 223333322211
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
. ..+......+.+++.+||+.+| +|||+.+|++.|+.+...
T Consensus 264 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 M---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 0 1122334678999999999999 999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.69 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=198.1
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeec---------
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN--------- 302 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~--------- 302 (530)
....++|+..+.||+|+||.||+|.. .+++.||+|++... .....+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 44567899999999999999999995 57899999987543 22345799999999999999999998443
Q ss_pred -----------------------------CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 009644 303 -----------------------------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353 (530)
Q Consensus 303 -----------------------------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 353 (530)
...++||||++ |+|.+.+...... ...+++..+..++.|++.||+|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34889999997 6888877642111 1368999999999999999999999
Q ss_pred CCCCeeecCCCCCcEEEc-CCCeEEEeecCCcccccCCCCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHc
Q 009644 354 LVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELIS 431 (530)
Q Consensus 354 ~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~Ellt 431 (530)
.+|+||||||+|||++ +++.+||+|||+++............+|..|+|||.+.+. .++.++|||||||++|||++
T Consensus 160 --~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp --TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred --CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 5999999999999998 6899999999999977655555566789999999998764 48999999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHHHHhhc---------------cCCccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHH
Q 009644 432 GREAHGRNHSNSDQNLILQVKRSC---------------DLGKYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 432 G~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
|+.||......+....+....... ............ .+...+..+.+++.+||+.+| +|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 999998654322222211111000 000000011111 222345678999999999999 999999
Q ss_pred HHHH
Q 009644 495 QIAG 498 (530)
Q Consensus 495 eVl~ 498 (530)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=335.94 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=203.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.+.|+..+.||+|+||.||+|.. .+++.||+|.+.. ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45688999999999999999985 4688999998753 335789999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998642 68999999999999999999999 59999999999999999999999999999876543
Q ss_pred C-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 391 H-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .+. ..
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~------~~~---~~ 240 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNN------PPT---LE 240 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC------CCC---CC
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCC------CCC---Cc
Confidence 3 22345588899999999999999999999999999999999999975432 22222222111 011 12
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
......+.+++.+||+.+| +|||+.++++.
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2234678999999999999 99999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=346.06 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=201.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE----cCCCEEEEEEcccc-------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQT-------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~-------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
.++|+..+.||+|+||.||+++. .+++.||+|++... ..+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999996 46889999987642 235678899999999 7999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999998653 68999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCC--CcCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH-HHHHHHhhccCC
Q 009644 384 LKLVTGSH--HAGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN-LILQVKRSCDLG 458 (530)
Q Consensus 384 a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~-~~~~~~~~~~~~ 458 (530)
++...... ......||..|+|||++.+ ..++.++|||||||++|||+||+.||.......... +....... .
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~-- 282 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-E-- 282 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-C--
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-C--
Confidence 98654322 2233468999999999875 457899999999999999999999997554332222 22222111 0
Q ss_pred ccccccccccchhHHHHHHHHHHHcccCCC-CCC-----CHHHHHHH
Q 009644 459 KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRP-----SMRQIAGE 499 (530)
Q Consensus 459 ~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~~ 499 (530)
...+......+.+++.+||..+| +|| |++|+++.
T Consensus 283 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11223344678899999999999 999 99999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=335.62 Aligned_cols=244 Identities=17% Similarity=0.278 Sum_probs=202.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|...+.||+|+||.||++... +++.+|+|.+... ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999965 5788999986543 346788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999987653 68999999999999999999999 599999999999999999999999999998764
Q ss_pred CCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... .. .
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~~---------~ 233 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKN-EY---------S 233 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTT-CC---------C
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhc-cC---------C
Confidence 322 23345588899999999998999999999999999999999999975432 1222222211 00 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.+......+.+++.+|++.+| +|||++|+++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 IPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112234578899999999999 99999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.71 Aligned_cols=260 Identities=23% Similarity=0.411 Sum_probs=205.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-----cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecC--ce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-----QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENH--QQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~--~~ 305 (530)
.++|+..+.||+|+||.||++++ .+++.||+|++... ..+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 35789999987643 3467899999999999999999999987654 78
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999998753 268999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CchHHHHHHHH
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHS---------NSDQNLILQVK 452 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~---------~~~~~~~~~~~ 452 (530)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... ...........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 7654322 1223466779999999888899999999999999999999998763210 00000000110
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
...... .....+...+..+.+++.+||+.+| +|||+.+|++.|+++.+.
T Consensus 274 ~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNN-----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTT-----CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcC-----CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000000 0001223445789999999999999 999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=332.59 Aligned_cols=242 Identities=14% Similarity=0.261 Sum_probs=202.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|... ++..||+|.+... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367899999999999999999965 5778999987543 235789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998653 68999999999999999999999 599999999999999999999999999997654
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... . . ..
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~-~------~---~~ 231 (284)
T 2vgo_A 166 SL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVNV-D------L---KF 231 (284)
T ss_dssp SS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTT-C------C---CC
T ss_pred cc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhcc-c------c---CC
Confidence 32 23345688999999999999999999999999999999999999975432 1222222111 1 0 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+......+.+++.+|++.+| +|||++++++
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 22334678999999999999 9999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.12 Aligned_cols=249 Identities=18% Similarity=0.299 Sum_probs=194.3
Q ss_pred cCCccc-eeeccCCcEEEEEEE-EcCCCEEEEEEcccc---cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEI-NIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT---QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~-~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~---~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
+.|++. +.||+|+||.||+|. ..+++.||+|++... ..+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 789999999999999 457899999987543 356799999999985 79999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe---EEEeecCCcccc
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT---AKVSDYGLLKLV 387 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~---~KI~DFGla~~~ 387 (530)
|+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 92 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998753 68999999999999999999999 59999999999999998765 999999999865
Q ss_pred cCCC--------CcCcccccccccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc-----------
Q 009644 388 TGSH--------HAGSTSAVDCFLDPELNLS-----KNYSAGSDVYSFGVFLLELISGREAHGRNHSNS----------- 443 (530)
Q Consensus 388 ~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~----------- 443 (530)
.... ......+|..|+|||++.. ..++.++||||||+++|||++|+.||.......
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 3221 1123348899999999864 568899999999999999999999997654322
Q ss_pred -hHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 444 -DQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 444 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.......+... .. ..... ........+.+++.+|++.+| +|||+.|+++
T Consensus 245 ~~~~~~~~i~~~-~~-~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEG-KY-EFPDK----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHC-CC-CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhcc-Cc-ccCch----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 01111111111 00 00000 111234678999999999999 9999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.62 Aligned_cols=247 Identities=19% Similarity=0.318 Sum_probs=203.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----------------cHHHHHHHHHHHHhcCCCCcceEEE
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----------------QIQNFLHEVKHIARVHHRHLVKLVG 297 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----------------~~~~~~~E~~il~~l~H~nIv~l~g 297 (530)
..++|...+.||+|+||.||+|... +++.||+|++... ..+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999964 5789999986532 2457889999999999999999999
Q ss_pred EEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---
Q 009644 298 FCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY--- 374 (530)
Q Consensus 298 ~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~--- 374 (530)
++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999997653 68999999999999999999999 5999999999999998775
Q ss_pred eEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 375 TAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 375 ~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
.+||+|||+++............||+.|+|||++. ..++.++|||||||++|||++|..||..... ......+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC
Confidence 69999999998876655555667999999999986 5799999999999999999999999986532 2333333322
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. .. .+. ......+..+.+++.+|++.+| +|||++|+++
T Consensus 263 ~-~~--~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 K-YY--FDF---NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp C-CC--CCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-CC--CCc---cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 00 000 0112334678999999999999 9999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=342.79 Aligned_cols=253 Identities=15% Similarity=0.257 Sum_probs=201.4
Q ss_pred HHHhhcCCccc-eeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 232 LKHATNNFSEI-NIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 232 l~~~t~~f~~~-~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
.+...+.|.+. +.||+|+||.||+|... +++.||+|.+... ....+.+|+.++.++ +||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455667776 88999999999999954 6899999986642 356899999999999 5799999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEee
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSD 380 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~D 380 (530)
..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred eEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999865322 368999999999999999999999 59999999999999998 78999999
Q ss_pred cCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 381 YGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 381 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
||+++............+|+.|+|||++....++.++||||||+++|||++|+.||..... ........... . ..
T Consensus 178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~-~-~~ 252 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVN-V-DY 252 (327)
T ss_dssp GGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-C-CC
T ss_pred CccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhcc-c-cc
Confidence 9999877654444556689999999999999999999999999999999999999976432 22222222110 0 00
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ..........+.+++.+||+.+| +|||++++++
T Consensus 253 ~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 253 S----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 11222345678999999999999 9999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.14 Aligned_cols=259 Identities=20% Similarity=0.321 Sum_probs=196.6
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEeecC
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--------IQNFLHEVKHIARVHHRHLVKLVGFCEENH 303 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~ 303 (530)
....++|+..+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 33457899999999999999999995 468999999876421 236889999999999999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999975 8998887643 268889999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCC-CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 384 LKLVTGSH-HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 384 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|.+||...........+...........+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 98764332 2334568999999999865 458999999999999999999999987654322211111111110000000
Q ss_pred c------c----ccc-----ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 D------K----TLG-----EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d------~----~l~-----~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ . ... .........+.+++.+|+..+| +|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0 000 0112334689999999999999 9999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.63 Aligned_cols=243 Identities=14% Similarity=0.249 Sum_probs=193.8
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcC--CCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVH--HRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~--H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.+|++.+.||+|+||.||++...+++.||||++... ..+.+.+|++++.+++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999878999999987532 3467899999999996 599999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
| +.+|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999998653 68899999999999999999999 5999999999999995 57999999999987644
Q ss_pred CCC---cCcccccccccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 390 SHH---AGSTSAVDCFLDPELNLS-----------KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 390 ~~~---~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ...........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~~~~ 284 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAIIDPN 284 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHCTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHHHhCcc
Confidence 321 234568999999999864 46899999999999999999999999754321 12222221110
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. .. ..+......+.+++.+||+.+| +|||+.|+++
T Consensus 285 ~-----~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 285 H-----EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp S-----CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-----cC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 0 00 0111224578899999999999 9999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=341.97 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=192.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356899999999999999999984 468899999876432 34578999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-----cCCCeEEEeecCC
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL-----EENYTAKVSDYGL 383 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl-----~~~~~~KI~DFGl 383 (530)
|||++ |+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 59999998653 68999999999999999999999 599999999999999 4556799999999
Q ss_pred cccccCCC-CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc--
Q 009644 384 LKLVTGSH-HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK-- 459 (530)
Q Consensus 384 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 459 (530)
++...... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+...........
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 98764332 22344578999999998864 589999999999999999999999976543221111111111000000
Q ss_pred -------c-------ccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 -------Y-------VDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 -------~-------~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ ....+.. ........+.+++.+||+.+| +|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0000000 111134678899999999999 9999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=335.20 Aligned_cols=254 Identities=20% Similarity=0.391 Sum_probs=197.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--CCC--EEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--DGS--LVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--~~~--~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|+..+.||+|+||.||+|.+. +++ .||+|.+... ..+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367899999999999999999853 233 5899986532 3467899999999999999999999998765 8
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999998653 268999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~--- 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGER--- 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCC---
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCCC---
Confidence 7654322 123346778999999988889999999999999999999 9999975532 2223322221100
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.......+..+.+++.+|++.+| +|||+.++++.|+++....
T Consensus 244 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 244 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 01122345688999999999999 9999999999999887543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=342.67 Aligned_cols=243 Identities=17% Similarity=0.276 Sum_probs=202.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|...+.||+|+||.||++... +++.+|+|.+... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999964 4788999986543 346789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987653 68999999999999999999999 599999999999999999999999999998764
Q ss_pred CCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||..... .......... .. .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~-~~---------~ 259 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKN-EY---------S 259 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT-CC---------C
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhcC-CC---------C
Confidence 322 23345688999999999988999999999999999999999999975432 1222222221 00 0
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+......+.+++.+||+.+| +|||+.|+++
T Consensus 260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233578899999999999 9999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.86 Aligned_cols=259 Identities=16% Similarity=0.326 Sum_probs=198.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ..+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999995 56899999987432 2457889999999999999999999997653
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999998753 68999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 175 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9875432 334568899999999876 789999999999999999999999998654322222221111000
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
.+.......+..........+.+++.+|+..+| +|||+.|+++ .++++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 011111111222223445788999999999999 9999999987 3555433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.36 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=203.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.+.|+..+.||+|+||.||+|+.. ++..||+|++... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456899999999999999999964 6889999987643 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLKL 386 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~~ 386 (530)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999987653 68999999999999999999999 59999999999999976 45699999999988
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
...........||+.|+|||++. ..++.++|||||||++|||++|..||..... ......+.... . ....+
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~-~-~~~~~--- 259 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGK-Y-TFDSP--- 259 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-C-CCCSG---
T ss_pred CCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-C-CCCch---
Confidence 76655555667999999999985 5799999999999999999999999976532 23333332221 0 01011
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhh
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGI 503 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i 503 (530)
.....+..+.+++.+||+.+| +|||+.|+++ .+++.
T Consensus 260 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 260 -EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred -hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 112334678999999999999 9999999986 35554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.11 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=200.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEee--cCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~L 307 (530)
.++|+..+.||+|+||.||++... +++.||+|.+.. ...+.+.+|++++++++||||+++++++.. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999964 688999998753 234678999999999999999999998853 567899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----eeecCCCCCcEEEcCCCeEEEeecC
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP-----LFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-----ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR--SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHH--C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcc--cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999764321 12589999999999999999999994 6 9999999999999999999999999
Q ss_pred CcccccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 383 LLKLVTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 383 la~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
+++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~-~~~--- 234 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG-KFR--- 234 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-CCC---
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhc-ccc---
Confidence 9987643321 1233578899999999988999999999999999999999999975432 2222222221 111
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHh
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEG 502 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~ 502 (530)
..+......+.+++.+||+.+| +|||+.||++.+..
T Consensus 235 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 -----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1122334688999999999999 99999999976543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=353.82 Aligned_cols=260 Identities=19% Similarity=0.347 Sum_probs=185.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 304 (530)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|+++|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999984 46889999987542 346789999999999999999999999443 56
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+ +|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 579999997642 68999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCC----------------------------CcCcccccccccCcccc-CCCCCCchhhHHHHHHHHHHHHc----
Q 009644 385 KLVTGSH----------------------------HAGSTSAVDCFLDPELN-LSKNYSAGSDVYSFGVFLLELIS---- 431 (530)
Q Consensus 385 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSfGvvl~Ellt---- 431 (530)
+...... ......||+.|+|||++ ....|+.++|||||||++|||+|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 8764221 11233578999999986 46679999999999999999999
Q ss_pred -------CCCCCCCCCCC--------------------chHHHHHHHHhhc------------------cCCcccccccc
Q 009644 432 -------GREAHGRNHSN--------------------SDQNLILQVKRSC------------------DLGKYVDKTLG 466 (530)
Q Consensus 432 -------G~~p~~~~~~~--------------------~~~~~~~~~~~~~------------------~~~~~~d~~l~ 466 (530)
|+++|.+.... .....+....... .........+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 66666443210 0000011000000 00000111111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhh
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGI 503 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i 503 (530)
.........+.+|+.+||..+| +|||++|+++. ++++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 2223345788999999999999 99999999873 4444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.21 Aligned_cols=248 Identities=17% Similarity=0.285 Sum_probs=204.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------------cHHHHHHHHHHHHhcC-CCCcceEEEEEe
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------------QIQNFLHEVKHIARVH-HRHLVKLVGFCE 300 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------------~~~~~~~E~~il~~l~-H~nIv~l~g~~~ 300 (530)
..++|+..+.||+|+||.||+|... +++.||+|.+... ..+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999964 6789999987532 1356889999999995 999999999999
Q ss_pred ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 301 ~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
.++..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999998653 68999999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCCCcCcccccccccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 381 YGLLKLVTGSHHAGSTSAVDCFLDPELNL------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 381 FGla~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
||+++............++..|+|||.+. ...++.++||||||+++|||++|+.||..... ..........
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~ 244 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSG 244 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHHHhcC
Confidence 99998776554445566889999999874 56789999999999999999999999975432 2222222221
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. .... ......+..+.+++.+|++.+| +|||+.|+++
T Consensus 245 -~~-~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 -NY-QFGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -CC-CCCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -Cc-ccCc----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 10 0000 1122345678999999999999 9999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=361.13 Aligned_cols=246 Identities=19% Similarity=0.326 Sum_probs=204.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccc------ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQ------TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~------~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|... +++.||+|++.. ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999964 789999998643 2456799999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~ 385 (530)
|||+.+|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999997653 68999999999999999999999 599999999999999 567899999999998
Q ss_pred cccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
............||+.|+|||++.+ .++.++|||||||++|||++|++||..... ......+.... .. ...
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~-~~-~~~--- 248 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEKGK-YT-FEL--- 248 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC-CC-CCS---
T ss_pred EcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCC-CC-CCC---
Confidence 7765544445568999999999865 799999999999999999999999976532 23333333221 00 000
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+..+.+++.+|++.+| +|||+.|+++
T Consensus 249 -~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 -PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1122345678999999999999 9999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.19 Aligned_cols=246 Identities=18% Similarity=0.271 Sum_probs=201.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999964 6889999987533 24678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998654 268999999999999999999999 59999999999999999999999999999865432
Q ss_pred C---CcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
. ......++..|+|||.+.+..+ +.++||||||+++|||++|+.||........ . ......... ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-~~~~~~~~~---~~----- 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E-YSDWKEKKT---YL----- 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-H-HHHHHTTCT---TS-----
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-H-HHHhhhccc---cc-----
Confidence 1 1234458889999999987765 7899999999999999999999976543321 1 111111100 00
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+.+++.+|++.+| +|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112334678899999999999 9999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.47 Aligned_cols=242 Identities=21% Similarity=0.358 Sum_probs=197.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+... ...++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999965 7899999987632 346788999999999 999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----------------
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---------------- 372 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---------------- 372 (530)
|||+++|+|.+++...... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999764211 1268999999999999999999999 59999999999999984
Q ss_pred ---CCeEEEeecCCcccccCCCCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHH
Q 009644 373 ---NYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLI 448 (530)
Q Consensus 373 ---~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~ 448 (530)
...+||+|||+++..... ....+|..|+|||.+.+. .++.++||||||+++|||++|.+++... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------DQW 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------HHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------hHH
Confidence 447999999999876543 234588999999998765 6678999999999999999999876432 111
Q ss_pred HHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 449 LQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 449 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...... .. ...+......+.+++.+||+.+| +|||+.|+++
T Consensus 238 ~~~~~~-~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 HEIRQG-RL--------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHTT-CC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcC-CC--------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 112111 11 11222334688999999999999 9999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.05 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=189.5
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999985 46889999987542 2457889999999999999999999997654
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||++ |+|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 6799999996 578888852 58899999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------- 456 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~------- 456 (530)
++............+|..|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHHHH
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence 98765444344556899999999999999999999999999999999999999765322 11111111000
Q ss_pred -------------CCcc--------cc----ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 -------------LGKY--------VD----KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 -------------~~~~--------~d----~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... .. +............+.+++.+|++.+| +|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 00 00000112235678999999999999 9999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=338.61 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=200.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEee----cCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~~L 307 (530)
.++|+..+.||+|+||.||++.. .+++.||+|++... ..+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999995 67899999987532 34678999999999999999999999863 347889
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++...... ...+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999863211 1368999999999999999999999 59999999999999999999999999998764
Q ss_pred cCCCCc----------CcccccccccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 388 TGSHHA----------GSTSAVDCFLDPELNLSKN---YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 388 ~~~~~~----------~~~~gt~~y~aPE~~~~~~---~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
...... ....+|..|+|||.+.... ++.++||||||+++|||++|+.||........ .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~ 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQNQ 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHCC
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhcc
Confidence 321110 1223688899999987554 68999999999999999999999853110000 011111111
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
... .........+.+++.+||+.+| +|||+.++++.|+.+...
T Consensus 264 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 264 LSI---------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred CCC---------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 000 1112334688999999999999 999999999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.09 Aligned_cols=254 Identities=19% Similarity=0.314 Sum_probs=197.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee--------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE-------- 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~-------- 301 (530)
.++|+..+.||+|+||.||+|+. .+++.||+|++... ....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36789999999999999999996 57899999987532 23578899999999999999999999977
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
.+..++||||++ |+|.+.+.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 346899999997 58888876543 268999999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCC-----CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 382 GLLKLVTGSH-----HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 382 Gla~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|+++.+.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998764221 1233457899999999875 568999999999999999999999998654332222222222111
Q ss_pred cCCcccccccc---------------ccchh------HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDKTLG---------------EQTVG------AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~~l~---------------~~~~~------~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... ..+... ..... ....+.+++.+|++.+| +|||++|+++
T Consensus 249 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPE--VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTT--TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Chh--hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 100 000000 00000 13458899999999999 9999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.19 Aligned_cols=258 Identities=19% Similarity=0.318 Sum_probs=201.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEE--cCCCEEEEEEccccc-----HHHHHHHHHHHHhc---CCCCcceEEEEEe----
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL--QDGSLVVIKRHLQTQ-----IQNFLHEVKHIARV---HHRHLVKLVGFCE---- 300 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~--~~~~~vavK~~~~~~-----~~~~~~E~~il~~l---~H~nIv~l~g~~~---- 300 (530)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 467889999875322 23577888887776 8999999999987
Q ss_pred -ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 301 -ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 301 -~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 799999986532 258999999999999999999999 599999999999999999999999
Q ss_pred ecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 380 DYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 380 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
|||+++............++..|+|||++.+..++.++||||||+++|||++|+.||...........+...........
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99999876544444455688999999999999999999999999999999999999986543221111111111000000
Q ss_pred c--------------ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 Y--------------VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 ~--------------~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ ....+..........+.+++.+||+.+| +|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0011111223445678999999999999 9999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.21 Aligned_cols=248 Identities=16% Similarity=0.290 Sum_probs=196.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----------HHHHHHHHHHHHhcCCCCcceEEEEEeec
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----------IQNFLHEVKHIARVHHRHLVKLVGFCEEN 302 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~H~nIv~l~g~~~~~ 302 (530)
..++|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999964 57899999875432 23588999999999999999999998765
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe---EEEe
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT---AKVS 379 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~---~KI~ 379 (530)
. .++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 899999999999999987542 68999999999999999999999 59999999999999987654 9999
Q ss_pred ecCCcccccCCCCcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 380 DYGLLKLVTGSHHAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 380 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
|||+++............+|..|+|||++. ...++.++||||||+++|||++|..||......... ....... .
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~-~ 236 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITSG-K 236 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHHHT-C
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHHhC-c
Confidence 999998765433233445889999999963 567899999999999999999999999765433221 1111111 0
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. .. ...........+.+++.+|++.+| +|||+.++++
T Consensus 237 ~-~~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 Y-NF----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-CC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-cc----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00 001112334688999999999999 9999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=334.04 Aligned_cols=246 Identities=17% Similarity=0.305 Sum_probs=201.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|...+.||+|+||.||+++.. +++.||+|.+... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467889999999999999999964 6889999987643 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCeEEEeecCCccccc
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL---EENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl---~~~~~~KI~DFGla~~~~ 388 (530)
+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999997653 68999999999999999999999 599999999999999 788999999999997643
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ..... ..
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~--~~~~~----~~ 230 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGY--YEFES----PF 230 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCC--CCCCT----TT
T ss_pred CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCC--CCCCc----cc
Confidence 32 22234588999999999999999999999999999999999999975432 22222222211 00000 11
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+..+.+++.+|++.+| +|||+.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22334688999999999999 9999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.52 Aligned_cols=256 Identities=18% Similarity=0.370 Sum_probs=197.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ-----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999964 48899999865322 345789999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988876542 68999999999999999999999 5999999999999999999999999999987644
Q ss_pred CC-CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh------------hc
Q 009644 390 SH-HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR------------SC 455 (530)
Q Consensus 390 ~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~------------~~ 455 (530)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..... ..
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 32 22345588899999998765 789999999999999999999999976543222111111100 00
Q ss_pred cCCccccccc------cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDKTL------GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~~l------~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.......+.+ ..........+.+++.+||+.+| +|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000111 01122345789999999999999 9999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.30 Aligned_cols=256 Identities=18% Similarity=0.267 Sum_probs=200.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+..+.||+|+||.||++... ++..||+|.+... ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357899999999999999999965 6889999987543 34678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998753 689999999999999999999982 28999999999999999999999999999765332
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------------cC
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-------------DL 457 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-------------~~ 457 (530)
......+|..|+|||++.+..++.++||||||+++|||+||+.||................... ..
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2234568899999999999999999999999999999999999997643221111100000000 00
Q ss_pred -------------Ccc----ccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 -------------GKY----VDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 -------------~~~----~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+. ....... ........+.+++.+||+.+| +|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 0000000 111234578999999999999 9999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.44 Aligned_cols=248 Identities=22% Similarity=0.382 Sum_probs=199.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
..++|+..+.||+|+||.||+|... +++.||+|.+... ..+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 4578999999999999999999965 5889999987643 4578999999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 107 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999997443 268999999999999999999999 5999999999999999999999999999987654322
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ... ..+..
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~-~~~------~~~~~ 250 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPP-PTF------RKPEL 250 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCC-CCC------SSGGG
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCC-ccc------CCccc
Confidence 2344588899999999999999999999999999999999999975432 122222211110 000 11222
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....+.+++.+||..+| +|||+.++++
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 34678999999999999 9999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=331.29 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=185.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc----HHH-HHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ----IQN-FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~----~~~-~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... ..+ +.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 56789999999999999999995 578899999876432 222 344555578889999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP-PLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
||++ |+|.+++...... ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 6888887652111 1368999999999999999999998 5 99999999999999999999999999998776
Q ss_pred CCCCcCcccccccccCcccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELN----LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
.........+|+.|+|||.+ ....++.++||||||+++|||+||+.||...... ........... ....
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~---- 234 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEP-SPQL---- 234 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHHHSC-CCCC----
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHhccC-CCCc----
Confidence 55444455689999999996 5667899999999999999999999999753321 12222222111 1110
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+..+.+++.+|++.+| +|||+.|+++
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 112234678999999999999 9999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.44 Aligned_cols=273 Identities=18% Similarity=0.254 Sum_probs=194.5
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc--
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ-- 304 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~-- 304 (530)
.+.....++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556678999999999999999999996 46889999987543 23467888899999999999999999966443
Q ss_pred -----eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEE
Q 009644 305 -----QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKV 378 (530)
Q Consensus 305 -----~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI 378 (530)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||.|||....+|+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999975 55555443211 113688999999999999999999922269999999999999997 899999
Q ss_pred eecCCcccccCCCCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--
Q 009644 379 SDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-- 455 (530)
Q Consensus 379 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-- 455 (530)
+|||+++............+|..|+|||++.+. .++.++|||||||++|||+||+.||...........+.......
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 999999987665555556789999999998655 48999999999999999999999998654322222111110000
Q ss_pred -------c-CC--cc-------ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhH
Q 009644 456 -------D-LG--KY-------VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQ 504 (530)
Q Consensus 456 -------~-~~--~~-------~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~ 504 (530)
. .. .. ....+..........+.+++.+||+.+| +|||+.|+++. ++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0 00 00 0000111222346789999999999999 99999999863 44443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=368.12 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=206.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEcC----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
..++|+..+.||+|+||.||+|.... +..||+|..... ..+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 35678889999999999999999643 457999986542 23678999999999999999999999854 5689
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999998643 268999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCCc--CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 387 VTGSHHA--GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 387 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
....... ....++..|+|||.+....++.++||||||+++|||++ |..||..... ......+......
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~------ 611 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL------ 611 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCC------
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCC------
Confidence 6543221 22345678999999988899999999999999999997 9999975432 2333333222111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+...+..+.+++.+||+.+| +|||+.+|++.|+++.+.+.
T Consensus 612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 1223345688999999999999 99999999999999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.67 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=195.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeecCc------eeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ------QLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~------~~LV~ 309 (530)
..+|...+.||+|+||.||+|+..++..+|+|++.... ....+|+++++.++||||+++++++...+. .++||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 35688999999999999999998777779999865432 223479999999999999999999965443 78999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeEEEeecCCccccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~~~~ 388 (530)
||++++ +.+.+..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 999765 4433332111 01368999999999999999999999 5999999999999999 79999999999999876
Q ss_pred CCCCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------------
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------------ 455 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------------ 455 (530)
.........+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.......
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 55555566789999999998764 59999999999999999999999998654322222221111000
Q ss_pred ---cCCccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 ---DLGKYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ---~~~~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+.. ........+.+++.+||+.+| +|||+.|+++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000111 122345689999999999999 9999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.00 Aligned_cols=193 Identities=21% Similarity=0.394 Sum_probs=164.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 304 (530)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 57899999999999999999995 45788999987642 246789999999999999999999999766 56
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+. |+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999995 69999997642 68999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCC-----------------------cCcccccccccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 009644 385 KLVTGSHH-----------------------AGSTSAVDCFLDPELN-LSKNYSAGSDVYSFGVFLLELISGREAH 436 (530)
Q Consensus 385 ~~~~~~~~-----------------------~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSfGvvl~ElltG~~p~ 436 (530)
+....... .....+|+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87643221 2345689999999986 5667999999999999999999854444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.75 Aligned_cols=244 Identities=22% Similarity=0.351 Sum_probs=194.9
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee----cCceeE
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQLL 307 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~~L 307 (530)
.|...+.||+|+||.||+|.. .++..||+|.+... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 467778999999999999995 45778999986532 34678999999999999999999999865 356899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeEEEeecCCccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKL 386 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~~ 386 (530)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+..++|+||||||+|||++ +++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999998653 68999999999999999999999412399999999999998 789999999999976
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.... ......+++.|+|||.+. +.++.++||||||+++|||++|+.||...... ............ ..
T Consensus 182 ~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-----~~--- 249 (290)
T 1t4h_A 182 KRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVK-----PA--- 249 (290)
T ss_dssp CCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCC-----CG---
T ss_pred cccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhccCC-----cc---
Confidence 5432 223445889999999875 56999999999999999999999999754322 222222222111 01
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+......+.+++.+||+.+| +|||+.|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122223578999999999999 9999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.21 Aligned_cols=252 Identities=21% Similarity=0.403 Sum_probs=197.4
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc--ccHHHHHHHHHHHHhc-CCCCcceEEEEEee-----
Q 009644 231 ELKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ--TQIQNFLHEVKHIARV-HHRHLVKLVGFCEE----- 301 (530)
Q Consensus 231 el~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~----- 301 (530)
++....++|+..+.||+|+||.||+|.. .+++.||+|.+.. ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3445578899999999999999999996 5688999998653 3457899999999999 89999999999976
Q ss_pred -cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 302 -NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 302 -~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEEee
Confidence 4678999999999999999986432 268999999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCC-CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh
Q 009644 381 YGLLKLVTGSH-HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454 (530)
Q Consensus 381 FGla~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~ 454 (530)
||++....... ......++..|+|||.+. ...++.++||||||+++|||++|+.||..... ..........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~ 249 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN 249 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHS
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcC
Confidence 99998764322 223345889999999987 56789999999999999999999999975432 1222222111
Q ss_pred ccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 455 CDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 455 ~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..... ........+.+++.+||..+| +|||+.++++
T Consensus 250 -~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 -PAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -CCCCC-------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -ccccC-------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 112234678999999999999 9999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.93 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=194.3
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeec------CceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN------HQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~~~~LV~ 309 (530)
.+|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++... ...++||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 46888899999999999999964 58999999875432 2345799999999999999999998542 2367999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCCccccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLLKLVT 388 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGla~~~~ 388 (530)
||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 133 e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99975 67666653211 11368999999999999999999999 599999999999999954 678999999999775
Q ss_pred CCCCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh----------ccC
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS----------CDL 457 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~----------~~~ 457 (530)
.........+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+...... ...
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 55444556789999999998764 7999999999999999999999999865432221111111000 000
Q ss_pred Cccccccccc------cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 458 GKYVDKTLGE------QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 458 ~~~~d~~l~~------~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.-+.+.. ........+.+++.+||..+| +|||+.|+++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1110011100 122335688999999999999 9999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=329.55 Aligned_cols=248 Identities=20% Similarity=0.354 Sum_probs=198.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
..++|++.+.||+|+||.||+|... ++..||+|.+... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3567999999999999999999965 5889999987543 45789999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999987643 268999999999999999999999 59999999999999999999999999997643221
Q ss_pred -CCcCcccccccccCcccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 391 -HHAGSTSAVDCFLDPELN-----LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 391 -~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
.......++..|+|||.+ ....++.++||||||+++|||++|+.||..... ........... ....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~-~~~~---- 242 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSD-PPTL---- 242 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC-CCCC----
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccC-Cccc----
Confidence 112334588899999997 467889999999999999999999999975432 22222222211 1000
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+......+.+++.+||+.+| +|||+.++++
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122334678999999999999 9999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.57 Aligned_cols=255 Identities=16% Similarity=0.249 Sum_probs=199.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--HHHHHHHHHHHHhcC--------CCCcceEEEEEe----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--IQNFLHEVKHIARVH--------HRHLVKLVGFCE---- 300 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~E~~il~~l~--------H~nIv~l~g~~~---- 300 (530)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46899999999999999999984 568899999987543 467889999999985 788999999987
Q ss_pred ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCC-----
Q 009644 301 ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP-PLFHMHFRTSNVLLEENY----- 374 (530)
Q Consensus 301 ~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~ivHrDLk~~NILl~~~~----- 374 (530)
.+...++||||+ +|+|.+++..... ..+++..+..++.|++.||+|||+ + +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEeccchhhhh
Confidence 556889999999 6677777765422 368999999999999999999999 6 999999999999999775
Q ss_pred --------------------------------------------eEEEeecCCcccccCCCCcCcccccccccCccccCC
Q 009644 375 --------------------------------------------TAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS 410 (530)
Q Consensus 375 --------------------------------------------~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~ 410 (530)
.+||+|||+++..... .....+|..|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence 7999999999876432 334568999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchH---HHHHHHHh-hccCC-----------ccccc------------
Q 009644 411 KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ---NLILQVKR-SCDLG-----------KYVDK------------ 463 (530)
Q Consensus 411 ~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~---~~~~~~~~-~~~~~-----------~~~d~------------ 463 (530)
..++.++|||||||++|||+||+.||......... ........ ..... .+...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999765433211 11111111 00000 00000
Q ss_pred --------cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 464 --------TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 464 --------~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.....+......+.+++.+||+.+| +|||+.|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001245566789999999999999 9999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=327.40 Aligned_cols=248 Identities=19% Similarity=0.320 Sum_probs=196.4
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
++|.....||+|+||.||+|.. .++..||+|.+... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556999999999999995 56789999987543 3467899999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeecCCcccccCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DFGla~~~~~~~ 391 (530)
++|+|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999865321 256789999999999999999999 59999999999999987 8999999999998764432
Q ss_pred C-cCcccccccccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 392 H-AGSTSAVDCFLDPELNLSK--NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
. .....++..|+|||.+... .++.++||||||+++|||++|+.||....... ......... .. .+ ..
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~-~~----~~---~~ 247 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKVGMF-KV----HP---EI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHHHHHHH-CC----CC---CC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHHhhccc-cc----cc---cc
Confidence 2 2344588899999998654 38999999999999999999999997433221 111111111 10 11 12
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+......+.+++.+||+.+| +|||+.++++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22344688999999999999 9999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.86 Aligned_cols=247 Identities=13% Similarity=0.156 Sum_probs=191.5
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc------ccHHHHHHHH---HHHHhcCCCCcceEE-------EE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ------TQIQNFLHEV---KHIARVHHRHLVKLV-------GF 298 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~------~~~~~~~~E~---~il~~l~H~nIv~l~-------g~ 298 (530)
.++|...+.||+|+||.||+|+. .+++.||||++.. ...+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999994 6789999998753 2346789999 455566899999998 76
Q ss_pred EeecC-----------------ceeEEeeccCCCChHHHhhccCCCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 009644 299 CEENH-----------------QQLLIYDYIPNGNVQNHLYDSEGLPI--GKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359 (530)
Q Consensus 299 ~~~~~-----------------~~~LV~Ey~~~GsL~~~l~~~~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~iv 359 (530)
+.+.+ ..++||||+ +|+|.+++......+. ..+++..++.++.|++.||+|||+ .+|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence 66553 278999999 6899999986432111 234468888999999999999999 5999
Q ss_pred ecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCCC-----------CCCchhhHHHHHHHHHH
Q 009644 360 HMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK-----------NYSAGSDVYSFGVFLLE 428 (530)
Q Consensus 360 HrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSfGvvl~E 428 (530)
||||||+|||++.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||||++||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999999986432 2233446 889999999877 89999999999999999
Q ss_pred HHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 429 LISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 429 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
|+||+.||........ ...+. . .....+..+.+++.+||+.+| +|||+.|+++ .++++.+
T Consensus 306 lltg~~Pf~~~~~~~~------------~~~~~-~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 306 IWCADLPITKDAALGG------------SEWIF-R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHSSCCC------CC------------SGGGG-S----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHCCCCCcccccccc------------hhhhh-h----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 9999999965432111 00000 0 112234678999999999999 9999999986 4555543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=368.57 Aligned_cols=244 Identities=18% Similarity=0.304 Sum_probs=203.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCcee
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~ 306 (530)
..++|+..+.||+|+||.||+|+.. +++.||+|++... ..+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999954 5788999987643 345688999999988 7999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999998753 68999999999999999999999 5999999999999999999999999999986
Q ss_pred ccC-CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 387 VTG-SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 387 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
... ........||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ......+... ..
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~-~~-------- 559 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEH-NV-------- 559 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHSS-CC--------
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHHhC-CC--------
Confidence 432 2334456799999999999999999999999999999999999999976432 2333333221 10
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCH-----HHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSM-----RQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~-----~eVl~ 498 (530)
.++.....++.+++.+||+.+| +||++ +||.+
T Consensus 560 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1223345688999999999999 99997 56553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.56 Aligned_cols=259 Identities=18% Similarity=0.314 Sum_probs=186.2
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
...++|+..+.||+|+||.||+|. ..+++.||+|.+... ..+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 345789999999999999999998 456889999987643 345788999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSE---GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
|||+++|+|.+++.... ......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999987421 1112368999999999999999999999 599999999999999999999999999987
Q ss_pred cccCCC------CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC
Q 009644 386 LVTGSH------HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458 (530)
Q Consensus 386 ~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 458 (530)
...... ......+|+.|+|||.+.. ..++.++||||||+++|||++|+.||........ ........ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~--~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLTLQND--PP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHTSS--CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHHhccC--CC
Confidence 654321 1123458889999999865 5689999999999999999999999976543221 11111111 00
Q ss_pred ccccc-cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 KYVDK-TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ~~~d~-~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..... ............+.+++.+||+.+| +|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 0001122334678999999999999 9999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=336.45 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=197.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~~ 305 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+... ....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999964 6889999987532 235688999999999999999999998764 678
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+. |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 6999998753 68999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC-----------cCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 386 LVTGSHH-----------AGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 386 ~~~~~~~-----------~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
....... .....+|..|+|||++. ...++.++||||||+++|||++|+.||...........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 7643211 11235788999999875 47799999999999999999999999986542221111111111
Q ss_pred hcc-------------------CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 454 SCD-------------------LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 454 ~~~-------------------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... ........+..........+.+++.+||+.+| +|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 00000001111122445678999999999999 9999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.60 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=199.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~~ 305 (530)
.++|+..+.||+|+||.||+|.. .++..||+|++... ..+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999995 46788999987632 236789999999999999999999999765 368
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+. |+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999996 6999998753 58999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCCC----cCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc----
Q 009644 386 LVTGSHH----AGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD---- 456 (530)
Q Consensus 386 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---- 456 (530)
....... .....+|+.|+|||++. ...++.++|||||||++|||++|+.||...........+........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7643322 23346899999999865 45589999999999999999999999987654433332222111000
Q ss_pred --------------CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 --------------LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 --------------~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
....-..............+.+++.+|++.+| +|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000011122344678999999999999 9999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.27 Aligned_cols=255 Identities=17% Similarity=0.288 Sum_probs=201.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE--cCCCEEEEEEccccc--HHHHHHHHHHHHhcCCC------CcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL--QDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHR------HLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~--~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~------nIv~l~g~~~~~~~~ 305 (530)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|+++++.++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 367899999986533 46788999999998665 499999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-------------
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE------------- 372 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~------------- 372 (530)
++||||+ +++|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8999999986532 258899999999999999999999 59999999999999987
Q ss_pred ------CCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 009644 373 ------NYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446 (530)
Q Consensus 373 ------~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 446 (530)
++.+||+|||+++..... .....+|..|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 234568899999999999999999999999999999999999998654332222
Q ss_pred HHHHHHhhcc--------CCccc---------------------c--ccccccchhHHHHHHHHHHHcccCCC-CCCCHH
Q 009644 447 LILQVKRSCD--------LGKYV---------------------D--KTLGEQTVGAATEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 447 ~~~~~~~~~~--------~~~~~---------------------d--~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
.+........ ..... . .............+.+++.+||+.+| +|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 2222111000 00000 0 00001223456789999999999999 999999
Q ss_pred HHHH
Q 009644 495 QIAG 498 (530)
Q Consensus 495 eVl~ 498 (530)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.54 Aligned_cols=197 Identities=17% Similarity=0.276 Sum_probs=172.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhc------CCCCcceEEEEEeecCcee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARV------HHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l------~H~nIv~l~g~~~~~~~~~ 306 (530)
..+|++.+.||+|+||.||+|... +++.||||++.... .+.+.+|++++..+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 467999999999999999999854 58899999987543 35678899998887 5779999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCe--EEEeecCCc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYT--AKVSDYGLL 384 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~--~KI~DFGla 384 (530)
+||||+. |+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999995 799999986532 258999999999999999999999 59999999999999999887 999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH 440 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 440 (530)
+..... .....+|+.|+|||++.+..++.++|||||||++|||+||++||....
T Consensus 250 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 334568899999999999999999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.04 Aligned_cols=252 Identities=19% Similarity=0.348 Sum_probs=182.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec------C
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN------H 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~ 303 (530)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ..+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 56889999997542 346788999999999999999999998654 5
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 78999988642 68999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
++..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9875432 234568899999999876 679999999999999999999999997654322222222211100
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+.......+..........+.+++.+|+..+| +|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000001111112334678999999999999 9999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.63 Aligned_cols=248 Identities=19% Similarity=0.319 Sum_probs=203.0
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
...++|++.+.||+|+||.||+|... +++.||+|++... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999964 6889999986532 35789999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CeEEEeecCCc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN---YTAKVSDYGLL 384 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~---~~~KI~DFGla 384 (530)
||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999987653 68999999999999999999999 599999999999999754 47999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
+............++..|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+... ... .+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~~~--~~-- 242 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETG-KYA--FD-- 242 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CCC--CC--
T ss_pred eeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC-CCC--CC--
Confidence 87655444444558889999999865 589999999999999999999999975432 2222222221 100 00
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. ......+..+.+++.+|+..+| +|||+.|+++
T Consensus 243 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0112234678999999999999 9999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.78 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=195.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-------cHHHHHHHHHHHHhcCCCCcceEEEEE--eecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-------QIQNFLHEVKHIARVHHRHLVKLVGFC--EENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~H~nIv~l~g~~--~~~~~~ 305 (530)
.++|.+.+.||+|+||.||++.. .++..+|+|.+... ..+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999995 46889999987643 245789999999999999999999998 445688
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
++||||+++| |.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 368999999999999999999999 599999999999999999999999999998
Q ss_pred cccCCC---CcCcccccccccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 386 LVTGSH---HAGSTSAVDCFLDPELNLSKN--YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 386 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
...... ......++..|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~-~~--- 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKG-SY--- 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHC-CC---
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcC-CC---
Confidence 764321 223445889999999987644 3789999999999999999999997543 22222222221 10
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+......+.+++.+|++.+| +|||++|+++
T Consensus 231 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 ------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122334678899999999999 9999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.31 Aligned_cols=255 Identities=15% Similarity=0.245 Sum_probs=203.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccH--------------------HHHHHHHHHHHhcCCCCcceE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI--------------------QNFLHEVKHIARVHHRHLVKL 295 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~--------------------~~~~~E~~il~~l~H~nIv~l 295 (530)
.++|...+.||+|+||.||+|.. +++.||+|.+..... +.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 899999998764321 789999999999999999999
Q ss_pred EEEEeecCceeEEeeccCCCChHHH------hhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 009644 296 VGFCEENHQQLLIYDYIPNGNVQNH------LYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVL 369 (530)
Q Consensus 296 ~g~~~~~~~~~LV~Ey~~~GsL~~~------l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NIL 369 (530)
++++.+.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+. .+|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHT-SCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhcc-CCEeecCCChHhEE
Confidence 9999999999999999999999998 54321 23789999999999999999999982 39999999999999
Q ss_pred EcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCchHHH
Q 009644 370 LEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK-NYSA-GSDVYSFGVFLLELISGREAHGRNHSNSDQNL 447 (530)
Q Consensus 370 l~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~ 447 (530)
++.++.+||+|||+++..... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||...... ...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence 999999999999999876443 23445688999999999877 6766 999999999999999999999865432 222
Q ss_pred HHHHHhhc-cCCc----ccccc----ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 448 ILQVKRSC-DLGK----YVDKT----LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 448 ~~~~~~~~-~~~~----~~d~~----l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+.... .... ...+. ...........+.+++.+||+.+| +|||+.|+++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22222211 1100 00000 000113345688999999999999 9999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=346.73 Aligned_cols=255 Identities=11% Similarity=0.050 Sum_probs=181.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhc--CCCCcceEE-------EEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARV--HHRHLVKLV-------GFC 299 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l--~H~nIv~l~-------g~~ 299 (530)
..+|...+.||+|+||.||+|... +++.||+|++.... .+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999954 78899999876532 34677886555554 699988755 444
Q ss_pred eec-----------------CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCC
Q 009644 300 EEN-----------------HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQR------LSIALGAAKGLEHLHSLVP 356 (530)
Q Consensus 300 ~~~-----------------~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~ 356 (530)
... ...++||||++ |+|.+++..... .+.+..+ ..++.|++.||+|||+ .
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQS--K 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHH--C
Confidence 433 23799999998 899999986532 3444555 7788999999999999 5
Q ss_pred CeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCC
Q 009644 357 PLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGRE 434 (530)
Q Consensus 357 ~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~ 434 (530)
+|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999998764321 13456689999999987 789999999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHhhccCCcccccccc-ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhH
Q 009644 435 AHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG-EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQ 504 (530)
Q Consensus 435 p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~ 504 (530)
||........... .............. ......+..+.+++.+||+.+| +|||+.++++ .++++.
T Consensus 292 Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 292 PFGLVTPGIKGSW-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp STTBCCTTCTTCC-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCcCcccccch-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 9986533211000 00000000000110 1122445789999999999999 9999999975 344443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.74 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=198.5
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
...++|+..+.||+|+||.||+|...+ .+|+|.+... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345788999999999999999999754 4899986532 235678899999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999997643 268899999999999999999999 5999999999999998 6799999999987643
Q ss_pred CC------CCcCcccccccccCccccCC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh
Q 009644 389 GS------HHAGSTSAVDCFLDPELNLS---------KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453 (530)
Q Consensus 389 ~~------~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~ 453 (530)
.. .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... .........
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~ 257 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT 257 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHHT
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcc
Confidence 21 11223347889999999864 4579999999999999999999999975432 222222222
Q ss_pred hccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 454 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
.. . +... .......+.+++.+||+.+| +|||+.++++.|+++.....
T Consensus 258 ~~-~-----~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 258 GM-K-----PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp TC-C-----CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CC-C-----CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11 1 1110 11223568899999999999 99999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=323.42 Aligned_cols=246 Identities=20% Similarity=0.340 Sum_probs=191.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEee-----------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEE----------- 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~----------- 301 (530)
.++|+..+.||+|+||.||+|+. .+++.||+|.+... ..+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46789999999999999999995 47899999987643 34678999999999999999999998865
Q ss_pred --cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEe
Q 009644 302 --NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379 (530)
Q Consensus 302 --~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~ 379 (530)
....++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCCCCEEEe
Confidence 456899999999999999998643 267889999999999999999999 599999999999999999999999
Q ss_pred ecCCcccccCCC---------------CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 009644 380 DYGLLKLVTGSH---------------HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNS 443 (530)
Q Consensus 380 DFGla~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~ 443 (530)
|||+++...... ......++..|+|||.+.+. .++.++||||||+++|||++ ||.... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence 999998654221 12234578899999998754 78999999999999999998 443211 1
Q ss_pred hHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 444 DQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........... .....+ .........+.+++.+|++.+| +|||+.++++
T Consensus 234 ~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNILKKLRSV---SIEFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHST---TCCCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccc---ccccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11222222111 111111 1333445678999999999999 9999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.62 Aligned_cols=251 Identities=21% Similarity=0.384 Sum_probs=190.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEe-----------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCE----------- 300 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~----------- 300 (530)
.++|...+.||+|+||.||+|... +++.||+|++... ..+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999965 4889999987543 3467899999999999999999999874
Q ss_pred ---ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeE
Q 009644 301 ---ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTA 376 (530)
Q Consensus 301 ---~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~ 376 (530)
+....++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 7999998642 68999999999999999999999 5999999999999997 57799
Q ss_pred EEeecCCcccccCCC----CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHH
Q 009644 377 KVSDYGLLKLVTGSH----HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQV 451 (530)
Q Consensus 377 KI~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~ 451 (530)
||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|||+||+.||....... .....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~ 237 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLI 237 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 999999998764321 1223446888999998765 779999999999999999999999998654322 11211
Q ss_pred HhhccC-------------Ccccc-------ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 452 KRSCDL-------------GKYVD-------KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 452 ~~~~~~-------------~~~~d-------~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...... ...+. ..+..........+.+++.+|++.+| +|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111100 00000 00011122345788999999999999 9999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.45 Aligned_cols=252 Identities=19% Similarity=0.299 Sum_probs=177.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----cHHHHHHHHH-HHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----QIQNFLHEVK-HIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----~~~~~~~E~~-il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|... +++.||+|++... ...++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888899999999999999964 6889999987543 2345666666 677789999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP-PLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
||++ |+|.+++..........+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9997 588887764211112378999999999999999999999 5 99999999999999999999999999998775
Q ss_pred CCCCcCcccccccccCcccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELN----LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
.........++..|+|||.+ .+..++.++||||||+++|||++|+.||....... ..... ......+.
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~---~~~~~~~~ 249 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQ---VVKGDPPQ 249 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC---CCCSCCCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHH---HhcCCCCC
Confidence 54444445688999999998 46678999999999999999999999997532210 01110 10101111
Q ss_pred ccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+.. ........+.+++.+||+.+| +|||+.+|++
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111 122345689999999999999 9999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=332.78 Aligned_cols=200 Identities=19% Similarity=0.275 Sum_probs=172.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc--HHHHHHHHHHHHhcC-CC-----CcceEEEEEeecCce
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ--IQNFLHEVKHIARVH-HR-----HLVKLVGFCEENHQQ 305 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~E~~il~~l~-H~-----nIv~l~g~~~~~~~~ 305 (530)
..++|+..+.||+|+||.||+|... +++.||+|++.... ...+..|+.++..++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 3578999999999999999999954 67889999986543 456788999998884 55 499999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCeEEEeecCC
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE--ENYTAKVSDYGL 383 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~--~~~~~KI~DFGl 383 (530)
++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+...+|+||||||+|||++ .++.+||+|||+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999995 699999986532 258999999999999999999996436999999999999995 478899999999
Q ss_pred cccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH 440 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~ 440 (530)
++..... .....+|+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 208 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 208 SCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432 334568899999999999999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.08 Aligned_cols=251 Identities=17% Similarity=0.302 Sum_probs=194.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ---- 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~---- 305 (530)
.++|...+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999995 46889999987642 246788999999999999999999999877654
Q ss_pred --eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 306 --LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 306 --~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
++||||+. |+|.+++.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688887742 58999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.......
T Consensus 191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 9865432 234567899999999877 789999999999999999999999997654222111111110000
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+..........+.+++.+|++.+| +|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000001111122345788999999999999 9999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.48 Aligned_cols=251 Identities=18% Similarity=0.302 Sum_probs=194.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc-----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ----- 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~----- 304 (530)
.++|...+.||+|+||.||+|.. .+|+.||+|++... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46789999999999999999995 46889999987542 24578899999999999999999999987654
Q ss_pred -eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 305 -QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 305 -~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
.++||||+. |+|.+++.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 688887742 58999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.......
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9865432 234467889999999876 678999999999999999999999997654322111111110000
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+.....+.+..........+.+++.+|++.+| +|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000111111222233456789999999999999 9999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.63 Aligned_cols=258 Identities=17% Similarity=0.265 Sum_probs=181.2
Q ss_pred CCcc-ceeeccCCcEEEEEEEEc---CCCEEEEEEccccc-HHHHHHHHHHHHhcCCCCcceEEEEEee--cCceeEEee
Q 009644 238 NFSE-INIIGEGSFGLAYKGLLQ---DGSLVVIKRHLQTQ-IQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLLIYD 310 (530)
Q Consensus 238 ~f~~-~~~LG~G~fG~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~LV~E 310 (530)
.|+. .++||+|+||.||+|+.. ++..||+|++.... ...+.+|+++|++++||||+++++++.. +...++|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 3554 358999999999999965 47789999987543 4578999999999999999999999954 678999999
Q ss_pred ccCCCChHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCeEEEeecC
Q 009644 311 YIPNGNVQNHLYDSEG----LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL----EENYTAKVSDYG 382 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl----~~~~~~KI~DFG 382 (530)
|+. |+|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 996 688888763211 111258999999999999999999999 599999999999999 778999999999
Q ss_pred CcccccCCC----CcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc------hHHHHHHH
Q 009644 383 LLKLVTGSH----HAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNS------DQNLILQV 451 (530)
Q Consensus 383 la~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~------~~~~~~~~ 451 (530)
+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||....... ....+..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 998764321 1234568999999999887 459999999999999999999999997543310 01111111
Q ss_pred Hhhcc---CCcccc----------------cccc---------ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 452 KRSCD---LGKYVD----------------KTLG---------EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 452 ~~~~~---~~~~~d----------------~~l~---------~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..... ...+.+ .... .........+.+++.+||..+| +|||++|+++
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 000000 0000 0000113567899999999999 9999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.92 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=189.2
Q ss_pred CCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
.|...+.||+|+||+||.+...+|+.||||++.....+.+.+|++++.++ +||||+++++++.+++..++||||+. |+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 34556889999999998777778999999998877777889999999987 89999999999999999999999995 79
Q ss_pred hHHHhhccCCCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-------------CeEEEeec
Q 009644 317 VQNHLYDSEGLPI--GKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-------------YTAKVSDY 381 (530)
Q Consensus 317 L~~~l~~~~~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-------------~~~KI~DF 381 (530)
|.+++........ ...++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999986532111 011333567899999999999999 599999999999999754 58999999
Q ss_pred CCcccccCCCC-----cCcccccccccCccccCC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHH
Q 009644 382 GLLKLVTGSHH-----AGSTSAVDCFLDPELNLS-------KNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLI 448 (530)
Q Consensus 382 Gla~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~ 448 (530)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....... ..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~-- 249 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SN-- 249 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HH--
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HH--
Confidence 99987654322 123458999999999865 678999999999999999999 999997543221 11
Q ss_pred HHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 449 LQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 449 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
........... ...........+.+++.+|++.+| +|||+.+|++
T Consensus 250 -i~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 -IIRGIFSLDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHTCCCCCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HhcCCCCcccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111111 001234556789999999999999 9999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.27 Aligned_cols=255 Identities=17% Similarity=0.275 Sum_probs=199.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CC-CEEEEEEcccc--cHHHHHHHHHHHHhcCCCC------cceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DG-SLVVIKRHLQT--QIQNFLHEVKHIARVHHRH------LVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~-~~vavK~~~~~--~~~~~~~E~~il~~l~H~n------Iv~l~g~~~~~~~~ 305 (530)
.++|++.+.||+|+||.||+|... ++ ..||+|++... ..+.+.+|++++++++|+| ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999964 34 68999998653 3467889999999997665 99999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---------------
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL--------------- 370 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl--------------- 370 (530)
++||||+ +|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6788887776432 268999999999999999999999 599999999999999
Q ss_pred ----cCCCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH
Q 009644 371 ----EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN 446 (530)
Q Consensus 371 ----~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~ 446 (530)
+.++.+||+|||+++..... .....+|..|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 67889999999999865432 234568999999999999999999999999999999999999998654322222
Q ss_pred HHHHHHhhcc--------CCccc-------c----------------ccccccchhHHHHHHHHHHHcccCCC-CCCCHH
Q 009644 447 LILQVKRSCD--------LGKYV-------D----------------KTLGEQTVGAATEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 447 ~~~~~~~~~~--------~~~~~-------d----------------~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
.+........ ..... + .............+.+++.+||+.+| +|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 2222111000 00000 0 00001122345688999999999999 999999
Q ss_pred HHHH
Q 009644 495 QIAG 498 (530)
Q Consensus 495 eVl~ 498 (530)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.83 Aligned_cols=260 Identities=18% Similarity=0.284 Sum_probs=199.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--HHHHHHHHHHHHhcC-----------CCCcceEEEEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--IQNFLHEVKHIARVH-----------HRHLVKLVGFCEE 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-----------H~nIv~l~g~~~~ 301 (530)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... .+.+.+|+.++.+++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 36799999999999999999995 568899999987543 456889999999886 8999999999976
Q ss_pred cC----ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEc-----
Q 009644 302 NH----QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVP-PLFHMHFRTSNVLLE----- 371 (530)
Q Consensus 302 ~~----~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~ivHrDLk~~NILl~----- 371 (530)
.+ ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8999999986432 258999999999999999999999 6 999999999999994
Q ss_pred -CCCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc---hHHH
Q 009644 372 -ENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNS---DQNL 447 (530)
Q Consensus 372 -~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~---~~~~ 447 (530)
..+.+||+|||+++..... .....+|..|+|||++.+..++.++||||||+++|||+||+.||....... ....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 4458999999999876432 234568899999999999999999999999999999999999998654221 1111
Q ss_pred HHHHHh-hccCCcc-----------------cc--------------ccccccchhHHHHHHHHHHHcccCCC-CCCCHH
Q 009644 448 ILQVKR-SCDLGKY-----------------VD--------------KTLGEQTVGAATEMMELALQCVDVSS-RRPSMR 494 (530)
Q Consensus 448 ~~~~~~-~~~~~~~-----------------~d--------------~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~ 494 (530)
+..... ....... .. ......+......+.+++.+||+.+| +|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 111111 0000000 00 00011334567889999999999999 999999
Q ss_pred HHHH--HHHhh
Q 009644 495 QIAG--ELEGI 503 (530)
Q Consensus 495 eVl~--~L~~i 503 (530)
|+++ .+++.
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 9987 34443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=322.97 Aligned_cols=247 Identities=14% Similarity=0.241 Sum_probs=194.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcC--CCCcceEEEEEeecCcee
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVH--HRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~--H~nIv~l~g~~~~~~~~~ 306 (530)
...++|+..+.||+|+||.||++...+++.||+|.+... ..+.+.+|++++.+++ ||||+++++++..++..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345779999999999999999999888999999987532 3467899999999996 599999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||| +.+++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++ +.+||+|||+++.
T Consensus 105 lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 9999 56889999998653 68999999999999999999999 59999999999999965 8999999999987
Q ss_pred ccCCCC---cCcccccccccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHH
Q 009644 387 VTGSHH---AGSTSAVDCFLDPELNLS-----------KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVK 452 (530)
Q Consensus 387 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~ 452 (530)
...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ........
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~ 253 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII 253 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHHHHH
Confidence 643322 123458899999999865 47899999999999999999999999754321 11111111
Q ss_pred hhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 453 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
.... .. ..+......+.+++.+||+.+| +|||+.|+++.
T Consensus 254 ~~~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 DPNH-----EI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CTTS-----CC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccc-----cc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1100 00 1112224678999999999999 99999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.10 Aligned_cols=246 Identities=19% Similarity=0.285 Sum_probs=188.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEEeeccCC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
..+|+..+.||+|+||+||.....+++.||||++.......+.+|+++++++ +|||||++++++.+....++||||+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 4568888999999999976555667899999998766555677899999999 89999999999999999999999995
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCeEEEeecCCcccccC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-----NYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-----~~~~KI~DFGla~~~~~ 389 (530)
|+|.+++..... .+...++..++.|++.||+|||+ .+|+||||||+|||++. ...+||+|||+++....
T Consensus 102 g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 699999986542 34444567899999999999999 59999999999999943 34688999999987653
Q ss_pred CC----CcCcccccccccCccccC---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 390 SH----HAGSTSAVDCFLDPELNL---SKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 390 ~~----~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
.. ......||+.|+|||++. ...++.++|||||||++|||+| |..||....... ..........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~~~~~~~---- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACSL---- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHHTTCCCC----
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHHhccCCc----
Confidence 32 223345899999999987 4677889999999999999999 899986443211 1111111111
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
............+.+++.+||+.+| +|||+.+|++
T Consensus 248 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 --DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0011122344567899999999999 9999999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=319.92 Aligned_cols=248 Identities=17% Similarity=0.306 Sum_probs=178.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc----HHH-HHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ----IQN-FLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~----~~~-~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
.++|+..+.||+|+||.||+|... +++.||+|.+.... ..+ +..+..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999964 68899999876432 223 344455678889999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+ ++.+..+..... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 555555554332 2689999999999999999999981 2899999999999999999999999999987655
Q ss_pred CCCcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
........++..|+|||.+. ...++.++||||||+++|||++|+.||..... ............. +.
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~------~~ 249 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEP------PL 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCC------CC
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCC------CC
Confidence 44444556889999999984 56789999999999999999999999975432 2222222222110 00
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+ .........+.+++.+||+.+| +|||+.++++
T Consensus 250 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 L-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 0111234678999999999999 9999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.65 Aligned_cols=250 Identities=17% Similarity=0.272 Sum_probs=172.5
Q ss_pred hcCCccce-eeccCCcEEEEEEEEc-CCCEEEEEEcccccHHHHHHHH-HHHHhcCCCCcceEEEEEee----cCceeEE
Q 009644 236 TNNFSEIN-IIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEV-KHIARVHHRHLVKLVGFCEE----NHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~-~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~-~il~~l~H~nIv~l~g~~~~----~~~~~LV 308 (530)
.++|.+.+ .||+|+||.||+|... +++.||+|++.... ...+|+ ..+..++||||+++++++.. +...++|
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 56788854 6999999999999965 68999999976532 223333 34566799999999999976 4558999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~ 385 (530)
|||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 105 ~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999986532 368999999999999999999999 59999999999999976 4569999999998
Q ss_pred cccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
..... ......+|+.|+|||++....++.++||||||+++|||++|+.||.................... .....
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~--- 254 (336)
T 3fhr_A 180 ETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPN--- 254 (336)
T ss_dssp EC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCT---
T ss_pred ecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc-cccCc---
Confidence 65432 22345678999999999888999999999999999999999999975543221110000000000 00000
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.........+.+++.+|++.+| +|||+.|+++
T Consensus 255 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 255 -PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1122345688999999999999 9999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=325.49 Aligned_cols=240 Identities=18% Similarity=0.326 Sum_probs=197.4
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---------HHHHHHHHHHHHhcC--CCCcceEEEEE
Q 009644 232 LKHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---------IQNFLHEVKHIARVH--HRHLVKLVGFC 299 (530)
Q Consensus 232 l~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~--H~nIv~l~g~~ 299 (530)
.....++|+..+.||+|+||.||+|.. .+++.||+|.+.... .+.+.+|+.++++++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999984 568899999876432 245778999999996 59999999999
Q ss_pred eecCceeEEeeccCC-CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeEE
Q 009644 300 EENHQQLLIYDYIPN-GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTAK 377 (530)
Q Consensus 300 ~~~~~~~LV~Ey~~~-GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~K 377 (530)
...+..++||||+.+ ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 89999998653 68999999999999999999999 5999999999999999 789999
Q ss_pred EeecCCcccccCCCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
|+|||+++...... .....+|..|+|||++.+..+ +.++||||||+++|||++|+.||.... .. ....
T Consensus 191 L~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~---~~~~-- 259 (320)
T 3a99_A 191 LIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI---IRGQ-- 259 (320)
T ss_dssp ECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---HHCC--
T ss_pred EeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh---hccc--
Confidence 99999998765432 334568899999999876665 688999999999999999999996321 11 1111
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.. ........+.+++.+||+.+| +|||++||++
T Consensus 260 --~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 --VF-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --CC-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 112234678999999999999 9999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.07 Aligned_cols=239 Identities=19% Similarity=0.326 Sum_probs=189.9
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---------HHHHHHHHHHHHhc----CCCCcceEEEE
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---------IQNFLHEVKHIARV----HHRHLVKLVGF 298 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---------~~~~~~E~~il~~l----~H~nIv~l~g~ 298 (530)
....++|+..+.||+|+||.||+|.. .+++.||+|.+.... ...+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999984 568899999976432 22456799999999 89999999999
Q ss_pred EeecCceeEEeec-cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeE
Q 009644 299 CEENHQQLLIYDY-IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTA 376 (530)
Q Consensus 299 ~~~~~~~~LV~Ey-~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~ 376 (530)
+...+..++|||| +.+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 78999999998753 68999999999999999999999 5999999999999999 89999
Q ss_pred EEeecCCcccccCCCCcCcccccccccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 377 KVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYS-AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 377 KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
||+|||+++...... .....++..|+|||++.+..+. .++||||||+++|||++|+.||... .... ....
T Consensus 180 kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~---~~~~ 250 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEIL---EAEL 250 (312)
T ss_dssp EECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHH---HTCC
T ss_pred EEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHHh---hhcc
Confidence 999999998765432 3345688899999998776664 5899999999999999999999632 1111 1110
Q ss_pred cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+......+.+++.+||+.+| +|||+.|+++
T Consensus 251 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 -----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122334678899999999998 9999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.50 Aligned_cols=230 Identities=11% Similarity=0.067 Sum_probs=183.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEccccc------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQTQ------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999964 48899999976432 36799999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++++|.+++.. .....++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999953 23556788999999999999999 599999999999999999999998554
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
|++ .++.++||||||+++|||+||+.||............. . ..... .+.....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~--~~~~~-~~~~~~~ 228 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---R--DTAGQ-PIEPADI 228 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---B--CTTSC-BCCHHHH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---H--HhccC-CCChhhc
Confidence 333 37899999999999999999999998654321000000 0 00000 0000112
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
....+..+.+++.+||+.+| +| |+.|+++.|+++....
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 23445678999999999999 99 9999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=345.71 Aligned_cols=237 Identities=19% Similarity=0.324 Sum_probs=192.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEc--CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCc-----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ--DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQ----- 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~----- 304 (530)
.++|++.+.||+|+||.||+|... +++.||||.+... ..+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999965 5889999987543 23568899999999999999999999987765
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+++++|.+++.. .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987653 58999999999999999999999 599999999999999986 8999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
+..... ....||+.|+|||++.+. ++.++|||||||++|||++|.+||....... +. .
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------~~----~- 286 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------LP----E- 286 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------CC----T-
T ss_pred hhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-------------cc----c-
Confidence 876543 445689999999998654 4899999999999999999998876422110 00 0
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCC-CHHHHHHHHHhhHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRP-SMRQIAGELEGIQE 505 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RP-t~~eVl~~L~~i~~ 505 (530)
..........+.+++.+||+.+| +|| +++++...|.+++.
T Consensus 287 -~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 -DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00111233578899999999999 999 57777777877654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=345.71 Aligned_cols=265 Identities=20% Similarity=0.239 Sum_probs=203.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEee------cCce
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEE------NHQQ 305 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~------~~~~ 305 (530)
++|++.+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999995 56889999986542 34678999999999999999999999765 6778
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---eEEEeecC
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY---TAKVSDYG 382 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~---~~KI~DFG 382 (530)
++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 9999999999999999865321 258889999999999999999999 5999999999999999665 49999999
Q ss_pred CcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHH----HHHhhc---
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLIL----QVKRSC--- 455 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~----~~~~~~--- 455 (530)
+++............+|..|+|||.+.+..++.++||||||+++|||++|..||....... .... ......
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~--~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV--QWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH--HSSTTCC------CCSC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh--hhhhhhhcccchhhhhh
Confidence 9998766555555678999999999999999999999999999999999999997542110 0000 000000
Q ss_pred -cCCcc--cc---ccccccchhHHHHHHHHHHHcccCCC-CCCCHHH-----HHHHHHhhHHHh
Q 009644 456 -DLGKY--VD---KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQ-----IAGELEGIQERE 507 (530)
Q Consensus 456 -~~~~~--~d---~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~e-----Vl~~L~~i~~~~ 507 (530)
..... .. +............+.+++.+|+..+| +|||+.+ ..+.++.++...
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000 00 01112344567889999999999999 9999988 556777776544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=304.45 Aligned_cols=226 Identities=18% Similarity=0.281 Sum_probs=178.9
Q ss_pred hcCCccc-eeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHH-HhcCCCCcceEEEEEee----cCceeEE
Q 009644 236 TNNFSEI-NIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHI-ARVHHRHLVKLVGFCEE----NHQQLLI 308 (530)
Q Consensus 236 t~~f~~~-~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il-~~l~H~nIv~l~g~~~~----~~~~~LV 308 (530)
.++|... +.||+|+||.||++.. .+++.||+|.+.. ...+.+|++++ +..+||||+++++++.. +...++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3567776 7899999999999995 5688999999864 34678899988 55599999999999977 6778999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~ 385 (530)
|||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 94 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp ECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999987532 268999999999999999999999 59999999999999998 7899999999986
Q ss_pred cccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc--
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK-- 463 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 463 (530)
... +..++.++||||||+++|||+||+.||........ . ......+..
T Consensus 169 ~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~--~~~~~~~~~~~ 218 (299)
T 3m2w_A 169 ETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------S--PGMKTRIRMGQ 218 (299)
T ss_dssp ECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTC
T ss_pred ccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------h--HHHHHHHhhcc
Confidence 532 24578899999999999999999999975432110 0 000000000
Q ss_pred -cccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 464 -TLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 464 -~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... ........+.+++.+||+.+| +|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 112345789999999999999 9999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.38 Aligned_cols=239 Identities=16% Similarity=0.152 Sum_probs=184.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc-----------HHHHHHHHHHHHhcC---------CCCcceE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----------IQNFLHEVKHIARVH---------HRHLVKL 295 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~---------H~nIv~l 295 (530)
.++|+..+.||+|+||.||+|+. +++.||+|++.... .+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 68999999876432 378899999999885 8888888
Q ss_pred EEEEe------------------------------ecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 009644 296 VGFCE------------------------------ENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAA 345 (530)
Q Consensus 296 ~g~~~------------------------------~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia 345 (530)
.+++. ..+..++||||+++|++.+.+.. ..+++.++..++.|++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 87643 26789999999999987777643 2689999999999999
Q ss_pred HHHHHhh-cCCCCeeecCCCCCcEEEcCCC--------------------eEEEeecCCcccccCCCCcCcccccccccC
Q 009644 346 KGLEHLH-SLVPPLFHMHFRTSNVLLEENY--------------------TAKVSDYGLLKLVTGSHHAGSTSAVDCFLD 404 (530)
Q Consensus 346 ~gL~yLH-~~~~~ivHrDLk~~NILl~~~~--------------------~~KI~DFGla~~~~~~~~~~~~~gt~~y~a 404 (530)
.||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 172 ~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 9999999 7 5999999999999999887 9999999999876532 3468999999
Q ss_pred ccccCCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHc
Q 009644 405 PELNLSKNYSAGSDVYSFGVF-LLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQC 483 (530)
Q Consensus 405 PE~~~~~~~s~ksDVwSfGvv-l~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~C 483 (530)
||++.+.. +.++||||+|++ .+++++|..||.... ................ ..............+.+++.+|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhhccC---cccchhhhhhcCHHHHHHHHHH
Confidence 99998666 899999998777 778889999874210 0001111111111111 1111123445678899999999
Q ss_pred ccCCCCCCCHHHHH
Q 009644 484 VDVSSRRPSMRQIA 497 (530)
Q Consensus 484 l~~~p~RPt~~eVl 497 (530)
|+.+ |++|++
T Consensus 320 L~~d----sa~e~l 329 (336)
T 2vuw_A 320 LNFS----SATDLL 329 (336)
T ss_dssp GGSS----SHHHHH
T ss_pred hccC----CHHHHH
Confidence 9865 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.91 Aligned_cols=240 Identities=13% Similarity=0.122 Sum_probs=178.3
Q ss_pred hcCCccceeeccCCcEEEEEEE-EcCCCEEEEEEccc------ccHHHHHHHHHHHHhcCC-CCcc--------------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQ------TQIQNFLHEVKHIARVHH-RHLV-------------- 293 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~-~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~H-~nIv-------------- 293 (530)
+.+|...+.||+|+||.||+|. ..+|+.||||++.. ...+.|.+|+.++..++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4457778999999999999999 55789999998762 124678999999999977 3211
Q ss_pred -------eEEEEEee-----cCceeEEeeccCCCChHHHhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 009644 294 -------KLVGFCEE-----NHQQLLIYDYIPNGNVQNHLYDSE--GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLF 359 (530)
Q Consensus 294 -------~l~g~~~~-----~~~~~LV~Ey~~~GsL~~~l~~~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~iv 359 (530)
.+..++.. ....+++|+++ +|+|.+++.... ......+++..++.++.|++.||+|||+ .+|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcc
Confidence 11111111 12456777766 789999885210 0111357888999999999999999999 5999
Q ss_pred ecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCcccc----------CCCCCCchhhHHHHHHHHHHH
Q 009644 360 HMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELN----------LSKNYSAGSDVYSFGVFLLEL 429 (530)
Q Consensus 360 HrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSfGvvl~El 429 (530)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999865433 334456 899999998 666789999999999999999
Q ss_pred HcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 430 ISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 430 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+||+.||........ ....+.. ....+..+.+++.+||+.+| +|||+.++++
T Consensus 311 ltg~~Pf~~~~~~~~----------------~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 311 WCADLPNTDDAALGG----------------SEWIFRS-CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHSSCCCCTTGGGSC----------------SGGGGSS-CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCcchhhh----------------HHHHHhh-cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999975432110 0111110 11233679999999999999 9999888754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=282.51 Aligned_cols=181 Identities=15% Similarity=0.091 Sum_probs=127.9
Q ss_pred eeccCCcEEEEEEE-EcCCCEEEEEEcccc-------------cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEE
Q 009644 244 IIGEGSFGLAYKGL-LQDGSLVVIKRHLQT-------------QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 244 ~LG~G~fG~Vy~g~-~~~~~~vavK~~~~~-------------~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV 308 (530)
..+.|++|.+..++ +--|+.+++|.+... ..++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666655 345788999986532 235799999999999 799999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||++||+|.++|.... .++.. .|+.||+.||+|+|+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998653 56654 488999999999999 699999999999999999999999999998765
Q ss_pred CCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 009644 389 GSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA 435 (530)
Q Consensus 389 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p 435 (530)
.... .....||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 334569999999999854 577889999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=259.04 Aligned_cols=179 Identities=17% Similarity=0.171 Sum_probs=143.3
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEccccc-----------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-----------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
..+.||+|+||.||+|.. .+..+++|+..... .+.|.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 347899999999999965 46778888743211 245899999999999999996666666777889999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.. +..++.|+++||+|||+ ++|+||||||+|||+++ .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999864 45799999999999999 59999999999999999 999999999998754
Q ss_pred CCCc--------CcccccccccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 009644 390 SHHA--------GSTSAVDCFLDPELNLS--KNYSAGSDVYSFGVFLLELISGREAHG 437 (530)
Q Consensus 390 ~~~~--------~~~~gt~~y~aPE~~~~--~~~s~ksDVwSfGvvl~ElltG~~p~~ 437 (530)
.... ....||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3211 24458999999999876 668888999999999999988887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=210.07 Aligned_cols=150 Identities=11% Similarity=0.048 Sum_probs=120.7
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc---------------------cHHHHHHHHHHHHhc
Q 009644 229 ILELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT---------------------QIQNFLHEVKHIARV 287 (530)
Q Consensus 229 ~~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~---------------------~~~~~~~E~~il~~l 287 (530)
+..+......|+..+.||+|+||.||+|...+|+.||+|.+... ....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34444555677788999999999999999977999999987531 235689999999999
Q ss_pred CCCCcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 009644 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSN 367 (530)
Q Consensus 288 ~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~N 367 (530)
+ | +++.+++.. +..++||||+++|+|.+ +.. .+...++.|++.||+|||+ .+|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHH
Confidence 9 4 566665543 56699999999999998 421 1234699999999999999 599999999999
Q ss_pred EEEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccC
Q 009644 368 VLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409 (530)
Q Consensus 368 ILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 409 (530)
||++ ++.+||+|||+++.. ..++|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEET------------TSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeEC------------CCCCHHHHHH
Confidence 9999 999999999999743 2378888863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.9e-20 Score=180.34 Aligned_cols=133 Identities=13% Similarity=0.127 Sum_probs=105.3
Q ss_pred CccceeeccCCcEEEEEEEE-cCCCE--EEEEEccccc---------------------------HHHHHHHHHHHHhcC
Q 009644 239 FSEINIIGEGSFGLAYKGLL-QDGSL--VVIKRHLQTQ---------------------------IQNFLHEVKHIARVH 288 (530)
Q Consensus 239 f~~~~~LG~G~fG~Vy~g~~-~~~~~--vavK~~~~~~---------------------------~~~~~~E~~il~~l~ 288 (530)
|++.+.||+|+||.||+|.. .+|+. ||||...... ...+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 78888 9999753221 125789999999998
Q ss_pred CCCc--ceEEEEEeecCceeEEeeccCC-C----ChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCeee
Q 009644 289 HRHL--VKLVGFCEENHQQLLIYDYIPN-G----NVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH-SLVPPLFH 360 (530)
Q Consensus 289 H~nI--v~l~g~~~~~~~~~LV~Ey~~~-G----sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~ivH 360 (530)
|+++ ..++++ ...+|||||+.+ | +|.++... .++.++..++.|++.||.||| + .+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~--~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE--AELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT--SCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence 8754 444443 356899999942 4 66665432 223456789999999999999 8 59999
Q ss_pred cCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 361 MHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 361 rDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-16 Score=164.52 Aligned_cols=133 Identities=14% Similarity=0.100 Sum_probs=99.1
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----------------cHHH--------HHHHHHHHHhcCCCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----------------QIQN--------FLHEVKHIARVHHRH 291 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----------------~~~~--------~~~E~~il~~l~H~n 291 (530)
.-|++...||+|+||.||+|...+|+.||||++... .... ..+|...|.++++.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348899999999999999999889999999975321 0111 234667777775544
Q ss_pred cc--eEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 009644 292 LV--KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVL 369 (530)
Q Consensus 292 Iv--~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NIL 369 (530)
+. ..+++ ...+|||||+++++|.++... .....++.|++.+|.|||+ .+||||||||.|||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK--HGLIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEE
Confidence 32 22222 134799999999888664321 1234678999999999999 59999999999999
Q ss_pred EcCCC----------eEEEeecCCccc
Q 009644 370 LEENY----------TAKVSDYGLLKL 386 (530)
Q Consensus 370 l~~~~----------~~KI~DFGla~~ 386 (530)
+++++ .+.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 98876 489999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.3e-11 Score=120.73 Aligned_cols=142 Identities=13% Similarity=0.062 Sum_probs=113.1
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccc---ccHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEE
Q 009644 233 KHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ---TQIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 233 ~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV 308 (530)
......|.....++.|+++.||+.... ++.+++|.... .....+.+|+++++.+. |..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888888899999999998754 67899998764 33456889999999994 67788999999988899999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV--------------------------------- 355 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------- 355 (530)
|||+++.+|.+.+.. ......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999998876321 1123467889999999999820
Q ss_pred ------------------------CCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 356 ------------------------PPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 356 ------------------------~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
..++|+|+++.|||++++..+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876667899999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=117.76 Aligned_cols=135 Identities=14% Similarity=0.161 Sum_probs=101.7
Q ss_pred CCccceeec-cCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCCCC--cceEEEEEeecCceeEEeeccCC
Q 009644 238 NFSEINIIG-EGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRH--LVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 238 ~f~~~~~LG-~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~n--Iv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++.. ..++ .|..+.||+....+|..+++|.........+.+|+++++.+++.+ +.+++++...++..++||||+++
T Consensus 21 ~~~~-~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 21 GYDW-AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp TCEE-EECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCce-EecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 4444 3444 556699999987777889999876554456889999999996544 56689988888889999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV--------------------------------------- 355 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------- 355 (530)
.+|. .. ..+. ..++.+++..|..||+..
T Consensus 100 ~~l~--~~--------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 100 QDLL--SS--------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp EETT--TS--------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cccC--cC--------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 8884 21 1121 256777888888888741
Q ss_pred -----------------CCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 356 -----------------PPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 356 -----------------~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
..++|+|++|.|||++++..++|.|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1299999999999998876778999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.1e-10 Score=115.39 Aligned_cols=138 Identities=13% Similarity=0.279 Sum_probs=107.0
Q ss_pred cceeeccCCcEEEEEEEEcCCCEEEEEEcc--ccc----HHHHHHHHHHHHhcC--CCCcceEEEEEeec---CceeEEe
Q 009644 241 EINIIGEGSFGLAYKGLLQDGSLVVIKRHL--QTQ----IQNFLHEVKHIARVH--HRHLVKLVGFCEEN---HQQLLIY 309 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~--~~~----~~~~~~E~~il~~l~--H~nIv~l~g~~~~~---~~~~LV~ 309 (530)
..+.|+.|.++.||+....+ ..+++|+.. ... ...+.+|.++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45789999999999988754 578888765 322 346788999999996 45688999998776 4589999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL----------------------------------- 354 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------- 354 (530)
||+++..+.+... ..++..++..++.++++.|..||+.
T Consensus 121 e~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999887754211 2467888899999999999999972
Q ss_pred ---------------------CCCeeecCCCCCcEEEcCCC--eEEEeecCCccc
Q 009644 355 ---------------------VPPLFHMHFRTSNVLLEENY--TAKVSDYGLLKL 386 (530)
Q Consensus 355 ---------------------~~~ivHrDLk~~NILl~~~~--~~KI~DFGla~~ 386 (530)
...++|+|+++.|||++.++ .+.|.||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 14699999999999999765 368999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.7e-09 Score=106.73 Aligned_cols=182 Identities=20% Similarity=0.263 Sum_probs=121.5
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcC-CCC--cceEEEEEeecC---ceeEEeeccCC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVH-HRH--LVKLVGFCEENH---QQLLIYDYIPN 314 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~-H~n--Iv~l~g~~~~~~---~~~LV~Ey~~~ 314 (530)
++.++.|.+..||+.. ..+++|..... ....+.+|.++++.+. +.. +.+++......+ ..|+|||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 3579999999999853 45888875543 3467889999999883 332 445665554433 35789999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL---------------------------------------- 354 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------------------------------------- 354 (530)
.+|.+.... .++..++..++.+++..|..||+.
T Consensus 101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 888754331 467777888888888888888851
Q ss_pred ----------------CCCeeecCCCCCcEEEcC--CCeEEEeecCCcccccCCCCc---Ccc---ccc-------ccc-
Q 009644 355 ----------------VPPLFHMHFRTSNVLLEE--NYTAKVSDYGLLKLVTGSHHA---GST---SAV-------DCF- 402 (530)
Q Consensus 355 ----------------~~~ivHrDLk~~NILl~~--~~~~KI~DFGla~~~~~~~~~---~~~---~gt-------~~y- 402 (530)
.+.++|+|+++.||++++ ...+.|.||+.+..-...... ... .+. ..|
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 024799999999999998 566889999988653221000 000 000 001
Q ss_pred -cC-ccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 009644 403 -LD-PELNLSKNYSAGSDVYSFGVFLLELISGREAH 436 (530)
Q Consensus 403 -~a-PE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~ 436 (530)
.. |+... ......+.|++|.++|++.+|..+|
T Consensus 254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 12110 1122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=7.6e-07 Score=86.83 Aligned_cols=135 Identities=17% Similarity=0.170 Sum_probs=95.4
Q ss_pred eeeccCCcE-EEEEEEEc-CCCEEEEEEcccccHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeeccCCCChHH
Q 009644 243 NIIGEGSFG-LAYKGLLQ-DGSLVVIKRHLQTQIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYIPNGNVQN 319 (530)
Q Consensus 243 ~~LG~G~fG-~Vy~g~~~-~~~~vavK~~~~~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~ 319 (530)
+.+..|..| .||+.... ++..+++|+.......++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 345556555 68987743 46678999877666778899999999884 3346788999999999999999999887766
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 009644 320 HLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL--------------------------------------------- 354 (530)
Q Consensus 320 ~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------------- 354 (530)
..... ......+..+++..|.-||+.
T Consensus 110 ~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 110 VLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 54321 111223444444444444431
Q ss_pred -----------CCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 355 -----------VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 355 -----------~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
...++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.9e-06 Score=86.15 Aligned_cols=134 Identities=14% Similarity=0.159 Sum_probs=93.5
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCC---CcceEEEEEe-ecCceeEEeeccCCCC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHR---HLVKLVGFCE-ENHQQLLIYDYIPNGN 316 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~---nIv~l~g~~~-~~~~~~LV~Ey~~~Gs 316 (530)
++.++.|....||+. +..+++|..... ....+.+|.++|..+.+. .+.+.+.++. ..+..++||||+++.+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 467889999999987 456788875432 346788999999999653 3567777764 4556789999999988
Q ss_pred hHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 009644 317 VQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL------------------------------------------ 354 (530)
Q Consensus 317 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------ 354 (530)
|.+.... .++..+...++.++++.|..||+.
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8763211 234444445555555555555532
Q ss_pred ----------------CCCeeecCCCCCcEEEcC---CCe-EEEeecCCccc
Q 009644 355 ----------------VPPLFHMHFRTSNVLLEE---NYT-AKVSDYGLLKL 386 (530)
Q Consensus 355 ----------------~~~ivHrDLk~~NILl~~---~~~-~KI~DFGla~~ 386 (530)
.+.++|+|+++.|||++. ++. +.|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 135699999999999987 344 58999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.6e-06 Score=85.65 Aligned_cols=77 Identities=9% Similarity=-0.007 Sum_probs=56.6
Q ss_pred ceee-ccCCcEEEEEEEEc-------CCCEEEEEEccccc------HHHHHHHHHHHHhcC-C--CCcceEEEEEeec--
Q 009644 242 INII-GEGSFGLAYKGLLQ-------DGSLVVIKRHLQTQ------IQNFLHEVKHIARVH-H--RHLVKLVGFCEEN-- 302 (530)
Q Consensus 242 ~~~L-G~G~fG~Vy~g~~~-------~~~~vavK~~~~~~------~~~~~~E~~il~~l~-H--~nIv~l~g~~~~~-- 302 (530)
.+.| +.|....+|+.... ++..+++|...... ...+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3677 88999999998764 25678888765432 246788999998884 2 3577888888665
Q ss_pred -CceeEEeeccCCCChH
Q 009644 303 -HQQLLIYDYIPNGNVQ 318 (530)
Q Consensus 303 -~~~~LV~Ey~~~GsL~ 318 (530)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.7e-05 Score=77.08 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=80.4
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC--CCCcceEEE------EEeecCceeEEeeccC
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH--HRHLVKLVG------FCEENHQQLLIYDYIP 313 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~--H~nIv~l~g------~~~~~~~~~LV~Ey~~ 313 (530)
.+.|+.|..+.||+....++ .+++|+.... ..+...|.+++..+. .-.+.+++. +....+..+++|||++
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 35576677899999987655 4888887653 344445666665552 112333332 1124567889999999
Q ss_pred CCChH--------------HHhhcc-CCC--CC------CCCCHHHH-------------------------------HH
Q 009644 314 NGNVQ--------------NHLYDS-EGL--PI------GKLTMRQR-------------------------------LS 339 (530)
Q Consensus 314 ~GsL~--------------~~l~~~-~~~--~~------~~l~~~~~-------------------------------~~ 339 (530)
+.++. ..++.. ... +. ..-.|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 111211 111 10 01123211 01
Q ss_pred HHHHHHHHHHHhhc-----------CCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 340 IALGAAKGLEHLHS-----------LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 340 i~~qia~gL~yLH~-----------~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
+...+..++++|+. ....++|+|+.+.|||++.++.+.|.||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11223445666652 23689999999999999888889999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=5.2e-05 Score=78.29 Aligned_cols=72 Identities=13% Similarity=0.173 Sum_probs=49.2
Q ss_pred ceeeccCCcEEEEEEEEc-CCCEEEEEEcccc----------cHHHHHHHHHHHHhcCC--C-CcceEEEEEeecCceeE
Q 009644 242 INIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT----------QIQNFLHEVKHIARVHH--R-HLVKLVGFCEENHQQLL 307 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~----------~~~~~~~E~~il~~l~H--~-nIv~l~g~~~~~~~~~L 307 (530)
.+.||.|.++.||++... ++..+++|..... ..+.+..|.+++..+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999753 4678999974321 12456789999988742 3 34466654 3445689
Q ss_pred EeeccCCC
Q 009644 308 IYDYIPNG 315 (530)
Q Consensus 308 V~Ey~~~G 315 (530)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00015 Score=72.63 Aligned_cols=141 Identities=12% Similarity=0.129 Sum_probs=95.3
Q ss_pred ccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC---CCCcceEEEEEeecCceeEEeeccCCCC
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH---HRHLVKLVGFCEENHQQLLIYDYIPNGN 316 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~---H~nIv~l~g~~~~~~~~~LV~Ey~~~Gs 316 (530)
...+.|+.|.+..+|+... ++..+++|.........|..|.+.|+.+. ...+.++++++...+..++||||+++..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 3457899999999999876 46678899877666677899999998883 3668899999888888999999999876
Q ss_pred hH--------H---HhhccCC-C----CC----C--------CCCHHHHH---HHH----------------HHHHHH-H
Q 009644 317 VQ--------N---HLYDSEG-L----PI----G--------KLTMRQRL---SIA----------------LGAAKG-L 348 (530)
Q Consensus 317 L~--------~---~l~~~~~-~----~~----~--------~l~~~~~~---~i~----------------~qia~g-L 348 (530)
+. . .|+.... . +. + .-+|.... ++. ..+..- .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 52 1 1222211 0 00 0 12454321 111 111111 2
Q ss_pred HHhh--cCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 349 EHLH--SLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 349 ~yLH--~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
..|. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2342 2236899999999999999887 8888974
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00045 Score=69.29 Aligned_cols=142 Identities=10% Similarity=0.013 Sum_probs=74.5
Q ss_pred eeeccCCcEE-EEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcCC--CCcceEEEEEeecCceeEEeeccCCCChHH
Q 009644 243 NIIGEGSFGL-AYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHH--RHLVKLVGFCEENHQQLLIYDYIPNGNVQN 319 (530)
Q Consensus 243 ~~LG~G~fG~-Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~H--~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~ 319 (530)
+.|+.|.... +|+....++..+++|........++..|+.++..+.. -.+.+++.+..+.+ +++||++.+..+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTE 101 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHH
Confidence 4565555444 6676654466777776544322345567777776632 23566777654433 78999997766654
Q ss_pred HhhccC---------------------CCCCCCCCHHHHHH--------------------HHHHHHHHHHHh----hcC
Q 009644 320 HLYDSE---------------------GLPIGKLTMRQRLS--------------------IALGAAKGLEHL----HSL 354 (530)
Q Consensus 320 ~l~~~~---------------------~~~~~~l~~~~~~~--------------------i~~qia~gL~yL----H~~ 354 (530)
++.... ......++...... ....+...++.+ ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 432110 00011122111000 000111122222 111
Q ss_pred CCCeeecCCCCCcEEEcCC----CeEEEeecCCccc
Q 009644 355 VPPLFHMHFRTSNVLLEEN----YTAKVSDYGLLKL 386 (530)
Q Consensus 355 ~~~ivHrDLk~~NILl~~~----~~~KI~DFGla~~ 386 (530)
.+.++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 2579999999999999874 6789999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0008 Score=69.99 Aligned_cols=77 Identities=13% Similarity=0.092 Sum_probs=48.9
Q ss_pred CCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcCccc--ccccccCccccCCC---CCCchhhHHHHHHHHHHHH
Q 009644 356 PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS--AVDCFLDPELNLSK---NYSAGSDVYSFGVFLLELI 430 (530)
Q Consensus 356 ~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~s~ksDVwSfGvvl~Ell 430 (530)
+.++|+|+++.|||++.++ ++|.||+.+..-.......... -...|.+|+..... .-....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 6899999999999999876 9999999886532110000000 11236666655321 1123456668888888887
Q ss_pred cCC
Q 009644 431 SGR 433 (530)
Q Consensus 431 tG~ 433 (530)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00095 Score=65.52 Aligned_cols=76 Identities=13% Similarity=0.166 Sum_probs=56.9
Q ss_pred CCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc---HHHHHHHHHHHHhcCC---CCcceEEEEEeecCceeEEeec
Q 009644 238 NFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHH---RHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H---~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.+..++.+|.|..+.||+....||+.+++|+..... ...|..|.+.|+.+.- --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455668899999999999999999999999865432 2457889999998842 2345566542 34789999
Q ss_pred cCCCCh
Q 009644 312 IPNGNV 317 (530)
Q Consensus 312 ~~~GsL 317 (530)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0029 Score=62.87 Aligned_cols=158 Identities=9% Similarity=0.056 Sum_probs=87.0
Q ss_pred cCHHHHHHhhcCCcc-----ceeeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCC--cceEEEE
Q 009644 227 LTILELKHATNNFSE-----INIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRH--LVKLVGF 298 (530)
Q Consensus 227 ~~~~el~~~t~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~n--Iv~l~g~ 298 (530)
++..++......|.. .+.|+.|....+|+....++ .+++|..... ..+.+..|+.++..+.... +.+++..
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 344455555555543 35677788899999987666 5778876652 3345667888887773212 2333321
Q ss_pred ------EeecCceeEEeeccCCCChHH--------------Hhhcc-CCCCCC---C---CCHHHHHH------------
Q 009644 299 ------CEENHQQLLIYDYIPNGNVQN--------------HLYDS-EGLPIG---K---LTMRQRLS------------ 339 (530)
Q Consensus 299 ------~~~~~~~~LV~Ey~~~GsL~~--------------~l~~~-~~~~~~---~---l~~~~~~~------------ 339 (530)
....+..+++|||+++..+.. .++.. ...... . ..|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 122356789999998765321 11211 010000 0 11222110
Q ss_pred HHHHHHHHHHHhhcC-----CCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 340 IALGAAKGLEHLHSL-----VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 340 i~~qia~gL~yLH~~-----~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
+...+...+++++.. ...++|+|+.+.|||++++..+.|.||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555421 2479999999999999987666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0011 Score=69.41 Aligned_cols=71 Identities=18% Similarity=0.265 Sum_probs=51.3
Q ss_pred eeeccCCcEEEEEEEEcC--------CCEEEEEEcccccH-HHHHHHHHHHHhcCCCC-cceEEEEEeecCceeEEeecc
Q 009644 243 NIIGEGSFGLAYKGLLQD--------GSLVVIKRHLQTQI-QNFLHEVKHIARVHHRH-LVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+.|+.|....+|+....+ +..+++|+...... +.+..|..+++.+...+ ..++++.+.+ .+||||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 678889999999998753 46888998744233 66778999998884333 3677776643 3899999
Q ss_pred CCCCh
Q 009644 313 PNGNV 317 (530)
Q Consensus 313 ~~GsL 317 (530)
++.+|
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 76443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0013 Score=64.87 Aligned_cols=69 Identities=9% Similarity=0.020 Sum_probs=44.4
Q ss_pred ceeeccCCcEEEEEEEEcCCCEEEEEEcccccH--HHHHHHHHHHHhcCCCCc-ceEEEEEeecCceeEEeecc-CCCCh
Q 009644 242 INIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI--QNFLHEVKHIARVHHRHL-VKLVGFCEENHQQLLIYDYI-PNGNV 317 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~-~~GsL 317 (530)
++.|+.|....+|+. ..+++|+...... -+..+|..+++.+....+ .++++++ .+.-++++||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 578999999999998 4578887654311 123568888877742222 4666554 33457899999 55444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0058 Score=60.78 Aligned_cols=141 Identities=9% Similarity=0.058 Sum_probs=80.8
Q ss_pred eeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCC--CcceEEEE-----EeecCceeEEeeccC
Q 009644 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHR--HLVKLVGF-----CEENHQQLLIYDYIP 313 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~--nIv~l~g~-----~~~~~~~~LV~Ey~~ 313 (530)
..++ |....||+....+|+.+++|..... ....+..|..++..+... .+.+++.. ...++..+++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4677 8888999987767777999987632 355677788888877421 23444432 122445678999998
Q ss_pred CCChH-----------HH---hhcc-CCCC---CCCCCHHHH----------------------HHHHHHHHHHHHHhh-
Q 009644 314 NGNVQ-----------NH---LYDS-EGLP---IGKLTMRQR----------------------LSIALGAAKGLEHLH- 352 (530)
Q Consensus 314 ~GsL~-----------~~---l~~~-~~~~---~~~l~~~~~----------------------~~i~~qia~gL~yLH- 352 (530)
+..+. .. ++.. ...+ ....++... ...+..++..++-+-
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 01 1111 0000 012222211 011112222222111
Q ss_pred c-CCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 353 S-LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 353 ~-~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
. ....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 124689999999999999 4 899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0048 Score=64.98 Aligned_cols=72 Identities=17% Similarity=0.092 Sum_probs=47.9
Q ss_pred ceeeccCCcEEEEEEEEcC-CCEEEEEEccccc--HHHHHHHHHHHHhcCCCCc-ceEEEEEeecCceeEEeeccCCCCh
Q 009644 242 INIIGEGSFGLAYKGLLQD-GSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHL-VKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nI-v~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
++.|+.|-...+|+....+ +..+++|+..... .-+-.+|..++..+...++ .++++++.. .+||||+++.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 3678889899999998765 4678888764321 1122589999999865444 577877732 259999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0084 Score=61.49 Aligned_cols=139 Identities=15% Similarity=0.182 Sum_probs=82.2
Q ss_pred eeeccCCcEEEEEEEEc--------CCCEEEEEEcccc--cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeec
Q 009644 243 NIIGEGSFGLAYKGLLQ--------DGSLVVIKRHLQT--QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~--------~~~~vavK~~~~~--~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
+.|..|-...+|+.... ++..+++|+.... ......+|.++++.+. +.-..++++++.++ +||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 56777888889998864 2467888885432 3456778999998883 33346777776542 99999
Q ss_pred cCCCChHHH-----------------hhccCCCCC-CCCC--HHHHHHHHHHHH-------------------HHHHHhh
Q 009644 312 IPNGNVQNH-----------------LYDSEGLPI-GKLT--MRQRLSIALGAA-------------------KGLEHLH 352 (530)
Q Consensus 312 ~~~GsL~~~-----------------l~~~~~~~~-~~l~--~~~~~~i~~qia-------------------~gL~yLH 352 (530)
+++.+|..- |+... .+. .... +.++.++..++. ..++.|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~-~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGME-MPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCC-CSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCC-CCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 987654311 11110 111 1122 344444443332 1233332
Q ss_pred ----cC--CCCeeecCCCCCcEEEcCC----CeEEEeecCCccc
Q 009644 353 ----SL--VPPLFHMHFRTSNVLLEEN----YTAKVSDYGLLKL 386 (530)
Q Consensus 353 ----~~--~~~ivHrDLk~~NILl~~~----~~~KI~DFGla~~ 386 (530)
.. ...++|+|+.+.|||++.+ +.+.+.||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 1368999999999999876 7899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0072 Score=61.39 Aligned_cols=71 Identities=13% Similarity=0.087 Sum_probs=44.1
Q ss_pred eeeccCCcEEEEEEEEcC---------CCEEEEEEccccc--HHHHHHHHHHHHhcCCCC-cceEEEEEeecCceeEEee
Q 009644 243 NIIGEGSFGLAYKGLLQD---------GSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRH-LVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~---------~~~vavK~~~~~~--~~~~~~E~~il~~l~H~n-Iv~l~g~~~~~~~~~LV~E 310 (530)
+.|+.|....+|+....+ +..+++|+..... ..+...|.++++.+...+ ..++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 567888889999988654 2678888765322 113467888888874333 44677654 2 368999
Q ss_pred ccCCCCh
Q 009644 311 YIPNGNV 317 (530)
Q Consensus 311 y~~~GsL 317 (530)
|+++.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.026 Score=56.73 Aligned_cols=72 Identities=15% Similarity=0.161 Sum_probs=44.9
Q ss_pred ceeecc--CCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC---CCCcceEEEE------EeecCceeEEee
Q 009644 242 INIIGE--GSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH---HRHLVKLVGF------CEENHQQLLIYD 310 (530)
Q Consensus 242 ~~~LG~--G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~---H~nIv~l~g~------~~~~~~~~LV~E 310 (530)
.+.+.. |....||+....+| .+++|+...... ..|+.++..|. -|++.+.+.. ....+..+++||
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred eEEeeccCccccceEEEEeCCC-CEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEe
Confidence 345533 33689999987667 889997654432 35666666552 2224444432 223467789999
Q ss_pred ccCCCCh
Q 009644 311 YIPNGNV 317 (530)
Q Consensus 311 y~~~GsL 317 (530)
|+++..+
T Consensus 102 ~i~G~~~ 108 (339)
T 3i1a_A 102 FIHAPNG 108 (339)
T ss_dssp CCCCCBT
T ss_pred ccCCCcC
Confidence 9988765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.51 E-value=0.15 Score=47.83 Aligned_cols=103 Identities=8% Similarity=0.021 Sum_probs=66.8
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~ 394 (530)
-+|.+.|..... ++++++++.++.|.+.+|.-+-....+ ..+=.-|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhcccC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 378999987653 899999999999999998776210011 1223346889999999888764 2111
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA 435 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p 435 (530)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122367888763 4557889999999999998874443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.015 Score=66.12 Aligned_cols=69 Identities=17% Similarity=0.005 Sum_probs=53.0
Q ss_pred CChhhhHHHHHHhhhhhCCCCCCCCCC---CCCCCcCcc------------ccccccCCCCCCceeee------------
Q 009644 39 TDHKVYAEALLACKSALGTPGQSSGRI---GRYPCIRQR------------ACLNCYEPKDPGVASLI------------ 91 (530)
Q Consensus 39 ~~~~~~~~~~~~~k~~~~~~~~~~g~~---~~~pc~~~~------------~~~~c~~~~~~~~~~~~------------ 91 (530)
.++..|+.|+.+||...+.+ +|.++- ..+||.|.| .|+.|+. ..+|++|.
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEEEECG
T ss_pred ccchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecC--CCCEEEEECccCCCCCcCch
Confidence 45667999999999999766 997642 357877789 9999975 35677764
Q ss_pred -cCCCcccccccc-CCCcCCC
Q 009644 92 -FHRIPEICALSF-NPNFFHS 110 (530)
Q Consensus 92 -~~~~~~~~~~~~-~~~~~~~ 110 (530)
+..++.|..+++ +.|.+.+
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG 362 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVS 362 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHH
T ss_pred HHhccccceEeeecccccccc
Confidence 556778899999 7887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.22 E-value=0.11 Score=54.00 Aligned_cols=72 Identities=7% Similarity=0.000 Sum_probs=48.3
Q ss_pred ceeeccCCcEEEEEEEEcC--------CCEEEEEEccccc--HHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEee
Q 009644 242 INIIGEGSFGLAYKGLLQD--------GSLVVIKRHLQTQ--IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~~--~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++.+..|-...+|+....+ +..+++|+..... .-+-.+|..+++.+. +.-..++++.+. -++|||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 3577778888999988753 5778888854322 112357888888874 333456666442 368999
Q ss_pred ccCCCCh
Q 009644 311 YIPNGNV 317 (530)
Q Consensus 311 y~~~GsL 317 (530)
|+++.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.062 Score=36.68 Aligned_cols=23 Identities=26% Similarity=0.317 Sum_probs=12.2
Q ss_pred eeeehhHHHHHHHHHHHHHHHHH
Q 009644 158 AAVVGGVVAALLVIGFVVFVYIC 180 (530)
Q Consensus 158 ~~iv~~~~~~~~~~~~~~~~~~~ 180 (530)
.+|++++++++++++++++++++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~ 33 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGL 33 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEeehhHHHHHHHHHHHHHHH
Confidence 35666666655555544444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.39 E-value=0.052 Score=37.01 Aligned_cols=22 Identities=18% Similarity=0.495 Sum_probs=11.8
Q ss_pred eeehhHHHHHHHHHHHHHHHHH
Q 009644 159 AVVGGVVAALLVIGFVVFVYIC 180 (530)
Q Consensus 159 ~iv~~~~~~~~~~~~~~~~~~~ 180 (530)
+|++++++++++++++++++++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~ 32 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAV 32 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEeehHHHHHHHHHHHHHHH
Confidence 4666666655555444444333
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=92.18 E-value=0.15 Score=50.26 Aligned_cols=67 Identities=22% Similarity=0.197 Sum_probs=43.9
Q ss_pred hhhhHHHHHHhhhhhCCCC---CCCCCCCCCCCcCccccccccCCC-CCCceeee---------------cCCCcccccc
Q 009644 41 HKVYAEALLACKSALGTPG---QSSGRIGRYPCIRQRACLNCYEPK-DPGVASLI---------------FHRIPEICAL 101 (530)
Q Consensus 41 ~~~~~~~~~~~k~~~~~~~---~~~g~~~~~pc~~~~~~~~c~~~~-~~~~~~~~---------------~~~~~~~~~~ 101 (530)
..+|.+|+.++|...+.+. +|.. ..+||.+.|.|+.|.... ..+++.+. +..++.+..+
T Consensus 4 ~~~~~~aL~~~k~~~~~~~~l~~W~~--~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 4 NPQDKQALLQIKKDLGNPTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CHHHHHHHHHHHHHTTCCGGGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CHHHHHHHHHHHHhcCCcccccCCCC--CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 4568999999999997543 5744 247898889999997532 13454443 2334456666
Q ss_pred ccCC-CcCC
Q 009644 102 SFNP-NFFH 109 (530)
Q Consensus 102 ~~~~-~~~~ 109 (530)
++++ |.+.
T Consensus 82 ~L~~~n~l~ 90 (313)
T 1ogq_A 82 YIGGINNLV 90 (313)
T ss_dssp EEEEETTEE
T ss_pred eCCCCCccc
Confidence 6663 5543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.32 E-value=0.72 Score=47.17 Aligned_cols=29 Identities=21% Similarity=0.331 Sum_probs=24.6
Q ss_pred eeecCCCCCcEEE------cCCCeEEEeecCCccc
Q 009644 358 LFHMHFRTSNVLL------EENYTAKVSDYGLLKL 386 (530)
Q Consensus 358 ivHrDLk~~NILl------~~~~~~KI~DFGla~~ 386 (530)
++|+|+.+.|||+ +++..+++.||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999988753
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=90.52 E-value=0.22 Score=33.89 Aligned_cols=8 Identities=25% Similarity=0.646 Sum_probs=4.2
Q ss_pred eeehhHHH
Q 009644 159 AVVGGVVA 166 (530)
Q Consensus 159 ~iv~~~~~ 166 (530)
.+++++++
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 45555555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=89.01 E-value=0.32 Score=53.00 Aligned_cols=67 Identities=15% Similarity=0.005 Sum_probs=46.5
Q ss_pred CChhhhHHHHHHhhhhhCCCCCCC--C-------CCCCCCCcCcc---ccccccCCCCCCceeee-------------cC
Q 009644 39 TDHKVYAEALLACKSALGTPGQSS--G-------RIGRYPCIRQR---ACLNCYEPKDPGVASLI-------------FH 93 (530)
Q Consensus 39 ~~~~~~~~~~~~~k~~~~~~~~~~--g-------~~~~~pc~~~~---~~~~c~~~~~~~~~~~~-------------~~ 93 (530)
..+..|++|+.+||...+.+ +|. | .|..+.+.|.| .|+.|+.. .+|+++. +.
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~-~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGK-NWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-GCCCCC------CCCCCSSCGGGTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGG
T ss_pred hhHHHHHHHHHHHHHHcCCC-CcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHh
Confidence 35567999999999998654 444 2 12112333458 99999753 5777774 45
Q ss_pred CCccccccccCCCcC
Q 009644 94 RIPEICALSFNPNFF 108 (530)
Q Consensus 94 ~~~~~~~~~~~~~~~ 108 (530)
.++.+..+++++|.+
T Consensus 103 ~L~~L~~L~Ls~N~~ 117 (636)
T 4eco_A 103 QLTELEVLALGSHGE 117 (636)
T ss_dssp GCTTCCEEESCCGGG
T ss_pred cCccceEEECcCCcc
Confidence 677899999999975
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.37 E-value=5.5 Score=36.94 Aligned_cols=117 Identities=13% Similarity=0.141 Sum_probs=79.0
Q ss_pred cCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009644 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366 (530)
Q Consensus 287 l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~ 366 (530)
..||+.+.. .+-.+.+.+.+.|+.-+ +...|-.- ..++...+++++..|+.--.++++ -+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecc
Confidence 378988876 45556666555555443 23333221 157889999999999887766654 367789999
Q ss_pred cEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 009644 367 NVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHG 437 (530)
Q Consensus 367 NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~ 437 (530)
|++++.++.+++.-.|+...+ +|. .++...=.-.+=+++..+++++..|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764322 221 22333334477788889999987764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.28 E-value=4.9 Score=37.40 Aligned_cols=115 Identities=10% Similarity=0.098 Sum_probs=76.7
Q ss_pred cCCCCcceEEEEEeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCC
Q 009644 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE-HLHSLVPPLFHMHFRT 365 (530)
Q Consensus 287 l~H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~-yLH~~~~~ivHrDLk~ 365 (530)
..||++ -...-.+++.+.+.++.-+++.=...++ .++..++++++..++.-.. ++++ -+|--|.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeC
Confidence 368887 3344466667667676654443333332 5788999999999887665 5554 46778899
Q ss_pred CcEEEcCCCeEEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhH-HHHHHHHHHHHcCCCCCC
Q 009644 366 SNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDV-YSFGVFLLELISGREAHG 437 (530)
Q Consensus 366 ~NILl~~~~~~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV-wSfGvvl~ElltG~~p~~ 437 (530)
+|++++.++.++|.-.|+-.. ++|.- .+ ..|. -++=+++..++.++..|.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~----------------lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES----------------LPPDE-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT----------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCccc----------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999988776432 23322 12 2233 367778888888877653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 530 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-49
Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 28/281 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRH 291
+ IG GSFG YKG V +K Q+Q F +EV + + H +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
++ +G+ ++ + ++ +HL+ E K M + + IA A+G+++L
Sbjct: 66 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYL 120
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV---TGSHHAGSTSAVDCFLDPELN 408
H + H +++N+ L E+ T K+ D+GL + +GSH S ++ PE+
Sbjct: 121 H--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 409 LSKN---YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465
++ YS SDVY+FG+ L EL++G+ + ++ N+ +I V R Y+ L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIFMVGR-----GYLSPDL 231
Query: 466 GEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
+ M L +C+ RP QI +E +
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 6e-47
Identities = 56/272 (20%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+ +G G FG + G + V +K + FL E + ++ H+ LV+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
L + +I +Y+ NG++ + L G KLT+ + L +A A+G+ +
Sbjct: 73 LYAVVTQEP-IYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKN 412
H R +N+L+ + + K++D+GL +L+ + + A + PE
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472
++ SDV+SFG+ L E+++ ++ +I ++R + +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRM---------VRPDNC 235
Query: 473 ATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
E+ +L C RP+ + LE
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-46
Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 22/275 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKR-HLQTQIQNFLHEVKHIARVHHRHLVKL 295
+ IG+G FG G G+ V +K Q FL E + ++ H +LV+L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 296 VGFCEENHQQL-LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
+G E L ++ +Y+ G++ ++L L L +L + +E+L
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYS 414
H NVL+ E+ AKVSD+GL K + + G + PE K +S
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWTAPEALREKKFS 178
Query: 415 AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474
SDV+SFG+ L E+ S D ++ +V++ + + G
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKM---------DAPDGCPP 227
Query: 475 EMMELALQCVDVS-SRRPSMRQIAGELEGIQEREI 508
+ E+ C + + RPS Q+ +LE I+ E+
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-45
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 22/274 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+ + + IG G FGL + G + V IK R ++F+ E + + ++ H LV+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
L G C E L+++++ +G + ++L GL L + L +G+ +L
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEE- 119
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKN 412
+ H N L+ EN KVSD+G+ + V + ST + PE+
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472
YS+ SDV+SFGV + E+ S + N SNS+ ++ + L + A
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFRL---------YKPRLA 227
Query: 473 ATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
+T + ++ C RP+ ++ +L I E
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 1e-45
Identities = 62/302 (20%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 228 TILELKHATNNFSE---------INIIGEGSFGLAYKGLL----QDGSLVVIKR----HL 270
T + A F++ +IG G FG G L + V IK +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 271 QTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG 330
+ Q ++FL E + + H +++ L G ++ ++I +++ NG++ + L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ----NDG 123
Query: 331 KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390
+ T+ Q + + G A G+++L H N+L+ N KVSD+GL + +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 391 HHAGSTSAVDC------FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444
+ ++ + PE + +++ SDV+S+G+ + E++S E ++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTN 239
Query: 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
Q++I +++ L + + + +L L C + RP QI L+ +
Sbjct: 240 QDVINAIEQDYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
Query: 504 QE 505
Sbjct: 291 IR 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (390), Expect = 1e-43
Identities = 62/290 (21%), Positives = 123/290 (42%), Gaps = 28/290 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQD-GSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLV 293
+ + + +G G +G Y+G+ + V +K + +++ FL E + + H +LV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+L+G C +I +++ GN+ ++L + +++ L +A + +E+L
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK 133
Query: 354 LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC--FLDPELNLSK 411
H N L+ EN+ KV+D+GL +L+TG + A + PE
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 412 NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471
+S SDV++FGV L E+ + + S +L+ + + +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE-------- 243
Query: 472 AATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGRLHSEFGEEID 520
++ EL C + S RPS +I E + + S +E++
Sbjct: 244 ---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ------ESSISDEVE 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-43
Identities = 55/272 (20%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI--QNFLHEVKHIARVHHRHLVK 294
+ + + +G G FG+ G + V IK + + F+ E K + + H LV+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
L G C + +I +Y+ NG + N+L + + +Q L + + +E+L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD--CFLDPELNLSKN 412
H N L+ + KVSD+GL + V + S + + PE+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472
+S+ SD+++FGV + E+ S + +NS+ + + L + A
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRL---------YRPHLA 226
Query: 473 ATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ ++ + C RP+ + + + +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 2e-42
Identities = 62/310 (20%), Positives = 116/310 (37%), Gaps = 46/310 (14%)
Query: 229 ILELKHATNNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKR----HLQTQIQNFL 278
+L L++ NN + IGEG+FG ++ + ++V +K +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 279 HEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIG-------- 330
E +A + ++VKL+G C L+++Y+ G++ L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 331 -----------KLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVS 379
L+ ++L IA A G+ +L H T N L+ EN K++
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIA 182
Query: 380 DYGLLKLVTGSHHAGSTSAVD---CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAH 436
D+GL + + + + + ++ PE Y+ SDV+++GV L E+ S
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 437 GRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQ 495
++ + + D + E+ L C + RPS
Sbjct: 243 YYGMAHEEV-----------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 496 IAGELEGIQE 505
I L+ + E
Sbjct: 292 IHRILQRMCE 301
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 44/229 (19%), Positives = 97/229 (42%), Gaps = 15/229 (6%)
Query: 230 LELKHATNNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR----HLQTQIQNFLHEVKHI 284
+ELK ++F +I+ +G G+ G+ +K G ++ K + E++ +
Sbjct: 1 MELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 285 ARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA 344
+ ++V G + + + +++ G++ L + G++ + +++
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAV 113
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD 404
KGL +L + H + SN+L+ K+ D+G+ + A S ++
Sbjct: 114 IKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMS 171
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVK 452
PE +YS SD++S G+ L+E+ GR + + QV+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 64/283 (22%), Positives = 124/283 (43%), Gaps = 31/283 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGS-----LVVIKR----HLQTQIQNFLHEVKHIARV 287
+ + +IG G FG YKG+L+ S V IK + + Q +FL E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 288 HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
H ++++L G + ++I +Y+ NG + L + + G+ ++ Q + + G A G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAG 122
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FL 403
+++L + H N+L+ N KVSD+GL +++ A T++ +
Sbjct: 123 MKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463
PE + +++ SDV+SFG+ + E+++ E SN + + D
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----------MKAINDG 229
Query: 464 TLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
+ + + +L +QC +RRP I L+ +
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-42
Identities = 59/270 (21%), Positives = 110/270 (40%), Gaps = 22/270 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVK 294
+ +G+G FG + G + V IK + + FL E + + ++ H LV+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
L E ++ +Y+ G++ + L G + + Q + +A A G+ ++
Sbjct: 77 LYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVE-- 130
Query: 355 VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPELNLSKN 412
H R +N+L+ EN KV+D+GL +L+ + + A + PE L
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 413 YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472
++ SDV+SFG+ L EL + ++ ++ QV+R +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRM---------PCPPEC 239
Query: 473 ATEMMELALQCVDVS-SRRPSMRQIAGELE 501
+ +L QC RP+ + LE
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 9e-42
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 33/302 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSL---VVIKR----HLQTQIQNFLHEVKHIARV-H 288
N+ ++IGEG+FG K ++ L IKR + ++F E++ + ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLP-----------IGKLTMRQR 337
H +++ L+G CE L +Y P+GN+ + L S L L+ +Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS 397
L A A+G+++L H N+L+ ENY AK++D+GL +
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 398 AVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457
++ E Y+ SDV+S+GV L E++S + L ++ + L
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQGYRL 245
Query: 458 GKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGRLHSEFG 516
E+ + E+ +L QC RPS QI L + E +++
Sbjct: 246 ---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296
Query: 517 EE 518
E+
Sbjct: 297 EK 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-41
Identities = 68/310 (21%), Positives = 125/310 (40%), Gaps = 35/310 (11%)
Query: 215 AVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGLLQDGS----LVVIKR-- 268
A++P Q ++ + I +F+E+ IG G FG Y G L D +K
Sbjct: 8 ALNPELVQAVQHVVI-GPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 269 --HLQTQIQNFLHEVKHIARVHHRHLVKLVGFC-EENHQQLLIYDYIPNGNVQNHLYDSE 325
++ FL E + H +++ L+G C L++ Y+ +G+++N + +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 326 GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385
P T++ + L AKG++ L H N +L+E +T KV+D+GL +
Sbjct: 125 HNP----TVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 386 LVTGSHHAGSTSAVDC-----FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNH 440
+ + ++ E ++ ++ SDV+SFGV L EL++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 441 SNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGE 499
+ D + L R +Y + E+ L+C RPS ++
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPD-----------PLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 500 LEGIQEREIG 509
+ I IG
Sbjct: 288 ISAIFSTFIG 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 7e-41
Identities = 53/269 (19%), Positives = 103/269 (38%), Gaps = 32/269 (11%)
Query: 239 FSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIARVHHRH 291
FS++ IG GSFG Y +++ +V IK+ + Q+ + EV+ + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
++ G H L+ +Y L + ++ GA +GL +L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYL 131
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK 411
HS + H + N+LL E K+ D+G ++ ++ T ++ PE+ L+
Sbjct: 132 HSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY---WMAPEVILAM 186
Query: 412 N---YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468
+ Y DV+S G+ +EL + ++ S I Q + + +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE----- 241
Query: 469 TVGAATEMMELALQCVDVS-SRRPSMRQI 496
C+ RP+ +
Sbjct: 242 ------YFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-39
Identities = 60/300 (20%), Positives = 124/300 (41%), Gaps = 35/300 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKR----HLQTQIQNFLHEVKHIAR 286
+ +G+GSFG+ Y+G+ + + V IK + FL+E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGL-----PIGKLTMRQRLSIA 341
+ H+V+L+G + L+I + + G+++++L + ++ + + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD- 400
A G+ +L++ H N ++ E++T K+ D+G+ + + + +
Sbjct: 140 GEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 401 --CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG 458
++ PE ++ SDV+SFGV L E+ + E + SN L
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----------LR 246
Query: 459 KYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE---REIGRLHSE 514
++ L ++ + EL C + RPS +I ++ E RE+ +SE
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 306
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-39
Identities = 54/299 (18%), Positives = 109/299 (36%), Gaps = 33/299 (11%)
Query: 231 ELKHATNNFSEINI-IGEGSFGLAYKGLLQ---DGSLVVIKR----HLQTQIQNFLHEVK 282
+L +N +I +G G+FG +G+ + V IK + + + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 283 HIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIAL 342
+ ++ + ++V+L+G C+ +L+ + G + L ++ + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLH 116
Query: 343 GAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC- 401
+ G+++L H NVLL + AK+SD+GL K + + +
Sbjct: 117 QVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 402 ---FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDL 457
+ PE + +S+ SDV+S+GV + E +S + + + I Q KR
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 230
Query: 458 GKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQEREIGRLHSEF 515
E E+ L C RP + + ++
Sbjct: 231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-39
Identities = 52/296 (17%), Positives = 114/296 (38%), Gaps = 40/296 (13%)
Query: 245 IGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLH--EVKHIARVHHRHLVKLVGFCEEN 302
IG+G FG ++G G V +K + +++ E+ + H +++ + ++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 303 HQQL----LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV--- 355
+ L+ DY +G++ ++L +T+ + +AL A GL HLH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 356 ---PPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTS-----------AVDC 401
P + H ++ N+L+++N T ++D GL + + A +
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 402 FLDPELNLSKNYSAGSDVYSFGVFLLELISGR---------EAHGRNHSNSDQNLILQVK 452
D +D+Y+ G+ E+ + + SD ++ K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQERE 507
C+ + Q+ A M ++ +C + + R + +I L + ++E
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 64/295 (21%), Positives = 108/295 (36%), Gaps = 40/295 (13%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL------QDGSLVVIKR----HLQTQIQNFLHEVKHIAR 286
N S +G G+FG + V +K T+ + + E+K ++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 287 V-HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPI-------------GKL 332
+ +H ++V L+G C L+I +Y G++ N L I L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
+ LS + AKG+ L S H N+LL K+ D+GL + + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 393 AGSTSAVD---CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLIL 449
++ PE + Y+ SDV+S+G+FL EL S + D
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYK 259
Query: 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+K + A EM ++ C D +RP+ +QI +E
Sbjct: 260 MIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-38
Identities = 51/272 (18%), Positives = 102/272 (37%), Gaps = 26/272 (9%)
Query: 238 NFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRH 291
++ + IG GS+G K DG ++V K + + Q + EV + + H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 292 LVKLVGFC--EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+V+ N ++ +Y G++ + + L L + L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG-TKERQYLDEEFVLRVMTQLTLALK 123
Query: 350 HLHSL---VPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT-GSHHAGSTSAVDCFLDP 405
H + H + +NV L+ K+ D+GL +++ + A + ++ P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465
E +Y+ SD++S G L EL + I + K +Y D
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD--- 240
Query: 466 GEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
E+ E+ + +++ RPS+ +I
Sbjct: 241 ---------ELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 7e-38
Identities = 48/285 (16%), Positives = 116/285 (40%), Gaps = 27/285 (9%)
Query: 220 DTQNLKQL-TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR---HLQTQI 274
D + L++L +I+ + ++ IG+G+ G Y + + G V I++ Q +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 275 QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTM 334
+ ++E+ + + ++V + + ++ +Y+ G++ + + + +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDE 115
Query: 335 RQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394
Q ++ + LE LHS + H ++ N+LL + + K++D+G +T
Sbjct: 116 GQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 395 STSAVD-CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVK 452
ST ++ PE+ K Y D++S G+ +E+I G N + +
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 453 RSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ + + +C+D+ +R S +++
Sbjct: 234 PELQNPEKLSA-----------IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-38
Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 32/274 (11%)
Query: 241 EINIIGEGSFGLAYKGLLQD---GSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRHL 292
E +G G+FG KG Q V +K + L E + ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
V+++G CE +L+ + G + +L + + + + + + G+++L
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 124
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPELN 408
H NVLL + AK+SD+GL K + + + PE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 409 LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468
+S+ SDV+SFGV + E S + R S+ +L+ +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR----- 237
Query: 469 TVGAATEMMELALQCVDVS-SRRPSMRQIAGELE 501
EM +L C RP + L
Sbjct: 238 ------EMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 4e-37
Identities = 52/268 (19%), Positives = 104/268 (38%), Gaps = 29/268 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKRHLQTQIQN------FLHEVKHIARVHH 289
+F +G+G FG Y Q ++ +K + Q++ EV+ + + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++++L G+ + + LI +Y P G V L + K ++ + A L
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALS 120
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
+ HS + H + N+LL K++D+G S + +L PE+
Sbjct: 121 YCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE 177
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
+ + D++S GV E + G+ N I +V+ +V +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVTE------ 229
Query: 470 VGAATEMMELALQCVDVS-SRRPSMRQI 496
+L + + + S+RP +R++
Sbjct: 230 -----GARDLISRLLKHNPSQRPMLREV 252
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (348), Expect = 4e-37
Identities = 48/282 (17%), Positives = 110/282 (39%), Gaps = 22/282 (7%)
Query: 222 QNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR---HLQTQIQNF 277
Q Q ++ H +++ +G G+FG+ ++ G+ K ++ +
Sbjct: 11 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 70
Query: 278 LHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQR 337
E++ ++ + H LV L E++++ ++IY+++ G + + D K++ +
Sbjct: 71 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEA 126
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL--EENYTAKVSDYGLLKLVTGSHHAGS 395
+ KGL H+H H+ + N++ + + K+ D+GL +
Sbjct: 127 VEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 184
Query: 396 TSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455
T+ F PE+ K +D++S GV L+SG G + + + +
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 244
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
D G + + + + + + R ++ Q
Sbjct: 245 DD---------SAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-37
Identities = 46/272 (16%), Positives = 105/272 (38%), Gaps = 27/272 (9%)
Query: 236 TNNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR---HLQTQIQNFLHEVKHIARVHHRH 291
+ + I +G+G+FG YK + L K + ++++++ E+ +A H +
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+VKL+ + ++ ++ G V + + E LT Q + L +L
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYL 126
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF------LDP 405
H + H + N+L + K++D+G+ T + + + +
Sbjct: 127 HDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465
E + + Y +DV+S G+ L+E+ H H + ++L++ +S
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRW 241
Query: 466 GEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ +C++ + R + Q+
Sbjct: 242 SS-------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 2e-36
Identities = 52/267 (19%), Positives = 102/267 (38%), Gaps = 31/267 (11%)
Query: 243 NIIGEGSFGLAYKGLL-QDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRHLVKLV 296
IG GSF YKGL + V +++ Q F E + + + H ++V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 297 GFCEENHQQ----LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
E + +L+ + + +G ++ +L + ++ S KGL+ LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH 129
Query: 353 SLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSK 411
+ PP+ H + N+ + + K+ D GL L A + F+ PE+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEM-YEE 187
Query: 412 NYSAGSDVYSFGVFLLELISGREA-HGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470
Y DVY+FG+ +LE+ + ++ + + K
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP------- 240
Query: 471 GAATEMMELALQCVDVS-SRRPSMRQI 496
E+ E+ C+ + R S++ +
Sbjct: 241 ----EVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-36
Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 29/282 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL----QDGSLVVIKR----HLQTQIQNFLHEVKHIARVH 288
IGEG FG ++G+ V IK + + FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
H H+VKL+G EN +I + G +++ L L + + A + L
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTAL 121
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV--DCFLDPE 406
+L S H NVL+ N K+ D+GL + + S + ++ ++ PE
Sbjct: 122 AYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466
+ +++ SDV+ FGV + E++ + N+D ++ +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP--- 236
Query: 467 EQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQERE 507
+ L +C SRRP ++ +L I E E
Sbjct: 237 --------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 9e-36
Identities = 51/284 (17%), Positives = 104/284 (36%), Gaps = 34/284 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL----QDGSLVVIKR------HLQTQIQNFLHEVKHIAR 286
+ + +G+GSFG+ +G V +K + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK 346
+ HR+L++L G ++ + P G++ + L + G + A+ A+
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAE 122
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----F 402
G+ +L S H N+LL K+ D+GL++ + + +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGKYV 461
PE ++ +S SD + FGV L E+ + + + S + I + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 462 DKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQ 504
+ ++ + +QC RP+ + L Q
Sbjct: 241 PQ-----------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 59/280 (21%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 239 FSEINIIGEGSFGLAYKG-LLQDGSLVVIK--------RHLQTQIQNFLHEVKHIARVHH 289
F +I ++G G+FG YKG + +G V I + L E +A V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
H+ +L+G C + LI +P G + +++ + + + + L+ + AKG+
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMN 125
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD---CFLDPE 406
+L L H NVL++ K++D+GL KL+ ++ E
Sbjct: 126 YLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466
L + Y+ SDV+S+GV + EL++ S+ + IL+
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI--- 240
Query: 467 EQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
++ + ++C + RP R++ E +
Sbjct: 241 --------DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 61/298 (20%), Positives = 106/298 (35%), Gaps = 45/298 (15%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGS------LVVIKR----HLQTQIQNFLHEVKHIAR 286
N ++G G+FG S V +K ++ + + E+K + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 287 V-HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYD------------------SEGL 327
+ H ++V L+G C + LI++Y G++ N+L E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 328 PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387
+ LT L A AKG+E L H NVL+ K+ D+GL + +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 388 ---TGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD 444
+ G+ ++ PE Y+ SDV+S+G+ L E+ S D
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVD 273
Query: 445 QNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELE 501
N ++ + +Q A E+ + C +RPS + L
Sbjct: 274 ANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-35
Identities = 59/295 (20%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL--------QDGSLVVIKR----HLQTQIQNFLHEVKHI 284
+ +GEG+FG + V +K + + + + E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 285 ARV-HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHL-----------YDSEGLPIGKL 332
+ H++++ L+G C ++ +I +Y GN++ +L Y+ P +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 333 TMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392
+ + +S A A+G+E+L S H NVL+ E+ K++D+GL + + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 393 AGSTSAVDC---FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLIL 449
T+ ++ PE + Y+ SDV+SFGV L E+ + + + +L
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 450 QVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGI 503
+ D E+ + C S+RP+ +Q+ +L+ I
Sbjct: 251 KEGHRMDKPSNCTN-----------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-35
Identities = 47/271 (17%), Positives = 102/271 (37%), Gaps = 29/271 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHRH 291
++ + +GEG++G V +K +N E+ ++H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+VK G E + Q L +Y G + + + + G+ +L
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYL 119
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV---DCFLDPE-L 407
H + + H + N+LL+E K+SD+GL + ++ + + ++ PE L
Sbjct: 120 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR-EAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466
+ ++ DV+S G+ L +++G + S + + + K + K +D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS--- 234
Query: 467 EQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ L + + + S R ++ I
Sbjct: 235 --------APLALLHKILVENPSARITIPDI 257
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (327), Expect = 3e-34
Identities = 50/295 (16%), Positives = 118/295 (40%), Gaps = 22/295 (7%)
Query: 209 ISPYPGAVSPIDTQNLKQLTILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK 267
I+ Y I + + Q ++ + + + +G G+FG+ ++ + G + V K
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60
Query: 268 ---RHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDS 324
+E+ + ++HH L+ L E+ ++ +LI +++ G + + +
Sbjct: 61 FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 120
Query: 325 EGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE--ENYTAKVSDYG 382
+ K++ + ++ A +GL+H+H + H+ + N++ E + + K+ D+G
Sbjct: 121 D----YKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 383 LLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSN 442
L + T+A F PE+ + +D+++ GV L+SG
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF---AGE 231
Query: 443 SDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
D + VKR + + + + E + + +R ++
Sbjct: 232 DDLETLQNVKR----CDW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 9e-34
Identities = 45/273 (16%), Positives = 96/273 (35%), Gaps = 21/273 (7%)
Query: 231 ELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIK----RHLQTQIQNFLHEVKHIA 285
+ + + + +++G G+F + LV IK + L+ + + +E+ +
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAA 345
++ H ++V L E LI + G + + + + G T R +
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVL 117
Query: 346 KGLEHLHS-LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD 404
+++LH + L+E+ +SD+GL K+ + ++
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464
PE+ K YS D +S GV L+ G + IL+ + D + D
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD-- 235
Query: 465 LGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ + ++ +R + Q
Sbjct: 236 -------ISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 4e-33
Identities = 51/279 (18%), Positives = 107/279 (38%), Gaps = 29/279 (10%)
Query: 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIA 285
K +F I+GEGSF L IK + ++ E ++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 286 RVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAA 345
R+ H VKL +++ + Y NG + ++ IG
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIV 118
Query: 346 KGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC---F 402
LE+LH + H + N+LL E+ +++D+G K+++ ++ +
Sbjct: 119 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 403 LDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462
+ PEL K+ SD+++ G + +L++G + ++ + ++ + +Y
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIK----LEY-- 227
Query: 463 KTLGEQTVGAATEMMELALQCVDVSSRRPSMRQIAGELE 501
E+ A +++E L +D ++R ++ G
Sbjct: 228 -DFPEKFFPKARDLVEKLLV-LDA-TKRLGCEEMEGYGP 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 9e-33
Identities = 41/261 (15%), Positives = 97/261 (37%), Gaps = 21/261 (8%)
Query: 242 INIIGEGSFGLAYKGL-LQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHHRHLVKLVGF 298
+G G FG+ ++ + + K + T E+ + HR+++ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPL 358
E + ++I+++I ++ + S +L R+ +S + L+ LHS +
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSH--NI 123
Query: 359 FHMHFRTSNVLL--EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAG 416
H R N++ + T K+ ++G + + + + PE++ S
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 417 SDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEM 476
+D++S G + L+SG + I+ + + D + + + E
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE---------ISIEA 234
Query: 477 MELALQCVDVS-SRRPSMRQI 496
M+ + + R + +
Sbjct: 235 MDFVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (309), Expect = 2e-32
Identities = 45/280 (16%), Positives = 101/280 (36%), Gaps = 37/280 (13%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIK------------RHLQTQIQNFLHEVKHI 284
N+ I+G G + + + +K +Q + L EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 285 ARVH-HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALG 343
+V H ++++L E N L++D + G + ++L + L+ ++ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRA 118
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL 403
+ + LH L + H + N+LL+++ K++D+G + +L
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 404 DPEL------NLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457
PE+ + Y D++S GV + L++G +I+
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 458 GKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
++ D + + +L + + V +R + +
Sbjct: 237 PEWDD---------YSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (307), Expect = 2e-31
Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 18/231 (7%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIK---------RHLQTQIQNFLHEVKHIAR 286
N+FS IIG G FG Y G + +K + +T N + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 287 VHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAK 346
+V + + I D + G++ HL G + A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 118
Query: 347 GLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE 406
GLEH+H+ + + + +N+LL+E+ ++SD GL + S
Sbjct: 119 GLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 176
Query: 407 LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457
L Y + +D +S G L +L+ G R H D++ I ++ + +
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAV 226
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-31
Identities = 60/296 (20%), Positives = 109/296 (36%), Gaps = 39/296 (13%)
Query: 237 NNFSEINIIGEGSFGLAYKGL------LQDGSLVVIKR----HLQTQIQNFLHEVKHIAR 286
+ +G G+FG + V +K ++ + + E+K +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 287 -VHHRHLVKLVGFC-EENHQQLLIYDYIPNGNVQNHLYD-----------SEGLPIGKLT 333
HH ++V L+G C + ++I ++ GN+ +L E L LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 334 MRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA 393
+ + + AKG+E L S H N+LL E K+ D+GL + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 394 GSTSAVD---CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQ 450
++ PE + Y+ SDV+SFGV L E+ S + ++ +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR 248
Query: 451 VKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQE 505
+ + D T EM + L C S+RP+ ++ L + +
Sbjct: 249 RLKEGTRMRAPDYT--------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 118 bits (296), Expect = 1e-30
Identities = 48/287 (16%), Positives = 108/287 (37%), Gaps = 29/287 (10%)
Query: 233 KHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIA 285
H ++ + I+G G + L+ V +K + F E ++ A
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 286 RVHHRHLVKLVGFCEENHQQL----LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIA 341
++H +V + E ++ +Y+ +++ ++ G +T ++ + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVI 117
Query: 342 LGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC 401
A + L H + H + +N+++ KV D+G+ + + S ++ + +A
Sbjct: 118 ADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 402 ----FLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457
+L PE + A SDVYS G L E+++G +S ++ Q R
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVRE--- 229
Query: 458 GKYVDKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQIAGELEGIQ 504
E ++ AL + +R + ++ +L +
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALA-KNPENRYQTAAEMRADLVRVH 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 56/290 (19%), Positives = 104/290 (35%), Gaps = 33/290 (11%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR----HLQTQIQNFLHEVKHIARVHHR 290
++ ++ IGEG++G+ + V IK+ QT Q L E+K + R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
+++ + + + Y+ + LY L L+ +GL++
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL--LKTQHLSNDHICYFLYQILRGLKY 124
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDPE 406
+HS + H + SN+LL K+ D+GL ++ H + PE
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 407 -LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG------- 458
+ SK Y+ D++S G L E++S R H N IL + S
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 459 -----------KYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
A ++ ++L + + + +R + Q
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 42/284 (14%), Positives = 92/284 (32%), Gaps = 31/284 (10%)
Query: 228 TILELKHATNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR---------HLQTQIQNF 277
T+ ++ + + +G G F + K G K ++
Sbjct: 1 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 278 LHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQR 337
EV + + H +++ L E +LI + + G + + L + LT +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEA 115
Query: 338 LSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL----EENYTAKVSDYGLLKLVTGSHHA 393
G+ +LHS + H + N++L K+ D+GL + +
Sbjct: 116 TEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 394 GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR 453
+ F+ PE+ + +D++S GV L+SG + + V
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
Query: 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ E + + + + +R +++
Sbjct: 234 EFED---------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 238 NFSEINIIGEGSFGLAYKG-LLQDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLV 296
++++ +IG GSFG+ Y+ L G LV IK+ LQ + E++ + ++ H ++V+L
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-KNRELQIMRKLDHCNIVRLR 79
Query: 297 GFCEENHQQ------LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
F + ++ L+ DY+P + + S L + + L +
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAY 137
Query: 351 LHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
+HS + H + N+LL + K+ D+G K + S + PEL
Sbjct: 138 IHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 410 SK-NYSAGSDVYSFGVFLLELISGR 433
+Y++ DV+S G L EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 41/206 (19%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR------HLQTQIQNFLHEVKHIARV-H 288
+F ++G+GSFG + + IK + ++ + E + ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 289 HRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGL 348
H L + + + +Y+ G++ H+ K + + A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 116
Query: 349 EHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAV-DCFLDPEL 407
+ LHS + + + N+LL+++ K++D+G+ K +T ++ PE+
Sbjct: 117 QFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 408 NLSKNYSAGSDVYSFGVFLLELISGR 433
L + Y+ D +SFGV L E++ G+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 5e-28
Identities = 45/285 (15%), Positives = 90/285 (31%), Gaps = 25/285 (8%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNFLHEVKHIARVHHRHLVK 294
N + IG GSFG Y G + G V IK ++T+ E K + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 295 LVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL 354
+ +C ++ + + L D K +++ L +A +E++HS
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 355 VPPLFHMHFRTSNVL---LEENYTAKVSDYGLLKLVTGS--------HHAGSTSAVDCFL 403
H + N L ++ + D+GL K + + + +
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463
+L S D+ S G L+ G + + + ++ K +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMST 235
Query: 464 TLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQERE 507
+ G +E C + +P + + R+
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 28/288 (9%)
Query: 235 ATNNFSEINIIGEGSFGLAYKG--LLQDGSLVVIKR--------HLQTQIQNFLHEVKHI 284
A + + IGEG++G +K L G V +KR + + ++H+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 285 ARVHHRHLVKLVGFCEENHQQLLIYDYIPNGNVQN-HLYDSEGLPIGKLTMRQRLSIALG 343
H ++V+L C + + +V + +P + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 344 AAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL 403
+GL+ LHS + H + N+L+ + K++D+GL ++ + S +
Sbjct: 125 LLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------- 456
PE+ L +Y+ D++S G E+ + + IL V
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 457 -------LGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ + + +L L+C+ + ++R S
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 54/282 (19%), Positives = 102/282 (36%), Gaps = 34/282 (12%)
Query: 242 INIIGEGSFGLAYKG-LLQDGSLVVIKR--------HLQTQIQNFLHEVKHIARVHHRHL 292
++ +GEG F YK +V IK+ + L E+K + + H ++
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 293 VKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
+ L+ L++D++ +S LT + L +GLE+LH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH 117
Query: 353 SLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD-CFLDPE-LNLS 410
+ H + +N+LL+EN K++D+GL K + A + V + PE L +
Sbjct: 118 Q--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS---------------C 455
+ Y G D+++ G L EL+ + I + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 456 DLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ L A ++++L + R + Q
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 2e-27
Identities = 46/288 (15%), Positives = 96/288 (33%), Gaps = 29/288 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-HLQTQIQNFLHEVKHIARV-HHRHLV 293
++ IGEGSFG+ ++G L + V IK ++ E + + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 294 KLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHS 353
+ F +E +L+ D + G L D G K +++ A ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE 119
Query: 354 LVPPLFHMHFRTSNVLLEENYT-----AKVSDYGLLKLV--------TGSHHAGSTSAVD 400
L + + N L+ + V D+G++K + S
Sbjct: 120 K--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 401 CFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460
++ +L + S D+ + G + + G + +++ ++ K
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-----KK 232
Query: 461 VDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQIAGELEGIQERE 507
L E G E + +++ P + G + ER
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 109 bits (273), Expect = 2e-27
Identities = 48/284 (16%), Positives = 100/284 (35%), Gaps = 31/284 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIK-----RHLQTQIQNFLHEVKHIARVHHRH 291
+ + IGEG++G+ YK G +K + + + E+ + + H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+VKL + +L+++++ + G L S L G+ +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--LDPELNL 409
H + H + N+L+ K++D+GL + + V + L
Sbjct: 117 HD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 410 SKNYSAGSDVYSFGVFLLELISGR----------------EAHGRNHSNSDQNLILQVKR 453
SK YS D++S G E+++G G +S + N+ K
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 454 SCDLGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+ Y G ++L + + + ++R + +Q
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-27
Identities = 49/284 (17%), Positives = 106/284 (37%), Gaps = 31/284 (10%)
Query: 238 NFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHRH 291
NF ++ IGEG++G+ YK G +V +K+ + + E+ + ++H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 292 LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHL 351
+VKL+ ++ L+++++ Q+ + + + + S +GL
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 352 HSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVD-CFLDPELNLS 410
HS + H + N+L+ K++D+GL + + V + PE+ L
Sbjct: 119 HS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 411 KNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------------- 456
Y S D++S G E+++ R + I + + D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 457 ---LGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
K+ + + + L Q + ++R S +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 47/263 (17%), Positives = 98/263 (37%), Gaps = 22/263 (8%)
Query: 244 IIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEE 301
++G G G + + +K EV+ R H+V++V E
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 302 NHQQ----LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPP 357
+ L++ + + G + + + D T R+ I + +++LHS+
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHSI--N 131
Query: 358 LFHMHFRTSNVLL---EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYS 414
+ H + N+L N K++D+G K T + + ++ PE+ + Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191
Query: 415 AGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAAT 474
D++S GV + L+ G +SN + +K +G+Y V
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPF---YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-- 246
Query: 475 EMMELALQCVDVS-SRRPSMRQI 496
E+ L + ++R ++ +
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 8e-27
Identities = 52/271 (19%), Positives = 112/271 (41%), Gaps = 27/271 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR------HLQTQIQNFLHEVKHIARVHH 289
+F + +G GSFG + +G +K Q+++ E ++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
++++ G ++ Q +I DYI G + + L S+ P A LE
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALE 118
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
+LHS + + + N+LL++N K++D+G K V + + ++ PE+
Sbjct: 119 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVS 174
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
+K Y+ D +SFG+ + E+++G SN+ + + + ++
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPFFNE------ 226
Query: 470 VGAATEMMELALQCVDVSSRRPSMRQIAGEL 500
+++ + D+S R +++ ++
Sbjct: 227 --DVKDLLSRLIT-RDLSQRLGNLQNGTEDV 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-24
Identities = 41/208 (19%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIARVHH 289
N+F + ++G+G+FG G +K + ++ + + E + + H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
L L + + + + +Y G + HL + LE
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALE 119
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDC----FLDP 405
+LHS + + + N++L+++ K++D+GL K G+T C +L P
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG---ISDGATMKTFCGTPEYLAP 174
Query: 406 ELNLSKNYSAGSDVYSFGVFLLELISGR 433
E+ +Y D + GV + E++ GR
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 3e-24
Identities = 46/234 (19%), Positives = 97/234 (41%), Gaps = 17/234 (7%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVK 294
+++ + +G G + ++ + + + VV+K + + E+K + + +++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 295 LVGFCEE--NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLH 352
L ++ + L+++++ N + + LT K L++ H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFYMYEILKALDYCH 146
Query: 353 SLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS- 410
S+ + H + NV++ E+ ++ D+GL + A F PEL +
Sbjct: 147 SM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGKYVDK 463
+ Y D++S G L +I +E H N DQ I +V + DL Y+DK
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-24
Identities = 41/233 (17%), Positives = 90/233 (38%), Gaps = 17/233 (7%)
Query: 237 NNFSEINIIGEGSFGLAYKG-LLQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHR 290
+ + ++ IG+G+FG +K + G V +K+ + L E+K + + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 291 HLVKLVGFCEENHQQLLIYD---YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
++V L+ C Y+ ++ L + K T+ + + G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPE- 406
L ++H + H + +NVL+ + K++D+GL + + + ++ + +
Sbjct: 130 LYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 407 -----LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454
L ++Y D++ G + E+ + N LI Q+ S
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.9 bits (248), Expect = 1e-23
Identities = 58/273 (21%), Positives = 108/273 (39%), Gaps = 31/273 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR------HLQTQIQNFLHEVKHIARVHH 289
+ F I +G GSFG + G+ +K QI++ L+E + + V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
LVKL ++N ++ +Y+ G + +HL IG+ + A E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFE 155
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
+LHSL L + + N+L+++ +V+D+G K V G + L PE+ L
Sbjct: 156 YLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIIL 211
Query: 410 SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469
SK Y+ D ++ GV + E+ +G Q V +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPSHFSS------ 263
Query: 470 VGAATEMMELALQC--VDVSSRRPSMRQIAGEL 500
++ +L VD++ R +++ ++
Sbjct: 264 -----DLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-22
Identities = 40/285 (14%), Positives = 98/285 (34%), Gaps = 29/285 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHR 290
+ ++ +G G++G + + G+ V IK+ + + E++ + + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
+++ L+ + D+ + KL + + KGL +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLS 410
+H+ + H + N+ + E+ K+ D+GL + S G +
Sbjct: 137 IHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTGYVVTRWYRAPEVILNW 193
Query: 411 KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS---------------- 454
Y+ D++S G + E+I+G+ + I++V +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 455 --CDLGKYVDKTLGEQTVGAATEMMELALQCVDV-SSRRPSMRQI 496
L + K A+ + L + + + + +R + +
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 6e-22
Identities = 47/286 (16%), Positives = 99/286 (34%), Gaps = 33/286 (11%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHR 290
+ ++ IGEG++G +K + +V +KR + + L E+ + + H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 291 HLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEH 350
++V+L + + L++++ + + G L S KGL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGF 116
Query: 351 LHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCF--LDPELN 408
H + H + N+L+ N K++++GL + S V + L
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 409 LSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQ-NLILQVKRSCDLGKYVD----- 462
+K YS D++S G EL + + DQ I ++ + ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 463 -----------KTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+L +L + + +R S +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 1e-21
Identities = 45/275 (16%), Positives = 94/275 (34%), Gaps = 41/275 (14%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKRHLQTQIQN---------FLHEVKHIAR 286
+ + ++G G FG Y G+ + D V IK + +I + EV + +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 287 VHHRH--LVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA 344
V +++L+ + E +LI + G L S
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQV 119
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLL-EENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL 403
+ + H H+ + H + N+L+ K+ D+G L+ + + +
Sbjct: 120 LEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYS 176
Query: 404 DPE-LNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462
PE + + + + V+S G+ L +++ G + + + + S
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-------- 228
Query: 463 KTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
+E L C+ + S RP+ +I
Sbjct: 229 -----------SECQHLIRWCLALRPSDRPTFEEI 252
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 2e-19
Identities = 45/287 (15%), Positives = 103/287 (35%), Gaps = 31/287 (10%)
Query: 236 TNNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHH 289
+ ++ +G G++G + G V +K+ + E++ + + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
+++ L+ D ++ ++ KLT + +GL+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLK 135
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNL 409
++HS + H + SN+ + E+ K+ D+GL + + + PE+ L
Sbjct: 136 YIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--WYRAPEIML 191
Query: 410 S-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD------------ 456
+ +Y+ D++S G + EL++GR LIL++ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 457 ------LGKYVDKTLGEQTVGAATEMMELALQCVDVS-SRRPSMRQI 496
L + +GA ++L + + + +R + Q
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 1e-18
Identities = 41/230 (17%), Positives = 85/230 (36%), Gaps = 22/230 (9%)
Query: 237 NNFSEINIIGEGSFGLAYKGL-LQDGSLVVIKR-----HLQTQIQNFLHEVKHIARVHHR 290
+ + IG G+ G+ V IK+ QT + E+ + V+H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 291 HLVKLVGFC------EENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA 344
+++ L+ EE L+ + + Q +L + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQM 128
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLD 404
G++HLHS + H + SN++++ + T K+ D+GL + S +
Sbjct: 129 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 405 PELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS 454
PE+ L Y D++S G + E++ + N +++ +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 4e-18
Identities = 52/280 (18%), Positives = 95/280 (33%), Gaps = 30/280 (10%)
Query: 237 NNFSEINIIGEGSFGLAYKGLL----QDGSLVVIKR-------HLQTQIQNFLHEVKHIA 285
NF + ++G G++G + G L +K ++ E + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 286 RV-HHRHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGA 344
+ LV L + + LI DYI G + HL E + T +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 345 AKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFL- 403
LEHLH L + + + N+LL+ N ++D+GL K +
Sbjct: 139 VLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 404 ---DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460
D + D +S GV + EL++G + + Q I + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--- 253
Query: 461 VDKTLGEQTVGAATEMMELALQCVDVSSRRPSMRQIAGEL 500
++ A ++++ L D R + A E+
Sbjct: 254 ---PYPQEMSALAKDLIQRLLM-KDPKKRLGCGPRDADEI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.2 bits (191), Expect = 3e-16
Identities = 38/234 (16%), Positives = 83/234 (35%), Gaps = 19/234 (8%)
Query: 242 INIIGEGSFGLAYKGL-LQDGSLVVIK--RHLQTQIQNFLHEVKHIARVHH--------- 289
+ +G G F + + + + V +K R + + E+K + RV+
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 290 --RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKG 347
H++KL+ + + +N L + + + I+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 348 LEHLHSLVPPLFHMHFRTSNVLLEEN----YTAKVSDYGLLKLVTGSHHAGSTSAVDCFL 403
L+++H + H + NVL+E ++ L H ++ +
Sbjct: 138 LDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 404 DPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDL 457
PE+ L + G+D++S + ELI+G + +S + + +L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.0 bits (147), Expect = 2e-11
Identities = 30/204 (14%), Positives = 56/204 (27%), Gaps = 36/204 (17%)
Query: 243 NIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQI-------------QNFLHEVKHIARVHH 289
++GEG + + V+K H +F AR
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 290 RHLVKLVGFCEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLE 349
R L KL G Y + N + + E + + + + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE---VLDMILEEVA 117
Query: 350 HLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELN- 408
+ + H NVL+ E + D+ G L+ ++
Sbjct: 118 KFYH--RGIVHGDLSQYNVLVSE-EGIWIIDFP---QSVEVGEEGWRE----ILERDVRN 167
Query: 409 ----LSKNYSAGSDVYSFGVFLLE 428
S+ Y D+ S +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 530 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.26 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 96.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.56 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=422.52 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=203.6
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++|+..+.||+|+||.||+|++.+++.||||++... ..++|.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 578888999999999999999988889999998653 357899999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA- 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~- 393 (530)
|+|.+++.... ..+++..++.++.|+|.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 85 g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999987653 268999999999999999999999 59999999999999999999999999999876543322
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhH
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGA 472 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 472 (530)
....||..|+|||++.+..|+.++|||||||++|||+|+..|+.... ........+...... ..+...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~---------~~p~~~ 227 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRL---------YKPRLA 227 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCC---------CCCTTS
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCC---------CCcccc
Confidence 23457889999999999999999999999999999999655544332 223334444332111 112233
Q ss_pred HHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 473 ATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 473 ~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
+.++.+++.+||+.+| +||||+||++.|+++.+.
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 4688999999999999 999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=419.19 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=205.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccc-----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQ-----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|++.+.||+|+||.||+|+++ ..||||++.. ...+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999864 3599998753 345789999999999999999999999865 56899999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++..... .+++.+++.++.|||+||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999976542 69999999999999999999999 69999999999999999999999999999876432
Q ss_pred C---CcCcccccccccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNLS---KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
. ......||+.|||||++.. ..|+.++|||||||++|||+||+.||....... .....+... ...+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~-----~~~p~ 230 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRG-----YLSPD 230 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHT-----SCCCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcC-----CCCCc
Confidence 2 2234568999999999864 458999999999999999999999997654322 222222221 12222
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
+.......+..+.+++.+||+.+| +||||+||++.|+.+.+
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 233444556789999999999999 99999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-53 Score=423.02 Aligned_cols=252 Identities=24% Similarity=0.435 Sum_probs=200.2
Q ss_pred cCCccceeeccCCcEEEEEEEEcC-C---CEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD-G---SLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~-~---~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|+..+.||+|+||+||+|+.+. + ..||||.+... ..++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999999643 2 25889986532 346799999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
||||++|+|.+++.... +.+++.+++.++.|||+||+|||+ ++|+||||||+||||++++++||+|||+|+.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999988653 268999999999999999999999 699999999999999999999999999998765
Q ss_pred CCCCc------CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 389 GSHHA------GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 389 ~~~~~------~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
..... ....+|+.|||||.+.++.++.++|||||||++|||+| |+.||..... ......+......
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~---- 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRL---- 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----
Confidence 43221 12236888999999999999999999999999999998 8999975432 2333443332111
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +||||+||++.|+++++.
T Consensus 253 -----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 -----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1233445788999999999999 999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=414.02 Aligned_cols=253 Identities=22% Similarity=0.408 Sum_probs=209.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|++.+.||+|+||.||+|++++++.||||++... ..+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4678888999999999999999988889999998653 35789999999999999999999998865 56789999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
+|+|.+++..... ..+++.+++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 91 ~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998865432 258999999999999999999999 6999999999999999999999999999998754432
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....+|+.|+|||++.++.++.++|||||||++|||+||..|+..... .......+...... ..+..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~~~~~---------~~p~~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERGYRM---------VRPDN 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCC---------CCCTT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhcCCC---------CCccc
Confidence 2345588899999999989999999999999999999997666554332 22333333322111 11223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
.+.++.+++.+||+.+| +||||+||++.|+.+..
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 44678999999999999 99999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=408.35 Aligned_cols=249 Identities=22% Similarity=0.396 Sum_probs=211.7
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
++|+..+.||+|+||+||+|++++++.||||++... ..++|.+|+.++++++|||||+++|+|.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 678899999999999999999988889999987643 457899999999999999999999999999999999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCc-
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHA- 393 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~- 393 (530)
|+|.+++..... .+++..+.+++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 84 g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 84 GCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999876543 68999999999999999999999 69999999999999999999999999999876544322
Q ss_pred -CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 394 -GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 394 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
....+|..|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+...... ..+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~---------~~p~~ 225 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRL---------YRPHL 225 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC---------CCCTT
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCC---------CCccc
Confidence 23457889999999999999999999999999999998 8999976532 2333333332111 12223
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
.+..+.+++.+||+.+| +|||+++|++.|.++
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 44688999999999999 999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-52 Score=417.50 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=212.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|++.+.||+|+||+||+|+.. +++.||||++... ..++|.+|+++|++++|||||+++|+|.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 467888899999999999999975 5788999997643 4578999999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++..... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999976432 378999999999999999999999 6999999999999999999999999999998754432
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.....++..|+|||++.+..|+.++|||||||++|||++|..|+...... ......+..... + ..+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~~~~~------~---~~~~ 239 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYR------M---ERPE 239 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTCC------C---CCCT
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHhcCCC------C---CCCc
Confidence 23344788899999999999999999999999999999987776544322 222222222211 1 1223
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
..+..+.+++.+||+.+| +||||+||++.|+.+.+
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 445689999999999999 99999999999988753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=412.63 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=207.3
Q ss_pred cCCcccee-eccCCcEEEEEEEEc---CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINI-IGEGSFGLAYKGLLQ---DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~-LG~G~fG~Vy~g~~~---~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|...+. ||+|+||.||+|.++ ++..||||++... ..++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999854 3457999987542 34679999999999999999999999965 468899
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999986543 279999999999999999999999 699999999999999999999999999999775
Q ss_pred CCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 389 GSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 389 ~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
.... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~~~~------ 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM------ 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCCC------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCC------
Confidence 4322 223457889999999999999999999999999999998 89999865432 333333322111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
+.+...+.++.+++.+||+.+| +||||.+|++.|+.+...-
T Consensus 232 ---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1233445788999999999999 9999999999999887543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=407.61 Aligned_cols=253 Identities=24% Similarity=0.447 Sum_probs=202.5
Q ss_pred cCCccceeeccCCcEEEEEEEEcCC-----CEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDG-----SLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
+.|+..++||+|+||.||+|.+++. ..||||++... ...+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997543 36999987542 34579999999999999999999999999999999
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+.+|++.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999887654 279999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
..... .....||..|||||++.++.++.++|||||||++|||+||..|+..... .......+......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~~~------ 232 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAINDGFRL------ 232 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTCCC------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHHhccCCC------
Confidence 54322 1233478899999999999999999999999999999997766654432 22333333322111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +||||.||++.|+++.+.
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 ---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1223345688999999999999 999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=406.36 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=205.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5789999999999999999996 46889999987542 2457899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998653 68999999999999999999999 5999999999999999999999999999987654
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.. .....||+.|||||++.+..|+.++|||||||++|||+||+.||.... .......+... . .. .+
T Consensus 159 ~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~-~------~~---~p 224 (263)
T d2j4za1 159 SR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRV-E------FT---FP 224 (263)
T ss_dssp CC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTT-C------CC---CC
T ss_pred Cc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHcC-C------CC---CC
Confidence 32 334569999999999999999999999999999999999999997543 22333333221 1 01 12
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+.++.+++.+||+.+| +|||++|+++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2334678899999999999 9999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=406.71 Aligned_cols=244 Identities=16% Similarity=0.351 Sum_probs=205.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
++|+..+.||+|+||+||+|+. .+|+.||+|++... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999994 57899999987532 3567999999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 68999999999999999999999 599999999999999999999999999999775433
Q ss_pred CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 392 HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
......||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ............ ... ..+..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~-~~~------~~~~~ 241 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGT-PEL------QNPEK 241 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCS-CCC------SSGGG
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCC-CCC------CCccc
Confidence 33455699999999999999999999999999999999999999975432 222222222211 000 12233
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+..+.+++.+||+.+| +|||++|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 45688999999999999 9999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=406.77 Aligned_cols=246 Identities=17% Similarity=0.254 Sum_probs=201.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|++.+.||+|+||+||+|+. .+|+.||+|++.... .+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35799999999999999999996 568999999875432 3468999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 y~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999754 279999999999999999999999 59999999999999999999999999999876433
Q ss_pred C---CcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 391 H---HAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 391 ~---~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
. ......||+.|||||++.+..+ +.++|||||||++|||+||+.||......... .......... .
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~~~~~~--------~ 226 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTY--------L 226 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHHTTCTT--------S
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCCCC--------C
Confidence 2 2344569999999999988776 57899999999999999999999765433221 1111111110 0
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+.++.+++.+||+.+| +|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122334678899999999999 9999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=406.82 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=199.4
Q ss_pred eeeccCCcEEEEEEEEcC---CCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccCC
Q 009644 243 NIIGEGSFGLAYKGLLQD---GSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIPN 314 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~---~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~~ 314 (530)
+.||+|+||.||+|.+++ ++.||||++... ..++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 457999987542 24579999999999999999999999965 467899999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC--
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH-- 392 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~-- 392 (530)
|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998653 68999999999999999999999 5999999999999999999999999999987654322
Q ss_pred --cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 393 --AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 393 --~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ......+...... ..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~---------~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM---------GCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC---------CCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC---------CCC
Confidence 123357889999999999999999999999999999998 8999975432 2333333322111 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
...+.++.+++.+||+.+| +||||++|++.|+....
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 3445788999999999999 99999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=407.90 Aligned_cols=250 Identities=19% Similarity=0.321 Sum_probs=192.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee--cCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE--NHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~--~~~~~L 307 (530)
.++|++.+.||+|+||.||+|+. .+|+.||+|.+... ..+.+.+|++++++++|||||++++++.+ ++..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999995 56899999986533 34568999999999999999999999864 456899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLV---PPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
||||+++|+|.+++...... ...+++.++..++.|++.||+|||+.. .+||||||||+|||+++++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998753211 136899999999999999999999831 25999999999999999999999999999
Q ss_pred ccccCCCC-cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 385 KLVTGSHH-AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 385 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
+.+..... .....||+.|||||++.+..|+.++|||||||++|||+||+.||.... .......+... ...
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~-~~~----- 232 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREG-KFR----- 232 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT-CCC-----
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcC-CCC-----
Confidence 98754332 344568999999999999999999999999999999999999997543 22333333222 111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+...+.++.+++.+||+.+| +|||++|+++
T Consensus 233 ---~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1222344678999999999999 9999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=410.24 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=205.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC-C-----CEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD-G-----SLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~-~-----~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~ 304 (530)
.++|++.+.||+|+||+||+|+... + ..||+|.+... ....|.+|+.++.++ +|||||+++|++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678999999999999999999643 2 26899987543 235789999999998 89999999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGL------------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTS 366 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~ 366 (530)
.++||||+++|+|.++|+..... ....+++.+++.++.|+++||+|||+ ++||||||||+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDlKp~ 193 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAAR 193 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCSGG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCchh
Confidence 99999999999999999765321 12358999999999999999999999 69999999999
Q ss_pred cEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 009644 367 NVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSN 442 (530)
Q Consensus 367 NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~ 442 (530)
|||++.++.+||+|||+|+....... .....+|+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654332 223457899999999999999999999999999999998 89999765443
Q ss_pred chHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHH
Q 009644 443 SDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELE 501 (530)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~ 501 (530)
. .....+...... +.+...+..+.+++.+||+.+| +||||+||++.|.
T Consensus 274 ~--~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A--NFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 222222221111 1233445689999999999999 9999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=404.90 Aligned_cols=246 Identities=20% Similarity=0.338 Sum_probs=204.1
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ---TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+.|++.+.||+|+||.||+|+. .++..||+|++.. ...+.|.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5688899999999999999995 4688999998754 34567999999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC-
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH- 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~- 391 (530)
++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 9999999987653 269999999999999999999999 599999999999999999999999999997654321
Q ss_pred CcCcccccccccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 392 HAGSTSAVDCFLDPELNL-----SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
......||+.|+|||++. ...|+.++|||||||++|||+||+.||......+ ....+.... . +. .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i~~~~-~-----~~-~ 235 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKIAKSE-P-----PT-L 235 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHHSC-C-----CC-C
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCC-C-----CC-C
Confidence 234566899999999974 5568999999999999999999999997654332 222222211 0 01 1
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+...+.++.+++.+||+.+| +|||++|+++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223445788999999999999 9999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-51 Score=410.20 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=213.1
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEE
Q 009644 230 LELKHATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFC 299 (530)
Q Consensus 230 ~el~~~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~ 299 (530)
.+++...++|++.+.||+|+||+||+|+.+ +++.||||++... ..++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556789999999999999999999964 3568999997643 245799999999999999999999999
Q ss_pred eecCceeEEeeccCCCChHHHhhccCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009644 300 EENHQQLLIYDYIPNGNVQNHLYDSEG-------------------LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFH 360 (530)
Q Consensus 300 ~~~~~~~LV~Ey~~~GsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivH 360 (530)
.+.+..++||||+++|+|.+++..... .....+++.+++.|+.|++.||+|||+ ++|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEe
Confidence 999999999999999999999975321 112258999999999999999999999 69999
Q ss_pred cCCCCCcEEEcCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCC
Q 009644 361 MHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR-EAH 436 (530)
Q Consensus 361 rDLk~~NILl~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~-~p~ 436 (530)
|||||+|||++.++.+||+|||+|+....... .....+++.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987644322 23345788999999999999999999999999999999996 566
Q ss_pred CCCCCCchHHHHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHH
Q 009644 437 GRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQE 505 (530)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~ 505 (530)
.... .......+.... . .+.+...+.++.+++.+||+.+| +||||.||++.|+++.+
T Consensus 244 ~~~~---~~e~~~~v~~~~-~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMA---HEEVIYYVRDGN-I--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSC---HHHHHHHHHTTC-C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCC---HHHHHHHHHcCC-C--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 5442 223333333221 1 11233445688999999999999 99999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=402.01 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=206.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc--HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeeccC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ--IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~~ 313 (530)
.++|++.+.||+|+||.||+|+.++++.||||++.... .+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 36789999999999999999999888899999986543 4679999999999999999999999965 56789999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC-
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH- 392 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~- 392 (530)
+|+|..++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+||||++++++||+|||+++.......
T Consensus 95 ~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999876432 268999999999999999999999 5999999999999999999999999999987654332
Q ss_pred -cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchh
Q 009644 393 -AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVG 471 (530)
Q Consensus 393 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 471 (530)
.....+|+.|+|||++..+.++.++|||||||++|||+||..|+..... .......+...... +.+..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~~~~~---------~~~~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRM---------PCPPE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCC---------CCCTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHhcCCC---------CCCcc
Confidence 2334588999999999999999999999999999999997776654432 23344444332111 12233
Q ss_pred HHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 472 AATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 472 ~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.+.++.+++.+||+.+| +||||++|++.|++....
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 45688999999999999 999999999999987643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=399.45 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=200.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC----CCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD----GSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.++|++.+.||+|+||.||+|+... +..||||.+... ..+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4678999999999999999998643 346888887532 24579999999999999999999999964 67899
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999887654 268999999999999999999999 59999999999999999999999999999876
Q ss_pred cCCCC--cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCcccccc
Q 009644 388 TGSHH--AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKT 464 (530)
Q Consensus 388 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 464 (530)
..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ ....+......
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~~------- 228 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERL------- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCC-------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC-------
Confidence 54332 233457889999999999999999999999999999998 888887654332 33333322111
Q ss_pred ccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhh
Q 009644 465 LGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREI 508 (530)
Q Consensus 465 l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~ 508 (530)
..+...+..+.+++.+||+.+| +|||++||++.|+++++.+.
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1233445789999999999999 99999999999999987754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-50 Score=406.73 Aligned_cols=248 Identities=18% Similarity=0.268 Sum_probs=191.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
..+.|++.+.||+|+||+||+|+. .+++.||||++.... .+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 346799999999999999999996 468899999876432 346789999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCeEEEeecCCccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE---ENYTAKVSDYGLLKL 386 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~---~~~~~KI~DFGla~~ 386 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999997642 69999999999999999999999 6999999999999995 578999999999987
Q ss_pred ccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
...........||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+.... . ..+.
T Consensus 160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~-~--~~~~--- 230 (307)
T d1a06a_ 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAE-Y--EFDS--- 230 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHTTC-C--CCCT---
T ss_pred ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHhccC-C--CCCC---
Confidence 7655555566799999999999999999999999999999999999999975432 22333332211 0 0111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
......+..+.+++.+||+.+| +|||++|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1222344678999999999999 9999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=410.48 Aligned_cols=261 Identities=17% Similarity=0.260 Sum_probs=205.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
.++|+.++.||+|+||+||+|+. .+|+.||+|++.. ...+.+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999995 5688999998653 224678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+++|+|.+++.+.. .+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999998653 689999999999999999999972 38999999999999999999999999999976432
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--c-----------C
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC--D-----------L 457 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~--~-----------~ 457 (530)
......||+.|+|||++.+..|+.++||||+||++|||+||+.||................... . .
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2335579999999999999999999999999999999999999997654432211100000000 0 0
Q ss_pred C-cccc----------------ccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhh
Q 009644 458 G-KYVD----------------KTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGI 503 (530)
Q Consensus 458 ~-~~~d----------------~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i 503 (530)
. ...+ ..... .....+.++.+++.+||+.|| +|||++|+++ .+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 0000 00000 011124578999999999999 9999999987 35543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=398.01 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=201.1
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc-HHHHHHHHHHHHhcCCCCcceEEEEEee-cCceeEEeeccCC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ-IQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQQLLIYDYIPN 314 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~~~ 314 (530)
++|+..+.||+|+||.||+|+++ |+.||||++.... .++|.+|++++++++|||||+++|+|.+ .+..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 56788899999999999999985 7789999987544 5679999999999999999999999865 4668999999999
Q ss_pred CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCCcC
Q 009644 315 GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHHAG 394 (530)
Q Consensus 315 GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~~~ 394 (530)
|+|.++|..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 158 (262)
T ss_dssp EEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccceecCCC--Cc
Confidence 999999976431 158999999999999999999999 69999999999999999999999999999875433 23
Q ss_pred cccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccccccccchhHH
Q 009644 395 STSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTVGAA 473 (530)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 473 (530)
...++..|+|||++.+..++.++|||||||++|||+| |++||...... .....+..... + +.+...+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~~~------~---~~~~~~~ 226 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYK------M---DAPDGCP 226 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCC------C---CCCTTCC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCC------C---CCCccCC
Confidence 3457888999999999999999999999999999999 67777654332 33333332211 1 1233344
Q ss_pred HHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHh
Q 009644 474 TEMMELALQCVDVSS-RRPSMRQIAGELEGIQERE 507 (530)
Q Consensus 474 ~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~ 507 (530)
.++.+++.+||+.+| +||||.+|++.|+++...+
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 688999999999999 9999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=391.92 Aligned_cols=242 Identities=22% Similarity=0.355 Sum_probs=194.4
Q ss_pred ccceeeccCCcEEEEEEEEc-CCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee----cCceeEEe
Q 009644 240 SEINIIGEGSFGLAYKGLLQ-DGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE----NHQQLLIY 309 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~----~~~~~LV~ 309 (530)
+..+.||+|+||+||+|+.. ++..||+|.+... ..+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45578999999999999964 5789999986543 34578999999999999999999999865 34679999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCeEEEeecCCccccc
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE-ENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~-~~~~~KI~DFGla~~~~ 388 (530)
||+++|+|.+++.... .+++.++..++.||+.||+|||+..++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998753 68999999999999999999999523499999999999996 57899999999998654
Q ss_pred CCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccccc
Q 009644 389 GSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQ 468 (530)
Q Consensus 389 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 468 (530)
.. ......||+.|||||++. +.|+.++|||||||++|||+||+.||..... .......+..... ++. .
T Consensus 167 ~~-~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~-----~~~---~ 234 (270)
T d1t4ha_ 167 AS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK-----PAS---F 234 (270)
T ss_dssp TT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC-----CGG---G
T ss_pred CC-ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCC-----Ccc---c
Confidence 33 233456999999999985 4699999999999999999999999975432 2222222222111 111 1
Q ss_pred chhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 469 TVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 469 ~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+.....++.+++.+||+.+| +|||++|+++
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22234578899999999999 9999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=402.05 Aligned_cols=242 Identities=18% Similarity=0.292 Sum_probs=202.8
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++.+.||+|+||+||+|+. .+++.||||++... ..+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999996 56899999987532 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988653 78999999999999999999999 5999999999999999999999999999987653
Q ss_pred CC---CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SH---HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.. ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.... .......+... ..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~-~~--------- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKIIKL-EY--------- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTT-CC---------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHHcC-CC---------
Confidence 32 2234569999999999999999999999999999999999999997543 22333332221 10
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+...+.++.+++.+||+.+| +|||++|+++
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1122334678999999999999 9999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=398.37 Aligned_cols=247 Identities=17% Similarity=0.275 Sum_probs=207.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc---------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT---------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.+.|++.+.||+|+||+||+|+. .+|+.||||++... ..+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 56899999986532 246799999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----eEEEeec
Q 009644 306 LLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY----TAKVSDY 381 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~----~~KI~DF 381 (530)
++|||||++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999998753 68999999999999999999999 5999999999999998776 5999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
|+|+............+|+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+... .. ..
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~-~~-~~- 235 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAV-NY-EF- 235 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTT-CC-CC-
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHHHHHHhc-CC-CC-
Confidence 999987665555666789999999999999999999999999999999999999986432 2222332221 00 00
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. .......+..+.+++.+||+.+| +|||++|+++
T Consensus 236 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 E---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01222345678899999999999 9999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=398.73 Aligned_cols=262 Identities=19% Similarity=0.316 Sum_probs=207.1
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHH--HhcCCCCcceEEEEEeecC----ceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHI--ARVHHRHLVKLVGFCEENH----QQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il--~~l~H~nIv~l~g~~~~~~----~~~LV~E 310 (530)
.+|...+.||+|+||.||+|++ +|+.||||++.....+++..|.+++ .+++|||||+++|+|.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4566778999999999999997 5789999999877777776666655 5679999999999997654 5789999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL------VPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
||++|+|.++|++. .+++.+++.++.|+|.||+|||+. .++||||||||+||||++++.+||+|||++
T Consensus 82 y~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999864 689999999999999999999973 269999999999999999999999999999
Q ss_pred ccccCCCC-----cCcccccccccCccccCCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCc----------
Q 009644 385 KLVTGSHH-----AGSTSAVDCFLDPELNLSKN------YSAGSDVYSFGVFLLELISGREAHGRNHSNS---------- 443 (530)
Q Consensus 385 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~---------- 443 (530)
+....... .....||+.|+|||++.+.. ++.++|||||||+||||+||..|+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 87754321 22345899999999987543 6789999999999999999988875322111
Q ss_pred -hHHHHHHHHhhccCCccccccccc--cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhc
Q 009644 444 -DQNLILQVKRSCDLGKYVDKTLGE--QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIG 509 (530)
Q Consensus 444 -~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~ 509 (530)
......... .....++.++. ...+....+.+++.+||+.+| +||||.||++.|+++.+.+..
T Consensus 236 ~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred chHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 111111111 11222333323 244566789999999999999 999999999999999877654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=401.51 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=203.5
Q ss_pred cCCccceeeccCCcEEEEEEEEc-CCC----EEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQ-DGS----LVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~----~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~L 307 (530)
.+|+.++.||+|+||+||+|... +|+ .||+|++.. ...++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999954 343 588887653 2356899999999999999999999999875 5678
Q ss_pred EeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccc
Q 009644 308 IYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLV 387 (530)
Q Consensus 308 V~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~ 387 (530)
+|||+.+|+|.+++.... ..+++..++.++.|||.||+|||+ ++||||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999988754 378999999999999999999999 59999999999999999999999999999977
Q ss_pred cCCCCc---CcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccccc
Q 009644 388 TGSHHA---GSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYVDK 463 (530)
Q Consensus 388 ~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 463 (530)
...... ....||..|+|||++.++.|+.++|||||||++|||+| |++||......+.. ..+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i~~~~~~------ 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERL------ 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHHHHTCCC------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCCCC------
Confidence 543322 23347899999999999999999999999999999999 78888755433322 222222111
Q ss_pred cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 464 TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 464 ~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
..+...+..+.+++.+||+.+| +|||+.||++.|+.+...
T Consensus 233 ---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1223345688999999999999 999999999999887643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=401.66 Aligned_cols=241 Identities=22% Similarity=0.362 Sum_probs=199.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
..|+.++.||+|+||.||+|+. .+++.||||++... ..+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588999999999999999995 56889999987532 2356899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
|||++|+|..++.... .+++.++..++.||+.||.|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987766542 68999999999999999999999 6999999999999999999999999999987543
Q ss_pred CCCcCcccccccccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLS---KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLG 466 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 466 (530)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ...+..+... .....
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~~~-~~~~~------ 234 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQN-ESPAL------ 234 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHS-CCCCC------
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhC-CCCCC------
Confidence 234579999999999863 5689999999999999999999999975432 2222222221 11111
Q ss_pred ccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 467 EQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 467 ~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.+...+..+.+++.+||+.+| +|||++|+++
T Consensus 235 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112234678999999999999 9999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-49 Score=406.79 Aligned_cols=248 Identities=19% Similarity=0.343 Sum_probs=207.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
-++|++.+.||+|+||.||+|+. .+|+.||||++.... .+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999995 568999999876543 35688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCeEEEeecCCcccccC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE--NYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~--~~~~KI~DFGla~~~~~ 389 (530)
|++|+|.+++.... +.+++.++..++.||+.||+|||+ .+||||||||+|||++. ++.+||+|||+|+.+..
T Consensus 105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999996543 269999999999999999999999 59999999999999964 67899999999998776
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
........||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+.... . . .+. ...
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~-~-~-~~~---~~~ 249 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCD-W-N-MDD---SAF 249 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC-C-C-SCC---GGG
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-C-C-CCc---ccc
Confidence 6555566799999999999999999999999999999999999999975432 23333332211 0 0 010 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+..+.+++.+||..+| +|||++|+++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2344678999999999999 9999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=399.70 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=210.8
Q ss_pred cCCccceeeccCCcEEEEEEEEcC-CC--EEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD-GS--LVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~--~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|+..+.||+|+||.||+|++++ +. .||||++... ..++|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999999654 44 4677876432 345799999999999 799999999999999999999
Q ss_pred eeccCCCChHHHhhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEE
Q 009644 309 YDYIPNGNVQNHLYDSE-----------GLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAK 377 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~K 377 (530)
|||+++|+|.++|+... ......+++.+++.++.|||.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcCCCceE
Confidence 99999999999997541 1122479999999999999999999999 6999999999999999999999
Q ss_pred EeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCchHHHHHHHHhhcc
Q 009644 378 VSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGRE-AHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 378 I~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~-p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
|+|||+++............+|..|+|||.+.+..|+.++|||||||++|||++|.. ||... ....+...+.....
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKLPQGYR 244 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHGGGTCC
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhcCC
Confidence 999999987654444445568899999999999999999999999999999999765 55433 22233333332211
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcc
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSE 514 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~ 514 (530)
.+.+...+.++.+++.+||+.+| +||||+||++.|+++.+.........
T Consensus 245 ---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~~ 294 (309)
T d1fvra_ 245 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294 (309)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCB
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCCCc
Confidence 11233445789999999999999 99999999999999987654444333
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.2e-49 Score=404.45 Aligned_cols=248 Identities=19% Similarity=0.337 Sum_probs=208.3
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... .+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999995 578999999876433 35688999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCeEEEeecCCcccccC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE--ENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~--~~~~~KI~DFGla~~~~~ 389 (530)
+++|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 108 ~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999886543 269999999999999999999999 5999999999999998 578999999999998876
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
........+|+.|+|||++.+..|+.++|||||||++|||+||+.||..... ......+.... . . .+. ...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~-~-~-~~~---~~~ 252 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCD-W-E-FDE---DAF 252 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCC-C-C-CCS---STT
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-C-C-CCc---ccc
Confidence 6555566789999999999999999999999999999999999999975432 23333333221 0 0 000 122
Q ss_pred hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+..+.+++.+||+.+| +|||++|+++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3345688999999999999 9999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=390.84 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=200.0
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEcC------CCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 234 HATNNFSEINIIGEGSFGLAYKGLLQD------GSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 234 ~~t~~f~~~~~LG~G~fG~Vy~g~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
...++|++.+.||+|+||.||+|.... ++.||||++... ..+.+.+|..++.++ +|+|||.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999998532 358999987643 345688888888887 789999999998664
Q ss_pred -CceeEEeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 303 -HQQLLIYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 303 -~~~~LV~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
...++|||||++|+|.++++..... ....+++.+++.++.||+.||+|||+ ++||||||||+|||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILL 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCccceeE
Confidence 5689999999999999999754321 12358999999999999999999999 699999999999999
Q ss_pred cCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCchHH
Q 009644 371 EENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR-EAHGRNHSNSDQN 446 (530)
Q Consensus 371 ~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~-~p~~~~~~~~~~~ 446 (530)
++++.+||+|||+|+....... .....||+.|+|||.+.+..++.++|||||||++|||+||. +||....... .
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~ 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--H
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999987644322 23446899999999999999999999999999999999975 5665443322 2
Q ss_pred HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 447 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
....+...... ..+...+.++.+++.+||+.+| +|||++||++.|+++++.
T Consensus 246 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22222222111 1222344678999999999999 999999999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=392.05 Aligned_cols=249 Identities=20% Similarity=0.394 Sum_probs=196.6
Q ss_pred cCCccceeeccCCcEEEEEEEEcC--C--CEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQD--G--SLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~--~--~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
++|++.+.||+|+||.||+|++.. + ..||||++... ..++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998542 2 36899986532 24679999999999999999999999976 4678
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++....+ .+++..++.++.|+|.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998876542 69999999999999999999999 6999999999999999999999999999998
Q ss_pred ccCCCC----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHHHHHHHhhccCCccc
Q 009644 387 VTGSHH----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNLILQVKRSCDLGKYV 461 (530)
Q Consensus 387 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (530)
+..... .....++..|+|||.+.+..++.++|||||||++|||+| |+.||.... ......++......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~---- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGER---- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCC----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCC----
Confidence 754332 122346778999999999999999999999999999998 899997543 22333333322110
Q ss_pred cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhh
Q 009644 462 DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGI 503 (530)
Q Consensus 462 d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i 503 (530)
+ +.+...+..+.+++.+||+.+| +||||.||++.|++.
T Consensus 234 -~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -L---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0 1223344678999999999999 999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=396.73 Aligned_cols=243 Identities=18% Similarity=0.283 Sum_probs=206.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEE
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
-++|++++.||+|+||.||+|+. .+++.||+|++.+. ..+.+.+|+.+|++++|||||++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999995 57899999987643 346789999999999999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
||||++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998764 68999999999999999999999 599999999999999999999999999998764
Q ss_pred CC-CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GS-HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.. .......||+.|+|||++.+..|+.++||||+||++|||++|++||..... .......... .. .
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~~~-~~---------~ 223 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILME-EI---------R 223 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-CC---------C
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHhcC-CC---------C
Confidence 43 334556799999999999999999999999999999999999999986532 2222222221 11 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
.+...+.++.+++.+||+.+| +||+ ++|+++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222344678999999999999 9995 778775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=390.30 Aligned_cols=248 Identities=23% Similarity=0.420 Sum_probs=200.5
Q ss_pred ceeeccCCcEEEEEEEEcCC----CEEEEEEccc----ccHHHHHHHHHHHHhcCCCCcceEEEEEee-cCceeEEeecc
Q 009644 242 INIIGEGSFGLAYKGLLQDG----SLVVIKRHLQ----TQIQNFLHEVKHIARVHHRHLVKLVGFCEE-NHQQLLIYDYI 312 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~~----~~vavK~~~~----~~~~~~~~E~~il~~l~H~nIv~l~g~~~~-~~~~~LV~Ey~ 312 (530)
.++||+|+||+||+|++.++ ..||||++.. ...++|.+|+++|++++|||||+++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999996542 2589998753 234679999999999999999999999876 46789999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSHH 392 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~~ 392 (530)
++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999886542 67889999999999999999999 6999999999999999999999999999987654322
Q ss_pred -----cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 393 -----AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 393 -----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
.....+|..|+|||.+....++.++||||||+++|||+||+.||....... .....+..... . .
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~g~~---~------~ 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRR---L------L 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC---C------C
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC---C------C
Confidence 122347889999999999999999999999999999999888876543221 22222222111 0 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
.+.....++.+++.+||+.+| +||||.||++.|++++..
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 122344688999999999999 999999999999999865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=390.85 Aligned_cols=257 Identities=22% Similarity=0.399 Sum_probs=205.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEcC--------CCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeec
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQD--------GSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEEN 302 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~ 302 (530)
.++|++.+.||+|+||.||+|+... +..||||++... ...++.+|...+.++ +|||||+++|+|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999998532 247999987543 346788999999998 899999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGL-----------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE 371 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~ 371 (530)
+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+||||||||+|||++
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecccceeec
Confidence 9999999999999999999765321 12468999999999999999999999 5999999999999999
Q ss_pred CCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCchHHH
Q 009644 372 ENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELIS-GREAHGRNHSNSDQNL 447 (530)
Q Consensus 372 ~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~Ellt-G~~p~~~~~~~~~~~~ 447 (530)
.++.+||+|||+++....... .....+++.|+|||.+.++.|+.++|||||||++|||+| |.+||..... ...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HHH
Confidence 999999999999997754432 233457889999999999999999999999999999998 6777764432 233
Q ss_pred HHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 448 ILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 448 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
...+...... ..+...+..+.+++.+||+.+| +|||+.||++.|+++.+.
T Consensus 247 ~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 FKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 3333322111 1222344678999999999999 999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=395.79 Aligned_cols=268 Identities=20% Similarity=0.347 Sum_probs=213.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEccccc----HHHHHHHHHHHHhcCCCCcceEEEEEeecCce
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQTQ----IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQ 305 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~~----~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~ 305 (530)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ...|.+|++++++++|||||+++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999863 35789999986432 34689999999999999999999999999999
Q ss_pred eEEeeccCCCChHHHhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 306 LLIYDYIPNGNVQNHLYDSEG-----LPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 306 ~LV~Ey~~~GsL~~~l~~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
++||||+++|+|.+++..... .....+++..+..++.|+|+||.|||+ ++|+||||||+|||+++++++||+|
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999999875321 112357999999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCchHHHHHHHHhhcc
Q 009644 381 YGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGR-EAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 381 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~-~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
||+|+.+..... .....+|+.|+|||.+.+..++.++||||||+++|||+||. +||.... .......+.....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLRFVMEGGL 253 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHHHHHTTCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHhCCC
Confidence 999987654332 22335789999999999999999999999999999999985 5564332 2233333332211
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCccccc
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGE 517 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~e 517 (530)
.+.+...+..+.+++.+||+.+| +||||++|++.|++..+.........++|
T Consensus 254 ---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~~~~ 306 (308)
T d1p4oa_ 254 ---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 306 (308)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred ---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCCCCC
Confidence 11223344689999999999999 99999999999998876543333333333
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.3e-48 Score=383.54 Aligned_cols=246 Identities=17% Similarity=0.291 Sum_probs=205.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------------cHHHHHHHHHHHHhcC-CCCcceEEEEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------------QIQNFLHEVKHIARVH-HRHLVKLVGFCEEN 302 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------------~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~ 302 (530)
++|++.+.||+|+||+||+|+. .+++.||||++... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999995 57889999986532 1245889999999997 99999999999999
Q ss_pred CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecC
Q 009644 303 HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYG 382 (530)
Q Consensus 303 ~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFG 382 (530)
+..++||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999998653 68999999999999999999999 599999999999999999999999999
Q ss_pred CcccccCCCCcCcccccccccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc
Q 009644 383 LLKLVTGSHHAGSTSAVDCFLDPELNL------SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD 456 (530)
Q Consensus 383 la~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~ 456 (530)
+++.+..........||..|+|||.+. ...++.++||||+||++|||+||+.||..... ......+... .
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~~~-~ 231 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSG-N 231 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT-C
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHHhC-C
Confidence 999876655555667899999999875 34578999999999999999999999986532 2222222221 1
Q ss_pred CCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 457 LGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 457 ~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. .... ......+.++.+++.+||+.+| +|||++||++
T Consensus 232 ~-~~~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 Y-QFGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C-CCCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C-CCCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 0111 1223445689999999999999 9999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-47 Score=381.01 Aligned_cols=253 Identities=17% Similarity=0.293 Sum_probs=201.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecC----c
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENH----Q 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~----~ 304 (530)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ..+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999995 57899999987532 2357899999999999999999999997654 3
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.|+||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhh
Confidence 789999999999999987653 68999999999999999999999 59999999999999999999999999998
Q ss_pred ccccCCC----CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 385 KLVTGSH----HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 385 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~~~~~~~~--- 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDPI--- 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCCC---
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HHHHHHHHhcCCC---
Confidence 7654322 22344689999999999999999999999999999999999999975432 2222222221110
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCC-CHHHHHHHHHhhH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRP-SMRQIAGELEGIQ 504 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RP-t~~eVl~~L~~i~ 504 (530)
.+ .......+..+.+++.+|++.+| +|| |++++...|.++.
T Consensus 233 -~~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 -PP--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -CG--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -CC--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 01222344688999999999999 999 8999999998875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-48 Score=391.00 Aligned_cols=240 Identities=20% Similarity=0.334 Sum_probs=203.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++++.||+|+||+||+|+. .+|+.||||++... ..+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5789999999999999999995 56899999987642 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+++|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999988653 67889999999999999999999 6999999999999999999999999999988654
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. .....||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+... .. ..+
T Consensus 157 ~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~-~~---------~~p 221 (316)
T d1fota_ 157 V--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILNA-EL---------RFP 221 (316)
T ss_dssp C--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHC-CC---------CCC
T ss_pred c--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHHHHHcC-CC---------CCC
Confidence 3 3456799999999999999999999999999999999999999975432 2333333221 10 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CCC-----CHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RRP-----SMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~RP-----t~~eVl~ 498 (530)
...+.++.+++.+|++.+| +|| |++++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2334678899999999998 885 8999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=386.97 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=208.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEc------CCCEEEEEEcccc----cHHHHHHHHHHHHhc-CCCCcceEEEEEeecC
Q 009644 235 ATNNFSEINIIGEGSFGLAYKGLLQ------DGSLVVIKRHLQT----QIQNFLHEVKHIARV-HHRHLVKLVGFCEENH 303 (530)
Q Consensus 235 ~t~~f~~~~~LG~G~fG~Vy~g~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~H~nIv~l~g~~~~~~ 303 (530)
..++|++.+.||+|+||.||+|++. ++..||||++... ...+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3578889999999999999999853 3568999997643 345789999999999 7999999999999999
Q ss_pred ceeEEeeccCCCChHHHhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGL-------------PIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLL 370 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl 370 (530)
..++||||+++|+|.++++..... ....+++.+++.++.||+.||+|||+ +++|||||||+|||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILL 178 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccccccc
Confidence 999999999999999999764321 12368999999999999999999999 599999999999999
Q ss_pred cCCCeEEEeecCCcccccCCCC---cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCchHH
Q 009644 371 EENYTAKVSDYGLLKLVTGSHH---AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISG-REAHGRNHSNSDQN 446 (530)
Q Consensus 371 ~~~~~~KI~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG-~~p~~~~~~~~~~~ 446 (530)
+.++.+|++|||+++....... .....+|+.|+|||.+.+..++.++|||||||++|||+|+ .+||....... .
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999987654322 2334588999999999999999999999999999999995 55554433322 1
Q ss_pred HHHHHHhhccCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHH
Q 009644 447 LILQVKRSCDLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQER 506 (530)
Q Consensus 447 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~ 506 (530)
....+...... ..+...+..+.+++.+||+.+| +||||+||+++|++++..
T Consensus 257 ~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 FYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11222221110 1122344689999999999999 999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=390.85 Aligned_cols=248 Identities=17% Similarity=0.255 Sum_probs=206.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccH--HHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQI--QNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|++.+.||+|+||+||+|.. .+++.||+|.+..... ..+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 56899999999999999999996 4688999998875543 45789999999999999999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCeEEEeecCCcccccCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE--NYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~--~~~~KI~DFGla~~~~~~ 390 (530)
++|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997653 268999999999999999999999 59999999999999985 458999999999987655
Q ss_pred CCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccch
Q 009644 391 HHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQTV 470 (530)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 470 (530)
.......+|+.|+|||...+..|+.++||||+||++|||++|+.||..... ......+.... . . .+. ....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~~~-~-~-~~~---~~~~ 228 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAE-Y-T-FDE---EAFK 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTC-C-C-CCH---HHHT
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-C-C-CCh---hhcc
Confidence 545556689999999999999999999999999999999999999976532 23333332211 0 0 000 0112
Q ss_pred hHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 471 GAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 471 ~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
..+.++.+++.+|+..+| +|||++|+++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234678999999999999 9999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-47 Score=392.14 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=199.3
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc------HHHHHHH---HHHHHhcCCCCcceEEEEEeecCcee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ------IQNFLHE---VKHIARVHHRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~E---~~il~~l~H~nIv~l~g~~~~~~~~~ 306 (530)
++|++.+.||+|+||.||+|+. .+|+.||+|++.... ...+.+| +++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999995 468999999876432 2234444 66677778999999999999999999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998753 68899999999999999999999 6999999999999999999999999999987
Q ss_pred ccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 387 VTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
+... ......||+.|+|||++.. ..|+.++|||||||++|||+||+.||............... .. .. .
T Consensus 157 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~--~~----~-- 226 (364)
T d1omwa3 157 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LT--MA----V-- 226 (364)
T ss_dssp CSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-SS--CC----C--
T ss_pred cCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cc--CC----C--
Confidence 6543 2345679999999999874 56899999999999999999999999876544332222111 11 00 0
Q ss_pred cccchhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 466 GEQTVGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 466 ~~~~~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
..+...+.++.+++.+||+.+| +||| ++|+++
T Consensus 227 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1122334678999999999999 9999 677764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=390.23 Aligned_cols=250 Identities=18% Similarity=0.296 Sum_probs=201.0
Q ss_pred hcCCccce-eeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhc-CCCCcceEEEEEee----cCceeEE
Q 009644 236 TNNFSEIN-IIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARV-HHRHLVKLVGFCEE----NHQQLLI 308 (530)
Q Consensus 236 t~~f~~~~-~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l-~H~nIv~l~g~~~~----~~~~~LV 308 (530)
.++|++.. .||+|+||.||+|+. .+++.||||++.. ...+.+|++++.++ +|||||++++++.+ +...|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 46788775 599999999999995 6789999999864 34678899997765 89999999999865 4678999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCeEEEeecCCcc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE---NYTAKVSDYGLLK 385 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~---~~~~KI~DFGla~ 385 (530)
||||++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++ ++.+||+|||+|+
T Consensus 88 mEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccccceee
Confidence 999999999999986432 269999999999999999999999 59999999999999985 5679999999999
Q ss_pred cccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccc
Q 009644 386 LVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTL 465 (530)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 465 (530)
............||+.|+|||++.+..|+.++|||||||++|||+||+.||........... .......... .+
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~~---~~ 236 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY---EF 236 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---SC
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCCC---CC
Confidence 87766666667799999999999999999999999999999999999999976543322111 1111111110 11
Q ss_pred cc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 466 GE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 466 ~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
+. .....+.++.+++.+|++.+| +|||+.|+++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 222345688999999999999 9999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-47 Score=390.87 Aligned_cols=240 Identities=22% Similarity=0.335 Sum_probs=204.5
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEe
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIY 309 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~ 309 (530)
++|++++.||+|+||.||+|+. .+|+.||||++... ..+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999996 56899999987532 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccC
Q 009644 310 DYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTG 389 (530)
Q Consensus 310 Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~ 389 (530)
||+.+|+|.+++.... .+++.++..++.||+.||.|||+ .+||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998763 68999999999999999999999 5999999999999999999999999999997754
Q ss_pred CCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccccc
Q 009644 390 SHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGEQT 469 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 469 (530)
. .....||+.|||||++.+..|+.++|||||||++|||+||+.||.... .......+.... . ..+
T Consensus 194 ~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~-~---------~~p 258 (350)
T d1rdqe_ 194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGK-V---------RFP 258 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-C---------CCC
T ss_pred c--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhcCC-C---------CCC
Confidence 3 344679999999999999999999999999999999999999997543 223333332221 0 112
Q ss_pred hhHHHHHHHHHHHcccCCC-CC-----CCHHHHHH
Q 009644 470 VGAATEMMELALQCVDVSS-RR-----PSMRQIAG 498 (530)
Q Consensus 470 ~~~~~~l~~li~~Cl~~~p-~R-----Pt~~eVl~ 498 (530)
...+.++.+++.+||+.+| +| ||++++++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2334678999999999998 78 58999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=382.66 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=195.3
Q ss_pred cceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 241 EINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--------IQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 241 ~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
.+++||+|+||+||+|+. .+|+.||||++.... .+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 458999999999999995 568999999875332 23588999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+.++++..+.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9888777665433 268889999999999999999999 699999999999999999999999999998765443
Q ss_pred C-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc--------
Q 009644 392 H-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV-------- 461 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 461 (530)
. .....+|+.|+|||++.. ..|+.++|||||||++|||+||++||......+....+...........+.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2 334568999999999865 468999999999999999999999997654332222222221111000000
Q ss_pred -------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 -------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 -------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
...+..........+.+++.+|++.|| +|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000011112334678999999999999 9999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=387.76 Aligned_cols=242 Identities=19% Similarity=0.355 Sum_probs=202.3
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc------cHHHHHHHHHHHH-hcCCCCcceEEEEEeecCceeEE
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT------QIQNFLHEVKHIA-RVHHRHLVKLVGFCEENHQQLLI 308 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~------~~~~~~~E~~il~-~l~H~nIv~l~g~~~~~~~~~LV 308 (530)
++|++.+.||+|+||+||+|+. .+++.||||++.+. ..+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999995 46889999997642 3456788888776 68999999999999999999999
Q ss_pred eeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccccc
Q 009644 309 YDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVT 388 (530)
Q Consensus 309 ~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~ 388 (530)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998753 68999999999999999999999 599999999999999999999999999998664
Q ss_pred CCC-CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccccccccc
Q 009644 389 GSH-HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVDKTLGE 467 (530)
Q Consensus 389 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 467 (530)
... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ......+... . + .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~-~------~---~ 221 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMD-N------P---F 221 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-C------C---C
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHcC-C------C---C
Confidence 332 23445689999999999999999999999999999999999999975432 2333333221 1 1 1
Q ss_pred cchhHHHHHHHHHHHcccCCC-CCCCHH-HHHH
Q 009644 468 QTVGAATEMMELALQCVDVSS-RRPSMR-QIAG 498 (530)
Q Consensus 468 ~~~~~~~~l~~li~~Cl~~~p-~RPt~~-eVl~ 498 (530)
.+...+.++.+++.+||+.+| +|||+. ++++
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122334678999999999999 999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=377.19 Aligned_cols=256 Identities=18% Similarity=0.321 Sum_probs=198.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+.++.||+|+||+||+|+. .+++.||+|++... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999995 67899999987532 24678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
|+.+ ++.+++..... ..+++.++..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 55555543322 368999999999999999999999 59999999999999999999999999999877543
Q ss_pred C-CcCcccccccccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc---CCc------
Q 009644 391 H-HAGSTSAVDCFLDPELNLSKN-YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD---LGK------ 459 (530)
Q Consensus 391 ~-~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~------ 459 (530)
. ......+|+.|+|||.+.... ++.++|||||||++|||++|+.||...........+........ ...
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3 334456899999999877665 57899999999999999999999975532221111111111000 000
Q ss_pred -------cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 460 -------YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 460 -------~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
................+.+++.+|++.+| +|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000001122334678999999999999 9999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=373.18 Aligned_cols=257 Identities=18% Similarity=0.293 Sum_probs=199.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cC-CCEEEEEEcccc-----cHHHHHHHHHHHHhc---CCCCcceEEEEEee----
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QD-GSLVVIKRHLQT-----QIQNFLHEVKHIARV---HHRHLVKLVGFCEE---- 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~-~~~vavK~~~~~-----~~~~~~~E~~il~~l---~H~nIv~l~g~~~~---- 301 (530)
.++|++++.||+|+||+||+|+. ++ ++.||||++... ....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999996 34 567999987532 223567888887766 89999999999853
Q ss_pred -cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEee
Q 009644 302 -NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSD 380 (530)
Q Consensus 302 -~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~D 380 (530)
....+++|||+.+|++........ ..+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCeeecc
Confidence 346899999998877765544332 368999999999999999999999 5999999999999999999999999
Q ss_pred cCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCC--
Q 009644 381 YGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLG-- 458 (530)
Q Consensus 381 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 458 (530)
||+++............||+.|+|||++.+..|+.++||||+||++|||+||+.||...........+..........
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 999987765555566779999999999999999999999999999999999999997654322222222221110000
Q ss_pred ------------ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 ------------KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ------------~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.................+.+++.+||+.+| +|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000011111223345678899999999999 9999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.1e-46 Score=370.69 Aligned_cols=255 Identities=17% Similarity=0.284 Sum_probs=199.0
Q ss_pred cCCccceeeccCCcEEEEEEEEcCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEeec
Q 009644 237 NNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYDY 311 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~Ey 311 (530)
++|+.++.||+|+||+||+|+.++|+.||||++... ..+.+.+|+.+|++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 579999999999999999999989999999987542 246799999999999999999999999999999999999
Q ss_pred cCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCCC
Q 009644 312 IPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 312 ~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~~ 391 (530)
+.++.+..+.... +.+++.++..++.|++.||+|||+ .+||||||||+|||++.++.+|++|||++.......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9877666665443 379999999999999999999999 599999999999999999999999999998765433
Q ss_pred C-cCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCccc--------
Q 009644 392 H-AGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYV-------- 461 (530)
Q Consensus 392 ~-~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 461 (530)
. .....+++.|+|||.+.. ..++.++|||||||++|||++|+.||......+....+...........+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2 334458889999999875 456999999999999999999999997654322222222211111000000
Q ss_pred c-------c-cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 462 D-------K-TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 462 d-------~-~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. + ............+.+++.+|++.|| +|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 0011223345678999999999999 9999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=367.20 Aligned_cols=236 Identities=18% Similarity=0.332 Sum_probs=194.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc---------HHHHHHHHHHHHhcC--CCCcceEEEEEeecC
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ---------IQNFLHEVKHIARVH--HRHLVKLVGFCEENH 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~--H~nIv~l~g~~~~~~ 303 (530)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999995 578999999875421 134678999999996 899999999999999
Q ss_pred ceeEEeeccCC-CChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCeEEEeec
Q 009644 304 QQLLIYDYIPN-GNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-NYTAKVSDY 381 (530)
Q Consensus 304 ~~~LV~Ey~~~-GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-~~~~KI~DF 381 (530)
..++||||+.+ +++.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 67888887653 68999999999999999999999 69999999999999985 579999999
Q ss_pred CCcccccCCCCcCcccccccccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 382 GLLKLVTGSHHAGSTSAVDCFLDPELNLSKNY-SAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 382 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
|+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||... .. .... ...
T Consensus 156 G~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~----i~~~---~~~ 222 (273)
T d1xwsa_ 156 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EE----IIRG---QVF 222 (273)
T ss_dssp TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH----HHHC---CCC
T ss_pred ccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hH----Hhhc---ccC
Confidence 999875433 2345679999999999987765 56799999999999999999999642 11 1111 001
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
. +...+.++.+++.+||+.+| +|||++|+++
T Consensus 223 ~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 F-------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 12234678999999999999 9999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-45 Score=364.28 Aligned_cols=268 Identities=16% Similarity=0.191 Sum_probs=204.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCcce-EEEEEeecCceeEEeeccC
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHLVK-LVGFCEENHQQLLIYDYIP 313 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nIv~-l~g~~~~~~~~~LV~Ey~~ 313 (530)
++|++.+.||+|+||.||+|+. .+++.||||..... ..+++..|++++++++|+|++. +.++..+++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 5799999999999999999995 56889999986543 3356889999999997776555 455557778889999999
Q ss_pred CCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCeEEEeecCCcccccCC
Q 009644 314 NGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLE---ENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 314 ~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~---~~~~~KI~DFGla~~~~~~ 390 (530)
+|+|.+.+.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 86 ~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 567777666543 278999999999999999999999 6999999999999986 4567999999999977543
Q ss_pred CC--------cCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcccc
Q 009644 391 HH--------AGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKYVD 462 (530)
Q Consensus 391 ~~--------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 462 (530)
.. .....||+.|||||.+.+..++.++|||||||++|||+||+.||...........+....... ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----~~ 234 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MS 234 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-----HH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-----CC
Confidence 21 223458999999999999999999999999999999999999998655433322222221110 00
Q ss_pred ccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCcccc
Q 009644 463 KTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFG 516 (530)
Q Consensus 463 ~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~ 516 (530)
..........+.++.+++..||..+| +||+++++.+.|+.+.....-.....++
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~D 289 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 00111122344678999999999998 9999999999999987765554444444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-44 Score=360.16 Aligned_cols=270 Identities=16% Similarity=0.224 Sum_probs=215.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-cHHHHHHHHHHHHhcCC-CCcceEEEEEeecCceeEEeecc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-QIQNFLHEVKHIARVHH-RHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H-~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
.++|++.+.||+|+||+||+|+. .+|+.||||..... ....+.+|+++++.+.| +|++.+++++..+...++||||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 36799999999999999999995 46889999986543 33567889999999965 89999999999999999999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCeEEEeecCCcccc
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEE-----NYTAKVSDYGLLKLV 387 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~-----~~~~KI~DFGla~~~ 387 (530)
+|+|.+++..... .++..++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.+
T Consensus 84 -~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 7899999876542 68999999999999999999999 69999999999999974 578999999999876
Q ss_pred cCCC--------CcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCc
Q 009644 388 TGSH--------HAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGK 459 (530)
Q Consensus 388 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 459 (530)
.... ......||+.|||||++.+..++.++|||||||++|||+||+.||..............+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-
Confidence 4322 1223458999999999999999999999999999999999999998665544443333332211000
Q ss_pred cccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHHHHhhHHHhhcCCCccccc
Q 009644 460 YVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGELEGIQEREIGRLHSEFGE 517 (530)
Q Consensus 460 ~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~L~~i~~~~~~~~~~~~~e 517 (530)
...+.....+.++.+++..|+..+| +||+++.+.+.|+++.+.........++.
T Consensus 236 ----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 236 ----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp ----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred ----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 0011122334678899999999998 99999999999999887655544444443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=371.61 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcCCCCcceEEEEEeec------CceeEEee
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVHHRHLVKLVGFCEEN------HQQLLIYD 310 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~H~nIv~l~g~~~~~------~~~~LV~E 310 (530)
+|+..++||+|+||+||+|+. .+|+.||||++.... ..+.+|+++|++++||||+++++++... .+.++|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 577889999999999999996 468999999876432 2345799999999999999999998543 34789999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-eEEEeecCCcccccC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY-TAKVSDYGLLKLVTG 389 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~-~~KI~DFGla~~~~~ 389 (530)
|+++|.+......... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 100 y~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred ccCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9986644433322111 1369999999999999999999999 5999999999999999775 899999999998766
Q ss_pred CCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhh----------c---
Q 009644 390 SHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRS----------C--- 455 (530)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~----------~--- 455 (530)
........|+..|+|||.+.+ ..|+.++||||+||++|||++|+.||......+....+...... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 655666778999999998765 57899999999999999999999999765432221111111000 0
Q ss_pred --cCCccccccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 456 --DLGKYVDKTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 456 --~~~~~~d~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
............ ........+.+++.+|++.|| +|||+.|+++ .++++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000000000001 122345678999999999999 9999999986 3555543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8e-44 Score=361.60 Aligned_cols=252 Identities=17% Similarity=0.289 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccccHHHHHHHHHHHHhcC-CCCcceEEEEEee--cCceeEEeecc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQIQNFLHEVKHIARVH-HRHLVKLVGFCEE--NHQQLLIYDYI 312 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~~~~~~~E~~il~~l~-H~nIv~l~g~~~~--~~~~~LV~Ey~ 312 (530)
++|++++.||+|+||+||+|+. .+++.||+|++.....+++.+|+++|++++ ||||+++++++.. ....++||||+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5799999999999999999995 578999999998888889999999999995 9999999999874 35689999999
Q ss_pred CCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CeEEEeecCCcccccCCC
Q 009644 313 PNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEEN-YTAKVSDYGLLKLVTGSH 391 (530)
Q Consensus 313 ~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~-~~~KI~DFGla~~~~~~~ 391 (530)
.+|+|..+.. .+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+|+......
T Consensus 115 ~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 115 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999977642 68999999999999999999999 599999999999999865 579999999999876665
Q ss_pred CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHH-HHHHHH---------hhccCC--
Q 009644 392 HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQN-LILQVK---------RSCDLG-- 458 (530)
Q Consensus 392 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~-~~~~~~---------~~~~~~-- 458 (530)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... .+.... ......
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 56666789999999998765 57999999999999999999999997655432211 111100 000000
Q ss_pred ----cccc--------ccccc-cchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 ----KYVD--------KTLGE-QTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 ----~~~d--------~~l~~-~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
.... ..... .......++.+++.+|+..+| +|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000 112334678999999999999 9999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=367.53 Aligned_cols=260 Identities=16% Similarity=0.328 Sum_probs=196.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH------ 303 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~------ 303 (530)
.++|+.++.||+|+||+||+|.. .+|+.||||++... ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999995 56899999997642 2457889999999999999999999997654
Q ss_pred ceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCC
Q 009644 304 QQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGL 383 (530)
Q Consensus 304 ~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGl 383 (530)
..++||||+ +++|..+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccccccccc
Confidence 569999999 56787776542 69999999999999999999999 5999999999999999999999999999
Q ss_pred cccccCCCCcCcccccccccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc-------
Q 009644 384 LKLVTGSHHAGSTSAVDCFLDPELNLS-KNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------- 455 (530)
Q Consensus 384 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------- 455 (530)
|+..... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...................
T Consensus 168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 9876543 345568999999999875 457899999999999999999999997653222211111111000
Q ss_pred -----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhhHHH
Q 009644 456 -----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGIQER 506 (530)
Q Consensus 456 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i~~~ 506 (530)
.........+..........+.+++.+|+..+| +|||++|+++. ++++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 011111111122223345678899999999999 99999999974 6665443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=360.59 Aligned_cols=256 Identities=18% Similarity=0.274 Sum_probs=193.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee--------
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE-------- 301 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~-------- 301 (530)
.++|++++.||+|+||+||+|+. .+|+.||||++... ..+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999995 57899999986532 34678999999999999999999999855
Q ss_pred cCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeec
Q 009644 302 NHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDY 381 (530)
Q Consensus 302 ~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DF 381 (530)
.+..++||||+.++.+..+.... ..++..++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999877766554332 268899999999999999999999 59999999999999999999999999
Q ss_pred CCcccccCCC-----CcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc
Q 009644 382 GLLKLVTGSH-----HAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC 455 (530)
Q Consensus 382 Gla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~ 455 (530)
|+++...... ......||+.|+|||.+.+. .|+.++|||||||++|||++|+.||...........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998664322 22334589999999998754 68999999999999999999999997654332222222222111
Q ss_pred cCC---ccccc--------c-ccccc-------hhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 456 DLG---KYVDK--------T-LGEQT-------VGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 456 ~~~---~~~d~--------~-l~~~~-------~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... ..... . ..... ......+.+++.+||+.|| +|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 00000 0 00000 1113456789999999999 9999999884
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=365.79 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=195.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc----cHHHHHHHHHHHHhcCCCCcceEEEEEeecC----cee
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT----QIQNFLHEVKHIARVHHRHLVKLVGFCEENH----QQL 306 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~----~~~ 306 (530)
+.+|+.++.||+|+||+||+|+. .+|+.||||++... ..+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999984 57999999997643 2457899999999999999999999997653 234
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCccc
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKL 386 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~ 386 (530)
+++||+.+|+|.+++... .+++.++..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667799999999753 68999999999999999999999 5999999999999999999999999999987
Q ss_pred ccCCCC----cCcccccccccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc------
Q 009644 387 VTGSHH----AGSTSAVDCFLDPELNL-SKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC------ 455 (530)
Q Consensus 387 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~------ 455 (530)
...... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||...................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 643322 23445889999999985 4567899999999999999999999997654322221111111000
Q ss_pred ------------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH--HHhh
Q 009644 456 ------------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE--LEGI 503 (530)
Q Consensus 456 ------------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~--L~~i 503 (530)
...................++.+++.+|++.|| +|||++|+++. +++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000000011112233578899999999999 99999999874 4443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=350.62 Aligned_cols=253 Identities=17% Similarity=0.261 Sum_probs=201.0
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeecCceeEEee
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEENHQQLLIYD 310 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~~~~~LV~E 310 (530)
++|+.++.||+|+||+||+|+. .+++.||||++... ..+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 57889999986432 34678999999999999999999999999999999999
Q ss_pred ccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCcccccCC
Q 009644 311 YIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLLKLVTGS 390 (530)
Q Consensus 311 y~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~~~~~~ 390 (530)
++.+++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999888776542 68899999999999999999999 59999999999999999999999999999887544
Q ss_pred CC-cCcccccccccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhcc--CC--------
Q 009644 391 HH-AGSTSAVDCFLDPELNLSKN-YSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCD--LG-------- 458 (530)
Q Consensus 391 ~~-~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~--~~-------- 458 (530)
.. .....++..|+|||.+.... ++.++|||||||++|||++|+.||....... .....+..... ..
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhh
Confidence 32 23344677899999987665 6899999999999999999999976543322 22222211100 00
Q ss_pred --ccc-------cccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH
Q 009644 459 --KYV-------DKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG 498 (530)
Q Consensus 459 --~~~-------d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~ 498 (530)
... ..............+.+++.+|++.+| +|||++||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 001111223344678899999999999 9999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=358.41 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=201.5
Q ss_pred cCCccceeeccCCcEEEEEEEE----cCCCEEEEEEcccc-------cHHHHHHHHHHHHhcCC-CCcceEEEEEeecCc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL----QDGSLVVIKRHLQT-------QIQNFLHEVKHIARVHH-RHLVKLVGFCEENHQ 304 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~H-~nIv~l~g~~~~~~~ 304 (530)
++|++.+.||+|+||+||+|+. .+|+.||+|.+... ..+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999984 24789999987532 24568899999999965 899999999999999
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.++||||+.+|+|.+++.... .++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998764 57888999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCC--CcCcccccccccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhccCCcc
Q 009644 385 KLVTGSH--HAGSTSAVDCFLDPELNLSK--NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSCDLGKY 460 (530)
Q Consensus 385 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (530)
+.+.... ......+++.|+|||.+... .++.++|||||||+||||+||+.||...........+.........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--- 253 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--- 253 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC---
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC---
Confidence 8764332 23445688999999998754 4688999999999999999999999876555444443333222111
Q ss_pred ccccccccchhHHHHHHHHHHHcccCCC-CCCC-----HHHHHH
Q 009644 461 VDKTLGEQTVGAATEMMELALQCVDVSS-RRPS-----MRQIAG 498 (530)
Q Consensus 461 ~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt-----~~eVl~ 498 (530)
..+...+.++.+++.+|++.+| +||| ++|+++
T Consensus 254 ------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1223445789999999999999 9994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=359.33 Aligned_cols=253 Identities=16% Similarity=0.251 Sum_probs=187.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEee------cCc
Q 009644 237 NNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEE------NHQ 304 (530)
Q Consensus 237 ~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~------~~~ 304 (530)
++|++++.||+|+||+||+|+. .+|+.||||++... ..+.+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999995 46899999997632 34568899999999999999999999964 367
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.|+||||+.++ +.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceeeechhhh
Confidence 89999999655 444443 268999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHh-----------
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKR----------- 453 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~----------- 453 (530)
+............+|+.|+|||++.+..++.++||||+||++|||++|+.||...........+.....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 887665555666789999999999999999999999999999999999999975532211111111000
Q ss_pred ---------hccCC---------ccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 454 ---------SCDLG---------KYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 454 ---------~~~~~---------~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..... ....+............+.+++.+|+..+| +|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000011111223456788999999999999 99999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=357.57 Aligned_cols=260 Identities=18% Similarity=0.329 Sum_probs=197.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE-cCCCEEEEEEcccc-----cHHHHHHHHHHHHhcCCCCcceEEEEEeec-----Cc
Q 009644 236 TNNFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQT-----QIQNFLHEVKHIARVHHRHLVKLVGFCEEN-----HQ 304 (530)
Q Consensus 236 t~~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~H~nIv~l~g~~~~~-----~~ 304 (530)
+++|++++.||+|+||+||+|+. .+|+.||||++... ..+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999994 57999999997643 235688999999999999999999998643 34
Q ss_pred eeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEEeecCCc
Q 009644 305 QLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKVSDYGLL 384 (530)
Q Consensus 305 ~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI~DFGla 384 (530)
.+++|||+.+|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchh
Confidence 56777888899999998643 69999999999999999999999 59999999999999999999999999999
Q ss_pred ccccCCCCcCcccccccccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCchHHHHHHHHhhc--------
Q 009644 385 KLVTGSHHAGSTSAVDCFLDPELNLSK-NYSAGSDVYSFGVFLLELISGREAHGRNHSNSDQNLILQVKRSC-------- 455 (530)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~~~~~~~~~~~~-------- 455 (530)
..... ......|+..|+|||...+. .++.++|||||||++|||++|+.||...........+.......
T Consensus 169 ~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 169 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp -CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 76533 23445688899999987765 46899999999999999999999997654322222222211100
Q ss_pred ----------cCCccccccccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHH--HHHhhHH
Q 009644 456 ----------DLGKYVDKTLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAG--ELEGIQE 505 (530)
Q Consensus 456 ----------~~~~~~d~~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~--~L~~i~~ 505 (530)
.........+..........+.+++.+|++.|| +|||++|+++ .+++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000000011111112334678899999999999 9999999987 4555443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-37 Score=318.17 Aligned_cols=261 Identities=16% Similarity=0.219 Sum_probs=189.5
Q ss_pred CCccceeeccCCcEEEEEEEE-cCCCEEEEEEccccc--HHHHHHHHHHHHhcC-----------CCCcceEEEEEeec-
Q 009644 238 NFSEINIIGEGSFGLAYKGLL-QDGSLVVIKRHLQTQ--IQNFLHEVKHIARVH-----------HRHLVKLVGFCEEN- 302 (530)
Q Consensus 238 ~f~~~~~LG~G~fG~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-----------H~nIv~l~g~~~~~- 302 (530)
+|+++++||+|+||+||+|+. .+|+.||||++.... .+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 489999999999999999995 578999999987653 356788999988875 57899999988654
Q ss_pred -CceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC------e
Q 009644 303 -HQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENY------T 375 (530)
Q Consensus 303 -~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~------~ 375 (530)
...+++|+++..+........... ...+++..+..++.|++.||+|||+. .+|+||||||+|||++.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccce
Confidence 456677777665544333322211 23688999999999999999999974 4899999999999998654 4
Q ss_pred EEEeecCCcccccCCCCcCcccccccccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCch----HHHHHHH
Q 009644 376 AKVSDYGLLKLVTGSHHAGSTSAVDCFLDPELNLSKNYSAGSDVYSFGVFLLELISGREAHGRNHSNSD----QNLILQV 451 (530)
Q Consensus 376 ~KI~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSfGvvl~ElltG~~p~~~~~~~~~----~~~~~~~ 451 (530)
+|++|||.++.... ......+|+.|+|||++....++.++||||+||+++||++|+.||........ .......
T Consensus 171 ~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 171 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 99999999986543 23455689999999999999999999999999999999999999975432211 1111111
Q ss_pred Hhhcc------------------------CCccccc-------cccccchhHHHHHHHHHHHcccCCC-CCCCHHHHHHH
Q 009644 452 KRSCD------------------------LGKYVDK-------TLGEQTVGAATEMMELALQCVDVSS-RRPSMRQIAGE 499 (530)
Q Consensus 452 ~~~~~------------------------~~~~~d~-------~l~~~~~~~~~~l~~li~~Cl~~~p-~RPt~~eVl~~ 499 (530)
..... +...... ............+.+++.+|++.|| +|||++|+++.
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10000 0000000 0011234566789999999999999 99999999863
Q ss_pred --HHhh
Q 009644 500 --LEGI 503 (530)
Q Consensus 500 --L~~i 503 (530)
+++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 5444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9e-24 Score=196.38 Aligned_cols=160 Identities=14% Similarity=0.134 Sum_probs=119.3
Q ss_pred ccceeeccCCcEEEEEEEEcCCCEEEEEEcccc---------------------cHHHHHHHHHHHHhcCCCCcceEEEE
Q 009644 240 SEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQT---------------------QIQNFLHEVKHIARVHHRHLVKLVGF 298 (530)
Q Consensus 240 ~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~---------------------~~~~~~~E~~il~~l~H~nIv~l~g~ 298 (530)
.+.+.||+|+||.||+|+..+|+.||||.+... ......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999888999999975321 01234568889999999999998876
Q ss_pred EeecCceeEEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCeEEE
Q 009644 299 CEENHQQLLIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSLVPPLFHMHFRTSNVLLEENYTAKV 378 (530)
Q Consensus 299 ~~~~~~~~LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ivHrDLk~~NILl~~~~~~KI 378 (530)
. ..+++|||++++.+.+ ++......++.|++.||+|||+ .+|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998765433 2333456789999999999999 599999999999999965 5899
Q ss_pred eecCCcccccCCCCcCcccccccccC------ccccCCCCCCchhhHHHHHHHH
Q 009644 379 SDYGLLKLVTGSHHAGSTSAVDCFLD------PELNLSKNYSAGSDVYSFGVFL 426 (530)
Q Consensus 379 ~DFGla~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDVwSfGvvl 426 (530)
+|||+|+........ .|.. .+.+ .+.|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999765322110 1111 1111 46688899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=4.2e-06 Score=78.74 Aligned_cols=144 Identities=15% Similarity=0.082 Sum_probs=96.0
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEcCCCEEEEEEccccc---HHHHHHHHHHHHhcC-CCCcceEEEEEeecCcee
Q 009644 231 ELKHATNNFSEINIIGEGSFGLAYKGLLQDGSLVVIKRHLQTQ---IQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQL 306 (530)
Q Consensus 231 el~~~t~~f~~~~~LG~G~fG~Vy~g~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~ 306 (530)
+++..-.+|+..+..+-++.+.||+... +++.+++|+..... ...+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 5566667777665544445578998875 45567788765432 335778888888774 434677888888888999
Q ss_pred EEeeccCCCChHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 009644 307 LIYDYIPNGNVQNHLYDSEGLPIGKLTMRQRLSIALGAAKGLEHLHSL-------------------------------- 354 (530)
Q Consensus 307 LV~Ey~~~GsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------------------------------- 354 (530)
+|||++++.++.+..... .. ...++.++++.|..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999988775543211 11 112333344444444421
Q ss_pred -------------------------CCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 355 -------------------------VPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 355 -------------------------~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
...++|+|+.|.|||++++...-|.||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137899999999999987777799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=5.9e-06 Score=77.26 Aligned_cols=74 Identities=11% Similarity=0.195 Sum_probs=56.9
Q ss_pred eeccCCc-EEEEEEEEcCCCEEEEEEcccccHHHHHHHHHHHHhcC--CCCcceEEEEEeecCceeEEeeccCCCCh
Q 009644 244 IIGEGSF-GLAYKGLLQDGSLVVIKRHLQTQIQNFLHEVKHIARVH--HRHLVKLVGFCEENHQQLLIYDYIPNGNV 317 (530)
Q Consensus 244 ~LG~G~f-G~Vy~g~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~--H~nIv~l~g~~~~~~~~~LV~Ey~~~GsL 317 (530)
.+..|.. +.||+....++..+++|.........+..|...++.+. .-.+.+++++..+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555553 68999988788888999877666666788988888774 33467788888888889999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.50 E-value=0.00035 Score=69.74 Aligned_cols=73 Identities=14% Similarity=0.190 Sum_probs=48.3
Q ss_pred ceeeccCCcEEEEEEEEcC-CCEEEEEEcccc----------cHHHHHHHHHHHHhcC-C--CCcceEEEEEeecCceeE
Q 009644 242 INIIGEGSFGLAYKGLLQD-GSLVVIKRHLQT----------QIQNFLHEVKHIARVH-H--RHLVKLVGFCEENHQQLL 307 (530)
Q Consensus 242 ~~~LG~G~fG~Vy~g~~~~-~~~vavK~~~~~----------~~~~~~~E~~il~~l~-H--~nIv~l~g~~~~~~~~~L 307 (530)
.+.||.|....||+....+ ++.+++|..... ..++...|.+.|..+. + ..+.+++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3578999999999998544 678889864321 1234566888887662 2 3466676653 445679
Q ss_pred EeeccCCCC
Q 009644 308 IYDYIPNGN 316 (530)
Q Consensus 308 V~Ey~~~Gs 316 (530)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.26 E-value=0.0069 Score=58.16 Aligned_cols=66 Identities=11% Similarity=0.077 Sum_probs=44.8
Q ss_pred cEEEEEEEEcCCCEEEEEEcccc--cHHHHHHHHHHHHhcCCCCc--ceEEE-----EEeecCceeEEeeccCCC
Q 009644 250 FGLAYKGLLQDGSLVVIKRHLQT--QIQNFLHEVKHIARVHHRHL--VKLVG-----FCEENHQQLLIYDYIPNG 315 (530)
Q Consensus 250 fG~Vy~g~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~H~nI--v~l~g-----~~~~~~~~~LV~Ey~~~G 315 (530)
--.||+...++|+.+++|..... ..+++..|...+..|....+ +..+. ....++..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 35899999999999999987654 45678889888887742222 11111 123455678899998754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=96.24 E-value=0.0017 Score=61.91 Aligned_cols=70 Identities=23% Similarity=0.235 Sum_probs=49.3
Q ss_pred hhhHHHHHHhhhhhCCC---CCCCCCCCCCCCcCccccccccCCCC-CCceeee---------------cCCCccccccc
Q 009644 42 KVYAEALLACKSALGTP---GQSSGRIGRYPCIRQRACLNCYEPKD-PGVASLI---------------FHRIPEICALS 102 (530)
Q Consensus 42 ~~~~~~~~~~k~~~~~~---~~~~g~~~~~pc~~~~~~~~c~~~~~-~~~~~~~---------------~~~~~~~~~~~ 102 (530)
++|.+|+.++|+....+ .+|.. +.|||.+.|.|+.|...+. -+|+.++ +..++.++.++
T Consensus 5 ~~e~~aLl~~k~~~~~~~~l~sW~~--~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 5 PQDKQALLQIKKDLGNPTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp HHHHHHHHHHHHHTTCCGGGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred HHHHHHHHHHHHHCCCCCcCCCCCC--CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 46889999999988654 45743 3599998999999976432 4777764 23455677778
Q ss_pred cCC-CcCCCCCCCC
Q 009644 103 FNP-NFFHSNSEFP 115 (530)
Q Consensus 103 ~~~-~~~~~~~~~~ 115 (530)
+++ |.+. |++|
T Consensus 83 Ls~~N~l~--g~iP 94 (313)
T d1ogqa_ 83 IGGINNLV--GPIP 94 (313)
T ss_dssp EEEETTEE--SCCC
T ss_pred cccccccc--cccc
Confidence 875 5554 4555
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.11 E-value=0.013 Score=57.67 Aligned_cols=71 Identities=15% Similarity=0.184 Sum_probs=49.4
Q ss_pred eeeccCCcEEEEEEEEcCC--------CEEEEEEcccc-cHHHHHHHHHHHHhcC-CCCcceEEEEEeecCceeEEeecc
Q 009644 243 NIIGEGSFGLAYKGLLQDG--------SLVVIKRHLQT-QIQNFLHEVKHIARVH-HRHLVKLVGFCEENHQQLLIYDYI 312 (530)
Q Consensus 243 ~~LG~G~fG~Vy~g~~~~~--------~~vavK~~~~~-~~~~~~~E~~il~~l~-H~nIv~l~g~~~~~~~~~LV~Ey~ 312 (530)
+.|+.|-.-.+|+....++ ..|++++.... ...+..+|..+++.+. +.-..++++++.+ .+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 6788899999999986543 45666665422 2345668999988884 4334578888753 5899999
Q ss_pred CCCCh
Q 009644 313 PNGNV 317 (530)
Q Consensus 313 ~~GsL 317 (530)
++.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 86544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.56 E-value=0.02 Score=54.14 Aligned_cols=158 Identities=9% Similarity=0.043 Sum_probs=82.0
Q ss_pred cCHHHHHHhhcCCccce-----eeccCCcEEEEEEEEcCCCEEEEEEcccc-cHHHHHHHHHHHHhcCCCCc--ceEEE-
Q 009644 227 LTILELKHATNNFSEIN-----IIGEGSFGLAYKGLLQDGSLVVIKRHLQT-QIQNFLHEVKHIARVHHRHL--VKLVG- 297 (530)
Q Consensus 227 ~~~~el~~~t~~f~~~~-----~LG~G~fG~Vy~g~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~H~nI--v~l~g- 297 (530)
++..|++....+|.+.+ .|..|---+.|+....+|+ +++|+.... ..++...|++++..+...++ ...+-
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence 55677887778886643 3446666889999877665 788886543 33455667777777643221 11110
Q ss_pred -----EEeecCceeEEeeccCCCChHH--------------Hhhcc---CCCC-CCCCCH------------------HH
Q 009644 298 -----FCEENHQQLLIYDYIPNGNVQN--------------HLYDS---EGLP-IGKLTM------------------RQ 336 (530)
Q Consensus 298 -----~~~~~~~~~LV~Ey~~~GsL~~--------------~l~~~---~~~~-~~~l~~------------------~~ 336 (530)
+.........++.+..+..... .++.. ...+ ...... ..
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0112234455666655432210 00000 0000 000000 01
Q ss_pred HHHHHHHHHHHHHHhhc--CCCCeeecCCCCCcEEEcCCCeEEEeecCCcc
Q 009644 337 RLSIALGAAKGLEHLHS--LVPPLFHMHFRTSNVLLEENYTAKVSDYGLLK 385 (530)
Q Consensus 337 ~~~i~~qia~gL~yLH~--~~~~ivHrDLk~~NILl~~~~~~KI~DFGla~ 385 (530)
....+......+.-.+. ...++||+|+.+.||+++.+...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222333222 12489999999999999998777899999874
|